id	sid	tid	token	lemma	pos
ihlr-27183	1	1	the	the	DET
ihlr-27183	1	2	safe	safe	ADJ
ihlr-27183	1	3	harbor	harbor	NOUN
ihlr-27183	1	4	of	of	ADP
ihlr-27183	1	5	35	35	NUM
ihlr-27183	1	6	u.s.c	u.s.c	ADJ
ihlr-27183	1	7	.	.	PUNCT
ihlr-27183	2	1	§	§	PROPN
ihlr-27183	2	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	2	3	):	):	PUNCT
ihlr-27183	2	4	the	the	DET
ihlr-27183	2	5	costly	costly	ADJ
ihlr-27183	2	6	confusion	confusion	NOUN
ihlr-27183	2	7	about	about	ADP
ihlr-27183	2	8	the	the	DET
ihlr-27183	2	9	scope	scope	NOUN
ihlr-27183	2	10	of	of	ADP
ihlr-27183	2	11	“	"	PUNCT
ihlr-27183	2	12	patented	patented	ADJ
ihlr-27183	2	13	invention	invention	NOUN
ihlr-27183	2	14	”	"	PUNCT
ihlr-27183	2	15	abraham	abraham	PROPN
ihlr-27183	2	16	phillips	phillips	PROPN
ihlr-27183	2	17	*	*	PROPN
ihlr-27183	2	18	i.	i.	PROPN
ihlr-27183	2	19	introduction	introduction	PROPN
ihlr-27183	2	20	a.	a.	NOUN
ihlr-27183	2	21	the	the	DET
ihlr-27183	2	22	problem	problem	NOUN
ihlr-27183	2	23	to	to	PART
ihlr-27183	2	24	be	be	AUX
ihlr-27183	2	25	solved	solve	VERB
ihlr-27183	2	26	a	a	DET
ihlr-27183	2	27	patent	patent	NOUN
ihlr-27183	2	28	in	in	ADP
ihlr-27183	2	29	the	the	DET
ihlr-27183	2	30	united	united	PROPN
ihlr-27183	2	31	states	states	PROPN
ihlr-27183	2	32	conveys	convey	VERB
ihlr-27183	2	33	an	an	DET
ihlr-27183	2	34	exclusive	exclusive	ADJ
ihlr-27183	2	35	right	right	NOUN
ihlr-27183	2	36	over	over	ADP
ihlr-27183	2	37	an	an	DET
ihlr-27183	2	38	invention	invention	NOUN
ihlr-27183	2	39	for	for	ADP
ihlr-27183	2	40	a	a	DET
ihlr-27183	2	41	limited	limited	ADJ
ihlr-27183	2	42	term,1	term,1	NOUN
ihlr-27183	2	43	often	often	ADV
ihlr-27183	2	44	about	about	ADV
ihlr-27183	2	45	seventeen	seventeen	NUM
ihlr-27183	2	46	years.2	years.2	NOUN
ihlr-27183	2	47	during	during	ADP
ihlr-27183	2	48	this	this	DET
ihlr-27183	2	49	interval	interval	NOUN
ihlr-27183	2	50	,	,	PUNCT
ihlr-27183	2	51	the	the	DET
ihlr-27183	2	52	patent	patent	NOUN
ihlr-27183	2	53	holder	holder	NOUN
ihlr-27183	2	54	has	have	VERB
ihlr-27183	2	55	the	the	DET
ihlr-27183	2	56	right	right	NOUN
ihlr-27183	2	57	to	to	PART
ihlr-27183	2	58	stop	stop	VERB
ihlr-27183	2	59	others	other	NOUN
ihlr-27183	2	60	from	from	ADP
ihlr-27183	2	61	making	make	VERB
ihlr-27183	2	62	,	,	PUNCT
ihlr-27183	2	63	using	use	VERB
ihlr-27183	2	64	,	,	PUNCT
ihlr-27183	2	65	selling	selling	NOUN
ihlr-27183	2	66	,	,	PUNCT
ihlr-27183	2	67	importing	importing	NOUN
ihlr-27183	2	68	,	,	PUNCT
ihlr-27183	2	69	or	or	CCONJ
ihlr-27183	2	70	offering	offer	VERB
ihlr-27183	2	71	to	to	PART
ihlr-27183	2	72	sell	sell	VERB
ihlr-27183	2	73	the	the	DET
ihlr-27183	2	74	claimed	claim	VERB
ihlr-27183	2	75	invention	invention	NOUN
ihlr-27183	2	76	in	in	ADP
ihlr-27183	2	77	the	the	DET
ihlr-27183	2	78	united	united	ADJ
ihlr-27183	2	79	states.3	states.3	PROPN
ihlr-27183	2	80	this	this	DET
ihlr-27183	2	81	power	power	NOUN
ihlr-27183	2	82	to	to	PART
ihlr-27183	2	83	exclude	exclude	VERB
ihlr-27183	2	84	had	have	VERB
ihlr-27183	2	85	a	a	DET
ihlr-27183	2	86	compounded	compound	VERB
ihlr-27183	2	87	effect	effect	NOUN
ihlr-27183	2	88	for	for	ADP
ihlr-27183	2	89	drug	drug	NOUN
ihlr-27183	2	90	and	and	CCONJ
ihlr-27183	2	91	medical	medical	ADJ
ihlr-27183	2	92	device	device	NOUN
ihlr-27183	2	93	inventions	invention	NOUN
ihlr-27183	2	94	requiring	require	VERB
ihlr-27183	2	95	u.s	u.s	PROPN
ihlr-27183	2	96	.	.	PROPN
ihlr-27183	2	97	food	food	PROPN
ihlr-27183	2	98	and	and	CCONJ
ihlr-27183	2	99	drug	drug	PROPN
ihlr-27183	2	100	administration	administration	NOUN
ihlr-27183	2	101	(	(	PUNCT
ihlr-27183	2	102	“	"	PUNCT
ihlr-27183	2	103	fda	fda	PROPN
ihlr-27183	2	104	”	"	PUNCT
ihlr-27183	2	105	)	)	PUNCT
ihlr-27183	2	106	approval	approval	NOUN
ihlr-27183	2	107	prior	prior	ADV
ihlr-27183	2	108	to	to	ADP
ihlr-27183	2	109	market	market	NOUN
ihlr-27183	2	110	entry	entry	NOUN
ihlr-27183	2	111	.	.	PUNCT
ihlr-27183	3	1	stopping	stop	VERB
ihlr-27183	3	2	a	a	DET
ihlr-27183	3	3	future	future	ADJ
ihlr-27183	3	4	competitor	competitor	NOUN
ihlr-27183	3	5	from	from	ADP
ihlr-27183	3	6	using	use	VERB
ihlr-27183	3	7	an	an	DET
ihlr-27183	3	8	fda	fda	PROPN
ihlr-27183	3	9	-	-	PUNCT
ihlr-27183	3	10	regulated	regulate	VERB
ihlr-27183	3	11	invention	invention	NOUN
ihlr-27183	3	12	throughout	throughout	ADP
ihlr-27183	3	13	the	the	DET
ihlr-27183	3	14	entire	entire	ADJ
ihlr-27183	3	15	patent	patent	NOUN
ihlr-27183	3	16	term	term	NOUN
ihlr-27183	3	17	also	also	ADV
ihlr-27183	3	18	prohibited	prohibit	VERB
ihlr-27183	3	19	the	the	DET
ihlr-27183	3	20	competitor	competitor	NOUN
ihlr-27183	3	21	from	from	ADP
ihlr-27183	3	22	beginning	begin	VERB
ihlr-27183	3	23	the	the	DET
ihlr-27183	3	24	fda	fda	PROPN
ihlr-27183	3	25	approval	approval	NOUN
ihlr-27183	3	26	process	process	NOUN
ihlr-27183	3	27	until	until	SCONJ
ihlr-27183	3	28	the	the	DET
ihlr-27183	3	29	patent	patent	NOUN
ihlr-27183	3	30	expired	expire	VERB
ihlr-27183	3	31	.	.	PUNCT
ihlr-27183	4	1	quantitatively	quantitatively	ADV
ihlr-27183	4	2	,	,	PUNCT
ihlr-27183	4	3	this	this	PRON
ihlr-27183	4	4	extended	extend	VERB
ihlr-27183	4	5	the	the	DET
ihlr-27183	4	6	legal	legal	ADJ
ihlr-27183	4	7	monopoly	monopoly	NOUN
ihlr-27183	4	8	of	of	ADP
ihlr-27183	4	9	the	the	DET
ihlr-27183	4	10	patent	patent	NOUN
ihlr-27183	4	11	holder	holder	NOUN
ihlr-27183	4	12	by	by	ADP
ihlr-27183	4	13	between	between	ADP
ihlr-27183	4	14	one	one	NUM
ihlr-27183	4	15	-	-	PUNCT
ihlr-27183	4	16	and	and	CCONJ
ihlr-27183	4	17	-	-	PUNCT
ihlr-27183	4	18	a	a	DET
ihlr-27183	4	19	-	-	PUNCT
ihlr-27183	4	20	half	half	NOUN
ihlr-27183	4	21	to	to	ADP
ihlr-27183	4	22	six	six	NUM
ihlr-27183	4	23	years	year	NOUN
ihlr-27183	4	24	for	for	ADP
ihlr-27183	4	25	the	the	DET
ihlr-27183	4	26	competitor	competitor	NOUN
ihlr-27183	4	27	’s	’s	PART
ihlr-27183	4	28	clinical	clinical	ADJ
ihlr-27183	4	29	trials	trial	NOUN
ihlr-27183	4	30	alone.4	alone.4	ADV
ihlr-27183	4	31	meanwhile	meanwhile	ADV
ihlr-27183	4	32	,	,	PUNCT
ihlr-27183	4	33	the	the	DET
ihlr-27183	4	34	invention	invention	NOUN
ihlr-27183	4	35	owner	owner	NOUN
ihlr-27183	4	36	’s	’s	PART
ihlr-27183	4	37	path	path	NOUN
ihlr-27183	4	38	to	to	ADP
ihlr-27183	4	39	fda	fda	PROPN
ihlr-27183	4	40	approval	approval	NOUN
ihlr-27183	4	41	for	for	ADP
ihlr-27183	4	42	a	a	DET
ihlr-27183	4	43	regulated	regulated	ADJ
ihlr-27183	4	44	drug	drug	NOUN
ihlr-27183	4	45	or	or	CCONJ
ihlr-27183	4	46	medical	medical	ADJ
ihlr-27183	4	47	device	device	NOUN
ihlr-27183	4	48	was	be	AUX
ihlr-27183	4	49	often	often	ADV
ihlr-27183	4	50	not	not	PART
ihlr-27183	4	51	without	without	ADP
ihlr-27183	4	52	a	a	DET
ihlr-27183	4	53	symmetric	symmetric	ADJ
ihlr-27183	4	54	grievance	grievance	NOUN
ihlr-27183	4	55	.	.	PUNCT
ihlr-27183	5	1	the	the	DET
ihlr-27183	5	2	patent	patent	NOUN
ihlr-27183	5	3	holder	holder	NOUN
ihlr-27183	5	4	commonly	commonly	ADV
ihlr-27183	5	5	obtained	obtain	VERB
ihlr-27183	5	6	fda	fda	PROPN
ihlr-27183	5	7	approval	approval	PROPN
ihlr-27183	5	8	long	long	ADV
ihlr-27183	5	9	after	after	ADP
ihlr-27183	5	10	their	their	PRON
ihlr-27183	5	11	original	original	ADJ
ihlr-27183	5	12	patent	patent	NOUN
ihlr-27183	5	13	filing	filing	NOUN
ihlr-27183	5	14	date	date	NOUN
ihlr-27183	5	15	–	–	PUNCT
ihlr-27183	5	16	the	the	DET
ihlr-27183	5	17	date	date	NOUN
ihlr-27183	5	18	which	which	PRON
ihlr-27183	5	19	started	start	VERB
ihlr-27183	5	20	the	the	DET
ihlr-27183	5	21	clock	clock	NOUN
ihlr-27183	5	22	on	on	ADP
ihlr-27183	5	23	the	the	DET
ihlr-27183	5	24	twenty	twenty	NUM
ihlr-27183	5	25	-	-	PUNCT
ihlr-27183	5	26	year	year	NOUN
ihlr-27183	5	27	term	term	NOUN
ihlr-27183	5	28	.	.	PUNCT
ihlr-27183	6	1	accordingly	accordingly	ADV
ihlr-27183	6	2	,	,	PUNCT
ihlr-27183	6	3	the	the	DET
ihlr-27183	6	4	inventor	inventor	NOUN
ihlr-27183	6	5	waited	wait	VERB
ihlr-27183	6	6	several	several	ADJ
ihlr-27183	6	7	years	year	NOUN
ihlr-27183	6	8	for	for	ADP
ihlr-27183	6	9	fda	fda	PROPN
ihlr-27183	6	10	approval	approval	NOUN
ihlr-27183	6	11	to	to	PART
ihlr-27183	6	12	sell	sell	VERB
ihlr-27183	6	13	the	the	DET
ihlr-27183	6	14	regulated	regulated	ADJ
ihlr-27183	6	15	invention	invention	NOUN
ihlr-27183	6	16	,	,	PUNCT
ihlr-27183	6	17	thereby	thereby	ADV
ihlr-27183	6	18	shortening	shorten	VERB
ihlr-27183	6	19	the	the	DET
ihlr-27183	6	20	effective	effective	ADJ
ihlr-27183	6	21	patent	patent	NOUN
ihlr-27183	6	22	term	term	NOUN
ihlr-27183	6	23	.	.	PUNCT
ihlr-27183	7	1	unsurprisingly	unsurprisingly	ADV
ihlr-27183	7	2	,	,	PUNCT
ihlr-27183	7	3	a	a	DET
ihlr-27183	7	4	patent	patent	NOUN
ihlr-27183	7	5	holder	holder	NOUN
ihlr-27183	7	6	’s	’s	PART
ihlr-27183	7	7	enjoyment	enjoyment	NOUN
ihlr-27183	7	8	of	of	ADP
ihlr-27183	7	9	no	no	DET
ihlr-27183	7	10	competition	competition	NOUN
ihlr-27183	7	11	while	while	SCONJ
ihlr-27183	7	12	a	a	DET
ihlr-27183	7	13	generic	generic	NOUN
ihlr-27183	7	14	sought	seek	VERB
ihlr-27183	7	15	fda	fda	PROPN
ihlr-27183	7	16	approval	approval	NOUN
ihlr-27183	7	17	was	be	AUX
ihlr-27183	7	18	often	often	ADV
ihlr-27183	7	19	deemed	deem	VERB
ihlr-27183	7	20	warranted	warrant	VERB
ihlr-27183	7	21	by	by	ADP
ihlr-27183	7	22	the	the	DET
ihlr-27183	7	23	patent	patent	NOUN
ihlr-27183	7	24	holder	holder	NOUN
ihlr-27183	7	25	’s	’s	PART
ihlr-27183	7	26	own	own	ADJ
ihlr-27183	7	27	“	"	PUNCT
ihlr-27183	7	28	regulatory	regulatory	ADJ
ihlr-27183	7	29	entanglements	entanglement	NOUN
ihlr-27183	7	30	”	"	PUNCT
ihlr-27183	7	31	on	on	ADP
ihlr-27183	7	32	the	the	DET
ihlr-27183	7	33	front	front	ADJ
ihlr-27183	7	34	end	end	NOUN
ihlr-27183	7	35	of	of	ADP
ihlr-27183	7	36	selling	sell	VERB
ihlr-27183	7	37	a	a	DET
ihlr-27183	7	38	patented	patented	ADJ
ihlr-27183	7	39	drug.5	drug.5	NOUN
ihlr-27183	7	40	while	while	SCONJ
ihlr-27183	7	41	this	this	DET
ihlr-27183	7	42	rationale	rationale	NOUN
ihlr-27183	7	43	may	may	AUX
ihlr-27183	7	44	reek	reek	VERB
ihlr-27183	7	45	of	of	ADP
ihlr-27183	7	46	the	the	DET
ihlr-27183	7	47	unsatisfying	unsatisfying	ADJ
ihlr-27183	7	48	fallacy	fallacy	NOUN
ihlr-27183	7	49	that	that	SCONJ
ihlr-27183	7	50	“	"	PUNCT
ihlr-27183	7	51	two	two	NUM
ihlr-27183	7	52	wrongs	wrong	NOUN
ihlr-27183	7	53	make	make	VERB
ihlr-27183	7	54	a	a	DET
ihlr-27183	7	55	right	right	NOUN
ihlr-27183	7	56	,	,	PUNCT
ihlr-27183	7	57	”	"	PUNCT
ihlr-27183	7	58	it	it	PRON
ihlr-27183	7	59	nevertheless	nevertheless	ADV
ihlr-27183	7	60	prevailed	prevail	VERB
ihlr-27183	7	61	during	during	ADP
ihlr-27183	7	62	legislative	legislative	ADJ
ihlr-27183	7	63	silence	silence	NOUN
ihlr-27183	7	64	.	.	PUNCT
ihlr-27183	8	1	resolving	resolve	VERB
ihlr-27183	8	2	this	this	DET
ihlr-27183	8	3	symmetric	symmetric	ADJ
ihlr-27183	8	4	distortion	distortion	NOUN
ihlr-27183	8	5	is	be	AUX
ihlr-27183	8	6	a	a	DET
ihlr-27183	8	7	subject	subject	ADJ
ihlr-27183	8	8	courts	court	NOUN
ihlr-27183	8	9	and	and	CCONJ
ihlr-27183	8	10	legislatures	legislature	NOUN
ihlr-27183	8	11	have	have	AUX
ihlr-27183	8	12	wrestled	wrestle	VERB
ihlr-27183	8	13	with	with	ADP
ihlr-27183	8	14	for	for	ADP
ihlr-27183	8	15	decades	decade	NOUN
ihlr-27183	8	16	.	.	PUNCT
ihlr-27183	9	1	*	*	PUNCT
ihlr-27183	9	2	j.d	j.d	PROPN
ihlr-27183	9	3	.	.	PROPN
ihlr-27183	9	4	candidate	candidate	NOUN
ihlr-27183	9	5	,	,	PUNCT
ihlr-27183	9	6	2023	2023	NUM
ihlr-27183	9	7	,	,	PUNCT
ihlr-27183	9	8	indiana	indiana	PROPN
ihlr-27183	9	9	university	university	PROPN
ihlr-27183	9	10	–	–	PUNCT
ihlr-27183	9	11	robert	robert	PROPN
ihlr-27183	9	12	h.	h.	PROPN
ihlr-27183	9	13	mckinney	mckinney	PROPN
ihlr-27183	9	14	school	school	PROPN
ihlr-27183	9	15	of	of	ADP
ihlr-27183	9	16	law	law	NOUN
ihlr-27183	9	17	;	;	PUNCT
ihlr-27183	9	18	b.s	b.s	PROPN
ihlr-27183	9	19	.	.	PROPN
ihlr-27183	9	20	,	,	PUNCT
ihlr-27183	9	21	2013	2013	NUM
ihlr-27183	9	22	,	,	PUNCT
ihlr-27183	9	23	university	university	NOUN
ihlr-27183	9	24	of	of	ADP
ihlr-27183	9	25	illinois	illinois	PROPN
ihlr-27183	9	26	,	,	PUNCT
ihlr-27183	9	27	urbana	urbana	PROPN
ihlr-27183	9	28	-	-	PUNCT
ihlr-27183	9	29	champaign	champaign	PROPN
ihlr-27183	9	30	.	.	PUNCT
ihlr-27183	10	1	1	1	NUM
ihlr-27183	10	2	.	.	NOUN
ihlr-27183	10	3	35	35	NUM
ihlr-27183	10	4	u.s.c	u.s.c	NOUN
ihlr-27183	10	5	.	.	PUNCT
ihlr-27183	11	1	§	§	PROPN
ihlr-27183	11	2	154(a)(2	154(a)(2	NUM
ihlr-27183	11	3	)	)	PUNCT
ihlr-27183	11	4	(	(	PUNCT
ihlr-27183	11	5	2013	2013	NUM
ihlr-27183	11	6	)	)	PUNCT
ihlr-27183	11	7	.	.	PUNCT
ihlr-27183	12	1	the	the	DET
ihlr-27183	12	2	exact	exact	ADJ
ihlr-27183	12	3	term	term	NOUN
ihlr-27183	12	4	of	of	ADP
ihlr-27183	12	5	exclusionary	exclusionary	ADJ
ihlr-27183	12	6	rights	right	NOUN
ihlr-27183	12	7	over	over	ADP
ihlr-27183	12	8	a	a	DET
ihlr-27183	12	9	patented	patented	ADJ
ihlr-27183	12	10	invention	invention	NOUN
ihlr-27183	12	11	begins	begin	VERB
ihlr-27183	12	12	on	on	ADP
ihlr-27183	12	13	the	the	DET
ihlr-27183	12	14	day	day	NOUN
ihlr-27183	12	15	the	the	DET
ihlr-27183	12	16	associated	associated	ADJ
ihlr-27183	12	17	patent	patent	NOUN
ihlr-27183	12	18	issues	issue	NOUN
ihlr-27183	12	19	and	and	CCONJ
ihlr-27183	12	20	terminates	terminate	VERB
ihlr-27183	12	21	twenty	twenty	NUM
ihlr-27183	12	22	years	year	NOUN
ihlr-27183	12	23	from	from	ADP
ihlr-27183	12	24	its	its	PRON
ihlr-27183	12	25	earliest	early	ADJ
ihlr-27183	12	26	application	application	NOUN
ihlr-27183	12	27	’s	’s	PART
ihlr-27183	12	28	filing	filing	NOUN
ihlr-27183	12	29	date	date	NOUN
ihlr-27183	12	30	.	.	PUNCT
ihlr-27183	13	1	2	2	X
ihlr-27183	13	2	.	.	X
ihlr-27183	14	1	i	i	PRON
ihlr-27183	14	2	d.	d.	VERB
ihlr-27183	14	3	the	the	DET
ihlr-27183	14	4	interval	interval	NOUN
ihlr-27183	14	5	over	over	ADP
ihlr-27183	14	6	which	which	PRON
ihlr-27183	14	7	an	an	DET
ihlr-27183	14	8	inventor	inventor	NOUN
ihlr-27183	14	9	may	may	AUX
ihlr-27183	14	10	enforce	enforce	VERB
ihlr-27183	14	11	a	a	DET
ihlr-27183	14	12	patent	patent	NOUN
ihlr-27183	14	13	is	be	AUX
ihlr-27183	14	14	often	often	ADV
ihlr-27183	14	15	around	around	ADP
ihlr-27183	14	16	seventeen	seventeen	NUM
ihlr-27183	14	17	years	year	NOUN
ihlr-27183	14	18	because	because	SCONJ
ihlr-27183	14	19	patents	patent	NOUN
ihlr-27183	14	20	often	often	ADV
ihlr-27183	14	21	grant	grant	VERB
ihlr-27183	14	22	two	two	NUM
ihlr-27183	14	23	to	to	PART
ihlr-27183	14	24	three	three	NUM
ihlr-27183	14	25	years	year	NOUN
ihlr-27183	14	26	after	after	ADP
ihlr-27183	14	27	their	their	PRON
ihlr-27183	14	28	earliest	early	ADJ
ihlr-27183	14	29	filing	filing	NOUN
ihlr-27183	14	30	date	date	NOUN
ihlr-27183	14	31	.	.	PUNCT
ihlr-27183	15	1	3	3	X
ihlr-27183	15	2	.	.	NOUN
ihlr-27183	15	3	35	35	NUM
ihlr-27183	15	4	u.s.c	u.s.c	NOUN
ihlr-27183	15	5	.	.	PUNCT
ihlr-27183	16	1	§	§	PROPN
ihlr-27183	16	2	154(a)(1	154(a)(1	NUM
ihlr-27183	16	3	)	)	PUNCT
ihlr-27183	16	4	(	(	PUNCT
ihlr-27183	16	5	2013	2013	NUM
ihlr-27183	16	6	)	)	PUNCT
ihlr-27183	16	7	.	.	PUNCT
ihlr-27183	17	1	4	4	X
ihlr-27183	17	2	.	.	X
ihlr-27183	17	3	step	step	NOUN
ihlr-27183	17	4	3	3	NUM
ihlr-27183	17	5	:	:	PUNCT
ihlr-27183	17	6	clinical	clinical	ADJ
ihlr-27183	17	7	research	research	NOUN
ihlr-27183	17	8	,	,	PUNCT
ihlr-27183	17	9	u.s	u.s	PROPN
ihlr-27183	17	10	.	.	PROPN
ihlr-27183	17	11	food	food	PROPN
ihlr-27183	17	12	&	&	CCONJ
ihlr-27183	17	13	drug	drug	PROPN
ihlr-27183	17	14	admin	admin	PROPN
ihlr-27183	17	15	.	.	PROPN
ihlr-27183	17	16	,	,	PUNCT
ihlr-27183	17	17	https://www.fda.gov/patients/	https://www.fda.gov/patients/	ADP
ihlr-27183	17	18	drug	drug	NOUN
ihlr-27183	17	19	-	-	PUNCT
ihlr-27183	17	20	development	development	NOUN
ihlr-27183	17	21	-	-	PUNCT
ihlr-27183	17	22	process	process	NOUN
ihlr-27183	17	23	/	/	SYM
ihlr-27183	17	24	step-3	step-3	NUM
ihlr-27183	17	25	-	-	PUNCT
ihlr-27183	17	26	clinical	clinical	ADJ
ihlr-27183	17	27	-	-	PUNCT
ihlr-27183	17	28	research	research	NOUN
ihlr-27183	18	1	[	[	X
ihlr-27183	18	2	https://perma.cc/z76b-nzel	https://perma.cc/z76b-nzel	X
ihlr-27183	18	3	]	]	X
ihlr-27183	18	4	(	(	PUNCT
ihlr-27183	18	5	last	last	ADJ
ihlr-27183	18	6	updated	update	VERB
ihlr-27183	18	7	jan	jan	PROPN
ihlr-27183	18	8	.	.	PROPN
ihlr-27183	18	9	4	4	NUM
ihlr-27183	18	10	,	,	PUNCT
ihlr-27183	18	11	2018	2018	NUM
ihlr-27183	18	12	)	)	PUNCT
ihlr-27183	18	13	(	(	PUNCT
ihlr-27183	18	14	clinical	clinical	ADJ
ihlr-27183	18	15	trials	trial	NOUN
ihlr-27183	18	16	are	be	AUX
ihlr-27183	18	17	generally	generally	ADV
ihlr-27183	18	18	the	the	DET
ihlr-27183	18	19	longest	long	ADJ
ihlr-27183	18	20	phase	phase	NOUN
ihlr-27183	18	21	of	of	ADP
ihlr-27183	18	22	fda	fda	PROPN
ihlr-27183	18	23	approval	approval	PROPN
ihlr-27183	18	24	)	)	PUNCT
ihlr-27183	18	25	.	.	PUNCT
ihlr-27183	19	1	5	5	X
ihlr-27183	19	2	.	.	X
ihlr-27183	19	3	roche	roche	NOUN
ihlr-27183	19	4	products	products	PROPN
ihlr-27183	19	5	,	,	PUNCT
ihlr-27183	19	6	inc	inc	PROPN
ihlr-27183	19	7	.	.	PROPN
ihlr-27183	19	8	v.	v.	ADP
ihlr-27183	19	9	bolar	bolar	PROPN
ihlr-27183	19	10	pharm	pharm	PROPN
ihlr-27183	19	11	.	.	PUNCT
ihlr-27183	20	1	co.	co.	PROPN
ihlr-27183	20	2	,	,	PUNCT
ihlr-27183	20	3	733	733	NUM
ihlr-27183	20	4	f.2d	f.2d	ADP
ihlr-27183	20	5	858	858	NUM
ihlr-27183	20	6	,	,	PUNCT
ihlr-27183	20	7	864	864	NUM
ihlr-27183	20	8	(	(	PUNCT
ihlr-27183	20	9	fed	fed	PROPN
ihlr-27183	20	10	.	.	PUNCT
ihlr-27183	20	11	cir	cir	PROPN
ihlr-27183	20	12	.	.	PROPN
ihlr-27183	20	13	1984	1984	NUM
ihlr-27183	20	14	)	)	PUNCT
ihlr-27183	20	15	(	(	PUNCT
ihlr-27183	20	16	prior	prior	ADV
ihlr-27183	20	17	to	to	ADP
ihlr-27183	20	18	§	§	PROPN
ihlr-27183	20	19	156	156	NUM
ihlr-27183	20	20	of	of	ADP
ihlr-27183	20	21	the	the	DET
ihlr-27183	20	22	hatch	hatch	PROPN
ihlr-27183	20	23	-	-	PUNCT
ihlr-27183	20	24	waxman	waxman	PROPN
ihlr-27183	20	25	act	act	PROPN
ihlr-27183	20	26	,	,	PUNCT
ihlr-27183	20	27	the	the	DET
ihlr-27183	20	28	filing	filing	NOUN
ihlr-27183	20	29	date	date	NOUN
ihlr-27183	20	30	started	start	VERB
ihlr-27183	20	31	the	the	DET
ihlr-27183	20	32	patent	patent	NOUN
ihlr-27183	20	33	term	term	NOUN
ihlr-27183	20	34	clock	clock	NOUN
ihlr-27183	20	35	even	even	ADV
ihlr-27183	20	36	though	though	SCONJ
ihlr-27183	20	37	the	the	DET
ihlr-27183	20	38	drug	drug	NOUN
ihlr-27183	20	39	was	be	AUX
ihlr-27183	20	40	not	not	PART
ihlr-27183	20	41	approved	approve	VERB
ihlr-27183	20	42	by	by	ADP
ihlr-27183	20	43	the	the	DET
ihlr-27183	20	44	fda	fda	PROPN
ihlr-27183	20	45	and	and	CCONJ
ihlr-27183	20	46	could	could	AUX
ihlr-27183	20	47	not	not	PART
ihlr-27183	20	48	be	be	AUX
ihlr-27183	20	49	sold	sell	VERB
ihlr-27183	20	50	)	)	PUNCT
ihlr-27183	20	51	.	.	PUNCT
ihlr-27183	21	1	144	144	NUM
ihlr-27183	21	2	indiana	indiana	PROPN
ihlr-27183	21	3	health	health	PROPN
ihlr-27183	21	4	law	law	PROPN
ihlr-27183	21	5	review	review	NOUN
ihlr-27183	21	6	[	[	X
ihlr-27183	21	7	vol	vol	NOUN
ihlr-27183	21	8	.	.	PUNCT
ihlr-27183	21	9	20:143	20:143	PROPN
ihlr-27183	21	10	b.	b.	PROPN
ihlr-27183	21	11	executive	executive	PROPN
ihlr-27183	21	12	summary	summary	NOUN
ihlr-27183	21	13	to	to	PART
ihlr-27183	21	14	understand	understand	VERB
ihlr-27183	21	15	current	current	ADJ
ihlr-27183	21	16	problems	problem	NOUN
ihlr-27183	21	17	with	with	ADP
ihlr-27183	21	18	the	the	DET
ihlr-27183	21	19	statutory	statutory	ADJ
ihlr-27183	21	20	solution	solution	NOUN
ihlr-27183	21	21	to	to	ADP
ihlr-27183	21	22	patent	patent	NOUN
ihlr-27183	21	23	term	term	NOUN
ihlr-27183	21	24	distortions	distortion	NOUN
ihlr-27183	21	25	arising	arise	VERB
ihlr-27183	21	26	from	from	ADP
ihlr-27183	21	27	fda	fda	PROPN
ihlr-27183	21	28	approval	approval	NOUN
ihlr-27183	21	29	,	,	PUNCT
ihlr-27183	21	30	this	this	DET
ihlr-27183	21	31	note	note	NOUN
ihlr-27183	21	32	begins	begin	VERB
ihlr-27183	21	33	with	with	ADP
ihlr-27183	21	34	describing	describe	VERB
ihlr-27183	21	35	the	the	DET
ihlr-27183	21	36	judicial	judicial	ADJ
ihlr-27183	21	37	tool	tool	NOUN
ihlr-27183	21	38	most	most	ADV
ihlr-27183	21	39	promising	promising	ADJ
ihlr-27183	21	40	to	to	PART
ihlr-27183	21	41	resolve	resolve	VERB
ihlr-27183	21	42	the	the	DET
ihlr-27183	21	43	most	most	ADV
ihlr-27183	21	44	contentious	contentious	ADJ
ihlr-27183	21	45	distortion	distortion	NOUN
ihlr-27183	21	46	–	–	PUNCT
ihlr-27183	21	47	an	an	DET
ihlr-27183	21	48	“	"	PUNCT
ihlr-27183	21	49	experimental	experimental	ADJ
ihlr-27183	21	50	use	use	NOUN
ihlr-27183	21	51	exemption	exemption	NOUN
ihlr-27183	21	52	”	"	PUNCT
ihlr-27183	21	53	to	to	ADP
ihlr-27183	21	54	patent	patent	NOUN
ihlr-27183	21	55	infringement	infringement	NOUN
ihlr-27183	21	56	granted	grant	VERB
ihlr-27183	21	57	under	under	ADP
ihlr-27183	21	58	certain	certain	ADJ
ihlr-27183	21	59	circumstances.6	circumstances.6	NOUN
ihlr-27183	21	60	after	after	ADP
ihlr-27183	21	61	explaining	explain	VERB
ihlr-27183	21	62	how	how	SCONJ
ihlr-27183	21	63	the	the	DET
ihlr-27183	21	64	experimental	experimental	ADJ
ihlr-27183	21	65	use	use	NOUN
ihlr-27183	21	66	exemption	exemption	NOUN
ihlr-27183	21	67	ultimately	ultimately	ADV
ihlr-27183	21	68	failed	fail	VERB
ihlr-27183	21	69	to	to	PART
ihlr-27183	21	70	provide	provide	VERB
ihlr-27183	21	71	satisfactory	satisfactory	ADJ
ihlr-27183	21	72	results	result	NOUN
ihlr-27183	21	73	,	,	PUNCT
ihlr-27183	21	74	the	the	DET
ihlr-27183	21	75	note	note	NOUN
ihlr-27183	21	76	introduces	introduce	VERB
ihlr-27183	21	77	the	the	DET
ihlr-27183	21	78	responsive	responsive	ADJ
ihlr-27183	21	79	legislative	legislative	ADJ
ihlr-27183	21	80	solution	solution	NOUN
ihlr-27183	21	81	–	–	PUNCT
ihlr-27183	21	82	the	the	DET
ihlr-27183	21	83	hatch	hatch	NOUN
ihlr-27183	21	84	-	-	PUNCT
ihlr-27183	21	85	waxman	waxman	PROPN
ihlr-27183	21	86	act	act	NOUN
ihlr-27183	21	87	(	(	PUNCT
ihlr-27183	21	88	“	"	PUNCT
ihlr-27183	21	89	act	act	PROPN
ihlr-27183	21	90	”	"	PUNCT
ihlr-27183	21	91	)	)	PUNCT
ihlr-27183	21	92	.	.	PUNCT
ihlr-27183	22	1	the	the	DET
ihlr-27183	22	2	note	note	NOUN
ihlr-27183	22	3	then	then	ADV
ihlr-27183	22	4	assesses	assess	VERB
ihlr-27183	22	5	the	the	DET
ihlr-27183	22	6	language	language	NOUN
ihlr-27183	22	7	of	of	ADP
ihlr-27183	22	8	the	the	DET
ihlr-27183	22	9	act	act	NOUN
ihlr-27183	22	10	and	and	CCONJ
ihlr-27183	22	11	unfolds	unfold	VERB
ihlr-27183	22	12	the	the	DET
ihlr-27183	22	13	case	case	NOUN
ihlr-27183	22	14	law	law	NOUN
ihlr-27183	22	15	developing	develop	VERB
ihlr-27183	22	16	its	its	PRON
ihlr-27183	22	17	most	most	ADV
ihlr-27183	22	18	litigated	litigate	VERB
ihlr-27183	22	19	terms	term	NOUN
ihlr-27183	22	20	.	.	PUNCT
ihlr-27183	23	1	after	after	ADP
ihlr-27183	23	2	criticizing	criticize	VERB
ihlr-27183	23	3	the	the	DET
ihlr-27183	23	4	act	act	NOUN
ihlr-27183	23	5	’s	’s	PART
ihlr-27183	23	6	use	use	NOUN
ihlr-27183	23	7	of	of	ADP
ihlr-27183	23	8	undefined	undefined	ADJ
ihlr-27183	23	9	statutory	statutory	ADJ
ihlr-27183	23	10	terms	term	NOUN
ihlr-27183	23	11	–	–	PUNCT
ihlr-27183	23	12	which	which	PRON
ihlr-27183	23	13	do	do	AUX
ihlr-27183	23	14	not	not	PART
ihlr-27183	23	15	secure	secure	VERB
ihlr-27183	23	16	a	a	DET
ihlr-27183	23	17	preferable	preferable	ADJ
ihlr-27183	23	18	symmetry	symmetry	NOUN
ihlr-27183	23	19	between	between	ADP
ihlr-27183	23	20	complementary	complementary	ADJ
ihlr-27183	23	21	sections	section	NOUN
ihlr-27183	23	22	of	of	ADP
ihlr-27183	23	23	the	the	DET
ihlr-27183	23	24	act	act	NOUN
ihlr-27183	23	25	–	–	PUNCT
ihlr-27183	23	26	the	the	DET
ihlr-27183	23	27	note	note	NOUN
ihlr-27183	23	28	explains	explain	VERB
ihlr-27183	23	29	how	how	SCONJ
ihlr-27183	23	30	courts	court	NOUN
ihlr-27183	23	31	now	now	ADV
ihlr-27183	23	32	disagree	disagree	VERB
ihlr-27183	23	33	,	,	PUNCT
ihlr-27183	23	34	at	at	ADP
ihlr-27183	23	35	least	least	ADJ
ihlr-27183	23	36	in	in	ADP
ihlr-27183	23	37	part	part	NOUN
ihlr-27183	23	38	,	,	PUNCT
ihlr-27183	23	39	on	on	ADP
ihlr-27183	23	40	the	the	DET
ihlr-27183	23	41	scope	scope	NOUN
ihlr-27183	23	42	of	of	ADP
ihlr-27183	23	43	what	what	PRON
ihlr-27183	23	44	inventions	invention	NOUN
ihlr-27183	23	45	are	be	AUX
ihlr-27183	23	46	shielded	shield	VERB
ihlr-27183	23	47	from	from	ADP
ihlr-27183	23	48	patent	patent	NOUN
ihlr-27183	23	49	infringement	infringement	NOUN
ihlr-27183	23	50	claims	claim	VERB
ihlr-27183	23	51	.	.	PUNCT
ihlr-27183	24	1	after	after	ADP
ihlr-27183	24	2	suggesting	suggest	VERB
ihlr-27183	24	3	a	a	DET
ihlr-27183	24	4	legislative	legislative	ADJ
ihlr-27183	24	5	amendment	amendment	NOUN
ihlr-27183	24	6	to	to	ADP
ihlr-27183	24	7	the	the	DET
ihlr-27183	24	8	act	act	NOUN
ihlr-27183	24	9	,	,	PUNCT
ihlr-27183	24	10	the	the	DET
ihlr-27183	24	11	note	note	NOUN
ihlr-27183	24	12	then	then	ADV
ihlr-27183	24	13	focuses	focus	VERB
ihlr-27183	24	14	on	on	ADP
ihlr-27183	24	15	a	a	DET
ihlr-27183	24	16	certain	certain	ADJ
ihlr-27183	24	17	class	class	NOUN
ihlr-27183	24	18	of	of	ADP
ihlr-27183	24	19	inventions	invention	NOUN
ihlr-27183	24	20	commonly	commonly	ADV
ihlr-27183	24	21	known	know	VERB
ihlr-27183	24	22	as	as	ADP
ihlr-27183	24	23	research	research	NOUN
ihlr-27183	24	24	tools	tool	NOUN
ihlr-27183	24	25	.	.	PUNCT
ihlr-27183	25	1	these	these	DET
ihlr-27183	25	2	inventions	invention	NOUN
ihlr-27183	25	3	are	be	AUX
ihlr-27183	25	4	not	not	PART
ihlr-27183	25	5	themselves	themselves	PRON
ihlr-27183	25	6	subject	subject	ADJ
ihlr-27183	25	7	to	to	ADP
ihlr-27183	25	8	fda	fda	PROPN
ihlr-27183	25	9	approval	approval	PROPN
ihlr-27183	25	10	–	–	PUNCT
ihlr-27183	25	11	though	though	SCONJ
ihlr-27183	25	12	they	they	PRON
ihlr-27183	25	13	are	be	AUX
ihlr-27183	25	14	consistently	consistently	ADV
ihlr-27183	25	15	used	use	VERB
ihlr-27183	25	16	in	in	ADP
ihlr-27183	25	17	obtaining	obtain	VERB
ihlr-27183	25	18	fda	fda	PROPN
ihlr-27183	25	19	approval	approval	NOUN
ihlr-27183	25	20	for	for	ADP
ihlr-27183	25	21	other	other	ADJ
ihlr-27183	25	22	products	product	NOUN
ihlr-27183	25	23	.	.	PUNCT
ihlr-27183	26	1	research	research	NOUN
ihlr-27183	26	2	tools	tool	NOUN
ihlr-27183	26	3	are	be	AUX
ihlr-27183	26	4	abundant	abundant	ADJ
ihlr-27183	26	5	in	in	ADP
ihlr-27183	26	6	a	a	DET
ihlr-27183	26	7	laboratory	laboratory	NOUN
ihlr-27183	26	8	and	and	CCONJ
ihlr-27183	26	9	include	include	VERB
ihlr-27183	26	10	at	at	ADP
ihlr-27183	26	11	least	least	ADJ
ihlr-27183	26	12	mechanical	mechanical	ADJ
ihlr-27183	26	13	,	,	PUNCT
ihlr-27183	26	14	biochemical	biochemical	ADJ
ihlr-27183	26	15	,	,	PUNCT
ihlr-27183	26	16	biological	biological	ADJ
ihlr-27183	26	17	,	,	PUNCT
ihlr-27183	26	18	and	and	CCONJ
ihlr-27183	26	19	chemical	chemical	NOUN
ihlr-27183	26	20	articles	article	NOUN
ihlr-27183	26	21	.	.	PUNCT
ihlr-27183	27	1	this	this	DET
ihlr-27183	27	2	note	note	NOUN
ihlr-27183	27	3	exposes	expose	VERB
ihlr-27183	27	4	uncertainty	uncertainty	NOUN
ihlr-27183	27	5	in	in	ADP
ihlr-27183	27	6	the	the	DET
ihlr-27183	27	7	status	status	NOUN
ihlr-27183	27	8	of	of	ADP
ihlr-27183	27	9	these	these	DET
ihlr-27183	27	10	tools	tool	NOUN
ihlr-27183	27	11	under	under	ADP
ihlr-27183	27	12	the	the	DET
ihlr-27183	27	13	act	act	NOUN
ihlr-27183	27	14	and	and	CCONJ
ihlr-27183	27	15	illustrates	illustrate	VERB
ihlr-27183	27	16	continued	continued	ADJ
ihlr-27183	27	17	uncertainty	uncertainty	NOUN
ihlr-27183	27	18	after	after	ADP
ihlr-27183	27	19	the	the	DET
ihlr-27183	27	20	judiciary	judiciary	NOUN
ihlr-27183	27	21	’s	’s	PART
ihlr-27183	27	22	failed	fail	VERB
ihlr-27183	27	23	attempt	attempt	NOUN
ihlr-27183	27	24	to	to	PART
ihlr-27183	27	25	clarify	clarify	VERB
ihlr-27183	27	26	.	.	PUNCT
ihlr-27183	28	1	the	the	DET
ihlr-27183	28	2	note	note	NOUN
ihlr-27183	28	3	also	also	ADV
ihlr-27183	28	4	briefly	briefly	ADV
ihlr-27183	28	5	assesses	assess	VERB
ihlr-27183	28	6	the	the	DET
ihlr-27183	28	7	general	general	ADJ
ihlr-27183	28	8	consequence	consequence	NOUN
ihlr-27183	28	9	of	of	ADP
ihlr-27183	28	10	this	this	DET
ihlr-27183	28	11	ambiguity	ambiguity	NOUN
ihlr-27183	28	12	.	.	PUNCT
ihlr-27183	29	1	the	the	DET
ihlr-27183	29	2	note	note	NOUN
ihlr-27183	29	3	then	then	ADV
ihlr-27183	29	4	illustrates	illustrate	VERB
ihlr-27183	29	5	the	the	DET
ihlr-27183	29	6	detrimental	detrimental	ADJ
ihlr-27183	29	7	effect	effect	NOUN
ihlr-27183	29	8	this	this	DET
ihlr-27183	29	9	uncertainty	uncertainty	NOUN
ihlr-27183	29	10	is	be	AUX
ihlr-27183	29	11	having	have	VERB
ihlr-27183	29	12	on	on	ADP
ihlr-27183	29	13	predictability	predictability	NOUN
ihlr-27183	29	14	of	of	ADP
ihlr-27183	29	15	litigation	litigation	NOUN
ihlr-27183	29	16	by	by	ADP
ihlr-27183	29	17	examining	examine	VERB
ihlr-27183	29	18	two	two	NUM
ihlr-27183	29	19	cases	case	NOUN
ihlr-27183	29	20	,	,	PUNCT
ihlr-27183	29	21	filed	file	VERB
ihlr-27183	29	22	on	on	ADP
ihlr-27183	29	23	the	the	DET
ihlr-27183	29	24	same	same	ADJ
ihlr-27183	29	25	day	day	NOUN
ihlr-27183	29	26	,	,	PUNCT
ihlr-27183	29	27	in	in	ADP
ihlr-27183	29	28	different	different	ADJ
ihlr-27183	29	29	jurisdictions	jurisdiction	NOUN
ihlr-27183	29	30	.	.	PUNCT
ihlr-27183	30	1	the	the	DET
ihlr-27183	30	2	cases	case	NOUN
ihlr-27183	30	3	have	have	VERB
ihlr-27183	30	4	materially	materially	ADV
ihlr-27183	30	5	equivalent	equivalent	ADJ
ihlr-27183	30	6	facts	fact	NOUN
ihlr-27183	30	7	–	–	PUNCT
ihlr-27183	30	8	the	the	DET
ihlr-27183	30	9	same	same	ADJ
ihlr-27183	30	10	plaintiff	plaintiff	NOUN
ihlr-27183	30	11	suing	sue	VERB
ihlr-27183	30	12	for	for	ADP
ihlr-27183	30	13	patent	patent	NOUN
ihlr-27183	30	14	infringement	infringement	NOUN
ihlr-27183	30	15	based	base	VERB
ihlr-27183	30	16	on	on	ADP
ihlr-27183	30	17	a	a	DET
ihlr-27183	30	18	similar	similar	ADJ
ihlr-27183	30	19	use	use	NOUN
ihlr-27183	30	20	of	of	ADP
ihlr-27183	30	21	the	the	DET
ihlr-27183	30	22	same	same	ADJ
ihlr-27183	30	23	patented	patented	ADJ
ihlr-27183	30	24	research	research	NOUN
ihlr-27183	30	25	tool	tool	NOUN
ihlr-27183	30	26	.	.	PUNCT
ihlr-27183	31	1	while	while	SCONJ
ihlr-27183	31	2	one	one	NUM
ihlr-27183	31	3	case	case	NOUN
ihlr-27183	31	4	has	have	AUX
ihlr-27183	31	5	now	now	ADV
ihlr-27183	31	6	settled	settle	VERB
ihlr-27183	31	7	,	,	PUNCT
ihlr-27183	31	8	the	the	DET
ihlr-27183	31	9	jurisdictions	jurisdiction	NOUN
ihlr-27183	31	10	still	still	ADV
ihlr-27183	31	11	have	have	VERB
ihlr-27183	31	12	conflicting	conflicting	ADJ
ihlr-27183	31	13	precedent	precedent	NOUN
ihlr-27183	31	14	on	on	ADP
ihlr-27183	31	15	the	the	DET
ihlr-27183	31	16	precise	precise	ADJ
ihlr-27183	31	17	issue	issue	NOUN
ihlr-27183	31	18	which	which	PRON
ihlr-27183	31	19	may	may	AUX
ihlr-27183	31	20	prove	prove	VERB
ihlr-27183	31	21	dispositive	dispositive	NOUN
ihlr-27183	31	22	in	in	ADP
ihlr-27183	31	23	future	future	ADJ
ihlr-27183	31	24	litigation	litigation	NOUN
ihlr-27183	31	25	.	.	PUNCT
ihlr-27183	32	1	the	the	DET
ihlr-27183	32	2	note	note	NOUN
ihlr-27183	32	3	concludes	conclude	VERB
ihlr-27183	32	4	by	by	ADP
ihlr-27183	32	5	proposing	propose	VERB
ihlr-27183	32	6	the	the	DET
ihlr-27183	32	7	judiciary	judiciary	NOUN
ihlr-27183	32	8	adopt	adopt	VERB
ihlr-27183	32	9	a	a	DET
ihlr-27183	32	10	bright	bright	ADJ
ihlr-27183	32	11	-	-	PUNCT
ihlr-27183	32	12	line	line	NOUN
ihlr-27183	32	13	rule	rule	NOUN
ihlr-27183	32	14	excluding	exclude	VERB
ihlr-27183	32	15	research	research	NOUN
ihlr-27183	32	16	tools	tool	NOUN
ihlr-27183	32	17	from	from	ADP
ihlr-27183	32	18	the	the	DET
ihlr-27183	32	19	purview	purview	NOUN
ihlr-27183	32	20	of	of	ADP
ihlr-27183	32	21	the	the	DET
ihlr-27183	32	22	act	act	NOUN
ihlr-27183	32	23	’s	’s	PART
ihlr-27183	32	24	safe	safe	ADJ
ihlr-27183	32	25	harbor	harbor	NOUN
ihlr-27183	32	26	.	.	PUNCT
ihlr-27183	33	1	though	though	SCONJ
ihlr-27183	33	2	legislative	legislative	ADJ
ihlr-27183	33	3	action	action	NOUN
ihlr-27183	33	4	would	would	AUX
ihlr-27183	33	5	be	be	AUX
ihlr-27183	33	6	preferable	preferable	ADJ
ihlr-27183	33	7	,	,	PUNCT
ihlr-27183	33	8	this	this	DET
ihlr-27183	33	9	note	note	NOUN
ihlr-27183	33	10	maintains	maintain	VERB
ihlr-27183	33	11	it	it	PRON
ihlr-27183	33	12	is	be	AUX
ihlr-27183	33	13	not	not	PART
ihlr-27183	33	14	required	require	VERB
ihlr-27183	33	15	for	for	ADP
ihlr-27183	33	16	a	a	DET
ihlr-27183	33	17	clear	clear	ADJ
ihlr-27183	33	18	interpretation	interpretation	NOUN
ihlr-27183	33	19	of	of	ADP
ihlr-27183	33	20	the	the	DET
ihlr-27183	33	21	statute	statute	NOUN
ihlr-27183	33	22	.	.	PUNCT
ihlr-27183	34	1	importantly	importantly	ADV
ihlr-27183	34	2	,	,	PUNCT
ihlr-27183	34	3	the	the	DET
ihlr-27183	34	4	judiciary	judiciary	NOUN
ihlr-27183	34	5	need	need	AUX
ihlr-27183	34	6	not	not	PART
ihlr-27183	34	7	fear	fear	VERB
ihlr-27183	34	8	entering	enter	VERB
ihlr-27183	34	9	the	the	DET
ihlr-27183	34	10	legislative	legislative	ADJ
ihlr-27183	34	11	realm	realm	NOUN
ihlr-27183	34	12	to	to	PART
ihlr-27183	34	13	clarify	clarify	VERB
ihlr-27183	34	14	the	the	DET
ihlr-27183	34	15	uncertainty	uncertainty	NOUN
ihlr-27183	34	16	–	–	PUNCT
ihlr-27183	34	17	and	and	CCONJ
ihlr-27183	34	18	it	it	PRON
ihlr-27183	34	19	is	be	AUX
ihlr-27183	34	20	in	in	ADP
ihlr-27183	34	21	fact	fact	NOUN
ihlr-27183	34	22	the	the	DET
ihlr-27183	34	23	judiciary	judiciary	NOUN
ihlr-27183	34	24	’s	’s	PART
ihlr-27183	34	25	duty	duty	NOUN
ihlr-27183	34	26	.	.	PUNCT
ihlr-27183	35	1	rather	rather	ADV
ihlr-27183	35	2	,	,	PUNCT
ihlr-27183	35	3	for	for	SCONJ
ihlr-27183	35	4	the	the	DET
ihlr-27183	35	5	judiciary	judiciary	NOUN
ihlr-27183	35	6	to	to	PART
ihlr-27183	35	7	remain	remain	VERB
ihlr-27183	35	8	silent	silent	ADJ
ihlr-27183	35	9	while	while	SCONJ
ihlr-27183	35	10	a	a	DET
ihlr-27183	35	11	well	well	ADV
ihlr-27183	35	12	-	-	PUNCT
ihlr-27183	35	13	defined	define	VERB
ihlr-27183	35	14	industry	industry	NOUN
ihlr-27183	35	15	is	be	AUX
ihlr-27183	35	16	subject	subject	ADJ
ihlr-27183	35	17	to	to	ADP
ihlr-27183	35	18	unpredictable	unpredictable	ADJ
ihlr-27183	35	19	liability	liability	NOUN
ihlr-27183	35	20	,	,	PUNCT
ihlr-27183	35	21	arising	arise	VERB
ihlr-27183	35	22	from	from	ADP
ihlr-27183	35	23	everyday	everyday	ADJ
ihlr-27183	35	24	business	business	NOUN
ihlr-27183	35	25	decisions	decision	NOUN
ihlr-27183	35	26	,	,	PUNCT
ihlr-27183	35	27	may	may	AUX
ihlr-27183	35	28	constitute	constitute	VERB
ihlr-27183	35	29	a	a	DET
ihlr-27183	35	30	dereliction	dereliction	NOUN
ihlr-27183	35	31	of	of	ADP
ihlr-27183	35	32	duty	duty	NOUN
ihlr-27183	35	33	.	.	PUNCT
ihlr-27183	36	1	c.	c.	NOUN
ihlr-27183	36	2	from	from	ADP
ihlr-27183	36	3	the	the	DET
ihlr-27183	36	4	experimental	experimental	ADJ
ihlr-27183	36	5	use	use	NOUN
ihlr-27183	36	6	doctrine	doctrine	NOUN
ihlr-27183	36	7	to	to	ADP
ihlr-27183	36	8	a	a	DET
ihlr-27183	36	9	statute	statute	NOUN
ihlr-27183	36	10	sprouting	sprout	VERB
ihlr-27183	36	11	from	from	ADP
ihlr-27183	36	12	a	a	DET
ihlr-27183	36	13	germinate	germinate	NOUN
ihlr-27183	36	14	sentence	sentence	NOUN
ihlr-27183	36	15	written	write	VERB
ihlr-27183	36	16	by	by	ADP
ihlr-27183	36	17	justice	justice	NOUN
ihlr-27183	36	18	story	story	NOUN
ihlr-27183	36	19	in	in	ADP
ihlr-27183	36	20	1813	1813	NUM
ihlr-27183	36	21	,	,	PUNCT
ihlr-27183	36	22	the	the	DET
ihlr-27183	36	23	common	common	ADJ
ihlr-27183	36	24	law	law	NOUN
ihlr-27183	36	25	exemption	exemption	NOUN
ihlr-27183	36	26	against	against	ADP
ihlr-27183	36	27	patent	patent	NOUN
ihlr-27183	36	28	infringement	infringement	NOUN
ihlr-27183	36	29	grew	grow	VERB
ihlr-27183	36	30	into	into	ADP
ihlr-27183	36	31	the	the	DET
ihlr-27183	36	32	experimental	experimental	ADJ
ihlr-27183	36	33	6	6	NUM
ihlr-27183	36	34	.	.	PUNCT
ihlr-27183	37	1	moore	moore	PROPN
ihlr-27183	37	2	u.s.a	u.s.a	PROPN
ihlr-27183	37	3	.	.	PROPN
ihlr-27183	37	4	,	,	PUNCT
ihlr-27183	37	5	inc	inc	PROPN
ihlr-27183	37	6	.	.	PROPN
ihlr-27183	37	7	v.	v.	ADP
ihlr-27183	37	8	standard	standard	ADJ
ihlr-27183	37	9	reg	reg	NOUN
ihlr-27183	37	10	.	.	PUNCT
ihlr-27183	37	11	,	,	PUNCT
ihlr-27183	37	12	144	144	NUM
ihlr-27183	37	13	f.	f.	PROPN
ihlr-27183	37	14	supp	supp	PROPN
ihlr-27183	37	15	.	.	PUNCT
ihlr-27183	38	1	2d	2d	NOUN
ihlr-27183	38	2	188	188	NUM
ihlr-27183	38	3	,	,	PUNCT
ihlr-27183	38	4	196	196	NUM
ihlr-27183	38	5	(	(	PUNCT
ihlr-27183	38	6	w.d.n.y	w.d.n.y	PROPN
ihlr-27183	38	7	.	.	NOUN
ihlr-27183	38	8	2001	2001	NUM
ihlr-27183	38	9	)	)	PUNCT
ihlr-27183	38	10	.	.	PUNCT
ihlr-27183	39	1	2023	2023	NUM
ihlr-27183	39	2	]	]	PUNCT
ihlr-27183	39	3	the	the	DET
ihlr-27183	39	4	safe	safe	ADJ
ihlr-27183	39	5	harbor	harbor	NOUN
ihlr-27183	39	6	of	of	ADP
ihlr-27183	39	7	35	35	NUM
ihlr-27183	39	8	u.s.c	u.s.c	ADJ
ihlr-27183	39	9	.	.	PUNCT
ihlr-27183	40	1	§	§	PROPN
ihlr-27183	40	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	40	3	)	)	PUNCT
ihlr-27183	40	4	145	145	NUM
ihlr-27183	40	5	use	use	NOUN
ihlr-27183	40	6	doctrine.7	doctrine.7	NOUN
ihlr-27183	40	7	justice	justice	NOUN
ihlr-27183	40	8	story	story	NOUN
ihlr-27183	40	9	recognized	recognize	VERB
ihlr-27183	40	10	a	a	DET
ihlr-27183	40	11	sort	sort	NOUN
ihlr-27183	40	12	of	of	ADP
ihlr-27183	40	13	honor	honor	NOUN
ihlr-27183	40	14	in	in	ADP
ihlr-27183	40	15	curiosity	curiosity	NOUN
ihlr-27183	40	16	without	without	ADP
ihlr-27183	40	17	monetary	monetary	ADJ
ihlr-27183	40	18	gain	gain	NOUN
ihlr-27183	40	19	and	and	CCONJ
ihlr-27183	40	20	thought	think	VERB
ihlr-27183	40	21	it	it	PRON
ihlr-27183	40	22	was	be	AUX
ihlr-27183	40	23	incompatible	incompatible	ADJ
ihlr-27183	40	24	with	with	ADP
ihlr-27183	40	25	the	the	DET
ihlr-27183	40	26	patent	patent	NOUN
ihlr-27183	40	27	laws	law	NOUN
ihlr-27183	40	28	to	to	PART
ihlr-27183	40	29	punish	punish	VERB
ihlr-27183	40	30	a	a	DET
ihlr-27183	40	31	purely	purely	ADV
ihlr-27183	40	32	inquisitive	inquisitive	ADJ
ihlr-27183	40	33	mind.8	mind.8	NOUN
ihlr-27183	40	34	with	with	ADP
ihlr-27183	40	35	a	a	DET
ihlr-27183	40	36	subtle	subtle	ADJ
ihlr-27183	40	37	boldness	boldness	NOUN
ihlr-27183	40	38	,	,	PUNCT
ihlr-27183	40	39	story	story	NOUN
ihlr-27183	40	40	asserted	assert	VERB
ihlr-27183	40	41	“	"	PUNCT
ihlr-27183	40	42	it	it	PRON
ihlr-27183	40	43	could	could	AUX
ihlr-27183	40	44	never	never	ADV
ihlr-27183	40	45	have	have	AUX
ihlr-27183	40	46	been	be	AUX
ihlr-27183	40	47	the	the	DET
ihlr-27183	40	48	intention	intention	NOUN
ihlr-27183	40	49	of	of	ADP
ihlr-27183	40	50	the	the	DET
ihlr-27183	40	51	legislature	legislature	NOUN
ihlr-27183	40	52	to	to	PART
ihlr-27183	40	53	punish	punish	VERB
ihlr-27183	40	54	a	a	DET
ihlr-27183	40	55	man	man	NOUN
ihlr-27183	40	56	,	,	PUNCT
ihlr-27183	40	57	who	who	PRON
ihlr-27183	40	58	constructed	construct	VERB
ihlr-27183	40	59	such	such	DET
ihlr-27183	40	60	a	a	DET
ihlr-27183	40	61	machine	machine	NOUN
ihlr-27183	40	62	merely	merely	ADV
ihlr-27183	40	63	for	for	ADP
ihlr-27183	40	64	philosophical	philosophical	ADJ
ihlr-27183	40	65	experiments	experiment	NOUN
ihlr-27183	40	66	,	,	PUNCT
ihlr-27183	40	67	or	or	CCONJ
ihlr-27183	40	68	for	for	ADP
ihlr-27183	40	69	the	the	DET
ihlr-27183	40	70	purpose	purpose	NOUN
ihlr-27183	40	71	of	of	ADP
ihlr-27183	40	72	ascertaining	ascertain	VERB
ihlr-27183	40	73	the	the	DET
ihlr-27183	40	74	sufficiency	sufficiency	NOUN
ihlr-27183	40	75	of	of	ADP
ihlr-27183	40	76	the	the	DET
ihlr-27183	40	77	machine	machine	NOUN
ihlr-27183	40	78	to	to	PART
ihlr-27183	40	79	produce	produce	VERB
ihlr-27183	40	80	its	its	PRON
ihlr-27183	40	81	described	describe	VERB
ihlr-27183	40	82	effects	effect	NOUN
ihlr-27183	40	83	.	.	PUNCT
ihlr-27183	40	84	”9	”9	NOUN
ihlr-27183	40	85	this	this	PRON
ihlr-27183	40	86	became	became	AUX
ihlr-27183	40	87	known	know	VERB
ihlr-27183	40	88	as	as	ADP
ihlr-27183	40	89	the	the	DET
ihlr-27183	40	90	common	common	ADJ
ihlr-27183	40	91	law	law	NOUN
ihlr-27183	40	92	exemption	exemption	NOUN
ihlr-27183	40	93	to	to	ADP
ihlr-27183	40	94	patent	patent	NOUN
ihlr-27183	40	95	infringement	infringement	NOUN
ihlr-27183	40	96	.	.	PUNCT
ihlr-27183	41	1	forty	forty	NUM
ihlr-27183	41	2	-	-	PUNCT
ihlr-27183	41	3	eight	eight	NUM
ihlr-27183	41	4	years	year	NOUN
ihlr-27183	41	5	later	later	ADV
ihlr-27183	41	6	this	this	DET
ihlr-27183	41	7	doctrine	doctrine	NOUN
ihlr-27183	41	8	stated	state	VERB
ihlr-27183	41	9	that	that	SCONJ
ihlr-27183	41	10	an	an	DET
ihlr-27183	41	11	“	"	PUNCT
ihlr-27183	41	12	experiment	experiment	NOUN
ihlr-27183	41	13	with	with	ADP
ihlr-27183	41	14	a	a	DET
ihlr-27183	41	15	patented	patented	ADJ
ihlr-27183	41	16	article	article	NOUN
ihlr-27183	41	17	for	for	ADP
ihlr-27183	41	18	the	the	DET
ihlr-27183	41	19	sole	sole	ADJ
ihlr-27183	41	20	purpose	purpose	NOUN
ihlr-27183	41	21	of	of	ADP
ihlr-27183	41	22	gratifying	gratify	VERB
ihlr-27183	41	23	a	a	DET
ihlr-27183	41	24	philosophical	philosophical	ADJ
ihlr-27183	41	25	taste	taste	NOUN
ihlr-27183	41	26	,	,	PUNCT
ihlr-27183	41	27	or	or	CCONJ
ihlr-27183	41	28	curiosity	curiosity	NOUN
ihlr-27183	41	29	,	,	PUNCT
ihlr-27183	41	30	or	or	CCONJ
ihlr-27183	41	31	for	for	ADP
ihlr-27183	41	32	mere	mere	ADJ
ihlr-27183	41	33	amusement	amusement	NOUN
ihlr-27183	41	34	”	"	PUNCT
ihlr-27183	41	35	is	be	AUX
ihlr-27183	41	36	not	not	PART
ihlr-27183	41	37	patent	patent	NOUN
ihlr-27183	41	38	infringement	infringement	NOUN
ihlr-27183	41	39	–	–	PUNCT
ihlr-27183	41	40	considerably	considerably	ADV
ihlr-27183	41	41	close	close	ADJ
ihlr-27183	41	42	to	to	ADP
ihlr-27183	41	43	justice	justice	NOUN
ihlr-27183	41	44	story	story	NOUN
ihlr-27183	41	45	’s	’s	PART
ihlr-27183	41	46	own	own	ADJ
ihlr-27183	41	47	description.10	description.10	NOUN
ihlr-27183	41	48	in	in	ADP
ihlr-27183	41	49	fact	fact	NOUN
ihlr-27183	41	50	,	,	PUNCT
ihlr-27183	41	51	the	the	DET
ihlr-27183	41	52	doctrine	doctrine	NOUN
ihlr-27183	41	53	departed	depart	VERB
ihlr-27183	41	54	from	from	ADP
ihlr-27183	41	55	its	its	PRON
ihlr-27183	41	56	origins	origin	NOUN
ihlr-27183	41	57	for	for	ADP
ihlr-27183	41	58	over	over	ADP
ihlr-27183	41	59	a	a	PRON
ihlr-27183	41	60	century	century	NOUN
ihlr-27183	41	61	.	.	PUNCT
ihlr-27183	42	1	gradually	gradually	ADV
ihlr-27183	42	2	,	,	PUNCT
ihlr-27183	42	3	in	in	ADP
ihlr-27183	42	4	applying	apply	VERB
ihlr-27183	42	5	this	this	DET
ihlr-27183	42	6	doctrine	doctrine	NOUN
ihlr-27183	42	7	,	,	PUNCT
ihlr-27183	42	8	a	a	DET
ihlr-27183	42	9	distinction	distinction	NOUN
ihlr-27183	42	10	resulted	result	VERB
ihlr-27183	42	11	in	in	ADP
ihlr-27183	42	12	the	the	DET
ihlr-27183	42	13	emergence	emergence	NOUN
ihlr-27183	42	14	of	of	ADP
ihlr-27183	42	15	two	two	NUM
ihlr-27183	42	16	branches	branch	NOUN
ihlr-27183	42	17	of	of	ADP
ihlr-27183	42	18	thought	thought	NOUN
ihlr-27183	42	19	within	within	ADP
ihlr-27183	42	20	cases	case	NOUN
ihlr-27183	42	21	.	.	PUNCT
ihlr-27183	43	1	the	the	DET
ihlr-27183	43	2	broadest	broad	ADJ
ihlr-27183	43	3	view	view	NOUN
ihlr-27183	43	4	maintained	maintain	VERB
ihlr-27183	43	5	experimental	experimental	ADJ
ihlr-27183	43	6	use	use	NOUN
ihlr-27183	43	7	defenses	defense	NOUN
ihlr-27183	43	8	to	to	ADP
ihlr-27183	43	9	patent	patent	NOUN
ihlr-27183	43	10	infringement	infringement	NOUN
ihlr-27183	43	11	could	could	AUX
ihlr-27183	43	12	be	be	AUX
ihlr-27183	43	13	honored	honor	VERB
ihlr-27183	43	14	even	even	ADV
ihlr-27183	43	15	when	when	SCONJ
ihlr-27183	43	16	the	the	DET
ihlr-27183	43	17	use	use	NOUN
ihlr-27183	43	18	was	be	AUX
ihlr-27183	43	19	for	for	ADP
ihlr-27183	43	20	business	business	NOUN
ihlr-27183	43	21	purposes	purpose	NOUN
ihlr-27183	43	22	–	–	PUNCT
ihlr-27183	43	23	as	as	ADV
ihlr-27183	43	24	long	long	ADV
ihlr-27183	43	25	as	as	SCONJ
ihlr-27183	43	26	the	the	DET
ihlr-27183	43	27	product	product	NOUN
ihlr-27183	43	28	was	be	AUX
ihlr-27183	43	29	not	not	PART
ihlr-27183	43	30	sold	sell	VERB
ihlr-27183	43	31	or	or	CCONJ
ihlr-27183	43	32	intended	intend	VERB
ihlr-27183	43	33	for	for	ADP
ihlr-27183	43	34	sale.11	sale.11	NOUN
ihlr-27183	43	35	the	the	DET
ihlr-27183	43	36	public	public	ADJ
ihlr-27183	43	37	policy	policy	NOUN
ihlr-27183	43	38	rationale	rationale	NOUN
ihlr-27183	43	39	was	be	AUX
ihlr-27183	43	40	to	to	PART
ihlr-27183	43	41	allow	allow	VERB
ihlr-27183	43	42	competitors	competitor	NOUN
ihlr-27183	43	43	to	to	PART
ihlr-27183	43	44	seek	seek	VERB
ihlr-27183	43	45	improvements	improvement	NOUN
ihlr-27183	43	46	upon	upon	SCONJ
ihlr-27183	43	47	another	another	DET
ihlr-27183	43	48	’s	’s	NOUN
ihlr-27183	43	49	invention	invention	NOUN
ihlr-27183	43	50	without	without	ADP
ihlr-27183	43	51	liability	liability	NOUN
ihlr-27183	43	52	and	and	CCONJ
ihlr-27183	43	53	,	,	PUNCT
ihlr-27183	43	54	in	in	ADP
ihlr-27183	43	55	theory	theory	NOUN
ihlr-27183	43	56	,	,	PUNCT
ihlr-27183	43	57	accelerate	accelerate	VERB
ihlr-27183	43	58	innovation.12	innovation.12	NOUN
ihlr-27183	43	59	the	the	DET
ihlr-27183	43	60	narrower	narrow	ADJ
ihlr-27183	43	61	view	view	NOUN
ihlr-27183	43	62	held	hold	VERB
ihlr-27183	43	63	the	the	DET
ihlr-27183	43	64	experimental	experimental	ADJ
ihlr-27183	43	65	use	use	NOUN
ihlr-27183	43	66	exemption	exemption	NOUN
ihlr-27183	43	67	was	be	AUX
ihlr-27183	43	68	to	to	PART
ihlr-27183	43	69	be	be	AUX
ihlr-27183	43	70	forfeited	forfeit	VERB
ihlr-27183	43	71	as	as	ADP
ihlr-27183	43	72	a	a	DET
ihlr-27183	43	73	defense	defense	NOUN
ihlr-27183	43	74	if	if	SCONJ
ihlr-27183	43	75	the	the	DET
ihlr-27183	43	76	patented	patented	ADJ
ihlr-27183	43	77	product	product	NOUN
ihlr-27183	43	78	was	be	AUX
ihlr-27183	43	79	used	use	VERB
ihlr-27183	43	80	“	"	PUNCT
ihlr-27183	43	81	in	in	ADP
ihlr-27183	43	82	keeping	keep	VERB
ihlr-27183	43	83	with	with	ADP
ihlr-27183	43	84	a	a	DET
ihlr-27183	43	85	legitimate	legitimate	ADJ
ihlr-27183	43	86	business	business	NOUN
ihlr-27183	43	87	of	of	ADP
ihlr-27183	43	88	the	the	DET
ihlr-27183	43	89	using	use	VERB
ihlr-27183	43	90	agency.13	agency.13	PROPN
ihlr-27183	43	91	thus	thus	ADV
ihlr-27183	43	92	,	,	PUNCT
ihlr-27183	43	93	courts	court	NOUN
ihlr-27183	43	94	were	be	AUX
ihlr-27183	43	95	divided	divide	VERB
ihlr-27183	43	96	on	on	ADP
ihlr-27183	43	97	whether	whether	SCONJ
ihlr-27183	43	98	the	the	DET
ihlr-27183	43	99	experimental	experimental	ADJ
ihlr-27183	43	100	use	use	NOUN
ihlr-27183	43	101	exemption	exemption	NOUN
ihlr-27183	43	102	could	could	AUX
ihlr-27183	43	103	be	be	AUX
ihlr-27183	43	104	used	use	VERB
ihlr-27183	43	105	as	as	ADP
ihlr-27183	43	106	a	a	DET
ihlr-27183	43	107	means	means	NOUN
ihlr-27183	43	108	of	of	ADP
ihlr-27183	43	109	shielding	shield	VERB
ihlr-27183	43	110	oneself	oneself	PRON
ihlr-27183	43	111	from	from	ADP
ihlr-27183	43	112	liability	liability	NOUN
ihlr-27183	43	113	while	while	SCONJ
ihlr-27183	43	114	actively	actively	ADV
ihlr-27183	43	115	advancing	advance	VERB
ihlr-27183	43	116	a	a	DET
ihlr-27183	43	117	business	business	NOUN
ihlr-27183	43	118	interest	interest	NOUN
ihlr-27183	43	119	.	.	PUNCT
ihlr-27183	44	1	in	in	ADP
ihlr-27183	44	2	a	a	DET
ihlr-27183	44	3	fundamental	fundamental	ADJ
ihlr-27183	44	4	sense	sense	NOUN
ihlr-27183	44	5	,	,	PUNCT
ihlr-27183	44	6	this	this	DET
ihlr-27183	44	7	conceptual	conceptual	ADJ
ihlr-27183	44	8	divide	divide	NOUN
ihlr-27183	44	9	over	over	ADP
ihlr-27183	44	10	public	public	ADJ
ihlr-27183	44	11	policy	policy	NOUN
ihlr-27183	44	12	and	and	CCONJ
ihlr-27183	44	13	the	the	DET
ihlr-27183	44	14	role	role	NOUN
ihlr-27183	44	15	of	of	ADP
ihlr-27183	44	16	patents	patent	NOUN
ihlr-27183	44	17	is	be	AUX
ihlr-27183	44	18	still	still	ADV
ihlr-27183	44	19	present	present	ADJ
ihlr-27183	44	20	today	today	NOUN
ihlr-27183	44	21	.	.	PUNCT
ihlr-27183	45	1	in	in	ADP
ihlr-27183	45	2	1984	1984	NUM
ihlr-27183	45	3	,	,	PUNCT
ihlr-27183	45	4	the	the	DET
ihlr-27183	45	5	broader	broad	ADJ
ihlr-27183	45	6	branch	branch	NOUN
ihlr-27183	45	7	of	of	ADP
ihlr-27183	45	8	case	case	NOUN
ihlr-27183	45	9	law	law	NOUN
ihlr-27183	45	10	invited	invite	VERB
ihlr-27183	45	11	a	a	DET
ihlr-27183	45	12	generic	generic	ADJ
ihlr-27183	45	13	drug	drug	NOUN
ihlr-27183	45	14	manufacturer	manufacturer	NOUN
ihlr-27183	45	15	to	to	PART
ihlr-27183	45	16	offer	offer	VERB
ihlr-27183	45	17	the	the	DET
ihlr-27183	45	18	experimental	experimental	ADJ
ihlr-27183	45	19	use	use	NOUN
ihlr-27183	45	20	doctrine	doctrine	NOUN
ihlr-27183	45	21	as	as	ADP
ihlr-27183	45	22	a	a	DET
ihlr-27183	45	23	defense	defense	NOUN
ihlr-27183	45	24	against	against	ADP
ihlr-27183	45	25	patent	patent	NOUN
ihlr-27183	45	26	infringement.14	infringement.14	PROPN
ihlr-27183	45	27	in	in	ADP
ihlr-27183	45	28	roche	roche	PROPN
ihlr-27183	45	29	products	product	NOUN
ihlr-27183	45	30	v.	v.	ADP
ihlr-27183	45	31	bolar	bolar	PROPN
ihlr-27183	45	32	pharmaceuticals	pharmaceutical	NOUN
ihlr-27183	45	33	,	,	PUNCT
ihlr-27183	45	34	the	the	DET
ihlr-27183	45	35	generic	generic	ADJ
ihlr-27183	45	36	manufacturer	manufacturer	NOUN
ihlr-27183	45	37	used	use	VERB
ihlr-27183	45	38	a	a	DET
ihlr-27183	45	39	patented	patent	VERB
ihlr-27183	45	40	drug	drug	NOUN
ihlr-27183	45	41	–	–	PUNCT
ihlr-27183	45	42	prior	prior	ADV
ihlr-27183	45	43	to	to	ADP
ihlr-27183	45	44	the	the	DET
ihlr-27183	45	45	patent	patent	NOUN
ihlr-27183	45	46	’s	’s	PART
ihlr-27183	45	47	expiration	expiration	NOUN
ihlr-27183	45	48	–	–	PUNCT
ihlr-27183	45	49	in	in	ADP
ihlr-27183	45	50	seeking	seek	VERB
ihlr-27183	45	51	its	its	PRON
ihlr-27183	45	52	fda	fda	PROPN
ihlr-27183	45	53	approval.15	approval.15	PROPN
ihlr-27183	45	54	bolar	bolar	PROPN
ihlr-27183	45	55	pharmaceuticals	pharmaceutical	NOUN
ihlr-27183	45	56	had	have	AUX
ihlr-27183	45	57	imported	import	VERB
ihlr-27183	45	58	the	the	DET
ihlr-27183	45	59	patented	patented	ADJ
ihlr-27183	45	60	substance	substance	NOUN
ihlr-27183	45	61	to	to	PART
ihlr-27183	45	62	assess	assess	VERB
ihlr-27183	45	63	parameters	parameter	NOUN
ihlr-27183	45	64	required	require	VERB
ihlr-27183	45	65	by	by	ADP
ihlr-27183	45	66	the	the	DET
ihlr-27183	45	67	fda	fda	PROPN
ihlr-27183	45	68	to	to	PART
ihlr-27183	45	69	prove	prove	VERB
ihlr-27183	45	70	bioequivalence	bioequivalence	NOUN
ihlr-27183	45	71	,	,	PUNCT
ihlr-27183	45	72	thus	thus	ADV
ihlr-27183	45	73	ensuring	ensure	VERB
ihlr-27183	45	74	the	the	DET
ihlr-27183	45	75	generic	generic	ADJ
ihlr-27183	45	76	version	version	NOUN
ihlr-27183	45	77	7	7	NUM
ihlr-27183	45	78	.	.	PUNCT
ihlr-27183	46	1	whittemore	whittemore	PROPN
ihlr-27183	46	2	v.	v.	ADP
ihlr-27183	46	3	cutter	cutter	NOUN
ihlr-27183	46	4	,	,	PUNCT
ihlr-27183	46	5	29	29	NUM
ihlr-27183	46	6	fed	feed	VERB
ihlr-27183	46	7	.	.	PUNCT
ihlr-27183	47	1	cas	cas	PROPN
ihlr-27183	47	2	.	.	PROPN
ihlr-27183	47	3	1120	1120	NUM
ihlr-27183	47	4	,	,	PUNCT
ihlr-27183	47	5	1121	1121	NUM
ihlr-27183	47	6	(	(	PUNCT
ihlr-27183	47	7	c.c.d	c.c.d	NOUN
ihlr-27183	47	8	.	.	PUNCT
ihlr-27183	48	1	mass	mass	PROPN
ihlr-27183	48	2	.	.	PROPN
ihlr-27183	48	3	1813	1813	NUM
ihlr-27183	48	4	)	)	PUNCT
ihlr-27183	48	5	.	.	PUNCT
ihlr-27183	49	1	8	8	X
ihlr-27183	49	2	.	.	X
ihlr-27183	50	1	i	i	PRON
ihlr-27183	50	2	d.	d.	PROPN
ihlr-27183	50	3	9	9	NUM
ihlr-27183	50	4	.	.	PUNCT
ihlr-27183	51	1	i	i	PRON
ihlr-27183	51	2	d.	d.	PROPN
ihlr-27183	51	3	10	10	NUM
ihlr-27183	51	4	.	.	PUNCT
ihlr-27183	52	1	poppenhusen	poppenhusen	PROPN
ihlr-27183	52	2	v.	v.	ADP
ihlr-27183	52	3	falke	falke	PROPN
ihlr-27183	52	4	,	,	PUNCT
ihlr-27183	52	5	19	19	NUM
ihlr-27183	52	6	fed	feed	VERB
ihlr-27183	52	7	.	.	PUNCT
ihlr-27183	53	1	cas	cas	PROPN
ihlr-27183	53	2	.	.	PROPN
ihlr-27183	53	3	1048	1048	NUM
ihlr-27183	53	4	,	,	PUNCT
ihlr-27183	53	5	1049	1049	NUM
ihlr-27183	53	6	(	(	PUNCT
ihlr-27183	53	7	c.c.s.d.n.y	c.c.s.d.n.y	PROPN
ihlr-27183	53	8	.	.	PROPN
ihlr-27183	53	9	1861	1861	NUM
ihlr-27183	53	10	)	)	PUNCT
ihlr-27183	53	11	.	.	PUNCT
ihlr-27183	54	1	11	11	NUM
ihlr-27183	54	2	.	.	X
ihlr-27183	55	1	see	see	VERB
ihlr-27183	55	2	chesterfield	chesterfield	PROPN
ihlr-27183	55	3	v.	v.	PROPN
ihlr-27183	55	4	united	united	PROPN
ihlr-27183	55	5	states	states	PROPN
ihlr-27183	55	6	,	,	PUNCT
ihlr-27183	55	7	159	159	NUM
ihlr-27183	55	8	f.	f.	PROPN
ihlr-27183	55	9	supp	supp	PROPN
ihlr-27183	55	10	.	.	PUNCT
ihlr-27183	56	1	371	371	NUM
ihlr-27183	56	2	,	,	PUNCT
ihlr-27183	56	3	375	375	NUM
ihlr-27183	56	4	(	(	PUNCT
ihlr-27183	56	5	ct	ct	PROPN
ihlr-27183	56	6	.	.	PUNCT
ihlr-27183	56	7	cl	cl	NOUN
ihlr-27183	56	8	.	.	PROPN
ihlr-27183	56	9	1958	1958	NUM
ihlr-27183	56	10	)	)	PUNCT
ihlr-27183	57	1	(	(	PUNCT
ihlr-27183	57	2	experimentation	experimentation	NOUN
ihlr-27183	57	3	with	with	ADP
ihlr-27183	57	4	patented	patented	ADJ
ihlr-27183	57	5	steel	steel	NOUN
ihlr-27183	57	6	alloys	alloy	NOUN
ihlr-27183	57	7	excused	excuse	VERB
ihlr-27183	57	8	under	under	ADP
ihlr-27183	57	9	experimental	experimental	ADJ
ihlr-27183	57	10	use	use	NOUN
ihlr-27183	57	11	inter	inter	ADJ
ihlr-27183	57	12	alia	alia	NOUN
ihlr-27183	57	13	because	because	SCONJ
ihlr-27183	57	14	no	no	DET
ihlr-27183	57	15	evidence	evidence	NOUN
ihlr-27183	57	16	suggested	suggest	VERB
ihlr-27183	57	17	the	the	DET
ihlr-27183	57	18	manufacture	manufacture	NOUN
ihlr-27183	57	19	sold	sell	VERB
ihlr-27183	57	20	or	or	CCONJ
ihlr-27183	57	21	intended	intend	VERB
ihlr-27183	57	22	it	it	PRON
ihlr-27183	57	23	for	for	ADP
ihlr-27183	57	24	sale	sale	NOUN
ihlr-27183	57	25	)	)	PUNCT
ihlr-27183	57	26	;	;	PUNCT
ihlr-27183	57	27	dugan	dugan	VERB
ihlr-27183	57	28	v.	v.	PROPN
ihlr-27183	57	29	lear	lear	PROPN
ihlr-27183	57	30	avia	avia	PROPN
ihlr-27183	57	31	,	,	PUNCT
ihlr-27183	57	32	55	55	NUM
ihlr-27183	57	33	f.	f.	PROPN
ihlr-27183	57	34	supp	supp	PROPN
ihlr-27183	57	35	.	.	PUNCT
ihlr-27183	58	1	223	223	NUM
ihlr-27183	58	2	(	(	PUNCT
ihlr-27183	58	3	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	58	4	.	.	PROPN
ihlr-27183	58	5	1944	1944	NUM
ihlr-27183	58	6	)	)	PUNCT
ihlr-27183	58	7	,	,	PUNCT
ihlr-27183	58	8	aff'd	aff'd	NOUN
ihlr-27183	58	9	sub	sub	PROPN
ihlr-27183	58	10	nom	nom	PROPN
ihlr-27183	58	11	.	.	PROPN
ihlr-27183	58	12	dugan	dugan	PROPN
ihlr-27183	58	13	v.	v.	PROPN
ihlr-27183	58	14	lear	lear	PROPN
ihlr-27183	58	15	,	,	PUNCT
ihlr-27183	58	16	inc	inc	PROPN
ihlr-27183	58	17	.	.	PROPN
ihlr-27183	58	18	,	,	PUNCT
ihlr-27183	58	19	156	156	NUM
ihlr-27183	58	20	f.2d	f.2d	SYM
ihlr-27183	58	21	29	29	NUM
ihlr-27183	58	22	(	(	PUNCT
ihlr-27183	58	23	2d	2d	NUM
ihlr-27183	58	24	cir	cir	NOUN
ihlr-27183	58	25	.	.	PUNCT
ihlr-27183	58	26	1946	1946	NUM
ihlr-27183	58	27	)	)	PUNCT
ihlr-27183	59	1	(	(	PUNCT
ihlr-27183	59	2	building	building	NOUN
ihlr-27183	59	3	of	of	ADP
ihlr-27183	59	4	a	a	DET
ihlr-27183	59	5	patented	patented	ADJ
ihlr-27183	59	6	device	device	NOUN
ihlr-27183	59	7	was	be	AUX
ihlr-27183	59	8	protected	protect	VERB
ihlr-27183	59	9	from	from	ADP
ihlr-27183	59	10	infringement	infringement	NOUN
ihlr-27183	59	11	because	because	SCONJ
ihlr-27183	59	12	,	,	PUNCT
ihlr-27183	59	13	though	though	SCONJ
ihlr-27183	59	14	it	it	PRON
ihlr-27183	59	15	was	be	AUX
ihlr-27183	59	16	built	build	VERB
ihlr-27183	59	17	by	by	ADP
ihlr-27183	59	18	a	a	DET
ihlr-27183	59	19	business	business	NOUN
ihlr-27183	59	20	,	,	PUNCT
ihlr-27183	59	21	it	it	PRON
ihlr-27183	59	22	was	be	AUX
ihlr-27183	59	23	not	not	PART
ihlr-27183	59	24	sold	sell	VERB
ihlr-27183	59	25	or	or	CCONJ
ihlr-27183	59	26	intended	intend	VERB
ihlr-27183	59	27	for	for	ADP
ihlr-27183	59	28	sale	sale	NOUN
ihlr-27183	59	29	)	)	PUNCT
ihlr-27183	59	30	;	;	PUNCT
ihlr-27183	59	31	akro	akro	PROPN
ihlr-27183	59	32	agate	agate	PROPN
ihlr-27183	59	33	co.	co.	PROPN
ihlr-27183	59	34	v.	v.	ADP
ihlr-27183	59	35	master	master	PROPN
ihlr-27183	59	36	marble	marble	PROPN
ihlr-27183	59	37	co.	co.	PROPN
ihlr-27183	59	38	,	,	PUNCT
ihlr-27183	59	39	18	18	NUM
ihlr-27183	59	40	f.	f.	PROPN
ihlr-27183	59	41	supp	supp	PROPN
ihlr-27183	59	42	.	.	PUNCT
ihlr-27183	60	1	305	305	NUM
ihlr-27183	60	2	(	(	PUNCT
ihlr-27183	60	3	n.d.w	n.d.w	NOUN
ihlr-27183	60	4	.	.	PROPN
ihlr-27183	60	5	va	va	PROPN
ihlr-27183	60	6	.	.	PROPN
ihlr-27183	60	7	1937	1937	NUM
ihlr-27183	60	8	)	)	PUNCT
ihlr-27183	60	9	(	(	PUNCT
ihlr-27183	60	10	making	make	VERB
ihlr-27183	60	11	and	and	CCONJ
ihlr-27183	60	12	using	use	VERB
ihlr-27183	60	13	a	a	DET
ihlr-27183	60	14	patented	patented	ADJ
ihlr-27183	60	15	product	product	NOUN
ihlr-27183	60	16	was	be	AUX
ihlr-27183	60	17	protected	protect	VERB
ihlr-27183	60	18	from	from	ADP
ihlr-27183	60	19	infringement	infringement	NOUN
ihlr-27183	60	20	because	because	SCONJ
ihlr-27183	60	21	,	,	PUNCT
ihlr-27183	60	22	though	though	SCONJ
ihlr-27183	60	23	it	it	PRON
ihlr-27183	60	24	was	be	AUX
ihlr-27183	60	25	made	make	VERB
ihlr-27183	60	26	and	and	CCONJ
ihlr-27183	60	27	confirmed	confirm	VERB
ihlr-27183	60	28	to	to	PART
ihlr-27183	60	29	work	work	VERB
ihlr-27183	60	30	with	with	ADP
ihlr-27183	60	31	production	production	NOUN
ihlr-27183	60	32	equipment	equipment	NOUN
ihlr-27183	60	33	,	,	PUNCT
ihlr-27183	60	34	it	it	PRON
ihlr-27183	60	35	was	be	AUX
ihlr-27183	60	36	not	not	PART
ihlr-27183	60	37	commercially	commercially	ADV
ihlr-27183	60	38	sold	sell	VERB
ihlr-27183	60	39	)	)	PUNCT
ihlr-27183	60	40	.	.	PUNCT
ihlr-27183	61	1	12	12	NUM
ihlr-27183	61	2	.	.	PUNCT
ihlr-27183	62	1	dugan	dugan	VERB
ihlr-27183	62	2	v.	v.	ADP
ihlr-27183	62	3	lear	lear	PROPN
ihlr-27183	62	4	avia	avia	PROPN
ihlr-27183	62	5	,	,	PUNCT
ihlr-27183	62	6	55	55	NUM
ihlr-27183	62	7	f.	f.	PROPN
ihlr-27183	62	8	supp	supp	PROPN
ihlr-27183	62	9	.	.	PUNCT
ihlr-27183	63	1	223	223	NUM
ihlr-27183	63	2	,	,	PUNCT
ihlr-27183	63	3	228	228	NUM
ihlr-27183	63	4	(	(	PUNCT
ihlr-27183	63	5	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	63	6	.	.	PROPN
ihlr-27183	63	7	1944	1944	NUM
ihlr-27183	63	8	)	)	PUNCT
ihlr-27183	63	9	.	.	PUNCT
ihlr-27183	64	1	13	13	NUM
ihlr-27183	64	2	.	.	X
ihlr-27183	64	3	pitcairn	pitcairn	PROPN
ihlr-27183	64	4	v.	v.	PROPN
ihlr-27183	64	5	united	united	PROPN
ihlr-27183	64	6	states	states	PROPN
ihlr-27183	64	7	,	,	PUNCT
ihlr-27183	64	8	547	547	NUM
ihlr-27183	64	9	f.2d	f.2d	NOUN
ihlr-27183	64	10	1106	1106	NUM
ihlr-27183	64	11	,	,	PUNCT
ihlr-27183	64	12	1125	1125	NUM
ihlr-27183	64	13	-	-	SYM
ihlr-27183	64	14	26	26	NUM
ihlr-27183	64	15	(	(	PUNCT
ihlr-27183	64	16	ct	ct	PROPN
ihlr-27183	64	17	.	.	PUNCT
ihlr-27183	64	18	cl	cl	NOUN
ihlr-27183	64	19	.	.	PUNCT
ihlr-27183	64	20	1976	1976	NUM
ihlr-27183	64	21	)	)	PUNCT
ihlr-27183	64	22	.	.	PUNCT
ihlr-27183	65	1	14	14	NUM
ihlr-27183	65	2	.	.	PUNCT
ihlr-27183	66	1	roche	roche	PROPN
ihlr-27183	66	2	products	products	PROPN
ihlr-27183	66	3	,	,	PUNCT
ihlr-27183	66	4	inc	inc	PROPN
ihlr-27183	66	5	.	.	PROPN
ihlr-27183	66	6	,	,	PUNCT
ihlr-27183	66	7	733	733	NUM
ihlr-27183	66	8	f.2d	f.2d	X
ihlr-27183	66	9	at	at	ADP
ihlr-27183	66	10	862	862	NUM
ihlr-27183	66	11	.	.	PUNCT
ihlr-27183	67	1	15	15	NUM
ihlr-27183	67	2	.	.	PUNCT
ihlr-27183	68	1	i	i	PRON
ihlr-27183	68	2	d.	d.	PROPN
ihlr-27183	68	3	at	at	ADP
ihlr-27183	68	4	860	860	NUM
ihlr-27183	68	5	.	.	PUNCT
ihlr-27183	68	6	146	146	NUM
ihlr-27183	68	7	indiana	indiana	PROPN
ihlr-27183	68	8	health	health	PROPN
ihlr-27183	68	9	law	law	PROPN
ihlr-27183	68	10	review	review	NOUN
ihlr-27183	68	11	[	[	X
ihlr-27183	68	12	vol	vol	NOUN
ihlr-27183	68	13	.	.	PUNCT
ihlr-27183	68	14	20:143	20:143	PROPN
ihlr-27183	68	15	would	would	AUX
ihlr-27183	68	16	be	be	AUX
ihlr-27183	68	17	market	market	NOUN
ihlr-27183	68	18	-	-	PUNCT
ihlr-27183	68	19	ready	ready	ADJ
ihlr-27183	68	20	soon	soon	ADV
ihlr-27183	68	21	after	after	SCONJ
ihlr-27183	68	22	roche	roche	PROPN
ihlr-27183	68	23	’s	’s	PART
ihlr-27183	68	24	patent	patent	PROPN
ihlr-27183	68	25	expired.16	expired.16	PROPN
ihlr-27183	68	26	in	in	ADP
ihlr-27183	68	27	an	an	DET
ihlr-27183	68	28	unusually	unusually	ADV
ihlr-27183	68	29	forceful	forceful	ADJ
ihlr-27183	68	30	opinion	opinion	NOUN
ihlr-27183	68	31	,	,	PUNCT
ihlr-27183	68	32	the	the	DET
ihlr-27183	68	33	newly	newly	ADV
ihlr-27183	68	34	minted17	minted17	NOUN
ihlr-27183	68	35	federal	federal	ADJ
ihlr-27183	68	36	circuit	circuit	NOUN
ihlr-27183	68	37	declined	decline	VERB
ihlr-27183	68	38	to	to	PART
ihlr-27183	68	39	extend	extend	VERB
ihlr-27183	68	40	the	the	DET
ihlr-27183	68	41	experimental	experimental	ADJ
ihlr-27183	68	42	use	use	NOUN
ihlr-27183	68	43	doctrine	doctrine	NOUN
ihlr-27183	68	44	to	to	PART
ihlr-27183	68	45	protect	protect	VERB
ihlr-27183	68	46	generics	generic	NOUN
ihlr-27183	68	47	seeking	seek	VERB
ihlr-27183	68	48	fda	fda	PROPN
ihlr-27183	68	49	approval	approval	PROPN
ihlr-27183	68	50	,	,	PUNCT
ihlr-27183	68	51	emphasizing	emphasize	VERB
ihlr-27183	68	52	the	the	DET
ihlr-27183	68	53	doctrine	doctrine	NOUN
ihlr-27183	68	54	was	be	AUX
ihlr-27183	68	55	ill	ill	ADV
ihlr-27183	68	56	-	-	PUNCT
ihlr-27183	68	57	fitted	fit	VERB
ihlr-27183	68	58	for	for	ADP
ihlr-27183	68	59	the	the	DET
ihlr-27183	68	60	circumstances	circumstance	NOUN
ihlr-27183	68	61	and	and	CCONJ
ihlr-27183	68	62	that	that	SCONJ
ihlr-27183	68	63	the	the	DET
ihlr-27183	68	64	federal	federal	ADJ
ihlr-27183	68	65	circuit	circuit	NOUN
ihlr-27183	68	66	was	be	AUX
ihlr-27183	68	67	not	not	PART
ihlr-27183	68	68	authorized	authorize	VERB
ihlr-27183	68	69	to	to	PART
ihlr-27183	68	70	rewrite	rewrite	VERB
ihlr-27183	68	71	patent	patent	NOUN
ihlr-27183	68	72	law.18	law.18	PROPN
ihlr-27183	68	73	thus	thus	ADV
ihlr-27183	68	74	,	,	PUNCT
ihlr-27183	68	75	while	while	SCONJ
ihlr-27183	68	76	generic	generic	ADJ
ihlr-27183	68	77	drug	drug	NOUN
ihlr-27183	68	78	manufacturers	manufacturer	NOUN
ihlr-27183	68	79	once	once	ADV
ihlr-27183	68	80	offered	offer	VERB
ihlr-27183	68	81	the	the	DET
ihlr-27183	68	82	experimental	experimental	ADJ
ihlr-27183	68	83	use	use	NOUN
ihlr-27183	68	84	exemption	exemption	NOUN
ihlr-27183	68	85	with	with	ADP
ihlr-27183	68	86	a	a	DET
ihlr-27183	68	87	flicker	flicker	NOUN
ihlr-27183	68	88	of	of	ADP
ihlr-27183	68	89	hope	hope	NOUN
ihlr-27183	68	90	that	that	SCONJ
ihlr-27183	68	91	it	it	PRON
ihlr-27183	68	92	might	might	AUX
ihlr-27183	68	93	protect	protect	VERB
ihlr-27183	68	94	their	their	PRON
ihlr-27183	68	95	pursuit	pursuit	NOUN
ihlr-27183	68	96	of	of	ADP
ihlr-27183	68	97	fda	fda	PROPN
ihlr-27183	68	98	approval	approval	NOUN
ihlr-27183	68	99	in	in	ADP
ihlr-27183	68	100	advance	advance	NOUN
ihlr-27183	68	101	of	of	ADP
ihlr-27183	68	102	patent	patent	NOUN
ihlr-27183	68	103	expiration	expiration	NOUN
ihlr-27183	68	104	,	,	PUNCT
ihlr-27183	68	105	the	the	DET
ihlr-27183	68	106	roche	roche	PROPN
ihlr-27183	68	107	court	court	PROPN
ihlr-27183	68	108	formally	formally	ADV
ihlr-27183	68	109	snuffed	snuff	VERB
ihlr-27183	68	110	out	out	ADP
ihlr-27183	68	111	exactly	exactly	ADV
ihlr-27183	68	112	that	that	DET
ihlr-27183	68	113	wish	wish	VERB
ihlr-27183	68	114	.	.	PUNCT
ihlr-27183	69	1	in	in	ADP
ihlr-27183	69	2	its	its	PRON
ihlr-27183	69	3	stated	state	VERB
ihlr-27183	69	4	refusal	refusal	NOUN
ihlr-27183	69	5	to	to	PART
ihlr-27183	69	6	act	act	VERB
ihlr-27183	69	7	in	in	ADP
ihlr-27183	69	8	a	a	DET
ihlr-27183	69	9	legislative	legislative	ADJ
ihlr-27183	69	10	manner,19	manner,19	NOUN
ihlr-27183	69	11	the	the	DET
ihlr-27183	69	12	roche	roche	PROPN
ihlr-27183	69	13	court	court	PROPN
ihlr-27183	69	14	deliberately	deliberately	ADV
ihlr-27183	69	15	highlighted	highlight	VERB
ihlr-27183	69	16	the	the	DET
ihlr-27183	69	17	strong	strong	ADJ
ihlr-27183	69	18	public	public	ADJ
ihlr-27183	69	19	policy	policy	NOUN
ihlr-27183	69	20	rationale	rationale	NOUN
ihlr-27183	69	21	for	for	ADP
ihlr-27183	69	22	an	an	DET
ihlr-27183	69	23	exemption	exemption	NOUN
ihlr-27183	69	24	.	.	PUNCT
ihlr-27183	70	1	the	the	DET
ihlr-27183	70	2	public	public	ADJ
ihlr-27183	70	3	welfare	welfare	NOUN
ihlr-27183	70	4	,	,	PUNCT
ihlr-27183	70	5	in	in	ADP
ihlr-27183	70	6	the	the	DET
ihlr-27183	70	7	form	form	NOUN
ihlr-27183	70	8	of	of	ADP
ihlr-27183	70	9	affordable	affordable	ADJ
ihlr-27183	70	10	drug	drug	NOUN
ihlr-27183	70	11	prices	price	NOUN
ihlr-27183	70	12	,	,	PUNCT
ihlr-27183	70	13	depends	depend	VERB
ihlr-27183	70	14	on	on	ADP
ihlr-27183	70	15	price	price	NOUN
ihlr-27183	70	16	competition	competition	NOUN
ihlr-27183	70	17	as	as	ADV
ihlr-27183	70	18	much	much	ADV
ihlr-27183	70	19	as	as	ADP
ihlr-27183	70	20	protecting	protect	VERB
ihlr-27183	70	21	the	the	DET
ihlr-27183	70	22	right	right	NOUN
ihlr-27183	70	23	to	to	PART
ihlr-27183	70	24	profit	profit	VERB
ihlr-27183	70	25	from	from	ADP
ihlr-27183	70	26	a	a	DET
ihlr-27183	70	27	large	large	ADJ
ihlr-27183	70	28	investment.20	investment.20	NOUN
ihlr-27183	70	29	without	without	ADP
ihlr-27183	70	30	the	the	DET
ihlr-27183	70	31	former	former	ADJ
ihlr-27183	70	32	,	,	PUNCT
ihlr-27183	70	33	fewer	few	ADJ
ihlr-27183	70	34	can	can	AUX
ihlr-27183	70	35	afford	afford	VERB
ihlr-27183	70	36	the	the	DET
ihlr-27183	70	37	drugs	drug	NOUN
ihlr-27183	70	38	produced	produce	VERB
ihlr-27183	70	39	;	;	PUNCT
ihlr-27183	70	40	without	without	ADP
ihlr-27183	70	41	the	the	DET
ihlr-27183	70	42	latter	latter	ADJ
ihlr-27183	70	43	,	,	PUNCT
ihlr-27183	70	44	the	the	DET
ihlr-27183	70	45	drugs	drug	NOUN
ihlr-27183	70	46	may	may	AUX
ihlr-27183	70	47	never	never	ADV
ihlr-27183	70	48	be	be	AUX
ihlr-27183	70	49	developed	develop	VERB
ihlr-27183	70	50	at	at	ADV
ihlr-27183	70	51	all	all	ADV
ihlr-27183	70	52	.	.	PUNCT
ihlr-27183	71	1	even	even	ADV
ihlr-27183	71	2	so	so	ADV
ihlr-27183	71	3	,	,	PUNCT
ihlr-27183	71	4	the	the	DET
ihlr-27183	71	5	court	court	NOUN
ihlr-27183	71	6	noted	note	VERB
ihlr-27183	71	7	the	the	DET
ihlr-27183	71	8	strength	strength	NOUN
ihlr-27183	71	9	of	of	ADP
ihlr-27183	71	10	any	any	DET
ihlr-27183	71	11	public	public	ADJ
ihlr-27183	71	12	policy	policy	NOUN
ihlr-27183	71	13	rationale	rationale	NOUN
ihlr-27183	71	14	as	as	ADP
ihlr-27183	71	15	immaterial	immaterial	ADJ
ihlr-27183	71	16	to	to	ADP
ihlr-27183	71	17	their	their	PRON
ihlr-27183	71	18	task	task	NOUN
ihlr-27183	71	19	–	–	PUNCT
ihlr-27183	71	20	naming	name	VERB
ihlr-27183	71	21	the	the	DET
ihlr-27183	71	22	legislature	legislature	NOUN
ihlr-27183	71	23	as	as	ADP
ihlr-27183	71	24	the	the	DET
ihlr-27183	71	25	proper	proper	ADJ
ihlr-27183	71	26	forum	forum	NOUN
ihlr-27183	71	27	for	for	ADP
ihlr-27183	71	28	such	such	DET
ihlr-27183	71	29	a	a	DET
ihlr-27183	71	30	debate	debate	NOUN
ihlr-27183	71	31	and	and	CCONJ
ihlr-27183	71	32	referencing	reference	VERB
ihlr-27183	71	33	pending	pende	VERB
ihlr-27183	71	34	legislation	legislation	NOUN
ihlr-27183	71	35	on	on	ADP
ihlr-27183	71	36	the	the	DET
ihlr-27183	71	37	very	very	ADJ
ihlr-27183	71	38	issue.21	issue.21	NOUN
ihlr-27183	71	39	the	the	DET
ihlr-27183	71	40	roche	roche	PROPN
ihlr-27183	71	41	opinion	opinion	NOUN
ihlr-27183	71	42	has	have	AUX
ihlr-27183	71	43	been	be	AUX
ihlr-27183	71	44	interpreted	interpret	VERB
ihlr-27183	71	45	as	as	ADP
ihlr-27183	71	46	a	a	DET
ihlr-27183	71	47	“	"	PUNCT
ihlr-27183	71	48	very	very	ADV
ihlr-27183	71	49	narrow	narrow	ADJ
ihlr-27183	71	50	”	"	PUNCT
ihlr-27183	71	51	experimental	experimental	ADJ
ihlr-27183	71	52	use	use	NOUN
ihlr-27183	71	53	exemption.22	exemption.22	NOUN
ihlr-27183	71	54	the	the	DET
ihlr-27183	71	55	often	often	ADV
ihlr-27183	71	56	-	-	PUNCT
ihlr-27183	71	57	quoted	quote	VERB
ihlr-27183	71	58	standard	standard	NOUN
ihlr-27183	71	59	from	from	ADP
ihlr-27183	71	60	roche	roche	PROPN
ihlr-27183	71	61	holds	hold	VERB
ihlr-27183	71	62	the	the	DET
ihlr-27183	71	63	exemption	exemption	NOUN
ihlr-27183	71	64	is	be	AUX
ihlr-27183	71	65	limited	limit	VERB
ihlr-27183	71	66	to	to	ADP
ihlr-27183	71	67	actions	action	NOUN
ihlr-27183	71	68	performed	perform	VERB
ihlr-27183	71	69	“	"	PUNCT
ihlr-27183	71	70	for	for	ADP
ihlr-27183	71	71	amusement	amusement	NOUN
ihlr-27183	71	72	,	,	PUNCT
ihlr-27183	71	73	to	to	PART
ihlr-27183	71	74	satisfy	satisfy	VERB
ihlr-27183	71	75	idle	idle	ADJ
ihlr-27183	71	76	curiosity	curiosity	NOUN
ihlr-27183	71	77	,	,	PUNCT
ihlr-27183	71	78	or	or	CCONJ
ihlr-27183	71	79	for	for	ADP
ihlr-27183	71	80	strictly	strictly	ADV
ihlr-27183	71	81	philosophical	philosophical	ADJ
ihlr-27183	71	82	inquiry	inquiry	NOUN
ihlr-27183	71	83	”	"	PUNCT
ihlr-27183	71	84	–	–	PUNCT
ihlr-27183	71	85	a	a	DET
ihlr-27183	71	86	hermetically	hermetically	NOUN
ihlr-27183	71	87	sealed	seal	VERB
ihlr-27183	71	88	version	version	NOUN
ihlr-27183	71	89	of	of	ADP
ihlr-27183	71	90	the	the	DET
ihlr-27183	71	91	poppenhusen	poppenhusen	NOUN
ihlr-27183	71	92	wording	wording	NOUN
ihlr-27183	71	93	from	from	ADP
ihlr-27183	71	94	the	the	DET
ihlr-27183	71	95	mid	mid	PROPN
ihlr-27183	71	96	-	-	ADJ
ihlr-27183	71	97	nineteenth	nineteenth	ADJ
ihlr-27183	71	98	century.23	century.23	ADJ
ihlr-27183	71	99	within	within	ADP
ihlr-27183	71	100	months	month	NOUN
ihlr-27183	71	101	of	of	ADP
ihlr-27183	71	102	the	the	DET
ihlr-27183	71	103	roche	roche	NOUN
ihlr-27183	71	104	decision	decision	NOUN
ihlr-27183	71	105	,	,	PUNCT
ihlr-27183	71	106	the	the	DET
ihlr-27183	71	107	drug	drug	NOUN
ihlr-27183	71	108	price	price	NOUN
ihlr-27183	71	109	competition	competition	NOUN
ihlr-27183	71	110	and	and	CCONJ
ihlr-27183	71	111	patent	patent	NOUN
ihlr-27183	71	112	term	term	NOUN
ihlr-27183	71	113	restoration	restoration	NOUN
ihlr-27183	71	114	act	act	NOUN
ihlr-27183	71	115	(	(	PUNCT
ihlr-27183	71	116	“	"	PUNCT
ihlr-27183	71	117	the	the	DET
ihlr-27183	71	118	act	act	NOUN
ihlr-27183	71	119	”	"	PUNCT
ihlr-27183	71	120	or	or	CCONJ
ihlr-27183	71	121	“	"	PUNCT
ihlr-27183	71	122	the	the	DET
ihlr-27183	71	123	hatch	hatch	PROPN
ihlr-27183	71	124	-	-	PUNCT
ihlr-27183	71	125	waxman	waxman	PROPN
ihlr-27183	71	126	act	act	PROPN
ihlr-27183	71	127	”	"	PUNCT
ihlr-27183	71	128	)	)	PUNCT
ihlr-27183	71	129	was	be	AUX
ihlr-27183	71	130	signed	sign	VERB
ihlr-27183	71	131	into	into	ADP
ihlr-27183	71	132	law	law	NOUN
ihlr-27183	71	133	in	in	ADP
ihlr-27183	71	134	september	september	PROPN
ihlr-27183	71	135	of	of	ADP
ihlr-27183	71	136	1984.24	1984.24	NUM
ihlr-27183	71	137	as	as	SCONJ
ihlr-27183	71	138	designed	design	VERB
ihlr-27183	71	139	,	,	PUNCT
ihlr-27183	71	140	§	§	PROPN
ihlr-27183	71	141	271(e)(1	271(e)(1	PROPN
ihlr-27183	71	142	)	)	PUNCT
ihlr-27183	71	143	of	of	ADP
ihlr-27183	71	144	the	the	DET
ihlr-27183	71	145	hatch	hatch	PROPN
ihlr-27183	71	146	-	-	PUNCT
ihlr-27183	71	147	waxman	waxman	PROPN
ihlr-27183	71	148	act	act	PROPN
ihlr-27183	71	149	,	,	PUNCT
ihlr-27183	71	150	16	16	NUM
ihlr-27183	71	151	.	.	PUNCT
ihlr-27183	72	1	i	i	PRON
ihlr-27183	72	2	d.	d.	PROPN
ihlr-27183	72	3	17	17	NUM
ihlr-27183	72	4	.	.	PUNCT
ihlr-27183	73	1	u.s	u.s	PROPN
ihlr-27183	73	2	.	.	PROPN
ihlr-27183	73	3	ct	ct	PROPN
ihlr-27183	73	4	.	.	PROPN
ihlr-27183	73	5	of	of	ADP
ihlr-27183	73	6	app	app	PROPN
ihlr-27183	73	7	.	.	PUNCT
ihlr-27183	74	1	for	for	ADP
ihlr-27183	74	2	the	the	DET
ihlr-27183	74	3	fed	fed	PROPN
ihlr-27183	74	4	.	.	PUNCT
ihlr-27183	74	5	cir	cir	PROPN
ihlr-27183	74	6	.	.	PROPN
ihlr-27183	74	7	,	,	PUNCT
ihlr-27183	74	8	https://cafc.uscourts.gov/home/the-court/about-thecourt/	https://cafc.uscourts.gov/home/the-court/about-thecourt/	PROPN
ihlr-27183	74	9	[	[	PUNCT
ihlr-27183	74	10	https://perma.cc/tu97-7d48	https://perma.cc/tu97-7d48	NOUN
ihlr-27183	74	11	]	]	PUNCT
ihlr-27183	74	12	(	(	PUNCT
ihlr-27183	74	13	last	last	ADV
ihlr-27183	74	14	visited	visit	VERB
ihlr-27183	74	15	dec	dec	PROPN
ihlr-27183	74	16	.	.	PROPN
ihlr-27183	74	17	17	17	NUM
ihlr-27183	74	18	,	,	PUNCT
ihlr-27183	74	19	2022	2022	NUM
ihlr-27183	74	20	)	)	PUNCT
ihlr-27183	74	21	(	(	PUNCT
ihlr-27183	74	22	the	the	DET
ihlr-27183	74	23	federal	federal	ADJ
ihlr-27183	74	24	circuit	circuit	NOUN
ihlr-27183	74	25	formed	form	VERB
ihlr-27183	74	26	as	as	ADP
ihlr-27183	74	27	an	an	DET
ihlr-27183	74	28	article	article	NOUN
ihlr-27183	74	29	iii	iii	NUM
ihlr-27183	74	30	court	court	PROPN
ihlr-27183	74	31	on	on	ADP
ihlr-27183	74	32	october	october	PROPN
ihlr-27183	74	33	1	1	NUM
ihlr-27183	74	34	,	,	PUNCT
ihlr-27183	74	35	1982	1982	NUM
ihlr-27183	74	36	,	,	PUNCT
ihlr-27183	74	37	by	by	ADP
ihlr-27183	74	38	the	the	DET
ihlr-27183	74	39	merging	merging	NOUN
ihlr-27183	74	40	of	of	ADP
ihlr-27183	74	41	the	the	DET
ihlr-27183	74	42	united	united	PROPN
ihlr-27183	74	43	states	states	PROPN
ihlr-27183	74	44	court	court	PROPN
ihlr-27183	74	45	of	of	ADP
ihlr-27183	74	46	customs	customs	PROPN
ihlr-27183	74	47	and	and	CCONJ
ihlr-27183	74	48	patent	patent	NOUN
ihlr-27183	74	49	appeals	appeal	NOUN
ihlr-27183	74	50	and	and	CCONJ
ihlr-27183	74	51	the	the	DET
ihlr-27183	74	52	appellate	appellate	ADJ
ihlr-27183	74	53	division	division	NOUN
ihlr-27183	74	54	of	of	ADP
ihlr-27183	74	55	the	the	DET
ihlr-27183	74	56	united	united	PROPN
ihlr-27183	74	57	states	states	PROPN
ihlr-27183	74	58	court	court	PROPN
ihlr-27183	74	59	of	of	ADP
ihlr-27183	74	60	claims	claim	NOUN
ihlr-27183	74	61	)	)	PUNCT
ihlr-27183	74	62	.	.	PUNCT
ihlr-27183	75	1	18	18	NUM
ihlr-27183	75	2	.	.	PUNCT
ihlr-27183	76	1	roche	roche	PROPN
ihlr-27183	76	2	products	products	PROPN
ihlr-27183	76	3	,	,	PUNCT
ihlr-27183	76	4	inc	inc	PROPN
ihlr-27183	76	5	.	.	PROPN
ihlr-27183	76	6	,	,	PUNCT
ihlr-27183	76	7	733	733	NUM
ihlr-27183	76	8	f.2d	f.2d	X
ihlr-27183	76	9	at	at	ADP
ihlr-27183	76	10	862	862	NUM
ihlr-27183	76	11	-	-	SYM
ihlr-27183	76	12	65	65	NUM
ihlr-27183	76	13	(	(	PUNCT
ihlr-27183	76	14	the	the	DET
ihlr-27183	76	15	federal	federal	ADJ
ihlr-27183	76	16	circuit	circuit	NOUN
ihlr-27183	76	17	flags	flag	VERB
ihlr-27183	76	18	the	the	DET
ihlr-27183	76	19	expansive	expansive	ADJ
ihlr-27183	76	20	view	view	NOUN
ihlr-27183	76	21	of	of	ADP
ihlr-27183	76	22	experimental	experimental	ADJ
ihlr-27183	76	23	use	use	NOUN
ihlr-27183	76	24	shielding	shielding	NOUN
ihlr-27183	76	25	“	"	PUNCT
ihlr-27183	76	26	experiment	experiment	NOUN
ihlr-27183	76	27	”	"	PUNCT
ihlr-27183	76	28	as	as	ADP
ihlr-27183	76	29	“	"	PUNCT
ihlr-27183	76	30	obiter	obiter	NOUN
ihlr-27183	76	31	dictum	dictum	NOUN
ihlr-27183	76	32	”	"	PUNCT
ihlr-27183	76	33	and	and	CCONJ
ihlr-27183	76	34	refuses	refuse	VERB
ihlr-27183	76	35	to	to	PART
ihlr-27183	76	36	“	"	PUNCT
ihlr-27183	76	37	rewrite	rewrite	VERB
ihlr-27183	76	38	the	the	DET
ihlr-27183	76	39	patent	patent	NOUN
ihlr-27183	76	40	laws	law	NOUN
ihlr-27183	76	41	”	"	PUNCT
ihlr-27183	76	42	)	)	PUNCT
ihlr-27183	76	43	.	.	PUNCT
ihlr-27183	77	1	19	19	NUM
ihlr-27183	77	2	.	.	PUNCT
ihlr-27183	78	1	i	i	PRON
ihlr-27183	78	2	d.	d.	PROPN
ihlr-27183	78	3	at	at	ADP
ihlr-27183	78	4	863	863	NUM
ihlr-27183	78	5	-	-	SYM
ihlr-27183	78	6	64	64	NUM
ihlr-27183	78	7	(	(	PUNCT
ihlr-27183	78	8	“	"	PUNCT
ihlr-27183	78	9	parties	party	NOUN
ihlr-27183	78	10	.	.	PUNCT
ihlr-27183	78	11	.	.	PUNCT
ihlr-27183	79	1	.seem	.seem	VERB
ihlr-27183	79	2	to	to	PART
ihlr-27183	79	3	think	think	VERB
ihlr-27183	79	4	.	.	PUNCT
ihlr-27183	79	5	.	.	PUNCT
ihlr-27183	80	1	.we	.we	NUM
ihlr-27183	80	2	must	must	AUX
ihlr-27183	80	3	resolve	resolve	VERB
ihlr-27183	80	4	a	a	DET
ihlr-27183	80	5	conflict	conflict	NOUN
ihlr-27183	80	6	between	between	ADP
ihlr-27183	80	7	the	the	DET
ihlr-27183	80	8	federal	federal	ADJ
ihlr-27183	80	9	food	food	NOUN
ihlr-27183	80	10	,	,	PUNCT
ihlr-27183	80	11	drug	drug	NOUN
ihlr-27183	80	12	,	,	PUNCT
ihlr-27183	80	13	and	and	CCONJ
ihlr-27183	80	14	cosmetic	cosmetic	ADJ
ihlr-27183	80	15	act	act	NOUN
ihlr-27183	80	16	.	.	PUNCT
ihlr-27183	80	17	.	.	PUNCT
ihlr-27183	81	1	.and	.and	PUNCT
ihlr-27183	82	1	the	the	DET
ihlr-27183	82	2	patent	patent	NOUN
ihlr-27183	82	3	act	act	PROPN
ihlr-27183	82	4	[	[	X
ihlr-27183	82	5	.	.	PUNCT
ihlr-27183	82	6	]	]	X
ihlr-27183	83	1	we	we	PRON
ihlr-27183	83	2	decline	decline	VERB
ihlr-27183	83	3	the	the	DET
ihlr-27183	83	4	opportunity	opportunity	NOUN
ihlr-27183	83	5	here	here	ADV
ihlr-27183	83	6	,	,	PUNCT
ihlr-27183	83	7	however	however	ADV
ihlr-27183	83	8	,	,	PUNCT
ihlr-27183	83	9	to	to	PART
ihlr-27183	83	10	engage	engage	VERB
ihlr-27183	83	11	in	in	ADP
ihlr-27183	83	12	legislative	legislative	ADJ
ihlr-27183	83	13	activity	activity	NOUN
ihlr-27183	83	14	proper	proper	ADJ
ihlr-27183	83	15	only	only	ADV
ihlr-27183	83	16	for	for	ADP
ihlr-27183	83	17	the	the	DET
ihlr-27183	83	18	congress	congress	NOUN
ihlr-27183	83	19	.	.	PUNCT
ihlr-27183	83	20	”	"	PUNCT
ihlr-27183	83	21	)	)	PUNCT
ihlr-27183	83	22	.	.	PUNCT
ihlr-27183	84	1	20	20	NUM
ihlr-27183	84	2	.	.	PUNCT
ihlr-27183	85	1	i	i	PRON
ihlr-27183	85	2	d.	d.	PROPN
ihlr-27183	85	3	at	at	ADP
ihlr-27183	85	4	865	865	NUM
ihlr-27183	85	5	.	.	PUNCT
ihlr-27183	85	6	21	21	NUM
ihlr-27183	85	7	.	.	PUNCT
ihlr-27183	86	1	i	i	PRON
ihlr-27183	86	2	d.	d.	PROPN
ihlr-27183	86	3	(	(	PUNCT
ihlr-27183	86	4	the	the	DET
ihlr-27183	86	5	federal	federal	ADJ
ihlr-27183	86	6	circuit	circuit	NOUN
ihlr-27183	86	7	emphasized	emphasize	VERB
ihlr-27183	86	8	the	the	DET
ihlr-27183	86	9	fact	fact	NOUN
ihlr-27183	86	10	congress	congress	PROPN
ihlr-27183	86	11	was	be	AUX
ihlr-27183	86	12	actively	actively	ADV
ihlr-27183	86	13	debating	debate	VERB
ihlr-27183	86	14	the	the	DET
ihlr-27183	86	15	drug	drug	NOUN
ihlr-27183	86	16	price	price	NOUN
ihlr-27183	86	17	competition	competition	NOUN
ihlr-27183	86	18	act	act	NOUN
ihlr-27183	86	19	of	of	ADP
ihlr-27183	86	20	1983	1983	NUM
ihlr-27183	86	21	)	)	PUNCT
ihlr-27183	86	22	.	.	PUNCT
ihlr-27183	87	1	22	22	NUM
ihlr-27183	87	2	.	.	PUNCT
ihlr-27183	87	3	madey	madey	PROPN
ihlr-27183	87	4	v.	v.	PROPN
ihlr-27183	87	5	duke	duke	PROPN
ihlr-27183	87	6	university	university	PROPN
ihlr-27183	87	7	,	,	PUNCT
ihlr-27183	87	8	307	307	NUM
ihlr-27183	87	9	f.3d	f.3d	NUM
ihlr-27183	87	10	1351	1351	NUM
ihlr-27183	87	11	,	,	PUNCT
ihlr-27183	87	12	1362	1362	NUM
ihlr-27183	87	13	(	(	PUNCT
ihlr-27183	87	14	fed	fed	PROPN
ihlr-27183	87	15	.	.	PUNCT
ihlr-27183	87	16	cir	cir	PROPN
ihlr-27183	87	17	.	.	PROPN
ihlr-27183	87	18	2002	2002	NUM
ihlr-27183	87	19	)	)	PUNCT
ihlr-27183	87	20	.	.	PUNCT
ihlr-27183	88	1	23	23	NUM
ihlr-27183	88	2	.	.	PUNCT
ihlr-27183	89	1	roche	roche	PROPN
ihlr-27183	89	2	products	products	PROPN
ihlr-27183	89	3	,	,	PUNCT
ihlr-27183	89	4	inc	inc	PROPN
ihlr-27183	89	5	.	.	PROPN
ihlr-27183	89	6	,	,	PUNCT
ihlr-27183	89	7	733	733	NUM
ihlr-27183	89	8	f.2d	f.2d	X
ihlr-27183	89	9	at	at	ADP
ihlr-27183	89	10	863	863	NUM
ihlr-27183	89	11	;	;	PUNCT
ihlr-27183	89	12	see	see	VERB
ihlr-27183	89	13	also	also	ADV
ihlr-27183	89	14	madey	madey	ADJ
ihlr-27183	89	15	,	,	PUNCT
ihlr-27183	89	16	307	307	NUM
ihlr-27183	89	17	f.3d	f.3d	NUM
ihlr-27183	89	18	at	at	ADP
ihlr-27183	89	19	1362	1362	NUM
ihlr-27183	89	20	(	(	PUNCT
ihlr-27183	89	21	quoting	quote	VERB
ihlr-27183	89	22	embrex	embrex	PROPN
ihlr-27183	89	23	,	,	PUNCT
ihlr-27183	89	24	inc	inc	PROPN
ihlr-27183	89	25	.	.	PROPN
ihlr-27183	90	1	v.	v.	PROPN
ihlr-27183	90	2	serv	serv	PROPN
ihlr-27183	90	3	.	.	PUNCT
ihlr-27183	91	1	eng’g	eng’g	PROPN
ihlr-27183	91	2	corp	corp	PROPN
ihlr-27183	91	3	.	.	PROPN
ihlr-27183	91	4	,	,	PUNCT
ihlr-27183	91	5	216	216	NUM
ihlr-27183	91	6	f.3d	f.3d	NUM
ihlr-27183	91	7	1343	1343	NUM
ihlr-27183	91	8	(	(	PUNCT
ihlr-27183	91	9	fed	fed	PROPN
ihlr-27183	91	10	.	.	PUNCT
ihlr-27183	91	11	cir	cir	PROPN
ihlr-27183	91	12	.	.	PROPN
ihlr-27183	91	13	2000	2000	NUM
ihlr-27183	91	14	)	)	PUNCT
ihlr-27183	91	15	)	)	PUNCT
ihlr-27183	91	16	(	(	PUNCT
ihlr-27183	91	17	consistent	consistent	ADJ
ihlr-27183	91	18	reliance	reliance	NOUN
ihlr-27183	91	19	on	on	ADP
ihlr-27183	91	20	roche	roche	PROPN
ihlr-27183	91	21	’s	’s	PART
ihlr-27183	91	22	language	language	NOUN
ihlr-27183	91	23	)	)	PUNCT
ihlr-27183	91	24	.	.	PUNCT
ihlr-27183	92	1	24	24	NUM
ihlr-27183	92	2	.	.	PUNCT
ihlr-27183	93	1	president	president	PROPN
ihlr-27183	93	2	's	's	PART
ihlr-27183	93	3	remarks	remark	NOUN
ihlr-27183	93	4	on	on	ADP
ihlr-27183	93	5	signing	sign	VERB
ihlr-27183	93	6	the	the	DET
ihlr-27183	93	7	drug	drug	NOUN
ihlr-27183	93	8	price	price	NOUN
ihlr-27183	93	9	competition	competition	NOUN
ihlr-27183	93	10	and	and	CCONJ
ihlr-27183	93	11	patent	patent	NOUN
ihlr-27183	93	12	term	term	NOUN
ihlr-27183	93	13	restoration	restoration	NOUN
ihlr-27183	93	14	act	act	NOUN
ihlr-27183	93	15	of	of	ADP
ihlr-27183	93	16	1984	1984	NUM
ihlr-27183	93	17	at	at	ADP
ihlr-27183	93	18	the	the	DET
ihlr-27183	93	19	white	white	PROPN
ihlr-27183	93	20	house	house	PROPN
ihlr-27183	93	21	,	,	PUNCT
ihlr-27183	93	22	washington	washington	PROPN
ihlr-27183	93	23	d.c	d.c	PROPN
ihlr-27183	93	24	.	.	PROPN
ihlr-27183	93	25	,	,	PUNCT
ihlr-27183	93	26	20	20	NUM
ihlr-27183	93	27	pub	pub	NOUN
ihlr-27183	93	28	.	.	PUNCT
ihlr-27183	94	1	papers	paper	NOUN
ihlr-27183	94	2	39	39	NUM
ihlr-27183	94	3	(	(	PUNCT
ihlr-27183	94	4	sept	sept	PROPN
ihlr-27183	94	5	.	.	PROPN
ihlr-27183	94	6	24	24	NUM
ihlr-27183	94	7	,	,	PUNCT
ihlr-27183	94	8	1984	1984	NUM
ihlr-27183	94	9	)	)	PUNCT
ihlr-27183	94	10	(	(	PUNCT
ihlr-27183	94	11	ronald	ronald	PROPN
ihlr-27183	94	12	reagan	reagan	PROPN
ihlr-27183	94	13	signed	sign	VERB
ihlr-27183	94	14	the	the	DET
ihlr-27183	94	15	hatch	hatch	NOUN
ihlr-27183	94	16	-	-	PUNCT
ihlr-27183	94	17	waxman	waxman	PROPN
ihlr-27183	94	18	act	act	NOUN
ihlr-27183	94	19	into	into	ADP
ihlr-27183	94	20	law	law	NOUN
ihlr-27183	94	21	on	on	ADP
ihlr-27183	94	22	september	september	PROPN
ihlr-27183	94	23	24	24	NUM
ihlr-27183	94	24	,	,	PUNCT
ihlr-27183	94	25	1984	1984	NUM
ihlr-27183	94	26	)	)	PUNCT
ihlr-27183	94	27	.	.	PUNCT
ihlr-27183	95	1	2023	2023	NUM
ihlr-27183	95	2	]	]	PUNCT
ihlr-27183	95	3	the	the	DET
ihlr-27183	95	4	safe	safe	ADJ
ihlr-27183	95	5	harbor	harbor	NOUN
ihlr-27183	95	6	of	of	ADP
ihlr-27183	95	7	35	35	NUM
ihlr-27183	95	8	u.s.c	u.s.c	ADJ
ihlr-27183	95	9	.	.	PUNCT
ihlr-27183	96	1	§	§	PROPN
ihlr-27183	96	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	96	3	)	)	PUNCT
ihlr-27183	96	4	147	147	NUM
ihlr-27183	96	5	commonly	commonly	ADV
ihlr-27183	96	6	referred	refer	VERB
ihlr-27183	96	7	to	to	ADP
ihlr-27183	96	8	as	as	ADP
ihlr-27183	96	9	the	the	DET
ihlr-27183	96	10	“	"	PUNCT
ihlr-27183	96	11	safe	safe	ADJ
ihlr-27183	96	12	harbor	harbor	NOUN
ihlr-27183	96	13	”	"	PUNCT
ihlr-27183	96	14	provision	provision	NOUN
ihlr-27183	96	15	,	,	PUNCT
ihlr-27183	96	16	successfully	successfully	ADV
ihlr-27183	96	17	allows	allow	VERB
ihlr-27183	96	18	a	a	DET
ihlr-27183	96	19	generic	generic	ADJ
ihlr-27183	96	20	drug	drug	NOUN
ihlr-27183	96	21	manufacturer	manufacturer	NOUN
ihlr-27183	96	22	to	to	PART
ihlr-27183	96	23	use	use	VERB
ihlr-27183	96	24	a	a	DET
ihlr-27183	96	25	patented	patent	VERB
ihlr-27183	96	26	drug	drug	NOUN
ihlr-27183	96	27	prior	prior	ADV
ihlr-27183	96	28	to	to	ADP
ihlr-27183	96	29	patent	patent	NOUN
ihlr-27183	96	30	expiration	expiration	NOUN
ihlr-27183	96	31	when	when	SCONJ
ihlr-27183	96	32	generating	generate	VERB
ihlr-27183	96	33	data	datum	NOUN
ihlr-27183	96	34	for	for	ADP
ihlr-27183	96	35	fda	fda	PROPN
ihlr-27183	96	36	submission	submission	NOUN
ihlr-27183	96	37	:	:	PUNCT
ihlr-27183	96	38	it	it	PRON
ihlr-27183	96	39	shall	shall	AUX
ihlr-27183	96	40	not	not	PART
ihlr-27183	96	41	be	be	AUX
ihlr-27183	96	42	an	an	DET
ihlr-27183	96	43	act	act	NOUN
ihlr-27183	96	44	of	of	ADP
ihlr-27183	96	45	infringement	infringement	NOUN
ihlr-27183	96	46	to	to	PART
ihlr-27183	96	47	make	make	VERB
ihlr-27183	96	48	,	,	PUNCT
ihlr-27183	96	49	use	use	NOUN
ihlr-27183	96	50	,	,	PUNCT
ihlr-27183	96	51	offer	offer	VERB
ihlr-27183	96	52	to	to	PART
ihlr-27183	96	53	sell	sell	VERB
ihlr-27183	96	54	,	,	PUNCT
ihlr-27183	96	55	or	or	CCONJ
ihlr-27183	96	56	sell	sell	VERB
ihlr-27183	96	57	within	within	ADP
ihlr-27183	96	58	the	the	DET
ihlr-27183	96	59	united	united	PROPN
ihlr-27183	96	60	states	states	PROPN
ihlr-27183	96	61	or	or	CCONJ
ihlr-27183	96	62	import	import	VERB
ihlr-27183	96	63	into	into	ADP
ihlr-27183	96	64	the	the	DET
ihlr-27183	96	65	united	united	PROPN
ihlr-27183	96	66	states	states	PROPN
ihlr-27183	96	67	a	a	DET
ihlr-27183	96	68	patented	patented	ADJ
ihlr-27183	96	69	invention	invention	NOUN
ihlr-27183	96	70	.	.	PUNCT
ihlr-27183	96	71	.	.	PUNCT
ihlr-27183	96	72	.	.	PUNCT
ihlr-27183	97	1	solely	solely	ADV
ihlr-27183	97	2	for	for	ADP
ihlr-27183	97	3	uses	use	NOUN
ihlr-27183	97	4	reasonably	reasonably	ADV
ihlr-27183	97	5	related	relate	VERB
ihlr-27183	97	6	to	to	ADP
ihlr-27183	97	7	the	the	DET
ihlr-27183	97	8	development	development	NOUN
ihlr-27183	97	9	and	and	CCONJ
ihlr-27183	97	10	submission	submission	NOUN
ihlr-27183	97	11	of	of	ADP
ihlr-27183	97	12	information	information	NOUN
ihlr-27183	97	13	under	under	ADP
ihlr-27183	97	14	a	a	DET
ihlr-27183	97	15	federal	federal	ADJ
ihlr-27183	97	16	law	law	NOUN
ihlr-27183	97	17	which	which	PRON
ihlr-27183	97	18	regulates	regulate	VERB
ihlr-27183	97	19	the	the	DET
ihlr-27183	97	20	manufacture	manufacture	NOUN
ihlr-27183	97	21	,	,	PUNCT
ihlr-27183	97	22	use	use	NOUN
ihlr-27183	97	23	,	,	PUNCT
ihlr-27183	97	24	or	or	CCONJ
ihlr-27183	97	25	sale	sale	NOUN
ihlr-27183	97	26	of	of	ADP
ihlr-27183	97	27	drugs	drug	NOUN
ihlr-27183	97	28	or	or	CCONJ
ihlr-27183	97	29	veterinary	veterinary	ADJ
ihlr-27183	97	30	biological	biological	ADJ
ihlr-27183	97	31	products.25	products.25	NOUN
ihlr-27183	97	32	when	when	SCONJ
ihlr-27183	97	33	construing	construe	VERB
ihlr-27183	97	34	the	the	DET
ihlr-27183	97	35	terms	term	NOUN
ihlr-27183	97	36	of	of	ADP
ihlr-27183	97	37	the	the	DET
ihlr-27183	97	38	statute	statute	NOUN
ihlr-27183	97	39	above	above	ADV
ihlr-27183	97	40	,	,	PUNCT
ihlr-27183	97	41	it	it	PRON
ihlr-27183	97	42	is	be	AUX
ihlr-27183	97	43	interesting	interesting	ADJ
ihlr-27183	97	44	to	to	PART
ihlr-27183	97	45	consider	consider	VERB
ihlr-27183	97	46	the	the	DET
ihlr-27183	97	47	judicial	judicial	ADJ
ihlr-27183	97	48	interpretation	interpretation	NOUN
ihlr-27183	97	49	of	of	ADP
ihlr-27183	97	50	its	its	PRON
ihlr-27183	97	51	sister	sister	NOUN
ihlr-27183	97	52	statute	statute	NOUN
ihlr-27183	97	53	–	–	PUNCT
ihlr-27183	97	54	§	§	PROPN
ihlr-27183	97	55	156	156	NUM
ihlr-27183	97	56	,	,	PUNCT
ihlr-27183	97	57	relating	relate	VERB
ihlr-27183	97	58	to	to	ADP
ihlr-27183	97	59	extension	extension	NOUN
ihlr-27183	97	60	of	of	ADP
ihlr-27183	97	61	a	a	DET
ihlr-27183	97	62	patent	patent	NOUN
ihlr-27183	97	63	term	term	NOUN
ihlr-27183	97	64	–	–	PUNCT
ihlr-27183	97	65	also	also	ADV
ihlr-27183	97	66	part	part	NOUN
ihlr-27183	97	67	of	of	ADP
ihlr-27183	97	68	the	the	DET
ihlr-27183	97	69	hatch	hatch	NOUN
ihlr-27183	97	70	-	-	PUNCT
ihlr-27183	97	71	waxman	waxman	NOUN
ihlr-27183	97	72	act.26	act.26	NOUN
ihlr-27183	97	73	in	in	ADP
ihlr-27183	97	74	addition	addition	NOUN
ihlr-27183	97	75	to	to	ADP
ihlr-27183	97	76	providing	provide	VERB
ihlr-27183	97	77	a	a	DET
ihlr-27183	97	78	remedy	remedy	NOUN
ihlr-27183	97	79	for	for	ADP
ihlr-27183	97	80	generics	generic	NOUN
ihlr-27183	97	81	being	be	AUX
ihlr-27183	97	82	delayed	delay	VERB
ihlr-27183	97	83	in	in	ADP
ihlr-27183	97	84	market	market	NOUN
ihlr-27183	97	85	entry	entry	NOUN
ihlr-27183	97	86	,	,	PUNCT
ihlr-27183	97	87	the	the	DET
ihlr-27183	97	88	hatch	hatch	NOUN
ihlr-27183	97	89	-	-	PUNCT
ihlr-27183	97	90	waxman	waxman	NOUN
ihlr-27183	97	91	legislation	legislation	NOUN
ihlr-27183	97	92	also	also	ADV
ihlr-27183	97	93	sought	seek	VERB
ihlr-27183	97	94	to	to	PART
ihlr-27183	97	95	remedy	remedy	VERB
ihlr-27183	97	96	the	the	DET
ihlr-27183	97	97	symmetric	symmetric	ADJ
ihlr-27183	97	98	distortion	distortion	NOUN
ihlr-27183	97	99	on	on	ADP
ihlr-27183	97	100	the	the	DET
ihlr-27183	97	101	effective	effective	ADJ
ihlr-27183	97	102	start	start	NOUN
ihlr-27183	97	103	date	date	NOUN
ihlr-27183	97	104	of	of	ADP
ihlr-27183	97	105	a	a	DET
ihlr-27183	97	106	patent	patent	NOUN
ihlr-27183	97	107	term.27	term.27	PROPN
ihlr-27183	97	108	as	as	ADP
ihlr-27183	97	109	introduced	introduce	VERB
ihlr-27183	97	110	above	above	ADV
ihlr-27183	97	111	,	,	PUNCT
ihlr-27183	97	112	the	the	DET
ihlr-27183	97	113	patent	patent	NOUN
ihlr-27183	97	114	term	term	NOUN
ihlr-27183	97	115	would	would	AUX
ihlr-27183	97	116	often	often	ADV
ihlr-27183	97	117	begin	begin	VERB
ihlr-27183	97	118	before	before	SCONJ
ihlr-27183	97	119	the	the	DET
ihlr-27183	97	120	fda	fda	PROPN
ihlr-27183	97	121	had	have	AUX
ihlr-27183	97	122	approved	approve	VERB
ihlr-27183	97	123	the	the	DET
ihlr-27183	97	124	drug	drug	NOUN
ihlr-27183	97	125	for	for	ADP
ihlr-27183	97	126	use	use	NOUN
ihlr-27183	97	127	–	–	PUNCT
ihlr-27183	97	128	reducing	reduce	VERB
ihlr-27183	97	129	the	the	DET
ihlr-27183	97	130	profitable	profitable	ADJ
ihlr-27183	97	131	term	term	NOUN
ihlr-27183	97	132	of	of	ADP
ihlr-27183	97	133	the	the	DET
ihlr-27183	97	134	patent	patent	NOUN
ihlr-27183	97	135	on	on	ADP
ihlr-27183	97	136	its	its	PRON
ihlr-27183	97	137	front	front	ADJ
ihlr-27183	97	138	end.28	end.28	NOUN
ihlr-27183	97	139	this	this	DET
ihlr-27183	97	140	reduction	reduction	NOUN
ihlr-27183	97	141	in	in	ADP
ihlr-27183	97	142	profitable	profitable	ADJ
ihlr-27183	97	143	term	term	NOUN
ihlr-27183	97	144	was	be	AUX
ihlr-27183	97	145	not	not	PART
ihlr-27183	97	146	only	only	ADV
ihlr-27183	97	147	unpredictable	unpredictable	ADJ
ihlr-27183	97	148	,	,	PUNCT
ihlr-27183	97	149	but	but	CCONJ
ihlr-27183	97	150	out	out	ADP
ihlr-27183	97	151	of	of	ADP
ihlr-27183	97	152	the	the	DET
ihlr-27183	97	153	inventor	inventor	NOUN
ihlr-27183	97	154	’s	’s	PART
ihlr-27183	97	155	control	control	NOUN
ihlr-27183	97	156	while	while	SCONJ
ihlr-27183	97	157	the	the	DET
ihlr-27183	97	158	data	datum	NOUN
ihlr-27183	97	159	was	be	AUX
ihlr-27183	97	160	with	with	ADP
ihlr-27183	97	161	the	the	DET
ihlr-27183	97	162	fda	fda	PROPN
ihlr-27183	97	163	for	for	ADP
ihlr-27183	97	164	review	review	NOUN
ihlr-27183	97	165	and	and	CCONJ
ihlr-27183	97	166	approval	approval	NOUN
ihlr-27183	97	167	.	.	PUNCT
ihlr-27183	98	1	under	under	ADP
ihlr-27183	98	2	§	§	PROPN
ihlr-27183	98	3	156	156	NUM
ihlr-27183	98	4	of	of	ADP
ihlr-27183	98	5	the	the	DET
ihlr-27183	98	6	1984	1984	NUM
ihlr-27183	98	7	hatch	hatch	PROPN
ihlr-27183	98	8	-	-	PUNCT
ihlr-27183	98	9	waxman	waxman	NOUN
ihlr-27183	98	10	legislation	legislation	NOUN
ihlr-27183	98	11	,	,	PUNCT
ihlr-27183	98	12	an	an	DET
ihlr-27183	98	13	original	original	ADJ
ihlr-27183	98	14	drug	drug	NOUN
ihlr-27183	98	15	manufacture	manufacture	NOUN
ihlr-27183	98	16	can	can	AUX
ihlr-27183	98	17	receive	receive	VERB
ihlr-27183	98	18	a	a	DET
ihlr-27183	98	19	patent	patent	NOUN
ihlr-27183	98	20	term	term	NOUN
ihlr-27183	98	21	extension	extension	NOUN
ihlr-27183	98	22	if	if	SCONJ
ihlr-27183	98	23	the	the	DET
ihlr-27183	98	24	patent	patent	NOUN
ihlr-27183	98	25	term	term	NOUN
ihlr-27183	98	26	is	be	AUX
ihlr-27183	98	27	triggered	trigger	VERB
ihlr-27183	98	28	prior	prior	ADV
ihlr-27183	98	29	to	to	ADP
ihlr-27183	98	30	receiving	receive	VERB
ihlr-27183	98	31	regulatory	regulatory	ADJ
ihlr-27183	98	32	approval.29	approval.29	NOUN
ihlr-27183	98	33	the	the	DET
ihlr-27183	98	34	exact	exact	ADJ
ihlr-27183	98	35	extension	extension	NOUN
ihlr-27183	98	36	is	be	AUX
ihlr-27183	98	37	calculated	calculate	VERB
ihlr-27183	98	38	according	accord	VERB
ihlr-27183	98	39	to	to	ADP
ihlr-27183	98	40	the	the	DET
ihlr-27183	98	41	statute.30	statute.30	NOUN
ihlr-27183	98	42	importantly	importantly	ADV
ihlr-27183	98	43	,	,	PUNCT
ihlr-27183	98	44	this	this	DET
ihlr-27183	98	45	provision	provision	NOUN
ihlr-27183	98	46	is	be	AUX
ihlr-27183	98	47	codified	codify	VERB
ihlr-27183	98	48	using	use	VERB
ihlr-27183	98	49	the	the	DET
ihlr-27183	98	50	term	term	NOUN
ihlr-27183	98	51	“	"	PUNCT
ihlr-27183	98	52	product	product	NOUN
ihlr-27183	98	53	,	,	PUNCT
ihlr-27183	98	54	”	"	PUNCT
ihlr-27183	98	55	to	to	PART
ihlr-27183	98	56	describe	describe	VERB
ihlr-27183	98	57	those	those	DET
ihlr-27183	98	58	items	item	NOUN
ihlr-27183	98	59	falling	fall	VERB
ihlr-27183	98	60	within	within	ADP
ihlr-27183	98	61	its	its	PRON
ihlr-27183	98	62	ambit.31	ambit.31	NOUN
ihlr-27183	98	63	indeed	indeed	ADV
ihlr-27183	98	64	,	,	PUNCT
ihlr-27183	98	65	the	the	DET
ihlr-27183	98	66	statute	statute	NOUN
ihlr-27183	98	67	explicitly	explicitly	ADV
ihlr-27183	98	68	defines	define	VERB
ihlr-27183	98	69	“	"	PUNCT
ihlr-27183	98	70	product	product	NOUN
ihlr-27183	98	71	”	"	PUNCT
ihlr-27183	98	72	to	to	PART
ihlr-27183	98	73	refer	refer	VERB
ihlr-27183	98	74	to	to	ADP
ihlr-27183	98	75	“	"	PUNCT
ihlr-27183	98	76	[	[	X
ihlr-27183	98	77	a]ny	a]ny	PROPN
ihlr-27183	98	78	medical	medical	ADJ
ihlr-27183	98	79	device	device	NOUN
ihlr-27183	98	80	,	,	PUNCT
ihlr-27183	98	81	food	food	NOUN
ihlr-27183	98	82	additive	additive	NOUN
ihlr-27183	98	83	,	,	PUNCT
ihlr-27183	98	84	or	or	CCONJ
ihlr-27183	98	85	color	color	NOUN
ihlr-27183	98	86	additive	additive	ADJ
ihlr-27183	98	87	subject	subject	NOUN
ihlr-27183	98	88	to	to	ADP
ihlr-27183	98	89	regulation	regulation	NOUN
ihlr-27183	98	90	under	under	ADP
ihlr-27183	98	91	the	the	DET
ihlr-27183	98	92	federal	federal	ADJ
ihlr-27183	98	93	food	food	NOUN
ihlr-27183	98	94	,	,	PUNCT
ihlr-27183	98	95	drug	drug	NOUN
ihlr-27183	98	96	,	,	PUNCT
ihlr-27183	98	97	and	and	CCONJ
ihlr-27183	98	98	cosmetic	cosmetic	ADJ
ihlr-27183	98	99	act	act	NOUN
ihlr-27183	98	100	.	.	PUNCT
ihlr-27183	99	1	”32	”32	VERB
ihlr-27183	99	2	in	in	ADP
ihlr-27183	99	3	an	an	DET
ihlr-27183	99	4	unsuspected	unsuspected	ADJ
ihlr-27183	99	5	contrast	contrast	NOUN
ihlr-27183	99	6	,	,	PUNCT
ihlr-27183	99	7	and	and	CCONJ
ihlr-27183	99	8	despite	despite	SCONJ
ihlr-27183	99	9	the	the	DET
ihlr-27183	99	10	symmetry	symmetry	NOUN
ihlr-27183	99	11	in	in	ADP
ihlr-27183	99	12	function	function	NOUN
ihlr-27183	99	13	,	,	PUNCT
ihlr-27183	99	14	§	§	PROPN
ihlr-27183	99	15	271(e)(1	271(e)(1	NOUN
ihlr-27183	99	16	)	)	PUNCT
ihlr-27183	99	17	uses	use	VERB
ihlr-27183	99	18	“	"	PUNCT
ihlr-27183	99	19	patented	patented	ADJ
ihlr-27183	99	20	invention	invention	NOUN
ihlr-27183	99	21	”	"	PUNCT
ihlr-27183	99	22	to	to	PART
ihlr-27183	99	23	describe	describe	VERB
ihlr-27183	99	24	articles	article	NOUN
ihlr-27183	99	25	within	within	ADP
ihlr-27183	99	26	its	its	PRON
ihlr-27183	99	27	scope	scope	NOUN
ihlr-27183	99	28	and	and	CCONJ
ihlr-27183	99	29	is	be	AUX
ihlr-27183	99	30	internally	internally	ADV
ihlr-27183	99	31	silent	silent	ADJ
ihlr-27183	99	32	on	on	ADP
ihlr-27183	99	33	defining	define	VERB
ihlr-27183	99	34	the	the	DET
ihlr-27183	99	35	term.33	term.33	NOUN
ihlr-27183	99	36	while	while	SCONJ
ihlr-27183	99	37	plot	plot	NOUN
ihlr-27183	99	38	twists	twist	NOUN
ihlr-27183	99	39	are	be	AUX
ihlr-27183	99	40	amusing	amusing	ADJ
ihlr-27183	99	41	at	at	ADP
ihlr-27183	99	42	the	the	DET
ihlr-27183	99	43	cinema	cinema	NOUN
ihlr-27183	99	44	,	,	PUNCT
ihlr-27183	99	45	they	they	PRON
ihlr-27183	99	46	are	be	AUX
ihlr-27183	99	47	good	good	ADJ
ihlr-27183	99	48	for	for	ADP
ihlr-27183	99	49	nothing	nothing	PRON
ihlr-27183	99	50	but	but	SCONJ
ihlr-27183	99	51	a	a	DET
ihlr-27183	99	52	law	law	NOUN
ihlr-27183	99	53	review	review	NOUN
ihlr-27183	99	54	article	article	NOUN
ihlr-27183	99	55	when	when	SCONJ
ihlr-27183	99	56	spotted	spot	VERB
ihlr-27183	99	57	in	in	ADP
ihlr-27183	99	58	legislation	legislation	NOUN
ihlr-27183	99	59	.	.	PUNCT
ihlr-27183	100	1	25	25	NUM
ihlr-27183	100	2	.	.	NOUN
ihlr-27183	100	3	35	35	NUM
ihlr-27183	100	4	u.s.c	u.s.c	NOUN
ihlr-27183	100	5	.	.	PUNCT
ihlr-27183	101	1	§	§	PROPN
ihlr-27183	101	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	101	3	)	)	PUNCT
ihlr-27183	101	4	(	(	PUNCT
ihlr-27183	101	5	2015	2015	NUM
ihlr-27183	101	6	)	)	PUNCT
ihlr-27183	101	7	.	.	PUNCT
ihlr-27183	102	1	26	26	NUM
ihlr-27183	102	2	.	.	NOUN
ihlr-27183	102	3	35	35	NUM
ihlr-27183	102	4	u.s.c	u.s.c	NOUN
ihlr-27183	102	5	.	.	PUNCT
ihlr-27183	103	1	§	§	PROPN
ihlr-27183	103	2	156(c	156(c	PROPN
ihlr-27183	103	3	)	)	PUNCT
ihlr-27183	103	4	(	(	PUNCT
ihlr-27183	103	5	2015	2015	NUM
ihlr-27183	103	6	)	)	PUNCT
ihlr-27183	103	7	.	.	PUNCT
ihlr-27183	104	1	27	27	NUM
ihlr-27183	104	2	.	.	PUNCT
ihlr-27183	105	1	i	i	PRON
ihlr-27183	105	2	d.	d.	PROPN
ihlr-27183	105	3	28	28	NUM
ihlr-27183	105	4	.	.	PUNCT
ihlr-27183	106	1	proveris	proveris	PROPN
ihlr-27183	106	2	sci	sci	PROPN
ihlr-27183	106	3	.	.	PROPN
ihlr-27183	106	4	corp	corp	PROPN
ihlr-27183	106	5	.	.	PROPN
ihlr-27183	107	1	v.	v.	PROPN
ihlr-27183	107	2	innovasystems	innovasystems	PROPN
ihlr-27183	107	3	,	,	PUNCT
ihlr-27183	107	4	inc	inc	PROPN
ihlr-27183	107	5	.	.	PROPN
ihlr-27183	107	6	,	,	PUNCT
ihlr-27183	107	7	536	536	NUM
ihlr-27183	107	8	f.3d	f.3d	NUM
ihlr-27183	107	9	1256	1256	NUM
ihlr-27183	107	10	,	,	PUNCT
ihlr-27183	107	11	1261	1261	NUM
ihlr-27183	107	12	(	(	PUNCT
ihlr-27183	107	13	fed	fed	PROPN
ihlr-27183	107	14	.	.	PUNCT
ihlr-27183	107	15	cir	cir	PROPN
ihlr-27183	107	16	.	.	PROPN
ihlr-27183	107	17	2008	2008	NUM
ihlr-27183	107	18	)	)	PUNCT
ihlr-27183	107	19	.	.	PUNCT
ihlr-27183	108	1	29	29	NUM
ihlr-27183	108	2	.	.	X
ihlr-27183	108	3	35	35	NUM
ihlr-27183	108	4	u.s.c	u.s.c	NOUN
ihlr-27183	108	5	.	.	PUNCT
ihlr-27183	109	1	§	§	PROPN
ihlr-27183	109	2	156(c	156(c	PROPN
ihlr-27183	109	3	)	)	PUNCT
ihlr-27183	109	4	(	(	PUNCT
ihlr-27183	109	5	2015	2015	NUM
ihlr-27183	109	6	)	)	PUNCT
ihlr-27183	109	7	.	.	PUNCT
ihlr-27183	110	1	30	30	NUM
ihlr-27183	110	2	.	.	PUNCT
ihlr-27183	111	1	i	i	PRON
ihlr-27183	111	2	d.	d.	PROPN
ihlr-27183	111	3	31	31	NUM
ihlr-27183	111	4	.	.	PUNCT
ihlr-27183	112	1	§	§	PROPN
ihlr-27183	112	2	156(a	156(a	PROPN
ihlr-27183	112	3	)	)	PUNCT
ihlr-27183	112	4	.	.	PUNCT
ihlr-27183	113	1	32	32	NUM
ihlr-27183	113	2	.	.	PUNCT
ihlr-27183	114	1	§	§	PROPN
ihlr-27183	114	2	156(f	156(f	PROPN
ihlr-27183	114	3	)	)	PUNCT
ihlr-27183	114	4	.	.	PUNCT
ihlr-27183	115	1	33	33	NUM
ihlr-27183	115	2	.	.	NOUN
ihlr-27183	115	3	35	35	NUM
ihlr-27183	115	4	u.s.c	u.s.c	NOUN
ihlr-27183	115	5	.	.	PUNCT
ihlr-27183	116	1	§	§	PROPN
ihlr-27183	116	2	271	271	NUM
ihlr-27183	116	3	(	(	PUNCT
ihlr-27183	116	4	2015	2015	NUM
ihlr-27183	116	5	)	)	PUNCT
ihlr-27183	116	6	.	.	PUNCT
ihlr-27183	117	1	148	148	NUM
ihlr-27183	117	2	indiana	indiana	PROPN
ihlr-27183	117	3	health	health	NOUN
ihlr-27183	117	4	law	law	NOUN
ihlr-27183	117	5	review	review	NOUN
ihlr-27183	117	6	[	[	X
ihlr-27183	117	7	vol	vol	NOUN
ihlr-27183	117	8	.	.	PUNCT
ihlr-27183	117	9	20:143	20:143	PROPN
ihlr-27183	117	10	ii	ii	PROPN
ihlr-27183	117	11	.	.	PUNCT
ihlr-27183	117	12	background	background	NOUN
ihlr-27183	117	13	:	:	PUNCT
ihlr-27183	117	14	the	the	DET
ihlr-27183	117	15	status	status	NOUN
ihlr-27183	117	16	of	of	ADP
ihlr-27183	117	17	judicial	judicial	ADJ
ihlr-27183	117	18	interpretation	interpretation	NOUN
ihlr-27183	117	19	a.	a.	NOUN
ihlr-27183	117	20	a	a	DET
ihlr-27183	117	21	tale	tale	NOUN
ihlr-27183	117	22	of	of	ADP
ihlr-27183	117	23	two	two	NUM
ihlr-27183	117	24	terms	term	NOUN
ihlr-27183	117	25	though	though	SCONJ
ihlr-27183	117	26	the	the	DET
ihlr-27183	117	27	legislative	legislative	ADJ
ihlr-27183	117	28	act	act	NOUN
ihlr-27183	117	29	prevented	prevent	VERB
ihlr-27183	117	30	extending	extend	VERB
ihlr-27183	117	31	a	a	DET
ihlr-27183	117	32	patent	patent	NOUN
ihlr-27183	117	33	monopoly	monopoly	NOUN
ihlr-27183	117	34	during	during	ADP
ihlr-27183	117	35	the	the	DET
ihlr-27183	117	36	delay	delay	NOUN
ihlr-27183	117	37	of	of	ADP
ihlr-27183	117	38	fda	fda	PROPN
ihlr-27183	117	39	approval	approval	PROPN
ihlr-27183	117	40	,	,	PUNCT
ihlr-27183	117	41	it	it	PRON
ihlr-27183	117	42	has	have	AUX
ihlr-27183	117	43	not	not	PART
ihlr-27183	117	44	alleviated	alleviate	VERB
ihlr-27183	117	45	the	the	DET
ihlr-27183	117	46	judiciary	judiciary	NOUN
ihlr-27183	117	47	’s	’s	PART
ihlr-27183	117	48	interpretive	interpretive	ADJ
ihlr-27183	117	49	role	role	NOUN
ihlr-27183	117	50	.	.	PUNCT
ihlr-27183	118	1	litigation	litigation	NOUN
ihlr-27183	118	2	over	over	ADP
ihlr-27183	118	3	the	the	DET
ihlr-27183	118	4	statutory	statutory	ADJ
ihlr-27183	118	5	scope	scope	NOUN
ihlr-27183	118	6	of	of	ADP
ihlr-27183	118	7	both	both	CCONJ
ihlr-27183	118	8	applicable	applicable	ADJ
ihlr-27183	118	9	subject	subject	NOUN
ihlr-27183	118	10	matter	matter	NOUN
ihlr-27183	118	11	and	and	CCONJ
ihlr-27183	118	12	activity	activity	NOUN
ihlr-27183	118	13	has	have	AUX
ihlr-27183	118	14	been	be	AUX
ihlr-27183	118	15	frequent	frequent	ADJ
ihlr-27183	118	16	.	.	PUNCT
ihlr-27183	119	1	two	two	NUM
ihlr-27183	119	2	terms	term	NOUN
ihlr-27183	119	3	of	of	ADP
ihlr-27183	119	4	§	§	PROPN
ihlr-27183	119	5	271(e)(1	271(e)(1	NOUN
ihlr-27183	119	6	)	)	PUNCT
ihlr-27183	119	7	have	have	AUX
ihlr-27183	119	8	received	receive	VERB
ihlr-27183	119	9	the	the	DET
ihlr-27183	119	10	most	most	ADJ
ihlr-27183	119	11	attention	attention	NOUN
ihlr-27183	119	12	:	:	PUNCT
ihlr-27183	119	13	the	the	DET
ihlr-27183	119	14	scope	scope	NOUN
ihlr-27183	119	15	of	of	ADP
ihlr-27183	119	16	“	"	PUNCT
ihlr-27183	119	17	patented	patented	ADJ
ihlr-27183	119	18	invention	invention	NOUN
ihlr-27183	119	19	,	,	PUNCT
ihlr-27183	119	20	”	"	PUNCT
ihlr-27183	119	21	as	as	SCONJ
ihlr-27183	119	22	alluded	allude	VERB
ihlr-27183	119	23	to	to	ADP
ihlr-27183	119	24	above	above	ADV
ihlr-27183	119	25	;	;	PUNCT
ihlr-27183	119	26	and	and	CCONJ
ihlr-27183	119	27	the	the	DET
ihlr-27183	119	28	scope	scope	NOUN
ihlr-27183	119	29	of	of	ADP
ihlr-27183	119	30	“	"	PUNCT
ihlr-27183	119	31	reasonably	reasonably	ADV
ihlr-27183	119	32	related	related	ADJ
ihlr-27183	119	33	.	.	PUNCT
ihlr-27183	120	1	”34	”34	ADJ
ihlr-27183	120	2	debate	debate	NOUN
ihlr-27183	120	3	concerning	concern	VERB
ihlr-27183	120	4	the	the	DET
ihlr-27183	120	5	former	former	ADJ
ihlr-27183	120	6	term	term	NOUN
ihlr-27183	120	7	seeks	seek	VERB
ihlr-27183	120	8	to	to	PART
ihlr-27183	120	9	characterize	characterize	VERB
ihlr-27183	120	10	eligible	eligible	ADJ
ihlr-27183	120	11	inventions	invention	NOUN
ihlr-27183	120	12	by	by	ADP
ihlr-27183	120	13	several	several	ADJ
ihlr-27183	120	14	criteria	criterion	NOUN
ihlr-27183	120	15	,	,	PUNCT
ihlr-27183	120	16	which	which	PRON
ihlr-27183	120	17	will	will	AUX
ihlr-27183	120	18	be	be	AUX
ihlr-27183	120	19	explored	explore	VERB
ihlr-27183	120	20	below	below	ADV
ihlr-27183	120	21	,	,	PUNCT
ihlr-27183	120	22	and	and	CCONJ
ihlr-27183	120	23	debate	debate	NOUN
ihlr-27183	120	24	concerning	concern	VERB
ihlr-27183	120	25	the	the	DET
ihlr-27183	120	26	latter	latter	ADJ
ihlr-27183	120	27	seeks	seek	VERB
ihlr-27183	120	28	to	to	PART
ihlr-27183	120	29	characterize	characterize	VERB
ihlr-27183	120	30	what	what	PRON
ihlr-27183	120	31	fda	fda	PROPN
ihlr-27183	120	32	approval	approval	NOUN
ihlr-27183	120	33	activity	activity	NOUN
ihlr-27183	120	34	the	the	DET
ihlr-27183	120	35	statute	statute	NOUN
ihlr-27183	120	36	intended	intend	VERB
ihlr-27183	120	37	to	to	PART
ihlr-27183	120	38	protect	protect	VERB
ihlr-27183	120	39	.	.	PUNCT
ihlr-27183	121	1	b.	b.	PROPN
ihlr-27183	121	2	reasonably	reasonably	ADV
ihlr-27183	121	3	related	relate	VERB
ihlr-27183	121	4	naturally	naturally	ADV
ihlr-27183	121	5	,	,	PUNCT
ihlr-27183	121	6	a	a	DET
ihlr-27183	121	7	‘	'	PUNCT
ihlr-27183	121	8	reasonableness	reasonableness	NOUN
ihlr-27183	121	9	’	'	PUNCT
ihlr-27183	121	10	standard	standard	NOUN
ihlr-27183	121	11	left	leave	VERB
ihlr-27183	121	12	ripe	ripe	NOUN
ihlr-27183	121	13	for	for	ADP
ihlr-27183	121	14	judicial	judicial	ADJ
ihlr-27183	121	15	interpretation	interpretation	NOUN
ihlr-27183	121	16	results	result	NOUN
ihlr-27183	121	17	in	in	ADP
ihlr-27183	121	18	substantial	substantial	ADJ
ihlr-27183	121	19	case	case	NOUN
ihlr-27183	121	20	law	law	NOUN
ihlr-27183	121	21	.	.	PUNCT
ihlr-27183	122	1	this	this	DET
ihlr-27183	122	2	case	case	NOUN
ihlr-27183	122	3	law	law	NOUN
ihlr-27183	122	4	has	have	AUX
ihlr-27183	122	5	shaped	shape	VERB
ihlr-27183	122	6	the	the	DET
ihlr-27183	122	7	outer	outer	ADJ
ihlr-27183	122	8	boundaries	boundary	NOUN
ihlr-27183	122	9	of	of	ADP
ihlr-27183	122	10	the	the	DET
ihlr-27183	122	11	exemptions	exemption	NOUN
ihlr-27183	122	12	of	of	ADP
ihlr-27183	122	13	§	§	PROPN
ihlr-27183	122	14	271(e)(1	271(e)(1	PROPN
ihlr-27183	122	15	)	)	PUNCT
ihlr-27183	122	16	,	,	PUNCT
ihlr-27183	122	17	but	but	CCONJ
ihlr-27183	122	18	the	the	DET
ihlr-27183	122	19	exact	exact	ADJ
ihlr-27183	122	20	contours	contours	NOUN
ihlr-27183	122	21	form	form	NOUN
ihlr-27183	122	22	only	only	ADV
ihlr-27183	122	23	a	a	DET
ihlr-27183	122	24	blurry	blurry	ADJ
ihlr-27183	122	25	line	line	NOUN
ihlr-27183	122	26	.	.	PUNCT
ihlr-27183	123	1	where	where	SCONJ
ihlr-27183	123	2	§	§	PROPN
ihlr-27183	123	3	156	156	NUM
ihlr-27183	123	4	offered	offer	VERB
ihlr-27183	123	5	tidy	tidy	ADJ
ihlr-27183	123	6	definitions	definition	NOUN
ihlr-27183	123	7	to	to	PART
ihlr-27183	123	8	assist	assist	VERB
ihlr-27183	123	9	in	in	ADP
ihlr-27183	123	10	assessing	assess	VERB
ihlr-27183	123	11	its	its	PRON
ihlr-27183	123	12	reach	reach	NOUN
ihlr-27183	123	13	,	,	PUNCT
ihlr-27183	123	14	§	§	PROPN
ihlr-27183	123	15	271(e)(1	271(e)(1	NOUN
ihlr-27183	123	16	)	)	PUNCT
ihlr-27183	123	17	has	have	AUX
ihlr-27183	123	18	instead	instead	ADV
ihlr-27183	123	19	relied	rely	VERB
ihlr-27183	123	20	on	on	ADP
ihlr-27183	123	21	the	the	DET
ihlr-27183	123	22	generation	generation	NOUN
ihlr-27183	123	23	of	of	ADP
ihlr-27183	123	24	a	a	DET
ihlr-27183	123	25	sizable	sizable	ADJ
ihlr-27183	123	26	body	body	NOUN
ihlr-27183	123	27	of	of	ADP
ihlr-27183	123	28	case	case	NOUN
ihlr-27183	123	29	law.35	law.35	ADJ
ihlr-27183	123	30	1	1	NUM
ihlr-27183	123	31	.	.	PUNCT
ihlr-27183	123	32	expansive	expansive	ADJ
ihlr-27183	123	33	scope	scope	NOUN
ihlr-27183	123	34	what	what	PRON
ihlr-27183	123	35	is	be	AUX
ihlr-27183	123	36	“	"	PUNCT
ihlr-27183	123	37	reasonably	reasonably	ADV
ihlr-27183	123	38	related	relate	VERB
ihlr-27183	123	39	”	"	PUNCT
ihlr-27183	123	40	to	to	ADP
ihlr-27183	123	41	fda	fda	PROPN
ihlr-27183	123	42	approval	approval	PROPN
ihlr-27183	123	43	is	be	AUX
ihlr-27183	123	44	perhaps	perhaps	ADV
ihlr-27183	123	45	the	the	DET
ihlr-27183	123	46	best	good	ADJ
ihlr-27183	123	47	understood	understand	VERB
ihlr-27183	123	48	,	,	PUNCT
ihlr-27183	123	49	and	and	CCONJ
ihlr-27183	123	50	the	the	DET
ihlr-27183	123	51	least	least	ADJ
ihlr-27183	123	52	consequential	consequential	ADJ
ihlr-27183	123	53	,	,	PUNCT
ihlr-27183	123	54	of	of	ADP
ihlr-27183	123	55	the	the	DET
ihlr-27183	123	56	two	two	NUM
ihlr-27183	123	57	terms	term	NOUN
ihlr-27183	123	58	.	.	PUNCT
ihlr-27183	124	1	reasonably	reasonably	ADV
ihlr-27183	124	2	related	relate	VERB
ihlr-27183	124	3	activity	activity	NOUN
ihlr-27183	124	4	has	have	AUX
ihlr-27183	124	5	been	be	AUX
ihlr-27183	124	6	held	hold	VERB
ihlr-27183	124	7	to	to	PART
ihlr-27183	124	8	include	include	VERB
ihlr-27183	124	9	:	:	PUNCT
ihlr-27183	124	10	early	early	ADJ
ihlr-27183	124	11	experimentation	experimentation	NOUN
ihlr-27183	124	12	where	where	SCONJ
ihlr-27183	124	13	some	some	PRON
ihlr-27183	124	14	or	or	CCONJ
ihlr-27183	124	15	even	even	ADV
ihlr-27183	124	16	all	all	DET
ihlr-27183	124	17	information	information	NOUN
ihlr-27183	124	18	may	may	AUX
ihlr-27183	124	19	never	never	ADV
ihlr-27183	124	20	be	be	AUX
ihlr-27183	124	21	submitted	submit	VERB
ihlr-27183	124	22	to	to	ADP
ihlr-27183	124	23	the	the	DET
ihlr-27183	124	24	fda;36	fda;36	NOUN
ihlr-27183	124	25	experimentation	experimentation	NOUN
ihlr-27183	124	26	with	with	ADP
ihlr-27183	124	27	a	a	DET
ihlr-27183	124	28	patented	patented	ADJ
ihlr-27183	124	29	peptide	peptide	NOUN
ihlr-27183	124	30	in	in	ADP
ihlr-27183	124	31	hopes	hope	NOUN
ihlr-27183	124	32	of	of	ADP
ihlr-27183	124	33	success	success	NOUN
ihlr-27183	124	34	and	and	CCONJ
ihlr-27183	124	35	eventual	eventual	ADJ
ihlr-27183	124	36	fda	fda	PROPN
ihlr-27183	124	37	submissions	submission	NOUN
ihlr-27183	124	38	for	for	ADP
ihlr-27183	124	39	an	an	DET
ihlr-27183	124	40	investigational	investigational	ADJ
ihlr-27183	124	41	new	new	ADJ
ihlr-27183	124	42	drug	drug	NOUN
ihlr-27183	124	43	(	(	PUNCT
ihlr-27183	124	44	“	"	PUNCT
ihlr-27183	124	45	ind	ind	NOUN
ihlr-27183	124	46	”	"	PUNCT
ihlr-27183	124	47	)	)	PUNCT
ihlr-27183	124	48	application;37	application;37	ADJ
ihlr-27183	124	49	use	use	NOUN
ihlr-27183	124	50	of	of	ADP
ihlr-27183	124	51	data	datum	NOUN
ihlr-27183	124	52	from	from	ADP
ihlr-27183	124	53	clinical	clinical	ADJ
ihlr-27183	124	54	study	study	NOUN
ihlr-27183	124	55	for	for	ADP
ihlr-27183	124	56	purposes	purpose	NOUN
ihlr-27183	124	57	other	other	ADJ
ihlr-27183	124	58	than	than	ADP
ihlr-27183	124	59	fda	fda	PROPN
ihlr-27183	124	60	submissions	submission	NOUN
ihlr-27183	124	61	;	;	PUNCT
ihlr-27183	124	62	and	and	CCONJ
ihlr-27183	124	63	activities	activity	NOUN
ihlr-27183	124	64	targeting	target	VERB
ihlr-27183	124	65	revision	revision	NOUN
ihlr-27183	124	66	of	of	ADP
ihlr-27183	124	67	a	a	DET
ihlr-27183	124	68	drug	drug	NOUN
ihlr-27183	124	69	label.38	label.38	NOUN
ihlr-27183	124	70	further	far	ADV
ihlr-27183	124	71	,	,	PUNCT
ihlr-27183	124	72	the	the	DET
ihlr-27183	124	73	protection	protection	NOUN
ihlr-27183	124	74	of	of	ADP
ihlr-27183	124	75	the	the	DET
ihlr-27183	124	76	safe	safe	ADJ
ihlr-27183	124	77	harbor	harbor	NOUN
ihlr-27183	124	78	extends	extend	VERB
ihlr-27183	124	79	to	to	ADP
ihlr-27183	124	80	drug	drug	NOUN
ihlr-27183	124	81	production	production	NOUN
ihlr-27183	124	82	runs	run	NOUN
ihlr-27183	124	83	for	for	ADP
ihlr-27183	124	84	qualification	qualification	NOUN
ihlr-27183	124	85	of	of	ADP
ihlr-27183	124	86	processes	process	NOUN
ihlr-27183	124	87	and	and	CCONJ
ihlr-27183	124	88	equipment	equipment	NOUN
ihlr-27183	124	89	under	under	ADP
ihlr-27183	124	90	a	a	DET
ihlr-27183	124	91	federal	federal	ADJ
ihlr-27183	124	92	regulation.39	regulation.39	NOUN
ihlr-27183	124	93	however	however	ADV
ihlr-27183	124	94	,	,	PUNCT
ihlr-27183	124	95	designating	designate	VERB
ihlr-27183	124	96	some	some	PRON
ihlr-27183	124	97	of	of	ADP
ihlr-27183	124	98	the	the	DET
ihlr-27183	124	99	resulting	result	VERB
ihlr-27183	124	100	product	product	NOUN
ihlr-27183	124	101	from	from	ADP
ihlr-27183	124	102	a	a	DET
ihlr-27183	124	103	qualification	qualification	NOUN
ihlr-27183	124	104	run	run	NOUN
ihlr-27183	124	105	as	as	ADP
ihlr-27183	124	106	“	"	PUNCT
ihlr-27183	124	107	commercial	commercial	ADJ
ihlr-27183	124	108	inventory	inventory	NOUN
ihlr-27183	124	109	,	,	PUNCT
ihlr-27183	124	110	”	"	PUNCT
ihlr-27183	124	111	though	though	SCONJ
ihlr-27183	124	112	not	not	PART
ihlr-27183	124	113	decisive	decisive	ADJ
ihlr-27183	124	114	,	,	PUNCT
ihlr-27183	124	115	risks	risk	VERB
ihlr-27183	124	116	forfeiture	forfeiture	NOUN
ihlr-27183	124	117	of	of	ADP
ihlr-27183	124	118	the	the	DET
ihlr-27183	124	119	safe	safe	ADJ
ihlr-27183	124	120	harbor.40	harbor.40	NOUN
ihlr-27183	124	121	the	the	DET
ihlr-27183	124	122	supreme	supreme	PROPN
ihlr-27183	124	123	court	court	PROPN
ihlr-27183	124	124	case	case	NOUN
ihlr-27183	124	125	of	of	ADP
ihlr-27183	124	126	merck	merck	NOUN
ihlr-27183	124	127	,	,	PUNCT
ihlr-27183	124	128	which	which	PRON
ihlr-27183	124	129	considered	consider	VERB
ihlr-27183	124	130	early	early	ADJ
ihlr-27183	124	131	experimentation	experimentation	NOUN
ihlr-27183	124	132	,	,	PUNCT
ihlr-27183	124	133	is	be	AUX
ihlr-27183	124	134	generally	generally	ADV
ihlr-27183	124	135	regarded	regard	VERB
ihlr-27183	124	136	as	as	ADP
ihlr-27183	124	137	an	an	DET
ihlr-27183	124	138	inflection	inflection	NOUN
ihlr-27183	124	139	point	point	NOUN
ihlr-27183	124	140	solidifying	solidify	VERB
ihlr-27183	124	141	an	an	DET
ihlr-27183	124	142	expansive	expansive	ADJ
ihlr-27183	124	143	view	view	NOUN
ihlr-27183	124	144	of	of	ADP
ihlr-27183	124	145	“	"	PUNCT
ihlr-27183	124	146	reasonably	reasonably	ADV
ihlr-27183	124	147	related	related	ADJ
ihlr-27183	124	148	.	.	PUNCT
ihlr-27183	125	1	”41	”41	PROPN
ihlr-27183	125	2	merck	merck	PROPN
ihlr-27183	125	3	34	34	NUM
ihlr-27183	125	4	.	.	PUNCT
ihlr-27183	126	1	§	§	PROPN
ihlr-27183	126	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	126	3	)	)	PUNCT
ihlr-27183	126	4	.	.	PUNCT
ihlr-27183	127	1	35	35	NUM
ihlr-27183	127	2	.	.	NOUN
ihlr-27183	127	3	35	35	NUM
ihlr-27183	127	4	u.s.c	u.s.c	NOUN
ihlr-27183	127	5	.	.	PUNCT
ihlr-27183	128	1	§	§	PROPN
ihlr-27183	128	2	156(f	156(f	PROPN
ihlr-27183	128	3	)	)	PUNCT
ihlr-27183	128	4	(	(	PUNCT
ihlr-27183	128	5	2015	2015	NUM
ihlr-27183	128	6	)	)	PUNCT
ihlr-27183	128	7	.	.	PUNCT
ihlr-27183	129	1	36	36	NUM
ihlr-27183	129	2	.	.	X
ihlr-27183	129	3	merck	merck	PROPN
ihlr-27183	129	4	kgaa	kgaa	PROPN
ihlr-27183	129	5	v.	v.	PROPN
ihlr-27183	129	6	integra	integra	PROPN
ihlr-27183	129	7	lifesciences	lifesciences	PROPN
ihlr-27183	130	1	i	i	PROPN
ihlr-27183	130	2	,	,	PUNCT
ihlr-27183	130	3	ltd	ltd	PROPN
ihlr-27183	130	4	.	.	PROPN
ihlr-27183	130	5	,	,	PUNCT
ihlr-27183	130	6	545	545	NUM
ihlr-27183	130	7	u.s	u.s	PROPN
ihlr-27183	130	8	.	.	PROPN
ihlr-27183	130	9	193	193	NUM
ihlr-27183	130	10	,	,	PUNCT
ihlr-27183	130	11	206	206	NUM
ihlr-27183	130	12	(	(	PUNCT
ihlr-27183	130	13	2005	2005	NUM
ihlr-27183	130	14	)	)	PUNCT
ihlr-27183	130	15	.	.	PUNCT
ihlr-27183	131	1	37	37	NUM
ihlr-27183	131	2	.	.	PUNCT
ihlr-27183	131	3	integra	integra	PROPN
ihlr-27183	131	4	lifesciences	lifesciences	PROPN
ihlr-27183	131	5	i	i	PROPN
ihlr-27183	131	6	,	,	PUNCT
ihlr-27183	131	7	ltd	ltd	PROPN
ihlr-27183	131	8	.	.	PROPN
ihlr-27183	132	1	v.	v.	PROPN
ihlr-27183	132	2	merck	merck	PROPN
ihlr-27183	132	3	kgaa	kgaa	PROPN
ihlr-27183	132	4	,	,	PUNCT
ihlr-27183	132	5	496	496	NUM
ihlr-27183	132	6	f.3d	f.3d	NUM
ihlr-27183	132	7	1334	1334	NUM
ihlr-27183	132	8	,	,	PUNCT
ihlr-27183	132	9	1341	1341	NUM
ihlr-27183	132	10	(	(	PUNCT
ihlr-27183	132	11	fed	fed	PROPN
ihlr-27183	132	12	.	.	PUNCT
ihlr-27183	132	13	cir	cir	PROPN
ihlr-27183	132	14	.	.	PROPN
ihlr-27183	132	15	2007	2007	NUM
ihlr-27183	132	16	)	)	PUNCT
ihlr-27183	132	17	.	.	PUNCT
ihlr-27183	133	1	38	38	NUM
ihlr-27183	133	2	.	.	PUNCT
ihlr-27183	134	1	classen	classen	PROPN
ihlr-27183	134	2	immunotherapies	immunotherapies	PROPN
ihlr-27183	134	3	,	,	PUNCT
ihlr-27183	134	4	inc	inc	PROPN
ihlr-27183	134	5	.	.	PROPN
ihlr-27183	135	1	v.	v.	PROPN
ihlr-27183	135	2	elan	elan	PROPN
ihlr-27183	135	3	pharm	pharm	PROPN
ihlr-27183	135	4	.	.	PROPN
ihlr-27183	135	5	,	,	PUNCT
ihlr-27183	135	6	inc	inc	PROPN
ihlr-27183	135	7	.	.	PROPN
ihlr-27183	135	8	,	,	PUNCT
ihlr-27183	135	9	786	786	NUM
ihlr-27183	135	10	f.3d	f.3d	NUM
ihlr-27183	135	11	892	892	NUM
ihlr-27183	135	12	,	,	PUNCT
ihlr-27183	135	13	899	899	NUM
ihlr-27183	135	14	(	(	PUNCT
ihlr-27183	135	15	fed	fed	PROPN
ihlr-27183	135	16	.	.	PUNCT
ihlr-27183	135	17	cir	cir	PROPN
ihlr-27183	135	18	.	.	PROPN
ihlr-27183	135	19	2015	2015	NUM
ihlr-27183	135	20	)	)	PUNCT
ihlr-27183	135	21	.	.	PUNCT
ihlr-27183	136	1	39	39	NUM
ihlr-27183	136	2	.	.	PUNCT
ihlr-27183	137	1	amgen	amgen	PROPN
ihlr-27183	137	2	,	,	PUNCT
ihlr-27183	137	3	inc	inc	PROPN
ihlr-27183	137	4	.	.	PROPN
ihlr-27183	138	1	v.	v.	ADP
ihlr-27183	138	2	hospira	hospira	PROPN
ihlr-27183	138	3	,	,	PUNCT
ihlr-27183	138	4	inc	inc	PROPN
ihlr-27183	138	5	.	.	PROPN
ihlr-27183	138	6	,	,	PUNCT
ihlr-27183	138	7	944	944	NUM
ihlr-27183	138	8	f.3d	f.3d	NUM
ihlr-27183	138	9	1327	1327	NUM
ihlr-27183	138	10	,	,	PUNCT
ihlr-27183	138	11	1339	1339	NUM
ihlr-27183	138	12	-	-	SYM
ihlr-27183	138	13	40	40	NUM
ihlr-27183	138	14	(	(	PUNCT
ihlr-27183	138	15	fed	fed	PROPN
ihlr-27183	138	16	.	.	PUNCT
ihlr-27183	138	17	cir	cir	PROPN
ihlr-27183	138	18	.	.	PROPN
ihlr-27183	138	19	2019	2019	NUM
ihlr-27183	138	20	)	)	PUNCT
ihlr-27183	138	21	.	.	PUNCT
ihlr-27183	139	1	40	40	NUM
ihlr-27183	139	2	.	.	PUNCT
ihlr-27183	140	1	i	i	PRON
ihlr-27183	140	2	d.	d.	PROPN
ihlr-27183	140	3	at	at	ADP
ihlr-27183	140	4	1340	1340	NUM
ihlr-27183	140	5	(	(	PUNCT
ihlr-27183	140	6	two	two	NUM
ihlr-27183	140	7	batches	batch	NOUN
ihlr-27183	140	8	designated	designate	VERB
ihlr-27183	140	9	as	as	ADP
ihlr-27183	140	10	“	"	PUNCT
ihlr-27183	140	11	commercial	commercial	ADJ
ihlr-27183	140	12	inventory	inventory	NOUN
ihlr-27183	140	13	,	,	PUNCT
ihlr-27183	140	14	”	"	PUNCT
ihlr-27183	140	15	one	one	NUM
ihlr-27183	140	16	was	be	AUX
ihlr-27183	140	17	shielded	shield	VERB
ihlr-27183	140	18	,	,	PUNCT
ihlr-27183	140	19	and	and	CCONJ
ihlr-27183	140	20	the	the	DET
ihlr-27183	140	21	other	other	ADJ
ihlr-27183	140	22	was	be	AUX
ihlr-27183	140	23	not	not	PART
ihlr-27183	140	24	)	)	PUNCT
ihlr-27183	140	25	.	.	PUNCT
ihlr-27183	141	1	41	41	NUM
ihlr-27183	141	2	.	.	PUNCT
ihlr-27183	142	1	daniel	daniel	PROPN
ihlr-27183	142	2	wobbekind	wobbekind	PROPN
ihlr-27183	142	3	,	,	PUNCT
ihlr-27183	142	4	integra	integra	PROPN
ihlr-27183	142	5	lifesciences	lifescience	NOUN
ihlr-27183	142	6	i	i	PROPN
ihlr-27183	142	7	,	,	PUNCT
ihlr-27183	142	8	ltd	ltd	PROPN
ihlr-27183	142	9	.	.	PROPN
ihlr-27183	142	10	v.	v.	PROPN
ihlr-27183	142	11	merck	merck	PROPN
ihlr-27183	142	12	kgaa	kgaa	PROPN
ihlr-27183	142	13	:	:	PUNCT
ihlr-27183	142	14	re	re	VERB
ihlr-27183	142	15	-	-	VERB
ihlr-27183	142	16	examining	examine	VERB
ihlr-27183	142	17	the	the	DET
ihlr-27183	142	18	broad	broad	ADJ
ihlr-27183	142	19	2023	2023	NUM
ihlr-27183	142	20	]	]	PUNCT
ihlr-27183	142	21	the	the	DET
ihlr-27183	142	22	safe	safe	ADJ
ihlr-27183	142	23	harbor	harbor	NOUN
ihlr-27183	142	24	of	of	ADP
ihlr-27183	142	25	35	35	NUM
ihlr-27183	142	26	u.s.c	u.s.c	ADJ
ihlr-27183	142	27	.	.	PUNCT
ihlr-27183	143	1	§	§	PROPN
ihlr-27183	143	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	143	3	)	)	PUNCT
ihlr-27183	143	4	149	149	NUM
ihlr-27183	143	5	will	will	AUX
ihlr-27183	143	6	be	be	AUX
ihlr-27183	143	7	unfolded	unfold	VERB
ihlr-27183	143	8	later	later	ADV
ihlr-27183	143	9	in	in	ADP
ihlr-27183	143	10	this	this	DET
ihlr-27183	143	11	note	note	NOUN
ihlr-27183	143	12	with	with	ADP
ihlr-27183	143	13	focus	focus	NOUN
ihlr-27183	143	14	on	on	ADP
ihlr-27183	143	15	how	how	SCONJ
ihlr-27183	143	16	its	its	PRON
ihlr-27183	143	17	broad	broad	ADJ
ihlr-27183	143	18	language	language	NOUN
ihlr-27183	143	19	has	have	AUX
ihlr-27183	143	20	an	an	DET
ihlr-27183	143	21	inevitable	inevitable	ADJ
ihlr-27183	143	22	influence	influence	NOUN
ihlr-27183	143	23	on	on	ADP
ihlr-27183	143	24	the	the	DET
ihlr-27183	143	25	scope	scope	NOUN
ihlr-27183	143	26	of	of	ADP
ihlr-27183	143	27	the	the	DET
ihlr-27183	143	28	patented	patented	ADJ
ihlr-27183	143	29	invention	invention	NOUN
ihlr-27183	143	30	.	.	PUNCT
ihlr-27183	144	1	2	2	X
ihlr-27183	144	2	.	.	X
ihlr-27183	144	3	not	not	PART
ihlr-27183	144	4	routine	routine	VERB
ihlr-27183	144	5	one	one	NUM
ihlr-27183	144	6	judicial	judicial	ADJ
ihlr-27183	144	7	limitation	limitation	NOUN
ihlr-27183	144	8	on	on	ADP
ihlr-27183	144	9	what	what	PRON
ihlr-27183	144	10	constitutes	constitute	VERB
ihlr-27183	144	11	“	"	PUNCT
ihlr-27183	144	12	reasonably	reasonably	ADV
ihlr-27183	144	13	related	related	ADJ
ihlr-27183	144	14	”	"	PUNCT
ihlr-27183	144	15	under	under	ADP
ihlr-27183	144	16	the	the	DET
ihlr-27183	144	17	safe	safe	ADJ
ihlr-27183	144	18	harbor	harbor	NOUN
ihlr-27183	144	19	looks	look	VERB
ihlr-27183	144	20	at	at	ADP
ihlr-27183	144	21	the	the	DET
ihlr-27183	144	22	type	type	NOUN
ihlr-27183	144	23	of	of	ADP
ihlr-27183	144	24	submission	submission	NOUN
ihlr-27183	144	25	which	which	PRON
ihlr-27183	144	26	might	might	AUX
ihlr-27183	144	27	be	be	AUX
ihlr-27183	144	28	generated	generate	VERB
ihlr-27183	144	29	from	from	ADP
ihlr-27183	144	30	the	the	DET
ihlr-27183	144	31	activity.42	activity.42	NOUN
ihlr-27183	144	32	specifically	specifically	ADV
ihlr-27183	144	33	,	,	PUNCT
ihlr-27183	144	34	courts	court	NOUN
ihlr-27183	144	35	distinguish	distinguish	VERB
ihlr-27183	144	36	between	between	ADP
ihlr-27183	144	37	activity	activity	NOUN
ihlr-27183	144	38	resulting	result	VERB
ihlr-27183	144	39	in	in	ADP
ihlr-27183	144	40	“	"	PUNCT
ihlr-27183	144	41	routine	routine	ADJ
ihlr-27183	144	42	”	"	PUNCT
ihlr-27183	144	43	and	and	CCONJ
ihlr-27183	144	44	“	"	PUNCT
ihlr-27183	144	45	not	not	PART
ihlr-27183	144	46	routine	routine	ADJ
ihlr-27183	144	47	”	"	PUNCT
ihlr-27183	144	48	submissions	submission	NOUN
ihlr-27183	144	49	to	to	ADP
ihlr-27183	144	50	the	the	DET
ihlr-27183	144	51	fda.43	fda.43	NOUN
ihlr-27183	144	52	though	though	SCONJ
ihlr-27183	144	53	both	both	DET
ihlr-27183	144	54	types	type	NOUN
ihlr-27183	144	55	of	of	ADP
ihlr-27183	144	56	activities	activity	NOUN
ihlr-27183	144	57	may	may	AUX
ihlr-27183	144	58	be	be	AUX
ihlr-27183	144	59	related	relate	VERB
ihlr-27183	144	60	to	to	ADP
ihlr-27183	144	61	obtaining	obtain	VERB
ihlr-27183	144	62	or	or	CCONJ
ihlr-27183	144	63	maintaining	maintain	VERB
ihlr-27183	144	64	fda	fda	PROPN
ihlr-27183	144	65	approval	approval	NOUN
ihlr-27183	144	66	,	,	PUNCT
ihlr-27183	144	67	only	only	ADV
ihlr-27183	144	68	activities	activity	NOUN
ihlr-27183	144	69	which	which	PRON
ihlr-27183	144	70	are	be	AUX
ihlr-27183	144	71	deemed	deem	VERB
ihlr-27183	144	72	“	"	PUNCT
ihlr-27183	144	73	not	not	PART
ihlr-27183	144	74	routine	routine	ADJ
ihlr-27183	144	75	”	"	PUNCT
ihlr-27183	144	76	are	be	AUX
ihlr-27183	144	77	eligible	eligible	ADJ
ihlr-27183	144	78	for	for	ADP
ihlr-27183	144	79	shielding	shielding	NOUN
ihlr-27183	144	80	under	under	ADP
ihlr-27183	144	81	the	the	DET
ihlr-27183	144	82	safe	safe	ADJ
ihlr-27183	144	83	harbor.44	harbor.44	NOUN
ihlr-27183	144	84	while	while	SCONJ
ihlr-27183	144	85	this	this	DET
ihlr-27183	144	86	requirement	requirement	NOUN
ihlr-27183	144	87	receives	receive	VERB
ihlr-27183	144	88	particular	particular	ADJ
ihlr-27183	144	89	attention	attention	NOUN
ihlr-27183	144	90	with	with	ADP
ihlr-27183	144	91	post	post	ADJ
ihlr-27183	144	92	-	-	ADJ
ihlr-27183	144	93	approval	approval	ADJ
ihlr-27183	144	94	activity	activity	NOUN
ihlr-27183	144	95	,	,	PUNCT
ihlr-27183	144	96	its	its	PRON
ihlr-27183	144	97	waiver	waiver	NOUN
ihlr-27183	144	98	should	should	AUX
ihlr-27183	144	99	not	not	PART
ihlr-27183	144	100	be	be	AUX
ihlr-27183	144	101	assumed	assume	VERB
ihlr-27183	144	102	simply	simply	ADV
ihlr-27183	144	103	because	because	SCONJ
ihlr-27183	144	104	a	a	DET
ihlr-27183	144	105	product	product	NOUN
ihlr-27183	144	106	has	have	AUX
ihlr-27183	144	107	not	not	PART
ihlr-27183	144	108	yet	yet	ADV
ihlr-27183	144	109	received	receive	VERB
ihlr-27183	144	110	fda	fda	PROPN
ihlr-27183	144	111	approval	approval	NOUN
ihlr-27183	144	112	.	.	PUNCT
ihlr-27183	145	1	such	such	DET
ihlr-27183	145	2	an	an	DET
ihlr-27183	145	3	absolute	absolute	ADJ
ihlr-27183	145	4	rule	rule	NOUN
ihlr-27183	145	5	might	might	AUX
ihlr-27183	145	6	encourage	encourage	VERB
ihlr-27183	145	7	gamesmanship	gamesmanship	NOUN
ihlr-27183	145	8	on	on	ADP
ihlr-27183	145	9	the	the	DET
ihlr-27183	145	10	part	part	NOUN
ihlr-27183	145	11	of	of	ADP
ihlr-27183	145	12	the	the	DET
ihlr-27183	145	13	manufacturer	manufacturer	NOUN
ihlr-27183	145	14	.	.	PUNCT
ihlr-27183	146	1	for	for	ADP
ihlr-27183	146	2	example	example	NOUN
ihlr-27183	146	3	,	,	PUNCT
ihlr-27183	146	4	production	production	NOUN
ihlr-27183	146	5	of	of	ADP
ihlr-27183	146	6	commercial	commercial	ADJ
ihlr-27183	146	7	product	product	NOUN
ihlr-27183	146	8	prior	prior	ADV
ihlr-27183	146	9	to	to	ADP
ihlr-27183	146	10	fdaapproval	fdaapproval	NOUN
ihlr-27183	146	11	would	would	AUX
ihlr-27183	146	12	be	be	AUX
ihlr-27183	146	13	disallowed	disallow	VERB
ihlr-27183	146	14	afterward	afterward	ADV
ihlr-27183	146	15	while	while	SCONJ
ihlr-27183	146	16	the	the	DET
ihlr-27183	146	17	controlling	control	VERB
ihlr-27183	146	18	patent	patent	NOUN
ihlr-27183	146	19	is	be	AUX
ihlr-27183	146	20	still	still	ADV
ihlr-27183	146	21	in	in	ADP
ihlr-27183	146	22	force	force	NOUN
ihlr-27183	146	23	.	.	PUNCT
ihlr-27183	147	1	accordingly	accordingly	ADV
ihlr-27183	147	2	,	,	PUNCT
ihlr-27183	147	3	the	the	DET
ihlr-27183	147	4	court	court	NOUN
ihlr-27183	147	5	has	have	AUX
ihlr-27183	147	6	allowed	allow	VERB
ihlr-27183	147	7	discretion	discretion	NOUN
ihlr-27183	147	8	on	on	ADP
ihlr-27183	147	9	this	this	DET
ihlr-27183	147	10	matter	matter	NOUN
ihlr-27183	147	11	and	and	CCONJ
ihlr-27183	147	12	referred	refer	VERB
ihlr-27183	147	13	to	to	ADP
ihlr-27183	147	14	the	the	DET
ihlr-27183	147	15	american	american	ADJ
ihlr-27183	147	16	heritage	heritage	PROPN
ihlr-27183	147	17	dictionary	dictionary	PROPN
ihlr-27183	147	18	to	to	PART
ihlr-27183	147	19	define	define	VERB
ihlr-27183	147	20	“	"	PUNCT
ihlr-27183	147	21	routine	routine	ADJ
ihlr-27183	147	22	”	"	PUNCT
ihlr-27183	147	23	as	as	ADP
ihlr-27183	147	24	an	an	DET
ihlr-27183	147	25	activity	activity	NOUN
ihlr-27183	147	26	which	which	PRON
ihlr-27183	147	27	is	be	AUX
ihlr-27183	147	28	“	"	PUNCT
ihlr-27183	147	29	habitual	habitual	ADJ
ihlr-27183	147	30	”	"	PUNCT
ihlr-27183	147	31	or	or	CCONJ
ihlr-27183	147	32	“	"	PUNCT
ihlr-27183	147	33	regular	regular	ADJ
ihlr-27183	147	34	.	.	PUNCT
ihlr-27183	148	1	”45	”45	PROPN
ihlr-27183	148	2	hence	hence	ADV
ihlr-27183	148	3	,	,	PUNCT
ihlr-27183	148	4	the	the	DET
ihlr-27183	148	5	word	word	NOUN
ihlr-27183	148	6	“	"	PUNCT
ihlr-27183	148	7	reasonable	reasonable	ADJ
ihlr-27183	148	8	”	"	PUNCT
ihlr-27183	148	9	does	do	AUX
ihlr-27183	148	10	not	not	PART
ihlr-27183	148	11	merely	merely	ADV
ihlr-27183	148	12	convey	convey	VERB
ihlr-27183	148	13	a	a	DET
ihlr-27183	148	14	degree	degree	NOUN
ihlr-27183	148	15	of	of	ADP
ihlr-27183	148	16	relatedness	relatedness	NOUN
ihlr-27183	148	17	but	but	CCONJ
ihlr-27183	148	18	also	also	ADV
ihlr-27183	148	19	a	a	DET
ihlr-27183	148	20	second	second	ADJ
ihlr-27183	148	21	qualifying	qualifying	NOUN
ihlr-27183	148	22	quality	quality	NOUN
ihlr-27183	148	23	concerning	concern	VERB
ihlr-27183	148	24	the	the	DET
ihlr-27183	148	25	activity	activity	NOUN
ihlr-27183	148	26	’s	’s	PART
ihlr-27183	148	27	output	output	NOUN
ihlr-27183	148	28	.	.	PUNCT
ihlr-27183	149	1	so	so	ADV
ihlr-27183	149	2	,	,	PUNCT
ihlr-27183	149	3	factual	factual	ADJ
ihlr-27183	149	4	relatedness	relatedness	NOUN
ihlr-27183	149	5	,	,	PUNCT
ihlr-27183	149	6	though	though	SCONJ
ihlr-27183	149	7	necessary	necessary	ADJ
ihlr-27183	149	8	,	,	PUNCT
ihlr-27183	149	9	is	be	AUX
ihlr-27183	149	10	not	not	PART
ihlr-27183	149	11	alone	alone	ADJ
ihlr-27183	149	12	sufficient	sufficient	ADJ
ihlr-27183	149	13	to	to	PART
ihlr-27183	149	14	satisfy	satisfy	VERB
ihlr-27183	149	15	“	"	PUNCT
ihlr-27183	149	16	reasonably	reasonably	ADV
ihlr-27183	149	17	related	related	ADJ
ihlr-27183	149	18	.	.	PUNCT
ihlr-27183	149	19	”	"	PUNCT
ihlr-27183	150	1	the	the	DET
ihlr-27183	150	2	activity	activity	NOUN
ihlr-27183	150	3	must	must	AUX
ihlr-27183	150	4	also	also	ADV
ihlr-27183	150	5	be	be	AUX
ihlr-27183	150	6	non	non	ADJ
ihlr-27183	150	7	-	-	ADJ
ihlr-27183	150	8	routine	routine	ADJ
ihlr-27183	150	9	.	.	PUNCT
ihlr-27183	151	1	as	as	ADP
ihlr-27183	151	2	for	for	ADP
ihlr-27183	151	3	sample	sample	NOUN
ihlr-27183	151	4	submissions	submission	NOUN
ihlr-27183	151	5	,	,	PUNCT
ihlr-27183	151	6	which	which	PRON
ihlr-27183	151	7	do	do	AUX
ihlr-27183	151	8	not	not	PART
ihlr-27183	151	9	rise	rise	VERB
ihlr-27183	151	10	above	above	ADP
ihlr-27183	151	11	routine	routine	NOUN
ihlr-27183	151	12	,	,	PUNCT
ihlr-27183	151	13	the	the	DET
ihlr-27183	151	14	federal	federal	ADJ
ihlr-27183	151	15	circuit	circuit	NOUN
ihlr-27183	151	16	has	have	AUX
ihlr-27183	151	17	clarified	clarify	VERB
ihlr-27183	151	18	among	among	ADP
ihlr-27183	151	19	them	they	PRON
ihlr-27183	151	20	are	be	AUX
ihlr-27183	151	21	some	some	DET
ihlr-27183	151	22	activities	activity	NOUN
ihlr-27183	151	23	,	,	PUNCT
ihlr-27183	151	24	which	which	PRON
ihlr-27183	151	25	are	be	AUX
ihlr-27183	151	26	continued	continue	VERB
ihlr-27183	151	27	throughout	throughout	ADP
ihlr-27183	151	28	market	market	NOUN
ihlr-27183	151	29	availability	availability	NOUN
ihlr-27183	151	30	–	–	PUNCT
ihlr-27183	151	31	such	such	ADJ
ihlr-27183	151	32	as	as	ADP
ihlr-27183	151	33	quality	quality	NOUN
ihlr-27183	151	34	control	control	NOUN
ihlr-27183	151	35	processes	process	NOUN
ihlr-27183	151	36	and	and	CCONJ
ihlr-27183	151	37	reporting	report	VERB
ihlr-27183	151	38	adverse	adverse	ADJ
ihlr-27183	151	39	effects	effect	NOUN
ihlr-27183	151	40	of	of	ADP
ihlr-27183	151	41	a	a	DET
ihlr-27183	151	42	vaccine	vaccine	NOUN
ihlr-27183	151	43	when	when	SCONJ
ihlr-27183	151	44	administered	administer	VERB
ihlr-27183	151	45	according	accord	VERB
ihlr-27183	151	46	to	to	ADP
ihlr-27183	151	47	a	a	DET
ihlr-27183	151	48	patented	patent	VERB
ihlr-27183	151	49	low	low	ADJ
ihlr-27183	151	50	-	-	PUNCT
ihlr-27183	151	51	risk	risk	NOUN
ihlr-27183	151	52	method.46	method.46	PROPN
ihlr-27183	151	53	in	in	ADP
ihlr-27183	151	54	contrast	contrast	NOUN
ihlr-27183	151	55	,	,	PUNCT
ihlr-27183	151	56	protected	protect	VERB
ihlr-27183	151	57	”	"	PUNCT
ihlr-27183	151	58	non	non	ADJ
ihlr-27183	151	59	-	-	ADJ
ihlr-27183	151	60	routine	routine	ADJ
ihlr-27183	151	61	”	"	PUNCT
ihlr-27183	151	62	fda	fda	PROPN
ihlr-27183	151	63	reporting	reporting	NOUN
ihlr-27183	151	64	has	have	AUX
ihlr-27183	151	65	been	be	AUX
ihlr-27183	151	66	held	hold	VERB
ihlr-27183	151	67	to	to	PART
ihlr-27183	151	68	include	include	VERB
ihlr-27183	151	69	:	:	PUNCT
ihlr-27183	151	70	(	(	PUNCT
ihlr-27183	151	71	1	1	X
ihlr-27183	151	72	)	)	PUNCT
ihlr-27183	151	73	submissions	submission	NOUN
ihlr-27183	151	74	to	to	PART
ihlr-27183	151	75	revise	revise	VERB
ihlr-27183	151	76	a	a	DET
ihlr-27183	151	77	drug	drug	NOUN
ihlr-27183	151	78	label;47	label;47	NOUN
ihlr-27183	151	79	(	(	PUNCT
ihlr-27183	151	80	2	2	X
ihlr-27183	151	81	)	)	PUNCT
ihlr-27183	151	82	experimentation	experimentation	NOUN
ihlr-27183	151	83	which	which	PRON
ihlr-27183	151	84	has	have	VERB
ihlr-27183	151	85	the	the	DET
ihlr-27183	151	86	potential	potential	NOUN
ihlr-27183	151	87	to	to	PART
ihlr-27183	151	88	result	result	VERB
ihlr-27183	151	89	in	in	ADP
ihlr-27183	151	90	an	an	DET
ihlr-27183	151	91	fda	fda	PROPN
ihlr-27183	151	92	submission;48	submission;48	NOUN
ihlr-27183	151	93	and	and	CCONJ
ihlr-27183	151	94	(	(	PUNCT
ihlr-27183	151	95	3	3	X
ihlr-27183	151	96	)	)	PUNCT
ihlr-27183	151	97	preparation	preparation	NOUN
ihlr-27183	151	98	for	for	ADP
ihlr-27183	151	99	a	a	DET
ihlr-27183	151	100	mandatory	mandatory	ADJ
ihlr-27183	151	101	fda	fda	PROPN
ihlr-27183	151	102	pre	pre	NOUN
ihlr-27183	151	103	-	-	NOUN
ihlr-27183	151	104	approval	approval	ADJ
ihlr-27183	151	105	inspection.49	inspection.49	NOUN
ihlr-27183	151	106	from	from	ADP
ihlr-27183	151	107	a	a	DET
ihlr-27183	151	108	theoretical	theoretical	ADJ
ihlr-27183	151	109	viewpoint	viewpoint	NOUN
ihlr-27183	151	110	,	,	PUNCT
ihlr-27183	151	111	two	two	NUM
ihlr-27183	151	112	characteristics	characteristic	NOUN
ihlr-27183	151	113	are	be	AUX
ihlr-27183	151	114	often	often	ADV
ihlr-27183	151	115	used	use	VERB
ihlr-27183	151	116	to	to	PART
ihlr-27183	151	117	signify	signify	VERB
ihlr-27183	151	118	routine	routine	NOUN
ihlr-27183	151	119	.	.	PUNCT
ihlr-27183	152	1	first	first	ADV
ihlr-27183	152	2	,	,	PUNCT
ihlr-27183	152	3	as	as	SCONJ
ihlr-27183	152	4	introduced	introduce	VERB
ihlr-27183	152	5	above	above	ADV
ihlr-27183	152	6	,	,	PUNCT
ihlr-27183	152	7	the	the	DET
ihlr-27183	152	8	“	"	PUNCT
ihlr-27183	152	9	regularity	regularity	NOUN
ihlr-27183	152	10	”	"	PUNCT
ihlr-27183	152	11	of	of	ADP
ihlr-27183	152	12	a	a	DET
ihlr-27183	152	13	submission	submission	NOUN
ihlr-27183	152	14	–	–	PUNCT
ihlr-27183	152	15	especially	especially	ADV
ihlr-27183	152	16	one	one	NUM
ihlr-27183	152	17	which	which	PRON
ihlr-27183	152	18	would	would	AUX
ihlr-27183	152	19	continue	continue	VERB
ihlr-27183	152	20	throughout	throughout	ADP
ihlr-27183	152	21	market	market	NOUN
ihlr-27183	152	22	availability	availability	NOUN
ihlr-27183	152	23	–	–	PUNCT
ihlr-27183	152	24	supports	support	VERB
ihlr-27183	152	25	the	the	DET
ihlr-27183	152	26	“	"	PUNCT
ihlr-27183	152	27	routineness	routineness	NOUN
ihlr-27183	152	28	”	"	PUNCT
ihlr-27183	152	29	of	of	ADP
ihlr-27183	152	30	the	the	DET
ihlr-27183	152	31	activity	activity	NOUN
ihlr-27183	152	32	used	use	VERB
ihlr-27183	152	33	to	to	PART
ihlr-27183	152	34	generate	generate	VERB
ihlr-27183	152	35	the	the	DET
ihlr-27183	152	36	submission.50	submission.50	PROPN
ihlr-27183	152	37	second	second	PROPN
ihlr-27183	152	38	,	,	PUNCT
ihlr-27183	152	39	an	an	DET
ihlr-27183	152	40	activity	activity	NOUN
ihlr-27183	152	41	must	must	AUX
ihlr-27183	152	42	scope	scope	VERB
ihlr-27183	152	43	of	of	ADP
ihlr-27183	152	44	the	the	DET
ihlr-27183	152	45	s	s	PROPN
ihlr-27183	152	46	271(e)(1	271(e)(1	NOUN
ihlr-27183	152	47	)	)	PUNCT
ihlr-27183	152	48	safe	safe	ADJ
ihlr-27183	152	49	harbor	harbor	NOUN
ihlr-27183	152	50	,	,	PUNCT
ihlr-27183	152	51	23	23	NUM
ihlr-27183	152	52	berkeley	berkeley	PROPN
ihlr-27183	152	53	tech	tech	NOUN
ihlr-27183	152	54	.	.	PUNCT
ihlr-27183	153	1	l.j	l.j	PROPN
ihlr-27183	153	2	.	.	PROPN
ihlr-27183	153	3	107	107	NUM
ihlr-27183	153	4	,	,	PUNCT
ihlr-27183	153	5	138	138	NUM
ihlr-27183	153	6	(	(	PUNCT
ihlr-27183	153	7	2008	2008	NUM
ihlr-27183	153	8	)	)	PUNCT
ihlr-27183	153	9	.	.	PUNCT
ihlr-27183	154	1	42	42	NUM
ihlr-27183	154	2	.	.	PUNCT
ihlr-27183	155	1	i	i	PRON
ihlr-27183	155	2	d.	d.	PROPN
ihlr-27183	155	3	at	at	ADP
ihlr-27183	155	4	1338	1338	NUM
ihlr-27183	155	5	.	.	PUNCT
ihlr-27183	156	1	43	43	NUM
ihlr-27183	156	2	.	.	PUNCT
ihlr-27183	157	1	integra	integra	PROPN
ihlr-27183	157	2	lifesciences	lifesciences	PROPN
ihlr-27183	157	3	i	i	PROPN
ihlr-27183	157	4	,	,	PUNCT
ihlr-27183	157	5	ltd	ltd	PROPN
ihlr-27183	157	6	.	.	PROPN
ihlr-27183	158	1	v.	v.	PROPN
ihlr-27183	158	2	merck	merck	PROPN
ihlr-27183	158	3	kgaa	kgaa	PROPN
ihlr-27183	158	4	,	,	PUNCT
ihlr-27183	158	5	496	496	NUM
ihlr-27183	158	6	f.3d	f.3d	NUM
ihlr-27183	158	7	1334	1334	NUM
ihlr-27183	158	8	,	,	PUNCT
ihlr-27183	158	9	1343	1343	NUM
ihlr-27183	158	10	(	(	PUNCT
ihlr-27183	158	11	fed	fed	PROPN
ihlr-27183	158	12	.	.	PUNCT
ihlr-27183	158	13	cir	cir	PROPN
ihlr-27183	158	14	.	.	PROPN
ihlr-27183	158	15	2007	2007	NUM
ihlr-27183	158	16	)	)	PUNCT
ihlr-27183	158	17	.	.	PUNCT
ihlr-27183	159	1	44	44	NUM
ihlr-27183	159	2	.	.	PUNCT
ihlr-27183	159	3	momenta	momenta	PROPN
ihlr-27183	159	4	pharm	pharm	PROPN
ihlr-27183	159	5	.	.	PUNCT
ihlr-27183	159	6	,	,	PUNCT
ihlr-27183	159	7	inc	inc	PROPN
ihlr-27183	159	8	.	.	PROPN
ihlr-27183	160	1	v.	v.	ADP
ihlr-27183	160	2	amphastar	amphastar	PROPN
ihlr-27183	160	3	pharm	pharm	PROPN
ihlr-27183	160	4	.	.	PROPN
ihlr-27183	160	5	,	,	PUNCT
ihlr-27183	160	6	inc	inc	PROPN
ihlr-27183	160	7	.	.	PROPN
ihlr-27183	160	8	,	,	PUNCT
ihlr-27183	160	9	686	686	NUM
ihlr-27183	160	10	f.3d	f.3d	NUM
ihlr-27183	160	11	1348	1348	NUM
ihlr-27183	160	12	,	,	PUNCT
ihlr-27183	160	13	1358	1358	NUM
ihlr-27183	160	14	(	(	PUNCT
ihlr-27183	160	15	fed	fed	PROPN
ihlr-27183	160	16	.	.	PUNCT
ihlr-27183	160	17	cir	cir	PROPN
ihlr-27183	160	18	.	.	PROPN
ihlr-27183	160	19	2012	2012	NUM
ihlr-27183	160	20	)	)	PUNCT
ihlr-27183	160	21	.	.	PUNCT
ihlr-27183	161	1	45	45	NUM
ihlr-27183	161	2	.	.	PUNCT
ihlr-27183	161	3	momenta	momenta	PROPN
ihlr-27183	161	4	pharm	pharm	PROPN
ihlr-27183	161	5	.	.	PUNCT
ihlr-27183	161	6	,	,	PUNCT
ihlr-27183	161	7	inc	inc	PROPN
ihlr-27183	161	8	.	.	PROPN
ihlr-27183	161	9	v.	v.	PROPN
ihlr-27183	161	10	teva	teva	PROPN
ihlr-27183	161	11	pharm	pharm	PROPN
ihlr-27183	161	12	.	.	PUNCT
ihlr-27183	162	1	u.s.a	u.s.a	PROPN
ihlr-27183	162	2	.	.	PROPN
ihlr-27183	162	3	,	,	PUNCT
ihlr-27183	162	4	inc	inc	PROPN
ihlr-27183	162	5	.	.	PROPN
ihlr-27183	162	6	,	,	PUNCT
ihlr-27183	162	7	809	809	PROPN
ihlr-27183	162	8	f.3d	f.3d	NUM
ihlr-27183	162	9	610	610	NUM
ihlr-27183	162	10	,	,	PUNCT
ihlr-27183	162	11	620	620	NUM
ihlr-27183	162	12	(	(	PUNCT
ihlr-27183	162	13	fed	fed	PROPN
ihlr-27183	162	14	.	.	PUNCT
ihlr-27183	162	15	cir	cir	PROPN
ihlr-27183	162	16	.	.	PROPN
ihlr-27183	162	17	2015	2015	NUM
ihlr-27183	162	18	)	)	PUNCT
ihlr-27183	162	19	.	.	PUNCT
ihlr-27183	163	1	46	46	NUM
ihlr-27183	163	2	.	.	PUNCT
ihlr-27183	164	1	classen	classen	PROPN
ihlr-27183	164	2	immunotherapies	immunotherapies	PROPN
ihlr-27183	164	3	,	,	PUNCT
ihlr-27183	164	4	inc	inc	PROPN
ihlr-27183	164	5	.	.	PROPN
ihlr-27183	165	1	v.	v.	PROPN
ihlr-27183	165	2	biogen	biogen	PROPN
ihlr-27183	165	3	idec	idec	PROPN
ihlr-27183	165	4	,	,	PUNCT
ihlr-27183	165	5	659	659	NUM
ihlr-27183	165	6	f.3d	f.3d	NUM
ihlr-27183	165	7	1057	1057	NUM
ihlr-27183	165	8	,	,	PUNCT
ihlr-27183	165	9	1072	1072	NUM
ihlr-27183	165	10	(	(	PUNCT
ihlr-27183	165	11	fed	fed	PROPN
ihlr-27183	165	12	.	.	PUNCT
ihlr-27183	165	13	cir	cir	PROPN
ihlr-27183	165	14	.	.	PROPN
ihlr-27183	165	15	2011	2011	NUM
ihlr-27183	165	16	)	)	PUNCT
ihlr-27183	165	17	;	;	PUNCT
ihlr-27183	165	18	see	see	VERB
ihlr-27183	165	19	also	also	ADV
ihlr-27183	165	20	momenta	momenta	NOUN
ihlr-27183	165	21	pharm	pharm	NOUN
ihlr-27183	165	22	,	,	PUNCT
ihlr-27183	165	23	809	809	NUM
ihlr-27183	165	24	f.3d	f.3d	NUM
ihlr-27183	165	25	at	at	ADP
ihlr-27183	165	26	618	618	NUM
ihlr-27183	165	27	.	.	PUNCT
ihlr-27183	166	1	47	47	NUM
ihlr-27183	166	2	.	.	PUNCT
ihlr-27183	167	1	elan	elan	PROPN
ihlr-27183	167	2	pharms	pharms	PROPN
ihlr-27183	167	3	,	,	PUNCT
ihlr-27183	167	4	786	786	NUM
ihlr-27183	167	5	f.3d	f.3d	NUM
ihlr-27183	167	6	at	at	ADP
ihlr-27183	167	7	898	898	NUM
ihlr-27183	167	8	.	.	PUNCT
ihlr-27183	168	1	48	48	NUM
ihlr-27183	168	2	.	.	PUNCT
ihlr-27183	169	1	integra	integra	PROPN
ihlr-27183	169	2	lifesciences	lifesciences	PROPN
ihlr-27183	169	3	i	i	PROPN
ihlr-27183	169	4	,	,	PUNCT
ihlr-27183	169	5	ltd	ltd	PROPN
ihlr-27183	169	6	.	.	PROPN
ihlr-27183	170	1	v.	v.	PROPN
ihlr-27183	170	2	merck	merck	PROPN
ihlr-27183	170	3	kgaa	kgaa	PROPN
ihlr-27183	170	4	,	,	PUNCT
ihlr-27183	170	5	496	496	NUM
ihlr-27183	170	6	f.3d	f.3d	NUM
ihlr-27183	170	7	1334	1334	NUM
ihlr-27183	170	8	,	,	PUNCT
ihlr-27183	170	9	1340	1340	NUM
ihlr-27183	170	10	-	-	SYM
ihlr-27183	170	11	48	48	NUM
ihlr-27183	170	12	(	(	PUNCT
ihlr-27183	170	13	fed	fed	PROPN
ihlr-27183	170	14	.	.	PUNCT
ihlr-27183	170	15	cir	cir	PROPN
ihlr-27183	170	16	.	.	PROPN
ihlr-27183	170	17	2007	2007	NUM
ihlr-27183	170	18	)	)	PUNCT
ihlr-27183	170	19	.	.	PUNCT
ihlr-27183	171	1	49	49	NUM
ihlr-27183	171	2	.	.	PUNCT
ihlr-27183	172	1	amgen	amgen	PROPN
ihlr-27183	172	2	,	,	PUNCT
ihlr-27183	172	3	944	944	NUM
ihlr-27183	172	4	f.3d	f.3d	NUM
ihlr-27183	172	5	at	at	ADP
ihlr-27183	172	6	1339	1339	NUM
ihlr-27183	172	7	-	-	SYM
ihlr-27183	172	8	44	44	NUM
ihlr-27183	172	9	.	.	PUNCT
ihlr-27183	172	10	50	50	NUM
ihlr-27183	172	11	.	.	PUNCT
ihlr-27183	172	12	momenta	momenta	PROPN
ihlr-27183	172	13	pharm	pharm	PROPN
ihlr-27183	172	14	,	,	PUNCT
ihlr-27183	172	15	809	809	NUM
ihlr-27183	172	16	f.3d	f.3d	NUM
ihlr-27183	172	17	at	at	ADP
ihlr-27183	172	18	620	620	NUM
ihlr-27183	172	19	.	.	PUNCT
ihlr-27183	172	20	150	150	NUM
ihlr-27183	172	21	indiana	indiana	PROPN
ihlr-27183	172	22	health	health	PROPN
ihlr-27183	172	23	law	law	NOUN
ihlr-27183	172	24	review	review	NOUN
ihlr-27183	172	25	[	[	X
ihlr-27183	172	26	vol	vol	NOUN
ihlr-27183	172	27	.	.	PUNCT
ihlr-27183	172	28	20:143	20:143	PROPN
ihlr-27183	172	29	produce	produce	VERB
ihlr-27183	172	30	submissions	submission	NOUN
ihlr-27183	172	31	presently	presently	ADV
ihlr-27183	172	32	required	require	VERB
ihlr-27183	172	33	to	to	PART
ihlr-27183	172	34	obtain	obtain	VERB
ihlr-27183	172	35	fda	fda	PROPN
ihlr-27183	172	36	approval	approval	NOUN
ihlr-27183	172	37	–	–	PUNCT
ihlr-27183	172	38	not	not	PART
ihlr-27183	172	39	merely	merely	ADV
ihlr-27183	172	40	maintain	maintain	VERB
ihlr-27183	172	41	fda	fda	PROPN
ihlr-27183	172	42	approval	approval	NOUN
ihlr-27183	172	43	–	–	PUNCT
ihlr-27183	172	44	for	for	SCONJ
ihlr-27183	172	45	it	it	PRON
ihlr-27183	172	46	to	to	PART
ihlr-27183	172	47	succeed	succeed	VERB
ihlr-27183	172	48	at	at	ADP
ihlr-27183	172	49	overcoming	overcome	VERB
ihlr-27183	172	50	the	the	DET
ihlr-27183	172	51	bar	bar	NOUN
ihlr-27183	172	52	against	against	ADP
ihlr-27183	172	53	routine	routine	ADJ
ihlr-27183	172	54	submissions.51	submissions.51	NOUN
ihlr-27183	172	55	the	the	DET
ihlr-27183	172	56	federal	federal	ADJ
ihlr-27183	172	57	circuit	circuit	PROPN
ihlr-27183	172	58	’s	’s	PART
ihlr-27183	172	59	use	use	NOUN
ihlr-27183	172	60	of	of	ADP
ihlr-27183	172	61	legislative	legislative	ADJ
ihlr-27183	172	62	history	history	NOUN
ihlr-27183	172	63	affirms	affirm	VERB
ihlr-27183	172	64	this	this	PRON
ihlr-27183	172	65	as	as	ADP
ihlr-27183	172	66	a	a	DET
ihlr-27183	172	67	minimum.52	minimum.52	NOUN
ihlr-27183	172	68	in	in	ADP
ihlr-27183	172	69	short	short	ADJ
ihlr-27183	172	70	,	,	PUNCT
ihlr-27183	172	71	if	if	SCONJ
ihlr-27183	172	72	the	the	DET
ihlr-27183	172	73	alleged	alleged	ADJ
ihlr-27183	172	74	infringing	infringe	VERB
ihlr-27183	172	75	activity	activity	NOUN
ihlr-27183	172	76	produces	produce	VERB
ihlr-27183	172	77	a	a	DET
ihlr-27183	172	78	submission	submission	NOUN
ihlr-27183	172	79	type	type	NOUN
ihlr-27183	172	80	which	which	PRON
ihlr-27183	172	81	continues	continue	VERB
ihlr-27183	172	82	during	during	ADP
ihlr-27183	172	83	market	market	NOUN
ihlr-27183	172	84	availability	availability	NOUN
ihlr-27183	172	85	,	,	PUNCT
ihlr-27183	172	86	the	the	DET
ihlr-27183	172	87	activity	activity	NOUN
ihlr-27183	172	88	is	be	AUX
ihlr-27183	172	89	likely	likely	ADV
ihlr-27183	172	90	routine	routine	ADJ
ihlr-27183	172	91	,	,	PUNCT
ihlr-27183	172	92	and	and	CCONJ
ihlr-27183	172	93	use	use	NOUN
ihlr-27183	172	94	of	of	ADP
ihlr-27183	172	95	the	the	DET
ihlr-27183	172	96	associated	associate	VERB
ihlr-27183	172	97	patented	patent	VERB
ihlr-27183	172	98	invention	invention	NOUN
ihlr-27183	172	99	will	will	AUX
ihlr-27183	172	100	likely	likely	ADV
ihlr-27183	172	101	not	not	PART
ihlr-27183	172	102	be	be	AUX
ihlr-27183	172	103	shielded	shield	VERB
ihlr-27183	172	104	.	.	PUNCT
ihlr-27183	173	1	b.	b.	PROPN
ihlr-27183	173	2	patented	patent	VERB
ihlr-27183	173	3	invention	invention	NOUN
ihlr-27183	173	4	not	not	PART
ihlr-27183	173	5	surprisingly	surprisingly	ADV
ihlr-27183	173	6	,	,	PUNCT
ihlr-27183	173	7	the	the	DET
ihlr-27183	173	8	generic	generic	ADJ
ihlr-27183	173	9	term	term	NOUN
ihlr-27183	173	10	“	"	PUNCT
ihlr-27183	173	11	patented	patented	ADJ
ihlr-27183	173	12	invention	invention	NOUN
ihlr-27183	173	13	”	"	PUNCT
ihlr-27183	173	14	of	of	ADP
ihlr-27183	173	15	§	§	PROPN
ihlr-27183	173	16	271(e)(1	271(e)(1	PROPN
ihlr-27183	173	17	)	)	PUNCT
ihlr-27183	173	18	of	of	ADP
ihlr-27183	173	19	the	the	DET
ihlr-27183	173	20	hatch	hatch	PROPN
ihlr-27183	173	21	-	-	PUNCT
ihlr-27183	173	22	waxman	waxman	PROPN
ihlr-27183	173	23	act	act	NOUN
ihlr-27183	173	24	invariably	invariably	ADV
ihlr-27183	173	25	includes	include	VERB
ihlr-27183	173	26	–	–	PUNCT
ihlr-27183	173	27	at	at	ADP
ihlr-27183	173	28	the	the	DET
ihlr-27183	173	29	very	very	ADV
ihlr-27183	173	30	least53	least53	NOUN
ihlr-27183	173	31	–	–	PUNCT
ihlr-27183	173	32	the	the	DET
ihlr-27183	173	33	use	use	NOUN
ihlr-27183	173	34	of	of	ADP
ihlr-27183	173	35	a	a	DET
ihlr-27183	173	36	drug	drug	NOUN
ihlr-27183	173	37	when	when	SCONJ
ihlr-27183	173	38	that	that	DET
ihlr-27183	173	39	use	use	NOUN
ihlr-27183	173	40	is	be	AUX
ihlr-27183	173	41	“	"	PUNCT
ihlr-27183	173	42	reasonably	reasonably	ADV
ihlr-27183	173	43	related	relate	VERB
ihlr-27183	173	44	”	"	PUNCT
ihlr-27183	173	45	to	to	ADP
ihlr-27183	173	46	obtaining	obtain	VERB
ihlr-27183	173	47	fda	fda	PROPN
ihlr-27183	173	48	approval	approval	NOUN
ihlr-27183	173	49	on	on	ADP
ihlr-27183	173	50	that	that	DET
ihlr-27183	173	51	same	same	ADJ
ihlr-27183	173	52	drug.54	drug.54	NOUN
ihlr-27183	173	53	in	in	ADP
ihlr-27183	173	54	bounding	bound	VERB
ihlr-27183	173	55	that	that	DET
ihlr-27183	173	56	scope	scope	NOUN
ihlr-27183	173	57	,	,	PUNCT
ihlr-27183	173	58	the	the	DET
ihlr-27183	173	59	statutory	statutory	ADJ
ihlr-27183	173	60	language	language	NOUN
ihlr-27183	173	61	identifies	identify	VERB
ihlr-27183	173	62	no	no	DET
ihlr-27183	173	63	obvious	obvious	ADJ
ihlr-27183	173	64	limitation	limitation	NOUN
ihlr-27183	173	65	to	to	ADP
ihlr-27183	173	66	the	the	DET
ihlr-27183	173	67	statute	statute	NOUN
ihlr-27183	173	68	’s	’s	PART
ihlr-27183	173	69	patented	patented	ADJ
ihlr-27183	173	70	invention	invention	NOUN
ihlr-27183	173	71	.	.	PUNCT
ihlr-27183	174	1	indeed	indeed	ADV
ihlr-27183	174	2	,	,	PUNCT
ihlr-27183	174	3	§	§	PROPN
ihlr-27183	174	4	271	271	NUM
ihlr-27183	174	5	uses	use	VERB
ihlr-27183	174	6	“	"	PUNCT
ihlr-27183	174	7	patented	patented	ADJ
ihlr-27183	174	8	invention	invention	NOUN
ihlr-27183	174	9	”	"	PUNCT
ihlr-27183	174	10	throughout	throughout	ADP
ihlr-27183	174	11	to	to	PART
ihlr-27183	174	12	refer	refer	VERB
ihlr-27183	174	13	to	to	ADP
ihlr-27183	174	14	all	all	DET
ihlr-27183	174	15	inventions	invention	NOUN
ihlr-27183	174	16	without	without	ADP
ihlr-27183	174	17	regard	regard	NOUN
ihlr-27183	174	18	for	for	ADP
ihlr-27183	174	19	their	their	PRON
ihlr-27183	174	20	status	status	NOUN
ihlr-27183	174	21	under	under	ADP
ihlr-27183	174	22	federal	federal	ADJ
ihlr-27183	174	23	regulations	regulation	NOUN
ihlr-27183	174	24	or	or	CCONJ
ihlr-27183	174	25	otherwise.55	otherwise.55	NOUN
ihlr-27183	174	26	it	it	PRON
ihlr-27183	174	27	is	be	AUX
ihlr-27183	174	28	not	not	PART
ihlr-27183	174	29	clear	clear	ADJ
ihlr-27183	174	30	whether	whether	SCONJ
ihlr-27183	174	31	the	the	DET
ihlr-27183	174	32	patented	patent	VERB
ihlr-27183	174	33	invention	invention	NOUN
ihlr-27183	174	34	shielded	shielded	NOUN
ihlr-27183	174	35	must	must	AUX
ihlr-27183	174	36	be	be	AUX
ihlr-27183	174	37	used	use	VERB
ihlr-27183	174	38	in	in	ADP
ihlr-27183	174	39	connection	connection	NOUN
ihlr-27183	174	40	with	with	ADP
ihlr-27183	174	41	its	its	PRON
ihlr-27183	174	42	own	own	ADJ
ihlr-27183	174	43	fda	fda	PROPN
ihlr-27183	174	44	approval	approval	NOUN
ihlr-27183	174	45	.	.	PUNCT
ihlr-27183	175	1	further	far	ADV
ihlr-27183	175	2	,	,	PUNCT
ihlr-27183	175	3	it	it	PRON
ihlr-27183	175	4	is	be	AUX
ihlr-27183	175	5	not	not	PART
ihlr-27183	175	6	clear	clear	ADJ
ihlr-27183	175	7	whether	whether	SCONJ
ihlr-27183	175	8	the	the	DET
ihlr-27183	175	9	patented	patented	ADJ
ihlr-27183	175	10	invention	invention	NOUN
ihlr-27183	175	11	must	must	AUX
ihlr-27183	175	12	be	be	AUX
ihlr-27183	175	13	subject	subject	ADJ
ihlr-27183	175	14	to	to	ADP
ihlr-27183	175	15	fda	fda	PROPN
ihlr-27183	175	16	approval	approval	NOUN
ihlr-27183	175	17	at	at	ADV
ihlr-27183	175	18	all	all	ADV
ihlr-27183	175	19	.	.	PUNCT
ihlr-27183	176	1	by	by	ADP
ihlr-27183	176	2	comparison	comparison	NOUN
ihlr-27183	176	3	,	,	PUNCT
ihlr-27183	176	4	while	while	SCONJ
ihlr-27183	176	5	the	the	DET
ihlr-27183	176	6	common	common	ADJ
ihlr-27183	176	7	law	law	NOUN
ihlr-27183	176	8	exception	exception	NOUN
ihlr-27183	176	9	has	have	VERB
ihlr-27183	176	10	the	the	DET
ihlr-27183	176	11	reach	reach	NOUN
ihlr-27183	176	12	of	of	ADP
ihlr-27183	176	13	t	t	PROPN
ihlr-27183	176	14	-	-	PUNCT
ihlr-27183	176	15	rex	rex	PROPN
ihlr-27183	176	16	arms	arms	PROPN
ihlr-27183	176	17	,	,	PUNCT
ihlr-27183	176	18	the	the	DET
ihlr-27183	176	19	act	act	NOUN
ihlr-27183	176	20	is	be	AUX
ihlr-27183	176	21	linguistically	linguistically	ADV
ihlr-27183	176	22	poised	poise	VERB
ihlr-27183	176	23	with	with	ADP
ihlr-27183	176	24	the	the	DET
ihlr-27183	176	25	reach	reach	NOUN
ihlr-27183	176	26	of	of	ADP
ihlr-27183	176	27	an	an	DET
ihlr-27183	176	28	orangutang	orangutang	PROPN
ihlr-27183	176	29	gliding	glide	VERB
ihlr-27183	176	30	through	through	ADP
ihlr-27183	176	31	the	the	DET
ihlr-27183	176	32	treetops	treetop	NOUN
ihlr-27183	176	33	.	.	PUNCT
ihlr-27183	177	1	even	even	ADV
ihlr-27183	177	2	so	so	ADV
ihlr-27183	177	3	,	,	PUNCT
ihlr-27183	177	4	courts	court	NOUN
ihlr-27183	177	5	have	have	AUX
ihlr-27183	177	6	defined	define	VERB
ihlr-27183	177	7	“	"	PUNCT
ihlr-27183	177	8	patented	patented	ADJ
ihlr-27183	177	9	invention	invention	NOUN
ihlr-27183	177	10	”	"	PUNCT
ihlr-27183	177	11	with	with	ADP
ihlr-27183	177	12	some	some	DET
ihlr-27183	177	13	particularity.56	particularity.56	NOUN
ihlr-27183	177	14	while	while	SCONJ
ihlr-27183	177	15	courts	court	NOUN
ihlr-27183	177	16	agree	agree	VERB
ihlr-27183	177	17	the	the	DET
ihlr-27183	177	18	term	term	NOUN
ihlr-27183	177	19	is	be	AUX
ihlr-27183	177	20	not	not	PART
ihlr-27183	177	21	limited	limit	VERB
ihlr-27183	177	22	to	to	ADP
ihlr-27183	177	23	pharmaceutical	pharmaceutical	ADJ
ihlr-27183	177	24	drugs	drug	NOUN
ihlr-27183	177	25	,	,	PUNCT
ihlr-27183	177	26	a	a	DET
ihlr-27183	177	27	close	close	ADJ
ihlr-27183	177	28	look	look	NOUN
ihlr-27183	177	29	reveals	reveal	VERB
ihlr-27183	177	30	courts	court	NOUN
ihlr-27183	177	31	disagree	disagree	VERB
ihlr-27183	177	32	on	on	ADP
ihlr-27183	177	33	whether	whether	SCONJ
ihlr-27183	177	34	the	the	DET
ihlr-27183	177	35	patented	patented	ADJ
ihlr-27183	177	36	invention	invention	NOUN
ihlr-27183	177	37	’s	’s	PART
ihlr-27183	177	38	regulatory	regulatory	ADJ
ihlr-27183	177	39	status	status	NOUN
ihlr-27183	177	40	under	under	ADP
ihlr-27183	177	41	the	the	DET
ihlr-27183	177	42	fda	fda	PROPN
ihlr-27183	177	43	is	be	AUX
ihlr-27183	177	44	required	require	VERB
ihlr-27183	177	45	.	.	PUNCT
ihlr-27183	178	1	1	1	X
ihlr-27183	178	2	.	.	X
ihlr-27183	178	3	not	not	PART
ihlr-27183	178	4	all	all	ADV
ihlr-27183	178	5	about	about	ADP
ihlr-27183	178	6	drugs	drug	NOUN
ihlr-27183	178	7	first	first	ADV
ihlr-27183	178	8	,	,	PUNCT
ihlr-27183	178	9	the	the	DET
ihlr-27183	178	10	supreme	supreme	PROPN
ihlr-27183	178	11	court	court	PROPN
ihlr-27183	178	12	in	in	ADP
ihlr-27183	178	13	eli	eli	PROPN
ihlr-27183	178	14	lilly	lilly	PROPN
ihlr-27183	178	15	v.	v.	PROPN
ihlr-27183	178	16	medtronic	medtronic	PROPN
ihlr-27183	178	17	clarified	clarify	VERB
ihlr-27183	178	18	that	that	SCONJ
ihlr-27183	178	19	“	"	PUNCT
ihlr-27183	178	20	patented	patented	ADJ
ihlr-27183	178	21	invention	invention	NOUN
ihlr-27183	178	22	”	"	PUNCT
ihlr-27183	178	23	includes	include	VERB
ihlr-27183	178	24	“	"	PUNCT
ihlr-27183	178	25	all	all	DET
ihlr-27183	178	26	inventions	invention	NOUN
ihlr-27183	178	27	,	,	PUNCT
ihlr-27183	178	28	not	not	PART
ihlr-27183	178	29	drug	drug	NOUN
ihlr-27183	178	30	related	relate	VERB
ihlr-27183	178	31	inventions	invention	NOUN
ihlr-27183	178	32	alone	alone	ADV
ihlr-27183	178	33	.	.	PUNCT
ihlr-27183	179	1	”57	”57	PROPN
ihlr-27183	179	2	unsurprisingly	unsurprisingly	ADV
ihlr-27183	179	3	,	,	PUNCT
ihlr-27183	179	4	it	it	PRON
ihlr-27183	179	5	is	be	AUX
ihlr-27183	179	6	settled	settle	VERB
ihlr-27183	179	7	that	that	SCONJ
ihlr-27183	179	8	the	the	DET
ihlr-27183	179	9	statute	statute	NOUN
ihlr-27183	179	10	shields	shield	VERB
ihlr-27183	179	11	the	the	DET
ihlr-27183	179	12	use	use	NOUN
ihlr-27183	179	13	of	of	ADP
ihlr-27183	179	14	patented	patent	VERB
ihlr-27183	179	15	processes	process	NOUN
ihlr-27183	179	16	,	,	PUNCT
ihlr-27183	179	17	pharmaceutical	pharmaceutical	ADJ
ihlr-27183	179	18	manufacturing	manufacturing	NOUN
ihlr-27183	179	19	equipment	equipment	NOUN
ihlr-27183	179	20	,	,	PUNCT
ihlr-27183	179	21	medical	medical	ADJ
ihlr-27183	179	22	devices	device	NOUN
ihlr-27183	179	23	,	,	PUNCT
ihlr-27183	179	24	and	and	CCONJ
ihlr-27183	179	25	pharmaceuticals	pharmaceutical	NOUN
ihlr-27183	179	26	from	from	ADP
ihlr-27183	179	27	infringement	infringement	NOUN
ihlr-27183	179	28	when	when	SCONJ
ihlr-27183	179	29	used	use	VERB
ihlr-27183	179	30	to	to	PART
ihlr-27183	179	31	approve	approve	VERB
ihlr-27183	179	32	those	those	DET
ihlr-27183	179	33	technologies	technology	NOUN
ihlr-27183	179	34	under	under	ADP
ihlr-27183	179	35	their	their	PRON
ihlr-27183	179	36	respective	respective	ADJ
ihlr-27183	179	37	fda	fda	PROPN
ihlr-27183	179	38	regulations.58	regulations.58	NOUN
ihlr-27183	179	39	this	this	DET
ihlr-27183	179	40	holding	holding	NOUN
ihlr-27183	179	41	aligns	align	VERB
ihlr-27183	179	42	with	with	ADP
ihlr-27183	179	43	the	the	DET
ihlr-27183	179	44	intent	intent	NOUN
ihlr-27183	179	45	to	to	PART
ihlr-27183	179	46	ensure	ensure	VERB
ihlr-27183	179	47	a	a	DET
ihlr-27183	179	48	competitor	competitor	NOUN
ihlr-27183	179	49	can	can	AUX
ihlr-27183	179	50	introduce	introduce	VERB
ihlr-27183	179	51	a	a	DET
ihlr-27183	179	52	generic	generic	ADJ
ihlr-27183	179	53	product	product	NOUN
ihlr-27183	179	54	to	to	ADP
ihlr-27183	179	55	market	market	NOUN
ihlr-27183	179	56	immediately	immediately	ADV
ihlr-27183	179	57	upon	upon	SCONJ
ihlr-27183	179	58	patent	patent	NOUN
ihlr-27183	179	59	expiration	expiration	NOUN
ihlr-27183	179	60	.	.	PUNCT
ihlr-27183	180	1	notably	notably	ADV
ihlr-27183	180	2	,	,	PUNCT
ihlr-27183	180	3	the	the	DET
ihlr-27183	180	4	statement	statement	NOUN
ihlr-27183	180	5	in	in	ADP
ihlr-27183	180	6	eli	eli	PROPN
ihlr-27183	180	7	lilly	lilly	PROPN
ihlr-27183	180	8	is	be	AUX
ihlr-27183	180	9	made	make	VERB
ihlr-27183	180	10	without	without	ADP
ihlr-27183	180	11	caveat	caveat	NOUN
ihlr-27183	180	12	and	and	CCONJ
ihlr-27183	180	13	has	have	VERB
ihlr-27183	180	14	51	51	NUM
ihlr-27183	180	15	.	.	PUNCT
ihlr-27183	181	1	integra	integra	PROPN
ihlr-27183	181	2	lifesciences	lifesciences	PROPN
ihlr-27183	181	3	i	i	PRON
ihlr-27183	181	4	,	,	PUNCT
ihlr-27183	181	5	496	496	NUM
ihlr-27183	181	6	f.3d	f.3d	NUM
ihlr-27183	181	7	at	at	ADP
ihlr-27183	181	8	1343	1343	NUM
ihlr-27183	181	9	.	.	PUNCT
ihlr-27183	182	1	52	52	NUM
ihlr-27183	182	2	.	.	PUNCT
ihlr-27183	183	1	biogen	biogen	PROPN
ihlr-27183	183	2	idec	idec	PROPN
ihlr-27183	183	3	,	,	PUNCT
ihlr-27183	183	4	659	659	NUM
ihlr-27183	183	5	f.3d	f.3d	NUM
ihlr-27183	183	6	at	at	ADP
ihlr-27183	183	7	1071	1071	NUM
ihlr-27183	183	8	(	(	PUNCT
ihlr-27183	183	9	quoting	quote	VERB
ihlr-27183	183	10	h.r	h.r	PROPN
ihlr-27183	183	11	.	.	PROPN
ihlr-27183	183	12	rep	rep	PROPN
ihlr-27183	183	13	.	.	PROPN
ihlr-27183	183	14	no	no	INTJ
ihlr-27183	183	15	.	.	NOUN
ihlr-27183	183	16	98	98	NUM
ihlr-27183	183	17	-	-	PUNCT
ihlr-27183	183	18	857(i	857(i	NUM
ihlr-27183	183	19	)	)	PUNCT
ihlr-27183	183	20	at	at	ADP
ihlr-27183	183	21	45	45	NUM
ihlr-27183	183	22	(	(	PUNCT
ihlr-27183	183	23	1984	1984	NUM
ihlr-27183	183	24	)	)	PUNCT
ihlr-27183	183	25	)	)	PUNCT
ihlr-27183	183	26	.	.	PUNCT
ihlr-27183	184	1	53	53	NUM
ihlr-27183	184	2	.	.	X
ihlr-27183	184	3	proveris	proveris	PROPN
ihlr-27183	184	4	sci	sci	PROPN
ihlr-27183	184	5	.	.	PROPN
ihlr-27183	184	6	,	,	PUNCT
ihlr-27183	184	7	536	536	NUM
ihlr-27183	184	8	f.3d	f.3d	NUM
ihlr-27183	184	9	at	at	ADP
ihlr-27183	184	10	1263	1263	NUM
ihlr-27183	184	11	.	.	PUNCT
ihlr-27183	185	1	54	54	NUM
ihlr-27183	185	2	.	.	NOUN
ihlr-27183	185	3	35	35	NUM
ihlr-27183	185	4	u.s.c	u.s.c	NOUN
ihlr-27183	185	5	.	.	PUNCT
ihlr-27183	186	1	§	§	PROPN
ihlr-27183	186	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	186	3	)	)	PUNCT
ihlr-27183	186	4	(	(	PUNCT
ihlr-27183	186	5	2015	2015	NUM
ihlr-27183	186	6	)	)	PUNCT
ihlr-27183	186	7	(	(	PUNCT
ihlr-27183	186	8	to	to	ADP
ihlr-27183	186	9	the	the	DET
ihlr-27183	186	10	author	author	NOUN
ihlr-27183	186	11	’s	’s	PART
ihlr-27183	186	12	knowledge	knowledge	NOUN
ihlr-27183	186	13	,	,	PUNCT
ihlr-27183	186	14	no	no	DET
ihlr-27183	186	15	case	case	NOUN
ihlr-27183	186	16	has	have	AUX
ihlr-27183	186	17	excluded	exclude	VERB
ihlr-27183	186	18	drugs	drug	NOUN
ihlr-27183	186	19	subject	subject	ADJ
ihlr-27183	186	20	to	to	ADP
ihlr-27183	186	21	fda	fda	PROPN
ihlr-27183	186	22	approval	approval	NOUN
ihlr-27183	186	23	from	from	ADP
ihlr-27183	186	24	the	the	DET
ihlr-27183	186	25	statutory	statutory	ADJ
ihlr-27183	186	26	reach	reach	NOUN
ihlr-27183	186	27	of	of	ADP
ihlr-27183	186	28	“	"	PUNCT
ihlr-27183	186	29	patented	patented	ADJ
ihlr-27183	186	30	invention	invention	NOUN
ihlr-27183	186	31	”	"	PUNCT
ihlr-27183	186	32	)	)	PUNCT
ihlr-27183	186	33	.	.	PUNCT
ihlr-27183	187	1	55	55	NUM
ihlr-27183	187	2	.	.	PUNCT
ihlr-27183	188	1	i	i	PRON
ihlr-27183	188	2	d.	d.	PROPN
ihlr-27183	188	3	56	56	NUM
ihlr-27183	188	4	.	.	PUNCT
ihlr-27183	189	1	i	i	PRON
ihlr-27183	189	2	d.	d.	PROPN
ihlr-27183	189	3	57	57	NUM
ihlr-27183	189	4	.	.	PUNCT
ihlr-27183	190	1	eli	eli	PROPN
ihlr-27183	190	2	lilly	lilly	PROPN
ihlr-27183	190	3	&	&	CCONJ
ihlr-27183	190	4	co.	co.	PROPN
ihlr-27183	191	1	v.	v.	ADP
ihlr-27183	191	2	medtronic	medtronic	PROPN
ihlr-27183	191	3	,	,	PUNCT
ihlr-27183	191	4	inc	inc	PROPN
ihlr-27183	191	5	.	.	PROPN
ihlr-27183	191	6	,	,	PUNCT
ihlr-27183	191	7	496	496	NUM
ihlr-27183	191	8	u.s	u.s	PROPN
ihlr-27183	191	9	.	.	PROPN
ihlr-27183	191	10	661	661	NUM
ihlr-27183	191	11	,	,	PUNCT
ihlr-27183	191	12	665	665	NUM
ihlr-27183	191	13	(	(	PUNCT
ihlr-27183	191	14	1990	1990	NUM
ihlr-27183	191	15	)	)	PUNCT
ihlr-27183	191	16	.	.	PUNCT
ihlr-27183	192	1	58	58	NUM
ihlr-27183	192	2	.	.	PUNCT
ihlr-27183	192	3	see	see	VERB
ihlr-27183	192	4	amgen	amgen	PROPN
ihlr-27183	192	5	inc	inc	PROPN
ihlr-27183	192	6	.	.	PROPN
ihlr-27183	192	7	,	,	PUNCT
ihlr-27183	192	8	944	944	NUM
ihlr-27183	192	9	f.3d	f.3d	NUM
ihlr-27183	192	10	at	at	ADP
ihlr-27183	192	11	1338	1338	NUM
ihlr-27183	192	12	-	-	SYM
ihlr-27183	192	13	40	40	NUM
ihlr-27183	192	14	;	;	PUNCT
ihlr-27183	192	15	elan	elan	PROPN
ihlr-27183	192	16	pharm	pharm	PROPN
ihlr-27183	192	17	.	.	PROPN
ihlr-27183	192	18	,	,	PUNCT
ihlr-27183	192	19	inc	inc	PROPN
ihlr-27183	192	20	.	.	PROPN
ihlr-27183	192	21	,	,	PUNCT
ihlr-27183	192	22	786	786	NUM
ihlr-27183	192	23	f.3d	f.3d	NUM
ihlr-27183	192	24	at	at	ADP
ihlr-27183	192	25	898	898	NUM
ihlr-27183	192	26	;	;	PUNCT
ihlr-27183	192	27	proveris	proveris	PROPN
ihlr-27183	192	28	sci	sci	PROPN
ihlr-27183	192	29	.	.	PROPN
ihlr-27183	192	30	,	,	PUNCT
ihlr-27183	192	31	536	536	NUM
ihlr-27183	192	32	f.3d	f.3d	NUM
ihlr-27183	192	33	at	at	ADP
ihlr-27183	192	34	1262	1262	NUM
ihlr-27183	192	35	.	.	PUNCT
ihlr-27183	193	1	2023	2023	NUM
ihlr-27183	193	2	]	]	PUNCT
ihlr-27183	193	3	the	the	DET
ihlr-27183	193	4	safe	safe	ADJ
ihlr-27183	193	5	harbor	harbor	NOUN
ihlr-27183	193	6	of	of	ADP
ihlr-27183	193	7	35	35	NUM
ihlr-27183	193	8	u.s.c	u.s.c	ADJ
ihlr-27183	193	9	.	.	PUNCT
ihlr-27183	194	1	§	§	PROPN
ihlr-27183	194	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	194	3	)	)	PUNCT
ihlr-27183	194	4	151	151	NUM
ihlr-27183	194	5	occasionally	occasionally	ADV
ihlr-27183	194	6	been	be	AUX
ihlr-27183	194	7	read	read	VERB
ihlr-27183	194	8	to	to	PART
ihlr-27183	194	9	suggest	suggest	VERB
ihlr-27183	194	10	a	a	DET
ihlr-27183	194	11	contrast	contrast	NOUN
ihlr-27183	194	12	to	to	ADP
ihlr-27183	194	13	the	the	DET
ihlr-27183	194	14	“	"	PUNCT
ihlr-27183	194	15	product	product	NOUN
ihlr-27183	194	16	”	"	PUNCT
ihlr-27183	194	17	of	of	ADP
ihlr-27183	194	18	§	§	PROPN
ihlr-27183	194	19	156	156	NUM
ihlr-27183	194	20	,	,	PUNCT
ihlr-27183	194	21	calling	call	VERB
ihlr-27183	194	22	into	into	ADP
ihlr-27183	194	23	question	question	NOUN
ihlr-27183	194	24	whether	whether	SCONJ
ihlr-27183	194	25	the	the	DET
ihlr-27183	194	26	“	"	PUNCT
ihlr-27183	194	27	patented	patented	ADJ
ihlr-27183	194	28	invention	invention	NOUN
ihlr-27183	194	29	”	"	PUNCT
ihlr-27183	194	30	must	must	AUX
ihlr-27183	194	31	itself	itself	PRON
ihlr-27183	194	32	be	be	AUX
ihlr-27183	194	33	subject	subject	ADJ
ihlr-27183	194	34	to	to	ADP
ihlr-27183	194	35	fda	fda	PROPN
ihlr-27183	194	36	approval.59	approval.59	VERB
ihlr-27183	194	37	2	2	NUM
ihlr-27183	194	38	.	.	NOUN
ihlr-27183	194	39	invention	invention	NOUN
ihlr-27183	194	40	’s	’s	PART
ihlr-27183	194	41	status	status	NOUN
ihlr-27183	194	42	under	under	ADP
ihlr-27183	194	43	regulation	regulation	NOUN
ihlr-27183	194	44	following	follow	VERB
ihlr-27183	194	45	eli	eli	PROPN
ihlr-27183	194	46	lilly	lilly	PROPN
ihlr-27183	194	47	,	,	PUNCT
ihlr-27183	194	48	the	the	DET
ihlr-27183	194	49	next	next	ADJ
ihlr-27183	194	50	seeming	seem	VERB
ihlr-27183	194	51	expansion	expansion	NOUN
ihlr-27183	194	52	in	in	ADP
ihlr-27183	194	53	the	the	DET
ihlr-27183	194	54	scope	scope	NOUN
ihlr-27183	194	55	of	of	ADP
ihlr-27183	194	56	what	what	PRON
ihlr-27183	194	57	the	the	DET
ihlr-27183	194	58	“	"	PUNCT
ihlr-27183	194	59	patented	patented	ADJ
ihlr-27183	194	60	invention	invention	NOUN
ihlr-27183	194	61	”	"	PUNCT
ihlr-27183	194	62	includes	include	VERB
ihlr-27183	194	63	came	come	VERB
ihlr-27183	194	64	from	from	ADP
ihlr-27183	194	65	the	the	DET
ihlr-27183	194	66	federal	federal	ADJ
ihlr-27183	194	67	circuit	circuit	NOUN
ihlr-27183	194	68	.	.	PUNCT
ihlr-27183	195	1	in	in	ADP
ihlr-27183	195	2	abtox	abtox	PROPN
ihlr-27183	195	3	v.	v.	ADP
ihlr-27183	195	4	exitron	exitron	PROPN
ihlr-27183	195	5	,	,	PUNCT
ihlr-27183	195	6	a	a	DET
ihlr-27183	195	7	defendant	defendant	NOUN
ihlr-27183	195	8	used	use	VERB
ihlr-27183	195	9	a	a	DET
ihlr-27183	195	10	plasma	plasma	NOUN
ihlr-27183	195	11	sterilizer	sterilizer	NOUN
ihlr-27183	195	12	–	–	PUNCT
ihlr-27183	195	13	not	not	PART
ihlr-27183	195	14	itself	itself	PRON
ihlr-27183	195	15	subject	subject	ADJ
ihlr-27183	195	16	to	to	ADP
ihlr-27183	195	17	§	§	PROPN
ihlr-27183	195	18	156	156	NUM
ihlr-27183	195	19	or	or	CCONJ
ihlr-27183	195	20	full	full	ADJ
ihlr-27183	195	21	fda	fda	PROPN
ihlr-27183	195	22	approval60	approval60	PROPN
ihlr-27183	195	23	,	,	PUNCT
ihlr-27183	195	24	and	and	CCONJ
ihlr-27183	195	25	was	be	AUX
ihlr-27183	195	26	granted	grant	VERB
ihlr-27183	195	27	summary	summary	NOUN
ihlr-27183	195	28	judgement	judgement	NOUN
ihlr-27183	195	29	for	for	ADP
ihlr-27183	195	30	non	non	NOUN
ihlr-27183	195	31	-	-	NOUN
ihlr-27183	195	32	infringement	infringement	NOUN
ihlr-27183	195	33	on	on	ADP
ihlr-27183	195	34	its	its	PRON
ihlr-27183	195	35	motion	motion	NOUN
ihlr-27183	195	36	to	to	PART
ihlr-27183	195	37	dismiss.61	dismiss.61	VERB
ihlr-27183	195	38	the	the	DET
ihlr-27183	195	39	abtox	abtox	NOUN
ihlr-27183	195	40	court	court	NOUN
ihlr-27183	195	41	reasoned	reason	VERB
ihlr-27183	195	42	the	the	DET
ihlr-27183	195	43	supreme	supreme	PROPN
ihlr-27183	195	44	court	court	PROPN
ihlr-27183	195	45	in	in	ADP
ihlr-27183	195	46	eli	eli	PROPN
ihlr-27183	195	47	lilly	lilly	PROPN
ihlr-27183	195	48	had	have	AUX
ihlr-27183	195	49	only	only	ADV
ihlr-27183	195	50	indicated	indicate	VERB
ihlr-27183	195	51	statutory	statutory	ADJ
ihlr-27183	195	52	symmetry	symmetry	NOUN
ihlr-27183	195	53	between	between	ADP
ihlr-27183	195	54	§	§	PROPN
ihlr-27183	195	55	156	156	NUM
ihlr-27183	195	56	and	and	CCONJ
ihlr-27183	195	57	§	§	PROPN
ihlr-27183	195	58	271	271	NUM
ihlr-27183	195	59	was	be	AUX
ihlr-27183	195	60	“	"	PUNCT
ihlr-27183	195	61	preferable	preferable	ADJ
ihlr-27183	195	62	but	but	CCONJ
ihlr-27183	195	63	not	not	PART
ihlr-27183	195	64	required	require	VERB
ihlr-27183	195	65	.	.	PUNCT
ihlr-27183	196	1	”62	”62	PROPN
ihlr-27183	196	2	hence	hence	ADV
ihlr-27183	196	3	,	,	PUNCT
ihlr-27183	196	4	according	accord	VERB
ihlr-27183	196	5	to	to	ADP
ihlr-27183	196	6	the	the	DET
ihlr-27183	196	7	abtox	abtox	NOUN
ihlr-27183	196	8	court	court	PROPN
ihlr-27183	196	9	’s	’s	PART
ihlr-27183	196	10	interpretation	interpretation	NOUN
ihlr-27183	196	11	,	,	PUNCT
ihlr-27183	196	12	the	the	DET
ihlr-27183	196	13	“	"	PUNCT
ihlr-27183	196	14	products	product	NOUN
ihlr-27183	196	15	”	"	PUNCT
ihlr-27183	196	16	of	of	ADP
ihlr-27183	196	17	§	§	PROPN
ihlr-27183	196	18	156	156	NUM
ihlr-27183	196	19	need	need	AUX
ihlr-27183	196	20	not	not	PART
ihlr-27183	196	21	refer	refer	VERB
ihlr-27183	196	22	to	to	ADP
ihlr-27183	196	23	the	the	DET
ihlr-27183	196	24	same	same	ADJ
ihlr-27183	196	25	class	class	NOUN
ihlr-27183	196	26	of	of	ADP
ihlr-27183	196	27	inventions	invention	NOUN
ihlr-27183	196	28	as	as	ADP
ihlr-27183	196	29	the	the	DET
ihlr-27183	196	30	“	"	PUNCT
ihlr-27183	196	31	patented	patented	ADJ
ihlr-27183	196	32	invention	invention	NOUN
ihlr-27183	196	33	”	"	PUNCT
ihlr-27183	196	34	of	of	ADP
ihlr-27183	196	35	§	§	PROPN
ihlr-27183	196	36	271	271	NUM
ihlr-27183	196	37	–	–	PUNCT
ihlr-27183	196	38	presumably	presumably	ADV
ihlr-27183	196	39	,	,	PUNCT
ihlr-27183	196	40	§	§	NOUN
ihlr-27183	196	41	271	271	NUM
ihlr-27183	196	42	including	include	VERB
ihlr-27183	196	43	a	a	DET
ihlr-27183	196	44	broader	broad	ADJ
ihlr-27183	196	45	class.63	class.63	NOUN
ihlr-27183	196	46	then	then	ADV
ihlr-27183	196	47	,	,	PUNCT
ihlr-27183	196	48	in	in	ADP
ihlr-27183	196	49	2005	2005	NUM
ihlr-27183	196	50	,	,	PUNCT
ihlr-27183	196	51	the	the	DET
ihlr-27183	196	52	supreme	supreme	PROPN
ihlr-27183	196	53	court	court	PROPN
ihlr-27183	196	54	subtly	subtly	ADV
ihlr-27183	196	55	weighed	weigh	VERB
ihlr-27183	196	56	in	in	ADP
ihlr-27183	196	57	on	on	ADP
ihlr-27183	196	58	the	the	DET
ihlr-27183	196	59	subject	subject	NOUN
ihlr-27183	196	60	in	in	ADP
ihlr-27183	196	61	merck	merck	PROPN
ihlr-27183	196	62	v.	v.	PROPN
ihlr-27183	196	63	integra	integra	PROPN
ihlr-27183	196	64	lifesciences.64	lifesciences.64	PROPN
ihlr-27183	196	65	though	though	ADV
ihlr-27183	196	66	,	,	PUNCT
ihlr-27183	196	67	merck	merck	PROPN
ihlr-27183	196	68	is	be	AUX
ihlr-27183	196	69	often	often	ADV
ihlr-27183	196	70	understood	understand	VERB
ihlr-27183	196	71	to	to	PART
ihlr-27183	196	72	turn	turn	VERB
ihlr-27183	196	73	on	on	ADP
ihlr-27183	196	74	the	the	DET
ihlr-27183	196	75	“	"	PUNCT
ihlr-27183	196	76	reasonably	reasonably	ADV
ihlr-27183	196	77	related	related	ADJ
ihlr-27183	196	78	”	"	PUNCT
ihlr-27183	196	79	term	term	NOUN
ihlr-27183	196	80	,	,	PUNCT
ihlr-27183	196	81	as	as	SCONJ
ihlr-27183	196	82	discussed	discuss	VERB
ihlr-27183	196	83	above	above	ADV
ihlr-27183	196	84	,	,	PUNCT
ihlr-27183	196	85	there	there	PRON
ihlr-27183	196	86	is	be	VERB
ihlr-27183	196	87	an	an	DET
ihlr-27183	196	88	aspect	aspect	NOUN
ihlr-27183	196	89	of	of	ADP
ihlr-27183	196	90	merck	merck	PROPN
ihlr-27183	196	91	’s	’s	PART
ihlr-27183	196	92	holding	holding	NOUN
ihlr-27183	196	93	which	which	PRON
ihlr-27183	196	94	is	be	AUX
ihlr-27183	196	95	inextricable	inextricable	ADJ
ihlr-27183	196	96	from	from	ADP
ihlr-27183	196	97	the	the	DET
ihlr-27183	196	98	scope	scope	NOUN
ihlr-27183	196	99	of	of	ADP
ihlr-27183	196	100	a	a	DET
ihlr-27183	196	101	“	"	PUNCT
ihlr-27183	196	102	patented	patented	ADJ
ihlr-27183	196	103	invention	invention	NOUN
ihlr-27183	196	104	.	.	PUNCT
ihlr-27183	197	1	”65	”65	NOUN
ihlr-27183	197	2	as	as	ADP
ihlr-27183	197	3	an	an	DET
ihlr-27183	197	4	observational	observational	ADJ
ihlr-27183	197	5	matter	matter	NOUN
ihlr-27183	197	6	,	,	PUNCT
ihlr-27183	197	7	a	a	DET
ihlr-27183	197	8	patented	patented	ADJ
ihlr-27183	197	9	compound	compound	NOUN
ihlr-27183	197	10	in	in	ADP
ihlr-27183	197	11	the	the	DET
ihlr-27183	197	12	preclinical	preclinical	ADJ
ihlr-27183	197	13	“	"	PUNCT
ihlr-27183	197	14	twilight	twilight	NOUN
ihlr-27183	197	15	zone”–having	zone”–having	PROPN
ihlr-27183	197	16	only	only	ADV
ihlr-27183	197	17	hopes	hope	NOUN
ihlr-27183	197	18	of	of	ADP
ihlr-27183	197	19	proving	prove	VERB
ihlr-27183	197	20	therapeutic	therapeutic	ADJ
ihlr-27183	197	21	–	–	PUNCT
ihlr-27183	197	22	is	be	AUX
ihlr-27183	197	23	not	not	PART
ihlr-27183	197	24	yet	yet	ADV
ihlr-27183	197	25	,	,	PUNCT
ihlr-27183	197	26	at	at	ADP
ihlr-27183	197	27	the	the	DET
ihlr-27183	197	28	time	time	NOUN
ihlr-27183	197	29	of	of	ADP
ihlr-27183	197	30	experimentation	experimentation	NOUN
ihlr-27183	197	31	,	,	PUNCT
ihlr-27183	197	32	subject	subject	ADJ
ihlr-27183	197	33	to	to	ADP
ihlr-27183	197	34	fda	fda	PROPN
ihlr-27183	197	35	approval	approval	PROPN
ihlr-27183	197	36	.	.	PUNCT
ihlr-27183	198	1	merck	merck	PROPN
ihlr-27183	198	2	held	hold	VERB
ihlr-27183	198	3	such	such	DET
ihlr-27183	198	4	a	a	DET
ihlr-27183	198	5	patented	patented	ADJ
ihlr-27183	198	6	compound	compound	NOUN
ihlr-27183	198	7	,	,	PUNCT
ihlr-27183	198	8	not	not	PART
ihlr-27183	198	9	yet	yet	ADV
ihlr-27183	198	10	subject	subject	ADJ
ihlr-27183	198	11	to	to	ADP
ihlr-27183	198	12	fda	fda	PROPN
ihlr-27183	198	13	approval	approval	NOUN
ihlr-27183	198	14	,	,	PUNCT
ihlr-27183	198	15	was	be	AUX
ihlr-27183	198	16	within	within	ADP
ihlr-27183	198	17	the	the	DET
ihlr-27183	198	18	ambit	ambit	NOUN
ihlr-27183	198	19	of	of	ADP
ihlr-27183	198	20	the	the	DET
ihlr-27183	198	21	safe	safe	ADJ
ihlr-27183	198	22	harbor.66	harbor.66	NOUN
ihlr-27183	198	23	public	public	ADJ
ihlr-27183	198	24	policy	policy	NOUN
ihlr-27183	198	25	motivation	motivation	NOUN
ihlr-27183	198	26	for	for	ADP
ihlr-27183	198	27	this	this	DET
ihlr-27183	198	28	outcome	outcome	NOUN
ihlr-27183	198	29	is	be	AUX
ihlr-27183	198	30	centered	center	VERB
ihlr-27183	198	31	on	on	ADP
ihlr-27183	198	32	encouraging	encourage	VERB
ihlr-27183	198	33	experimentation	experimentation	NOUN
ihlr-27183	198	34	with	with	ADP
ihlr-27183	198	35	potentially	potentially	ADV
ihlr-27183	198	36	useful	useful	ADJ
ihlr-27183	198	37	,	,	PUNCT
ihlr-27183	198	38	but	but	CCONJ
ihlr-27183	198	39	patented	patented	ADJ
ihlr-27183	198	40	compounds	compound	NOUN
ihlr-27183	198	41	.	.	PUNCT
ihlr-27183	199	1	questions	question	NOUN
ihlr-27183	199	2	remain	remain	VERB
ihlr-27183	199	3	whether	whether	SCONJ
ihlr-27183	199	4	this	this	DET
ihlr-27183	199	5	holding	holding	NOUN
ihlr-27183	199	6	unacceptably	unacceptably	ADV
ihlr-27183	199	7	erodes	erode	VERB
ihlr-27183	199	8	eli	eli	PROPN
ihlr-27183	199	9	lilly	lilly	PROPN
ihlr-27183	199	10	’s	’s	PART
ihlr-27183	199	11	preference	preference	NOUN
ihlr-27183	199	12	for	for	ADP
ihlr-27183	199	13	statutory	statutory	ADJ
ihlr-27183	199	14	symmetry	symmetry	NOUN
ihlr-27183	199	15	.	.	PUNCT
ihlr-27183	200	1	3	3	X
ihlr-27183	200	2	.	.	X
ihlr-27183	200	3	the	the	DET
ihlr-27183	200	4	standing	standing	NOUN
ihlr-27183	200	5	of	of	ADP
ihlr-27183	200	6	the	the	DET
ihlr-27183	200	7	research	research	NOUN
ihlr-27183	200	8	tool	tool	NOUN
ihlr-27183	200	9	while	while	SCONJ
ihlr-27183	200	10	merck	merck	PROPN
ihlr-27183	200	11	may	may	AUX
ihlr-27183	200	12	have	have	AUX
ihlr-27183	200	13	been	be	AUX
ihlr-27183	200	14	written	write	VERB
ihlr-27183	200	15	with	with	ADP
ihlr-27183	200	16	the	the	DET
ihlr-27183	200	17	defining	defining	NOUN
ihlr-27183	200	18	of	of	ADP
ihlr-27183	200	19	“	"	PUNCT
ihlr-27183	200	20	reasonably	reasonably	ADV
ihlr-27183	200	21	related	related	ADJ
ihlr-27183	200	22	”	"	PUNCT
ihlr-27183	200	23	in	in	ADP
ihlr-27183	200	24	mind	mind	NOUN
ihlr-27183	200	25	,	,	PUNCT
ihlr-27183	200	26	it	it	PRON
ihlr-27183	200	27	would	would	AUX
ihlr-27183	200	28	appear	appear	VERB
ihlr-27183	200	29	the	the	DET
ihlr-27183	200	30	reader	reader	NOUN
ihlr-27183	200	31	was	be	AUX
ihlr-27183	200	32	struck	strike	VERB
ihlr-27183	200	33	with	with	ADP
ihlr-27183	200	34	its	its	PRON
ihlr-27183	200	35	profound	profound	ADJ
ihlr-27183	200	36	effect	effect	NOUN
ihlr-27183	200	37	on	on	ADP
ihlr-27183	200	38	the	the	DET
ihlr-27183	200	39	“	"	PUNCT
ihlr-27183	200	40	patented	patented	ADJ
ihlr-27183	200	41	invention	invention	NOUN
ihlr-27183	200	42	”	"	PUNCT
ihlr-27183	200	43	term	term	NOUN
ihlr-27183	200	44	.	.	PUNCT
ihlr-27183	201	1	specifically	specifically	ADV
ihlr-27183	201	2	,	,	PUNCT
ihlr-27183	201	3	merck	merck	PROPN
ihlr-27183	201	4	held	hold	VERB
ihlr-27183	201	5	that	that	SCONJ
ihlr-27183	201	6	the	the	DET
ihlr-27183	201	7	safe	safe	ADJ
ihlr-27183	201	8	harbor	harbor	NOUN
ihlr-27183	201	9	is	be	AUX
ihlr-27183	201	10	not	not	PART
ihlr-27183	201	11	necessarily	necessarily	ADV
ihlr-27183	201	12	forfeited	forfeit	VERB
ihlr-27183	201	13	when	when	SCONJ
ihlr-27183	201	14	there	there	PRON
ihlr-27183	201	15	is	be	VERB
ihlr-27183	201	16	“	"	PUNCT
ihlr-27183	201	17	use	use	NOUN
ihlr-27183	201	18	of	of	ADP
ihlr-27183	201	19	patented	patent	VERB
ihlr-27183	201	20	compounds	compound	NOUN
ihlr-27183	201	21	in	in	ADP
ihlr-27183	201	22	experiments	experiment	NOUN
ihlr-27183	201	23	59	59	NUM
ihlr-27183	201	24	.	.	PUNCT
ihlr-27183	201	25	merck	merck	PROPN
ihlr-27183	201	26	kgaa	kgaa	PROPN
ihlr-27183	201	27	,	,	PUNCT
ihlr-27183	201	28	545	545	NUM
ihlr-27183	201	29	u.s	u.s	PROPN
ihlr-27183	201	30	.	.	PROPN
ihlr-27183	201	31	at	at	ADP
ihlr-27183	201	32	208	208	NUM
ihlr-27183	201	33	n.7	n.7	X
ihlr-27183	201	34	.	.	PUNCT
ihlr-27183	202	1	60	60	NUM
ihlr-27183	202	2	.	.	PUNCT
ihlr-27183	202	3	abtox	abtox	PROPN
ihlr-27183	202	4	,	,	PUNCT
ihlr-27183	202	5	inc	inc	PROPN
ihlr-27183	202	6	.	.	PROPN
ihlr-27183	203	1	v.	v.	PROPN
ihlr-27183	203	2	exitron	exitron	PROPN
ihlr-27183	203	3	corp	corp	PROPN
ihlr-27183	203	4	.	.	PROPN
ihlr-27183	203	5	,	,	PUNCT
ihlr-27183	203	6	122	122	NUM
ihlr-27183	203	7	f.3d	f.3d	NUM
ihlr-27183	203	8	1019	1019	NUM
ihlr-27183	203	9	,	,	PUNCT
ihlr-27183	203	10	1029	1029	NUM
ihlr-27183	203	11	(	(	PUNCT
ihlr-27183	203	12	fed	fed	PROPN
ihlr-27183	203	13	.	.	PUNCT
ihlr-27183	203	14	cir	cir	PROPN
ihlr-27183	203	15	.	.	PROPN
ihlr-27183	203	16	1997	1997	NUM
ihlr-27183	203	17	)	)	PUNCT
ihlr-27183	203	18	(	(	PUNCT
ihlr-27183	203	19	held	hold	VERB
ihlr-27183	203	20	the	the	DET
ihlr-27183	203	21	sterilizer	sterilizer	NOUN
ihlr-27183	203	22	was	be	AUX
ihlr-27183	203	23	a	a	DET
ihlr-27183	203	24	class	class	NOUN
ihlr-27183	203	25	ii	ii	NOUN
ihlr-27183	203	26	device	device	NOUN
ihlr-27183	203	27	not	not	PART
ihlr-27183	203	28	eligible	eligible	ADJ
ihlr-27183	203	29	for	for	ADP
ihlr-27183	203	30	a	a	DET
ihlr-27183	203	31	patent	patent	NOUN
ihlr-27183	203	32	term	term	NOUN
ihlr-27183	203	33	extension	extension	NOUN
ihlr-27183	203	34	under	under	ADP
ihlr-27183	203	35	§	§	PROPN
ihlr-27183	203	36	156	156	NUM
ihlr-27183	203	37	because	because	SCONJ
ihlr-27183	203	38	of	of	ADP
ihlr-27183	203	39	its	its	PRON
ihlr-27183	203	40	status	status	NOUN
ihlr-27183	203	41	as	as	ADP
ihlr-27183	203	42	subject	subject	ADJ
ihlr-27183	203	43	to	to	ADP
ihlr-27183	203	44	an	an	DET
ihlr-27183	203	45	abbreviated	abbreviate	VERB
ihlr-27183	203	46	fda	fda	PROPN
ihlr-27183	203	47	approval	approval	NOUN
ihlr-27183	203	48	process	process	NOUN
ihlr-27183	203	49	)	)	PUNCT
ihlr-27183	203	50	.	.	PUNCT
ihlr-27183	204	1	61	61	NUM
ihlr-27183	204	2	.	.	PUNCT
ihlr-27183	205	1	i	i	PRON
ihlr-27183	205	2	d.	d.	PROPN
ihlr-27183	205	3	62	62	NUM
ihlr-27183	205	4	.	.	PUNCT
ihlr-27183	206	1	i	i	PRON
ihlr-27183	206	2	d.	d.	PROPN
ihlr-27183	206	3	63	63	NUM
ihlr-27183	206	4	.	.	PUNCT
ihlr-27183	206	5	abtox	abtox	PROPN
ihlr-27183	206	6	,	,	PUNCT
ihlr-27183	206	7	122	122	NUM
ihlr-27183	206	8	f.3d	f.3d	NUM
ihlr-27183	206	9	at	at	ADP
ihlr-27183	206	10	1027	1027	NUM
ihlr-27183	206	11	.	.	PUNCT
ihlr-27183	207	1	64	64	NUM
ihlr-27183	207	2	.	.	PUNCT
ihlr-27183	207	3	merck	merck	PROPN
ihlr-27183	207	4	kgaa	kgaa	PROPN
ihlr-27183	207	5	v.	v.	PROPN
ihlr-27183	207	6	integra	integra	PROPN
ihlr-27183	207	7	lifesciences	lifesciences	PROPN
ihlr-27183	207	8	i	i	PROPN
ihlr-27183	207	9	,	,	PUNCT
ihlr-27183	207	10	ltd	ltd	PROPN
ihlr-27183	207	11	.	.	PROPN
ihlr-27183	207	12	,	,	PUNCT
ihlr-27183	207	13	545	545	NUM
ihlr-27183	207	14	u.s	u.s	PROPN
ihlr-27183	207	15	.	.	PROPN
ihlr-27183	207	16	193	193	NUM
ihlr-27183	207	17	(	(	PUNCT
ihlr-27183	207	18	2005	2005	NUM
ihlr-27183	207	19	)	)	PUNCT
ihlr-27183	207	20	.	.	PUNCT
ihlr-27183	208	1	65	65	NUM
ihlr-27183	208	2	.	.	PUNCT
ihlr-27183	209	1	i	i	PRON
ihlr-27183	209	2	d.	d.	PROPN
ihlr-27183	209	3	66	66	NUM
ihlr-27183	209	4	.	.	PUNCT
ihlr-27183	210	1	see	see	VERB
ihlr-27183	210	2	merck	merck	PROPN
ihlr-27183	210	3	kgaa	kgaa	PROPN
ihlr-27183	210	4	,	,	PUNCT
ihlr-27183	210	5	545	545	NUM
ihlr-27183	210	6	u.s	u.s	PROPN
ihlr-27183	210	7	.	.	PROPN
ihlr-27183	210	8	at	at	ADP
ihlr-27183	210	9	206	206	NUM
ihlr-27183	210	10	.	.	PUNCT
ihlr-27183	211	1	152	152	NUM
ihlr-27183	211	2	indiana	indiana	PROPN
ihlr-27183	211	3	health	health	PROPN
ihlr-27183	211	4	law	law	PROPN
ihlr-27183	211	5	review	review	NOUN
ihlr-27183	211	6	[	[	X
ihlr-27183	211	7	vol	vol	NOUN
ihlr-27183	211	8	.	.	PUNCT
ihlr-27183	211	9	20:143	20:143	PROPN
ihlr-27183	211	10	that	that	PRON
ihlr-27183	211	11	are	be	AUX
ihlr-27183	211	12	not	not	PART
ihlr-27183	211	13	ultimately	ultimately	ADV
ihlr-27183	211	14	submitted	submit	VERB
ihlr-27183	211	15	to	to	ADP
ihlr-27183	211	16	the	the	DET
ihlr-27183	211	17	fda	fda	PROPN
ihlr-27183	211	18	.	.	PUNCT
ihlr-27183	211	19	”67	”67	PROPN
ihlr-27183	211	20	further	far	ADV
ihlr-27183	211	21	,	,	PUNCT
ihlr-27183	211	22	merck	merck	PROPN
ihlr-27183	211	23	interprets	interpret	VERB
ihlr-27183	211	24	eli	eli	PROPN
ihlr-27183	211	25	lilly	lilly	PROPN
ihlr-27183	211	26	to	to	PART
ihlr-27183	211	27	hold	hold	VERB
ihlr-27183	211	28	§	§	PROPN
ihlr-27183	211	29	271(e)(1	271(e)(1	NOUN
ihlr-27183	211	30	)	)	PUNCT
ihlr-27183	211	31	“	"	PUNCT
ihlr-27183	211	32	exempted	exempt	VERB
ihlr-27183	211	33	from	from	ADP
ihlr-27183	211	34	infringement	infringement	NOUN
ihlr-27183	211	35	all	all	DET
ihlr-27183	211	36	uses	use	NOUN
ihlr-27183	211	37	of	of	ADP
ihlr-27183	211	38	patented	patent	VERB
ihlr-27183	211	39	compounds	compound	NOUN
ihlr-27183	211	40	‘	'	PUNCT
ihlr-27183	211	41	reasonably	reasonably	ADV
ihlr-27183	211	42	related	related	ADJ
ihlr-27183	211	43	’	'	PUNCT
ihlr-27183	211	44	to	to	ADP
ihlr-27183	211	45	the	the	DET
ihlr-27183	211	46	process	process	NOUN
ihlr-27183	211	47	of	of	ADP
ihlr-27183	211	48	developing	develop	VERB
ihlr-27183	211	49	information	information	NOUN
ihlr-27183	211	50	for	for	ADP
ihlr-27183	211	51	submission	submission	NOUN
ihlr-27183	211	52	under	under	ADP
ihlr-27183	211	53	any	any	DET
ihlr-27183	211	54	federal	federal	ADJ
ihlr-27183	211	55	law	law	NOUN
ihlr-27183	211	56	regulating	regulate	VERB
ihlr-27183	211	57	the	the	DET
ihlr-27183	211	58	manufacture	manufacture	NOUN
ihlr-27183	211	59	,	,	PUNCT
ihlr-27183	211	60	use	use	NOUN
ihlr-27183	211	61	,	,	PUNCT
ihlr-27183	211	62	or	or	CCONJ
ihlr-27183	211	63	distribution	distribution	NOUN
ihlr-27183	211	64	of	of	ADP
ihlr-27183	211	65	drugs	drug	NOUN
ihlr-27183	211	66	.	.	PUNCT
ihlr-27183	212	1	”68	”68	NOUN
ihlr-27183	212	2	it	it	PRON
ihlr-27183	212	3	is	be	AUX
ihlr-27183	212	4	not	not	PART
ihlr-27183	212	5	hard	hard	ADJ
ihlr-27183	212	6	to	to	PART
ihlr-27183	212	7	spot	spot	VERB
ihlr-27183	212	8	the	the	DET
ihlr-27183	212	9	implications	implication	NOUN
ihlr-27183	212	10	while	while	SCONJ
ihlr-27183	212	11	reading	read	VERB
ihlr-27183	212	12	with	with	ADP
ihlr-27183	212	13	the	the	DET
ihlr-27183	212	14	court	court	NOUN
ihlr-27183	212	15	’s	’s	PART
ihlr-27183	212	16	own	own	ADJ
ihlr-27183	212	17	emphasis	emphasis	NOUN
ihlr-27183	212	18	.	.	PUNCT
ihlr-27183	213	1	the	the	DET
ihlr-27183	213	2	patented	patent	VERB
ihlr-27183	213	3	compounds	compound	NOUN
ihlr-27183	213	4	being	be	AUX
ihlr-27183	213	5	used	use	VERB
ihlr-27183	213	6	are	be	AUX
ihlr-27183	213	7	not	not	PART
ihlr-27183	213	8	necessarily	necessarily	ADV
ihlr-27183	213	9	the	the	DET
ihlr-27183	213	10	same	same	ADJ
ihlr-27183	213	11	compounds	compound	NOUN
ihlr-27183	213	12	receiving	receive	VERB
ihlr-27183	213	13	,	,	PUNCT
ihlr-27183	213	14	or	or	CCONJ
ihlr-27183	213	15	subject	subject	VERB
ihlr-27183	213	16	to	to	ADP
ihlr-27183	213	17	,	,	PUNCT
ihlr-27183	213	18	the	the	DET
ihlr-27183	213	19	referenced	referenced	ADJ
ihlr-27183	213	20	fda	fda	PROPN
ihlr-27183	213	21	approval	approval	PROPN
ihlr-27183	213	22	.	.	PUNCT
ihlr-27183	214	1	merck	merck	PROPN
ihlr-27183	214	2	’s	’s	PART
ihlr-27183	214	3	broad	broad	ADJ
ihlr-27183	214	4	view	view	NOUN
ihlr-27183	214	5	of	of	ADP
ihlr-27183	214	6	§	§	PROPN
ihlr-27183	214	7	271(e)(1	271(e)(1	NOUN
ihlr-27183	214	8	)	)	PUNCT
ihlr-27183	214	9	provoked	provoke	VERB
ihlr-27183	214	10	a	a	DET
ihlr-27183	214	11	slew	slew	NOUN
ihlr-27183	214	12	of	of	ADP
ihlr-27183	214	13	articles	article	NOUN
ihlr-27183	214	14	warning	warn	VERB
ihlr-27183	214	15	the	the	DET
ihlr-27183	214	16	demise	demise	NOUN
ihlr-27183	214	17	of	of	ADP
ihlr-27183	214	18	laboratory	laboratory	NOUN
ihlr-27183	214	19	research	research	NOUN
ihlr-27183	214	20	tool	tool	NOUN
ihlr-27183	214	21	development	development	NOUN
ihlr-27183	214	22	under	under	ADP
ihlr-27183	214	23	the	the	DET
ihlr-27183	214	24	swelling	swell	VERB
ihlr-27183	214	25	safe	safe	ADJ
ihlr-27183	214	26	harbor	harbor	NOUN
ihlr-27183	214	27	of	of	ADP
ihlr-27183	214	28	§	§	PROPN
ihlr-27183	214	29	271(e)(1).69	271(e)(1).69	PROPN
ihlr-27183	214	30	anchored	anchor	VERB
ihlr-27183	214	31	in	in	ADP
ihlr-27183	214	32	policy	policy	NOUN
ihlr-27183	214	33	animating	animate	VERB
ihlr-27183	214	34	u.s	u.s	PROPN
ihlr-27183	214	35	.	.	PROPN
ihlr-27183	214	36	patent	patent	NOUN
ihlr-27183	214	37	law	law	NOUN
ihlr-27183	214	38	,	,	PUNCT
ihlr-27183	214	39	these	these	DET
ihlr-27183	214	40	critical	critical	ADJ
ihlr-27183	214	41	publications	publication	NOUN
ihlr-27183	214	42	argued	argue	VERB
ihlr-27183	214	43	limited	limited	ADJ
ihlr-27183	214	44	patent	patent	NOUN
ihlr-27183	214	45	enforcement	enforcement	NOUN
ihlr-27183	214	46	for	for	ADP
ihlr-27183	214	47	research	research	NOUN
ihlr-27183	214	48	tool	tool	NOUN
ihlr-27183	214	49	disclosures	disclosure	NOUN
ihlr-27183	214	50	would	would	AUX
ihlr-27183	214	51	result	result	VERB
ihlr-27183	214	52	in	in	ADP
ihlr-27183	214	53	fewer	few	ADJ
ihlr-27183	214	54	patents	patent	NOUN
ihlr-27183	214	55	being	be	AUX
ihlr-27183	214	56	made	make	VERB
ihlr-27183	214	57	public	public	ADJ
ihlr-27183	214	58	,	,	PUNCT
ihlr-27183	214	59	less	less	ADJ
ihlr-27183	214	60	progress	progress	NOUN
ihlr-27183	214	61	in	in	ADP
ihlr-27183	214	62	the	the	DET
ihlr-27183	214	63	art	art	NOUN
ihlr-27183	214	64	by	by	ADP
ihlr-27183	214	65	advancements	advancement	NOUN
ihlr-27183	214	66	thereupon	thereupon	ADV
ihlr-27183	214	67	,	,	PUNCT
ihlr-27183	214	68	and	and	CCONJ
ihlr-27183	214	69	a	a	DET
ihlr-27183	214	70	reduction	reduction	NOUN
ihlr-27183	214	71	in	in	ADP
ihlr-27183	214	72	related	related	ADJ
ihlr-27183	214	73	capital	capital	NOUN
ihlr-27183	214	74	investment.70	investment.70	NOUN
ihlr-27183	214	75	seventeen	seventeen	NUM
ihlr-27183	214	76	years	year	NOUN
ihlr-27183	214	77	later	later	ADV
ihlr-27183	214	78	,	,	PUNCT
ihlr-27183	214	79	questions	question	NOUN
ihlr-27183	214	80	remain	remain	VERB
ihlr-27183	214	81	whether	whether	SCONJ
ihlr-27183	214	82	merck	merck	PROPN
ihlr-27183	214	83	issued	issue	VERB
ihlr-27183	214	84	an	an	DET
ihlr-27183	214	85	“	"	PUNCT
ihlr-27183	214	86	open	open	ADJ
ihlr-27183	214	87	season	season	NOUN
ihlr-27183	214	88	”	"	PUNCT
ihlr-27183	214	89	on	on	ADP
ihlr-27183	214	90	the	the	DET
ihlr-27183	214	91	unlicensed	unlicensed	ADJ
ihlr-27183	214	92	use	use	NOUN
ihlr-27183	214	93	of	of	ADP
ihlr-27183	214	94	patented	patented	ADJ
ihlr-27183	214	95	research	research	NOUN
ihlr-27183	214	96	tools	tool	NOUN
ihlr-27183	214	97	.	.	PUNCT
ihlr-27183	215	1	it	it	PRON
ihlr-27183	215	2	is	be	AUX
ihlr-27183	215	3	difficult	difficult	ADJ
ihlr-27183	215	4	to	to	PART
ihlr-27183	215	5	say	say	VERB
ihlr-27183	215	6	to	to	ADP
ihlr-27183	215	7	what	what	DET
ihlr-27183	215	8	extent	extent	NOUN
ihlr-27183	215	9	these	these	DET
ihlr-27183	215	10	fears	fear	NOUN
ihlr-27183	215	11	came	come	VERB
ihlr-27183	215	12	to	to	PART
ihlr-27183	215	13	pass	pass	VERB
ihlr-27183	215	14	.	.	PUNCT
ihlr-27183	216	1	without	without	ADP
ihlr-27183	216	2	a	a	DET
ihlr-27183	216	3	control	control	NOUN
ihlr-27183	216	4	group	group	NOUN
ihlr-27183	216	5	(	(	PUNCT
ihlr-27183	216	6	against	against	ADP
ihlr-27183	216	7	which	which	PRON
ihlr-27183	216	8	a	a	DET
ihlr-27183	216	9	meaningful	meaningful	ADJ
ihlr-27183	216	10	change	change	NOUN
ihlr-27183	216	11	could	could	AUX
ihlr-27183	216	12	be	be	AUX
ihlr-27183	216	13	observed	observe	VERB
ihlr-27183	216	14	)	)	PUNCT
ihlr-27183	216	15	or	or	CCONJ
ihlr-27183	216	16	a	a	DET
ihlr-27183	216	17	dramatic	dramatic	ADJ
ihlr-27183	216	18	change	change	NOUN
ihlr-27183	216	19	in	in	ADP
ihlr-27183	216	20	the	the	DET
ihlr-27183	216	21	generation	generation	NOUN
ihlr-27183	216	22	of	of	ADP
ihlr-27183	216	23	research	research	NOUN
ihlr-27183	216	24	tool	tool	NOUN
ihlr-27183	216	25	technology	technology	NOUN
ihlr-27183	216	26	,	,	PUNCT
ihlr-27183	216	27	we	we	PRON
ihlr-27183	216	28	can	can	AUX
ihlr-27183	216	29	only	only	ADV
ihlr-27183	216	30	tentatively	tentatively	ADV
ihlr-27183	216	31	say	say	VERB
ihlr-27183	216	32	the	the	DET
ihlr-27183	216	33	effects	effect	NOUN
ihlr-27183	216	34	appear	appear	VERB
ihlr-27183	216	35	to	to	PART
ihlr-27183	216	36	have	have	AUX
ihlr-27183	216	37	been	be	AUX
ihlr-27183	216	38	minimal	minimal	ADJ
ihlr-27183	216	39	across	across	ADP
ihlr-27183	216	40	the	the	DET
ihlr-27183	216	41	research	research	NOUN
ihlr-27183	216	42	tool	tool	NOUN
ihlr-27183	216	43	industry	industry	NOUN
ihlr-27183	216	44	.	.	PUNCT
ihlr-27183	217	1	in	in	ADP
ihlr-27183	217	2	contrast	contrast	NOUN
ihlr-27183	217	3	,	,	PUNCT
ihlr-27183	217	4	a	a	DET
ihlr-27183	217	5	noticeable	noticeable	ADJ
ihlr-27183	217	6	effect	effect	NOUN
ihlr-27183	217	7	certainly	certainly	ADV
ihlr-27183	217	8	arose	arise	VERB
ihlr-27183	217	9	among	among	ADP
ihlr-27183	217	10	the	the	DET
ihlr-27183	217	11	courts	court	NOUN
ihlr-27183	217	12	.	.	PUNCT
ihlr-27183	218	1	a	a	DET
ihlr-27183	218	2	minority	minority	NOUN
ihlr-27183	218	3	of	of	ADP
ihlr-27183	218	4	cases	case	NOUN
ihlr-27183	218	5	have	have	AUX
ihlr-27183	218	6	in	in	ADP
ihlr-27183	218	7	fact	fact	NOUN
ihlr-27183	218	8	used	use	VERB
ihlr-27183	218	9	this	this	DET
ihlr-27183	218	10	language	language	NOUN
ihlr-27183	218	11	from	from	ADP
ihlr-27183	218	12	the	the	DET
ihlr-27183	218	13	supreme	supreme	PROPN
ihlr-27183	218	14	court	court	PROPN
ihlr-27183	218	15	in	in	ADP
ihlr-27183	218	16	merck	merck	PROPN
ihlr-27183	218	17	to	to	PART
ihlr-27183	218	18	disassociate	disassociate	VERB
ihlr-27183	218	19	the	the	DET
ihlr-27183	218	20	submission	submission	NOUN
ihlr-27183	218	21	of	of	ADP
ihlr-27183	218	22	fda	fda	PROPN
ihlr-27183	218	23	approval	approval	NOUN
ihlr-27183	218	24	from	from	ADP
ihlr-27183	218	25	the	the	DET
ihlr-27183	218	26	patented	patented	ADJ
ihlr-27183	218	27	invention.71	invention.71	NOUN
ihlr-27183	218	28	specifically	specifically	ADV
ihlr-27183	218	29	,	,	PUNCT
ihlr-27183	218	30	the	the	DET
ihlr-27183	218	31	safe	safe	ADJ
ihlr-27183	218	32	harbor	harbor	NOUN
ihlr-27183	218	33	has	have	AUX
ihlr-27183	218	34	been	be	AUX
ihlr-27183	218	35	used	use	VERB
ihlr-27183	218	36	to	to	PART
ihlr-27183	218	37	protect	protect	VERB
ihlr-27183	218	38	the	the	DET
ihlr-27183	218	39	use	use	NOUN
ihlr-27183	218	40	of	of	ADP
ihlr-27183	218	41	a	a	DET
ihlr-27183	218	42	patented	patented	ADJ
ihlr-27183	218	43	invention	invention	NOUN
ihlr-27183	218	44	for	for	ADP
ihlr-27183	218	45	the	the	DET
ihlr-27183	218	46	generation	generation	NOUN
ihlr-27183	218	47	of	of	ADP
ihlr-27183	218	48	data	datum	NOUN
ihlr-27183	218	49	to	to	PART
ihlr-27183	218	50	be	be	AUX
ihlr-27183	218	51	submitted	submit	VERB
ihlr-27183	218	52	pursuant	pursuant	ADV
ihlr-27183	218	53	to	to	ADP
ihlr-27183	218	54	the	the	DET
ihlr-27183	218	55	fda	fda	PROPN
ihlr-27183	218	56	approval	approval	NOUN
ihlr-27183	218	57	of	of	ADP
ihlr-27183	218	58	a	a	DET
ihlr-27183	218	59	second	second	ADJ
ihlr-27183	218	60	article.72	article.72	NOUN
ihlr-27183	218	61	for	for	ADP
ihlr-27183	218	62	example	example	NOUN
ihlr-27183	218	63	,	,	PUNCT
ihlr-27183	218	64	in	in	ADP
ihlr-27183	218	65	the	the	DET
ihlr-27183	218	66	2013	2013	NUM
ihlr-27183	218	67	case	case	NOUN
ihlr-27183	218	68	of	of	ADP
ihlr-27183	218	69	teva	teva	PROPN
ihlr-27183	218	70	pharms	pharm	NOUN
ihlr-27183	218	71	.	.	PUNCT
ihlr-27183	219	1	v.	v.	PROPN
ihlr-27183	219	2	sandoz	sandoz	PROPN
ihlr-27183	219	3	,	,	PUNCT
ihlr-27183	219	4	the	the	DET
ihlr-27183	219	5	u.s	u.s	PROPN
ihlr-27183	219	6	.	.	PROPN
ihlr-27183	219	7	district	district	PROPN
ihlr-27183	219	8	court	court	NOUN
ihlr-27183	219	9	for	for	ADP
ihlr-27183	219	10	the	the	DET
ihlr-27183	219	11	southern	southern	ADJ
ihlr-27183	219	12	district	district	NOUN
ihlr-27183	219	13	of	of	ADP
ihlr-27183	219	14	new	new	PROPN
ihlr-27183	219	15	york	york	PROPN
ihlr-27183	219	16	extended	extend	VERB
ihlr-27183	219	17	the	the	DET
ihlr-27183	219	18	safe	safe	ADJ
ihlr-27183	219	19	harbor	harbor	NOUN
ihlr-27183	219	20	to	to	ADP
ihlr-27183	219	21	patented	patent	VERB
ihlr-27183	219	22	polypeptide	polypeptide	ADJ
ihlr-27183	219	23	markers	marker	NOUN
ihlr-27183	219	24	used	use	VERB
ihlr-27183	219	25	to	to	PART
ihlr-27183	219	26	obtain	obtain	VERB
ihlr-27183	219	27	molecular	molecular	ADJ
ihlr-27183	219	28	weight	weight	NOUN
ihlr-27183	219	29	characteristics	characteristic	NOUN
ihlr-27183	219	30	of	of	ADP
ihlr-27183	219	31	67	67	NUM
ihlr-27183	219	32	.	.	PUNCT
ihlr-27183	220	1	i	i	PRON
ihlr-27183	220	2	d.	d.	PROPN
ihlr-27183	220	3	68	68	NUM
ihlr-27183	220	4	.	.	PUNCT
ihlr-27183	221	1	i	i	PRON
ihlr-27183	221	2	d.	d.	PROPN
ihlr-27183	221	3	69	69	NUM
ihlr-27183	221	4	.	.	PUNCT
ihlr-27183	222	1	see	see	VERB
ihlr-27183	222	2	wolrad	wolrad	PROPN
ihlr-27183	222	3	prinz	prinz	PROPN
ihlr-27183	222	4	,	,	PUNCT
ihlr-27183	222	5	research	research	NOUN
ihlr-27183	222	6	tool	tool	NOUN
ihlr-27183	222	7	patents	patent	NOUN
ihlr-27183	222	8	after	after	SCONJ
ihlr-27183	222	9	integra	integra	PROPN
ihlr-27183	222	10	v.	v.	PROPN
ihlr-27183	222	11	merck	merck	PROPN
ihlr-27183	222	12	have	have	AUX
ihlr-27183	222	13	they	they	PRON
ihlr-27183	222	14	reached	reach	VERB
ihlr-27183	222	15	a	a	DET
ihlr-27183	222	16	safe	safe	ADJ
ihlr-27183	222	17	harbor	harbor	NOUN
ihlr-27183	222	18	?	?	PUNCT
ihlr-27183	223	1	,	,	PUNCT
ihlr-27183	223	2	14	14	NUM
ihlr-27183	223	3	mich	mich	PROPN
ihlr-27183	223	4	.	.	PUNCT
ihlr-27183	223	5	telecomm	telecomm	PROPN
ihlr-27183	223	6	.	.	PUNCT
ihlr-27183	224	1	&	&	CCONJ
ihlr-27183	225	1	tech	tech	PROPN
ihlr-27183	225	2	.	.	PUNCT
ihlr-27183	226	1	l.	l.	PROPN
ihlr-27183	226	2	rev	rev	PROPN
ihlr-27183	226	3	.	.	PROPN
ihlr-27183	226	4	367	367	NUM
ihlr-27183	226	5	,	,	PUNCT
ihlr-27183	226	6	445	445	NUM
ihlr-27183	226	7	(	(	PUNCT
ihlr-27183	226	8	2008	2008	NUM
ihlr-27183	226	9	)	)	PUNCT
ihlr-27183	226	10	;	;	PUNCT
ihlr-27183	226	11	see	see	VERB
ihlr-27183	226	12	also	also	ADV
ihlr-27183	226	13	tara	tara	PROPN
ihlr-27183	226	14	stuart	stuart	PROPN
ihlr-27183	226	15	,	,	PUNCT
ihlr-27183	226	16	has	have	VERB
ihlr-27183	226	17	the	the	DET
ihlr-27183	226	18	supreme	supreme	PROPN
ihlr-27183	226	19	court	court	PROPN
ihlr-27183	226	20	incorrectly	incorrectly	ADV
ihlr-27183	226	21	expanded	expand	VERB
ihlr-27183	226	22	s	s	PROPN
ihlr-27183	226	23	271(e)(1	271(e)(1	NOUN
ihlr-27183	226	24	)	)	PUNCT
ihlr-27183	226	25	to	to	PART
ihlr-27183	226	26	risk	risk	VERB
ihlr-27183	226	27	a	a	DET
ihlr-27183	226	28	regulatory	regulatory	ADJ
ihlr-27183	226	29	taking	taking	NOUN
ihlr-27183	226	30	?	?	PUNCT
ihlr-27183	226	31	,	,	PUNCT
ihlr-27183	226	32	5	5	NUM
ihlr-27183	226	33	j.	j.	PROPN
ihlr-27183	226	34	marshall	marshall	PROPN
ihlr-27183	226	35	rev	rev	PROPN
ihlr-27183	226	36	.	.	PROPN
ihlr-27183	226	37	intell	intell	PROPN
ihlr-27183	226	38	.	.	PUNCT
ihlr-27183	227	1	prop	prop	PROPN
ihlr-27183	227	2	.	.	PUNCT
ihlr-27183	228	1	l.	l.	PROPN
ihlr-27183	228	2	216	216	NUM
ihlr-27183	228	3	,	,	PUNCT
ihlr-27183	228	4	237	237	NUM
ihlr-27183	228	5	(	(	PUNCT
ihlr-27183	228	6	2006	2006	NUM
ihlr-27183	228	7	)	)	PUNCT
ihlr-27183	228	8	;	;	PUNCT
ihlr-27183	228	9	joshua	joshua	PROPN
ihlr-27183	228	10	d.	d.	PROPN
ihlr-27183	228	11	sarnoff	sarnoff	PROPN
ihlr-27183	228	12	&	&	CCONJ
ihlr-27183	228	13	christopher	christopher	PROPN
ihlr-27183	228	14	m.	m.	PROPN
ihlr-27183	228	15	holman	holman	PROPN
ihlr-27183	228	16	,	,	PUNCT
ihlr-27183	228	17	recent	recent	ADJ
ihlr-27183	228	18	developments	development	NOUN
ihlr-27183	228	19	affecting	affect	VERB
ihlr-27183	228	20	the	the	DET
ihlr-27183	228	21	enforcement	enforcement	NOUN
ihlr-27183	228	22	,	,	PUNCT
ihlr-27183	228	23	procurement	procurement	NOUN
ihlr-27183	228	24	,	,	PUNCT
ihlr-27183	228	25	and	and	CCONJ
ihlr-27183	228	26	licensing	licensing	NOUN
ihlr-27183	228	27	of	of	ADP
ihlr-27183	228	28	research	research	NOUN
ihlr-27183	228	29	tool	tool	NOUN
ihlr-27183	228	30	patents	patent	NOUN
ihlr-27183	228	31	,	,	PUNCT
ihlr-27183	228	32	23	23	NUM
ihlr-27183	228	33	berkeley	berkeley	PROPN
ihlr-27183	228	34	tech	tech	NOUN
ihlr-27183	228	35	.	.	PUNCT
ihlr-27183	229	1	l.j	l.j	PROPN
ihlr-27183	229	2	.	.	PROPN
ihlr-27183	229	3	1299	1299	NUM
ihlr-27183	229	4	,	,	PUNCT
ihlr-27183	229	5	1365	1365	NUM
ihlr-27183	229	6	(	(	PUNCT
ihlr-27183	229	7	2008	2008	NUM
ihlr-27183	229	8	)	)	PUNCT
ihlr-27183	229	9	.	.	PUNCT
ihlr-27183	230	1	70	70	X
ihlr-27183	230	2	.	.	X
ihlr-27183	230	3	see	see	VERB
ihlr-27183	230	4	generally	generally	ADV
ihlr-27183	230	5	daniel	daniel	PROPN
ihlr-27183	230	6	wobbekind	wobbekind	PROPN
ihlr-27183	230	7	,	,	PUNCT
ihlr-27183	230	8	integra	integra	PROPN
ihlr-27183	230	9	lifesciences	lifescience	NOUN
ihlr-27183	230	10	i	i	PROPN
ihlr-27183	230	11	,	,	PUNCT
ihlr-27183	230	12	ltd	ltd	PROPN
ihlr-27183	230	13	.	.	PROPN
ihlr-27183	231	1	v.	v.	PROPN
ihlr-27183	231	2	merck	merck	PROPN
ihlr-27183	231	3	kgaa	kgaa	PROPN
ihlr-27183	231	4	:	:	PUNCT
ihlr-27183	232	1	reexamining	reexamine	VERB
ihlr-27183	232	2	the	the	DET
ihlr-27183	232	3	broad	broad	ADJ
ihlr-27183	232	4	scope	scope	NOUN
ihlr-27183	232	5	of	of	ADP
ihlr-27183	232	6	the	the	DET
ihlr-27183	232	7	s	s	PROPN
ihlr-27183	232	8	271(e)(1	271(e)(1	NOUN
ihlr-27183	232	9	)	)	PUNCT
ihlr-27183	232	10	safe	safe	ADJ
ihlr-27183	232	11	harbor	harbor	NOUN
ihlr-27183	232	12	,	,	PUNCT
ihlr-27183	232	13	23	23	NUM
ihlr-27183	232	14	berkeley	berkeley	PROPN
ihlr-27183	232	15	tech	tech	NOUN
ihlr-27183	232	16	.	.	PUNCT
ihlr-27183	233	1	l.j	l.j	PROPN
ihlr-27183	233	2	.	.	PROPN
ihlr-27183	233	3	107	107	NUM
ihlr-27183	233	4	,	,	PUNCT
ihlr-27183	233	5	138	138	NUM
ihlr-27183	233	6	(	(	PUNCT
ihlr-27183	233	7	2008	2008	NUM
ihlr-27183	233	8	)	)	PUNCT
ihlr-27183	233	9	(	(	PUNCT
ihlr-27183	233	10	arguing	argue	VERB
ihlr-27183	233	11	funds	fund	NOUN
ihlr-27183	233	12	for	for	ADP
ihlr-27183	233	13	research	research	NOUN
ihlr-27183	233	14	will	will	AUX
ihlr-27183	233	15	be	be	AUX
ihlr-27183	233	16	stifled	stifle	VERB
ihlr-27183	233	17	without	without	ADP
ihlr-27183	233	18	patent	patent	NOUN
ihlr-27183	233	19	enforceability	enforceability	NOUN
ihlr-27183	233	20	)	)	PUNCT
ihlr-27183	233	21	;	;	PUNCT
ihlr-27183	233	22	brendan	brendan	PROPN
ihlr-27183	233	23	m.	m.	PROPN
ihlr-27183	233	24	o'malley	o'malley	PROPN
ihlr-27183	233	25	,	,	PUNCT
ihlr-27183	233	26	merck	merck	PROPN
ihlr-27183	233	27	v.	v.	PROPN
ihlr-27183	233	28	integra	integra	PROPN
ihlr-27183	233	29	and	and	CCONJ
ihlr-27183	233	30	its	its	PRON
ihlr-27183	233	31	aftermath	aftermath	NOUN
ihlr-27183	233	32	:	:	PUNCT
ihlr-27183	233	33	a	a	DET
ihlr-27183	233	34	safe	safe	ADJ
ihlr-27183	233	35	harbor	harbor	NOUN
ihlr-27183	233	36	for	for	ADP
ihlr-27183	233	37	the	the	DET
ihlr-27183	233	38	commercial	commercial	ADJ
ihlr-27183	233	39	use	use	NOUN
ihlr-27183	233	40	of	of	ADP
ihlr-27183	233	41	biotechnology	biotechnology	NOUN
ihlr-27183	233	42	research	research	NOUN
ihlr-27183	233	43	tools	tool	NOUN
ihlr-27183	233	44	?	?	PUNCT
ihlr-27183	233	45	,	,	PUNCT
ihlr-27183	233	46	23	23	NUM
ihlr-27183	233	47	cardozo	cardozo	PROPN
ihlr-27183	233	48	arts	arts	PROPN
ihlr-27183	233	49	&	&	CCONJ
ihlr-27183	233	50	ent	ent	PROPN
ihlr-27183	233	51	.	.	PUNCT
ihlr-27183	234	1	l.	l.	PROPN
ihlr-27183	234	2	j.	j.	PROPN
ihlr-27183	234	3	739	739	PROPN
ihlr-27183	234	4	,	,	PUNCT
ihlr-27183	234	5	760	760	NUM
ihlr-27183	234	6	(	(	PUNCT
ihlr-27183	234	7	2006	2006	NUM
ihlr-27183	234	8	)	)	PUNCT
ihlr-27183	234	9	(	(	PUNCT
ihlr-27183	234	10	arguing	argue	VERB
ihlr-27183	234	11	an	an	DET
ihlr-27183	234	12	immediate	immediate	ADJ
ihlr-27183	234	13	financial	financial	ADJ
ihlr-27183	234	14	impact	impact	NOUN
ihlr-27183	234	15	to	to	ADP
ihlr-27183	234	16	researchers	researcher	NOUN
ihlr-27183	234	17	and	and	CCONJ
ihlr-27183	234	18	long	long	ADJ
ihlr-27183	234	19	-	-	PUNCT
ihlr-27183	234	20	term	term	NOUN
ihlr-27183	234	21	impact	impact	NOUN
ihlr-27183	234	22	on	on	ADP
ihlr-27183	234	23	public	public	ADJ
ihlr-27183	234	24	welfare	welfare	NOUN
ihlr-27183	234	25	)	)	PUNCT
ihlr-27183	234	26	.	.	PUNCT
ihlr-27183	235	1	71	71	NUM
ihlr-27183	235	2	.	.	PUNCT
ihlr-27183	236	1	see	see	VERB
ihlr-27183	236	2	teva	teva	PROPN
ihlr-27183	236	3	pharms	pharms	PROPN
ihlr-27183	236	4	.	.	PUNCT
ihlr-27183	237	1	usa	usa	PROPN
ihlr-27183	237	2	,	,	PUNCT
ihlr-27183	237	3	inc	inc	PROPN
ihlr-27183	237	4	.	.	PROPN
ihlr-27183	238	1	v.	v.	PROPN
ihlr-27183	238	2	sandoz	sandoz	PROPN
ihlr-27183	238	3	inc	inc	PROPN
ihlr-27183	239	1	.	.	PROPN
ihlr-27183	239	2	,	,	PUNCT
ihlr-27183	239	3	no	no	INTJ
ihlr-27183	239	4	.	.	NOUN
ihlr-27183	239	5	09	09	NUM
ihlr-27183	239	6	civ	civ	NOUN
ihlr-27183	239	7	.	.	PUNCT
ihlr-27183	240	1	10112	10112	NUM
ihlr-27183	240	2	,	,	PUNCT
ihlr-27183	240	3	2013	2013	NUM
ihlr-27183	240	4	wl	wl	NOUN
ihlr-27183	240	5	3732867	3732867	NUM
ihlr-27183	240	6	(	(	PUNCT
ihlr-27183	240	7	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	240	8	.	.	PROPN
ihlr-27183	241	1	july	july	PROPN
ihlr-27183	241	2	16	16	NUM
ihlr-27183	241	3	,	,	PUNCT
ihlr-27183	241	4	2013	2013	NUM
ihlr-27183	241	5	)	)	PUNCT
ihlr-27183	241	6	.	.	PUNCT
ihlr-27183	242	1	72	72	NUM
ihlr-27183	242	2	.	.	PUNCT
ihlr-27183	243	1	i	i	PRON
ihlr-27183	243	2	d.	d.	PROPN
ihlr-27183	243	3	2023	2023	NUM
ihlr-27183	243	4	]	]	PUNCT
ihlr-27183	244	1	the	the	DET
ihlr-27183	244	2	safe	safe	ADJ
ihlr-27183	244	3	harbor	harbor	NOUN
ihlr-27183	244	4	of	of	ADP
ihlr-27183	244	5	35	35	NUM
ihlr-27183	244	6	u.s.c	u.s.c	ADJ
ihlr-27183	244	7	.	.	PUNCT
ihlr-27183	245	1	§	§	PROPN
ihlr-27183	245	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	245	3	)	)	PUNCT
ihlr-27183	245	4	153	153	NUM
ihlr-27183	245	5	an	an	DET
ihlr-27183	245	6	active	active	ADJ
ihlr-27183	245	7	ingredient	ingredient	NOUN
ihlr-27183	245	8	in	in	ADP
ihlr-27183	245	9	a	a	DET
ihlr-27183	245	10	drug.73	drug.73	NOUN
ihlr-27183	245	11	the	the	DET
ihlr-27183	245	12	shielded	shielded	ADJ
ihlr-27183	245	13	markers	marker	NOUN
ihlr-27183	245	14	are	be	AUX
ihlr-27183	245	15	not	not	PART
ihlr-27183	245	16	a	a	DET
ihlr-27183	245	17	drug	drug	NOUN
ihlr-27183	245	18	nor	nor	CCONJ
ihlr-27183	245	19	subject	subject	NOUN
ihlr-27183	245	20	to	to	ADP
ihlr-27183	245	21	fda	fda	PROPN
ihlr-27183	245	22	approval.74	approval.74	PROPN
ihlr-27183	245	23	specifically	specifically	ADV
ihlr-27183	245	24	,	,	PUNCT
ihlr-27183	245	25	these	these	DET
ihlr-27183	245	26	markers	marker	NOUN
ihlr-27183	245	27	are	be	AUX
ihlr-27183	245	28	only	only	ADV
ihlr-27183	245	29	used	use	VERB
ihlr-27183	245	30	to	to	PART
ihlr-27183	245	31	extract	extract	VERB
ihlr-27183	245	32	data	datum	NOUN
ihlr-27183	245	33	from	from	ADP
ihlr-27183	245	34	the	the	DET
ihlr-27183	245	35	marketable	marketable	ADJ
ihlr-27183	245	36	drug	drug	NOUN
ihlr-27183	245	37	,	,	PUNCT
ihlr-27183	245	38	data	datum	NOUN
ihlr-27183	245	39	which	which	PRON
ihlr-27183	245	40	is	be	AUX
ihlr-27183	245	41	then	then	ADV
ihlr-27183	245	42	submitted	submit	VERB
ihlr-27183	245	43	to	to	ADP
ihlr-27183	245	44	the	the	DET
ihlr-27183	245	45	fda	fda	PROPN
ihlr-27183	245	46	for	for	ADP
ihlr-27183	245	47	approval	approval	NOUN
ihlr-27183	245	48	of	of	ADP
ihlr-27183	245	49	the	the	DET
ihlr-27183	245	50	marketable	marketable	ADJ
ihlr-27183	245	51	drug.75	drug.75	NOUN
ihlr-27183	245	52	hence	hence	ADV
ihlr-27183	245	53	,	,	PUNCT
ihlr-27183	245	54	the	the	DET
ihlr-27183	245	55	polypeptide	polypeptide	ADJ
ihlr-27183	245	56	markers	marker	NOUN
ihlr-27183	245	57	fall	fall	VERB
ihlr-27183	245	58	squarely	squarely	ADV
ihlr-27183	245	59	within	within	ADP
ihlr-27183	245	60	the	the	DET
ihlr-27183	245	61	research	research	NOUN
ihlr-27183	245	62	tool	tool	NOUN
ihlr-27183	245	63	class	class	NOUN
ihlr-27183	245	64	of	of	ADP
ihlr-27183	245	65	inventions	invention	NOUN
ihlr-27183	245	66	.	.	PUNCT
ihlr-27183	246	1	though	though	SCONJ
ihlr-27183	246	2	the	the	DET
ihlr-27183	246	3	merck	merck	PROPN
ihlr-27183	246	4	court	court	PROPN
ihlr-27183	246	5	explicitly	explicitly	ADV
ihlr-27183	246	6	declined	decline	VERB
ihlr-27183	246	7	to	to	PART
ihlr-27183	246	8	address	address	VERB
ihlr-27183	246	9	the	the	DET
ihlr-27183	246	10	issue	issue	NOUN
ihlr-27183	246	11	of	of	ADP
ihlr-27183	246	12	research	research	NOUN
ihlr-27183	246	13	tools,76	tools,76	X
ihlr-27183	246	14	the	the	DET
ihlr-27183	246	15	merck	merck	NOUN
ihlr-27183	246	16	holding	holding	NOUN
ihlr-27183	246	17	was	be	AUX
ihlr-27183	246	18	used	use	VERB
ihlr-27183	246	19	in	in	ADP
ihlr-27183	246	20	deciding	decide	VERB
ihlr-27183	246	21	the	the	DET
ihlr-27183	246	22	sandoz	sandoz	PROPN
ihlr-27183	246	23	case	case	NOUN
ihlr-27183	246	24	which	which	PRON
ihlr-27183	246	25	involved	involve	VERB
ihlr-27183	246	26	research	research	NOUN
ihlr-27183	246	27	tools.77	tools.77	NOUN
ihlr-27183	246	28	the	the	DET
ihlr-27183	246	29	supreme	supreme	PROPN
ihlr-27183	246	30	court	court	PROPN
ihlr-27183	246	31	’s	’s	PART
ihlr-27183	246	32	refusal	refusal	NOUN
ihlr-27183	246	33	to	to	PART
ihlr-27183	246	34	acknowledge	acknowledge	VERB
ihlr-27183	246	35	research	research	NOUN
ihlr-27183	246	36	tools	tool	NOUN
ihlr-27183	246	37	as	as	ADP
ihlr-27183	246	38	a	a	DET
ihlr-27183	246	39	distinct	distinct	ADJ
ihlr-27183	246	40	class	class	NOUN
ihlr-27183	246	41	has	have	AUX
ihlr-27183	246	42	perhaps	perhaps	ADV
ihlr-27183	246	43	inadvertently	inadvertently	ADV
ihlr-27183	246	44	brought	bring	VERB
ihlr-27183	246	45	them	they	PRON
ihlr-27183	246	46	under	under	ADP
ihlr-27183	246	47	the	the	DET
ihlr-27183	246	48	broad	broad	ADJ
ihlr-27183	246	49	principles	principle	NOUN
ihlr-27183	246	50	above	above	ADV
ihlr-27183	246	51	and	and	CCONJ
ihlr-27183	246	52	did	do	AUX
ihlr-27183	246	53	not	not	PART
ihlr-27183	246	54	foreclose	foreclose	VERB
ihlr-27183	246	55	the	the	DET
ihlr-27183	246	56	use	use	NOUN
ihlr-27183	246	57	of	of	ADP
ihlr-27183	246	58	merck	merck	NOUN
ihlr-27183	246	59	in	in	ADP
ihlr-27183	246	60	that	that	DET
ihlr-27183	246	61	context	context	NOUN
ihlr-27183	246	62	.	.	PUNCT
ihlr-27183	247	1	4	4	X
ihlr-27183	247	2	.	.	X
ihlr-27183	247	3	narrowing	narrow	VERB
ihlr-27183	247	4	at	at	ADP
ihlr-27183	247	5	the	the	DET
ihlr-27183	247	6	federal	federal	ADJ
ihlr-27183	247	7	circuit	circuit	NOUN
ihlr-27183	247	8	perhaps	perhaps	ADV
ihlr-27183	247	9	in	in	ADP
ihlr-27183	247	10	response	response	NOUN
ihlr-27183	247	11	to	to	ADP
ihlr-27183	247	12	a	a	DET
ihlr-27183	247	13	recognized	recognize	VERB
ihlr-27183	247	14	need	need	NOUN
ihlr-27183	247	15	,	,	PUNCT
ihlr-27183	247	16	or	or	CCONJ
ihlr-27183	247	17	echoing	echo	VERB
ihlr-27183	247	18	concern	concern	NOUN
ihlr-27183	247	19	for	for	ADP
ihlr-27183	247	20	research	research	NOUN
ihlr-27183	247	21	tool	tool	NOUN
ihlr-27183	247	22	patents	patent	NOUN
ihlr-27183	247	23	,	,	PUNCT
ihlr-27183	247	24	eighteen	eighteen	NUM
ihlr-27183	247	25	years	year	NOUN
ihlr-27183	247	26	after	after	ADP
ihlr-27183	247	27	eli	eli	PROPN
ihlr-27183	247	28	lilly	lilly	PROPN
ihlr-27183	247	29	,	,	PUNCT
ihlr-27183	247	30	and	and	CCONJ
ihlr-27183	247	31	three	three	NUM
ihlr-27183	247	32	years	year	NOUN
ihlr-27183	247	33	after	after	ADP
ihlr-27183	247	34	merck	merck	PROPN
ihlr-27183	247	35	,	,	PUNCT
ihlr-27183	247	36	the	the	DET
ihlr-27183	247	37	federal	federal	ADJ
ihlr-27183	247	38	circuit	circuit	NOUN
ihlr-27183	247	39	seemingly	seemingly	ADV
ihlr-27183	247	40	carved	carve	VERB
ihlr-27183	247	41	out	out	ADP
ihlr-27183	247	42	a	a	DET
ihlr-27183	247	43	limitation	limitation	NOUN
ihlr-27183	247	44	on	on	ADP
ihlr-27183	247	45	the	the	DET
ihlr-27183	247	46	statutory	statutory	ADJ
ihlr-27183	247	47	“	"	PUNCT
ihlr-27183	247	48	patented	patented	ADJ
ihlr-27183	247	49	invention	invention	NOUN
ihlr-27183	247	50	.	.	PUNCT
ihlr-27183	247	51	”	"	PUNCT
ihlr-27183	248	1	in	in	ADP
ihlr-27183	248	2	proveris	proveris	PROPN
ihlr-27183	248	3	v.	v.	ADP
ihlr-27183	248	4	innovasystems	innovasystem	NOUN
ihlr-27183	248	5	,	,	PUNCT
ihlr-27183	248	6	the	the	DET
ihlr-27183	248	7	federal	federal	ADJ
ihlr-27183	248	8	circuit	circuit	NOUN
ihlr-27183	248	9	held	hold	VERB
ihlr-27183	248	10	that	that	SCONJ
ihlr-27183	248	11	the	the	DET
ihlr-27183	248	12	use	use	NOUN
ihlr-27183	248	13	of	of	ADP
ihlr-27183	248	14	innova	innova	PROPN
ihlr-27183	248	15	’s	’s	PART
ihlr-27183	248	16	laboratory	laboratory	NOUN
ihlr-27183	248	17	equipment	equipment	NOUN
ihlr-27183	248	18	–	–	PUNCT
ihlr-27183	248	19	not	not	PART
ihlr-27183	248	20	itself	itself	PRON
ihlr-27183	248	21	subject	subject	ADJ
ihlr-27183	248	22	to	to	ADP
ihlr-27183	248	23	fda	fda	PROPN
ihlr-27183	248	24	approval	approval	NOUN
ihlr-27183	248	25	,	,	PUNCT
ihlr-27183	248	26	but	but	CCONJ
ihlr-27183	248	27	used	use	VERB
ihlr-27183	248	28	exclusively	exclusively	ADV
ihlr-27183	248	29	in	in	ADP
ihlr-27183	248	30	producing	produce	VERB
ihlr-27183	248	31	data	datum	NOUN
ihlr-27183	248	32	for	for	ADP
ihlr-27183	248	33	fda	fda	PROPN
ihlr-27183	248	34	approval	approval	PROPN
ihlr-27183	248	35	–	–	PUNCT
ihlr-27183	248	36	was	be	AUX
ihlr-27183	248	37	not	not	PART
ihlr-27183	248	38	shielded	shield	VERB
ihlr-27183	248	39	by	by	ADP
ihlr-27183	248	40	the	the	DET
ihlr-27183	248	41	safe	safe	ADJ
ihlr-27183	248	42	harbor	harbor	NOUN
ihlr-27183	248	43	of	of	ADP
ihlr-27183	248	44	§	§	PROPN
ihlr-27183	248	45	271(e)(1).78	271(e)(1).78	PROPN
ihlr-27183	248	46	the	the	DET
ihlr-27183	248	47	federal	federal	ADJ
ihlr-27183	248	48	circuit	circuit	NOUN
ihlr-27183	248	49	reasoned	reason	VERB
ihlr-27183	248	50	that	that	SCONJ
ihlr-27183	248	51	since	since	SCONJ
ihlr-27183	248	52	excluding	exclude	VERB
ihlr-27183	248	53	innovasystems	innovasystem	NOUN
ihlr-27183	248	54	from	from	ADP
ihlr-27183	248	55	use	use	NOUN
ihlr-27183	248	56	of	of	ADP
ihlr-27183	248	57	the	the	DET
ihlr-27183	248	58	patented	patented	ADJ
ihlr-27183	248	59	device	device	NOUN
ihlr-27183	248	60	would	would	AUX
ihlr-27183	248	61	not	not	PART
ihlr-27183	248	62	unfairly	unfairly	ADV
ihlr-27183	248	63	extend	extend	VERB
ihlr-27183	248	64	the	the	DET
ihlr-27183	248	65	life	life	NOUN
ihlr-27183	248	66	of	of	ADP
ihlr-27183	248	67	the	the	DET
ihlr-27183	248	68	patent	patent	NOUN
ihlr-27183	248	69	by	by	ADP
ihlr-27183	248	70	an	an	DET
ihlr-27183	248	71	approval	approval	NOUN
ihlr-27183	248	72	delay	delay	NOUN
ihlr-27183	248	73	,	,	PUNCT
ihlr-27183	248	74	the	the	DET
ihlr-27183	248	75	purpose	purpose	NOUN
ihlr-27183	248	76	of	of	ADP
ihlr-27183	248	77	the	the	DET
ihlr-27183	248	78	safe	safe	ADJ
ihlr-27183	248	79	harbor	harbor	NOUN
ihlr-27183	248	80	would	would	AUX
ihlr-27183	248	81	not	not	PART
ihlr-27183	248	82	be	be	AUX
ihlr-27183	248	83	served	serve	VERB
ihlr-27183	248	84	in	in	ADP
ihlr-27183	248	85	applying	apply	VERB
ihlr-27183	248	86	it	it	PRON
ihlr-27183	248	87	in	in	ADP
ihlr-27183	248	88	that	that	PRON
ihlr-27183	248	89	instance.79	instance.79	VERB
ihlr-27183	248	90	the	the	DET
ihlr-27183	248	91	federal	federal	ADJ
ihlr-27183	248	92	circuit	circuit	NOUN
ihlr-27183	248	93	explains	explain	VERB
ihlr-27183	248	94	this	this	PRON
ihlr-27183	248	95	in	in	ADP
ihlr-27183	248	96	plain	plain	ADJ
ihlr-27183	248	97	terms	term	NOUN
ihlr-27183	248	98	:	:	PUNCT
ihlr-27183	248	99	innova	innova	PROPN
ihlr-27183	248	100	is	be	AUX
ihlr-27183	248	101	not	not	PART
ihlr-27183	248	102	a	a	DET
ihlr-27183	248	103	party	party	NOUN
ihlr-27183	248	104	seeking	seek	VERB
ihlr-27183	248	105	fda	fda	PROPN
ihlr-27183	248	106	approval	approval	NOUN
ihlr-27183	248	107	for	for	ADP
ihlr-27183	248	108	a	a	DET
ihlr-27183	248	109	product	product	NOUN
ihlr-27183	248	110	in	in	ADP
ihlr-27183	248	111	order	order	NOUN
ihlr-27183	248	112	to	to	PART
ihlr-27183	248	113	enter	enter	VERB
ihlr-27183	248	114	the	the	DET
ihlr-27183	248	115	market	market	NOUN
ihlr-27183	248	116	to	to	PART
ihlr-27183	248	117	compete	compete	VERB
ihlr-27183	248	118	with	with	ADP
ihlr-27183	248	119	patentees	patentee	NOUN
ihlr-27183	248	120	.	.	PUNCT
ihlr-27183	249	1	because	because	SCONJ
ihlr-27183	249	2	the	the	DET
ihlr-27183	249	3	osa	osa	ADJ
ihlr-27183	249	4	device	device	NOUN
ihlr-27183	249	5	is	be	AUX
ihlr-27183	249	6	not	not	PART
ihlr-27183	249	7	subject	subject	ADJ
ihlr-27183	249	8	to	to	ADP
ihlr-27183	249	9	fda	fda	PROPN
ihlr-27183	249	10	premarket	premarket	PROPN
ihlr-27183	249	11	approval	approval	NOUN
ihlr-27183	249	12	,	,	PUNCT
ihlr-27183	249	13	and	and	CCONJ
ihlr-27183	249	14	therefore	therefore	ADV
ihlr-27183	249	15	faces	face	VERB
ihlr-27183	249	16	no	no	DET
ihlr-27183	249	17	regulatory	regulatory	ADJ
ihlr-27183	249	18	barriers	barrier	NOUN
ihlr-27183	249	19	to	to	ADP
ihlr-27183	249	20	market	market	NOUN
ihlr-27183	249	21	entry	entry	NOUN
ihlr-27183	249	22	upon	upon	SCONJ
ihlr-27183	249	23	patent	patent	NOUN
ihlr-27183	249	24	expiration	expiration	NOUN
ihlr-27183	249	25	,	,	PUNCT
ihlr-27183	249	26	innova	innova	PROPN
ihlr-27183	249	27	is	be	AUX
ihlr-27183	249	28	not	not	PART
ihlr-27183	249	29	a	a	DET
ihlr-27183	249	30	party	party	NOUN
ihlr-27183	249	31	who	who	PRON
ihlr-27183	249	32	,	,	PUNCT
ihlr-27183	249	33	prior	prior	ADV
ihlr-27183	249	34	to	to	ADP
ihlr-27183	249	35	enactment	enactment	NOUN
ihlr-27183	249	36	of	of	ADP
ihlr-27183	249	37	the	the	DET
ihlr-27183	249	38	hatch	hatch	PROPN
ihlr-27183	249	39	-	-	PUNCT
ihlr-27183	249	40	waxman	waxman	PROPN
ihlr-27183	249	41	act	act	PROPN
ihlr-27183	249	42	,	,	PUNCT
ihlr-27183	249	43	could	could	AUX
ihlr-27183	249	44	be	be	AUX
ihlr-27183	249	45	said	say	VERB
ihlr-27183	249	46	to	to	PART
ihlr-27183	249	47	have	have	AUX
ihlr-27183	249	48	been	be	AUX
ihlr-27183	249	49	adversely	adversely	ADV
ihlr-27183	249	50	affected	affect	VERB
ihlr-27183	249	51	by	by	ADP
ihlr-27183	249	52	the	the	DET
ihlr-27183	249	53	second	second	ADJ
ihlr-27183	249	54	distortion	distortion	NOUN
ihlr-27183	249	55	.	.	PUNCT
ihlr-27183	250	1	for	for	ADP
ihlr-27183	250	2	this	this	DET
ihlr-27183	250	3	reason	reason	NOUN
ihlr-27183	250	4	,	,	PUNCT
ihlr-27183	250	5	we	we	PRON
ihlr-27183	250	6	do	do	AUX
ihlr-27183	250	7	not	not	PART
ihlr-27183	250	8	think	think	VERB
ihlr-27183	250	9	congress	congress	PROPN
ihlr-27183	250	10	could	could	AUX
ihlr-27183	250	11	have	have	AUX
ihlr-27183	250	12	intended	intend	VERB
ihlr-27183	250	13	that	that	SCONJ
ihlr-27183	250	14	the	the	DET
ihlr-27183	250	15	safe	safe	ADJ
ihlr-27183	250	16	harbor	harbor	NOUN
ihlr-27183	250	17	of	of	ADP
ihlr-27183	250	18	§	§	PROPN
ihlr-27183	250	19	271(e)(1	271(e)(1	PROPN
ihlr-27183	250	20	)	)	PUNCT
ihlr-27183	250	21	apply	apply	VERB
ihlr-27183	250	22	to	to	ADP
ihlr-27183	250	23	it.80	it.80	NOUN
ihlr-27183	250	24	in	in	ADP
ihlr-27183	250	25	this	this	DET
ihlr-27183	250	26	excerpt	excerpt	NOUN
ihlr-27183	250	27	,	,	PUNCT
ihlr-27183	250	28	the	the	DET
ihlr-27183	250	29	proveris	proveris	PROPN
ihlr-27183	250	30	court	court	NOUN
ihlr-27183	250	31	underscores	underscore	VERB
ihlr-27183	250	32	key	key	ADJ
ihlr-27183	250	33	rationale	rationale	NOUN
ihlr-27183	250	34	and	and	CCONJ
ihlr-27183	250	35	issues	issue	NOUN
ihlr-27183	250	36	a	a	DET
ihlr-27183	250	37	single	single	ADJ
ihlr-27183	250	38	result	result	NOUN
ihlr-27183	250	39	in	in	ADP
ihlr-27183	250	40	harmony	harmony	NOUN
ihlr-27183	250	41	with	with	ADP
ihlr-27183	250	42	this	this	DET
ihlr-27183	250	43	note	note	NOUN
ihlr-27183	250	44	’s	’s	PART
ihlr-27183	250	45	call	call	NOUN
ihlr-27183	250	46	for	for	ADP
ihlr-27183	250	47	a	a	DET
ihlr-27183	250	48	bright	bright	ADJ
ihlr-27183	250	49	-	-	PUNCT
ihlr-27183	250	50	line	line	NOUN
ihlr-27183	250	51	rule	rule	NOUN
ihlr-27183	250	52	.	.	PUNCT
ihlr-27183	251	1	this	this	DET
ihlr-27183	251	2	decision	decision	NOUN
ihlr-27183	251	3	strengthened	strengthen	VERB
ihlr-27183	251	4	the	the	DET
ihlr-27183	251	5	case	case	NOUN
ihlr-27183	251	6	for	for	ADP
ihlr-27183	251	7	a	a	DET
ihlr-27183	251	8	general	general	ADJ
ihlr-27183	251	9	rule	rule	NOUN
ihlr-27183	251	10	excluding	exclude	VERB
ihlr-27183	251	11	patented	patented	ADJ
ihlr-27183	251	12	inventions	invention	NOUN
ihlr-27183	251	13	not	not	PART
ihlr-27183	251	14	subject	subject	ADJ
ihlr-27183	251	15	to	to	ADP
ihlr-27183	251	16	fda	fda	PROPN
ihlr-27183	251	17	approval	approval	NOUN
ihlr-27183	251	18	from	from	ADP
ihlr-27183	251	19	the	the	DET
ihlr-27183	251	20	safe	safe	ADJ
ihlr-27183	251	21	harbor	harbor	NOUN
ihlr-27183	251	22	.	.	PUNCT
ihlr-27183	252	1	however	however	ADV
ihlr-27183	252	2	,	,	PUNCT
ihlr-27183	252	3	sandoz	sandoz	PROPN
ihlr-27183	252	4	–	–	PUNCT
ihlr-27183	252	5	decided	decide	VERB
ihlr-27183	252	6	about	about	ADV
ihlr-27183	252	7	five	five	NUM
ihlr-27183	252	8	73	73	NUM
ihlr-27183	252	9	.	.	PUNCT
ihlr-27183	253	1	sandoz	sandoz	PROPN
ihlr-27183	253	2	,	,	PUNCT
ihlr-27183	253	3	2013	2013	NUM
ihlr-27183	253	4	wl	wl	NOUN
ihlr-27183	253	5	3732867	3732867	NUM
ihlr-27183	253	6	,	,	PUNCT
ihlr-27183	253	7	at	at	ADP
ihlr-27183	253	8	*	*	PROPN
ihlr-27183	253	9	1	1	NUM
ihlr-27183	253	10	.	.	NOUN
ihlr-27183	253	11	74	74	NUM
ihlr-27183	253	12	.	.	PUNCT
ihlr-27183	254	1	i	i	PRON
ihlr-27183	254	2	d.	d.	VERB
ihlr-27183	254	3	at	at	ADP
ihlr-27183	254	4	*	*	PROPN
ihlr-27183	254	5	2	2	NUM
ihlr-27183	254	6	.	.	X
ihlr-27183	254	7	75	75	NUM
ihlr-27183	254	8	.	.	PUNCT
ihlr-27183	255	1	i	i	PRON
ihlr-27183	255	2	d.	d.	PROPN
ihlr-27183	255	3	76	76	NUM
ihlr-27183	255	4	.	.	PUNCT
ihlr-27183	256	1	merck	merck	PROPN
ihlr-27183	256	2	kgaa	kgaa	PROPN
ihlr-27183	256	3	,	,	PUNCT
ihlr-27183	256	4	545	545	NUM
ihlr-27183	256	5	u.s	u.s	PROPN
ihlr-27183	256	6	.	.	PROPN
ihlr-27183	256	7	at	at	ADP
ihlr-27183	256	8	205	205	NUM
ihlr-27183	256	9	n.7	n.7	X
ihlr-27183	256	10	.	.	PUNCT
ihlr-27183	257	1	77	77	NUM
ihlr-27183	257	2	.	.	PUNCT
ihlr-27183	258	1	sandoz	sandoz	PROPN
ihlr-27183	258	2	,	,	PUNCT
ihlr-27183	258	3	2013	2013	NUM
ihlr-27183	258	4	wl	wl	NOUN
ihlr-27183	258	5	3732867	3732867	NUM
ihlr-27183	258	6	,	,	PUNCT
ihlr-27183	258	7	at	at	ADP
ihlr-27183	258	8	*	*	NOUN
ihlr-27183	258	9	8	8	NUM
ihlr-27183	258	10	.	.	PUNCT
ihlr-27183	258	11	78	78	NUM
ihlr-27183	258	12	.	.	PUNCT
ihlr-27183	259	1	proveris	proveris	PROPN
ihlr-27183	259	2	sci	sci	PROPN
ihlr-27183	259	3	.	.	PROPN
ihlr-27183	259	4	corp	corp	PROPN
ihlr-27183	259	5	.	.	PROPN
ihlr-27183	259	6	,	,	PUNCT
ihlr-27183	259	7	536	536	NUM
ihlr-27183	259	8	f.3d	f.3d	NUM
ihlr-27183	259	9	at	at	ADP
ihlr-27183	259	10	1266	1266	NUM
ihlr-27183	259	11	.	.	PUNCT
ihlr-27183	260	1	79	79	NUM
ihlr-27183	260	2	.	.	PUNCT
ihlr-27183	261	1	i	i	PRON
ihlr-27183	261	2	d.	d.	PROPN
ihlr-27183	261	3	at	at	ADP
ihlr-27183	261	4	1265	1265	NUM
ihlr-27183	261	5	.	.	PUNCT
ihlr-27183	262	1	80	80	NUM
ihlr-27183	262	2	.	.	PUNCT
ihlr-27183	263	1	i	i	PRON
ihlr-27183	263	2	d.	d.	PROPN
ihlr-27183	263	3	154	154	NUM
ihlr-27183	263	4	indiana	indiana	PROPN
ihlr-27183	263	5	health	health	PROPN
ihlr-27183	263	6	law	law	PROPN
ihlr-27183	263	7	review	review	NOUN
ihlr-27183	263	8	[	[	X
ihlr-27183	263	9	vol	vol	NOUN
ihlr-27183	263	10	.	.	PUNCT
ihlr-27183	263	11	20:143	20:143	NUM
ihlr-27183	263	12	years	year	NOUN
ihlr-27183	263	13	after	after	ADP
ihlr-27183	263	14	proveris	proveris	NOUN
ihlr-27183	263	15	–	–	PUNCT
ihlr-27183	263	16	has	have	AUX
ihlr-27183	263	17	not	not	PART
ihlr-27183	263	18	been	be	AUX
ihlr-27183	263	19	recognized	recognize	VERB
ihlr-27183	263	20	as	as	ADP
ihlr-27183	263	21	establishing	establish	VERB
ihlr-27183	263	22	a	a	DET
ihlr-27183	263	23	binding	bind	VERB
ihlr-27183	263	24	rule.81	rule.81	NOUN
ihlr-27183	263	25	it	it	PRON
ihlr-27183	263	26	would	would	AUX
ihlr-27183	263	27	appear	appear	VERB
ihlr-27183	263	28	this	this	PRON
ihlr-27183	263	29	is	be	AUX
ihlr-27183	263	30	because	because	SCONJ
ihlr-27183	263	31	of	of	ADP
ihlr-27183	263	32	the	the	DET
ihlr-27183	263	33	supreme	supreme	PROPN
ihlr-27183	263	34	court	court	PROPN
ihlr-27183	263	35	’s	’s	PART
ihlr-27183	263	36	unwillingness	unwillingness	NOUN
ihlr-27183	263	37	to	to	PART
ihlr-27183	263	38	concur	concur	VERB
ihlr-27183	263	39	on	on	ADP
ihlr-27183	263	40	such	such	DET
ihlr-27183	263	41	a	a	DET
ihlr-27183	263	42	categorical	categorical	ADJ
ihlr-27183	263	43	limitation	limitation	NOUN
ihlr-27183	263	44	.	.	PUNCT
ihlr-27183	264	1	in	in	ADP
ihlr-27183	264	2	the	the	DET
ihlr-27183	264	3	face	face	NOUN
ihlr-27183	264	4	of	of	ADP
ihlr-27183	264	5	such	such	ADJ
ihlr-27183	264	6	binding	bind	VERB
ihlr-27183	264	7	federal	federal	ADJ
ihlr-27183	264	8	circuit	circuit	NOUN
ihlr-27183	264	9	guidance	guidance	NOUN
ihlr-27183	264	10	,	,	PUNCT
ihlr-27183	264	11	how	how	SCONJ
ihlr-27183	264	12	did	do	AUX
ihlr-27183	264	13	sandoz	sandoz	PROPN
ihlr-27183	264	14	justify	justify	VERB
ihlr-27183	264	15	a	a	DET
ihlr-27183	264	16	dismissal	dismissal	NOUN
ihlr-27183	264	17	of	of	ADP
ihlr-27183	264	18	patent	patent	NOUN
ihlr-27183	264	19	infringement	infringement	NOUN
ihlr-27183	264	20	for	for	ADP
ihlr-27183	264	21	use	use	NOUN
ihlr-27183	264	22	of	of	ADP
ihlr-27183	264	23	the	the	DET
ihlr-27183	264	24	patented	patented	ADJ
ihlr-27183	264	25	polypeptide	polypeptide	ADJ
ihlr-27183	264	26	marker	marker	NOUN
ihlr-27183	264	27	?	?	PUNCT
ihlr-27183	265	1	surprisingly	surprisingly	ADV
ihlr-27183	265	2	,	,	PUNCT
ihlr-27183	265	3	sandoz	sandoz	PROPN
ihlr-27183	265	4	does	do	AUX
ihlr-27183	265	5	not	not	PART
ihlr-27183	265	6	interpret	interpret	VERB
ihlr-27183	265	7	proveris	proveris	NOUN
ihlr-27183	265	8	to	to	PART
ihlr-27183	265	9	narrow	narrow	VERB
ihlr-27183	265	10	,	,	PUNCT
ihlr-27183	265	11	or	or	CCONJ
ihlr-27183	265	12	even	even	ADV
ihlr-27183	265	13	consciously	consciously	ADV
ihlr-27183	265	14	impact	impact	NOUN
ihlr-27183	265	15	,	,	PUNCT
ihlr-27183	265	16	the	the	DET
ihlr-27183	265	17	statutory	statutory	ADJ
ihlr-27183	265	18	“	"	PUNCT
ihlr-27183	265	19	patented	patented	ADJ
ihlr-27183	265	20	invention	invention	NOUN
ihlr-27183	265	21	.	.	PUNCT
ihlr-27183	266	1	”82	”82	PROPN
ihlr-27183	266	2	instead	instead	ADV
ihlr-27183	266	3	,	,	PUNCT
ihlr-27183	266	4	sandoz	sandoz	PROPN
ihlr-27183	266	5	emphasizes	emphasize	VERB
ihlr-27183	266	6	proveris	proveris	PROPN
ihlr-27183	266	7	’s	’s	PART
ihlr-27183	266	8	reliance	reliance	NOUN
ihlr-27183	266	9	on	on	ADP
ihlr-27183	266	10	the	the	DET
ihlr-27183	266	11	statute	statute	NOUN
ihlr-27183	266	12	’s	’s	PART
ihlr-27183	266	13	requirement	requirement	NOUN
ihlr-27183	266	14	that	that	SCONJ
ihlr-27183	266	15	activity	activity	NOUN
ihlr-27183	266	16	is	be	AUX
ihlr-27183	266	17	“	"	PUNCT
ihlr-27183	266	18	solely	solely	ADV
ihlr-27183	266	19	for	for	ADP
ihlr-27183	266	20	uses	use	NOUN
ihlr-27183	266	21	”	"	PUNCT
ihlr-27183	266	22	related	relate	VERB
ihlr-27183	266	23	to	to	ADP
ihlr-27183	266	24	fda	fda	PROPN
ihlr-27183	266	25	approval.83	approval.83	PROPN
ihlr-27183	266	26	sandoz	sandoz	PROPN
ihlr-27183	266	27	points	point	VERB
ihlr-27183	266	28	out	out	ADP
ihlr-27183	266	29	that	that	SCONJ
ihlr-27183	266	30	in	in	ADP
ihlr-27183	266	31	proveris	proveris	NOUN
ihlr-27183	266	32	,	,	PUNCT
ihlr-27183	266	33	the	the	DET
ihlr-27183	266	34	defendant	defendant	NOUN
ihlr-27183	266	35	was	be	AUX
ihlr-27183	266	36	“	"	PUNCT
ihlr-27183	266	37	manufacturing	manufacture	VERB
ihlr-27183	266	38	and	and	CCONJ
ihlr-27183	266	39	selling	sell	VERB
ihlr-27183	266	40	a	a	DET
ihlr-27183	266	41	patented	patented	ADJ
ihlr-27183	266	42	device	device	NOUN
ihlr-27183	266	43	”	"	PUNCT
ihlr-27183	266	44	and	and	CCONJ
ihlr-27183	266	45	argued	argue	VERB
ihlr-27183	266	46	their	their	PRON
ihlr-27183	266	47	“	"	PUNCT
ihlr-27183	266	48	customers	customer	NOUN
ihlr-27183	266	49	’	'	PUNCT
ihlr-27183	266	50	activities”–being	activities”–bee	VERB
ihlr-27183	266	51	in	in	ADP
ihlr-27183	266	52	connection	connection	NOUN
ihlr-27183	266	53	with	with	ADP
ihlr-27183	266	54	seeking	seek	VERB
ihlr-27183	266	55	fda	fda	PROPN
ihlr-27183	266	56	approval	approval	PROPN
ihlr-27183	266	57	–	–	PUNCT
ihlr-27183	266	58	were	be	AUX
ihlr-27183	266	59	a	a	DET
ihlr-27183	266	60	basis	basis	NOUN
ihlr-27183	266	61	to	to	PART
ihlr-27183	266	62	grant	grant	VERB
ihlr-27183	266	63	the	the	DET
ihlr-27183	266	64	defendant	defendant	NOUN
ihlr-27183	266	65	shelter	shelter	VERB
ihlr-27183	266	66	under	under	ADP
ihlr-27183	266	67	the	the	DET
ihlr-27183	266	68	safe	safe	ADJ
ihlr-27183	266	69	harbor.84	harbor.84	NOUN
ihlr-27183	266	70	the	the	DET
ihlr-27183	266	71	defendant	defendant	NOUN
ihlr-27183	266	72	wanted	want	VERB
ihlr-27183	266	73	to	to	PART
ihlr-27183	266	74	sell	sell	VERB
ihlr-27183	266	75	a	a	DET
ihlr-27183	266	76	patented	patented	ADJ
ihlr-27183	266	77	product	product	NOUN
ihlr-27183	266	78	to	to	ADP
ihlr-27183	266	79	a	a	DET
ihlr-27183	266	80	customer	customer	NOUN
ihlr-27183	266	81	who	who	PRON
ihlr-27183	266	82	would	would	AUX
ihlr-27183	266	83	use	use	VERB
ihlr-27183	266	84	it	it	PRON
ihlr-27183	266	85	in	in	ADP
ihlr-27183	266	86	connection	connection	NOUN
ihlr-27183	266	87	with	with	ADP
ihlr-27183	266	88	fda	fda	PROPN
ihlr-27183	266	89	approval.85	approval.85	PROPN
ihlr-27183	266	90	accordingly	accordingly	ADV
ihlr-27183	266	91	,	,	PUNCT
ihlr-27183	266	92	had	have	VERB
ihlr-27183	266	93	the	the	DET
ihlr-27183	266	94	defendant	defendant	NOUN
ihlr-27183	266	95	in	in	ADP
ihlr-27183	266	96	proveris	proveris	PROPN
ihlr-27183	266	97	been	be	VERB
ihlr-27183	266	98	the	the	DET
ihlr-27183	266	99	one	one	NOUN
ihlr-27183	266	100	using	use	VERB
ihlr-27183	266	101	the	the	DET
ihlr-27183	266	102	patented	patented	ADJ
ihlr-27183	266	103	invention	invention	NOUN
ihlr-27183	266	104	,	,	PUNCT
ihlr-27183	266	105	according	accord	VERB
ihlr-27183	266	106	to	to	ADP
ihlr-27183	266	107	sandoz	sandoz	PROPN
ihlr-27183	266	108	at	at	ADP
ihlr-27183	266	109	least	least	ADJ
ihlr-27183	266	110	,	,	PUNCT
ihlr-27183	266	111	the	the	DET
ihlr-27183	266	112	safe	safe	ADJ
ihlr-27183	266	113	harbor	harbor	NOUN
ihlr-27183	266	114	may	may	AUX
ihlr-27183	266	115	very	very	ADV
ihlr-27183	266	116	well	well	ADV
ihlr-27183	266	117	have	have	VERB
ihlr-27183	266	118	applied.86	applied.86	NOUN
ihlr-27183	266	119	to	to	PART
ihlr-27183	266	120	clarify	clarify	VERB
ihlr-27183	266	121	,	,	PUNCT
ihlr-27183	266	122	sandoz	sandoz	PROPN
ihlr-27183	266	123	expressly	expressly	ADV
ihlr-27183	266	124	concludes	conclude	VERB
ihlr-27183	266	125	that	that	SCONJ
ihlr-27183	266	126	to	to	PART
ihlr-27183	266	127	read	read	VERB
ihlr-27183	266	128	proveris	proveris	NOUN
ihlr-27183	266	129	to	to	PART
ihlr-27183	266	130	hold	hold	VERB
ihlr-27183	266	131	that	that	SCONJ
ihlr-27183	266	132	laboratory	laboratory	NOUN
ihlr-27183	266	133	equipment	equipment	NOUN
ihlr-27183	266	134	forms	form	VERB
ihlr-27183	266	135	a	a	DET
ihlr-27183	266	136	class	class	NOUN
ihlr-27183	266	137	of	of	ADP
ihlr-27183	266	138	devices	device	NOUN
ihlr-27183	266	139	generally	generally	ADV
ihlr-27183	266	140	unprotected	unprotecte	VERB
ihlr-27183	266	141	by	by	ADP
ihlr-27183	266	142	the	the	DET
ihlr-27183	266	143	safe	safe	ADJ
ihlr-27183	266	144	harbor	harbor	NOUN
ihlr-27183	266	145	would	would	AUX
ihlr-27183	266	146	be	be	AUX
ihlr-27183	266	147	to	to	PART
ihlr-27183	266	148	“	"	PUNCT
ihlr-27183	266	149	read	read	VERB
ihlr-27183	266	150	proveris	proveris	NOUN
ihlr-27183	266	151	too	too	ADV
ihlr-27183	266	152	narrowly	narrowly	ADV
ihlr-27183	266	153	.	.	PUNCT
ihlr-27183	267	1	”87	”87	PROPN
ihlr-27183	267	2	in	in	ADP
ihlr-27183	267	3	sandoz	sandoz	PROPN
ihlr-27183	267	4	’s	’s	PART
ihlr-27183	267	5	view	view	NOUN
ihlr-27183	267	6	,	,	PUNCT
ihlr-27183	267	7	proveris	proveris	PROPN
ihlr-27183	267	8	did	do	AUX
ihlr-27183	267	9	not	not	PART
ihlr-27183	267	10	exclude	exclude	VERB
ihlr-27183	267	11	laboratory	laboratory	NOUN
ihlr-27183	267	12	equipment	equipment	NOUN
ihlr-27183	267	13	,	,	PUNCT
ihlr-27183	267	14	a	a	DET
ihlr-27183	267	15	subset	subset	NOUN
ihlr-27183	267	16	of	of	ADP
ihlr-27183	267	17	research	research	NOUN
ihlr-27183	267	18	tools	tool	NOUN
ihlr-27183	267	19	,	,	PUNCT
ihlr-27183	267	20	from	from	ADP
ihlr-27183	267	21	the	the	DET
ihlr-27183	267	22	reach	reach	NOUN
ihlr-27183	267	23	of	of	ADP
ihlr-27183	267	24	the	the	DET
ihlr-27183	267	25	safe	safe	ADJ
ihlr-27183	267	26	harbor	harbor	NOUN
ihlr-27183	267	27	,	,	PUNCT
ihlr-27183	267	28	but	but	CCONJ
ihlr-27183	267	29	rather	rather	ADV
ihlr-27183	267	30	,	,	PUNCT
ihlr-27183	267	31	the	the	DET
ihlr-27183	267	32	use	use	NOUN
ihlr-27183	267	33	of	of	ADP
ihlr-27183	267	34	a	a	DET
ihlr-27183	267	35	patented	patented	ADJ
ihlr-27183	267	36	invention	invention	NOUN
ihlr-27183	267	37	where	where	SCONJ
ihlr-27183	267	38	the	the	DET
ihlr-27183	267	39	user	user	NOUN
ihlr-27183	267	40	was	be	AUX
ihlr-27183	267	41	not	not	PART
ihlr-27183	267	42	seeking	seek	VERB
ihlr-27183	267	43	fda	fda	PROPN
ihlr-27183	267	44	approval.88	approval.88	PROPN
ihlr-27183	267	45	to	to	PART
ihlr-27183	267	46	construct	construct	VERB
ihlr-27183	267	47	proveris	proveri	NOUN
ihlr-27183	267	48	so	so	ADV
ihlr-27183	267	49	narrowly	narrowly	ADV
ihlr-27183	267	50	is	be	AUX
ihlr-27183	267	51	,	,	PUNCT
ihlr-27183	267	52	in	in	ADP
ihlr-27183	267	53	this	this	DET
ihlr-27183	267	54	author	author	NOUN
ihlr-27183	267	55	’s	’s	PART
ihlr-27183	267	56	opinion	opinion	NOUN
ihlr-27183	267	57	,	,	PUNCT
ihlr-27183	267	58	to	to	PART
ihlr-27183	267	59	corrupt	corrupt	VERB
ihlr-27183	267	60	the	the	DET
ihlr-27183	267	61	context	context	NOUN
ihlr-27183	267	62	and	and	CCONJ
ihlr-27183	267	63	conflate	conflate	VERB
ihlr-27183	267	64	the	the	DET
ihlr-27183	267	65	audience	audience	NOUN
ihlr-27183	267	66	with	with	ADP
ihlr-27183	267	67	the	the	DET
ihlr-27183	267	68	actors	actor	NOUN
ihlr-27183	267	69	.	.	PUNCT
ihlr-27183	268	1	regrettably	regrettably	ADV
ihlr-27183	268	2	,	,	PUNCT
ihlr-27183	268	3	whether	whether	SCONJ
ihlr-27183	268	4	fda	fda	PROPN
ihlr-27183	268	5	approval	approval	NOUN
ihlr-27183	268	6	was	be	AUX
ihlr-27183	268	7	sought	seek	VERB
ihlr-27183	268	8	concerning	concern	VERB
ihlr-27183	268	9	the	the	DET
ihlr-27183	268	10	patented	patent	VERB
ihlr-27183	268	11	invention	invention	NOUN
ihlr-27183	268	12	was	be	AUX
ihlr-27183	268	13	left	leave	VERB
ihlr-27183	268	14	optional	optional	ADJ
ihlr-27183	268	15	.	.	PUNCT
ihlr-27183	269	1	d.	d.	PROPN
ihlr-27183	269	2	summary	summary	NOUN
ihlr-27183	269	3	of	of	ADP
ihlr-27183	269	4	uncertainty	uncertainty	NOUN
ihlr-27183	269	5	concerning	concern	VERB
ihlr-27183	269	6	research	research	NOUN
ihlr-27183	269	7	tools	tool	NOUN
ihlr-27183	269	8	today	today	NOUN
ihlr-27183	269	9	,	,	PUNCT
ihlr-27183	269	10	all	all	DET
ihlr-27183	269	11	these	these	DET
ihlr-27183	269	12	factors	factor	NOUN
ihlr-27183	269	13	have	have	AUX
ihlr-27183	269	14	produced	produce	VERB
ihlr-27183	269	15	uncertainty	uncertainty	NOUN
ihlr-27183	269	16	concerning	concern	VERB
ihlr-27183	269	17	the	the	DET
ihlr-27183	269	18	safe	safe	ADJ
ihlr-27183	269	19	harbor	harbor	NOUN
ihlr-27183	269	20	’s	’s	PART
ihlr-27183	269	21	effect	effect	NOUN
ihlr-27183	269	22	on	on	ADP
ihlr-27183	269	23	the	the	DET
ihlr-27183	269	24	species	specie	NOUN
ihlr-27183	269	25	of	of	ADP
ihlr-27183	269	26	patented	patented	ADJ
ihlr-27183	269	27	invention	invention	NOUN
ihlr-27183	269	28	,	,	PUNCT
ihlr-27183	269	29	commonly	commonly	ADV
ihlr-27183	269	30	referred	refer	VERB
ihlr-27183	269	31	to	to	ADP
ihlr-27183	269	32	as	as	SCONJ
ihlr-27183	269	33	research	research	NOUN
ihlr-27183	269	34	tools.89	tools.89	NOUN
ihlr-27183	269	35	generally	generally	ADV
ihlr-27183	269	36	,	,	PUNCT
ihlr-27183	269	37	research	research	NOUN
ihlr-27183	269	38	tools	tool	NOUN
ihlr-27183	269	39	are	be	AUX
ihlr-27183	269	40	not	not	PART
ihlr-27183	269	41	subject	subject	ADJ
ihlr-27183	269	42	to	to	ADP
ihlr-27183	269	43	fda	fda	PROPN
ihlr-27183	269	44	approval	approval	NOUN
ihlr-27183	269	45	,	,	PUNCT
ihlr-27183	269	46	though	though	SCONJ
ihlr-27183	269	47	they	they	PRON
ihlr-27183	269	48	are	be	AUX
ihlr-27183	269	49	often	often	ADV
ihlr-27183	269	50	required	require	VERB
ihlr-27183	269	51	to	to	PART
ihlr-27183	269	52	generate	generate	VERB
ihlr-27183	269	53	data	datum	NOUN
ihlr-27183	269	54	demanded	demand	VERB
ihlr-27183	269	55	by	by	ADP
ihlr-27183	269	56	fda	fda	PROPN
ihlr-27183	269	57	submissions	submission	NOUN
ihlr-27183	269	58	.	.	PUNCT
ihlr-27183	270	1	sandoz	sandoz	PROPN
ihlr-27183	270	2	is	be	AUX
ihlr-27183	270	3	a	a	DET
ihlr-27183	270	4	district	district	NOUN
ihlr-27183	270	5	court	court	NOUN
ihlr-27183	270	6	decision	decision	NOUN
ihlr-27183	270	7	in	in	ADP
ihlr-27183	270	8	which	which	PRON
ihlr-27183	270	9	a	a	DET
ihlr-27183	270	10	research	research	NOUN
ihlr-27183	270	11	tool	tool	NOUN
ihlr-27183	270	12	was	be	AUX
ihlr-27183	270	13	brought	bring	VERB
ihlr-27183	270	14	under	under	ADP
ihlr-27183	270	15	the	the	DET
ihlr-27183	270	16	safe	safe	ADJ
ihlr-27183	270	17	harbor	harbor	NOUN
ihlr-27183	270	18	,	,	PUNCT
ihlr-27183	270	19	but	but	CCONJ
ihlr-27183	270	20	sandoz	sandoz	PROPN
ihlr-27183	270	21	is	be	AUX
ihlr-27183	270	22	in	in	ADP
ihlr-27183	270	23	the	the	DET
ihlr-27183	270	24	minority	minority	NOUN
ihlr-27183	270	25	on	on	ADP
ihlr-27183	270	26	this	this	DET
ihlr-27183	270	27	holding.90	holding.90	ADJ
ihlr-27183	270	28	proveris	proveris	NOUN
ihlr-27183	270	29	,	,	PUNCT
ihlr-27183	270	30	on	on	ADP
ihlr-27183	270	31	the	the	DET
ihlr-27183	270	32	other	other	ADJ
ihlr-27183	270	33	81	81	NUM
ihlr-27183	270	34	.	.	PUNCT
ihlr-27183	270	35	sandoz	sandoz	PROPN
ihlr-27183	270	36	,	,	PUNCT
ihlr-27183	270	37	2013	2013	NUM
ihlr-27183	270	38	wl	wl	NOUN
ihlr-27183	270	39	3732867	3732867	NUM
ihlr-27183	270	40	,	,	PUNCT
ihlr-27183	270	41	at	at	ADP
ihlr-27183	270	42	*	*	PROPN
ihlr-27183	270	43	8	8	NUM
ihlr-27183	270	44	.	.	PUNCT
ihlr-27183	270	45	82	82	NUM
ihlr-27183	270	46	.	.	PUNCT
ihlr-27183	271	1	i	i	PRON
ihlr-27183	271	2	d.	d.	VERB
ihlr-27183	271	3	at	at	ADP
ihlr-27183	271	4	*	*	PROPN
ihlr-27183	271	5	7	7	NUM
ihlr-27183	271	6	.	.	NOUN
ihlr-27183	271	7	83	83	NUM
ihlr-27183	271	8	.	.	PUNCT
ihlr-27183	272	1	i	i	PRON
ihlr-27183	272	2	d.	d.	VERB
ihlr-27183	272	3	at	at	ADP
ihlr-27183	272	4	*	*	PROPN
ihlr-27183	272	5	8	8	NUM
ihlr-27183	272	6	.	.	NOUN
ihlr-27183	272	7	84	84	NUM
ihlr-27183	272	8	.	.	PUNCT
ihlr-27183	273	1	i	i	PRON
ihlr-27183	273	2	d.	d.	PROPN
ihlr-27183	273	3	85	85	NUM
ihlr-27183	273	4	.	.	PUNCT
ihlr-27183	274	1	i	i	PRON
ihlr-27183	274	2	d.	d.	PROPN
ihlr-27183	274	3	86	86	NUM
ihlr-27183	274	4	.	.	PUNCT
ihlr-27183	275	1	i	i	PRON
ihlr-27183	275	2	d.	d.	PROPN
ihlr-27183	275	3	87	87	NUM
ihlr-27183	275	4	.	.	PUNCT
ihlr-27183	276	1	i	i	PRON
ihlr-27183	276	2	d.	d.	PROPN
ihlr-27183	276	3	88	88	NUM
ihlr-27183	276	4	.	.	PUNCT
ihlr-27183	277	1	i	i	PRON
ihlr-27183	277	2	d.	d.	PROPN
ihlr-27183	277	3	89	89	NUM
ihlr-27183	277	4	.	.	PUNCT
ihlr-27183	277	5	merck	merck	PROPN
ihlr-27183	277	6	kgaa	kgaa	PROPN
ihlr-27183	277	7	,	,	PUNCT
ihlr-27183	277	8	545	545	NUM
ihlr-27183	277	9	u.s	u.s	PROPN
ihlr-27183	277	10	.	.	PROPN
ihlr-27183	277	11	at	at	ADP
ihlr-27183	277	12	208	208	NUM
ihlr-27183	277	13	n.7	n.7	X
ihlr-27183	277	14	.	.	PUNCT
ihlr-27183	278	1	90	90	NUM
ihlr-27183	278	2	.	.	PUNCT
ihlr-27183	279	1	to	to	ADP
ihlr-27183	279	2	this	this	DET
ihlr-27183	279	3	author	author	NOUN
ihlr-27183	279	4	’s	’s	PART
ihlr-27183	279	5	knowledge	knowledge	NOUN
ihlr-27183	279	6	,	,	PUNCT
ihlr-27183	279	7	sandoz	sandoz	PROPN
ihlr-27183	279	8	is	be	AUX
ihlr-27183	279	9	the	the	DET
ihlr-27183	279	10	only	only	ADJ
ihlr-27183	279	11	district	district	NOUN
ihlr-27183	279	12	court	court	NOUN
ihlr-27183	279	13	which	which	PRON
ihlr-27183	279	14	has	have	AUX
ihlr-27183	279	15	explicitly	explicitly	ADV
ihlr-27183	279	16	included	include	VERB
ihlr-27183	279	17	in	in	ADP
ihlr-27183	279	18	the	the	DET
ihlr-27183	279	19	scope	scope	NOUN
ihlr-27183	279	20	of	of	ADP
ihlr-27183	279	21	“	"	PUNCT
ihlr-27183	279	22	patented	patented	ADJ
ihlr-27183	279	23	invention	invention	NOUN
ihlr-27183	279	24	”	"	PUNCT
ihlr-27183	279	25	drugs	drug	NOUN
ihlr-27183	279	26	not	not	PART
ihlr-27183	279	27	themselves	themselves	PRON
ihlr-27183	279	28	subject	subject	ADJ
ihlr-27183	279	29	to	to	ADP
ihlr-27183	279	30	fda	fda	PROPN
ihlr-27183	279	31	approval	approval	NOUN
ihlr-27183	279	32	–	–	PUNCT
ihlr-27183	279	33	many	many	ADJ
ihlr-27183	279	34	district	district	NOUN
ihlr-27183	279	35	courts	court	NOUN
ihlr-27183	279	36	have	have	AUX
ihlr-27183	279	37	remained	remain	VERB
ihlr-27183	279	38	silent	silent	ADJ
ihlr-27183	279	39	on	on	ADP
ihlr-27183	279	40	the	the	DET
ihlr-27183	279	41	issue	issue	NOUN
ihlr-27183	279	42	.	.	PUNCT
ihlr-27183	280	1	2023	2023	NUM
ihlr-27183	280	2	]	]	PUNCT
ihlr-27183	280	3	the	the	DET
ihlr-27183	280	4	safe	safe	ADJ
ihlr-27183	280	5	harbor	harbor	NOUN
ihlr-27183	280	6	of	of	ADP
ihlr-27183	280	7	35	35	NUM
ihlr-27183	280	8	u.s.c	u.s.c	ADJ
ihlr-27183	280	9	.	.	PUNCT
ihlr-27183	281	1	§	§	PROPN
ihlr-27183	281	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	281	3	)	)	PUNCT
ihlr-27183	281	4	155	155	NUM
ihlr-27183	281	5	hand	hand	NOUN
ihlr-27183	281	6	,	,	PUNCT
ihlr-27183	281	7	is	be	AUX
ihlr-27183	281	8	a	a	DET
ihlr-27183	281	9	federal	federal	ADJ
ihlr-27183	281	10	circuit	circuit	NOUN
ihlr-27183	281	11	decision	decision	NOUN
ihlr-27183	281	12	in	in	ADP
ihlr-27183	281	13	which	which	PRON
ihlr-27183	281	14	a	a	DET
ihlr-27183	281	15	research	research	NOUN
ihlr-27183	281	16	tool	tool	NOUN
ihlr-27183	281	17	was	be	AUX
ihlr-27183	281	18	excluded	exclude	VERB
ihlr-27183	281	19	from	from	ADP
ihlr-27183	281	20	the	the	DET
ihlr-27183	281	21	safe	safe	ADJ
ihlr-27183	281	22	harbor.91	harbor.91	NOUN
ihlr-27183	281	23	though	though	SCONJ
ihlr-27183	281	24	the	the	DET
ihlr-27183	281	25	supreme	supreme	PROPN
ihlr-27183	281	26	court	court	PROPN
ihlr-27183	281	27	has	have	AUX
ihlr-27183	281	28	used	use	VERB
ihlr-27183	281	29	broad	broad	ADJ
ihlr-27183	281	30	terms	term	NOUN
ihlr-27183	281	31	to	to	PART
ihlr-27183	281	32	define	define	VERB
ihlr-27183	281	33	the	the	DET
ihlr-27183	281	34	safe	safe	ADJ
ihlr-27183	281	35	harbor	harbor	NOUN
ihlr-27183	281	36	’s	’s	PART
ihlr-27183	281	37	“	"	PUNCT
ihlr-27183	281	38	patented	patented	ADJ
ihlr-27183	281	39	invention	invention	NOUN
ihlr-27183	281	40	”	"	PUNCT
ihlr-27183	281	41	and	and	CCONJ
ihlr-27183	281	42	expressly	expressly	ADV
ihlr-27183	281	43	avoided	avoid	VERB
ihlr-27183	281	44	answering	answer	VERB
ihlr-27183	281	45	the	the	DET
ihlr-27183	281	46	question	question	NOUN
ihlr-27183	281	47	of	of	ADP
ihlr-27183	281	48	whether	whether	SCONJ
ihlr-27183	281	49	a	a	DET
ihlr-27183	281	50	research	research	NOUN
ihlr-27183	281	51	tool	tool	NOUN
ihlr-27183	281	52	is	be	AUX
ihlr-27183	281	53	shielded	shield	VERB
ihlr-27183	281	54	under	under	ADP
ihlr-27183	281	55	§	§	PROPN
ihlr-27183	281	56	271(e)(1	271(e)(1	PROPN
ihlr-27183	281	57	)	)	PUNCT
ihlr-27183	281	58	,	,	PUNCT
ihlr-27183	281	59	at	at	ADP
ihlr-27183	281	60	least	least	ADV
ihlr-27183	281	61	two	two	NUM
ihlr-27183	281	62	district	district	NOUN
ihlr-27183	281	63	courts	court	NOUN
ihlr-27183	281	64	have	have	AUX
ihlr-27183	281	65	read	read	VERB
ihlr-27183	281	66	proveris	proveris	NOUN
ihlr-27183	281	67	to	to	PART
ihlr-27183	281	68	categorically	categorically	ADV
ihlr-27183	281	69	exclude	exclude	VERB
ihlr-27183	281	70	research	research	NOUN
ihlr-27183	281	71	tools	tool	NOUN
ihlr-27183	281	72	as	as	ADP
ihlr-27183	281	73	a	a	DET
ihlr-27183	281	74	“	"	PUNCT
ihlr-27183	281	75	patented	patented	ADJ
ihlr-27183	281	76	invention	invention	NOUN
ihlr-27183	281	77	”	"	PUNCT
ihlr-27183	281	78	under	under	ADP
ihlr-27183	281	79	§	§	PROPN
ihlr-27183	281	80	271(e)(1).92	271(e)(1).92	NUM
ihlr-27183	281	81	in	in	ADP
ihlr-27183	281	82	contrast	contrast	NOUN
ihlr-27183	281	83	,	,	PUNCT
ihlr-27183	281	84	the	the	DET
ihlr-27183	281	85	sandoz	sandoz	PROPN
ihlr-27183	281	86	decision	decision	NOUN
ihlr-27183	281	87	from	from	ADP
ihlr-27183	281	88	the	the	DET
ihlr-27183	281	89	southern	southern	ADJ
ihlr-27183	281	90	district	district	NOUN
ihlr-27183	281	91	of	of	ADP
ihlr-27183	281	92	new	new	PROPN
ihlr-27183	281	93	york	york	PROPN
ihlr-27183	281	94	above	above	ADP
ihlr-27183	281	95	dismissed	dismiss	VERB
ihlr-27183	281	96	multiple	multiple	ADJ
ihlr-27183	281	97	patent	patent	NOUN
ihlr-27183	281	98	infringement	infringement	NOUN
ihlr-27183	281	99	claims	claim	NOUN
ihlr-27183	281	100	arising	arise	VERB
ihlr-27183	281	101	from	from	ADP
ihlr-27183	281	102	the	the	DET
ihlr-27183	281	103	use	use	NOUN
ihlr-27183	281	104	of	of	ADP
ihlr-27183	281	105	patented	patent	VERB
ihlr-27183	281	106	polypeptide	polypeptide	ADJ
ihlr-27183	281	107	markers	marker	NOUN
ihlr-27183	281	108	to	to	PART
ihlr-27183	281	109	measure	measure	VERB
ihlr-27183	281	110	the	the	DET
ihlr-27183	281	111	molecular	molecular	ADJ
ihlr-27183	281	112	characteristics	characteristic	NOUN
ihlr-27183	281	113	of	of	ADP
ihlr-27183	281	114	a	a	DET
ihlr-27183	281	115	generic	generic	ADJ
ihlr-27183	281	116	drug	drug	NOUN
ihlr-27183	281	117	seeking	seek	VERB
ihlr-27183	281	118	fda	fda	PROPN
ihlr-27183	281	119	approval.93	approval.93	PROPN
ihlr-27183	281	120	characteristic	characteristic	ADJ
ihlr-27183	281	121	of	of	ADP
ihlr-27183	281	122	most	most	ADJ
ihlr-27183	281	123	research	research	NOUN
ihlr-27183	281	124	tools	tool	NOUN
ihlr-27183	281	125	,	,	PUNCT
ihlr-27183	281	126	the	the	DET
ihlr-27183	281	127	polypeptides	polypeptide	NOUN
ihlr-27183	281	128	were	be	AUX
ihlr-27183	281	129	themselves	themselves	PRON
ihlr-27183	281	130	not	not	PART
ihlr-27183	281	131	subject	subject	ADJ
ihlr-27183	281	132	to	to	ADP
ihlr-27183	281	133	fda	fda	PROPN
ihlr-27183	281	134	approval.94	approval.94	PROPN
ihlr-27183	281	135	interpreting	interpret	VERB
ihlr-27183	281	136	abtox	abtox	NOUN
ihlr-27183	281	137	,	,	PUNCT
ihlr-27183	281	138	the	the	DET
ihlr-27183	281	139	district	district	NOUN
ihlr-27183	281	140	court	court	NOUN
ihlr-27183	281	141	in	in	ADP
ihlr-27183	281	142	sandoz	sandoz	PROPN
ihlr-27183	281	143	firmly	firmly	ADV
ihlr-27183	281	144	asserted	assert	VERB
ihlr-27183	281	145	that	that	SCONJ
ihlr-27183	281	146	“	"	PUNCT
ihlr-27183	281	147	[	[	X
ihlr-27183	281	148	i]n	i]n	NOUN
ihlr-27183	281	149	construing	construe	VERB
ihlr-27183	281	150	that	that	SCONJ
ihlr-27183	281	151	all	all	DET
ihlr-27183	281	152	classes	class	NOUN
ihlr-27183	281	153	of	of	ADP
ihlr-27183	281	154	medical	medical	ADJ
ihlr-27183	281	155	devices	device	NOUN
ihlr-27183	281	156	fell	fall	VERB
ihlr-27183	281	157	within	within	ADP
ihlr-27183	281	158	the	the	DET
ihlr-27183	281	159	scope	scope	NOUN
ihlr-27183	281	160	of	of	ADP
ihlr-27183	281	161	the	the	DET
ihlr-27183	281	162	safe	safe	ADJ
ihlr-27183	281	163	harbor	harbor	NOUN
ihlr-27183	281	164	(	(	PUNCT
ihlr-27183	281	165	not	not	PART
ihlr-27183	281	166	just	just	ADV
ihlr-27183	281	167	those	those	PRON
ihlr-27183	281	168	subject	subject	ADJ
ihlr-27183	281	169	to	to	ADP
ihlr-27183	281	170	fda	fda	PROPN
ihlr-27183	281	171	approval	approval	PROPN
ihlr-27183	281	172	)	)	PUNCT
ihlr-27183	281	173	,	,	PUNCT
ihlr-27183	281	174	the	the	DET
ihlr-27183	281	175	federal	federal	ADJ
ihlr-27183	281	176	circuit	circuit	NOUN
ihlr-27183	281	177	relied	rely	VERB
ihlr-27183	281	178	upon	upon	SCONJ
ihlr-27183	281	179	the	the	DET
ihlr-27183	281	180	language	language	NOUN
ihlr-27183	281	181	of	of	ADP
ihlr-27183	281	182	the	the	DET
ihlr-27183	281	183	statute	statute	NOUN
ihlr-27183	281	184	and	and	CCONJ
ihlr-27183	281	185	the	the	DET
ihlr-27183	281	186	supreme	supreme	PROPN
ihlr-27183	281	187	court	court	PROPN
ihlr-27183	281	188	's	's	PART
ihlr-27183	281	189	broad	broad	ADJ
ihlr-27183	281	190	language	language	NOUN
ihlr-27183	281	191	in	in	ADP
ihlr-27183	281	192	eli	eli	PROPN
ihlr-27183	281	193	lilly	lilly	PROPN
ihlr-27183	281	194	.	.	PUNCT
ihlr-27183	282	1	”95	”95	NOUN
ihlr-27183	282	2	with	with	ADP
ihlr-27183	282	3	the	the	DET
ihlr-27183	282	4	supreme	supreme	PROPN
ihlr-27183	282	5	court	court	PROPN
ihlr-27183	282	6	holding	hold	VERB
ihlr-27183	282	7	a	a	DET
ihlr-27183	282	8	broad	broad	ADJ
ihlr-27183	282	9	view	view	NOUN
ihlr-27183	282	10	of	of	ADP
ihlr-27183	282	11	which	which	PRON
ihlr-27183	282	12	inventions	invention	NOUN
ihlr-27183	282	13	fall	fall	VERB
ihlr-27183	282	14	under	under	ADP
ihlr-27183	282	15	the	the	DET
ihlr-27183	282	16	safe	safe	ADJ
ihlr-27183	282	17	harbor	harbor	NOUN
ihlr-27183	282	18	,	,	PUNCT
ihlr-27183	282	19	the	the	DET
ihlr-27183	282	20	federal	federal	ADJ
ihlr-27183	282	21	circuit	circuit	NOUN
ihlr-27183	282	22	now	now	ADV
ihlr-27183	282	23	construing	construe	VERB
ihlr-27183	282	24	that	that	DET
ihlr-27183	282	25	precedent	precedent	NOUN
ihlr-27183	282	26	narrowly	narrowly	ADV
ihlr-27183	282	27	,	,	PUNCT
ihlr-27183	282	28	and	and	CCONJ
ihlr-27183	282	29	district	district	NOUN
ihlr-27183	282	30	courts	court	NOUN
ihlr-27183	282	31	landing	land	VERB
ihlr-27183	282	32	on	on	ADP
ihlr-27183	282	33	both	both	DET
ihlr-27183	282	34	sides	side	NOUN
ihlr-27183	282	35	and	and	CCONJ
ihlr-27183	282	36	in	in	AUX
ihlr-27183	282	37	-	-	PUNCT
ihlr-27183	282	38	between	between	NOUN
ihlr-27183	282	39	,	,	PUNCT
ihlr-27183	282	40	some	some	DET
ihlr-27183	282	41	enterprising	enterprise	VERB
ihlr-27183	282	42	innovators	innovator	NOUN
ihlr-27183	282	43	have	have	AUX
ihlr-27183	282	44	been	be	AUX
ihlr-27183	282	45	willing	willing	ADJ
ihlr-27183	282	46	to	to	PART
ihlr-27183	282	47	risk	risk	VERB
ihlr-27183	282	48	litigation	litigation	NOUN
ihlr-27183	282	49	rather	rather	ADV
ihlr-27183	282	50	than	than	ADP
ihlr-27183	282	51	seek	seek	VERB
ihlr-27183	282	52	licensing	licensing	NOUN
ihlr-27183	282	53	on	on	ADP
ihlr-27183	282	54	crucially	crucially	ADV
ihlr-27183	282	55	important	important	ADJ
ihlr-27183	282	56	technologies	technology	NOUN
ihlr-27183	282	57	.	.	PUNCT
ihlr-27183	283	1	iii	iii	X
ihlr-27183	283	2	.	.	PUNCT
ihlr-27183	283	3	use	use	NOUN
ihlr-27183	283	4	now	now	ADV
ihlr-27183	283	5	,	,	PUNCT
ihlr-27183	283	6	litigate	litigate	VERB
ihlr-27183	283	7	later	later	ADV
ihlr-27183	283	8	a.	a.	NOUN
ihlr-27183	283	9	two	two	NUM
ihlr-27183	283	10	controversies	controversy	NOUN
ihlr-27183	283	11	two	two	NUM
ihlr-27183	283	12	patent	patent	NOUN
ihlr-27183	283	13	infringement	infringement	NOUN
ihlr-27183	283	14	lawsuits	lawsuit	NOUN
ihlr-27183	283	15	,	,	PUNCT
ihlr-27183	283	16	one	one	NUM
ihlr-27183	283	17	still	still	ADV
ihlr-27183	283	18	pending	pende	VERB
ihlr-27183	283	19	,	,	PUNCT
ihlr-27183	283	20	highlight	highlight	VERB
ihlr-27183	283	21	the	the	DET
ihlr-27183	283	22	uncertainty	uncertainty	NOUN
ihlr-27183	283	23	around	around	ADP
ihlr-27183	283	24	research	research	NOUN
ihlr-27183	283	25	tools	tool	NOUN
ihlr-27183	283	26	under	under	ADP
ihlr-27183	283	27	the	the	DET
ihlr-27183	283	28	safe	safe	ADJ
ihlr-27183	283	29	harbor	harbor	NOUN
ihlr-27183	283	30	.	.	PUNCT
ihlr-27183	284	1	allele	allele	PROPN
ihlr-27183	284	2	biotechnology	biotechnology	PROPN
ihlr-27183	284	3	&	&	CCONJ
ihlr-27183	284	4	pharmaceuticals	pharmaceuticals	PROPN
ihlr-27183	284	5	inc	inc	PROPN
ihlr-27183	284	6	.	.	PROPN
ihlr-27183	284	7	filed	file	VERB
ihlr-27183	284	8	suit	suit	NOUN
ihlr-27183	284	9	against	against	ADP
ihlr-27183	284	10	two	two	NUM
ihlr-27183	284	11	defendants	defendant	NOUN
ihlr-27183	284	12	in	in	ADP
ihlr-27183	284	13	two	two	NUM
ihlr-27183	284	14	different	different	ADJ
ihlr-27183	284	15	federal	federal	ADJ
ihlr-27183	284	16	district	district	NOUN
ihlr-27183	284	17	courts	court	NOUN
ihlr-27183	284	18	on	on	ADP
ihlr-27183	284	19	the	the	DET
ihlr-27183	284	20	same	same	ADJ
ihlr-27183	284	21	day.96	day.96	NOUN
ihlr-27183	284	22	allele	allele	NOUN
ihlr-27183	284	23	filed	file	VERB
ihlr-27183	284	24	against	against	ADP
ihlr-27183	284	25	regeneron	regeneron	NOUN
ihlr-27183	284	26	in	in	ADP
ihlr-27183	284	27	the	the	DET
ihlr-27183	284	28	united	united	PROPN
ihlr-27183	284	29	states	states	PROPN
ihlr-27183	284	30	district	district	PROPN
ihlr-27183	284	31	court	court	NOUN
ihlr-27183	284	32	for	for	ADP
ihlr-27183	284	33	the	the	DET
ihlr-27183	284	34	southern	southern	ADJ
ihlr-27183	284	35	district	district	NOUN
ihlr-27183	284	36	of	of	ADP
ihlr-27183	284	37	new	new	PROPN
ihlr-27183	284	38	york	york	PROPN
ihlr-27183	284	39	on	on	ADP
ihlr-27183	284	40	october	october	PROPN
ihlr-27183	284	41	5	5	NUM
ihlr-27183	284	42	,	,	PUNCT
ihlr-27183	284	43	2020,97	2020,97	NUM
ihlr-27183	284	44	and	and	CCONJ
ihlr-27183	284	45	against	against	ADP
ihlr-27183	284	46	pfizer	pfizer	NOUN
ihlr-27183	284	47	in	in	ADP
ihlr-27183	284	48	the	the	DET
ihlr-27183	284	49	united	united	PROPN
ihlr-27183	284	50	states	states	PROPN
ihlr-27183	284	51	district	district	PROPN
ihlr-27183	284	52	court	court	NOUN
ihlr-27183	284	53	for	for	ADP
ihlr-27183	284	54	the	the	DET
ihlr-27183	284	55	southern	southern	ADJ
ihlr-27183	284	56	district	district	NOUN
ihlr-27183	284	57	of	of	ADP
ihlr-27183	284	58	california.98	california.98	PROPN
ihlr-27183	284	59	the	the	DET
ihlr-27183	284	60	lawsuits	lawsuit	NOUN
ihlr-27183	284	61	both	both	PRON
ihlr-27183	284	62	allege	allege	VERB
ihlr-27183	284	63	infringement	infringement	NOUN
ihlr-27183	284	64	of	of	ADP
ihlr-27183	284	65	the	the	DET
ihlr-27183	284	66	same	same	ADJ
ihlr-27183	284	67	patented	patent	VERB
ihlr-27183	284	68	91	91	NUM
ihlr-27183	284	69	.	.	PUNCT
ihlr-27183	285	1	proveris	proveris	PROPN
ihlr-27183	285	2	sci	sci	PROPN
ihlr-27183	285	3	.	.	PROPN
ihlr-27183	285	4	corp	corp	PROPN
ihlr-27183	285	5	.	.	PROPN
ihlr-27183	285	6	,	,	PUNCT
ihlr-27183	285	7	536	536	NUM
ihlr-27183	285	8	f.3d	f.3d	NUM
ihlr-27183	285	9	at	at	ADP
ihlr-27183	285	10	*	*	PROPN
ihlr-27183	285	11	1261	1261	NUM
ihlr-27183	285	12	.	.	PUNCT
ihlr-27183	286	1	92	92	NUM
ihlr-27183	286	2	.	.	PUNCT
ihlr-27183	287	1	allele	allele	PROPN
ihlr-27183	287	2	biotechnology	biotechnology	PROPN
ihlr-27183	287	3	&	&	CCONJ
ihlr-27183	287	4	pharm	pharm	PROPN
ihlr-27183	287	5	.	.	PROPN
ihlr-27183	287	6	,	,	PUNCT
ihlr-27183	287	7	inc	inc	PROPN
ihlr-27183	287	8	.	.	PROPN
ihlr-27183	287	9	v.	v.	ADP
ihlr-27183	287	10	pfizer	pfizer	PROPN
ihlr-27183	287	11	,	,	PUNCT
ihlr-27183	287	12	inc	inc	PROPN
ihlr-27183	287	13	.	.	PROPN
ihlr-27183	287	14	,	,	PUNCT
ihlr-27183	287	15	no	no	INTJ
ihlr-27183	287	16	.	.	NOUN
ihlr-27183	287	17	20	20	NUM
ihlr-27183	287	18	-	-	PUNCT
ihlr-27183	287	19	cv-01958	cv-01958	NOUN
ihlr-27183	287	20	-	-	PUNCT
ihlr-27183	287	21	h	h	NOUN
ihlr-27183	287	22	,	,	PUNCT
ihlr-27183	287	23	2021	2021	NUM
ihlr-27183	287	24	u.s	u.s	PROPN
ihlr-27183	287	25	.	.	PROPN
ihlr-27183	287	26	dist	dist	PROPN
ihlr-27183	287	27	.	.	PUNCT
ihlr-27183	288	1	lexis	lexis	NOUN
ihlr-27183	288	2	85347	85347	NUM
ihlr-27183	288	3	,	,	PUNCT
ihlr-27183	288	4	at	at	ADP
ihlr-27183	288	5	*	*	NOUN
ihlr-27183	288	6	12	12	NUM
ihlr-27183	288	7	(	(	PUNCT
ihlr-27183	288	8	s.d	s.d	PROPN
ihlr-27183	288	9	.	.	PROPN
ihlr-27183	288	10	cal	cal	PROPN
ihlr-27183	288	11	.	.	PUNCT
ihlr-27183	289	1	may	may	AUX
ihlr-27183	289	2	4	4	NUM
ihlr-27183	289	3	,	,	PUNCT
ihlr-27183	289	4	2021	2021	NUM
ihlr-27183	289	5	)	)	PUNCT
ihlr-27183	289	6	.	.	PUNCT
ihlr-27183	290	1	93	93	NUM
ihlr-27183	290	2	.	.	PUNCT
ihlr-27183	291	1	teva	teva	PROPN
ihlr-27183	291	2	pharma	pharma	PROPN
ihlr-27183	291	3	.	.	PROPN
ihlr-27183	292	1	usa	usa	PROPN
ihlr-27183	292	2	,	,	PUNCT
ihlr-27183	292	3	inc	inc	PROPN
ihlr-27183	292	4	.	.	PROPN
ihlr-27183	293	1	v.	v.	PROPN
ihlr-27183	293	2	sandoz	sandoz	PROPN
ihlr-27183	293	3	inc	inc	PROPN
ihlr-27183	293	4	.	.	PROPN
ihlr-27183	293	5	,	,	PUNCT
ihlr-27183	293	6	2013	2013	NUM
ihlr-27183	293	7	wl	wl	NOUN
ihlr-27183	293	8	3732867	3732867	NUM
ihlr-27183	293	9	,	,	PUNCT
ihlr-27183	293	10	*	*	PROPN
ihlr-27183	293	11	2	2	NUM
ihlr-27183	293	12	(	(	PUNCT
ihlr-27183	293	13	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	293	14	.	.	PROPN
ihlr-27183	293	15	2013	2013	NUM
ihlr-27183	293	16	)	)	PUNCT
ihlr-27183	293	17	.	.	PUNCT
ihlr-27183	294	1	94	94	NUM
ihlr-27183	294	2	.	.	PUNCT
ihlr-27183	295	1	i	i	PRON
ihlr-27183	295	2	d.	d.	PROPN
ihlr-27183	295	3	95	95	NUM
ihlr-27183	295	4	.	.	PUNCT
ihlr-27183	296	1	i	i	PRON
ihlr-27183	296	2	d.	d.	VERB
ihlr-27183	296	3	at	at	ADP
ihlr-27183	296	4	*	*	PROPN
ihlr-27183	296	5	7	7	NUM
ihlr-27183	296	6	.	.	NOUN
ihlr-27183	296	7	96	96	NUM
ihlr-27183	296	8	.	.	PUNCT
ihlr-27183	297	1	regeneron	regeneron	PROPN
ihlr-27183	297	2	has	have	VERB
ihlr-27183	297	3	its	its	PRON
ihlr-27183	297	4	principal	principal	ADJ
ihlr-27183	297	5	place	place	NOUN
ihlr-27183	297	6	of	of	ADP
ihlr-27183	297	7	business	business	NOUN
ihlr-27183	297	8	,	,	PUNCT
ihlr-27183	297	9	maintains	maintain	VERB
ihlr-27183	297	10	its	its	PRON
ihlr-27183	297	11	registered	register	VERB
ihlr-27183	297	12	office	office	NOUN
ihlr-27183	297	13	,	,	PUNCT
ihlr-27183	297	14	and	and	CCONJ
ihlr-27183	297	15	is	be	AUX
ihlr-27183	297	16	incorporated	incorporate	VERB
ihlr-27183	297	17	in	in	ADP
ihlr-27183	297	18	the	the	DET
ihlr-27183	297	19	state	state	NOUN
ihlr-27183	297	20	of	of	ADP
ihlr-27183	297	21	new	new	PROPN
ihlr-27183	297	22	york	york	PROPN
ihlr-27183	297	23	.	.	PUNCT
ihlr-27183	298	1	complaint	complaint	PROPN
ihlr-27183	298	2	,	,	PUNCT
ihlr-27183	298	3	allele	allele	PROPN
ihlr-27183	298	4	biotechnology	biotechnology	PROPN
ihlr-27183	298	5	&	&	CCONJ
ihlr-27183	298	6	pharm	pharm	PROPN
ihlr-27183	298	7	.	.	PROPN
ihlr-27183	298	8	,	,	PUNCT
ihlr-27183	298	9	inc	inc	PROPN
ihlr-27183	298	10	.	.	PROPN
ihlr-27183	299	1	v.	v.	PROPN
ihlr-27183	299	2	regeneron	regeneron	PROPN
ihlr-27183	299	3	pharm	pharm	PROPN
ihlr-27183	299	4	.	.	PUNCT
ihlr-27183	299	5	,	,	PUNCT
ihlr-27183	299	6	inc	inc	PROPN
ihlr-27183	299	7	.	.	PROPN
ihlr-27183	299	8	,	,	PUNCT
ihlr-27183	299	9	no	no	INTJ
ihlr-27183	299	10	.	.	NOUN
ihlr-27183	299	11	20	20	NUM
ihlr-27183	299	12	-	-	PUNCT
ihlr-27183	299	13	cv-08255	cv-08255	NOUN
ihlr-27183	299	14	,	,	PUNCT
ihlr-27183	299	15	2021	2021	NUM
ihlr-27183	299	16	wl	wl	NOUN
ihlr-27183	299	17	2880694	2880694	NUM
ihlr-27183	299	18	,	,	PUNCT
ihlr-27183	299	19	at	at	ADP
ihlr-27183	299	20	*	*	NOUN
ihlr-27183	299	21	1	1	NUM
ihlr-27183	299	22	(	(	PUNCT
ihlr-27183	299	23	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	299	24	.	.	PUNCT
ihlr-27183	299	25	apr	apr	PROPN
ihlr-27183	299	26	.	.	PROPN
ihlr-27183	299	27	8	8	NUM
ihlr-27183	299	28	,	,	PUNCT
ihlr-27183	299	29	2021	2021	NUM
ihlr-27183	299	30	)	)	PUNCT
ihlr-27183	299	31	.	.	PUNCT
ihlr-27183	300	1	thus	thus	ADV
ihlr-27183	300	2	,	,	PUNCT
ihlr-27183	300	3	venue	venue	NOUN
ihlr-27183	300	4	was	be	AUX
ihlr-27183	300	5	proper	proper	ADJ
ihlr-27183	300	6	and	and	CCONJ
ihlr-27183	300	7	easy	easy	ADJ
ihlr-27183	300	8	to	to	PART
ihlr-27183	300	9	attain	attain	VERB
ihlr-27183	300	10	in	in	ADP
ihlr-27183	300	11	the	the	DET
ihlr-27183	300	12	southern	southern	ADJ
ihlr-27183	300	13	district	district	NOUN
ihlr-27183	300	14	of	of	ADP
ihlr-27183	300	15	new	new	PROPN
ihlr-27183	300	16	york	york	PROPN
ihlr-27183	300	17	.	.	PUNCT
ihlr-27183	301	1	97	97	NUM
ihlr-27183	301	2	.	.	PUNCT
ihlr-27183	302	1	complaint	complaint	NOUN
ihlr-27183	302	2	,	,	PUNCT
ihlr-27183	302	3	allele	allele	PROPN
ihlr-27183	302	4	biotechnology	biotechnology	PROPN
ihlr-27183	302	5	&	&	CCONJ
ihlr-27183	302	6	pharm	pharm	PROPN
ihlr-27183	302	7	.	.	PROPN
ihlr-27183	302	8	,	,	PUNCT
ihlr-27183	302	9	inc	inc	PROPN
ihlr-27183	302	10	.	.	PROPN
ihlr-27183	303	1	v.	v.	PROPN
ihlr-27183	303	2	regeneron	regeneron	PROPN
ihlr-27183	303	3	pharm	pharm	PROPN
ihlr-27183	303	4	.	.	PUNCT
ihlr-27183	303	5	,	,	PUNCT
ihlr-27183	303	6	inc	inc	PROPN
ihlr-27183	303	7	.	.	PROPN
ihlr-27183	303	8	,	,	PUNCT
ihlr-27183	303	9	no	no	INTJ
ihlr-27183	303	10	.	.	NOUN
ihlr-27183	303	11	20	20	NUM
ihlr-27183	303	12	-	-	PUNCT
ihlr-27183	303	13	cv08255	cv08255	VERB
ihlr-27183	303	14	,	,	PUNCT
ihlr-27183	303	15	2021	2021	NUM
ihlr-27183	303	16	wl	wl	NOUN
ihlr-27183	303	17	2880694	2880694	NUM
ihlr-27183	303	18	,	,	PUNCT
ihlr-27183	303	19	at	at	ADP
ihlr-27183	303	20	*	*	NOUN
ihlr-27183	303	21	1	1	NUM
ihlr-27183	303	22	(	(	PUNCT
ihlr-27183	303	23	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	303	24	.	.	PUNCT
ihlr-27183	303	25	apr	apr	PROPN
ihlr-27183	303	26	.	.	PROPN
ihlr-27183	303	27	8	8	NUM
ihlr-27183	303	28	,	,	PUNCT
ihlr-27183	303	29	2021	2021	NUM
ihlr-27183	303	30	)	)	PUNCT
ihlr-27183	303	31	.	.	PUNCT
ihlr-27183	304	1	98	98	NUM
ihlr-27183	304	2	.	.	PUNCT
ihlr-27183	304	3	allele	allele	PROPN
ihlr-27183	304	4	biotechnology	biotechnology	PROPN
ihlr-27183	304	5	&	&	CCONJ
ihlr-27183	304	6	pharm	pharm	PROPN
ihlr-27183	304	7	.	.	PROPN
ihlr-27183	304	8	,	,	PUNCT
ihlr-27183	304	9	inc	inc	PROPN
ihlr-27183	304	10	.	.	PROPN
ihlr-27183	304	11	v.	v.	ADP
ihlr-27183	304	12	pfizer	pfizer	PROPN
ihlr-27183	304	13	,	,	PUNCT
ihlr-27183	304	14	inc	inc	PROPN
ihlr-27183	304	15	.	.	PROPN
ihlr-27183	304	16	,	,	PUNCT
ihlr-27183	304	17	no	no	INTJ
ihlr-27183	304	18	.	.	NOUN
ihlr-27183	304	19	20	20	NUM
ihlr-27183	304	20	-	-	PUNCT
ihlr-27183	304	21	cv-01958	cv-01958	NOUN
ihlr-27183	304	22	-	-	PUNCT
ihlr-27183	304	23	h	h	NOUN
ihlr-27183	304	24	,	,	PUNCT
ihlr-27183	304	25	2021	2021	NUM
ihlr-27183	304	26	u.s	u.s	PROPN
ihlr-27183	304	27	.	.	PROPN
ihlr-27183	304	28	dist	dist	PROPN
ihlr-27183	304	29	.	.	PUNCT
ihlr-27183	305	1	lexis	lexis	NOUN
ihlr-27183	305	2	85347	85347	NUM
ihlr-27183	305	3	,	,	PUNCT
ihlr-27183	305	4	at	at	ADP
ihlr-27183	305	5	*	*	NOUN
ihlr-27183	305	6	1	1	NUM
ihlr-27183	305	7	(	(	PUNCT
ihlr-27183	305	8	s.d	s.d	PROPN
ihlr-27183	305	9	.	.	PROPN
ihlr-27183	305	10	cal	cal	PROPN
ihlr-27183	305	11	.	.	PUNCT
ihlr-27183	306	1	may	may	AUX
ihlr-27183	306	2	4	4	NUM
ihlr-27183	306	3	,	,	PUNCT
ihlr-27183	306	4	2021	2021	NUM
ihlr-27183	306	5	)	)	PUNCT
ihlr-27183	306	6	.	.	PUNCT
ihlr-27183	307	1	156	156	NUM
ihlr-27183	307	2	indiana	indiana	PROPN
ihlr-27183	307	3	health	health	PROPN
ihlr-27183	307	4	law	law	PROPN
ihlr-27183	307	5	review	review	NOUN
ihlr-27183	307	6	[	[	X
ihlr-27183	307	7	vol	vol	NOUN
ihlr-27183	307	8	.	.	PUNCT
ihlr-27183	307	9	20:143	20:143	PROPN
ihlr-27183	307	10	technology	technology	PROPN
ihlr-27183	307	11	expressly	expressly	ADV
ihlr-27183	307	12	identified	identify	VERB
ihlr-27183	307	13	as	as	ADP
ihlr-27183	307	14	a	a	DET
ihlr-27183	307	15	research	research	NOUN
ihlr-27183	307	16	tool	tool	NOUN
ihlr-27183	307	17	.	.	PUNCT
ihlr-27183	308	1	further	far	ADV
ihlr-27183	308	2	,	,	PUNCT
ihlr-27183	308	3	the	the	DET
ihlr-27183	308	4	alleged	allege	VERB
ihlr-27183	308	5	activity	activity	NOUN
ihlr-27183	308	6	of	of	ADP
ihlr-27183	308	7	the	the	DET
ihlr-27183	308	8	defendants	defendant	NOUN
ihlr-27183	308	9	did	do	AUX
ihlr-27183	308	10	not	not	PART
ihlr-27183	308	11	materially	materially	ADV
ihlr-27183	308	12	differ	differ	VERB
ihlr-27183	308	13	.	.	PUNCT
ihlr-27183	309	1	both	both	DET
ihlr-27183	309	2	defendants	defendant	NOUN
ihlr-27183	309	3	,	,	PUNCT
ihlr-27183	309	4	among	among	ADP
ihlr-27183	309	5	other	other	ADJ
ihlr-27183	309	6	alleged	alleged	ADJ
ihlr-27183	309	7	activity	activity	NOUN
ihlr-27183	309	8	,	,	PUNCT
ihlr-27183	309	9	used	use	VERB
ihlr-27183	309	10	mneongreen	mneongreen	NOUN
ihlr-27183	309	11	in	in	ADP
ihlr-27183	309	12	neutralization	neutralization	NOUN
ihlr-27183	309	13	assays	assay	NOUN
ihlr-27183	309	14	which	which	PRON
ihlr-27183	309	15	inserted	insert	VERB
ihlr-27183	309	16	a	a	DET
ihlr-27183	309	17	gene	gene	NOUN
ihlr-27183	309	18	chimera	chimera	NOUN
ihlr-27183	309	19	from	from	ADP
ihlr-27183	309	20	allele	allele	PROPN
ihlr-27183	309	21	’s	’s	PART
ihlr-27183	309	22	fluorescent	fluorescent	ADJ
ihlr-27183	309	23	protein	protein	NOUN
ihlr-27183	309	24	into	into	ADP
ihlr-27183	309	25	the	the	DET
ihlr-27183	309	26	sars	sar	NOUN
ihlr-27183	309	27	-	-	PUNCT
ihlr-27183	309	28	cov2	cov2	PROPN
ihlr-27183	309	29	-	-	PUNCT
ihlr-27183	309	30	19	19	NUM
ihlr-27183	309	31	viral	viral	ADJ
ihlr-27183	309	32	genome	genome	NOUN
ihlr-27183	309	33	for	for	ADP
ihlr-27183	309	34	purposes	purpose	NOUN
ihlr-27183	309	35	of	of	ADP
ihlr-27183	309	36	tracking	track	VERB
ihlr-27183	309	37	its	its	PRON
ihlr-27183	309	38	proliferation	proliferation	NOUN
ihlr-27183	309	39	and	and	CCONJ
ihlr-27183	309	40	related	relate	VERB
ihlr-27183	309	41	behavior.99	behavior.99	NOUN
ihlr-27183	309	42	the	the	DET
ihlr-27183	309	43	choice	choice	NOUN
ihlr-27183	309	44	to	to	PART
ihlr-27183	309	45	file	file	VERB
ihlr-27183	309	46	in	in	ADP
ihlr-27183	309	47	two	two	NUM
ihlr-27183	309	48	different	different	ADJ
ihlr-27183	309	49	jurisdictions	jurisdiction	NOUN
ihlr-27183	309	50	,	,	PUNCT
ihlr-27183	309	51	though	though	SCONJ
ihlr-27183	309	52	perhaps	perhaps	ADV
ihlr-27183	309	53	essential	essential	ADJ
ihlr-27183	309	54	to	to	PART
ihlr-27183	309	55	easily	easily	ADV
ihlr-27183	309	56	ensure	ensure	VERB
ihlr-27183	309	57	proper	proper	ADJ
ihlr-27183	309	58	venue	venue	NOUN
ihlr-27183	309	59	,	,	PUNCT
ihlr-27183	309	60	may	may	AUX
ihlr-27183	309	61	prove	prove	VERB
ihlr-27183	309	62	to	to	PART
ihlr-27183	309	63	highlight	highlight	VERB
ihlr-27183	309	64	a	a	DET
ihlr-27183	309	65	particular	particular	ADJ
ihlr-27183	309	66	uncertainty	uncertainty	NOUN
ihlr-27183	309	67	in	in	ADP
ihlr-27183	309	68	the	the	DET
ihlr-27183	309	69	law	law	NOUN
ihlr-27183	309	70	on	on	ADP
ihlr-27183	309	71	an	an	DET
ihlr-27183	309	72	integral	integral	ADJ
ihlr-27183	309	73	issue	issue	NOUN
ihlr-27183	309	74	.	.	PUNCT
ihlr-27183	310	1	four	four	NUM
ihlr-27183	310	2	subjects	subject	NOUN
ihlr-27183	310	3	will	will	AUX
ihlr-27183	310	4	be	be	AUX
ihlr-27183	310	5	considered	consider	VERB
ihlr-27183	310	6	briefly	briefly	ADV
ihlr-27183	310	7	.	.	PUNCT
ihlr-27183	311	1	first	first	ADV
ihlr-27183	311	2	,	,	PUNCT
ihlr-27183	311	3	the	the	DET
ihlr-27183	311	4	prospect	prospect	NOUN
ihlr-27183	311	5	of	of	ADP
ihlr-27183	311	6	the	the	DET
ihlr-27183	311	7	remaining	remain	VERB
ihlr-27183	311	8	case	case	NOUN
ihlr-27183	311	9	going	go	VERB
ihlr-27183	311	10	to	to	ADP
ihlr-27183	311	11	trial	trial	NOUN
ihlr-27183	311	12	,	,	PUNCT
ihlr-27183	311	13	and	and	CCONJ
ihlr-27183	311	14	its	its	PRON
ihlr-27183	311	15	suitability	suitability	NOUN
ihlr-27183	311	16	for	for	ADP
ihlr-27183	311	17	appeal	appeal	NOUN
ihlr-27183	311	18	and	and	CCONJ
ihlr-27183	311	19	clarification	clarification	NOUN
ihlr-27183	311	20	of	of	ADP
ihlr-27183	311	21	an	an	DET
ihlr-27183	311	22	unresolved	unresolved	ADJ
ihlr-27183	311	23	issue	issue	NOUN
ihlr-27183	311	24	of	of	ADP
ihlr-27183	311	25	the	the	DET
ihlr-27183	311	26	safe	safe	ADJ
ihlr-27183	311	27	harbor	harbor	NOUN
ihlr-27183	311	28	’s	’s	PART
ihlr-27183	311	29	interpretation	interpretation	NOUN
ihlr-27183	311	30	will	will	AUX
ihlr-27183	311	31	be	be	AUX
ihlr-27183	311	32	addressed	address	VERB
ihlr-27183	311	33	in	in	ADP
ihlr-27183	311	34	this	this	DET
ihlr-27183	311	35	section	section	NOUN
ihlr-27183	311	36	.	.	PUNCT
ihlr-27183	312	1	second	second	ADJ
ihlr-27183	312	2	,	,	PUNCT
ihlr-27183	312	3	this	this	DET
ihlr-27183	312	4	section	section	NOUN
ihlr-27183	312	5	will	will	AUX
ihlr-27183	312	6	consider	consider	VERB
ihlr-27183	312	7	whether	whether	SCONJ
ihlr-27183	312	8	the	the	DET
ihlr-27183	312	9	relevant	relevant	ADJ
ihlr-27183	312	10	analysis	analysis	NOUN
ihlr-27183	312	11	offered	offer	VERB
ihlr-27183	312	12	by	by	ADP
ihlr-27183	312	13	the	the	DET
ihlr-27183	312	14	court	court	NOUN
ihlr-27183	312	15	so	so	ADV
ihlr-27183	312	16	far	far	ADV
ihlr-27183	312	17	is	be	AUX
ihlr-27183	312	18	legally	legally	ADV
ihlr-27183	312	19	satisfying	satisfying	ADJ
ihlr-27183	312	20	.	.	PUNCT
ihlr-27183	313	1	third	third	ADV
ihlr-27183	313	2	,	,	PUNCT
ihlr-27183	313	3	this	this	DET
ihlr-27183	313	4	section	section	NOUN
ihlr-27183	313	5	will	will	AUX
ihlr-27183	313	6	provide	provide	VERB
ihlr-27183	313	7	a	a	DET
ihlr-27183	313	8	brief	brief	ADJ
ihlr-27183	313	9	consideration	consideration	NOUN
ihlr-27183	313	10	of	of	ADP
ihlr-27183	313	11	the	the	DET
ihlr-27183	313	12	possible	possible	ADJ
ihlr-27183	313	13	outcomes	outcome	NOUN
ihlr-27183	313	14	.	.	PUNCT
ihlr-27183	314	1	lastly	lastly	ADV
ihlr-27183	314	2	,	,	PUNCT
ihlr-27183	314	3	a	a	DET
ihlr-27183	314	4	bright	bright	ADJ
ihlr-27183	314	5	-	-	PUNCT
ihlr-27183	314	6	line	line	NOUN
ihlr-27183	314	7	rule	rule	NOUN
ihlr-27183	314	8	will	will	AUX
ihlr-27183	314	9	be	be	AUX
ihlr-27183	314	10	proposed	propose	VERB
ihlr-27183	314	11	which	which	PRON
ihlr-27183	314	12	aims	aim	VERB
ihlr-27183	314	13	to	to	PART
ihlr-27183	314	14	resolve	resolve	VERB
ihlr-27183	314	15	statutory	statutory	ADJ
ihlr-27183	314	16	ambiguity	ambiguity	NOUN
ihlr-27183	314	17	.	.	PUNCT
ihlr-27183	315	1	1	1	X
ihlr-27183	315	2	.	.	X
ihlr-27183	315	3	patent	patent	NOUN
ihlr-27183	315	4	at	at	ADP
ihlr-27183	315	5	issue	issue	NOUN
ihlr-27183	315	6	prior	prior	ADV
ihlr-27183	315	7	to	to	ADP
ihlr-27183	315	8	the	the	DET
ihlr-27183	315	9	spread	spread	NOUN
ihlr-27183	315	10	and	and	CCONJ
ihlr-27183	315	11	discovery	discovery	NOUN
ihlr-27183	315	12	of	of	ADP
ihlr-27183	315	13	sars	sars	PROPN
ihlr-27183	315	14	-	-	PUNCT
ihlr-27183	315	15	cov2	cov2	PROPN
ihlr-27183	315	16	-	-	PUNCT
ihlr-27183	315	17	19	19	NUM
ihlr-27183	315	18	,	,	PUNCT
ihlr-27183	315	19	allele	allele	NOUN
ihlr-27183	315	20	had	have	AUX
ihlr-27183	315	21	developed	develop	VERB
ihlr-27183	315	22	and	and	CCONJ
ihlr-27183	315	23	patented	patented	ADJ
ihlr-27183	315	24	mneongreen	mneongreen	NOUN
ihlr-27183	315	25	–	–	PUNCT
ihlr-27183	315	26	a	a	DET
ihlr-27183	315	27	monomeric	monomeric	ADJ
ihlr-27183	315	28	fluorescent	fluorescent	NOUN
ihlr-27183	315	29	protein	protein	NOUN
ihlr-27183	315	30	–	–	PUNCT
ihlr-27183	315	31	as	as	SCONJ
ihlr-27183	315	32	united	united	PROPN
ihlr-27183	315	33	states	states	PROPN
ihlr-27183	315	34	patent	patent	NOUN
ihlr-27183	315	35	no	no	INTJ
ihlr-27183	315	36	.	.	PUNCT
ihlr-27183	316	1	10,221,221.100	10,221,221.100	NOUN
ihlr-27183	316	2	such	such	DET
ihlr-27183	316	3	a	a	DET
ihlr-27183	316	4	protein	protein	NOUN
ihlr-27183	316	5	is	be	AUX
ihlr-27183	316	6	useful	useful	ADJ
ihlr-27183	316	7	as	as	ADP
ihlr-27183	316	8	a	a	DET
ihlr-27183	316	9	biomarker	biomarker	NOUN
ihlr-27183	316	10	to	to	PART
ihlr-27183	316	11	track	track	VERB
ihlr-27183	316	12	or	or	CCONJ
ihlr-27183	316	13	identify	identify	VERB
ihlr-27183	316	14	certain	certain	ADJ
ihlr-27183	316	15	molecules	molecule	NOUN
ihlr-27183	316	16	and	and	CCONJ
ihlr-27183	316	17	,	,	PUNCT
ihlr-27183	316	18	among	among	ADP
ihlr-27183	316	19	other	other	ADJ
ihlr-27183	316	20	applications	application	NOUN
ihlr-27183	316	21	,	,	PUNCT
ihlr-27183	316	22	gives	give	VERB
ihlr-27183	316	23	researchers	researcher	NOUN
ihlr-27183	316	24	a	a	DET
ihlr-27183	316	25	window	window	NOUN
ihlr-27183	316	26	into	into	ADP
ihlr-27183	316	27	the	the	DET
ihlr-27183	316	28	effectiveness	effectiveness	NOUN
ihlr-27183	316	29	of	of	ADP
ihlr-27183	316	30	therapeutics	therapeutic	NOUN
ihlr-27183	316	31	designed	design	VERB
ihlr-27183	316	32	to	to	PART
ihlr-27183	316	33	generate	generate	VERB
ihlr-27183	316	34	antibodies.101	antibodies.101	PROPN
ihlr-27183	316	35	in	in	ADP
ihlr-27183	316	36	an	an	DET
ihlr-27183	316	37	effort	effort	NOUN
ihlr-27183	316	38	to	to	PART
ihlr-27183	316	39	enhance	enhance	VERB
ihlr-27183	316	40	the	the	DET
ihlr-27183	316	41	standing	standing	NOUN
ihlr-27183	316	42	of	of	ADP
ihlr-27183	316	43	its	its	PRON
ihlr-27183	316	44	cases	case	NOUN
ihlr-27183	316	45	against	against	ADP
ihlr-27183	316	46	regeneron	regeneron	NOUN
ihlr-27183	316	47	and	and	CCONJ
ihlr-27183	316	48	pfizer	pfizer	NOUN
ihlr-27183	316	49	,	,	PUNCT
ihlr-27183	316	50	allele	allele	PROPN
ihlr-27183	316	51	argued	argue	VERB
ihlr-27183	316	52	mneongreen	mneongreen	PROPN
ihlr-27183	316	53	is	be	AUX
ihlr-27183	316	54	the	the	DET
ihlr-27183	316	55	best	good	ADJ
ihlr-27183	316	56	fluorescent	fluorescent	ADJ
ihlr-27183	316	57	protein	protein	NOUN
ihlr-27183	316	58	available	available	ADJ
ihlr-27183	316	59	and	and	CCONJ
ihlr-27183	316	60	has	have	AUX
ihlr-27183	316	61	been	be	AUX
ihlr-27183	316	62	referred	refer	VERB
ihlr-27183	316	63	to	to	ADP
ihlr-27183	316	64	objectively	objectively	ADV
ihlr-27183	316	65	by	by	ADP
ihlr-27183	316	66	third	third	ADJ
ihlr-27183	316	67	-	-	PUNCT
ihlr-27183	316	68	parties	party	NOUN
ihlr-27183	316	69	as	as	ADP
ihlr-27183	316	70	the	the	DET
ihlr-27183	316	71	“	"	PUNCT
ihlr-27183	316	72	[	[	X
ihlr-27183	316	73	k]ing	k]ing	NOUN
ihlr-27183	316	74	of	of	ADP
ihlr-27183	316	75	fluorescent	fluorescent	ADJ
ihlr-27183	316	76	proteins	protein	NOUN
ihlr-27183	316	77	.	.	PUNCT
ihlr-27183	316	78	”102	”102	PROPN
ihlr-27183	317	1	2	2	NUM
ihlr-27183	317	2	.	.	NUM
ihlr-27183	317	3	accused	accuse	VERB
ihlr-27183	317	4	activity	activity	NOUN
ihlr-27183	317	5	before	before	ADP
ihlr-27183	317	6	pfizer	pfizer	NOUN
ihlr-27183	317	7	,	,	PUNCT
ihlr-27183	317	8	or	or	CCONJ
ihlr-27183	317	9	any	any	DET
ihlr-27183	317	10	other	other	ADJ
ihlr-27183	317	11	therapeutic	therapeutic	ADJ
ihlr-27183	317	12	developer	developer	NOUN
ihlr-27183	317	13	was	be	AUX
ihlr-27183	317	14	directly	directly	ADV
ihlr-27183	317	15	involved	involve	VERB
ihlr-27183	317	16	,	,	PUNCT
ihlr-27183	317	17	a	a	DET
ihlr-27183	317	18	university	university	NOUN
ihlr-27183	317	19	used	use	VERB
ihlr-27183	317	20	mneongreen	mneongreen	NOUN
ihlr-27183	317	21	to	to	PART
ihlr-27183	317	22	develop	develop	VERB
ihlr-27183	317	23	the	the	DET
ihlr-27183	317	24	“	"	PUNCT
ihlr-27183	317	25	gold	gold	ADJ
ihlr-27183	317	26	standard	standard	NOUN
ihlr-27183	317	27	”	"	PUNCT
ihlr-27183	317	28	covid-19	covid-19	PROPN
ihlr-27183	317	29	assay	assay	VERB
ihlr-27183	317	30	for	for	ADP
ihlr-27183	317	31	evaluating	evaluate	VERB
ihlr-27183	317	32	vaccine	vaccine	NOUN
ihlr-27183	317	33	effectiveness	effectiveness	NOUN
ihlr-27183	317	34	and	and	CCONJ
ihlr-27183	317	35	differentiating	differentiate	VERB
ihlr-27183	317	36	between	between	ADP
ihlr-27183	317	37	which	which	PRON
ihlr-27183	317	38	therapeutic	therapeutic	ADJ
ihlr-27183	317	39	was	be	AUX
ihlr-27183	317	40	most	most	ADV
ihlr-27183	317	41	and	and	CCONJ
ihlr-27183	317	42	least	least	ADJ
ihlr-27183	317	43	effective.103	effective.103	NUM
ihlr-27183	317	44	allele	allele	NOUN
ihlr-27183	317	45	alleges	allege	VERB
ihlr-27183	317	46	pfizer	pfizer	NOUN
ihlr-27183	317	47	and	and	CCONJ
ihlr-27183	317	48	biontech	biontech	NOUN
ihlr-27183	317	49	then	then	ADV
ihlr-27183	317	50	used	use	VERB
ihlr-27183	317	51	this	this	DET
ihlr-27183	317	52	assay	assay	NOUN
ihlr-27183	317	53	,	,	PUNCT
ihlr-27183	317	54	along	along	ADP
ihlr-27183	317	55	with	with	ADP
ihlr-27183	317	56	the	the	DET
ihlr-27183	317	57	patented	patented	ADJ
ihlr-27183	317	58	florescent	florescent	NOUN
ihlr-27183	317	59	protein	protein	NOUN
ihlr-27183	317	60	,	,	PUNCT
ihlr-27183	317	61	for	for	ADP
ihlr-27183	317	62	commercial	commercial	ADJ
ihlr-27183	317	63	testing	testing	NOUN
ihlr-27183	317	64	,	,	PUNCT
ihlr-27183	317	65	development	development	NOUN
ihlr-27183	317	66	,	,	PUNCT
ihlr-27183	317	67	and	and	CCONJ
ihlr-27183	317	68	ultimately	ultimately	ADV
ihlr-27183	317	69	selection	selection	NOUN
ihlr-27183	317	70	of	of	ADP
ihlr-27183	317	71	their	their	PRON
ihlr-27183	317	72	mrna	mrna	PROPN
ihlr-27183	317	73	prophylactic	prophylactic	ADJ
ihlr-27183	317	74	covid-19	covid-19	PROPN
ihlr-27183	317	75	vaccine	vaccine	NOUN
ihlr-27183	317	76	during	during	ADP
ihlr-27183	317	77	clinical	clinical	ADJ
ihlr-27183	317	78	trials.104	trials.104	NOUN
ihlr-27183	317	79	by	by	ADP
ihlr-27183	317	80	testing	test	VERB
ihlr-27183	317	81	antibody	antibody	NOUN
ihlr-27183	317	82	levels	level	NOUN
ihlr-27183	317	83	of	of	ADP
ihlr-27183	317	84	patients	patient	NOUN
ihlr-27183	317	85	during	during	ADP
ihlr-27183	317	86	clinical	clinical	ADJ
ihlr-27183	317	87	trials	trial	NOUN
ihlr-27183	317	88	,	,	PUNCT
ihlr-27183	317	89	pfizer	pfizer	NOUN
ihlr-27183	317	90	selected	select	VERB
ihlr-27183	317	91	a	a	DET
ihlr-27183	317	92	winning	win	VERB
ihlr-27183	317	93	vaccine	vaccine	NOUN
ihlr-27183	317	94	from	from	ADP
ihlr-27183	317	95	among	among	ADP
ihlr-27183	317	96	several	several	ADJ
ihlr-27183	317	97	bnt162	bnt162	NOUN
ihlr-27183	317	98	99	99	NUM
ihlr-27183	317	99	.	.	PUNCT
ihlr-27183	318	1	amendedcomplaint	amendedcomplaint	NOUN
ihlr-27183	318	2	at	at	ADP
ihlr-27183	318	3	4	4	NUM
ihlr-27183	318	4	,	,	PUNCT
ihlr-27183	318	5	allele	allele	PROPN
ihlr-27183	318	6	biotechnology	biotechnology	PROPN
ihlr-27183	318	7	&	&	CCONJ
ihlr-27183	318	8	pharm	pharm	PROPN
ihlr-27183	318	9	.	.	PROPN
ihlr-27183	318	10	,	,	PUNCT
ihlr-27183	318	11	inc	inc	PROPN
ihlr-27183	318	12	.	.	PROPN
ihlr-27183	318	13	v.	v.	ADP
ihlr-27183	318	14	pfizer	pfizer	PROPN
ihlr-27183	318	15	,	,	PUNCT
ihlr-27183	318	16	inc	inc	PROPN
ihlr-27183	318	17	.	.	PROPN
ihlr-27183	318	18	,	,	PUNCT
ihlr-27183	318	19	no	no	INTJ
ihlr-27183	318	20	.	.	NOUN
ihlr-27183	318	21	20	20	NUM
ihlr-27183	318	22	-	-	PUNCT
ihlr-27183	318	23	cv01958	cv01958	NOUN
ihlr-27183	318	24	-	-	PUNCT
ihlr-27183	318	25	h	h	NOUN
ihlr-27183	318	26	,	,	PUNCT
ihlr-27183	318	27	2021	2021	NUM
ihlr-27183	318	28	u.s	u.s	PROPN
ihlr-27183	318	29	.	.	PROPN
ihlr-27183	318	30	dist	dist	PROPN
ihlr-27183	318	31	.	.	PUNCT
ihlr-27183	319	1	lexis	lexis	NOUN
ihlr-27183	319	2	85347	85347	NUM
ihlr-27183	319	3	(	(	PUNCT
ihlr-27183	319	4	s.d	s.d	PROPN
ihlr-27183	319	5	.	.	PROPN
ihlr-27183	319	6	cal	cal	PROPN
ihlr-27183	319	7	.	.	PUNCT
ihlr-27183	320	1	feb	feb	PROPN
ihlr-27183	320	2	.	.	PROPN
ihlr-27183	320	3	25	25	NUM
ihlr-27183	320	4	,	,	PUNCT
ihlr-27183	320	5	2021	2021	NUM
ihlr-27183	320	6	)	)	PUNCT
ihlr-27183	320	7	.	.	PUNCT
ihlr-27183	321	1	100	100	NUM
ihlr-27183	321	2	.	.	PUNCT
ihlr-27183	322	1	i	i	PRON
ihlr-27183	322	2	d.	d.	PROPN
ihlr-27183	322	3	at	at	ADP
ihlr-27183	322	4	2	2	NUM
ihlr-27183	322	5	.	.	PUNCT
ihlr-27183	322	6	101	101	NUM
ihlr-27183	322	7	.	.	PUNCT
ihlr-27183	323	1	i	i	PRON
ihlr-27183	323	2	d.	d.	PROPN
ihlr-27183	323	3	at	at	ADP
ihlr-27183	323	4	4	4	NUM
ihlr-27183	323	5	.	.	NOUN
ihlr-27183	323	6	102	102	NUM
ihlr-27183	323	7	.	.	PUNCT
ihlr-27183	324	1	i	i	PRON
ihlr-27183	324	2	d.	d.	PROPN
ihlr-27183	324	3	at	at	ADP
ihlr-27183	324	4	6	6	NUM
ihlr-27183	324	5	.	.	NOUN
ihlr-27183	324	6	103	103	NUM
ihlr-27183	324	7	.	.	PUNCT
ihlr-27183	325	1	i	i	PRON
ihlr-27183	325	2	d.	d.	PROPN
ihlr-27183	325	3	at	at	ADP
ihlr-27183	325	4	2	2	NUM
ihlr-27183	325	5	.	.	PUNCT
ihlr-27183	325	6	104	104	NUM
ihlr-27183	325	7	.	.	PUNCT
ihlr-27183	326	1	i	i	PRON
ihlr-27183	326	2	d.	d.	PROPN
ihlr-27183	326	3	2023	2023	NUM
ihlr-27183	326	4	]	]	PUNCT
ihlr-27183	327	1	the	the	DET
ihlr-27183	327	2	safe	safe	ADJ
ihlr-27183	327	3	harbor	harbor	NOUN
ihlr-27183	327	4	of	of	ADP
ihlr-27183	327	5	35	35	NUM
ihlr-27183	327	6	u.s.c	u.s.c	ADJ
ihlr-27183	327	7	.	.	PUNCT
ihlr-27183	328	1	§	§	PROPN
ihlr-27183	328	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	328	3	)	)	PUNCT
ihlr-27183	328	4	157	157	NUM
ihlr-27183	328	5	mrna	mrna	PROPN
ihlr-27183	328	6	candidates.105	candidates.105	NOUN
ihlr-27183	328	7	similarly	similarly	ADV
ihlr-27183	328	8	,	,	PUNCT
ihlr-27183	328	9	allele	allele	NOUN
ihlr-27183	328	10	alleges	allege	VERB
ihlr-27183	328	11	regeneron	regeneron	NOUN
ihlr-27183	328	12	pharmaceuticals	pharmaceutical	NOUN
ihlr-27183	328	13	used	use	VERB
ihlr-27183	328	14	mneongreen	mneongreen	NOUN
ihlr-27183	328	15	to	to	PART
ihlr-27183	328	16	detect	detect	VERB
ihlr-27183	328	17	a	a	DET
ihlr-27183	328	18	pseudoparticle	pseudoparticle	NOUN
ihlr-27183	328	19	reporter	reporter	NOUN
ihlr-27183	328	20	indicating	indicate	VERB
ihlr-27183	328	21	the	the	DET
ihlr-27183	328	22	presence	presence	NOUN
ihlr-27183	328	23	of	of	ADP
ihlr-27183	328	24	sarscov-2	sarscov-2	NUM
ihlr-27183	328	25	neutralizing	neutralize	VERB
ihlr-27183	328	26	antibodies.106	antibodies.106	NOUN
ihlr-27183	328	27	in	in	ADP
ihlr-27183	328	28	sum	sum	NOUN
ihlr-27183	328	29	,	,	PUNCT
ihlr-27183	328	30	allele	allele	NOUN
ihlr-27183	328	31	alleged	allege	VERB
ihlr-27183	328	32	both	both	DET
ihlr-27183	328	33	pfizer	pfizer	NOUN
ihlr-27183	328	34	and	and	CCONJ
ihlr-27183	328	35	regeneron	regeneron	NOUN
ihlr-27183	328	36	emerged	emerge	VERB
ihlr-27183	328	37	as	as	ADP
ihlr-27183	328	38	front	front	ADJ
ihlr-27183	328	39	runners	runner	NOUN
ihlr-27183	328	40	in	in	ADP
ihlr-27183	328	41	the	the	DET
ihlr-27183	328	42	race	race	NOUN
ihlr-27183	328	43	to	to	ADP
ihlr-27183	328	44	a	a	DET
ihlr-27183	328	45	vaccine	vaccine	NOUN
ihlr-27183	328	46	precisely	precisely	ADV
ihlr-27183	328	47	because	because	SCONJ
ihlr-27183	328	48	of	of	ADP
ihlr-27183	328	49	their	their	PRON
ihlr-27183	328	50	unlicensed	unlicensed	ADJ
ihlr-27183	328	51	use	use	NOUN
ihlr-27183	328	52	of	of	ADP
ihlr-27183	328	53	mneongreen.107	mneongreen.107	NOUN
ihlr-27183	328	54	noting	note	VERB
ihlr-27183	328	55	mneongreen	mneongreen	NOUN
ihlr-27183	328	56	is	be	AUX
ihlr-27183	328	57	not	not	PART
ihlr-27183	328	58	itself	itself	PRON
ihlr-27183	328	59	subject	subject	ADJ
ihlr-27183	328	60	to	to	ADP
ihlr-27183	328	61	premarket	premarket	ADJ
ihlr-27183	328	62	approval	approval	NOUN
ihlr-27183	328	63	under	under	ADP
ihlr-27183	328	64	any	any	DET
ihlr-27183	328	65	federal	federal	ADJ
ihlr-27183	328	66	law	law	NOUN
ihlr-27183	328	67	,	,	PUNCT
ihlr-27183	328	68	allele	allele	NOUN
ihlr-27183	328	69	argued	argue	VERB
ihlr-27183	328	70	against	against	ADP
ihlr-27183	328	71	applying	apply	VERB
ihlr-27183	328	72	the	the	DET
ihlr-27183	328	73	safe	safe	ADJ
ihlr-27183	328	74	harbor.108	harbor.108	NOUN
ihlr-27183	328	75	3	3	NUM
ihlr-27183	328	76	.	.	PUNCT
ihlr-27183	329	1	legal	legal	ADJ
ihlr-27183	329	2	issue	issue	NOUN
ihlr-27183	329	3	:	:	PUNCT
ihlr-27183	329	4	complaint	complaint	NOUN
ihlr-27183	329	5	and	and	CCONJ
ihlr-27183	329	6	defense	defense	NOUN
ihlr-27183	329	7	allele	allele	NOUN
ihlr-27183	329	8	,	,	PUNCT
ihlr-27183	329	9	in	in	ADP
ihlr-27183	329	10	both	both	DET
ihlr-27183	329	11	complaints	complaint	NOUN
ihlr-27183	329	12	alleging	allege	VERB
ihlr-27183	329	13	infringement	infringement	NOUN
ihlr-27183	329	14	of	of	ADP
ihlr-27183	329	15	the	the	DET
ihlr-27183	329	16	221	221	NUM
ihlr-27183	329	17	patent	patent	NOUN
ihlr-27183	329	18	,	,	PUNCT
ihlr-27183	329	19	specifically	specifically	ADV
ihlr-27183	329	20	identify	identify	VERB
ihlr-27183	329	21	mneongreen	mneongreen	VERB
ihlr-27183	329	22	as	as	ADP
ihlr-27183	329	23	a	a	DET
ihlr-27183	329	24	research	research	NOUN
ihlr-27183	329	25	tool.109	tool.109	VERB
ihlr-27183	329	26	in	in	ADP
ihlr-27183	329	27	addition	addition	NOUN
ihlr-27183	329	28	to	to	ADP
ihlr-27183	329	29	denying	deny	VERB
ihlr-27183	329	30	nearly	nearly	ADV
ihlr-27183	329	31	all	all	PRON
ihlr-27183	329	32	of	of	ADP
ihlr-27183	329	33	allele	allele	PROPN
ihlr-27183	329	34	’s	’s	PART
ihlr-27183	329	35	allegations	allegation	NOUN
ihlr-27183	329	36	,	,	PUNCT
ihlr-27183	329	37	asserting	assert	VERB
ihlr-27183	329	38	allele	allele	PROPN
ihlr-27183	329	39	’s	’s	PART
ihlr-27183	329	40	patent	patent	NOUN
ihlr-27183	329	41	is	be	AUX
ihlr-27183	329	42	invalid	invalid	ADJ
ihlr-27183	329	43	,	,	PUNCT
ihlr-27183	329	44	and	and	CCONJ
ihlr-27183	329	45	asserting	assert	VERB
ihlr-27183	329	46	non	non	NOUN
ihlr-27183	329	47	-	-	NOUN
ihlr-27183	329	48	infringement	infringement	NOUN
ihlr-27183	329	49	of	of	ADP
ihlr-27183	329	50	the	the	DET
ihlr-27183	329	51	patent	patent	NOUN
ihlr-27183	329	52	,	,	PUNCT
ihlr-27183	329	53	pfizer	pfizer	NOUN
ihlr-27183	329	54	raised	raise	VERB
ihlr-27183	329	55	§	§	PROPN
ihlr-27183	329	56	271(e)(1	271(e)(1	PROPN
ihlr-27183	329	57	)	)	PUNCT
ihlr-27183	329	58	as	as	ADP
ihlr-27183	329	59	an	an	DET
ihlr-27183	329	60	affirmative	affirmative	ADJ
ihlr-27183	329	61	defense	defense	NOUN
ihlr-27183	329	62	against	against	ADP
ihlr-27183	329	63	patent	patent	NOUN
ihlr-27183	329	64	infringement.110	infringement.110	PROPN
ihlr-27183	329	65	accordingly	accordingly	ADV
ihlr-27183	329	66	,	,	PUNCT
ihlr-27183	329	67	pfizer	pfizer	NOUN
ihlr-27183	329	68	filed	file	VERB
ihlr-27183	329	69	a	a	DET
ihlr-27183	329	70	motion	motion	NOUN
ihlr-27183	329	71	to	to	PART
ihlr-27183	329	72	dismiss	dismiss	VERB
ihlr-27183	329	73	the	the	DET
ihlr-27183	329	74	lawsuit	lawsuit	NOUN
ihlr-27183	329	75	,	,	PUNCT
ihlr-27183	329	76	arguing	argue	VERB
ihlr-27183	329	77	its	its	PRON
ihlr-27183	329	78	use	use	NOUN
ihlr-27183	329	79	of	of	ADP
ihlr-27183	329	80	mneongreen	mneongreen	NOUN
ihlr-27183	329	81	was	be	AUX
ihlr-27183	329	82	sheltered	shelter	VERB
ihlr-27183	329	83	by	by	ADP
ihlr-27183	329	84	the	the	DET
ihlr-27183	329	85	statutory	statutory	ADJ
ihlr-27183	329	86	safe	safe	ADJ
ihlr-27183	329	87	harbor.111	harbor.111	NOUN
ihlr-27183	329	88	similarly	similarly	ADV
ihlr-27183	329	89	,	,	PUNCT
ihlr-27183	329	90	regeneron	regeneron	PROPN
ihlr-27183	329	91	filed	file	VERB
ihlr-27183	329	92	a	a	DET
ihlr-27183	329	93	motion	motion	NOUN
ihlr-27183	329	94	to	to	PART
ihlr-27183	329	95	dismiss	dismiss	VERB
ihlr-27183	329	96	under	under	ADP
ihlr-27183	329	97	federal	federal	ADJ
ihlr-27183	329	98	rules	rule	NOUN
ihlr-27183	329	99	of	of	ADP
ihlr-27183	329	100	civil	civil	ADJ
ihlr-27183	329	101	procedure	procedure	NOUN
ihlr-27183	329	102	12(b)(6	12(b)(6	NUM
ihlr-27183	329	103	)	)	PUNCT
ihlr-27183	329	104	,	,	PUNCT
ihlr-27183	329	105	arguing	argue	VERB
ihlr-27183	329	106	allele	allele	NOUN
ihlr-27183	329	107	had	have	AUX
ihlr-27183	329	108	failed	fail	VERB
ihlr-27183	329	109	to	to	PART
ihlr-27183	329	110	state	state	VERB
ihlr-27183	329	111	a	a	DET
ihlr-27183	329	112	claim	claim	NOUN
ihlr-27183	329	113	upon	upon	SCONJ
ihlr-27183	329	114	which	which	DET
ihlr-27183	329	115	relief	relief	NOUN
ihlr-27183	329	116	could	could	AUX
ihlr-27183	329	117	be	be	AUX
ihlr-27183	329	118	granted.112	granted.112	PROPN
ihlr-27183	329	119	as	as	SCONJ
ihlr-27183	329	120	expected	expect	VERB
ihlr-27183	329	121	,	,	PUNCT
ihlr-27183	329	122	regeneron	regeneron	PROPN
ihlr-27183	329	123	filed	file	VERB
ihlr-27183	329	124	its	its	PRON
ihlr-27183	329	125	support	support	NOUN
ihlr-27183	329	126	to	to	ADP
ihlr-27183	329	127	this	this	DET
ihlr-27183	329	128	motion	motion	NOUN
ihlr-27183	329	129	on	on	ADP
ihlr-27183	329	130	august	august	PROPN
ihlr-27183	329	131	20	20	NUM
ihlr-27183	329	132	,	,	PUNCT
ihlr-27183	329	133	2021.113	2021.113	NUM
ihlr-27183	329	134	unsurprisingly	unsurprisingly	ADV
ihlr-27183	329	135	,	,	PUNCT
ihlr-27183	329	136	it	it	PRON
ihlr-27183	329	137	ardently	ardently	ADV
ihlr-27183	329	138	pointed	point	VERB
ihlr-27183	329	139	out	out	ADP
ihlr-27183	329	140	that	that	SCONJ
ihlr-27183	329	141	sandoz	sandoz	PROPN
ihlr-27183	329	142	expressly	expressly	ADV
ihlr-27183	329	143	included	include	VERB
ihlr-27183	329	144	research	research	NOUN
ihlr-27183	329	145	tools	tool	NOUN
ihlr-27183	329	146	in	in	ADP
ihlr-27183	329	147	the	the	DET
ihlr-27183	329	148	safe	safe	ADJ
ihlr-27183	329	149	harbor	harbor	NOUN
ihlr-27183	329	150	:	:	PUNCT
ihlr-27183	329	151	emphasizing	emphasize	VERB
ihlr-27183	329	152	sandoz	sandoz	PROPN
ihlr-27183	329	153	’s	’s	PART
ihlr-27183	329	154	found	find	VERB
ihlr-27183	329	155	that	that	SCONJ
ihlr-27183	329	156	“	"	PUNCT
ihlr-27183	329	157	‘	'	PUNCT
ihlr-27183	329	158	[	[	X
ihlr-27183	329	159	t]he	t]he	ADV
ihlr-27183	329	160	statutory	statutory	ADJ
ihlr-27183	329	161	safe	safe	ADJ
ihlr-27183	329	162	harbor	harbor	NOUN
ihlr-27183	329	163	is	be	AUX
ihlr-27183	329	164	clear	clear	ADJ
ihlr-27183	329	165	’	'	PUNCT
ihlr-27183	329	166	and	and	CCONJ
ihlr-27183	329	167	‘	'	PUNCT
ihlr-27183	329	168	patented	patented	ADJ
ihlr-27183	329	169	invention	invention	NOUN
ihlr-27183	329	170	’	'	PUNCT
ihlr-27183	329	171	is	be	AUX
ihlr-27183	329	172	defined	define	VERB
ihlr-27183	329	173	by	by	ADP
ihlr-27183	329	174	35	35	NUM
ihlr-27183	329	175	u.s.c	u.s.c	NOUN
ihlr-27183	329	176	.	.	PUNCT
ihlr-27183	330	1	§	§	PROPN
ihlr-27183	330	2	100(a	100(a	PROPN
ihlr-27183	330	3	)	)	PUNCT
ihlr-27183	330	4	to	to	PART
ihlr-27183	330	5	broadly	broadly	ADV
ihlr-27183	330	6	mean	mean	VERB
ihlr-27183	330	7	‘	'	PUNCT
ihlr-27183	330	8	invention	invention	NOUN
ihlr-27183	330	9	or	or	CCONJ
ihlr-27183	330	10	discovery	discovery	NOUN
ihlr-27183	330	11	.	.	PUNCT
ihlr-27183	330	12	’”114	’”114	PROPN
ihlr-27183	330	13	further	far	ADV
ihlr-27183	330	14	,	,	PUNCT
ihlr-27183	330	15	regeneron	regeneron	PROPN
ihlr-27183	330	16	argues	argue	VERB
ihlr-27183	330	17	that	that	SCONJ
ihlr-27183	330	18	whatever	whatever	DET
ihlr-27183	330	19	proveris	proveri	NOUN
ihlr-27183	330	20	stated	state	VERB
ihlr-27183	330	21	concerning	concern	VERB
ihlr-27183	330	22	the	the	DET
ihlr-27183	330	23	term	term	NOUN
ihlr-27183	330	24	“	"	PUNCT
ihlr-27183	330	25	patented	patented	ADJ
ihlr-27183	330	26	invention	invention	NOUN
ihlr-27183	330	27	,	,	PUNCT
ihlr-27183	330	28	”	"	PUNCT
ihlr-27183	330	29	105	105	NUM
ihlr-27183	330	30	.	.	PUNCT
ihlr-27183	331	1	i	i	PRON
ihlr-27183	331	2	d.	d.	PROPN
ihlr-27183	331	3	at	at	ADP
ihlr-27183	331	4	10	10	NUM
ihlr-27183	331	5	-	-	SYM
ihlr-27183	331	6	11	11	NUM
ihlr-27183	331	7	.	.	PUNCT
ihlr-27183	332	1	106	106	NUM
ihlr-27183	332	2	.	.	PUNCT
ihlr-27183	333	1	amended	amend	VERB
ihlr-27183	333	2	complaint	complaint	NOUN
ihlr-27183	333	3	at	at	ADP
ihlr-27183	333	4	9	9	NUM
ihlr-27183	333	5	,	,	PUNCT
ihlr-27183	333	6	allele	allele	NOUN
ihlr-27183	333	7	biotechnology	biotechnology	PROPN
ihlr-27183	333	8	&	&	CCONJ
ihlr-27183	333	9	pharm	pharm	PROPN
ihlr-27183	333	10	.	.	PROPN
ihlr-27183	333	11	,	,	PUNCT
ihlr-27183	333	12	inc	inc	PROPN
ihlr-27183	333	13	.	.	PROPN
ihlr-27183	334	1	v.	v.	PROPN
ihlr-27183	334	2	regeneron	regeneron	PROPN
ihlr-27183	334	3	pharm	pharm	PROPN
ihlr-27183	334	4	.	.	PUNCT
ihlr-27183	334	5	,	,	PUNCT
ihlr-27183	334	6	inc	inc	PROPN
ihlr-27183	334	7	.	.	PROPN
ihlr-27183	334	8	,	,	PUNCT
ihlr-27183	334	9	no	no	INTJ
ihlr-27183	334	10	.	.	NOUN
ihlr-27183	334	11	20	20	NUM
ihlr-27183	334	12	-	-	PUNCT
ihlr-27183	334	13	cv-08255	cv-08255	NOUN
ihlr-27183	334	14	,	,	PUNCT
ihlr-27183	334	15	2021	2021	NUM
ihlr-27183	334	16	wl	wl	NOUN
ihlr-27183	334	17	2880694	2880694	NUM
ihlr-27183	334	18	(	(	PUNCT
ihlr-27183	334	19	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	334	20	apr	apr	PROPN
ihlr-27183	334	21	.	.	PROPN
ihlr-27183	334	22	8	8	NUM
ihlr-27183	334	23	,	,	PUNCT
ihlr-27183	334	24	2021	2021	NUM
ihlr-27183	334	25	)	)	PUNCT
ihlr-27183	334	26	.	.	PUNCT
ihlr-27183	335	1	107	107	NUM
ihlr-27183	335	2	.	.	PUNCT
ihlr-27183	336	1	amendedcomplaint	amendedcomplaint	NOUN
ihlr-27183	336	2	at	at	ADP
ihlr-27183	336	3	11	11	NUM
ihlr-27183	336	4	,	,	PUNCT
ihlr-27183	336	5	allele	allele	NOUN
ihlr-27183	336	6	biotechnology	biotechnology	PROPN
ihlr-27183	336	7	&	&	CCONJ
ihlr-27183	336	8	pharm	pharm	PROPN
ihlr-27183	336	9	.	.	PROPN
ihlr-27183	336	10	,	,	PUNCT
ihlr-27183	336	11	inc	inc	PROPN
ihlr-27183	336	12	.	.	PROPN
ihlr-27183	336	13	v.	v.	ADP
ihlr-27183	336	14	pfizer	pfizer	PROPN
ihlr-27183	336	15	,	,	PUNCT
ihlr-27183	336	16	inc	inc	PROPN
ihlr-27183	336	17	.	.	PROPN
ihlr-27183	336	18	,	,	PUNCT
ihlr-27183	336	19	no	no	INTJ
ihlr-27183	336	20	.	.	NOUN
ihlr-27183	336	21	20	20	NUM
ihlr-27183	336	22	-	-	PUNCT
ihlr-27183	336	23	cv01958	cv01958	NOUN
ihlr-27183	336	24	-	-	PUNCT
ihlr-27183	336	25	h	h	NOUN
ihlr-27183	336	26	,	,	PUNCT
ihlr-27183	336	27	2021	2021	NUM
ihlr-27183	336	28	u.s	u.s	PROPN
ihlr-27183	336	29	.	.	PROPN
ihlr-27183	336	30	dist	dist	PROPN
ihlr-27183	336	31	.	.	PUNCT
ihlr-27183	337	1	lexis	lexis	NOUN
ihlr-27183	337	2	85347	85347	NUM
ihlr-27183	337	3	(	(	PUNCT
ihlr-27183	337	4	s.d	s.d	PROPN
ihlr-27183	337	5	.	.	PROPN
ihlr-27183	337	6	cal	cal	PROPN
ihlr-27183	337	7	.	.	PUNCT
ihlr-27183	338	1	feb	feb	PROPN
ihlr-27183	338	2	.	.	PROPN
ihlr-27183	338	3	25	25	NUM
ihlr-27183	338	4	,	,	PUNCT
ihlr-27183	338	5	2021	2021	NUM
ihlr-27183	338	6	)	)	PUNCT
ihlr-27183	338	7	;	;	PUNCT
ihlr-27183	338	8	see	see	VERB
ihlr-27183	338	9	also	also	ADV
ihlr-27183	338	10	second	second	ADJ
ihlr-27183	338	11	amendedcomplaint	amendedcomplaint	NOUN
ihlr-27183	338	12	at	at	ADP
ihlr-27183	338	13	10	10	NUM
ihlr-27183	338	14	,	,	PUNCT
ihlr-27183	338	15	allele	allele	NOUN
ihlr-27183	338	16	biotechnology	biotechnology	PROPN
ihlr-27183	338	17	&	&	CCONJ
ihlr-27183	338	18	pharm	pharm	PROPN
ihlr-27183	338	19	.	.	PROPN
ihlr-27183	338	20	,	,	PUNCT
ihlr-27183	338	21	inc	inc	PROPN
ihlr-27183	338	22	.	.	PROPN
ihlr-27183	339	1	v.	v.	ADP
ihlr-27183	339	2	pfizer	pfizer	PROPN
ihlr-27183	339	3	,	,	PUNCT
ihlr-27183	339	4	inc	inc	PROPN
ihlr-27183	339	5	.	.	PROPN
ihlr-27183	339	6	,	,	PUNCT
ihlr-27183	339	7	no	no	INTJ
ihlr-27183	339	8	.	.	NOUN
ihlr-27183	339	9	20	20	NUM
ihlr-27183	339	10	-	-	PUNCT
ihlr-27183	339	11	cv-01958	cv-01958	NOUN
ihlr-27183	339	12	-	-	PUNCT
ihlr-27183	339	13	h	h	NOUN
ihlr-27183	339	14	,	,	PUNCT
ihlr-27183	339	15	2021	2021	NUM
ihlr-27183	339	16	u.s	u.s	PROPN
ihlr-27183	339	17	.	.	PROPN
ihlr-27183	339	18	dist	dist	PROPN
ihlr-27183	339	19	.	.	PUNCT
ihlr-27183	340	1	lexis	lexis	NOUN
ihlr-27183	340	2	85347	85347	NUM
ihlr-27183	340	3	(	(	PUNCT
ihlr-27183	340	4	s.d	s.d	PROPN
ihlr-27183	340	5	.	.	PROPN
ihlr-27183	340	6	cal	cal	PROPN
ihlr-27183	340	7	.	.	PUNCT
ihlr-27183	341	1	feb	feb	PROPN
ihlr-27183	341	2	.	.	PROPN
ihlr-27183	341	3	25	25	NUM
ihlr-27183	341	4	,	,	PUNCT
ihlr-27183	341	5	2021	2021	NUM
ihlr-27183	341	6	)	)	PUNCT
ihlr-27183	341	7	.	.	PUNCT
ihlr-27183	342	1	108	108	NUM
ihlr-27183	342	2	.	.	PUNCT
ihlr-27183	343	1	i	i	PRON
ihlr-27183	343	2	d.	d.	PROPN
ihlr-27183	343	3	at	at	ADP
ihlr-27183	343	4	7	7	NUM
ihlr-27183	343	5	.	.	NUM
ihlr-27183	343	6	109	109	NUM
ihlr-27183	343	7	.	.	PUNCT
ihlr-27183	344	1	i	i	PRON
ihlr-27183	344	2	d.	d.	PROPN
ihlr-27183	344	3	at	at	ADP
ihlr-27183	344	4	11	11	NUM
ihlr-27183	344	5	;	;	PUNCT
ihlr-27183	344	6	see	see	AUX
ihlr-27183	344	7	also	also	ADV
ihlr-27183	344	8	amendedcomplaint	amendedcomplaint	VERB
ihlr-27183	344	9	at	at	ADP
ihlr-27183	344	10	12	12	NUM
ihlr-27183	344	11	,	,	PUNCT
ihlr-27183	344	12	allele	allele	NOUN
ihlr-27183	344	13	biotechnology	biotechnology	PROPN
ihlr-27183	344	14	&	&	CCONJ
ihlr-27183	344	15	pharm	pharm	PROPN
ihlr-27183	344	16	.	.	PROPN
ihlr-27183	344	17	,	,	PUNCT
ihlr-27183	344	18	inc	inc	PROPN
ihlr-27183	344	19	.	.	PROPN
ihlr-27183	345	1	v.	v.	ADP
ihlr-27183	345	2	pfizer	pfizer	PROPN
ihlr-27183	345	3	,	,	PUNCT
ihlr-27183	345	4	inc	inc	PROPN
ihlr-27183	345	5	.	.	PROPN
ihlr-27183	345	6	,	,	PUNCT
ihlr-27183	345	7	no	no	INTJ
ihlr-27183	345	8	.	.	NOUN
ihlr-27183	345	9	20	20	NUM
ihlr-27183	345	10	-	-	PUNCT
ihlr-27183	345	11	cv-01958	cv-01958	NOUN
ihlr-27183	345	12	-	-	PUNCT
ihlr-27183	345	13	h	h	NOUN
ihlr-27183	345	14	,	,	PUNCT
ihlr-27183	345	15	2021	2021	NUM
ihlr-27183	345	16	u.s	u.s	PROPN
ihlr-27183	345	17	.	.	PROPN
ihlr-27183	345	18	dist	dist	PROPN
ihlr-27183	345	19	.	.	PUNCT
ihlr-27183	346	1	lexis	lexis	NOUN
ihlr-27183	346	2	85347	85347	NUM
ihlr-27183	346	3	(	(	PUNCT
ihlr-27183	346	4	s.d	s.d	PROPN
ihlr-27183	346	5	.	.	PROPN
ihlr-27183	346	6	cal	cal	PROPN
ihlr-27183	346	7	.	.	PUNCT
ihlr-27183	347	1	feb	feb	PROPN
ihlr-27183	347	2	.	.	PROPN
ihlr-27183	347	3	25	25	NUM
ihlr-27183	347	4	,	,	PUNCT
ihlr-27183	347	5	2021	2021	NUM
ihlr-27183	347	6	)	)	PUNCT
ihlr-27183	347	7	.	.	PUNCT
ihlr-27183	348	1	110	110	NUM
ihlr-27183	348	2	.	.	PUNCT
ihlr-27183	348	3	answer	answer	NOUN
ihlr-27183	348	4	at	at	ADP
ihlr-27183	348	5	34	34	NUM
ihlr-27183	348	6	,	,	PUNCT
ihlr-27183	348	7	allele	allele	PROPN
ihlr-27183	348	8	biotechnology	biotechnology	PROPN
ihlr-27183	348	9	&	&	CCONJ
ihlr-27183	348	10	pharm	pharm	PROPN
ihlr-27183	348	11	.	.	PROPN
ihlr-27183	348	12	,	,	PUNCT
ihlr-27183	348	13	inc	inc	PROPN
ihlr-27183	348	14	.	.	PROPN
ihlr-27183	348	15	v.	v.	ADP
ihlr-27183	348	16	pfizer	pfizer	PROPN
ihlr-27183	348	17	,	,	PUNCT
ihlr-27183	348	18	inc	inc	PROPN
ihlr-27183	348	19	.	.	PROPN
ihlr-27183	348	20	,	,	PUNCT
ihlr-27183	348	21	no	no	INTJ
ihlr-27183	348	22	.	.	NOUN
ihlr-27183	348	23	20	20	NUM
ihlr-27183	348	24	-	-	PUNCT
ihlr-27183	348	25	cv-01958	cv-01958	NOUN
ihlr-27183	348	26	-	-	PUNCT
ihlr-27183	348	27	h	h	NOUN
ihlr-27183	348	28	,	,	PUNCT
ihlr-27183	348	29	2021	2021	NUM
ihlr-27183	348	30	u.s	u.s	PROPN
ihlr-27183	348	31	.	.	PROPN
ihlr-27183	348	32	dist	dist	PROPN
ihlr-27183	348	33	.	.	PUNCT
ihlr-27183	349	1	lexis	lexis	NOUN
ihlr-27183	349	2	85347	85347	NUM
ihlr-27183	349	3	(	(	PUNCT
ihlr-27183	349	4	s.d	s.d	PROPN
ihlr-27183	349	5	.	.	PROPN
ihlr-27183	349	6	cal	cal	PROPN
ihlr-27183	349	7	.	.	PUNCT
ihlr-27183	350	1	june	june	PROPN
ihlr-27183	350	2	3	3	NUM
ihlr-27183	350	3	,	,	PUNCT
ihlr-27183	350	4	2021	2021	NUM
ihlr-27183	350	5	)	)	PUNCT
ihlr-27183	350	6	.	.	PUNCT
ihlr-27183	351	1	111	111	NUM
ihlr-27183	351	2	.	.	PUNCT
ihlr-27183	351	3	motion	motion	NOUN
ihlr-27183	351	4	to	to	PART
ihlr-27183	351	5	dismiss	dismiss	VERB
ihlr-27183	351	6	at	at	ADP
ihlr-27183	351	7	1	1	NUM
ihlr-27183	351	8	,	,	PUNCT
ihlr-27183	351	9	allele	allele	NOUN
ihlr-27183	351	10	biotechnology	biotechnology	NOUN
ihlr-27183	351	11	and	and	CCONJ
ihlr-27183	351	12	pharmaceuticals	pharmaceutical	NOUN
ihlr-27183	351	13	,	,	PUNCT
ihlr-27183	351	14	inc	inc	PROPN
ihlr-27183	351	15	.	.	PROPN
ihlr-27183	351	16	v.	v.	PROPN
ihlr-27183	351	17	pfizer	pfizer	PROPN
ihlr-27183	351	18	inc	inc	PROPN
ihlr-27183	351	19	.	.	PROPN
ihlr-27183	351	20	,	,	PUNCT
ihlr-27183	351	21	20	20	NUM
ihlr-27183	351	22	-	-	PUNCT
ihlr-27183	351	23	cv-01958	cv-01958	NOUN
ihlr-27183	351	24	-	-	PUNCT
ihlr-27183	351	25	h	h	NOUN
ihlr-27183	351	26	-	-	PUNCT
ihlr-27183	351	27	ags	ag	NOUN
ihlr-27183	351	28	,	,	PUNCT
ihlr-27183	351	29	2021	2021	NUM
ihlr-27183	351	30	wl	wl	NOUN
ihlr-27183	351	31	2774550	2774550	NUM
ihlr-27183	351	32	(	(	PUNCT
ihlr-27183	351	33	s.d	s.d	PROPN
ihlr-27183	351	34	.	.	PROPN
ihlr-27183	351	35	cal	cal	PROPN
ihlr-27183	351	36	.	.	PUNCT
ihlr-27183	352	1	april	april	PROPN
ihlr-27183	352	2	23	23	NUM
ihlr-27183	352	3	,	,	PUNCT
ihlr-27183	352	4	2021	2021	NUM
ihlr-27183	352	5	)	)	PUNCT
ihlr-27183	352	6	.	.	PUNCT
ihlr-27183	353	1	112	112	NUM
ihlr-27183	353	2	.	.	PUNCT
ihlr-27183	353	3	notice	notice	NOUN
ihlr-27183	353	4	of	of	ADP
ihlr-27183	353	5	motion	motion	NOUN
ihlr-27183	353	6	at	at	ADP
ihlr-27183	353	7	1	1	NUM
ihlr-27183	353	8	,	,	PUNCT
ihlr-27183	353	9	allele	allele	NOUN
ihlr-27183	353	10	biotechnology	biotechnology	PROPN
ihlr-27183	353	11	&	&	CCONJ
ihlr-27183	353	12	pharm	pharm	PROPN
ihlr-27183	353	13	.	.	PROPN
ihlr-27183	353	14	,	,	PUNCT
ihlr-27183	353	15	inc	inc	PROPN
ihlr-27183	353	16	.	.	PROPN
ihlr-27183	354	1	v.	v.	PROPN
ihlr-27183	354	2	regeneron	regeneron	PROPN
ihlr-27183	354	3	pharmaceuticals	pharmaceuticals	PROPN
ihlr-27183	354	4	,	,	PUNCT
ihlr-27183	354	5	inc	inc	PROPN
ihlr-27183	354	6	.	.	PROPN
ihlr-27183	354	7	,	,	PUNCT
ihlr-27183	354	8	no	no	INTJ
ihlr-27183	354	9	.	.	NOUN
ihlr-27183	354	10	20	20	NUM
ihlr-27183	354	11	-	-	PUNCT
ihlr-27183	354	12	cv-08255	cv-08255	NOUN
ihlr-27183	354	13	,	,	PUNCT
ihlr-27183	354	14	2021	2021	NUM
ihlr-27183	354	15	wl	wl	NOUN
ihlr-27183	354	16	2880694	2880694	NUM
ihlr-27183	354	17	(	(	PUNCT
ihlr-27183	354	18	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	354	19	aug	aug	PROPN
ihlr-27183	354	20	.	.	PROPN
ihlr-27183	354	21	20	20	NUM
ihlr-27183	354	22	,	,	PUNCT
ihlr-27183	354	23	2021	2021	NUM
ihlr-27183	354	24	)	)	PUNCT
ihlr-27183	354	25	.	.	PUNCT
ihlr-27183	355	1	113	113	NUM
ihlr-27183	355	2	.	.	PUNCT
ihlr-27183	356	1	reply	reply	NOUN
ihlr-27183	356	2	memorandum	memorandum	NOUN
ihlr-27183	356	3	of	of	ADP
ihlr-27183	356	4	law	law	NOUN
ihlr-27183	356	5	at	at	ADP
ihlr-27183	356	6	2	2	NUM
ihlr-27183	356	7	,	,	PUNCT
ihlr-27183	356	8	allele	allele	NOUN
ihlr-27183	356	9	biotechnology	biotechnology	PROPN
ihlr-27183	356	10	&	&	CCONJ
ihlr-27183	356	11	pharm	pharm	PROPN
ihlr-27183	356	12	.	.	PROPN
ihlr-27183	356	13	,	,	PUNCT
ihlr-27183	356	14	inc	inc	PROPN
ihlr-27183	356	15	.	.	PROPN
ihlr-27183	357	1	v.	v.	PROPN
ihlr-27183	357	2	regeneron	regeneron	PROPN
ihlr-27183	357	3	pharmaceuticals	pharmaceuticals	PROPN
ihlr-27183	357	4	,	,	PUNCT
ihlr-27183	357	5	inc	inc	PROPN
ihlr-27183	357	6	.	.	PROPN
ihlr-27183	357	7	,	,	PUNCT
ihlr-27183	357	8	no	no	INTJ
ihlr-27183	357	9	.	.	NOUN
ihlr-27183	357	10	20	20	NUM
ihlr-27183	357	11	-	-	PUNCT
ihlr-27183	357	12	cv-08255	cv-08255	NOUN
ihlr-27183	357	13	,	,	PUNCT
ihlr-27183	357	14	2021	2021	NUM
ihlr-27183	357	15	wl	wl	NOUN
ihlr-27183	357	16	2880694	2880694	NUM
ihlr-27183	357	17	(	(	PUNCT
ihlr-27183	357	18	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	357	19	aug	aug	PROPN
ihlr-27183	357	20	.	.	PROPN
ihlr-27183	357	21	20	20	NUM
ihlr-27183	357	22	,	,	PUNCT
ihlr-27183	357	23	2021	2021	NUM
ihlr-27183	357	24	)	)	PUNCT
ihlr-27183	357	25	.	.	PUNCT
ihlr-27183	358	1	114	114	NUM
ihlr-27183	358	2	.	.	PUNCT
ihlr-27183	359	1	i	i	PRON
ihlr-27183	359	2	d.	d.	PROPN
ihlr-27183	359	3	at	at	ADP
ihlr-27183	359	4	2	2	NUM
ihlr-27183	359	5	(	(	PUNCT
ihlr-27183	359	6	quoting	quote	VERB
ihlr-27183	359	7	teva	teva	PROPN
ihlr-27183	359	8	pharm	pharm	PROPN
ihlr-27183	359	9	’s	’s	PART
ihlr-27183	359	10	usa	usa	PROPN
ihlr-27183	359	11	,	,	PUNCT
ihlr-27183	359	12	inc	inc	PROPN
ihlr-27183	359	13	.	.	PROPN
ihlr-27183	359	14	v.	v.	PROPN
ihlr-27183	359	15	sandoz	sandoz	PROPN
ihlr-27183	359	16	,	,	PUNCT
ihlr-27183	359	17	inc	inc	PROPN
ihlr-27183	359	18	.	.	PROPN
ihlr-27183	359	19	,	,	PUNCT
ihlr-27183	359	20	2013	2013	NUM
ihlr-27183	359	21	wl	wl	NOUN
ihlr-27183	359	22	3732867	3732867	NUM
ihlr-27183	359	23	,	,	PUNCT
ihlr-27183	359	24	at	at	ADP
ihlr-27183	359	25	*	*	NUM
ihlr-27183	359	26	7	7	NUM
ihlr-27183	359	27	(	(	PUNCT
ihlr-27183	359	28	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	359	29	.	.	PROPN
ihlr-27183	359	30	2013	2013	NUM
ihlr-27183	359	31	)	)	PUNCT
ihlr-27183	359	32	)	)	PUNCT
ihlr-27183	359	33	.	.	PUNCT
ihlr-27183	360	1	158	158	NUM
ihlr-27183	360	2	indiana	indiana	PROPN
ihlr-27183	360	3	health	health	PROPN
ihlr-27183	360	4	law	law	PROPN
ihlr-27183	360	5	review	review	NOUN
ihlr-27183	360	6	[	[	X
ihlr-27183	360	7	vol	vol	NOUN
ihlr-27183	360	8	.	.	PUNCT
ihlr-27183	360	9	20:143	20:143	PROPN
ihlr-27183	360	10	and	and	CCONJ
ihlr-27183	360	11	a	a	DET
ihlr-27183	360	12	dependence	dependence	NOUN
ihlr-27183	360	13	on	on	ADP
ihlr-27183	360	14	it	it	PRON
ihlr-27183	360	15	being	be	AUX
ihlr-27183	360	16	subject	subject	ADJ
ihlr-27183	360	17	to	to	ADP
ihlr-27183	360	18	fda	fda	PROPN
ihlr-27183	360	19	approval	approval	NOUN
ihlr-27183	360	20	,	,	PUNCT
ihlr-27183	360	21	was	be	AUX
ihlr-27183	360	22	mere	mere	ADJ
ihlr-27183	360	23	dicta	dicta	ADJ
ihlr-27183	360	24	because	because	SCONJ
ihlr-27183	360	25	proveris	proveris	NOUN
ihlr-27183	360	26	itself	itself	PRON
ihlr-27183	360	27	did	do	AUX
ihlr-27183	360	28	not	not	PART
ihlr-27183	360	29	turn	turn	VERB
ihlr-27183	360	30	on	on	ADP
ihlr-27183	360	31	that	that	DET
ihlr-27183	360	32	holding.115	holding.115	PROPN
ihlr-27183	360	33	rather	rather	ADV
ihlr-27183	360	34	,	,	PUNCT
ihlr-27183	360	35	regeneron	regeneron	PROPN
ihlr-27183	360	36	argues	argue	VERB
ihlr-27183	360	37	,	,	PUNCT
ihlr-27183	360	38	proveris	proveris	PROPN
ihlr-27183	360	39	rejected	reject	VERB
ihlr-27183	360	40	application	application	NOUN
ihlr-27183	360	41	of	of	ADP
ihlr-27183	360	42	the	the	DET
ihlr-27183	360	43	safe	safe	ADJ
ihlr-27183	360	44	harbor	harbor	NOUN
ihlr-27183	360	45	“	"	PUNCT
ihlr-27183	360	46	because	because	SCONJ
ihlr-27183	360	47	the	the	DET
ihlr-27183	360	48	defendant	defendant	NOUN
ihlr-27183	360	49	’s	’s	PART
ihlr-27183	360	50	use	use	NOUN
ihlr-27183	360	51	was	be	AUX
ihlr-27183	360	52	not	not	PART
ihlr-27183	360	53	related	relate	VERB
ihlr-27183	360	54	to	to	ADP
ihlr-27183	360	55	generating	generate	VERB
ihlr-27183	360	56	data	datum	NOUN
ihlr-27183	360	57	for	for	ADP
ihlr-27183	360	58	fda	fda	PROPN
ihlr-27183	360	59	submission	submission	PROPN
ihlr-27183	360	60	.	.	PUNCT
ihlr-27183	360	61	”116	”116	PUNCT
ihlr-27183	361	1	asserting	assert	VERB
ihlr-27183	361	2	proveris	proveri	NOUN
ihlr-27183	361	3	offered	offer	VERB
ihlr-27183	361	4	only	only	ADV
ihlr-27183	361	5	dicta	dicta	ADJ
ihlr-27183	361	6	on	on	ADP
ihlr-27183	361	7	the	the	DET
ihlr-27183	361	8	scope	scope	NOUN
ihlr-27183	361	9	of	of	ADP
ihlr-27183	361	10	“	"	PUNCT
ihlr-27183	361	11	patented	patented	ADJ
ihlr-27183	361	12	invention	invention	NOUN
ihlr-27183	361	13	”	"	PUNCT
ihlr-27183	361	14	appears	appear	VERB
ihlr-27183	361	15	to	to	PART
ihlr-27183	361	16	be	be	AUX
ihlr-27183	361	17	bold	bold	ADJ
ihlr-27183	361	18	,	,	PUNCT
ihlr-27183	361	19	and	and	CCONJ
ihlr-27183	361	20	in	in	ADP
ihlr-27183	361	21	the	the	DET
ihlr-27183	361	22	minority	minority	NOUN
ihlr-27183	361	23	view	view	NOUN
ihlr-27183	361	24	.	.	PUNCT
ihlr-27183	362	1	however	however	ADV
ihlr-27183	362	2	,	,	PUNCT
ihlr-27183	362	3	the	the	DET
ihlr-27183	362	4	case	case	NOUN
ihlr-27183	362	5	has	have	AUX
ihlr-27183	362	6	been	be	AUX
ihlr-27183	362	7	filed	file	VERB
ihlr-27183	362	8	in	in	ADP
ihlr-27183	362	9	a	a	DET
ihlr-27183	362	10	jurisdiction	jurisdiction	NOUN
ihlr-27183	362	11	which	which	PRON
ihlr-27183	362	12	has	have	AUX
ihlr-27183	362	13	shown	show	VERB
ihlr-27183	362	14	favor	favor	NOUN
ihlr-27183	362	15	to	to	ADP
ihlr-27183	362	16	that	that	DET
ihlr-27183	362	17	vary	vary	VERB
ihlr-27183	362	18	approach	approach	NOUN
ihlr-27183	362	19	and	and	CCONJ
ihlr-27183	362	20	the	the	DET
ihlr-27183	362	21	litigation	litigation	NOUN
ihlr-27183	362	22	remains	remain	VERB
ihlr-27183	362	23	pending	pende	VERB
ihlr-27183	362	24	.	.	PUNCT
ihlr-27183	363	1	b.	b.	PROPN
ihlr-27183	363	2	status	status	NOUN
ihlr-27183	363	3	of	of	ADP
ihlr-27183	363	4	pfizer	pfizer	NOUN
ihlr-27183	363	5	litigation	litigation	NOUN
ihlr-27183	363	6	1	1	NUM
ihlr-27183	363	7	.	.	PUNCT
ihlr-27183	363	8	motion	motion	NOUN
ihlr-27183	363	9	to	to	PART
ihlr-27183	363	10	dismiss	dismiss	VERB
ihlr-27183	363	11	denied	deny	VERB
ihlr-27183	363	12	the	the	DET
ihlr-27183	363	13	action	action	NOUN
ihlr-27183	363	14	against	against	ADP
ihlr-27183	363	15	pfizer	pfizer	NOUN
ihlr-27183	363	16	was	be	AUX
ihlr-27183	363	17	filed	file	VERB
ihlr-27183	363	18	with	with	ADP
ihlr-27183	363	19	the	the	DET
ihlr-27183	363	20	united	united	PROPN
ihlr-27183	363	21	states	states	PROPN
ihlr-27183	363	22	district	district	PROPN
ihlr-27183	363	23	court	court	NOUN
ihlr-27183	363	24	for	for	ADP
ihlr-27183	363	25	the	the	DET
ihlr-27183	363	26	southern	southern	ADJ
ihlr-27183	363	27	district	district	NOUN
ihlr-27183	363	28	of	of	ADP
ihlr-27183	363	29	california	california	PROPN
ihlr-27183	363	30	.	.	PUNCT
ihlr-27183	364	1	prior	prior	ADV
ihlr-27183	364	2	to	to	ADP
ihlr-27183	364	3	resolution	resolution	NOUN
ihlr-27183	364	4	by	by	ADP
ihlr-27183	364	5	settlement	settlement	NOUN
ihlr-27183	364	6	on	on	ADP
ihlr-27183	364	7	january	january	PROPN
ihlr-27183	364	8	5th	5th	NOUN
ihlr-27183	364	9	,	,	PUNCT
ihlr-27183	364	10	2022	2022	NUM
ihlr-27183	364	11	,	,	PUNCT
ihlr-27183	364	12	three	three	NUM
ihlr-27183	364	13	orders	order	NOUN
ihlr-27183	364	14	on	on	ADP
ihlr-27183	364	15	motions	motion	NOUN
ihlr-27183	364	16	were	be	AUX
ihlr-27183	364	17	issued	issue	VERB
ihlr-27183	364	18	from	from	ADP
ihlr-27183	364	19	judge	judge	PROPN
ihlr-27183	364	20	marilyn	marilyn	PROPN
ihlr-27183	364	21	l.	l.	PROPN
ihlr-27183	364	22	huff.117	huff.117	VERB
ihlr-27183	364	23	two	two	NUM
ihlr-27183	364	24	related	relate	VERB
ihlr-27183	364	25	to	to	ADP
ihlr-27183	364	26	motions	motion	NOUN
ihlr-27183	364	27	to	to	PART
ihlr-27183	364	28	dismiss	dismiss	VERB
ihlr-27183	364	29	and	and	CCONJ
ihlr-27183	364	30	compel	compel	VERB
ihlr-27183	364	31	,	,	PUNCT
ihlr-27183	364	32	respectively	respectively	ADV
ihlr-27183	364	33	,	,	PUNCT
ihlr-27183	364	34	and	and	CCONJ
ihlr-27183	364	35	are	be	AUX
ihlr-27183	364	36	of	of	ADP
ihlr-27183	364	37	little	little	ADJ
ihlr-27183	364	38	import	import	NOUN
ihlr-27183	364	39	to	to	ADP
ihlr-27183	364	40	the	the	DET
ihlr-27183	364	41	safe	safe	ADJ
ihlr-27183	364	42	harbor	harbor	NOUN
ihlr-27183	364	43	issue.118	issue.118	NOUN
ihlr-27183	364	44	of	of	ADP
ihlr-27183	364	45	particular	particular	ADJ
ihlr-27183	364	46	interest	interest	NOUN
ihlr-27183	364	47	,	,	PUNCT
ihlr-27183	364	48	in	in	ADP
ihlr-27183	364	49	may	may	PROPN
ihlr-27183	364	50	2021	2021	NUM
ihlr-27183	364	51	,	,	PUNCT
ihlr-27183	364	52	the	the	DET
ihlr-27183	364	53	court	court	NOUN
ihlr-27183	364	54	denied	deny	VERB
ihlr-27183	364	55	pfizer	pfizer	NOUN
ihlr-27183	364	56	's	's	PART
ihlr-27183	364	57	motion	motion	NOUN
ihlr-27183	364	58	to	to	PART
ihlr-27183	364	59	dismiss	dismiss	VERB
ihlr-27183	364	60	under	under	ADP
ihlr-27183	364	61	federal	federal	ADJ
ihlr-27183	364	62	rules	rule	NOUN
ihlr-27183	364	63	of	of	ADP
ihlr-27183	364	64	civil	civil	ADJ
ihlr-27183	364	65	procedure	procedure	NOUN
ihlr-27183	364	66	12(b)(6	12(b)(6	NUM
ihlr-27183	364	67	)	)	PUNCT
ihlr-27183	364	68	on	on	ADP
ihlr-27183	364	69	the	the	DET
ihlr-27183	364	70	theory	theory	NOUN
ihlr-27183	364	71	that	that	SCONJ
ihlr-27183	364	72	,	,	PUNCT
ihlr-27183	364	73	as	as	ADP
ihlr-27183	364	74	a	a	DET
ihlr-27183	364	75	matter	matter	NOUN
ihlr-27183	364	76	of	of	ADP
ihlr-27183	364	77	law	law	NOUN
ihlr-27183	364	78	,	,	PUNCT
ihlr-27183	364	79	allele	allele	NOUN
ihlr-27183	364	80	had	have	AUX
ihlr-27183	364	81	failed	fail	VERB
ihlr-27183	364	82	to	to	PART
ihlr-27183	364	83	state	state	VERB
ihlr-27183	364	84	a	a	DET
ihlr-27183	364	85	claim	claim	NOUN
ihlr-27183	364	86	upon	upon	SCONJ
ihlr-27183	364	87	which	which	DET
ihlr-27183	364	88	relief	relief	NOUN
ihlr-27183	364	89	could	could	AUX
ihlr-27183	364	90	be	be	AUX
ihlr-27183	364	91	granted.119	granted.119	VERB
ihlr-27183	364	92	according	accord	VERB
ihlr-27183	364	93	to	to	ADP
ihlr-27183	364	94	pfizer	pfizer	NOUN
ihlr-27183	364	95	,	,	PUNCT
ihlr-27183	364	96	even	even	ADV
ihlr-27183	364	97	if	if	SCONJ
ihlr-27183	364	98	the	the	DET
ihlr-27183	364	99	patent	patent	NOUN
ihlr-27183	364	100	was	be	AUX
ihlr-27183	364	101	valid	valid	ADJ
ihlr-27183	364	102	and	and	CCONJ
ihlr-27183	364	103	pfizer	pfizer	NOUN
ihlr-27183	364	104	’s	’s	PART
ihlr-27183	364	105	activity	activity	NOUN
ihlr-27183	364	106	constituted	constitute	VERB
ihlr-27183	364	107	elements	element	NOUN
ihlr-27183	364	108	of	of	ADP
ihlr-27183	364	109	infringement	infringement	NOUN
ihlr-27183	364	110	,	,	PUNCT
ihlr-27183	364	111	as	as	SCONJ
ihlr-27183	364	112	allele	allele	NOUN
ihlr-27183	364	113	alleges	allege	VERB
ihlr-27183	364	114	,	,	PUNCT
ihlr-27183	364	115	the	the	DET
ihlr-27183	364	116	activity	activity	NOUN
ihlr-27183	364	117	was	be	AUX
ihlr-27183	364	118	shielded	shield	VERB
ihlr-27183	364	119	under	under	ADP
ihlr-27183	364	120	the	the	DET
ihlr-27183	364	121	safe	safe	ADJ
ihlr-27183	364	122	harbor	harbor	NOUN
ihlr-27183	364	123	of	of	ADP
ihlr-27183	364	124	§	§	PROPN
ihlr-27183	364	125	271(e)(1	271(e)(1	PROPN
ihlr-27183	364	126	)	)	PUNCT
ihlr-27183	364	127	and	and	CCONJ
ihlr-27183	364	128	,	,	PUNCT
ihlr-27183	364	129	as	as	ADP
ihlr-27183	364	130	such	such	ADJ
ihlr-27183	364	131	,	,	PUNCT
ihlr-27183	364	132	allele	allele	NOUN
ihlr-27183	364	133	was	be	AUX
ihlr-27183	364	134	never	never	ADV
ihlr-27183	364	135	entitled	entitle	VERB
ihlr-27183	364	136	to	to	ADP
ihlr-27183	364	137	any	any	PRON
ihlr-27183	364	138	of	of	ADP
ihlr-27183	364	139	the	the	DET
ihlr-27183	364	140	relief	relief	NOUN
ihlr-27183	364	141	it	it	PRON
ihlr-27183	364	142	requested.120	requested.120	ADJ
ihlr-27183	364	143	in	in	ADP
ihlr-27183	364	144	denying	deny	VERB
ihlr-27183	364	145	this	this	DET
ihlr-27183	364	146	motion	motion	NOUN
ihlr-27183	364	147	,	,	PUNCT
ihlr-27183	364	148	the	the	DET
ihlr-27183	364	149	court	court	NOUN
ihlr-27183	364	150	noted	note	VERB
ihlr-27183	364	151	that	that	SCONJ
ihlr-27183	364	152	two	two	NUM
ihlr-27183	364	153	federal	federal	ADJ
ihlr-27183	364	154	district	district	NOUN
ihlr-27183	364	155	courts	court	NOUN
ihlr-27183	364	156	have	have	AUX
ihlr-27183	364	157	held	hold	VERB
ihlr-27183	364	158	research	research	NOUN
ihlr-27183	364	159	tools	tool	NOUN
ihlr-27183	364	160	,	,	PUNCT
ihlr-27183	364	161	which	which	PRON
ihlr-27183	364	162	are	be	AUX
ihlr-27183	364	163	not	not	PART
ihlr-27183	364	164	subject	subject	ADJ
ihlr-27183	364	165	to	to	ADP
ihlr-27183	364	166	fda	fda	PROPN
ihlr-27183	364	167	approval	approval	PROPN
ihlr-27183	364	168	,	,	PUNCT
ihlr-27183	364	169	are	be	AUX
ihlr-27183	364	170	not	not	PART
ihlr-27183	364	171	shielded	shield	VERB
ihlr-27183	364	172	under	under	ADP
ihlr-27183	364	173	the	the	DET
ihlr-27183	364	174	safe	safe	ADJ
ihlr-27183	364	175	harbor.121	harbor.121	NOUN
ihlr-27183	364	176	though	though	SCONJ
ihlr-27183	364	177	the	the	DET
ihlr-27183	364	178	legal	legal	ADJ
ihlr-27183	364	179	standard	standard	NOUN
ihlr-27183	364	180	for	for	ADP
ihlr-27183	364	181	a	a	DET
ihlr-27183	364	182	successful	successful	ADJ
ihlr-27183	364	183	12(b)(6	12(b)(6	NUM
ihlr-27183	364	184	)	)	PUNCT
ihlr-27183	364	185	favors	favor	VERB
ihlr-27183	364	186	the	the	DET
ihlr-27183	364	187	plaintiff,122	plaintiff,122	NOUN
ihlr-27183	364	188	the	the	DET
ihlr-27183	364	189	u.s	u.s	PROPN
ihlr-27183	364	190	.	.	PROPN
ihlr-27183	364	191	district	district	PROPN
ihlr-27183	364	192	court	court	NOUN
ihlr-27183	364	193	for	for	ADP
ihlr-27183	364	194	the	the	DET
ihlr-27183	364	195	115	115	NUM
ihlr-27183	364	196	.	.	PUNCT
ihlr-27183	365	1	i	i	PRON
ihlr-27183	365	2	d.	d.	PROPN
ihlr-27183	365	3	116	116	NUM
ihlr-27183	365	4	.	.	PUNCT
ihlr-27183	366	1	i	i	PRON
ihlr-27183	366	2	d.	d.	PROPN
ihlr-27183	366	3	at	at	ADP
ihlr-27183	366	4	1	1	NUM
ihlr-27183	366	5	-	-	SYM
ihlr-27183	366	6	2	2	NUM
ihlr-27183	366	7	.	.	NOUN
ihlr-27183	366	8	117	117	NUM
ihlr-27183	366	9	.	.	PUNCT
ihlr-27183	367	1	see	see	VERB
ihlr-27183	367	2	allele	allele	PROPN
ihlr-27183	367	3	biotechnology	biotechnology	PROPN
ihlr-27183	367	4	&	&	CCONJ
ihlr-27183	367	5	pharm	pharm	PROPN
ihlr-27183	367	6	.	.	PROPN
ihlr-27183	367	7	,	,	PUNCT
ihlr-27183	367	8	inc	inc	PROPN
ihlr-27183	367	9	.	.	PROPN
ihlr-27183	367	10	v.	v.	ADP
ihlr-27183	367	11	pfizer	pfizer	PROPN
ihlr-27183	367	12	,	,	PUNCT
ihlr-27183	367	13	inc	inc	PROPN
ihlr-27183	367	14	.	.	PROPN
ihlr-27183	367	15	,	,	PUNCT
ihlr-27183	367	16	no	no	INTJ
ihlr-27183	367	17	.	.	NOUN
ihlr-27183	367	18	20	20	NUM
ihlr-27183	367	19	-	-	PUNCT
ihlr-27183	367	20	cv-01958	cv-01958	NOUN
ihlr-27183	367	21	-	-	PUNCT
ihlr-27183	367	22	h	h	NOUN
ihlr-27183	367	23	,	,	PUNCT
ihlr-27183	367	24	2021	2021	NUM
ihlr-27183	367	25	u.s	u.s	PROPN
ihlr-27183	367	26	.	.	PROPN
ihlr-27183	367	27	dist	dist	PROPN
ihlr-27183	367	28	.	.	PUNCT
ihlr-27183	368	1	lexis	lexis	NOUN
ihlr-27183	368	2	37287	37287	NUM
ihlr-27183	368	3	(	(	PUNCT
ihlr-27183	368	4	s.d	s.d	PROPN
ihlr-27183	368	5	.	.	PROPN
ihlr-27183	368	6	cal	cal	PROPN
ihlr-27183	368	7	.	.	PUNCT
ihlr-27183	369	1	feb	feb	PROPN
ihlr-27183	369	2	.	.	PROPN
ihlr-27183	369	3	26	26	NUM
ihlr-27183	369	4	,	,	PUNCT
ihlr-27183	369	5	2021	2021	NUM
ihlr-27183	369	6	)	)	PUNCT
ihlr-27183	369	7	.	.	PUNCT
ihlr-27183	370	1	see	see	VERB
ihlr-27183	370	2	also	also	ADV
ihlr-27183	370	3	allele	allele	PROPN
ihlr-27183	370	4	biotechnology	biotechnology	PROPN
ihlr-27183	370	5	&	&	CCONJ
ihlr-27183	370	6	pharm	pharm	PROPN
ihlr-27183	370	7	.	.	PROPN
ihlr-27183	370	8	,	,	PUNCT
ihlr-27183	370	9	inc	inc	PROPN
ihlr-27183	370	10	.	.	PROPN
ihlr-27183	371	1	v.	v.	ADP
ihlr-27183	371	2	pfizer	pfizer	PROPN
ihlr-27183	371	3	,	,	PUNCT
ihlr-27183	371	4	inc	inc	PROPN
ihlr-27183	371	5	.	.	PROPN
ihlr-27183	371	6	,	,	PUNCT
ihlr-27183	371	7	no	no	INTJ
ihlr-27183	371	8	.	.	NOUN
ihlr-27183	371	9	20	20	NUM
ihlr-27183	371	10	-	-	PUNCT
ihlr-27183	371	11	cv-01958	cv-01958	NOUN
ihlr-27183	371	12	-	-	PUNCT
ihlr-27183	371	13	h	h	NOUN
ihlr-27183	371	14	,	,	PUNCT
ihlr-27183	371	15	2021	2021	NUM
ihlr-27183	371	16	u.s	u.s	PROPN
ihlr-27183	371	17	.	.	PROPN
ihlr-27183	371	18	dist	dist	PROPN
ihlr-27183	371	19	.	.	PUNCT
ihlr-27183	372	1	lexis	lexis	NOUN
ihlr-27183	372	2	174654	174654	NUM
ihlr-27183	372	3	(	(	PUNCT
ihlr-27183	372	4	s.d	s.d	PROPN
ihlr-27183	372	5	.	.	PROPN
ihlr-27183	372	6	cal	cal	PROPN
ihlr-27183	372	7	.	.	PUNCT
ihlr-27183	373	1	sep	sep	INTJ
ihlr-27183	373	2	.	.	PROPN
ihlr-27183	373	3	13	13	NUM
ihlr-27183	373	4	,	,	PUNCT
ihlr-27183	373	5	2021	2021	NUM
ihlr-27183	373	6	)	)	PUNCT
ihlr-27183	373	7	.	.	PUNCT
ihlr-27183	374	1	118	118	NUM
ihlr-27183	374	2	.	.	PUNCT
ihlr-27183	375	1	i	i	PRON
ihlr-27183	375	2	d.	d.	PROPN
ihlr-27183	375	3	119	119	NUM
ihlr-27183	375	4	.	.	PUNCT
ihlr-27183	376	1	allele	allele	PROPN
ihlr-27183	376	2	biotechnology	biotechnology	PROPN
ihlr-27183	376	3	&	&	CCONJ
ihlr-27183	376	4	pharm	pharm	PROPN
ihlr-27183	376	5	.	.	PROPN
ihlr-27183	376	6	,	,	PUNCT
ihlr-27183	376	7	inc	inc	PROPN
ihlr-27183	376	8	.	.	PROPN
ihlr-27183	376	9	v.	v.	ADP
ihlr-27183	376	10	pfizer	pfizer	PROPN
ihlr-27183	376	11	,	,	PUNCT
ihlr-27183	376	12	inc	inc	PROPN
ihlr-27183	376	13	.	.	PROPN
ihlr-27183	376	14	,	,	PUNCT
ihlr-27183	376	15	20	20	NUM
ihlr-27183	376	16	-	-	PUNCT
ihlr-27183	376	17	cv-01958	cv-01958	NOUN
ihlr-27183	376	18	-	-	PUNCT
ihlr-27183	376	19	h	h	NOUN
ihlr-27183	376	20	-	-	PUNCT
ihlr-27183	376	21	ags	ag	NOUN
ihlr-27183	376	22	,	,	PUNCT
ihlr-27183	376	23	2021	2021	NUM
ihlr-27183	376	24	u.s	u.s	PROPN
ihlr-27183	376	25	.	.	PROPN
ihlr-27183	376	26	dist	dist	PROPN
ihlr-27183	376	27	.	.	PUNCT
ihlr-27183	377	1	lexis	lexis	NOUN
ihlr-27183	377	2	85347	85347	NUM
ihlr-27183	377	3	,	,	PUNCT
ihlr-27183	377	4	at	at	ADP
ihlr-27183	377	5	*	*	NOUN
ihlr-27183	377	6	3	3	NUM
ihlr-27183	377	7	(	(	PUNCT
ihlr-27183	377	8	s.d	s.d	PROPN
ihlr-27183	377	9	.	.	PROPN
ihlr-27183	377	10	cal	cal	PROPN
ihlr-27183	377	11	.	.	PUNCT
ihlr-27183	378	1	may	may	AUX
ihlr-27183	378	2	4	4	NUM
ihlr-27183	378	3	,	,	PUNCT
ihlr-27183	378	4	2021	2021	NUM
ihlr-27183	378	5	)	)	PUNCT
ihlr-27183	378	6	.	.	PUNCT
ihlr-27183	379	1	120	120	NUM
ihlr-27183	379	2	.	.	PUNCT
ihlr-27183	380	1	i	i	PRON
ihlr-27183	380	2	d.	d.	VERB
ihlr-27183	380	3	at	at	ADP
ihlr-27183	380	4	*	*	PROPN
ihlr-27183	380	5	5	5	NUM
ihlr-27183	380	6	.	.	NOUN
ihlr-27183	380	7	121	121	NUM
ihlr-27183	380	8	.	.	PUNCT
ihlr-27183	381	1	i	i	PRON
ihlr-27183	381	2	d.	d.	VERB
ihlr-27183	381	3	at	at	ADP
ihlr-27183	381	4	*	*	PROPN
ihlr-27183	381	5	11	11	NUM
ihlr-27183	381	6	.	.	PUNCT
ihlr-27183	382	1	see	see	AUX
ihlr-27183	382	2	also	also	ADV
ihlr-27183	382	3	isis	isis	NOUN
ihlr-27183	382	4	pharms	pharm	NOUN
ihlr-27183	382	5	.	.	PUNCT
ihlr-27183	382	6	,	,	PUNCT
ihlr-27183	382	7	inc	inc	PROPN
ihlr-27183	382	8	.	.	PROPN
ihlr-27183	383	1	v.	v.	ADP
ihlr-27183	383	2	santaris	santaris	PROPN
ihlr-27183	383	3	pharma	pharma	PROPN
ihlr-27183	383	4	a	a	DET
ihlr-27183	383	5	/	/	SYM
ihlr-27183	383	6	s	s	PROPN
ihlr-27183	383	7	corp	corp	PROPN
ihlr-27183	383	8	.	.	PROPN
ihlr-27183	383	9	,	,	PUNCT
ihlr-27183	383	10	no	no	INTJ
ihlr-27183	383	11	.	.	PUNCT
ihlr-27183	384	1	11cv02214	11cv02214	NUM
ihlr-27183	384	2	,	,	PUNCT
ihlr-27183	384	3	2012	2012	NUM
ihlr-27183	384	4	u.s	u.s	PROPN
ihlr-27183	384	5	.	.	PROPN
ihlr-27183	384	6	dist	dist	PROPN
ihlr-27183	384	7	.	.	PUNCT
ihlr-27183	385	1	lexis	lexis	PROPN
ihlr-27183	385	2	134107	134107	NUM
ihlr-27183	385	3	,	,	PUNCT
ihlr-27183	385	4	2012	2012	NUM
ihlr-27183	385	5	wl	wl	NOUN
ihlr-27183	385	6	4111157	4111157	NUM
ihlr-27183	385	7	,	,	PUNCT
ihlr-27183	385	8	at	at	ADP
ihlr-27183	385	9	*	*	NUM
ihlr-27183	385	10	4	4	NUM
ihlr-27183	385	11	(	(	PUNCT
ihlr-27183	385	12	s.d	s.d	PROPN
ihlr-27183	385	13	.	.	PROPN
ihlr-27183	385	14	cal	cal	PROPN
ihlr-27183	385	15	.	.	PUNCT
ihlr-27183	386	1	sept	sept	PROPN
ihlr-27183	386	2	.	.	PROPN
ihlr-27183	386	3	19	19	NUM
ihlr-27183	386	4	,	,	PUNCT
ihlr-27183	386	5	2012	2012	NUM
ihlr-27183	386	6	)	)	PUNCT
ihlr-27183	386	7	(	(	PUNCT
ihlr-27183	386	8	"	"	PUNCT
ihlr-27183	386	9	the	the	DET
ihlr-27183	386	10	safe	safe	ADJ
ihlr-27183	386	11	harbor	harbor	NOUN
ihlr-27183	386	12	does	do	AUX
ihlr-27183	386	13	not	not	PART
ihlr-27183	386	14	apply	apply	VERB
ihlr-27183	386	15	,	,	PUNCT
ihlr-27183	386	16	however	however	ADV
ihlr-27183	386	17	,	,	PUNCT
ihlr-27183	386	18	when	when	SCONJ
ihlr-27183	386	19	a	a	DET
ihlr-27183	386	20	biological	biological	ADJ
ihlr-27183	386	21	compound	compound	NOUN
ihlr-27183	386	22	is	be	AUX
ihlr-27183	386	23	used	use	VERB
ihlr-27183	386	24	to	to	PART
ihlr-27183	386	25	perform	perform	VERB
ihlr-27183	386	26	'	'	PUNCT
ihlr-27183	386	27	basic	basic	ADJ
ihlr-27183	386	28	scientific	scientific	ADJ
ihlr-27183	386	29	research	research	NOUN
ihlr-27183	386	30	'	'	PUNCT
ihlr-27183	386	31	or	or	CCONJ
ihlr-27183	386	32	as	as	ADP
ihlr-27183	386	33	a	a	DET
ihlr-27183	386	34	'	'	PUNCT
ihlr-27183	386	35	research	research	NOUN
ihlr-27183	386	36	tool	tool	NOUN
ihlr-27183	386	37	.	.	PUNCT
ihlr-27183	386	38	'	'	PUNCT
ihlr-27183	387	1	"	"	PUNCT
ihlr-27183	387	2	)	)	PUNCT
ihlr-27183	387	3	,	,	PUNCT
ihlr-27183	387	4	and	and	CCONJ
ihlr-27183	387	5	psn	psn	PROPN
ihlr-27183	387	6	ill	ill	PROPN
ihlr-27183	387	7	.	.	PROPN
ihlr-27183	387	8	,	,	PUNCT
ihlr-27183	387	9	llc	llc	PROPN
ihlr-27183	387	10	v.	v.	PROPN
ihlr-27183	387	11	abbott	abbott	PROPN
ihlr-27183	387	12	labs	labs	PROPN
ihlr-27183	387	13	.	.	PUNCT
ihlr-27183	387	14	&	&	CCONJ
ihlr-27183	387	15	abbott	abbott	PROPN
ihlr-27183	387	16	bioresearch	bioresearch	PROPN
ihlr-27183	387	17	ctr	ctr	PROPN
ihlr-27183	387	18	.	.	PROPN
ihlr-27183	387	19	,	,	PUNCT
ihlr-27183	387	20	inc	inc	PROPN
ihlr-27183	387	21	.	.	PROPN
ihlr-27183	387	22	,	,	PUNCT
ihlr-27183	387	23	no	no	INTJ
ihlr-27183	387	24	.	.	NOUN
ihlr-27183	387	25	09	09	NUM
ihlr-27183	387	26	c	c	NOUN
ihlr-27183	387	27	5879	5879	NUM
ihlr-27183	387	28	,	,	PUNCT
ihlr-27183	387	29	2011	2011	NUM
ihlr-27183	387	30	u.s	u.s	PROPN
ihlr-27183	387	31	.	.	PROPN
ihlr-27183	387	32	dist	dist	PROPN
ihlr-27183	387	33	.	.	PUNCT
ihlr-27183	388	1	lexis	lexis	NOUN
ihlr-27183	388	2	108055	108055	NUM
ihlr-27183	388	3	,	,	PUNCT
ihlr-27183	388	4	2011	2011	NUM
ihlr-27183	388	5	wl	wl	NOUN
ihlr-27183	388	6	4442825	4442825	NUM
ihlr-27183	388	7	,	,	PUNCT
ihlr-27183	388	8	at	at	ADP
ihlr-27183	388	9	*	*	NOUN
ihlr-27183	388	10	5	5	NUM
ihlr-27183	388	11	(	(	PUNCT
ihlr-27183	388	12	n.d	n.d	PROPN
ihlr-27183	388	13	.	.	PROPN
ihlr-27183	388	14	ill	ill	PROPN
ihlr-27183	388	15	.	.	PUNCT
ihlr-27183	389	1	sept	sept	PROPN
ihlr-27183	389	2	.	.	PROPN
ihlr-27183	389	3	20	20	NUM
ihlr-27183	389	4	,	,	PUNCT
ihlr-27183	389	5	2011	2011	NUM
ihlr-27183	389	6	)	)	PUNCT
ihlr-27183	389	7	(	(	PUNCT
ihlr-27183	389	8	"	"	PUNCT
ihlr-27183	389	9	proveris	proveris	NOUN
ihlr-27183	389	10	excluded	exclude	VERB
ihlr-27183	389	11	research	research	NOUN
ihlr-27183	389	12	tools	tool	NOUN
ihlr-27183	389	13	from	from	ADP
ihlr-27183	389	14	the	the	DET
ihlr-27183	389	15	purview	purview	NOUN
ihlr-27183	389	16	of	of	ADP
ihlr-27183	389	17	the	the	DET
ihlr-27183	389	18	safe	safe	ADJ
ihlr-27183	389	19	harbor	harbor	NOUN
ihlr-27183	389	20	exemption	exemption	NOUN
ihlr-27183	389	21	.	.	PUNCT
ihlr-27183	390	1	"	"	PUNCT
ihlr-27183	390	2	)	)	PUNCT
ihlr-27183	390	3	.	.	PUNCT
ihlr-27183	391	1	122	122	NUM
ihlr-27183	391	2	.	.	PUNCT
ihlr-27183	391	3	allele	allele	PROPN
ihlr-27183	391	4	biotechnology	biotechnology	PROPN
ihlr-27183	391	5	&	&	CCONJ
ihlr-27183	391	6	pharm	pharm	PROPN
ihlr-27183	391	7	.	.	PROPN
ihlr-27183	391	8	,	,	PUNCT
ihlr-27183	391	9	inc	inc	PROPN
ihlr-27183	391	10	.	.	PROPN
ihlr-27183	391	11	v.	v.	ADP
ihlr-27183	391	12	pfizer	pfizer	PROPN
ihlr-27183	391	13	,	,	PUNCT
ihlr-27183	391	14	inc	inc	PROPN
ihlr-27183	391	15	.	.	PROPN
ihlr-27183	391	16	,	,	PUNCT
ihlr-27183	391	17	20	20	NUM
ihlr-27183	391	18	-	-	PUNCT
ihlr-27183	391	19	cv-01958	cv-01958	NOUN
ihlr-27183	391	20	-	-	PUNCT
ihlr-27183	391	21	h	h	NOUN
ihlr-27183	391	22	-	-	PUNCT
ihlr-27183	391	23	ags	ag	NOUN
ihlr-27183	391	24	,	,	PUNCT
ihlr-27183	391	25	2021	2021	NUM
ihlr-27183	391	26	u.s	u.s	PROPN
ihlr-27183	391	27	.	.	PROPN
ihlr-27183	391	28	dist	dist	PROPN
ihlr-27183	391	29	.	.	PUNCT
ihlr-27183	392	1	lexis	lexis	NOUN
ihlr-27183	392	2	85347	85347	NUM
ihlr-27183	392	3	,	,	PUNCT
ihlr-27183	392	4	at	at	ADP
ihlr-27183	392	5	*	*	NOUN
ihlr-27183	392	6	4	4	NUM
ihlr-27183	392	7	(	(	PUNCT
ihlr-27183	392	8	requiring	require	VERB
ihlr-27183	392	9	all	all	DET
ihlr-27183	392	10	questions	question	NOUN
ihlr-27183	392	11	of	of	ADP
ihlr-27183	392	12	fact	fact	NOUN
ihlr-27183	392	13	to	to	PART
ihlr-27183	392	14	be	be	AUX
ihlr-27183	392	15	resolved	resolve	VERB
ihlr-27183	392	16	in	in	ADP
ihlr-27183	392	17	favor	favor	NOUN
ihlr-27183	392	18	of	of	ADP
ihlr-27183	392	19	the	the	DET
ihlr-27183	392	20	non	non	ADJ
ihlr-27183	392	21	-	-	ADJ
ihlr-27183	392	22	moving	moving	ADJ
ihlr-27183	392	23	party	party	NOUN
ihlr-27183	392	24	)	)	PUNCT
ihlr-27183	392	25	.	.	PUNCT
ihlr-27183	393	1	2023	2023	NUM
ihlr-27183	393	2	]	]	PUNCT
ihlr-27183	393	3	the	the	DET
ihlr-27183	393	4	safe	safe	ADJ
ihlr-27183	393	5	harbor	harbor	NOUN
ihlr-27183	393	6	of	of	ADP
ihlr-27183	393	7	35	35	NUM
ihlr-27183	393	8	u.s.c	u.s.c	ADJ
ihlr-27183	393	9	.	.	PUNCT
ihlr-27183	394	1	§	§	PROPN
ihlr-27183	394	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	394	3	)	)	PUNCT
ihlr-27183	394	4	159	159	NUM
ihlr-27183	394	5	southern	southern	ADJ
ihlr-27183	394	6	district	district	NOUN
ihlr-27183	394	7	of	of	ADP
ihlr-27183	394	8	california	california	PROPN
ihlr-27183	394	9	suggested	suggest	VERB
ihlr-27183	394	10	,	,	PUNCT
ihlr-27183	394	11	in	in	ADP
ihlr-27183	394	12	its	its	PRON
ihlr-27183	394	13	refusal	refusal	NOUN
ihlr-27183	394	14	to	to	PART
ihlr-27183	394	15	dismiss	dismiss	VERB
ihlr-27183	394	16	the	the	DET
ihlr-27183	394	17	action	action	NOUN
ihlr-27183	394	18	against	against	ADP
ihlr-27183	394	19	pfizer	pfizer	NOUN
ihlr-27183	394	20	,	,	PUNCT
ihlr-27183	394	21	that	that	SCONJ
ihlr-27183	394	22	it	it	PRON
ihlr-27183	394	23	reads	read	VERB
ihlr-27183	394	24	eli	eli	PROPN
ihlr-27183	394	25	lilly	lilly	PROPN
ihlr-27183	394	26	and	and	CCONJ
ihlr-27183	394	27	proveris	proveris	VERB
ihlr-27183	394	28	to	to	PART
ihlr-27183	394	29	teach	teach	VERB
ihlr-27183	394	30	research	research	NOUN
ihlr-27183	394	31	tools	tool	NOUN
ihlr-27183	394	32	are	be	AUX
ihlr-27183	394	33	outside	outside	ADP
ihlr-27183	394	34	the	the	DET
ihlr-27183	394	35	scope	scope	NOUN
ihlr-27183	394	36	of	of	ADP
ihlr-27183	394	37	the	the	DET
ihlr-27183	394	38	“	"	PUNCT
ihlr-27183	394	39	patented	patented	ADJ
ihlr-27183	394	40	invention	invention	NOUN
ihlr-27183	394	41	”	"	PUNCT
ihlr-27183	394	42	of	of	ADP
ihlr-27183	394	43	§	§	PROPN
ihlr-27183	394	44	271(e)(1).123	271(e)(1).123	NUM
ihlr-27183	394	45	interestingly	interestingly	ADV
ihlr-27183	394	46	,	,	PUNCT
ihlr-27183	394	47	discussion	discussion	NOUN
ihlr-27183	394	48	of	of	ADP
ihlr-27183	394	49	the	the	DET
ihlr-27183	394	50	supreme	supreme	PROPN
ihlr-27183	394	51	court	court	PROPN
ihlr-27183	394	52	case	case	NOUN
ihlr-27183	394	53	of	of	ADP
ihlr-27183	394	54	merck	merck	NOUN
ihlr-27183	394	55	–	–	PUNCT
ihlr-27183	394	56	a	a	DET
ihlr-27183	394	57	case	case	NOUN
ihlr-27183	394	58	which	which	PRON
ihlr-27183	394	59	contains	contain	VERB
ihlr-27183	394	60	what	what	PRON
ihlr-27183	394	61	some	some	PRON
ihlr-27183	394	62	have	have	AUX
ihlr-27183	394	63	viewed	view	VERB
ihlr-27183	394	64	as	as	ADP
ihlr-27183	394	65	expansive	expansive	ADJ
ihlr-27183	394	66	language	language	NOUN
ihlr-27183	394	67	suggesting	suggest	VERB
ihlr-27183	394	68	research	research	NOUN
ihlr-27183	394	69	tools	tool	NOUN
ihlr-27183	394	70	rest	rest	VERB
ihlr-27183	394	71	within	within	ADP
ihlr-27183	394	72	the	the	DET
ihlr-27183	394	73	ambit	ambit	NOUN
ihlr-27183	394	74	of	of	ADP
ihlr-27183	394	75	§	§	PROPN
ihlr-27183	394	76	271(e)(1)–is	271(e)(1)–is	PROPN
ihlr-27183	394	77	limited	limit	VERB
ihlr-27183	394	78	to	to	ADP
ihlr-27183	394	79	one	one	NUM
ihlr-27183	394	80	paragraph	paragraph	NOUN
ihlr-27183	394	81	and	and	CCONJ
ihlr-27183	394	82	avoided	avoid	VERB
ihlr-27183	394	83	entirely	entirely	ADV
ihlr-27183	394	84	in	in	ADP
ihlr-27183	394	85	the	the	DET
ihlr-27183	394	86	court	court	NOUN
ihlr-27183	394	87	’s	’s	PART
ihlr-27183	394	88	analysis	analysis	NOUN
ihlr-27183	394	89	section.124	section.124	VERB
ihlr-27183	394	90	aside	aside	ADV
ihlr-27183	394	91	from	from	ADP
ihlr-27183	394	92	several	several	ADJ
ihlr-27183	394	93	quotes	quote	NOUN
ihlr-27183	394	94	unanchored	unanchore	VERB
ihlr-27183	394	95	by	by	ADP
ihlr-27183	394	96	meaningful	meaningful	ADJ
ihlr-27183	394	97	context	context	NOUN
ihlr-27183	394	98	,	,	PUNCT
ihlr-27183	394	99	the	the	DET
ihlr-27183	394	100	court	court	NOUN
ihlr-27183	394	101	reports	report	VERB
ihlr-27183	394	102	merck	merck	PROPN
ihlr-27183	394	103	’s	’s	PART
ihlr-27183	394	104	broadest	broad	ADJ
ihlr-27183	394	105	statement	statement	NOUN
ihlr-27183	394	106	only	only	ADV
ihlr-27183	394	107	in	in	ADP
ihlr-27183	394	108	parentheses	parenthesis	NOUN
ihlr-27183	394	109	and	and	CCONJ
ihlr-27183	394	110	removes	remove	VERB
ihlr-27183	394	111	the	the	DET
ihlr-27183	394	112	supreme	supreme	PROPN
ihlr-27183	394	113	court	court	PROPN
ihlr-27183	394	114	’s	’s	PART
ihlr-27183	394	115	emphasis	emphasis	NOUN
ihlr-27183	394	116	.	.	PUNCT
ihlr-27183	395	1	indeed	indeed	ADV
ihlr-27183	395	2	,	,	PUNCT
ihlr-27183	395	3	the	the	DET
ihlr-27183	395	4	court	court	NOUN
ihlr-27183	395	5	’s	’s	PART
ihlr-27183	395	6	lack	lack	NOUN
ihlr-27183	395	7	of	of	ADP
ihlr-27183	395	8	focus	focus	NOUN
ihlr-27183	395	9	on	on	ADP
ihlr-27183	395	10	merck	merck	PROPN
ihlr-27183	395	11	suggested	suggest	VERB
ihlr-27183	395	12	it	it	PRON
ihlr-27183	395	13	would	would	AUX
ihlr-27183	395	14	not	not	PART
ihlr-27183	395	15	extend	extend	VERB
ihlr-27183	395	16	merck	merck	PROPN
ihlr-27183	395	17	’s	’s	PART
ihlr-27183	395	18	sweeping	sweeping	ADJ
ihlr-27183	395	19	principles	principle	NOUN
ihlr-27183	395	20	to	to	PART
ihlr-27183	395	21	research	research	VERB
ihlr-27183	395	22	tools.125	tools.125	NUM
ihlr-27183	395	23	notably	notably	ADV
ihlr-27183	395	24	,	,	PUNCT
ihlr-27183	395	25	merck	merck	PROPN
ihlr-27183	395	26	was	be	AUX
ihlr-27183	395	27	seemingly	seemingly	ADV
ihlr-27183	395	28	replaced	replace	VERB
ihlr-27183	395	29	with	with	ADP
ihlr-27183	395	30	a	a	DET
ihlr-27183	395	31	discussion	discussion	NOUN
ihlr-27183	395	32	easily	easily	ADV
ihlr-27183	395	33	distinguishing	distinguish	VERB
ihlr-27183	395	34	classen	classen	PROPN
ihlr-27183	395	35	v.	v.	PROPN
ihlr-27183	395	36	elan	elan	PROPN
ihlr-27183	395	37	pharms	pharm	NOUN
ihlr-27183	395	38	in	in	ADP
ihlr-27183	395	39	the	the	DET
ihlr-27183	395	40	court	court	NOUN
ihlr-27183	395	41	’s	’s	PART
ihlr-27183	395	42	brief	brief	ADJ
ihlr-27183	395	43	analysis	analysis	NOUN
ihlr-27183	395	44	and	and	CCONJ
ihlr-27183	395	45	subsequent	subsequent	ADJ
ihlr-27183	395	46	rejection	rejection	NOUN
ihlr-27183	395	47	of	of	ADP
ihlr-27183	395	48	pfizer	pfizer	NOUN
ihlr-27183	395	49	’s	’s	PART
ihlr-27183	395	50	motion	motion	NOUN
ihlr-27183	395	51	to	to	PART
ihlr-27183	395	52	dismiss.126	dismiss.126	VERB
ihlr-27183	395	53	perhaps	perhaps	ADV
ihlr-27183	395	54	merck	merck	PROPN
ihlr-27183	395	55	’s	’s	PART
ihlr-27183	395	56	direct	direct	ADJ
ihlr-27183	395	57	refusal	refusal	NOUN
ihlr-27183	395	58	to	to	PART
ihlr-27183	395	59	address	address	VERB
ihlr-27183	395	60	research	research	NOUN
ihlr-27183	395	61	tools	tool	NOUN
ihlr-27183	395	62	has	have	AUX
ihlr-27183	395	63	been	be	AUX
ihlr-27183	395	64	taken	take	VERB
ihlr-27183	395	65	by	by	ADP
ihlr-27183	395	66	some	some	DET
ihlr-27183	395	67	courts	court	NOUN
ihlr-27183	395	68	to	to	PART
ihlr-27183	395	69	relieve	relieve	VERB
ihlr-27183	395	70	its	its	PRON
ihlr-27183	395	71	application	application	NOUN
ihlr-27183	395	72	of	of	ADP
ihlr-27183	395	73	the	the	DET
ihlr-27183	395	74	general	general	ADJ
ihlr-27183	395	75	statements	statement	NOUN
ihlr-27183	395	76	therein.127	therein.127	VERB
ihlr-27183	395	77	the	the	DET
ihlr-27183	395	78	appropriateness	appropriateness	NOUN
ihlr-27183	395	79	of	of	ADP
ihlr-27183	395	80	this	this	DET
ihlr-27183	395	81	maneuver	maneuver	NOUN
ihlr-27183	395	82	will	will	AUX
ihlr-27183	395	83	be	be	AUX
ihlr-27183	395	84	considered	consider	VERB
ihlr-27183	395	85	later	later	ADV
ihlr-27183	395	86	.	.	PUNCT
ihlr-27183	396	1	though	though	SCONJ
ihlr-27183	396	2	not	not	PART
ihlr-27183	396	3	excepted	except	VERB
ihlr-27183	396	4	by	by	ADP
ihlr-27183	396	5	all	all	DET
ihlr-27183	396	6	courts	court	NOUN
ihlr-27183	396	7	,	,	PUNCT
ihlr-27183	396	8	the	the	DET
ihlr-27183	396	9	u.s	u.s	PROPN
ihlr-27183	396	10	.	.	PROPN
ihlr-27183	396	11	district	district	PROPN
ihlr-27183	396	12	court	court	NOUN
ihlr-27183	396	13	for	for	ADP
ihlr-27183	396	14	the	the	DET
ihlr-27183	396	15	southern	southern	ADJ
ihlr-27183	396	16	district	district	PROPN
ihlr-27183	396	17	of	of	ADP
ihlr-27183	396	18	california	california	PROPN
ihlr-27183	396	19	made	make	VERB
ihlr-27183	396	20	it	it	PRON
ihlr-27183	396	21	clear	clear	ADJ
ihlr-27183	396	22	,	,	PUNCT
ihlr-27183	396	23	as	as	ADP
ihlr-27183	396	24	a	a	DET
ihlr-27183	396	25	matter	matter	NOUN
ihlr-27183	396	26	of	of	ADP
ihlr-27183	396	27	law	law	NOUN
ihlr-27183	396	28	,	,	PUNCT
ihlr-27183	396	29	the	the	DET
ihlr-27183	396	30	safe	safe	ADJ
ihlr-27183	396	31	harbor	harbor	NOUN
ihlr-27183	396	32	would	would	AUX
ihlr-27183	396	33	not	not	PART
ihlr-27183	396	34	shield	shield	VERB
ihlr-27183	396	35	pfizer	pfizer	NOUN
ihlr-27183	396	36	’s	’s	PART
ihlr-27183	396	37	activity.128	activity.128	NOUN
ihlr-27183	396	38	since	since	SCONJ
ihlr-27183	396	39	juries	jury	NOUN
ihlr-27183	396	40	generally	generally	ADV
ihlr-27183	396	41	favor	favor	VERB
ihlr-27183	396	42	patent	patent	NOUN
ihlr-27183	396	43	holders	holder	NOUN
ihlr-27183	396	44	,	,	PUNCT
ihlr-27183	396	45	the	the	DET
ihlr-27183	396	46	parties	party	NOUN
ihlr-27183	396	47	could	could	AUX
ihlr-27183	396	48	assess	assess	VERB
ihlr-27183	396	49	their	their	PRON
ihlr-27183	396	50	chances	chance	NOUN
ihlr-27183	396	51	of	of	ADP
ihlr-27183	396	52	success	success	NOUN
ihlr-27183	396	53	and	and	CCONJ
ihlr-27183	396	54	the	the	DET
ihlr-27183	396	55	outcome	outcome	NOUN
ihlr-27183	396	56	of	of	ADP
ihlr-27183	396	57	the	the	DET
ihlr-27183	396	58	jury	jury	NOUN
ihlr-27183	396	59	trial	trial	NOUN
ihlr-27183	396	60	which	which	PRON
ihlr-27183	396	61	was	be	AUX
ihlr-27183	396	62	set	set	VERB
ihlr-27183	396	63	for	for	ADP
ihlr-27183	396	64	late	late	ADJ
ihlr-27183	396	65	2022	2022	NUM
ihlr-27183	396	66	.	.	PUNCT
ihlr-27183	397	1	this	this	PRON
ihlr-27183	397	2	proved	prove	VERB
ihlr-27183	397	3	enough	enough	ADJ
ihlr-27183	397	4	information	information	NOUN
ihlr-27183	397	5	to	to	PART
ihlr-27183	397	6	settle	settle	VERB
ihlr-27183	397	7	.	.	PUNCT
ihlr-27183	398	1	it	it	PRON
ihlr-27183	398	2	is	be	AUX
ihlr-27183	398	3	safe	safe	ADJ
ihlr-27183	398	4	to	to	PART
ihlr-27183	398	5	say	say	VERB
ihlr-27183	398	6	the	the	DET
ihlr-27183	398	7	terms	term	NOUN
ihlr-27183	398	8	of	of	ADP
ihlr-27183	398	9	the	the	DET
ihlr-27183	398	10	settlement	settlement	NOUN
ihlr-27183	398	11	were	be	AUX
ihlr-27183	398	12	in	in	ADP
ihlr-27183	398	13	allele	allele	PROPN
ihlr-27183	398	14	’s	’s	PART
ihlr-27183	398	15	favor	favor	NOUN
ihlr-27183	398	16	–	–	PUNCT
ihlr-27183	398	17	favor	favor	NOUN
ihlr-27183	398	18	obviously	obviously	ADV
ihlr-27183	398	19	dependent	dependent	ADJ
ihlr-27183	398	20	on	on	ADP
ihlr-27183	398	21	the	the	DET
ihlr-27183	398	22	court	court	NOUN
ihlr-27183	398	23	’s	’s	PART
ihlr-27183	398	24	refusal	refusal	NOUN
ihlr-27183	398	25	to	to	PART
ihlr-27183	398	26	apply	apply	VERB
ihlr-27183	398	27	the	the	DET
ihlr-27183	398	28	safe	safe	ADJ
ihlr-27183	398	29	harbor	harbor	NOUN
ihlr-27183	398	30	.	.	PUNCT
ihlr-27183	399	1	2	2	X
ihlr-27183	399	2	.	.	X
ihlr-27183	399	3	status	status	NOUN
ihlr-27183	399	4	of	of	ADP
ihlr-27183	399	5	regeneron	regeneron	PROPN
ihlr-27183	399	6	litigation	litigation	PROPN
ihlr-27183	399	7	a	a	DET
ihlr-27183	399	8	similar	similar	ADJ
ihlr-27183	399	9	motion	motion	NOUN
ihlr-27183	399	10	to	to	PART
ihlr-27183	399	11	dismiss	dismiss	VERB
ihlr-27183	399	12	was	be	AUX
ihlr-27183	399	13	filed	file	VERB
ihlr-27183	399	14	by	by	ADP
ihlr-27183	399	15	regeneron	regeneron	NOUN
ihlr-27183	399	16	on	on	ADP
ihlr-27183	399	17	august	august	PROPN
ihlr-27183	399	18	8	8	NUM
ihlr-27183	399	19	,	,	PUNCT
ihlr-27183	399	20	2021	2021	NUM
ihlr-27183	399	21	,	,	PUNCT
ihlr-27183	399	22	with	with	ADP
ihlr-27183	399	23	the	the	DET
ihlr-27183	399	24	southern	southern	ADJ
ihlr-27183	399	25	district	district	NOUN
ihlr-27183	399	26	of	of	ADP
ihlr-27183	399	27	new	new	PROPN
ihlr-27183	399	28	york	york	PROPN
ihlr-27183	399	29	,	,	PUNCT
ihlr-27183	399	30	which	which	PRON
ihlr-27183	399	31	was	be	AUX
ihlr-27183	399	32	dismissed	dismiss	VERB
ihlr-27183	399	33	on	on	ADP
ihlr-27183	399	34	march	march	PROPN
ihlr-27183	399	35	2	2	NUM
ihlr-27183	399	36	,	,	PUNCT
ihlr-27183	399	37	2022.129	2022.129	PROPN
ihlr-27183	399	38	a	a	DET
ihlr-27183	399	39	status	status	NOUN
ihlr-27183	399	40	update	update	NOUN
ihlr-27183	399	41	from	from	ADP
ihlr-27183	399	42	allele	allele	NOUN
ihlr-27183	399	43	on	on	ADP
ihlr-27183	399	44	december	december	PROPN
ihlr-27183	399	45	13	13	NUM
ihlr-27183	399	46	,	,	PUNCT
ihlr-27183	399	47	2021	2021	NUM
ihlr-27183	399	48	,	,	PUNCT
ihlr-27183	399	49	indicated	indicate	VERB
ihlr-27183	399	50	regeneron	regeneron	NOUN
ihlr-27183	399	51	had	have	AUX
ihlr-27183	399	52	ceased	cease	VERB
ihlr-27183	399	53	all	all	DET
ihlr-27183	399	54	use	use	NOUN
ihlr-27183	399	55	of	of	ADP
ihlr-27183	399	56	mneongreen	mneongreen	NOUN
ihlr-27183	399	57	in	in	ADP
ihlr-27183	399	58	its	its	PRON
ihlr-27183	399	59	current	current	ADJ
ihlr-27183	399	60	research	research	NOUN
ihlr-27183	399	61	and	and	CCONJ
ihlr-27183	399	62	development	development	NOUN
ihlr-27183	399	63	of	of	ADP
ihlr-27183	399	64	next	next	ADJ
ihlr-27183	399	65	generation	generation	NOUN
ihlr-27183	399	66	antibody	antibody	NOUN
ihlr-27183	399	67	cocktails	cocktail	NOUN
ihlr-27183	399	68	and	and	CCONJ
ihlr-27183	399	69	notified	notify	VERB
ihlr-27183	399	70	allele.130	allele.130	NOUN
ihlr-27183	399	71	allele	allele	NOUN
ihlr-27183	399	72	has	have	AUX
ihlr-27183	399	73	accordingly	accordingly	ADV
ihlr-27183	399	74	withdrawn	withdraw	VERB
ihlr-27183	399	75	123	123	NUM
ihlr-27183	399	76	.	.	PUNCT
ihlr-27183	400	1	see	see	VERB
ihlr-27183	400	2	santaris	santaris	ADJ
ihlr-27183	400	3	pharma	pharma	PROPN
ihlr-27183	400	4	a	a	DET
ihlr-27183	400	5	/	/	SYM
ihlr-27183	400	6	s	s	PROPN
ihlr-27183	400	7	corp	corp	PROPN
ihlr-27183	400	8	.	.	PROPN
ihlr-27183	400	9	,	,	PUNCT
ihlr-27183	400	10	u.s	u.s	PROPN
ihlr-27183	400	11	.	.	PROPN
ihlr-27183	400	12	dist	dist	NOUN
ihlr-27183	400	13	.	.	PUNCT
ihlr-27183	401	1	lexis	lexis	PROPN
ihlr-27183	401	2	134107	134107	NUM
ihlr-27183	401	3	,	,	PUNCT
ihlr-27183	401	4	at	at	ADP
ihlr-27183	401	5	*	*	NOUN
ihlr-27183	401	6	4	4	NUM
ihlr-27183	401	7	(	(	PUNCT
ihlr-27183	401	8	"	"	PUNCT
ihlr-27183	401	9	the	the	DET
ihlr-27183	401	10	safe	safe	ADJ
ihlr-27183	401	11	harbor	harbor	NOUN
ihlr-27183	401	12	does	do	AUX
ihlr-27183	401	13	not	not	PART
ihlr-27183	401	14	apply	apply	VERB
ihlr-27183	401	15	,	,	PUNCT
ihlr-27183	401	16	however	however	ADV
ihlr-27183	401	17	,	,	PUNCT
ihlr-27183	401	18	when	when	SCONJ
ihlr-27183	401	19	a	a	DET
ihlr-27183	401	20	biological	biological	ADJ
ihlr-27183	401	21	compound	compound	NOUN
ihlr-27183	401	22	is	be	AUX
ihlr-27183	401	23	used	use	VERB
ihlr-27183	401	24	to	to	PART
ihlr-27183	401	25	perform	perform	VERB
ihlr-27183	401	26	'	'	PUNCT
ihlr-27183	401	27	basic	basic	ADJ
ihlr-27183	401	28	scientific	scientific	ADJ
ihlr-27183	401	29	research	research	NOUN
ihlr-27183	401	30	'	'	PUNCT
ihlr-27183	401	31	or	or	CCONJ
ihlr-27183	401	32	as	as	ADP
ihlr-27183	401	33	a	a	DET
ihlr-27183	401	34	'	'	PUNCT
ihlr-27183	401	35	research	research	NOUN
ihlr-27183	401	36	tool	tool	NOUN
ihlr-27183	401	37	.	.	PUNCT
ihlr-27183	401	38	'	'	PUNCT
ihlr-27183	402	1	"	"	PUNCT
ihlr-27183	402	2	)	)	PUNCT
ihlr-27183	403	1	,	,	PUNCT
ihlr-27183	403	2	and	and	CCONJ
ihlr-27183	403	3	abbott	abbott	PROPN
ihlr-27183	403	4	labs	labs	PROPN
ihlr-27183	403	5	.	.	PUNCT
ihlr-27183	403	6	&	&	CCONJ
ihlr-27183	403	7	abbott	abbott	PROPN
ihlr-27183	403	8	bioresearch	bioresearch	PROPN
ihlr-27183	403	9	ctr	ctr	PROPN
ihlr-27183	403	10	.	.	PROPN
ihlr-27183	403	11	,	,	PUNCT
ihlr-27183	403	12	inc	inc	PROPN
ihlr-27183	403	13	.	.	PROPN
ihlr-27183	403	14	,	,	PUNCT
ihlr-27183	403	15	u.s	u.s	PROPN
ihlr-27183	403	16	.	.	PROPN
ihlr-27183	403	17	dist	dist	NOUN
ihlr-27183	403	18	.	.	PUNCT
ihlr-27183	404	1	lexis	lexis	NOUN
ihlr-27183	404	2	108055	108055	NUM
ihlr-27183	404	3	,	,	PUNCT
ihlr-27183	404	4	at	at	ADP
ihlr-27183	404	5	*	*	NOUN
ihlr-27183	404	6	5	5	NUM
ihlr-27183	404	7	(	(	PUNCT
ihlr-27183	404	8	"	"	PUNCT
ihlr-27183	404	9	proveris	proveris	NOUN
ihlr-27183	404	10	excluded	exclude	VERB
ihlr-27183	404	11	research	research	NOUN
ihlr-27183	404	12	tools	tool	NOUN
ihlr-27183	404	13	from	from	ADP
ihlr-27183	404	14	the	the	DET
ihlr-27183	404	15	purview	purview	NOUN
ihlr-27183	404	16	of	of	ADP
ihlr-27183	404	17	the	the	DET
ihlr-27183	404	18	safe	safe	ADJ
ihlr-27183	404	19	harbor	harbor	NOUN
ihlr-27183	404	20	exemption	exemption	NOUN
ihlr-27183	404	21	.	.	PUNCT
ihlr-27183	405	1	"	"	PUNCT
ihlr-27183	405	2	)	)	PUNCT
ihlr-27183	405	3	.	.	PUNCT
ihlr-27183	406	1	124	124	NUM
ihlr-27183	406	2	.	.	PUNCT
ihlr-27183	407	1	i	i	PRON
ihlr-27183	407	2	d.	d.	PROPN
ihlr-27183	407	3	125	125	NUM
ihlr-27183	407	4	.	.	PUNCT
ihlr-27183	408	1	i	i	PRON
ihlr-27183	408	2	d.	d.	VERB
ihlr-27183	408	3	at	at	ADP
ihlr-27183	408	4	*	*	PROPN
ihlr-27183	408	5	8	8	NUM
ihlr-27183	408	6	.	.	X
ihlr-27183	408	7	126	126	NUM
ihlr-27183	408	8	.	.	PUNCT
ihlr-27183	409	1	elan	elan	PROPN
ihlr-27183	409	2	pharm	pharm	PROPN
ihlr-27183	409	3	.	.	PROPN
ihlr-27183	409	4	,	,	PUNCT
ihlr-27183	409	5	inc	inc	PROPN
ihlr-27183	409	6	.	.	PROPN
ihlr-27183	409	7	,	,	PUNCT
ihlr-27183	409	8	786	786	NUM
ihlr-27183	409	9	f.3d	f.3d	NUM
ihlr-27183	409	10	at	at	ADP
ihlr-27183	409	11	896	896	NUM
ihlr-27183	409	12	-	-	SYM
ihlr-27183	409	13	97	97	NUM
ihlr-27183	409	14	(	(	PUNCT
ihlr-27183	409	15	the	the	DET
ihlr-27183	409	16	court	court	NOUN
ihlr-27183	409	17	states	state	VERB
ihlr-27183	409	18	the	the	DET
ihlr-27183	409	19	defendant	defendant	NOUN
ihlr-27183	409	20	’s	’s	PART
ihlr-27183	409	21	reliance	reliance	NOUN
ihlr-27183	409	22	on	on	ADP
ihlr-27183	409	23	elan	elan	PROPN
ihlr-27183	409	24	pharm	pharm	PROPN
ihlr-27183	409	25	.	.	PUNCT
ihlr-27183	410	1	is	be	AUX
ihlr-27183	410	2	misplaced	misplace	VERB
ihlr-27183	410	3	because	because	SCONJ
ihlr-27183	410	4	the	the	DET
ihlr-27183	410	5	issue	issue	NOUN
ihlr-27183	410	6	relates	relate	VERB
ihlr-27183	410	7	strongly	strongly	ADV
ihlr-27183	410	8	to	to	ADP
ihlr-27183	410	9	the	the	DET
ihlr-27183	410	10	nature	nature	NOUN
ihlr-27183	410	11	of	of	ADP
ihlr-27183	410	12	the	the	DET
ihlr-27183	410	13	activity	activity	NOUN
ihlr-27183	410	14	instead	instead	ADV
ihlr-27183	410	15	of	of	ADP
ihlr-27183	410	16	the	the	DET
ihlr-27183	410	17	invention	invention	NOUN
ihlr-27183	410	18	being	be	AUX
ihlr-27183	410	19	used	use	VERB
ihlr-27183	410	20	)	)	PUNCT
ihlr-27183	410	21	.	.	PUNCT
ihlr-27183	411	1	127	127	NUM
ihlr-27183	411	2	.	.	PUNCT
ihlr-27183	412	1	allele	allele	PROPN
ihlr-27183	412	2	biotechnology	biotechnology	PROPN
ihlr-27183	412	3	&	&	CCONJ
ihlr-27183	412	4	pharm	pharm	PROPN
ihlr-27183	412	5	.	.	PROPN
ihlr-27183	412	6	,	,	PUNCT
ihlr-27183	412	7	inc	inc	PROPN
ihlr-27183	412	8	.	.	PROPN
ihlr-27183	412	9	,	,	PUNCT
ihlr-27183	412	10	2021	2021	NUM
ihlr-27183	412	11	u.s	u.s	PROPN
ihlr-27183	412	12	.	.	PROPN
ihlr-27183	412	13	dist	dist	PROPN
ihlr-27183	412	14	.	.	PUNCT
ihlr-27183	413	1	lexis	lexis	NOUN
ihlr-27183	413	2	85347	85347	NUM
ihlr-27183	413	3	,	,	PUNCT
ihlr-27183	413	4	at	at	ADP
ihlr-27183	413	5	*	*	PROPN
ihlr-27183	413	6	15	15	NUM
ihlr-27183	413	7	.	.	NOUN
ihlr-27183	413	8	128	128	NUM
ihlr-27183	413	9	.	.	PUNCT
ihlr-27183	414	1	elan	elan	PROPN
ihlr-27183	414	2	pharm	pharm	PROPN
ihlr-27183	414	3	.	.	PROPN
ihlr-27183	414	4	,	,	PUNCT
ihlr-27183	414	5	inc	inc	PROPN
ihlr-27183	414	6	.	.	PROPN
ihlr-27183	414	7	,	,	PUNCT
ihlr-27183	414	8	786	786	NUM
ihlr-27183	414	9	f.3d	f.3d	NUM
ihlr-27183	414	10	at	at	ADP
ihlr-27183	414	11	896	896	NUM
ihlr-27183	414	12	-	-	SYM
ihlr-27183	414	13	99	99	NUM
ihlr-27183	414	14	.	.	PUNCT
ihlr-27183	415	1	129	129	NUM
ihlr-27183	415	2	.	.	PUNCT
ihlr-27183	416	1	status	status	NOUN
ihlr-27183	416	2	update	update	NOUN
ihlr-27183	416	3	at	at	ADP
ihlr-27183	416	4	1	1	NUM
ihlr-27183	416	5	,	,	PUNCT
ihlr-27183	416	6	allele	allele	NOUN
ihlr-27183	416	7	biotechnology	biotechnology	PROPN
ihlr-27183	416	8	&	&	CCONJ
ihlr-27183	416	9	pharm	pharm	PROPN
ihlr-27183	416	10	.	.	PROPN
ihlr-27183	416	11	,	,	PUNCT
ihlr-27183	416	12	inc	inc	PROPN
ihlr-27183	416	13	.	.	PROPN
ihlr-27183	417	1	v.	v.	PROPN
ihlr-27183	417	2	regeneron	regeneron	PROPN
ihlr-27183	417	3	pharmaceuticals	pharmaceuticals	PROPN
ihlr-27183	417	4	,	,	PUNCT
ihlr-27183	417	5	inc	inc	PROPN
ihlr-27183	417	6	.	.	PROPN
ihlr-27183	417	7	,	,	PUNCT
ihlr-27183	417	8	no	no	INTJ
ihlr-27183	417	9	.	.	NOUN
ihlr-27183	417	10	20	20	NUM
ihlr-27183	417	11	-	-	PUNCT
ihlr-27183	417	12	cv-08255	cv-08255	NOUN
ihlr-27183	417	13	,	,	PUNCT
ihlr-27183	417	14	2021	2021	NUM
ihlr-27183	417	15	wl	wl	NOUN
ihlr-27183	417	16	2880694	2880694	NUM
ihlr-27183	417	17	(	(	PUNCT
ihlr-27183	417	18	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	417	19	apr	apr	PROPN
ihlr-27183	417	20	.	.	PROPN
ihlr-27183	417	21	8	8	NUM
ihlr-27183	417	22	,	,	PUNCT
ihlr-27183	417	23	2021	2021	NUM
ihlr-27183	417	24	)	)	PUNCT
ihlr-27183	417	25	.	.	PUNCT
ihlr-27183	418	1	130	130	NUM
ihlr-27183	418	2	.	.	PUNCT
ihlr-27183	419	1	i	i	PRON
ihlr-27183	419	2	d.	d.	PROPN
ihlr-27183	419	3	160	160	NUM
ihlr-27183	419	4	indiana	indiana	PROPN
ihlr-27183	419	5	health	health	PROPN
ihlr-27183	419	6	law	law	PROPN
ihlr-27183	419	7	review	review	NOUN
ihlr-27183	419	8	[	[	X
ihlr-27183	419	9	vol	vol	NOUN
ihlr-27183	419	10	.	.	PUNCT
ihlr-27183	419	11	20:143	20:143	PROPN
ihlr-27183	419	12	associated	associate	VERB
ihlr-27183	419	13	allegations	allegation	NOUN
ihlr-27183	419	14	of	of	ADP
ihlr-27183	419	15	continued	continue	VERB
ihlr-27183	419	16	use	use	NOUN
ihlr-27183	419	17	of	of	ADP
ihlr-27183	419	18	their	their	PRON
ihlr-27183	419	19	patented	patented	ADJ
ihlr-27183	419	20	technology	technology	NOUN
ihlr-27183	419	21	,	,	PUNCT
ihlr-27183	419	22	but	but	CCONJ
ihlr-27183	419	23	has	have	AUX
ihlr-27183	419	24	retained	retain	VERB
ihlr-27183	419	25	other	other	ADJ
ihlr-27183	419	26	allegations.131	allegations.131	PROPN
ihlr-27183	419	27	while	while	SCONJ
ihlr-27183	419	28	regeneron	regeneron	PROPN
ihlr-27183	419	29	’s	’s	PART
ihlr-27183	419	30	move	move	NOUN
ihlr-27183	419	31	is	be	AUX
ihlr-27183	419	32	difficult	difficult	ADJ
ihlr-27183	419	33	to	to	PART
ihlr-27183	419	34	legally	legally	ADV
ihlr-27183	419	35	construe	construe	VERB
ihlr-27183	419	36	,	,	PUNCT
ihlr-27183	419	37	it	it	PRON
ihlr-27183	419	38	could	could	AUX
ihlr-27183	419	39	be	be	AUX
ihlr-27183	419	40	an	an	DET
ihlr-27183	419	41	indication	indication	NOUN
ihlr-27183	419	42	both	both	DET
ihlr-27183	419	43	parties	party	NOUN
ihlr-27183	419	44	are	be	AUX
ihlr-27183	419	45	also	also	ADV
ihlr-27183	419	46	likely	likely	ADJ
ihlr-27183	419	47	to	to	PART
ihlr-27183	419	48	negotiate	negotiate	VERB
ihlr-27183	419	49	a	a	DET
ihlr-27183	419	50	settlement	settlement	NOUN
ihlr-27183	419	51	.	.	PUNCT
ihlr-27183	420	1	3	3	X
ihlr-27183	420	2	.	.	X
ihlr-27183	420	3	settlement	settlement	NOUN
ihlr-27183	420	4	of	of	ADP
ihlr-27183	420	5	trial	trial	NOUN
ihlr-27183	420	6	:	:	PUNCT
ihlr-27183	420	7	jury	jury	NOUN
ihlr-27183	420	8	or	or	CCONJ
ihlr-27183	420	9	bench	bench	VERB
ihlr-27183	420	10	with	with	ADP
ihlr-27183	420	11	about	about	ADV
ihlr-27183	420	12	96	96	NUM
ihlr-27183	420	13	percent	percent	NOUN
ihlr-27183	420	14	of	of	ADP
ihlr-27183	420	15	patent	patent	NOUN
ihlr-27183	420	16	infringement	infringement	NOUN
ihlr-27183	420	17	lawsuits	lawsuit	NOUN
ihlr-27183	420	18	settled	settle	VERB
ihlr-27183	420	19	before	before	ADP
ihlr-27183	420	20	trial,132	trial,132	PROPN
ihlr-27183	420	21	it	it	PRON
ihlr-27183	420	22	is	be	AUX
ihlr-27183	420	23	statistically	statistically	ADV
ihlr-27183	420	24	unlikely	unlikely	ADJ
ihlr-27183	420	25	that	that	SCONJ
ihlr-27183	420	26	an	an	DET
ihlr-27183	420	27	individual	individual	ADJ
ihlr-27183	420	28	case	case	NOUN
ihlr-27183	420	29	would	would	AUX
ihlr-27183	420	30	receive	receive	VERB
ihlr-27183	420	31	a	a	DET
ihlr-27183	420	32	written	write	VERB
ihlr-27183	420	33	opinion	opinion	NOUN
ihlr-27183	420	34	from	from	ADP
ihlr-27183	420	35	a	a	DET
ihlr-27183	420	36	judge	judge	NOUN
ihlr-27183	420	37	on	on	ADP
ihlr-27183	420	38	appeal	appeal	NOUN
ihlr-27183	420	39	,	,	PUNCT
ihlr-27183	420	40	though	though	SCONJ
ihlr-27183	420	41	a	a	DET
ihlr-27183	420	42	case	case	NOUN
ihlr-27183	420	43	is	be	AUX
ihlr-27183	420	44	slightly	slightly	ADV
ihlr-27183	420	45	more	more	ADV
ihlr-27183	420	46	likely	likely	ADJ
ihlr-27183	420	47	to	to	PART
ihlr-27183	420	48	be	be	AUX
ihlr-27183	420	49	resolved	resolve	VERB
ihlr-27183	420	50	on	on	ADP
ihlr-27183	420	51	a	a	DET
ihlr-27183	420	52	granting	granting	NOUN
ihlr-27183	420	53	of	of	ADP
ihlr-27183	420	54	summary	summary	NOUN
ihlr-27183	420	55	judgment.133	judgment.133	PROPN
ihlr-27183	420	56	with	with	ADP
ihlr-27183	420	57	some	some	DET
ihlr-27183	420	58	lawsuits	lawsuit	NOUN
ihlr-27183	420	59	being	be	AUX
ihlr-27183	420	60	dismissed	dismiss	VERB
ihlr-27183	420	61	or	or	CCONJ
ihlr-27183	420	62	abandoned	abandon	VERB
ihlr-27183	420	63	,	,	PUNCT
ihlr-27183	420	64	only	only	ADV
ihlr-27183	420	65	about	about	ADV
ihlr-27183	420	66	1.5	1.5	NUM
ihlr-27183	420	67	percent	percent	NOUN
ihlr-27183	420	68	of	of	ADP
ihlr-27183	420	69	filed	file	VERB
ihlr-27183	420	70	patent	patent	NOUN
ihlr-27183	420	71	infringement	infringement	NOUN
ihlr-27183	420	72	lawsuits	lawsuit	NOUN
ihlr-27183	420	73	are	be	AUX
ihlr-27183	420	74	litigated	litigate	VERB
ihlr-27183	420	75	to	to	ADP
ihlr-27183	420	76	a	a	DET
ihlr-27183	420	77	conclusion.134	conclusion.134	NOUN
ihlr-27183	420	78	of	of	ADP
ihlr-27183	420	79	these	these	PRON
ihlr-27183	420	80	,	,	PUNCT
ihlr-27183	420	81	however	however	ADV
ihlr-27183	420	82	,	,	PUNCT
ihlr-27183	420	83	an	an	DET
ihlr-27183	420	84	increasing	increase	VERB
ihlr-27183	420	85	number	number	NOUN
ihlr-27183	420	86	are	be	AUX
ihlr-27183	420	87	being	be	AUX
ihlr-27183	420	88	submitted	submit	VERB
ihlr-27183	420	89	to	to	ADP
ihlr-27183	420	90	a	a	DET
ihlr-27183	420	91	jury	jury	NOUN
ihlr-27183	420	92	for	for	ADP
ihlr-27183	420	93	deliberations.135	deliberations.135	NOUN
ihlr-27183	420	94	though	though	SCONJ
ihlr-27183	420	95	jury	jury	NOUN
ihlr-27183	420	96	trials	trial	NOUN
ihlr-27183	420	97	significantly	significantly	ADV
ihlr-27183	420	98	increase	increase	VERB
ihlr-27183	420	99	both	both	DET
ihlr-27183	420	100	the	the	DET
ihlr-27183	420	101	chances	chance	NOUN
ihlr-27183	420	102	a	a	DET
ihlr-27183	420	103	patent	patent	NOUN
ihlr-27183	420	104	holder	holder	NOUN
ihlr-27183	420	105	wins	win	VERB
ihlr-27183	420	106	and	and	CCONJ
ihlr-27183	420	107	their	their	PRON
ihlr-27183	420	108	corresponding	correspond	VERB
ihlr-27183	420	109	average	average	NOUN
ihlr-27183	420	110	award,136	award,136	ADV
ihlr-27183	420	111	they	they	PRON
ihlr-27183	420	112	are	be	AUX
ihlr-27183	420	113	the	the	DET
ihlr-27183	420	114	costliest	costly	ADJ
ihlr-27183	420	115	form	form	NOUN
ihlr-27183	420	116	of	of	ADP
ihlr-27183	420	117	resolution.137	resolution.137	NOUN
ihlr-27183	420	118	for	for	ADP
ihlr-27183	420	119	a	a	DET
ihlr-27183	420	120	jury	jury	NOUN
ihlr-27183	420	121	trial	trial	NOUN
ihlr-27183	420	122	to	to	PART
ihlr-27183	420	123	advance	advance	VERB
ihlr-27183	420	124	,	,	PUNCT
ihlr-27183	420	125	both	both	DET
ihlr-27183	420	126	parties	party	NOUN
ihlr-27183	420	127	must	must	AUX
ihlr-27183	420	128	sharply	sharply	ADV
ihlr-27183	420	129	disagree	disagree	VERB
ihlr-27183	420	130	on	on	ADP
ihlr-27183	420	131	what	what	DET
ihlr-27183	420	132	damages	damage	NOUN
ihlr-27183	420	133	,	,	PUNCT
ihlr-27183	420	134	if	if	SCONJ
ihlr-27183	420	135	any	any	PRON
ihlr-27183	420	136	,	,	PUNCT
ihlr-27183	420	137	will	will	AUX
ihlr-27183	420	138	restore	restore	VERB
ihlr-27183	420	139	the	the	DET
ihlr-27183	420	140	interests	interest	NOUN
ihlr-27183	420	141	of	of	ADP
ihlr-27183	420	142	the	the	DET
ihlr-27183	420	143	plaintiff	plaintiff	NOUN
ihlr-27183	420	144	.	.	PUNCT
ihlr-27183	421	1	for	for	ADP
ihlr-27183	421	2	cases	case	NOUN
ihlr-27183	421	3	of	of	ADP
ihlr-27183	421	4	ordinary	ordinary	ADJ
ihlr-27183	421	5	circumstances	circumstance	NOUN
ihlr-27183	421	6	–	–	PUNCT
ihlr-27183	421	7	where	where	SCONJ
ihlr-27183	421	8	damages	damage	NOUN
ihlr-27183	421	9	from	from	ADP
ihlr-27183	421	10	comparable	comparable	ADJ
ihlr-27183	421	11	lawsuits	lawsuit	NOUN
ihlr-27183	421	12	are	be	AUX
ihlr-27183	421	13	readily	readily	ADV
ihlr-27183	421	14	available	available	ADJ
ihlr-27183	421	15	–	–	PUNCT
ihlr-27183	421	16	settlement	settlement	NOUN
ihlr-27183	421	17	is	be	AUX
ihlr-27183	421	18	likely	likely	ADJ
ihlr-27183	421	19	in	in	ADP
ihlr-27183	421	20	the	the	DET
ihlr-27183	421	21	best	good	ADJ
ihlr-27183	421	22	interest	interest	NOUN
ihlr-27183	421	23	of	of	ADP
ihlr-27183	421	24	both	both	DET
ihlr-27183	421	25	plaintiff	plaintiff	NOUN
ihlr-27183	421	26	and	and	CCONJ
ihlr-27183	421	27	defendant	defendant	NOUN
ihlr-27183	421	28	.	.	PUNCT
ihlr-27183	422	1	time	time	NOUN
ihlr-27183	422	2	and	and	CCONJ
ihlr-27183	422	3	resources	resource	NOUN
ihlr-27183	422	4	consumed	consume	VERB
ihlr-27183	422	5	by	by	ADP
ihlr-27183	422	6	trial	trial	NOUN
ihlr-27183	422	7	are	be	AUX
ihlr-27183	422	8	often	often	ADV
ihlr-27183	422	9	not	not	PART
ihlr-27183	422	10	worth	worth	ADJ
ihlr-27183	422	11	the	the	DET
ihlr-27183	422	12	statistically	statistically	ADV
ihlr-27183	422	13	larger	large	ADJ
ihlr-27183	422	14	award	award	NOUN
ihlr-27183	422	15	.	.	PUNCT
ihlr-27183	423	1	allele	allele	PROPN
ihlr-27183	423	2	,	,	PUNCT
ihlr-27183	423	3	however	however	ADV
ihlr-27183	423	4	,	,	PUNCT
ihlr-27183	423	5	filed	file	VERB
ihlr-27183	423	6	a	a	DET
ihlr-27183	423	7	case	case	NOUN
ihlr-27183	423	8	against	against	ADP
ihlr-27183	423	9	pfizer	pfizer	NOUN
ihlr-27183	423	10	which	which	PRON
ihlr-27183	423	11	was	be	AUX
ihlr-27183	423	12	not	not	PART
ihlr-27183	423	13	average	average	ADJ
ihlr-27183	423	14	in	in	ADP
ihlr-27183	423	15	several	several	ADJ
ihlr-27183	423	16	respects	respect	NOUN
ihlr-27183	423	17	.	.	PUNCT
ihlr-27183	424	1	it	it	PRON
ihlr-27183	424	2	was	be	AUX
ihlr-27183	424	3	arguably	arguably	ADV
ihlr-27183	424	4	worth	worth	ADJ
ihlr-27183	424	5	an	an	DET
ihlr-27183	424	6	extraordinary	extraordinary	ADJ
ihlr-27183	424	7	reward	reward	NOUN
ihlr-27183	424	8	.	.	PUNCT
ihlr-27183	425	1	when	when	SCONJ
ihlr-27183	425	2	viewed	view	VERB
ihlr-27183	425	3	as	as	ADP
ihlr-27183	425	4	a	a	DET
ihlr-27183	425	5	single	single	ADJ
ihlr-27183	425	6	industry	industry	NOUN
ihlr-27183	425	7	,	,	PUNCT
ihlr-27183	425	8	biotech	biotech	NOUN
ihlr-27183	425	9	and	and	CCONJ
ihlr-27183	425	10	pharmaceuticals	pharmaceutical	NOUN
ihlr-27183	425	11	garner	garner	NOUN
ihlr-27183	425	12	infringement	infringement	NOUN
ihlr-27183	425	13	damages	damage	NOUN
ihlr-27183	425	14	which	which	PRON
ihlr-27183	425	15	dwarf	dwarf	VERB
ihlr-27183	425	16	those	those	PRON
ihlr-27183	425	17	of	of	ADP
ihlr-27183	425	18	other	other	ADJ
ihlr-27183	425	19	industries.138	industries.138	PROPN
ihlr-27183	425	20	further	far	ADV
ihlr-27183	425	21	,	,	PUNCT
ihlr-27183	425	22	pfizer	pfizer	NOUN
ihlr-27183	425	23	has	have	AUX
ihlr-27183	425	24	made	make	VERB
ihlr-27183	425	25	a	a	DET
ihlr-27183	425	26	veritable	veritable	ADJ
ihlr-27183	425	27	fortune	fortune	NOUN
ihlr-27183	425	28	from	from	ADP
ihlr-27183	425	29	the	the	DET
ihlr-27183	425	30	vaccine.139	vaccine.139	NOUN
ihlr-27183	425	31	if	if	SCONJ
ihlr-27183	425	32	allele	allele	NOUN
ihlr-27183	425	33	had	have	AUX
ihlr-27183	425	34	been	be	AUX
ihlr-27183	425	35	left	leave	VERB
ihlr-27183	425	36	to	to	PART
ihlr-27183	425	37	convince	convince	VERB
ihlr-27183	425	38	a	a	DET
ihlr-27183	425	39	jury	jury	NOUN
ihlr-27183	425	40	pfizer	pfizer	NOUN
ihlr-27183	425	41	was	be	AUX
ihlr-27183	425	42	first	first	ADJ
ihlr-27183	425	43	to	to	ADP
ihlr-27183	425	44	an	an	DET
ihlr-27183	425	45	effective	effective	ADJ
ihlr-27183	425	46	therapeutic	therapeutic	NOUN
ihlr-27183	425	47	because	because	SCONJ
ihlr-27183	425	48	of	of	ADP
ihlr-27183	425	49	a	a	DET
ihlr-27183	425	50	deliberate	deliberate	ADJ
ihlr-27183	425	51	and	and	CCONJ
ihlr-27183	425	52	unauthorized	unauthorized	ADJ
ihlr-27183	425	53	use	use	NOUN
ihlr-27183	425	54	of	of	ADP
ihlr-27183	425	55	mneongreen	mneongreen	NOUN
ihlr-27183	425	56	,	,	PUNCT
ihlr-27183	425	57	allele	allele	NOUN
ihlr-27183	425	58	would	would	AUX
ihlr-27183	425	59	have	have	AUX
ihlr-27183	425	60	also	also	ADV
ihlr-27183	425	61	happily	happily	ADV
ihlr-27183	425	62	asked	ask	VERB
ihlr-27183	425	63	that	that	DET
ihlr-27183	425	64	jury	jury	NOUN
ihlr-27183	425	65	to	to	PART
ihlr-27183	425	66	consider	consider	VERB
ihlr-27183	425	67	exactly	exactly	ADV
ihlr-27183	425	68	131	131	NUM
ihlr-27183	425	69	.	.	PUNCT
ihlr-27183	426	1	i	i	PRON
ihlr-27183	426	2	d.	d.	PROPN
ihlr-27183	426	3	132	132	NUM
ihlr-27183	426	4	.	.	PUNCT
ihlr-27183	427	1	branka	branka	PROPN
ihlr-27183	427	2	vuleta	vuleta	PROPN
ihlr-27183	427	3	,	,	PUNCT
ihlr-27183	427	4	25	25	NUM
ihlr-27183	427	5	patent	patent	NOUN
ihlr-27183	427	6	litigation	litigation	NOUN
ihlr-27183	427	7	statistics	statistic	NOUN
ihlr-27183	427	8	-	-	PUNCT
ihlr-27183	427	9	high	high	ADJ
ihlr-27183	427	10	-	-	PUNCT
ihlr-27183	427	11	profile	profile	NOUN
ihlr-27183	427	12	feuds	feud	NOUN
ihlr-27183	427	13	about	about	ADP
ihlr-27183	427	14	intellectual	intellectual	ADJ
ihlr-27183	427	15	property	property	NOUN
ihlr-27183	427	16	,	,	PUNCT
ihlr-27183	427	17	legaljobs	legaljobs	PROPN
ihlr-27183	427	18	(	(	PUNCT
ihlr-27183	427	19	aug	aug	PROPN
ihlr-27183	427	20	.	.	PROPN
ihlr-27183	427	21	6	6	NUM
ihlr-27183	427	22	,	,	PUNCT
ihlr-27183	427	23	2021	2021	NUM
ihlr-27183	427	24	)	)	PUNCT
ihlr-27183	427	25	,	,	PUNCT
ihlr-27183	427	26	https://legaljobs.io/blog/patent-litigation-statistics/#:~:text=	https://legaljobs.io/blog/patent-litigation-statistics/#:~:text=	NOUN
ihlr-27183	427	27	a%3a	a%3a	PROPN
ihlr-27183	427	28	,	,	PUNCT
ihlr-27183	427	29	year%20in%20the%20united%20states	year%20in%20the%20united%20state	VERB
ihlr-27183	428	1	[	[	X
ihlr-27183	428	2	https://perma.cc/w59f-xz7h	https://perma.cc/w59f-xz7h	X
ihlr-27183	428	3	]	]	X
ihlr-27183	428	4	.	.	PUNCT
ihlr-27183	429	1	133	133	NUM
ihlr-27183	429	2	.	.	PUNCT
ihlr-27183	430	1	i	i	PRON
ihlr-27183	430	2	d.	d.	PROPN
ihlr-27183	430	3	134	134	NUM
ihlr-27183	430	4	.	.	PUNCT
ihlr-27183	431	1	i	i	PRON
ihlr-27183	431	2	d.	d.	PROPN
ihlr-27183	431	3	135	135	NUM
ihlr-27183	431	4	.	.	PUNCT
ihlr-27183	432	1	i	i	PRON
ihlr-27183	432	2	d.	d.	PROPN
ihlr-27183	432	3	136	136	NUM
ihlr-27183	432	4	.	.	PUNCT
ihlr-27183	433	1	landan	landan	PROPN
ihlr-27183	433	2	ansell	ansell	PROPN
ihlr-27183	433	3	et	et	PROPN
ihlr-27183	433	4	al	al	PROPN
ihlr-27183	433	5	.	.	PROPN
ihlr-27183	433	6	,	,	PUNCT
ihlr-27183	433	7	2018	2018	NUM
ihlr-27183	433	8	patent	patent	NOUN
ihlr-27183	433	9	litigation	litigation	NOUN
ihlr-27183	433	10	study	study	NOUN
ihlr-27183	433	11	,	,	PUNCT
ihlr-27183	433	12	price	price	NOUN
ihlr-27183	433	13	waterhouse	waterhouse	NOUN
ihlr-27183	433	14	coopers	cooper	NOUN
ihlr-27183	433	15	1	1	NUM
ihlr-27183	433	16	,	,	PUNCT
ihlr-27183	433	17	6	6	NUM
ihlr-27183	433	18	-	-	SYM
ihlr-27183	433	19	7	7	NUM
ihlr-27183	433	20	(	(	PUNCT
ihlr-27183	433	21	may	may	PROPN
ihlr-27183	433	22	2018	2018	NUM
ihlr-27183	433	23	)	)	PUNCT
ihlr-27183	433	24	,	,	PUNCT
ihlr-27183	433	25	https://www.ipwatchdog.com/wp-content/uploads/2018/09/2018-pwc-patent-litigationstudy.pdf	https://www.ipwatchdog.com/wp-content/uploads/2018/09/2018-pwc-patent-litigationstudy.pdf	NOUN
ihlr-27183	434	1	[	[	X
ihlr-27183	434	2	https://perma.cc/8hn5-33cq	https://perma.cc/8hn5-33cq	X
ihlr-27183	434	3	]	]	X
ihlr-27183	434	4	.	.	PUNCT
ihlr-27183	435	1	137	137	NUM
ihlr-27183	435	2	.	.	PUNCT
ihlr-27183	436	1	vuleta	vuleta	NOUN
ihlr-27183	436	2	,	,	PUNCT
ihlr-27183	436	3	supra	supra	PROPN
ihlr-27183	436	4	note	note	PROPN
ihlr-27183	436	5	132	132	NUM
ihlr-27183	436	6	.	.	NUM
ihlr-27183	436	7	138	138	NUM
ihlr-27183	436	8	.	.	PUNCT
ihlr-27183	437	1	ansell	ansell	PROPN
ihlr-27183	437	2	et	et	PROPN
ihlr-27183	437	3	al	al	PROPN
ihlr-27183	437	4	.	.	PROPN
ihlr-27183	437	5	,	,	PUNCT
ihlr-27183	437	6	supra	supra	PROPN
ihlr-27183	437	7	note	note	PROPN
ihlr-27183	437	8	136	136	NUM
ihlr-27183	437	9	(	(	PUNCT
ihlr-27183	437	10	in	in	ADP
ihlr-27183	437	11	a	a	DET
ihlr-27183	437	12	20	20	NUM
ihlr-27183	437	13	-	-	PUNCT
ihlr-27183	437	14	year	year	NOUN
ihlr-27183	437	15	study	study	NOUN
ihlr-27183	437	16	where	where	SCONJ
ihlr-27183	437	17	the	the	DET
ihlr-27183	437	18	median	median	ADJ
ihlr-27183	437	19	damage	damage	NOUN
ihlr-27183	437	20	award	award	NOUN
ihlr-27183	437	21	over	over	ADP
ihlr-27183	437	22	all	all	DET
ihlr-27183	437	23	industries	industry	NOUN
ihlr-27183	437	24	was	be	AUX
ihlr-27183	437	25	$	$	SYM
ihlr-27183	437	26	5.9	5.9	NUM
ihlr-27183	437	27	million	million	NUM
ihlr-27183	437	28	,	,	PUNCT
ihlr-27183	437	29	the	the	DET
ihlr-27183	437	30	biotech	biotech	NOUN
ihlr-27183	437	31	/	/	SYM
ihlr-27183	437	32	pharma	pharma	NOUN
ihlr-27183	437	33	industry	industry	NOUN
ihlr-27183	437	34	had	have	AUX
ihlr-27183	437	35	a	a	DET
ihlr-27183	437	36	median	median	ADJ
ihlr-27183	437	37	award	award	NOUN
ihlr-27183	437	38	per	per	ADP
ihlr-27183	437	39	case	case	NOUN
ihlr-27183	437	40	exceeding	exceed	VERB
ihlr-27183	437	41	$	$	SYM
ihlr-27183	437	42	20	20	NUM
ihlr-27183	437	43	million	million	NUM
ihlr-27183	437	44	)	)	PUNCT
ihlr-27183	437	45	.	.	PUNCT
ihlr-27183	438	1	139	139	NUM
ihlr-27183	438	2	.	.	X
ihlr-27183	438	3	zachary	zachary	PROPN
ihlr-27183	438	4	brennan	brennan	PROPN
ihlr-27183	438	5	,	,	PUNCT
ihlr-27183	438	6	moderna	moderna	PROPN
ihlr-27183	438	7	's	's	PART
ihlr-27183	438	8	covid-19	covid-19	PROPN
ihlr-27183	438	9	vaccine	vaccine	NOUN
ihlr-27183	438	10	sales	sale	NOUN
ihlr-27183	438	11	to	to	PART
ihlr-27183	438	12	trail	trail	NOUN
ihlr-27183	438	13	pfizer	pfizer	NOUN
ihlr-27183	438	14	's	's	PART
ihlr-27183	438	15	total	total	NOUN
ihlr-27183	438	16	significantly	significantly	ADV
ihlr-27183	438	17	in	in	ADP
ihlr-27183	438	18	2021	2021	NUM
ihlr-27183	438	19	and	and	CCONJ
ihlr-27183	438	20	2022	2022	NUM
ihlr-27183	438	21	,	,	PUNCT
ihlr-27183	438	22	endpoints	endpoint	NOUN
ihlr-27183	438	23	news	news	PROPN
ihlr-27183	438	24	(	(	PUNCT
ihlr-27183	438	25	aug	aug	PROPN
ihlr-27183	438	26	.	.	PROPN
ihlr-27183	438	27	5	5	NUM
ihlr-27183	438	28	,	,	PUNCT
ihlr-27183	438	29	2021	2021	NUM
ihlr-27183	438	30	)	)	PUNCT
ihlr-27183	438	31	,	,	PUNCT
ihlr-27183	438	32	https://endpts.com/modernas-covid-19vaccine-sales-to-trail-pfizers-total-significantly-in-2021-and-2022/	https://endpts.com/modernas-covid-19vaccine-sales-to-trail-pfizers-total-significantly-in-2021-and-2022/	VERB
ihlr-27183	438	33	[	[	X
ihlr-27183	438	34	https://perma.cc/a8j4-33eb	https://perma.cc/a8j4-33eb	X
ihlr-27183	438	35	]	]	X
ihlr-27183	438	36	.	.	PUNCT
ihlr-27183	439	1	2023	2023	NUM
ihlr-27183	439	2	]	]	PUNCT
ihlr-27183	439	3	the	the	DET
ihlr-27183	439	4	safe	safe	ADJ
ihlr-27183	439	5	harbor	harbor	NOUN
ihlr-27183	439	6	of	of	ADP
ihlr-27183	439	7	35	35	NUM
ihlr-27183	439	8	u.s.c	u.s.c	ADJ
ihlr-27183	439	9	.	.	PUNCT
ihlr-27183	440	1	§	§	PROPN
ihlr-27183	440	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	440	3	)	)	PUNCT
ihlr-27183	440	4	161	161	NUM
ihlr-27183	441	1	what	what	PRON
ihlr-27183	441	2	part	part	NOUN
ihlr-27183	441	3	of	of	ADP
ihlr-27183	441	4	pfizer	pfizer	PROPN
ihlr-27183	441	5	’s	’s	PART
ihlr-27183	441	6	projected	project	VERB
ihlr-27183	441	7	$	$	SYM
ihlr-27183	441	8	33	33	NUM
ihlr-27183	441	9	billion	billion	NUM
ihlr-27183	441	10	in	in	ADP
ihlr-27183	441	11	2021	2021	NUM
ihlr-27183	441	12	revenue	revenue	NOUN
ihlr-27183	441	13	belongs	belong	VERB
ihlr-27183	441	14	to	to	ADP
ihlr-27183	441	15	allele.140	allele.140	NOUN
ihlr-27183	441	16	though	though	SCONJ
ihlr-27183	441	17	pfizer	pfizer	NOUN
ihlr-27183	441	18	has	have	AUX
ihlr-27183	441	19	settled	settle	VERB
ihlr-27183	441	20	,	,	PUNCT
ihlr-27183	441	21	an	an	DET
ihlr-27183	441	22	analogous	analogous	ADJ
ihlr-27183	441	23	consideration	consideration	NOUN
ihlr-27183	441	24	applies	apply	VERB
ihlr-27183	441	25	against	against	ADP
ihlr-27183	441	26	regeneron	regeneron	NOUN
ihlr-27183	441	27	with	with	ADP
ihlr-27183	441	28	respect	respect	NOUN
ihlr-27183	441	29	to	to	ADP
ihlr-27183	441	30	the	the	DET
ihlr-27183	441	31	wide	wide	ADJ
ihlr-27183	441	32	use	use	NOUN
ihlr-27183	441	33	of	of	ADP
ihlr-27183	441	34	its	its	PRON
ihlr-27183	441	35	antibody	antibody	NOUN
ihlr-27183	441	36	cocktail	cocktail	NOUN
ihlr-27183	441	37	–	–	PUNCT
ihlr-27183	441	38	including	include	VERB
ihlr-27183	441	39	the	the	DET
ihlr-27183	441	40	high	high	ADJ
ihlr-27183	441	41	-	-	PUNCT
ihlr-27183	441	42	profile	profile	NOUN
ihlr-27183	441	43	treatment	treatment	NOUN
ihlr-27183	441	44	of	of	ADP
ihlr-27183	441	45	then	then	ADV
ihlr-27183	441	46	-	-	PUNCT
ihlr-27183	441	47	president	president	PROPN
ihlr-27183	441	48	donald	donald	PROPN
ihlr-27183	441	49	trump	trump	PROPN
ihlr-27183	441	50	,	,	PUNCT
ihlr-27183	441	51	after	after	SCONJ
ihlr-27183	441	52	he	he	PRON
ihlr-27183	441	53	contracted	contract	VERB
ihlr-27183	441	54	the	the	DET
ihlr-27183	441	55	illness	illness	NOUN
ihlr-27183	441	56	prior	prior	ADV
ihlr-27183	441	57	to	to	ADP
ihlr-27183	441	58	vaccine	vaccine	NOUN
ihlr-27183	441	59	availability	availability	NOUN
ihlr-27183	441	60	.	.	PUNCT
ihlr-27183	442	1	pleadings	pleading	NOUN
ihlr-27183	442	2	in	in	ADP
ihlr-27183	442	3	both	both	DET
ihlr-27183	442	4	cases	case	NOUN
ihlr-27183	442	5	force	force	VERB
ihlr-27183	442	6	an	an	DET
ihlr-27183	442	7	answer	answer	NOUN
ihlr-27183	442	8	on	on	ADP
ihlr-27183	442	9	the	the	DET
ihlr-27183	442	10	research	research	NOUN
ihlr-27183	442	11	tool	tool	NOUN
ihlr-27183	442	12	question	question	NOUN
ihlr-27183	442	13	–	–	PUNCT
ihlr-27183	442	14	an	an	DET
ihlr-27183	442	15	unresolved	unresolved	ADJ
ihlr-27183	442	16	conflict	conflict	NOUN
ihlr-27183	442	17	which	which	PRON
ihlr-27183	442	18	has	have	AUX
ihlr-27183	442	19	garnered	garner	VERB
ihlr-27183	442	20	much	much	ADJ
ihlr-27183	442	21	attention	attention	NOUN
ihlr-27183	442	22	.	.	PUNCT
ihlr-27183	443	1	though	though	SCONJ
ihlr-27183	443	2	allele	allele	NOUN
ihlr-27183	443	3	has	have	AUX
ihlr-27183	443	4	resolved	resolve	VERB
ihlr-27183	443	5	pfizer	pfizer	NOUN
ihlr-27183	443	6	’s	’s	PART
ihlr-27183	443	7	case	case	NOUN
ihlr-27183	443	8	without	without	ADP
ihlr-27183	443	9	option	option	NOUN
ihlr-27183	443	10	to	to	PART
ihlr-27183	443	11	refile	refile	VERB
ihlr-27183	443	12	,	,	PUNCT
ihlr-27183	443	13	it	it	PRON
ihlr-27183	443	14	is	be	AUX
ihlr-27183	443	15	conceivable	conceivable	ADJ
ihlr-27183	443	16	that	that	SCONJ
ihlr-27183	443	17	amicus	amicus	NOUN
ihlr-27183	443	18	briefs	brief	NOUN
ihlr-27183	443	19	and	and	CCONJ
ihlr-27183	443	20	similarly	similarly	ADV
ihlr-27183	443	21	interested	interested	ADJ
ihlr-27183	443	22	parties	party	NOUN
ihlr-27183	443	23	would	would	AUX
ihlr-27183	443	24	aptly	aptly	ADV
ihlr-27183	443	25	vie	vie	VERB
ihlr-27183	443	26	for	for	ADP
ihlr-27183	443	27	resolution	resolution	NOUN
ihlr-27183	443	28	on	on	ADP
ihlr-27183	443	29	this	this	DET
ihlr-27183	443	30	issue	issue	NOUN
ihlr-27183	443	31	.	.	PUNCT
ihlr-27183	444	1	this	this	DET
ihlr-27183	444	2	factor	factor	NOUN
ihlr-27183	444	3	suggests	suggest	VERB
ihlr-27183	444	4	regeneron	regeneron	PROPN
ihlr-27183	444	5	’s	’s	PART
ihlr-27183	444	6	case	case	NOUN
ihlr-27183	444	7	may	may	AUX
ihlr-27183	444	8	be	be	AUX
ihlr-27183	444	9	ripe	ripe	ADJ
ihlr-27183	444	10	for	for	ADP
ihlr-27183	444	11	escalation	escalation	NOUN
ihlr-27183	444	12	to	to	ADP
ihlr-27183	444	13	higher	high	ADJ
ihlr-27183	444	14	courts	court	NOUN
ihlr-27183	444	15	.	.	PUNCT
ihlr-27183	445	1	high	high	ADJ
ihlr-27183	445	2	-	-	PUNCT
ihlr-27183	445	3	profile	profile	NOUN
ihlr-27183	445	4	players	player	NOUN
ihlr-27183	445	5	produced	produce	VERB
ihlr-27183	445	6	a	a	DET
ihlr-27183	445	7	product	product	NOUN
ihlr-27183	445	8	which	which	PRON
ihlr-27183	445	9	has	have	AUX
ihlr-27183	445	10	become	become	VERB
ihlr-27183	445	11	a	a	DET
ihlr-27183	445	12	household	household	NOUN
ihlr-27183	445	13	name	name	NOUN
ihlr-27183	445	14	on	on	ADP
ihlr-27183	445	15	a	a	DET
ihlr-27183	445	16	global	global	ADJ
ihlr-27183	445	17	scale	scale	NOUN
ihlr-27183	445	18	–	–	PUNCT
ihlr-27183	445	19	largely	largely	ADV
ihlr-27183	445	20	due	due	ADJ
ihlr-27183	445	21	to	to	ADP
ihlr-27183	445	22	the	the	DET
ihlr-27183	445	23	significance	significance	NOUN
ihlr-27183	445	24	of	of	ADP
ihlr-27183	445	25	the	the	DET
ihlr-27183	445	26	covid-19	covid-19	PROPN
ihlr-27183	445	27	outbreak.141	outbreak.141	VERB
ihlr-27183	445	28	the	the	DET
ihlr-27183	445	29	accompanying	accompany	VERB
ihlr-27183	445	30	money	money	NOUN
ihlr-27183	445	31	,	,	PUNCT
ihlr-27183	445	32	motive	motive	NOUN
ihlr-27183	445	33	,	,	PUNCT
ihlr-27183	445	34	and	and	CCONJ
ihlr-27183	445	35	resources	resource	NOUN
ihlr-27183	445	36	may	may	AUX
ihlr-27183	445	37	help	help	VERB
ihlr-27183	445	38	extrude	extrude	VERB
ihlr-27183	445	39	a	a	DET
ihlr-27183	445	40	final	final	ADJ
ihlr-27183	445	41	answer	answer	NOUN
ihlr-27183	445	42	to	to	ADP
ihlr-27183	445	43	the	the	DET
ihlr-27183	445	44	research	research	NOUN
ihlr-27183	445	45	tool	tool	NOUN
ihlr-27183	445	46	question	question	NOUN
ihlr-27183	445	47	.	.	PUNCT
ihlr-27183	446	1	iv	iv	X
ihlr-27183	446	2	.	.	PUNCT
ihlr-27183	446	3	analysis	analysis	NOUN
ihlr-27183	446	4	a.	a.	NOUN
ihlr-27183	446	5	on	on	ADP
ihlr-27183	446	6	the	the	DET
ihlr-27183	446	7	denial	denial	NOUN
ihlr-27183	446	8	of	of	ADP
ihlr-27183	446	9	motions	motion	NOUN
ihlr-27183	446	10	for	for	ADP
ihlr-27183	446	11	summary	summary	NOUN
ihlr-27183	446	12	judgement	judgement	NOUN
ihlr-27183	446	13	1	1	NUM
ihlr-27183	446	14	.	.	PUNCT
ihlr-27183	447	1	right	right	ADJ
ihlr-27183	447	2	outcome	outcome	NOUN
ihlr-27183	447	3	it	it	PRON
ihlr-27183	447	4	is	be	AUX
ihlr-27183	447	5	helpful	helpful	ADJ
ihlr-27183	447	6	to	to	PART
ihlr-27183	447	7	understand	understand	VERB
ihlr-27183	447	8	the	the	DET
ihlr-27183	447	9	significance	significance	NOUN
ihlr-27183	447	10	of	of	ADP
ihlr-27183	447	11	the	the	DET
ihlr-27183	447	12	denial	denial	NOUN
ihlr-27183	447	13	to	to	PART
ihlr-27183	447	14	grant	grant	VERB
ihlr-27183	447	15	pfizer	pfizer	NOUN
ihlr-27183	447	16	’s	’s	PART
ihlr-27183	447	17	motion	motion	NOUN
ihlr-27183	447	18	to	to	PART
ihlr-27183	447	19	dismiss	dismiss	VERB
ihlr-27183	447	20	.	.	PUNCT
ihlr-27183	448	1	pfizer	pfizer	PROPN
ihlr-27183	448	2	asserted	assert	VERB
ihlr-27183	448	3	a	a	DET
ihlr-27183	448	4	motion	motion	NOUN
ihlr-27183	448	5	to	to	PART
ihlr-27183	448	6	dismiss	dismiss	VERB
ihlr-27183	448	7	because	because	SCONJ
ihlr-27183	448	8	of	of	ADP
ihlr-27183	448	9	allele	allele	PROPN
ihlr-27183	448	10	’s	’s	PART
ihlr-27183	448	11	alleged	alleged	ADJ
ihlr-27183	448	12	“	"	PUNCT
ihlr-27183	448	13	failure	failure	NOUN
ihlr-27183	448	14	to	to	PART
ihlr-27183	448	15	state	state	VERB
ihlr-27183	448	16	a	a	DET
ihlr-27183	448	17	claim	claim	NOUN
ihlr-27183	448	18	upon	upon	SCONJ
ihlr-27183	448	19	which	which	DET
ihlr-27183	448	20	relief	relief	NOUN
ihlr-27183	448	21	can	can	AUX
ihlr-27183	448	22	be	be	AUX
ihlr-27183	448	23	granted	grant	VERB
ihlr-27183	448	24	.	.	PUNCT
ihlr-27183	449	1	”142	”142	PRON
ihlr-27183	449	2	for	for	ADP
ihlr-27183	449	3	this	this	DET
ihlr-27183	449	4	motion	motion	NOUN
ihlr-27183	449	5	to	to	PART
ihlr-27183	449	6	succeed	succeed	VERB
ihlr-27183	449	7	against	against	ADP
ihlr-27183	449	8	the	the	DET
ihlr-27183	449	9	plaintiff	plaintiff	NOUN
ihlr-27183	449	10	,	,	PUNCT
ihlr-27183	449	11	the	the	DET
ihlr-27183	449	12	pleadings	pleading	NOUN
ihlr-27183	449	13	must	must	AUX
ihlr-27183	449	14	not	not	PART
ihlr-27183	449	15	contain	contain	VERB
ihlr-27183	449	16	“	"	PUNCT
ihlr-27183	449	17	enough	enough	ADJ
ihlr-27183	449	18	facts	fact	NOUN
ihlr-27183	449	19	to	to	PART
ihlr-27183	449	20	state	state	VERB
ihlr-27183	449	21	a	a	DET
ihlr-27183	449	22	claim	claim	NOUN
ihlr-27183	449	23	to	to	ADP
ihlr-27183	449	24	relief	relief	NOUN
ihlr-27183	449	25	that	that	PRON
ihlr-27183	449	26	is	be	AUX
ihlr-27183	449	27	plausible	plausible	ADJ
ihlr-27183	449	28	on	on	ADP
ihlr-27183	449	29	its	its	PRON
ihlr-27183	449	30	face	face	NOUN
ihlr-27183	449	31	.	.	PUNCT
ihlr-27183	449	32	”143	”143	NOUN
ihlr-27183	449	33	in	in	ADP
ihlr-27183	449	34	determining	determine	VERB
ihlr-27183	449	35	this	this	PRON
ihlr-27183	449	36	,	,	PUNCT
ihlr-27183	449	37	the	the	DET
ihlr-27183	449	38	court	court	NOUN
ihlr-27183	449	39	may	may	AUX
ihlr-27183	449	40	ignore	ignore	VERB
ihlr-27183	449	41	naked	naked	ADJ
ihlr-27183	449	42	assertions	assertion	NOUN
ihlr-27183	449	43	and	and	CCONJ
ihlr-27183	449	44	legal	legal	ADJ
ihlr-27183	449	45	conclusions	conclusion	NOUN
ihlr-27183	449	46	,	,	PUNCT
ihlr-27183	449	47	amounting	amount	VERB
ihlr-27183	449	48	to	to	ADP
ihlr-27183	449	49	formulaic	formulaic	ADJ
ihlr-27183	449	50	recitations	recitation	NOUN
ihlr-27183	449	51	of	of	ADP
ihlr-27183	449	52	the	the	DET
ihlr-27183	449	53	elements	element	NOUN
ihlr-27183	449	54	of	of	ADP
ihlr-27183	449	55	the	the	DET
ihlr-27183	449	56	cause	cause	NOUN
ihlr-27183	449	57	of	of	ADP
ihlr-27183	449	58	action	action	NOUN
ihlr-27183	449	59	–	–	PUNCT
ihlr-27183	449	60	but	but	CCONJ
ihlr-27183	449	61	only	only	ADV
ihlr-27183	449	62	when	when	SCONJ
ihlr-27183	449	63	they	they	PRON
ihlr-27183	449	64	are	be	AUX
ihlr-27183	449	65	lacking	lack	VERB
ihlr-27183	449	66	further	far	ADV
ihlr-27183	449	67	factual	factual	ADJ
ihlr-27183	449	68	enhancement.144	enhancement.144	PROPN
ihlr-27183	449	69	the	the	DET
ihlr-27183	449	70	burden	burden	NOUN
ihlr-27183	449	71	of	of	ADP
ihlr-27183	449	72	establishing	establish	VERB
ihlr-27183	449	73	a	a	DET
ihlr-27183	449	74	facially	facially	ADV
ihlr-27183	449	75	plausible	plausible	ADJ
ihlr-27183	449	76	claim	claim	NOUN
ihlr-27183	449	77	rests	rest	VERB
ihlr-27183	449	78	with	with	ADP
ihlr-27183	449	79	the	the	DET
ihlr-27183	449	80	plaintiff	plaintiff	NOUN
ihlr-27183	449	81	and	and	CCONJ
ihlr-27183	449	82	factual	factual	ADJ
ihlr-27183	449	83	disagreement	disagreement	NOUN
ihlr-27183	449	84	is	be	AUX
ihlr-27183	449	85	to	to	PART
ihlr-27183	449	86	be	be	AUX
ihlr-27183	449	87	resolved	resolve	VERB
ihlr-27183	449	88	in	in	ADP
ihlr-27183	449	89	favor	favor	NOUN
ihlr-27183	449	90	of	of	ADP
ihlr-27183	449	91	the	the	DET
ihlr-27183	449	92	nonmoving	nonmoving	NOUN
ihlr-27183	449	93	party.145	party.145	NOUN
ihlr-27183	449	94	after	after	SCONJ
ihlr-27183	449	95	a	a	DET
ihlr-27183	449	96	conforming	conform	VERB
ihlr-27183	449	97	rule	rule	NOUN
ihlr-27183	449	98	8	8	NUM
ihlr-27183	449	99	pleading	pleading	NOUN
ihlr-27183	449	100	is	be	AUX
ihlr-27183	449	101	submitted	submit	VERB
ihlr-27183	449	102	by	by	ADP
ihlr-27183	449	103	the	the	DET
ihlr-27183	449	104	plaintiff	plaintiff	NOUN
ihlr-27183	449	105	,	,	PUNCT
ihlr-27183	449	106	the	the	DET
ihlr-27183	449	107	burden	burden	NOUN
ihlr-27183	449	108	then	then	ADV
ihlr-27183	449	109	shifts	shift	NOUN
ihlr-27183	449	110	to	to	ADP
ihlr-27183	449	111	the	the	DET
ihlr-27183	449	112	defendant	defendant	NOUN
ihlr-27183	449	113	to	to	PART
ihlr-27183	449	114	show	show	VERB
ihlr-27183	449	115	,	,	PUNCT
ihlr-27183	449	116	even	even	ADV
ihlr-27183	449	117	if	if	SCONJ
ihlr-27183	449	118	the	the	DET
ihlr-27183	449	119	alleged	allege	VERB
ihlr-27183	449	120	facts	fact	NOUN
ihlr-27183	449	121	are	be	AUX
ihlr-27183	449	122	true	true	ADJ
ihlr-27183	449	123	,	,	PUNCT
ihlr-27183	449	124	the	the	DET
ihlr-27183	449	125	plaintiff	plaintiff	NOUN
ihlr-27183	449	126	would	would	AUX
ihlr-27183	449	127	not	not	PART
ihlr-27183	449	128	be	be	AUX
ihlr-27183	449	129	positioned	position	VERB
ihlr-27183	449	130	to	to	PART
ihlr-27183	449	131	collect	collect	VERB
ihlr-27183	449	132	any	any	DET
ihlr-27183	449	133	remedy.146	remedy.146	NOUN
ihlr-27183	449	134	here	here	ADV
ihlr-27183	449	135	,	,	PUNCT
ihlr-27183	449	136	pfizer	pfizer	PROPN
ihlr-27183	449	137	’s	’s	PART
ihlr-27183	449	138	argument	argument	NOUN
ihlr-27183	449	139	rested	rest	VERB
ihlr-27183	449	140	principally	principally	ADV
ihlr-27183	449	141	on	on	ADP
ihlr-27183	449	142	the	the	DET
ihlr-27183	449	143	safe	safe	ADJ
ihlr-27183	449	144	harbor	harbor	NOUN
ihlr-27183	449	145	for	for	SCONJ
ihlr-27183	449	146	protection	protection	NOUN
ihlr-27183	449	147	to	to	PART
ihlr-27183	449	148	bar	bar	NOUN
ihlr-27183	449	149	allele	allele	NOUN
ihlr-27183	449	150	from	from	ADP
ihlr-27183	449	151	any	any	DET
ihlr-27183	449	152	recovery	recovery	NOUN
ihlr-27183	449	153	.	.	PUNCT
ihlr-27183	450	1	with	with	ADP
ihlr-27183	450	2	the	the	DET
ihlr-27183	450	3	scope	scope	NOUN
ihlr-27183	450	4	of	of	ADP
ihlr-27183	450	5	the	the	DET
ihlr-27183	450	6	safe	safe	ADJ
ihlr-27183	450	7	harbor	harbor	NOUN
ihlr-27183	450	8	being	be	AUX
ihlr-27183	450	9	one	one	NUM
ihlr-27183	450	10	of	of	ADP
ihlr-27183	450	11	contention	contention	NOUN
ihlr-27183	450	12	and	and	CCONJ
ihlr-27183	450	13	the	the	DET
ihlr-27183	450	14	140	140	NUM
ihlr-27183	450	15	.	.	PUNCT
ihlr-27183	451	1	i	i	PRON
ihlr-27183	451	2	d.	d.	PROPN
ihlr-27183	451	3	141	141	NUM
ihlr-27183	451	4	.	.	PUNCT
ihlr-27183	452	1	i	i	PRON
ihlr-27183	452	2	d.	d.	PROPN
ihlr-27183	452	3	142	142	NUM
ihlr-27183	452	4	.	.	PUNCT
ihlr-27183	453	1	fed	fed	PROPN
ihlr-27183	453	2	.	.	PUNCT
ihlr-27183	454	1	r.	r.	PROPN
ihlr-27183	454	2	civ	civ	PROPN
ihlr-27183	454	3	.	.	PUNCT
ihlr-27183	455	1	p.	p.	NOUN
ihlr-27183	455	2	12(b)(6	12(b)(6	NUM
ihlr-27183	455	3	)	)	PUNCT
ihlr-27183	455	4	.	.	PUNCT
ihlr-27183	456	1	143	143	X
ihlr-27183	456	2	.	.	PUNCT
ihlr-27183	457	1	bell	bell	PROPN
ihlr-27183	457	2	atl	atl	PROPN
ihlr-27183	457	3	.	.	PROPN
ihlr-27183	457	4	corp	corp	PROPN
ihlr-27183	457	5	.	.	PROPN
ihlr-27183	458	1	v.	v.	CCONJ
ihlr-27183	458	2	twombly	twombly	ADV
ihlr-27183	458	3	,	,	PUNCT
ihlr-27183	458	4	550	550	NUM
ihlr-27183	458	5	u.s	u.s	PROPN
ihlr-27183	458	6	.	.	PROPN
ihlr-27183	458	7	544	544	NUM
ihlr-27183	458	8	,	,	PUNCT
ihlr-27183	458	9	570	570	NUM
ihlr-27183	458	10	(	(	PUNCT
ihlr-27183	458	11	2007	2007	NUM
ihlr-27183	458	12	)	)	PUNCT
ihlr-27183	458	13	.	.	PUNCT
ihlr-27183	459	1	144	144	NUM
ihlr-27183	459	2	.	.	PUNCT
ihlr-27183	460	1	i	i	PRON
ihlr-27183	460	2	d.	d.	PROPN
ihlr-27183	460	3	at	at	ADP
ihlr-27183	460	4	557	557	NUM
ihlr-27183	460	5	,	,	PUNCT
ihlr-27183	460	6	564	564	NUM
ihlr-27183	460	7	.	.	PUNCT
ihlr-27183	461	1	145	145	NUM
ihlr-27183	461	2	.	.	PUNCT
ihlr-27183	462	1	daniel	daniel	PROPN
ihlr-27183	462	2	c.	c.	PROPN
ihlr-27183	462	3	cooley	cooley	PROPN
ihlr-27183	462	4	&	&	CCONJ
ihlr-27183	462	5	justin	justin	PROPN
ihlr-27183	462	6	e.	e.	PROPN
ihlr-27183	462	7	loffredo	loffredo	PROPN
ihlr-27183	462	8	,	,	PUNCT
ihlr-27183	462	9	a	a	DET
ihlr-27183	462	10	refresher	refresher	NOUN
ihlr-27183	462	11	on	on	ADP
ihlr-27183	462	12	the	the	DET
ihlr-27183	462	13	standards	standard	NOUN
ihlr-27183	462	14	of	of	ADP
ihlr-27183	462	15	pleading	plead	VERB
ihlr-27183	462	16	direct	direct	ADJ
ihlr-27183	462	17	patent	patent	NOUN
ihlr-27183	462	18	infringement	infringement	NOUN
ihlr-27183	462	19	,	,	PUNCT
ihlr-27183	462	20	ip	ip	NOUN
ihlr-27183	462	21	litigator	litigator	NOUN
ihlr-27183	462	22	(	(	PUNCT
ihlr-27183	462	23	dec	dec	PROPN
ihlr-27183	462	24	.	.	PROPN
ihlr-27183	462	25	2020	2020	NUM
ihlr-27183	462	26	)	)	PUNCT
ihlr-27183	462	27	,	,	PUNCT
ihlr-27183	462	28	https://www.finnegan.com/en/insights/articles/arefresher-on-the-standards-of-pleading-direct-patent-infringement.html	https://www.finnegan.com/en/insights/articles/arefresher-on-the-standards-of-pleading-direct-patent-infringement.html	NOUN
ihlr-27183	463	1	[	[	X
ihlr-27183	463	2	https://perma.cc/497yhdwr	https://perma.cc/497yhdwr	NOUN
ihlr-27183	463	3	]	]	PUNCT
ihlr-27183	463	4	.	.	PUNCT
ihlr-27183	464	1	146	146	NUM
ihlr-27183	464	2	.	.	PUNCT
ihlr-27183	465	1	i	i	PRON
ihlr-27183	465	2	d.	d.	PROPN
ihlr-27183	465	3	162	162	NUM
ihlr-27183	466	1	indiana	indiana	PROPN
ihlr-27183	466	2	health	health	PROPN
ihlr-27183	466	3	law	law	PROPN
ihlr-27183	466	4	review	review	NOUN
ihlr-27183	467	1	[	[	X
ihlr-27183	467	2	vol	vol	NOUN
ihlr-27183	467	3	.	.	PUNCT
ihlr-27183	467	4	20:143	20:143	PROPN
ihlr-27183	467	5	precedent	precedent	NOUN
ihlr-27183	467	6	of	of	ADP
ihlr-27183	467	7	the	the	DET
ihlr-27183	467	8	southern	southern	ADJ
ihlr-27183	467	9	district	district	PROPN
ihlr-27183	467	10	of	of	ADP
ihlr-27183	467	11	california	california	PROPN
ihlr-27183	467	12	,	,	PUNCT
ihlr-27183	467	13	denial	denial	NOUN
ihlr-27183	467	14	of	of	ADP
ihlr-27183	467	15	a	a	DET
ihlr-27183	467	16	motion	motion	NOUN
ihlr-27183	467	17	to	to	PART
ihlr-27183	467	18	dismiss	dismiss	VERB
ihlr-27183	467	19	was	be	AUX
ihlr-27183	467	20	not	not	PART
ihlr-27183	467	21	surprising	surprising	ADJ
ihlr-27183	467	22	.	.	PUNCT
ihlr-27183	468	1	even	even	ADV
ihlr-27183	468	2	so	so	ADV
ihlr-27183	468	3	,	,	PUNCT
ihlr-27183	468	4	the	the	DET
ihlr-27183	468	5	scope	scope	NOUN
ihlr-27183	468	6	of	of	ADP
ihlr-27183	468	7	the	the	DET
ihlr-27183	468	8	safe	safe	ADJ
ihlr-27183	468	9	harbor	harbor	NOUN
ihlr-27183	468	10	will	will	AUX
ihlr-27183	468	11	likely	likely	ADV
ihlr-27183	468	12	be	be	AUX
ihlr-27183	468	13	questioned	question	VERB
ihlr-27183	468	14	again	again	ADV
ihlr-27183	468	15	in	in	ADP
ihlr-27183	468	16	the	the	DET
ihlr-27183	468	17	southern	southern	ADJ
ihlr-27183	468	18	district	district	NOUN
ihlr-27183	468	19	of	of	ADP
ihlr-27183	468	20	california	california	PROPN
ihlr-27183	468	21	.	.	PUNCT
ihlr-27183	469	1	similarly	similarly	ADV
ihlr-27183	469	2	,	,	PUNCT
ihlr-27183	469	3	and	and	CCONJ
ihlr-27183	469	4	relying	rely	VERB
ihlr-27183	469	5	on	on	ADP
ihlr-27183	469	6	similar	similar	ADJ
ihlr-27183	469	7	rationale	rationale	NOUN
ihlr-27183	469	8	,	,	PUNCT
ihlr-27183	469	9	the	the	DET
ihlr-27183	469	10	march	march	PROPN
ihlr-27183	469	11	2nd	2nd	PROPN
ihlr-27183	469	12	denial	denial	NOUN
ihlr-27183	469	13	of	of	ADP
ihlr-27183	469	14	regeneron	regeneron	PROPN
ihlr-27183	469	15	’s	’s	PART
ihlr-27183	469	16	motion	motion	NOUN
ihlr-27183	469	17	to	to	PART
ihlr-27183	469	18	dismiss	dismiss	VERB
ihlr-27183	469	19	will	will	AUX
ihlr-27183	469	20	likely	likely	ADV
ihlr-27183	469	21	not	not	PART
ihlr-27183	469	22	be	be	AUX
ihlr-27183	469	23	the	the	DET
ihlr-27183	469	24	last	last	ADJ
ihlr-27183	469	25	time	time	NOUN
ihlr-27183	469	26	the	the	DET
ihlr-27183	469	27	scope	scope	NOUN
ihlr-27183	469	28	of	of	ADP
ihlr-27183	469	29	the	the	DET
ihlr-27183	469	30	safe	safe	ADJ
ihlr-27183	469	31	harbor	harbor	NOUN
ihlr-27183	469	32	is	be	AUX
ihlr-27183	469	33	at	at	ADP
ihlr-27183	469	34	issue	issue	NOUN
ihlr-27183	469	35	in	in	ADP
ihlr-27183	469	36	the	the	DET
ihlr-27183	469	37	southern	southern	ADJ
ihlr-27183	469	38	district	district	NOUN
ihlr-27183	469	39	of	of	ADP
ihlr-27183	469	40	new	new	ADJ
ihlr-27183	469	41	york.147	york.147	NOUN
ihlr-27183	469	42	indeed	indeed	ADV
ihlr-27183	469	43	,	,	PUNCT
ihlr-27183	469	44	it	it	PRON
ihlr-27183	469	45	may	may	AUX
ihlr-27183	469	46	be	be	AUX
ihlr-27183	469	47	raised	raise	VERB
ihlr-27183	469	48	again	again	ADV
ihlr-27183	469	49	in	in	ADP
ihlr-27183	469	50	later	later	ADJ
ihlr-27183	469	51	proceedings	proceeding	NOUN
ihlr-27183	469	52	involving	involve	VERB
ihlr-27183	469	53	this	this	DET
ihlr-27183	469	54	same	same	ADJ
ihlr-27183	469	55	litigation	litigation	NOUN
ihlr-27183	469	56	.	.	PUNCT
ihlr-27183	470	1	whether	whether	SCONJ
ihlr-27183	470	2	the	the	DET
ihlr-27183	470	3	§	§	PROPN
ihlr-27183	470	4	271(e)(1	271(e)(1	NOUN
ihlr-27183	470	5	)	)	PUNCT
ihlr-27183	470	6	safe	safe	ADJ
ihlr-27183	470	7	harbor	harbor	NOUN
ihlr-27183	470	8	applies	apply	VERB
ihlr-27183	470	9	is	be	AUX
ihlr-27183	470	10	a	a	DET
ihlr-27183	470	11	mixed	mixed	ADJ
ihlr-27183	470	12	question	question	NOUN
ihlr-27183	470	13	of	of	ADP
ihlr-27183	470	14	law	law	NOUN
ihlr-27183	470	15	and	and	CCONJ
ihlr-27183	470	16	fact	fact	NOUN
ihlr-27183	470	17	.	.	PUNCT
ihlr-27183	471	1	as	as	ADP
ihlr-27183	471	2	to	to	ADP
ihlr-27183	471	3	law	law	NOUN
ihlr-27183	471	4	,	,	PUNCT
ihlr-27183	471	5	it	it	PRON
ihlr-27183	471	6	depends	depend	VERB
ihlr-27183	471	7	on	on	ADP
ihlr-27183	471	8	the	the	DET
ihlr-27183	471	9	definition	definition	NOUN
ihlr-27183	471	10	of	of	ADP
ihlr-27183	471	11	the	the	DET
ihlr-27183	471	12	“	"	PUNCT
ihlr-27183	471	13	patented	patented	ADJ
ihlr-27183	471	14	invention	invention	NOUN
ihlr-27183	471	15	”	"	PUNCT
ihlr-27183	471	16	of	of	ADP
ihlr-27183	471	17	§	§	PROPN
ihlr-27183	471	18	271(e)(1	271(e)(1	PROPN
ihlr-27183	471	19	)	)	PUNCT
ihlr-27183	471	20	.	.	PUNCT
ihlr-27183	472	1	as	as	ADP
ihlr-27183	472	2	to	to	PART
ihlr-27183	472	3	fact	fact	VERB
ihlr-27183	472	4	,	,	PUNCT
ihlr-27183	472	5	it	it	PRON
ihlr-27183	472	6	depends	depend	VERB
ihlr-27183	472	7	on	on	ADP
ihlr-27183	472	8	what	what	PRON
ihlr-27183	472	9	mneongreen	mneongreen	NOUN
ihlr-27183	472	10	is	be	AUX
ihlr-27183	472	11	and	and	CCONJ
ihlr-27183	472	12	where	where	SCONJ
ihlr-27183	472	13	it	it	PRON
ihlr-27183	472	14	falls	fall	VERB
ihlr-27183	472	15	in	in	ADP
ihlr-27183	472	16	relation	relation	NOUN
ihlr-27183	472	17	to	to	ADP
ihlr-27183	472	18	the	the	DET
ihlr-27183	472	19	judicially	judicially	ADV
ihlr-27183	472	20	endorsed	endorse	VERB
ihlr-27183	472	21	definition	definition	NOUN
ihlr-27183	472	22	.	.	PUNCT
ihlr-27183	473	1	whether	whether	SCONJ
ihlr-27183	473	2	these	these	DET
ihlr-27183	473	3	questions	question	NOUN
ihlr-27183	473	4	coincide	coincide	VERB
ihlr-27183	473	5	in	in	ADP
ihlr-27183	473	6	the	the	DET
ihlr-27183	473	7	law	law	NOUN
ihlr-27183	473	8	-	-	PUNCT
ihlr-27183	473	9	fact	fact	NOUN
ihlr-27183	473	10	continuum	continuum	NOUN
ihlr-27183	473	11	remains	remain	VERB
ihlr-27183	473	12	a	a	DET
ihlr-27183	473	13	mystery	mystery	NOUN
ihlr-27183	473	14	,	,	PUNCT
ihlr-27183	473	15	and	and	CCONJ
ihlr-27183	473	16	so	so	ADV
ihlr-27183	473	17	,	,	PUNCT
ihlr-27183	473	18	it	it	PRON
ihlr-27183	473	19	is	be	AUX
ihlr-27183	473	20	no	no	DET
ihlr-27183	473	21	surprise	surprise	NOUN
ihlr-27183	473	22	the	the	DET
ihlr-27183	473	23	court	court	NOUN
ihlr-27183	473	24	ultimately	ultimately	ADV
ihlr-27183	473	25	dismissed	dismiss	VERB
ihlr-27183	473	26	both	both	DET
ihlr-27183	473	27	defendant	defendant	NOUN
ihlr-27183	473	28	’s	’s	PART
ihlr-27183	473	29	motions	motion	NOUN
ihlr-27183	473	30	for	for	ADP
ihlr-27183	473	31	summary	summary	NOUN
ihlr-27183	473	32	judgement	judgement	NOUN
ihlr-27183	473	33	.	.	PUNCT
ihlr-27183	474	1	based	base	VERB
ihlr-27183	474	2	on	on	ADP
ihlr-27183	474	3	variation	variation	NOUN
ihlr-27183	474	4	between	between	ADP
ihlr-27183	474	5	courts	court	NOUN
ihlr-27183	474	6	,	,	PUNCT
ihlr-27183	474	7	it	it	PRON
ihlr-27183	474	8	is	be	AUX
ihlr-27183	474	9	difficult	difficult	ADJ
ihlr-27183	474	10	to	to	PART
ihlr-27183	474	11	say	say	VERB
ihlr-27183	474	12	whether	whether	SCONJ
ihlr-27183	474	13	mneongreen	mneongreen	NOUN
ihlr-27183	474	14	,	,	PUNCT
ihlr-27183	474	15	though	though	SCONJ
ihlr-27183	474	16	it	it	PRON
ihlr-27183	474	17	be	be	VERB
ihlr-27183	474	18	a	a	DET
ihlr-27183	474	19	research	research	NOUN
ihlr-27183	474	20	tool	tool	NOUN
ihlr-27183	474	21	,	,	PUNCT
ihlr-27183	474	22	falls	fall	VERB
ihlr-27183	474	23	under	under	ADP
ihlr-27183	474	24	the	the	DET
ihlr-27183	474	25	purview	purview	NOUN
ihlr-27183	474	26	of	of	ADP
ihlr-27183	474	27	the	the	DET
ihlr-27183	474	28	safe	safe	ADJ
ihlr-27183	474	29	harbor	harbor	NOUN
ihlr-27183	474	30	.	.	PUNCT
ihlr-27183	475	1	it	it	PRON
ihlr-27183	475	2	is	be	AUX
ihlr-27183	475	3	important	important	ADJ
ihlr-27183	475	4	to	to	PART
ihlr-27183	475	5	note	note	VERB
ihlr-27183	475	6	that	that	SCONJ
ihlr-27183	475	7	the	the	DET
ihlr-27183	475	8	court	court	NOUN
ihlr-27183	475	9	only	only	ADV
ihlr-27183	475	10	stated	state	VERB
ihlr-27183	475	11	pfizer	pfizer	NOUN
ihlr-27183	475	12	had	have	AUX
ihlr-27183	475	13	“	"	PUNCT
ihlr-27183	475	14	failed	fail	VERB
ihlr-27183	475	15	to	to	PART
ihlr-27183	475	16	demonstrate	demonstrate	VERB
ihlr-27183	475	17	that	that	SCONJ
ihlr-27183	475	18	the	the	DET
ihlr-27183	475	19	facts	fact	NOUN
ihlr-27183	475	20	alleged	allege	VERB
ihlr-27183	475	21	in	in	ADP
ihlr-27183	475	22	the	the	DET
ihlr-27183	475	23	[	[	X
ihlr-27183	475	24	complaint	complaint	NOUN
ihlr-27183	475	25	]	]	PUNCT
ihlr-27183	475	26	establish	establish	VERB
ihlr-27183	475	27	that	that	SCONJ
ihlr-27183	475	28	the	the	DET
ihlr-27183	475	29	allegedly	allegedly	ADV
ihlr-27183	475	30	infringing	infringe	VERB
ihlr-27183	475	31	activity	activity	NOUN
ihlr-27183	475	32	is	be	AUX
ihlr-27183	475	33	exempted	exempt	VERB
ihlr-27183	475	34	”	"	PUNCT
ihlr-27183	475	35	under	under	ADP
ihlr-27183	475	36	the	the	DET
ihlr-27183	475	37	safe	safe	ADJ
ihlr-27183	475	38	harbor.148	harbor.148	NOUN
ihlr-27183	475	39	the	the	DET
ihlr-27183	475	40	court	court	NOUN
ihlr-27183	475	41	may	may	AUX
ihlr-27183	475	42	be	be	AUX
ihlr-27183	475	43	alluding	allude	VERB
ihlr-27183	475	44	to	to	ADP
ihlr-27183	475	45	an	an	DET
ihlr-27183	475	46	answer	answer	NOUN
ihlr-27183	475	47	turning	turn	VERB
ihlr-27183	475	48	on	on	ADP
ihlr-27183	475	49	activity	activity	NOUN
ihlr-27183	475	50	instead	instead	ADV
ihlr-27183	475	51	of	of	ADP
ihlr-27183	475	52	subject	subject	ADJ
ihlr-27183	475	53	matter	matter	NOUN
ihlr-27183	475	54	contemplated	contemplate	VERB
ihlr-27183	475	55	by	by	ADP
ihlr-27183	475	56	the	the	DET
ihlr-27183	475	57	“	"	PUNCT
ihlr-27183	475	58	patented	patented	ADJ
ihlr-27183	475	59	invention	invention	NOUN
ihlr-27183	475	60	”	"	PUNCT
ihlr-27183	475	61	of	of	ADP
ihlr-27183	475	62	the	the	DET
ihlr-27183	475	63	safe	safe	ADJ
ihlr-27183	475	64	harbor	harbor	NOUN
ihlr-27183	475	65	.	.	PUNCT
ihlr-27183	476	1	2	2	X
ihlr-27183	476	2	.	.	NUM
ihlr-27183	476	3	limited	limited	ADJ
ihlr-27183	476	4	rationale	rationale	NOUN
ihlr-27183	476	5	the	the	DET
ihlr-27183	476	6	court	court	NOUN
ihlr-27183	476	7	,	,	PUNCT
ihlr-27183	476	8	in	in	ADP
ihlr-27183	476	9	its	its	PRON
ihlr-27183	476	10	denial	denial	NOUN
ihlr-27183	476	11	to	to	PART
ihlr-27183	476	12	dismiss	dismiss	VERB
ihlr-27183	476	13	the	the	DET
ihlr-27183	476	14	case	case	NOUN
ihlr-27183	476	15	against	against	ADP
ihlr-27183	476	16	pfizer	pfizer	NOUN
ihlr-27183	476	17	,	,	PUNCT
ihlr-27183	476	18	points	point	VERB
ihlr-27183	476	19	out	out	ADP
ihlr-27183	476	20	that	that	SCONJ
ihlr-27183	476	21	the	the	DET
ihlr-27183	476	22	defendant	defendant	NOUN
ihlr-27183	476	23	’s	’s	PART
ihlr-27183	476	24	reliance	reliance	NOUN
ihlr-27183	476	25	on	on	ADP
ihlr-27183	476	26	sandoz	sandoz	PROPN
ihlr-27183	476	27	is	be	AUX
ihlr-27183	476	28	unpersuasive	unpersuasive	ADJ
ihlr-27183	476	29	and	and	CCONJ
ihlr-27183	476	30	ineffectual	ineffectual	ADJ
ihlr-27183	476	31	because	because	SCONJ
ihlr-27183	476	32	it	it	PRON
ihlr-27183	476	33	is	be	AUX
ihlr-27183	476	34	a	a	DET
ihlr-27183	476	35	non	non	ADJ
ihlr-27183	476	36	-	-	ADJ
ihlr-27183	476	37	binding	binding	ADJ
ihlr-27183	476	38	district	district	NOUN
ihlr-27183	476	39	court	court	NOUN
ihlr-27183	476	40	opinion.149	opinion.149	ADV
ihlr-27183	476	41	however	however	ADV
ihlr-27183	476	42	,	,	PUNCT
ihlr-27183	476	43	this	this	DET
ihlr-27183	476	44	same	same	ADJ
ihlr-27183	476	45	rationale	rationale	NOUN
ihlr-27183	476	46	disembowels	disembowel	VERB
ihlr-27183	476	47	its	its	PRON
ihlr-27183	476	48	own	own	ADJ
ihlr-27183	476	49	reliance	reliance	NOUN
ihlr-27183	476	50	on	on	ADP
ihlr-27183	476	51	two	two	NUM
ihlr-27183	476	52	district	district	NOUN
ihlr-27183	476	53	courts	court	NOUN
ihlr-27183	476	54	who	who	PRON
ihlr-27183	476	55	have	have	AUX
ihlr-27183	476	56	interpreted	interpret	VERB
ihlr-27183	476	57	proveris	proveri	NOUN
ihlr-27183	476	58	to	to	PART
ihlr-27183	476	59	categorically	categorically	ADV
ihlr-27183	476	60	exclude	exclude	VERB
ihlr-27183	476	61	items	item	NOUN
ihlr-27183	476	62	not	not	PART
ihlr-27183	476	63	subject	subject	ADJ
ihlr-27183	476	64	to	to	ADP
ihlr-27183	476	65	fda	fda	PROPN
ihlr-27183	476	66	approval	approval	NOUN
ihlr-27183	476	67	from	from	ADP
ihlr-27183	476	68	the	the	DET
ihlr-27183	476	69	“	"	PUNCT
ihlr-27183	476	70	patented	patented	ADJ
ihlr-27183	476	71	invention	invention	NOUN
ihlr-27183	476	72	”	"	PUNCT
ihlr-27183	476	73	of	of	ADP
ihlr-27183	476	74	§	§	PROPN
ihlr-27183	476	75	271(e)(1).150	271(e)(1).150	NUM
ihlr-27183	476	76	the	the	DET
ihlr-27183	476	77	court	court	NOUN
ihlr-27183	476	78	resorts	resort	NOUN
ihlr-27183	476	79	to	to	ADP
ihlr-27183	476	80	‘	'	PUNCT
ihlr-27183	476	81	cherry	cherry	NOUN
ihlr-27183	476	82	picking	picking	NOUN
ihlr-27183	476	83	’	'	PUNCT
ihlr-27183	476	84	of	of	ADP
ihlr-27183	476	85	lateral	lateral	ADJ
ihlr-27183	476	86	,	,	PUNCT
ihlr-27183	476	87	nonbinding	nonbinding	NOUN
ihlr-27183	476	88	interpretations	interpretation	NOUN
ihlr-27183	476	89	of	of	ADP
ihlr-27183	476	90	proveris	proveris	NOUN
ihlr-27183	476	91	exactly	exactly	ADV
ihlr-27183	476	92	because	because	SCONJ
ihlr-27183	476	93	its	its	PRON
ihlr-27183	476	94	binding	bind	VERB
ihlr-27183	476	95	precedent	precedent	NOUN
ihlr-27183	476	96	–	–	PUNCT
ihlr-27183	476	97	the	the	DET
ihlr-27183	476	98	federal	federal	ADJ
ihlr-27183	476	99	circuit	circuit	NOUN
ihlr-27183	476	100	and	and	CCONJ
ihlr-27183	476	101	supreme	supreme	PROPN
ihlr-27183	476	102	court	court	PROPN
ihlr-27183	476	103	–	–	PUNCT
ihlr-27183	476	104	have	have	AUX
ihlr-27183	476	105	not	not	PART
ihlr-27183	476	106	yet	yet	ADV
ihlr-27183	476	107	enunciated	enunciate	VERB
ihlr-27183	476	108	the	the	DET
ihlr-27183	476	109	bright	bright	ADJ
ihlr-27183	476	110	-	-	PUNCT
ihlr-27183	476	111	line	line	NOUN
ihlr-27183	476	112	rule	rule	NOUN
ihlr-27183	476	113	it	it	PRON
ihlr-27183	476	114	seeks	seek	VERB
ihlr-27183	476	115	.	.	PUNCT
ihlr-27183	477	1	federal	federal	ADJ
ihlr-27183	477	2	district	district	NOUN
ihlr-27183	477	3	courts	court	NOUN
ihlr-27183	477	4	have	have	AUX
ihlr-27183	477	5	been	be	AUX
ihlr-27183	477	6	criticizing	criticize	VERB
ihlr-27183	477	7	each	each	DET
ihlr-27183	477	8	other	other	ADJ
ihlr-27183	477	9	’s	’s	PART
ihlr-27183	477	10	interpretation	interpretation	NOUN
ihlr-27183	477	11	of	of	ADP
ihlr-27183	477	12	their	their	PRON
ihlr-27183	477	13	mutually	mutually	ADV
ihlr-27183	477	14	binding	bind	VERB
ihlr-27183	477	15	precedent	precedent	NOUN
ihlr-27183	477	16	.	.	PUNCT
ihlr-27183	478	1	this	this	DET
ihlr-27183	478	2	silence	silence	NOUN
ihlr-27183	478	3	to	to	ADP
ihlr-27183	478	4	-	-	PUNCT
ihlr-27183	478	5	date	date	NOUN
ihlr-27183	478	6	by	by	ADP
ihlr-27183	478	7	the	the	DET
ihlr-27183	478	8	federal	federal	ADJ
ihlr-27183	478	9	circuit	circuit	NOUN
ihlr-27183	478	10	and	and	CCONJ
ihlr-27183	478	11	supreme	supreme	PROPN
ihlr-27183	478	12	court	court	PROPN
ihlr-27183	478	13	raises	raise	VERB
ihlr-27183	478	14	questions	question	NOUN
ihlr-27183	478	15	of	of	ADP
ihlr-27183	478	16	unacceptable	unacceptable	ADJ
ihlr-27183	478	17	ambiguity	ambiguity	NOUN
ihlr-27183	478	18	for	for	ADP
ihlr-27183	478	19	those	those	PRON
ihlr-27183	478	20	who	who	PRON
ihlr-27183	478	21	innovate	innovate	VERB
ihlr-27183	478	22	in	in	ADP
ihlr-27183	478	23	the	the	DET
ihlr-27183	478	24	field	field	NOUN
ihlr-27183	478	25	of	of	ADP
ihlr-27183	478	26	research	research	NOUN
ihlr-27183	478	27	tools	tool	NOUN
ihlr-27183	478	28	.	.	PUNCT
ihlr-27183	479	1	the	the	DET
ihlr-27183	479	2	court	court	NOUN
ihlr-27183	479	3	,	,	PUNCT
ihlr-27183	479	4	in	in	ADP
ihlr-27183	479	5	allele	allele	PROPN
ihlr-27183	479	6	’s	’s	PART
ihlr-27183	479	7	case	case	NOUN
ihlr-27183	479	8	against	against	ADP
ihlr-27183	479	9	pfizer	pfizer	NOUN
ihlr-27183	479	10	,	,	PUNCT
ihlr-27183	479	11	quotes	quote	VERB
ihlr-27183	479	12	from	from	ADP
ihlr-27183	479	13	proveris	proveris	NOUN
ihlr-27183	479	14	to	to	PART
ihlr-27183	479	15	purportedly	purportedly	ADV
ihlr-27183	479	16	show	show	VERB
ihlr-27183	479	17	a	a	DET
ihlr-27183	479	18	rule	rule	NOUN
ihlr-27183	479	19	requiring	require	VERB
ihlr-27183	479	20	an	an	DET
ihlr-27183	479	21	invention	invention	NOUN
ihlr-27183	479	22	be	be	AUX
ihlr-27183	479	23	subject	subject	ADJ
ihlr-27183	479	24	to	to	ADP
ihlr-27183	479	25	fda	fda	PROPN
ihlr-27183	479	26	approval	approval	NOUN
ihlr-27183	479	27	to	to	PART
ihlr-27183	479	28	receive	receive	VERB
ihlr-27183	479	29	safe	safe	ADJ
ihlr-27183	479	30	147	147	NUM
ihlr-27183	479	31	.	.	PUNCT
ihlr-27183	480	1	see	see	VERB
ihlr-27183	480	2	cooley	cooley	PROPN
ihlr-27183	480	3	&	&	CCONJ
ihlr-27183	480	4	loffredo	loffredo	PROPN
ihlr-27183	480	5	,	,	PUNCT
ihlr-27183	480	6	supra	supra	PROPN
ihlr-27183	480	7	note	note	NOUN
ihlr-27183	481	1	145	145	NUM
ihlr-27183	481	2	.	.	X
ihlr-27183	481	3	148	148	NUM
ihlr-27183	481	4	.	.	PUNCT
ihlr-27183	482	1	allele	allele	PROPN
ihlr-27183	482	2	biotechnology	biotechnology	PROPN
ihlr-27183	482	3	&	&	CCONJ
ihlr-27183	482	4	pharm	pharm	PROPN
ihlr-27183	482	5	.	.	PROPN
ihlr-27183	482	6	,	,	PUNCT
ihlr-27183	482	7	inc	inc	PROPN
ihlr-27183	482	8	.	.	PROPN
ihlr-27183	482	9	v.	v.	ADP
ihlr-27183	482	10	pfizer	pfizer	PROPN
ihlr-27183	482	11	,	,	PUNCT
ihlr-27183	482	12	inc	inc	PROPN
ihlr-27183	482	13	.	.	PROPN
ihlr-27183	482	14	,	,	PUNCT
ihlr-27183	482	15	no	no	INTJ
ihlr-27183	482	16	.	.	NOUN
ihlr-27183	482	17	20	20	NUM
ihlr-27183	482	18	-	-	PUNCT
ihlr-27183	482	19	cv-01958	cv-01958	NOUN
ihlr-27183	482	20	-	-	PUNCT
ihlr-27183	482	21	h	h	NOUN
ihlr-27183	482	22	,	,	PUNCT
ihlr-27183	482	23	2021	2021	NUM
ihlr-27183	482	24	u.s	u.s	PROPN
ihlr-27183	482	25	.	.	PROPN
ihlr-27183	482	26	dist	dist	PROPN
ihlr-27183	482	27	.	.	PUNCT
ihlr-27183	483	1	lexis	lexis	NOUN
ihlr-27183	483	2	85347	85347	NUM
ihlr-27183	483	3	,	,	PUNCT
ihlr-27183	483	4	at	at	ADP
ihlr-27183	483	5	*	*	NUM
ihlr-27183	483	6	18	18	NUM
ihlr-27183	483	7	(	(	PUNCT
ihlr-27183	483	8	s.d	s.d	PROPN
ihlr-27183	483	9	.	.	PROPN
ihlr-27183	483	10	cal	cal	PROPN
ihlr-27183	483	11	.	.	PUNCT
ihlr-27183	484	1	may	may	AUX
ihlr-27183	484	2	4	4	NUM
ihlr-27183	484	3	,	,	PUNCT
ihlr-27183	484	4	2021	2021	NUM
ihlr-27183	484	5	)	)	PUNCT
ihlr-27183	484	6	.	.	PUNCT
ihlr-27183	485	1	149	149	NUM
ihlr-27183	485	2	.	.	PUNCT
ihlr-27183	486	1	i	i	PRON
ihlr-27183	486	2	d.	d.	PROPN
ihlr-27183	486	3	at	at	ADP
ihlr-27183	486	4	*	*	PROPN
ihlr-27183	486	5	17	17	NUM
ihlr-27183	486	6	.	.	PUNCT
ihlr-27183	486	7	150	150	NUM
ihlr-27183	486	8	.	.	PUNCT
ihlr-27183	487	1	i	i	PRON
ihlr-27183	487	2	d.	d.	VERB
ihlr-27183	487	3	at	at	ADP
ihlr-27183	487	4	*	*	PROPN
ihlr-27183	487	5	12	12	NUM
ihlr-27183	487	6	;	;	PUNCT
ihlr-27183	487	7	see	see	VERB
ihlr-27183	487	8	also	also	ADV
ihlr-27183	487	9	eli	eli	PROPN
ihlr-27183	487	10	lilly	lilly	PROPN
ihlr-27183	487	11	&	&	CCONJ
ihlr-27183	487	12	co.	co.	PROPN
ihlr-27183	488	1	v.	v.	ADP
ihlr-27183	488	2	medtronic	medtronic	PROPN
ihlr-27183	488	3	,	,	PUNCT
ihlr-27183	488	4	inc	inc	PROPN
ihlr-27183	488	5	.	.	PROPN
ihlr-27183	488	6	,	,	PUNCT
ihlr-27183	488	7	496	496	NUM
ihlr-27183	488	8	u.s	u.s	PROPN
ihlr-27183	488	9	.	.	PROPN
ihlr-27183	488	10	661	661	NUM
ihlr-27183	488	11	,	,	PUNCT
ihlr-27183	488	12	665	665	NUM
ihlr-27183	488	13	,	,	PUNCT
ihlr-27183	488	14	672	672	NUM
ihlr-27183	488	15	(	(	PUNCT
ihlr-27183	488	16	1990	1990	NUM
ihlr-27183	488	17	)	)	PUNCT
ihlr-27183	488	18	(	(	PUNCT
ihlr-27183	488	19	to	to	PART
ihlr-27183	488	20	state	state	VERB
ihlr-27183	488	21	“	"	PUNCT
ihlr-27183	488	22	all	all	DET
ihlr-27183	488	23	inventions	invention	NOUN
ihlr-27183	488	24	,	,	PUNCT
ihlr-27183	488	25	not	not	PART
ihlr-27183	488	26	drug	drug	NOUN
ihlr-27183	488	27	related	relate	VERB
ihlr-27183	488	28	inventions	invention	NOUN
ihlr-27183	488	29	”	"	PUNCT
ihlr-27183	488	30	are	be	AUX
ihlr-27183	488	31	within	within	ADP
ihlr-27183	488	32	the	the	DET
ihlr-27183	488	33	ambit	ambit	NOUN
ihlr-27183	488	34	of	of	ADP
ihlr-27183	488	35	§	§	PROPN
ihlr-27183	488	36	271(e)(1	271(e)(1	NOUN
ihlr-27183	488	37	)	)	PUNCT
ihlr-27183	488	38	formally	formally	ADV
ihlr-27183	488	39	marks	mark	VERB
ihlr-27183	488	40	at	at	ADV
ihlr-27183	488	41	least	least	ADV
ihlr-27183	488	42	one	one	NUM
ihlr-27183	488	43	aspect	aspect	NOUN
ihlr-27183	488	44	of	of	ADP
ihlr-27183	488	45	asymmetry	asymmetry	NOUN
ihlr-27183	488	46	between	between	ADP
ihlr-27183	488	47	§	§	PROPN
ihlr-27183	488	48	156	156	NUM
ihlr-27183	488	49	and	and	CCONJ
ihlr-27183	488	50	§	§	PROPN
ihlr-27183	488	51	271	271	NUM
ihlr-27183	488	52	)	)	PUNCT
ihlr-27183	488	53	.	.	PUNCT
ihlr-27183	489	1	2023	2023	NUM
ihlr-27183	489	2	]	]	PUNCT
ihlr-27183	489	3	the	the	DET
ihlr-27183	489	4	safe	safe	ADJ
ihlr-27183	489	5	harbor	harbor	NOUN
ihlr-27183	489	6	of	of	ADP
ihlr-27183	489	7	35	35	NUM
ihlr-27183	489	8	u.s.c	u.s.c	ADJ
ihlr-27183	489	9	.	.	PUNCT
ihlr-27183	490	1	§	§	PROPN
ihlr-27183	490	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	490	3	)	)	PUNCT
ihlr-27183	490	4	163	163	NUM
ihlr-27183	490	5	harbor	harbor	NOUN
ihlr-27183	490	6	protection.151	protection.151	NOUN
ihlr-27183	490	7	after	after	ADP
ihlr-27183	490	8	noting	note	VERB
ihlr-27183	490	9	proveris	proveri	NOUN
ihlr-27183	490	10	’	'	PUNCT
ihlr-27183	490	11	patented	patented	ADJ
ihlr-27183	490	12	device	device	NOUN
ihlr-27183	490	13	is	be	AUX
ihlr-27183	490	14	not	not	PART
ihlr-27183	490	15	eligible	eligible	ADJ
ihlr-27183	490	16	for	for	ADP
ihlr-27183	490	17	§	§	PROPN
ihlr-27183	490	18	156	156	NUM
ihlr-27183	490	19	patent	patent	NOUN
ihlr-27183	490	20	term	term	NOUN
ihlr-27183	490	21	extension	extension	NOUN
ihlr-27183	490	22	because	because	SCONJ
ihlr-27183	490	23	it	it	PRON
ihlr-27183	490	24	is	be	AUX
ihlr-27183	490	25	not	not	PART
ihlr-27183	490	26	subject	subject	ADJ
ihlr-27183	490	27	to	to	ADP
ihlr-27183	490	28	fda	fda	PROPN
ihlr-27183	490	29	approval	approval	PROPN
ihlr-27183	490	30	,	,	PUNCT
ihlr-27183	490	31	the	the	DET
ihlr-27183	490	32	proveris	proveris	PROPN
ihlr-27183	490	33	court	court	NOUN
ihlr-27183	490	34	added	add	VERB
ihlr-27183	490	35	that	that	SCONJ
ihlr-27183	490	36	“	"	PUNCT
ihlr-27183	490	37	because	because	SCONJ
ihlr-27183	490	38	innova	innova	PROPN
ihlr-27183	490	39	's	's	PART
ihlr-27183	490	40	osa	osa	ADJ
ihlr-27183	490	41	device	device	NOUN
ihlr-27183	490	42	also	also	ADV
ihlr-27183	490	43	is	be	AUX
ihlr-27183	490	44	not	not	PART
ihlr-27183	490	45	subject	subject	ADJ
ihlr-27183	490	46	to	to	ADP
ihlr-27183	490	47	a	a	DET
ihlr-27183	490	48	required	require	VERB
ihlr-27183	490	49	fdca	fdca	ADJ
ihlr-27183	490	50	approval	approval	NOUN
ihlr-27183	490	51	process	process	NOUN
ihlr-27183	490	52	,	,	PUNCT
ihlr-27183	490	53	it	it	PRON
ihlr-27183	490	54	does	do	AUX
ihlr-27183	490	55	not	not	PART
ihlr-27183	490	56	need	need	VERB
ihlr-27183	490	57	the	the	DET
ihlr-27183	490	58	safe	safe	ADJ
ihlr-27183	490	59	harbor	harbor	NOUN
ihlr-27183	490	60	protection	protection	NOUN
ihlr-27183	490	61	afforded	afford	VERB
ihlr-27183	490	62	by	by	ADP
ihlr-27183	490	63	35	35	NUM
ihlr-27183	490	64	u.s.c	u.s.c	NOUN
ihlr-27183	490	65	.	.	PUNCT
ihlr-27183	491	1	§	§	PROPN
ihlr-27183	491	2	271(e)(1).”152	271(e)(1).”152	PROPN
ihlr-27183	491	3	the	the	DET
ihlr-27183	491	4	court	court	NOUN
ihlr-27183	491	5	relies	rely	VERB
ihlr-27183	491	6	heavily	heavily	ADV
ihlr-27183	491	7	on	on	ADP
ihlr-27183	491	8	this	this	DET
ihlr-27183	491	9	quotation	quotation	NOUN
ihlr-27183	491	10	.	.	PUNCT
ihlr-27183	492	1	while	while	SCONJ
ihlr-27183	492	2	it	it	PRON
ihlr-27183	492	3	is	be	AUX
ihlr-27183	492	4	true	true	ADJ
ihlr-27183	492	5	proveris	proveris	NOUN
ihlr-27183	492	6	goes	go	VERB
ihlr-27183	492	7	on	on	ADP
ihlr-27183	492	8	to	to	PART
ihlr-27183	492	9	treat	treat	VERB
ihlr-27183	492	10	subjection	subjection	NOUN
ihlr-27183	492	11	to	to	ADP
ihlr-27183	492	12	fda	fda	PROPN
ihlr-27183	492	13	approval	approval	NOUN
ihlr-27183	492	14	as	as	ADP
ihlr-27183	492	15	a	a	DET
ihlr-27183	492	16	requirement	requirement	NOUN
ihlr-27183	492	17	to	to	PART
ihlr-27183	492	18	be	be	AUX
ihlr-27183	492	19	under	under	ADP
ihlr-27183	492	20	the	the	DET
ihlr-27183	492	21	safe	safe	ADJ
ihlr-27183	492	22	harbor	harbor	NOUN
ihlr-27183	492	23	,	,	PUNCT
ihlr-27183	492	24	the	the	DET
ihlr-27183	492	25	last	last	ADJ
ihlr-27183	492	26	word	word	NOUN
ihlr-27183	492	27	on	on	ADP
ihlr-27183	492	28	that	that	DET
ihlr-27183	492	29	subject	subject	NOUN
ihlr-27183	492	30	from	from	ADP
ihlr-27183	492	31	the	the	DET
ihlr-27183	492	32	supreme	supreme	PROPN
ihlr-27183	492	33	court	court	PROPN
ihlr-27183	492	34	was	be	AUX
ihlr-27183	492	35	only	only	ADV
ihlr-27183	492	36	that	that	SCONJ
ihlr-27183	492	37	such	such	ADJ
ihlr-27183	492	38	symmetry	symmetry	NOUN
ihlr-27183	492	39	be	be	AUX
ihlr-27183	492	40	“	"	PUNCT
ihlr-27183	492	41	preferable	preferable	ADJ
ihlr-27183	492	42	.	.	PUNCT
ihlr-27183	492	43	”153	”153	NOUN
ihlr-27183	492	44	was	be	AUX
ihlr-27183	492	45	proveris	proveris	NOUN
ihlr-27183	492	46	wrong	wrong	ADJ
ihlr-27183	492	47	to	to	PART
ihlr-27183	492	48	add	add	VERB
ihlr-27183	492	49	a	a	DET
ihlr-27183	492	50	limitation	limitation	NOUN
ihlr-27183	492	51	the	the	DET
ihlr-27183	492	52	supreme	supreme	PROPN
ihlr-27183	492	53	court	court	PROPN
ihlr-27183	492	54	did	do	VERB
ihlr-27183	492	55	not	not	PART
ihlr-27183	492	56	?	?	PUNCT
ihlr-27183	493	1	was	be	AUX
ihlr-27183	493	2	this	this	DET
ihlr-27183	493	3	language	language	NOUN
ihlr-27183	493	4	mere	mere	ADJ
ihlr-27183	493	5	dicta	dicta	ADJ
ihlr-27183	493	6	,	,	PUNCT
ihlr-27183	493	7	as	as	SCONJ
ihlr-27183	493	8	sandoz	sandoz	PROPN
ihlr-27183	493	9	surmised	surmise	VERB
ihlr-27183	493	10	?	?	PUNCT
ihlr-27183	494	1	such	such	DET
ihlr-27183	494	2	a	a	DET
ihlr-27183	494	3	reading	reading	NOUN
ihlr-27183	494	4	of	of	ADP
ihlr-27183	494	5	proveris	proveris	NOUN
ihlr-27183	494	6	may	may	AUX
ihlr-27183	494	7	conflict	conflict	VERB
ihlr-27183	494	8	with	with	ADP
ihlr-27183	494	9	the	the	DET
ihlr-27183	494	10	holding	holding	NOUN
ihlr-27183	494	11	in	in	ADP
ihlr-27183	494	12	merck	merck	PROPN
ihlr-27183	494	13	,	,	PUNCT
ihlr-27183	494	14	where	where	SCONJ
ihlr-27183	494	15	the	the	DET
ihlr-27183	494	16	patented	patented	ADJ
ihlr-27183	494	17	peptides	peptide	NOUN
ihlr-27183	494	18	only	only	ADV
ihlr-27183	494	19	had	have	VERB
ihlr-27183	494	20	hopes	hope	NOUN
ihlr-27183	494	21	of	of	ADP
ihlr-27183	494	22	producing	produce	VERB
ihlr-27183	494	23	material	material	NOUN
ihlr-27183	494	24	for	for	ADP
ihlr-27183	494	25	fda	fda	PROPN
ihlr-27183	494	26	submissions	submission	NOUN
ihlr-27183	494	27	but	but	CCONJ
ihlr-27183	494	28	were	be	AUX
ihlr-27183	494	29	nonetheless	nonetheless	ADV
ihlr-27183	494	30	protected.154	protected.154	NOUN
ihlr-27183	494	31	is	be	AUX
ihlr-27183	494	32	the	the	DET
ihlr-27183	494	33	rule	rule	NOUN
ihlr-27183	494	34	potential	potential	ADJ
ihlr-27183	494	35	subjection	subjection	NOUN
ihlr-27183	494	36	to	to	ADP
ihlr-27183	494	37	fda	fda	PROPN
ihlr-27183	494	38	regulation	regulation	NOUN
ihlr-27183	494	39	?	?	PUNCT
ihlr-27183	495	1	further	far	ADV
ihlr-27183	495	2	,	,	PUNCT
ihlr-27183	495	3	abtox	abtox	NOUN
ihlr-27183	495	4	,	,	PUNCT
ihlr-27183	495	5	the	the	DET
ihlr-27183	495	6	federal	federal	ADJ
ihlr-27183	495	7	circuit	circuit	NOUN
ihlr-27183	495	8	decision	decision	NOUN
ihlr-27183	495	9	,	,	PUNCT
ihlr-27183	495	10	where	where	SCONJ
ihlr-27183	495	11	a	a	DET
ihlr-27183	495	12	non	non	ADJ
ihlr-27183	495	13	-	-	ADJ
ihlr-27183	495	14	fda	fda	ADJ
ihlr-27183	495	15	regulated	regulated	ADJ
ihlr-27183	495	16	plasma	plasma	NOUN
ihlr-27183	495	17	sterilizer	sterilizer	NOUN
ihlr-27183	495	18	was	be	AUX
ihlr-27183	495	19	shielded	shield	VERB
ihlr-27183	495	20	by	by	ADP
ihlr-27183	495	21	the	the	DET
ihlr-27183	495	22	safe	safe	ADJ
ihlr-27183	495	23	harbor	harbor	NOUN
ihlr-27183	495	24	,	,	PUNCT
ihlr-27183	495	25	has	have	AUX
ihlr-27183	495	26	not	not	PART
ihlr-27183	495	27	been	be	AUX
ihlr-27183	495	28	overruled.155	overruled.155	ADJ
ihlr-27183	495	29	in	in	ADP
ihlr-27183	495	30	sum	sum	NOUN
ihlr-27183	495	31	,	,	PUNCT
ihlr-27183	495	32	whether	whether	SCONJ
ihlr-27183	495	33	a	a	DET
ihlr-27183	495	34	district	district	NOUN
ihlr-27183	495	35	court	court	NOUN
ihlr-27183	495	36	should	should	AUX
ihlr-27183	495	37	require	require	VERB
ihlr-27183	495	38	a	a	DET
ihlr-27183	495	39	product	product	NOUN
ihlr-27183	495	40	be	be	AUX
ihlr-27183	495	41	subject	subject	ADJ
ihlr-27183	495	42	to	to	ADP
ihlr-27183	495	43	fda	fda	PROPN
ihlr-27183	495	44	approval	approval	NOUN
ihlr-27183	495	45	for	for	ADP
ihlr-27183	495	46	application	application	NOUN
ihlr-27183	495	47	of	of	ADP
ihlr-27183	495	48	the	the	DET
ihlr-27183	495	49	safe	safe	ADJ
ihlr-27183	495	50	harbor	harbor	NOUN
ihlr-27183	495	51	is	be	AUX
ihlr-27183	495	52	a	a	DET
ihlr-27183	495	53	matter	matter	NOUN
ihlr-27183	495	54	reasonable	reasonable	ADJ
ihlr-27183	495	55	interpretations	interpretation	NOUN
ihlr-27183	495	56	of	of	ADP
ihlr-27183	495	57	current	current	ADJ
ihlr-27183	495	58	case	case	NOUN
ihlr-27183	495	59	law	law	NOUN
ihlr-27183	495	60	can	can	AUX
ihlr-27183	495	61	(	(	PUNCT
ihlr-27183	495	62	and	and	CCONJ
ihlr-27183	495	63	do	do	AUX
ihlr-27183	495	64	)	)	PUNCT
ihlr-27183	495	65	differ	differ	VERB
ihlr-27183	495	66	on	on	ADP
ihlr-27183	495	67	.	.	PUNCT
ihlr-27183	496	1	further	far	ADV
ihlr-27183	496	2	,	,	PUNCT
ihlr-27183	496	3	three	three	NUM
ihlr-27183	496	4	times	time	NOUN
ihlr-27183	496	5	throughout	throughout	ADP
ihlr-27183	496	6	the	the	DET
ihlr-27183	496	7	denial	denial	NOUN
ihlr-27183	496	8	of	of	ADP
ihlr-27183	496	9	the	the	DET
ihlr-27183	496	10	motion	motion	NOUN
ihlr-27183	496	11	to	to	PART
ihlr-27183	496	12	dismiss	dismiss	VERB
ihlr-27183	496	13	,	,	PUNCT
ihlr-27183	496	14	the	the	DET
ihlr-27183	496	15	california	california	PROPN
ihlr-27183	496	16	district	district	PROPN
ihlr-27183	496	17	court	court	NOUN
ihlr-27183	496	18	emphasizes	emphasize	VERB
ihlr-27183	496	19	the	the	DET
ihlr-27183	496	20	‘	'	PUNCT
ihlr-27183	496	21	perfect	perfect	ADJ
ihlr-27183	496	22	“	"	PUNCT
ihlr-27183	496	23	product	product	NOUN
ihlr-27183	496	24	”	"	PUNCT
ihlr-27183	496	25	fit	fit	NOUN
ihlr-27183	496	26	’	'	PUNCT
ihlr-27183	496	27	described	describe	VERB
ihlr-27183	496	28	in	in	ADP
ihlr-27183	496	29	eli	eli	PROPN
ihlr-27183	496	30	lilly.156	lilly.156	PROPN
ihlr-27183	496	31	while	while	SCONJ
ihlr-27183	496	32	the	the	DET
ihlr-27183	496	33	symmetry	symmetry	NOUN
ihlr-27183	496	34	between	between	ADP
ihlr-27183	496	35	§	§	PROPN
ihlr-27183	496	36	156	156	NUM
ihlr-27183	496	37	and	and	CCONJ
ihlr-27183	496	38	§	§	PROPN
ihlr-27183	496	39	271	271	NUM
ihlr-27183	496	40	is	be	AUX
ihlr-27183	496	41	dependent	dependent	ADJ
ihlr-27183	496	42	on	on	ADP
ihlr-27183	496	43	an	an	DET
ihlr-27183	496	44	invention	invention	NOUN
ihlr-27183	496	45	itself	itself	PRON
ihlr-27183	496	46	being	be	AUX
ihlr-27183	496	47	subject	subject	ADJ
ihlr-27183	496	48	to	to	ADP
ihlr-27183	496	49	fda	fda	PROPN
ihlr-27183	496	50	approval	approval	PROPN
ihlr-27183	496	51	,	,	PUNCT
ihlr-27183	496	52	eli	eli	PROPN
ihlr-27183	496	53	lilly	lilly	PROPN
ihlr-27183	496	54	used	use	VERB
ihlr-27183	496	55	this	this	DET
ihlr-27183	496	56	fact	fact	NOUN
ihlr-27183	496	57	to	to	PART
ihlr-27183	496	58	explain	explain	VERB
ihlr-27183	496	59	why	why	SCONJ
ihlr-27183	496	60	§	§	PROPN
ihlr-27183	496	61	271(e)(1	271(e)(1	NOUN
ihlr-27183	496	62	)	)	PUNCT
ihlr-27183	496	63	extended	extend	VERB
ihlr-27183	496	64	to	to	ADP
ihlr-27183	496	65	a	a	DET
ihlr-27183	496	66	patented	patented	ADJ
ihlr-27183	496	67	medical	medical	ADJ
ihlr-27183	496	68	device	device	NOUN
ihlr-27183	496	69	,	,	PUNCT
ihlr-27183	496	70	refusing	refuse	VERB
ihlr-27183	496	71	to	to	PART
ihlr-27183	496	72	limit	limit	VERB
ihlr-27183	496	73	its	its	PRON
ihlr-27183	496	74	scope	scope	NOUN
ihlr-27183	496	75	to	to	ADP
ihlr-27183	496	76	drugs	drug	NOUN
ihlr-27183	496	77	,	,	PUNCT
ihlr-27183	496	78	to	to	PART
ihlr-27183	496	79	maintain	maintain	VERB
ihlr-27183	496	80	this	this	DET
ihlr-27183	496	81	symmetry	symmetry	NOUN
ihlr-27183	496	82	.	.	PUNCT
ihlr-27183	497	1	this	this	DET
ihlr-27183	497	2	maneuver	maneuver	NOUN
ihlr-27183	497	3	by	by	ADP
ihlr-27183	497	4	some	some	PRON
ihlr-27183	497	5	was	be	AUX
ihlr-27183	497	6	regarded	regard	VERB
ihlr-27183	497	7	as	as	ADP
ihlr-27183	497	8	expanding	expand	VERB
ihlr-27183	497	9	a	a	DET
ihlr-27183	497	10	term	term	NOUN
ihlr-27183	497	11	once	once	ADV
ihlr-27183	497	12	presumptively	presumptively	ADV
ihlr-27183	497	13	limited	limit	VERB
ihlr-27183	497	14	to	to	ADP
ihlr-27183	497	15	drugs	drug	NOUN
ihlr-27183	497	16	.	.	PUNCT
ihlr-27183	498	1	though	though	SCONJ
ihlr-27183	498	2	the	the	DET
ihlr-27183	498	3	connection	connection	NOUN
ihlr-27183	498	4	is	be	AUX
ihlr-27183	498	5	perfectly	perfectly	ADV
ihlr-27183	498	6	logical	logical	ADJ
ihlr-27183	498	7	,	,	PUNCT
ihlr-27183	498	8	eli	eli	PROPN
ihlr-27183	498	9	lilly	lilly	PROPN
ihlr-27183	498	10	is	be	AUX
ihlr-27183	498	11	not	not	PART
ihlr-27183	498	12	the	the	DET
ihlr-27183	498	13	latest	late	ADJ
ihlr-27183	498	14	binding	bind	VERB
ihlr-27183	498	15	precedent	precedent	NOUN
ihlr-27183	498	16	a	a	DET
ihlr-27183	498	17	district	district	NOUN
ihlr-27183	498	18	court	court	NOUN
ihlr-27183	498	19	must	must	AUX
ihlr-27183	498	20	reconcile	reconcile	VERB
ihlr-27183	498	21	before	before	ADP
ihlr-27183	498	22	arriving	arrive	VERB
ihlr-27183	498	23	at	at	ADP
ihlr-27183	498	24	a	a	DET
ihlr-27183	498	25	conclusion	conclusion	NOUN
ihlr-27183	498	26	.	.	PUNCT
ihlr-27183	499	1	merck	merck	PROPN
ihlr-27183	499	2	was	be	AUX
ihlr-27183	499	3	decided	decide	VERB
ihlr-27183	499	4	in	in	ADP
ihlr-27183	499	5	2005	2005	NUM
ihlr-27183	499	6	and	and	CCONJ
ihlr-27183	499	7	builds	build	VERB
ihlr-27183	499	8	on	on	ADP
ihlr-27183	499	9	eli	eli	PROPN
ihlr-27183	499	10	lilly	lilly	PROPN
ihlr-27183	499	11	to	to	PART
ihlr-27183	499	12	extend	extend	VERB
ihlr-27183	499	13	–	–	PUNCT
ihlr-27183	499	14	not	not	PART
ihlr-27183	499	15	limit	limit	NOUN
ihlr-27183	499	16	–	–	PUNCT
ihlr-27183	499	17	the	the	DET
ihlr-27183	499	18	scope	scope	NOUN
ihlr-27183	499	19	of	of	ADP
ihlr-27183	499	20	§	§	PROPN
ihlr-27183	499	21	271(e)(1	271(e)(1	NOUN
ihlr-27183	499	22	)	)	PUNCT
ihlr-27183	499	23	inventions	invention	NOUN
ihlr-27183	499	24	.	.	PUNCT
ihlr-27183	500	1	referring	refer	VERB
ihlr-27183	500	2	to	to	ADP
ihlr-27183	500	3	eli	eli	PROPN
ihlr-27183	500	4	lilly	lilly	PROPN
ihlr-27183	500	5	,	,	PUNCT
ihlr-27183	500	6	merck	merck	PROPN
ihlr-27183	500	7	states	state	NOUN
ihlr-27183	500	8	it	it	PRON
ihlr-27183	500	9	is	be	AUX
ihlr-27183	500	10	“	"	PUNCT
ihlr-27183	500	11	apparent	apparent	ADJ
ihlr-27183	500	12	from	from	ADP
ihlr-27183	500	13	the	the	DET
ihlr-27183	500	14	statutory	statutory	ADJ
ihlr-27183	500	15	text	text	NOUN
ihlr-27183	500	16	that	that	SCONJ
ihlr-27183	500	17	§	§	PROPN
ihlr-27183	500	18	271(e)(1	271(e)(1	PROPN
ihlr-27183	500	19	)	)	PUNCT
ihlr-27183	500	20	's	's	PART
ihlr-27183	500	21	exemption	exemption	NOUN
ihlr-27183	500	22	from	from	ADP
ihlr-27183	500	23	infringement	infringement	NOUN
ihlr-27183	500	24	extends	extend	VERB
ihlr-27183	500	25	to	to	ADP
ihlr-27183	500	26	all	all	DET
ihlr-27183	500	27	uses	use	NOUN
ihlr-27183	500	28	of	of	ADP
ihlr-27183	500	29	patented	patented	ADJ
ihlr-27183	500	30	inventions	invention	NOUN
ihlr-27183	500	31	that	that	PRON
ihlr-27183	500	32	are	be	AUX
ihlr-27183	500	33	reasonably	reasonably	ADV
ihlr-27183	500	34	related	related	ADJ
ihlr-27183	500	35	to	to	ADP
ihlr-27183	500	36	the	the	DET
ihlr-27183	500	37	development	development	NOUN
ihlr-27183	500	38	and	and	CCONJ
ihlr-27183	500	39	submission	submission	NOUN
ihlr-27183	500	40	of	of	ADP
ihlr-27183	500	41	any	any	DET
ihlr-27183	500	42	information	information	NOUN
ihlr-27183	500	43	under	under	ADP
ihlr-27183	500	44	the	the	DET
ihlr-27183	500	45	fdca	fdca	NOUN
ihlr-27183	500	46	.	.	PUNCT
ihlr-27183	500	47	”157	”157	NOUN
ihlr-27183	500	48	whether	whether	SCONJ
ihlr-27183	500	49	“	"	PUNCT
ihlr-27183	500	50	any	any	DET
ihlr-27183	500	51	information	information	NOUN
ihlr-27183	500	52	”	"	PUNCT
ihlr-27183	500	53	signifies	signify	VERB
ihlr-27183	500	54	that	that	SCONJ
ihlr-27183	500	55	the	the	DET
ihlr-27183	500	56	information	information	NOUN
ihlr-27183	500	57	need	need	AUX
ihlr-27183	500	58	not	not	PART
ihlr-27183	500	59	relate	relate	VERB
ihlr-27183	500	60	to	to	ADP
ihlr-27183	500	61	approval	approval	NOUN
ihlr-27183	500	62	of	of	ADP
ihlr-27183	500	63	the	the	DET
ihlr-27183	500	64	subject	subject	NOUN
ihlr-27183	500	65	patented	patented	ADJ
ihlr-27183	500	66	invention	invention	NOUN
ihlr-27183	500	67	has	have	AUX
ihlr-27183	500	68	not	not	PART
ihlr-27183	500	69	been	be	AUX
ihlr-27183	500	70	answered	answer	VERB
ihlr-27183	500	71	by	by	ADP
ihlr-27183	500	72	the	the	DET
ihlr-27183	500	73	supreme	supreme	PROPN
ihlr-27183	500	74	court	court	PROPN
ihlr-27183	500	75	,	,	PUNCT
ihlr-27183	500	76	and	and	CCONJ
ihlr-27183	500	77	as	as	SCONJ
ihlr-27183	500	78	we	we	PRON
ihlr-27183	500	79	have	have	AUX
ihlr-27183	500	80	already	already	ADV
ihlr-27183	500	81	seen	see	VERB
ihlr-27183	500	82	,	,	PUNCT
ihlr-27183	500	83	is	be	AUX
ihlr-27183	500	84	a	a	DET
ihlr-27183	500	85	subject	subject	NOUN
ihlr-27183	500	86	of	of	ADP
ihlr-27183	500	87	disagreement	disagreement	NOUN
ihlr-27183	500	88	in	in	ADP
ihlr-27183	500	89	lower	low	ADJ
ihlr-27183	500	90	courts.158	courts.158	NOUN
ihlr-27183	500	91	it	it	PRON
ihlr-27183	500	92	has	have	AUX
ihlr-27183	500	93	been	be	AUX
ihlr-27183	500	94	over	over	ADP
ihlr-27183	500	95	fifteen	fifteen	NUM
ihlr-27183	500	96	years	year	NOUN
ihlr-27183	500	97	since	since	SCONJ
ihlr-27183	500	98	this	this	DET
ihlr-27183	500	99	textualistic	textualistic	ADJ
ihlr-27183	500	100	statement	statement	NOUN
ihlr-27183	500	101	of	of	ADP
ihlr-27183	500	102	the	the	DET
ihlr-27183	500	103	statute	statute	NOUN
ihlr-27183	500	104	concerned	concerned	ADJ
ihlr-27183	500	105	holders	holder	NOUN
ihlr-27183	500	106	of	of	ADP
ihlr-27183	500	107	research	research	NOUN
ihlr-27183	500	108	tool	tool	NOUN
ihlr-27183	500	109	patents	patent	NOUN
ihlr-27183	500	110	.	.	PUNCT
ihlr-27183	501	1	admittedly	admittedly	ADV
ihlr-27183	501	2	,	,	PUNCT
ihlr-27183	501	3	the	the	DET
ihlr-27183	501	4	context	context	NOUN
ihlr-27183	501	5	is	be	AUX
ihlr-27183	501	6	principally	principally	ADV
ihlr-27183	501	7	151	151	NUM
ihlr-27183	501	8	.	.	PUNCT
ihlr-27183	502	1	i	i	PRON
ihlr-27183	502	2	d.	d.	VERB
ihlr-27183	502	3	at	at	ADP
ihlr-27183	502	4	*	*	PROPN
ihlr-27183	502	5	9	9	NUM
ihlr-27183	502	6	.	.	NOUN
ihlr-27183	502	7	152	152	NUM
ihlr-27183	502	8	.	.	PUNCT
ihlr-27183	503	1	proveris	proveris	PROPN
ihlr-27183	503	2	sci	sci	PROPN
ihlr-27183	503	3	.	.	PROPN
ihlr-27183	503	4	corp	corp	PROPN
ihlr-27183	503	5	.	.	PROPN
ihlr-27183	504	1	v.	v.	PROPN
ihlr-27183	504	2	innovasystems	innovasystems	PROPN
ihlr-27183	504	3	,	,	PUNCT
ihlr-27183	504	4	inc	inc	PROPN
ihlr-27183	504	5	.	.	PROPN
ihlr-27183	504	6	,	,	PUNCT
ihlr-27183	504	7	536	536	NUM
ihlr-27183	504	8	f.3d	f.3d	NUM
ihlr-27183	504	9	1256	1256	NUM
ihlr-27183	504	10	,	,	PUNCT
ihlr-27183	504	11	1266	1266	NUM
ihlr-27183	504	12	(	(	PUNCT
ihlr-27183	504	13	fed	fed	PROPN
ihlr-27183	504	14	.	.	PUNCT
ihlr-27183	504	15	cir	cir	PROPN
ihlr-27183	504	16	.	.	PROPN
ihlr-27183	504	17	2008	2008	NUM
ihlr-27183	504	18	)	)	PUNCT
ihlr-27183	504	19	.	.	PUNCT
ihlr-27183	505	1	153	153	NUM
ihlr-27183	505	2	.	.	PUNCT
ihlr-27183	506	1	eli	eli	PROPN
ihlr-27183	506	2	lilly	lilly	PROPN
ihlr-27183	506	3	&	&	CCONJ
ihlr-27183	506	4	co.	co.	PROPN
ihlr-27183	506	5	,	,	PUNCT
ihlr-27183	506	6	496	496	NUM
ihlr-27183	506	7	u.s	u.s	PROPN
ihlr-27183	506	8	.	.	PROPN
ihlr-27183	506	9	at	at	ADP
ihlr-27183	506	10	666	666	NUM
ihlr-27183	506	11	.	.	PUNCT
ihlr-27183	506	12	154	154	NUM
ihlr-27183	506	13	.	.	PUNCT
ihlr-27183	506	14	merck	merck	PROPN
ihlr-27183	506	15	kgaa	kgaa	PROPN
ihlr-27183	506	16	v.	v.	PROPN
ihlr-27183	506	17	integra	integra	PROPN
ihlr-27183	506	18	lifesciences	lifesciences	PROPN
ihlr-27183	506	19	i	i	PROPN
ihlr-27183	506	20	,	,	PUNCT
ihlr-27183	506	21	ltd	ltd	PROPN
ihlr-27183	506	22	.	.	PROPN
ihlr-27183	506	23	,	,	PUNCT
ihlr-27183	506	24	545	545	NUM
ihlr-27183	506	25	u.s	u.s	PROPN
ihlr-27183	506	26	.	.	PROPN
ihlr-27183	506	27	193	193	NUM
ihlr-27183	506	28	,	,	PUNCT
ihlr-27183	506	29	208	208	NUM
ihlr-27183	506	30	(	(	PUNCT
ihlr-27183	506	31	2005	2005	NUM
ihlr-27183	506	32	)	)	PUNCT
ihlr-27183	506	33	.	.	PUNCT
ihlr-27183	507	1	155	155	NUM
ihlr-27183	507	2	.	.	PUNCT
ihlr-27183	507	3	abtox	abtox	PROPN
ihlr-27183	507	4	,	,	PUNCT
ihlr-27183	507	5	122	122	NUM
ihlr-27183	507	6	f.3d	f.3d	NUM
ihlr-27183	507	7	at	at	ADP
ihlr-27183	507	8	1029	1029	NUM
ihlr-27183	507	9	.	.	PUNCT
ihlr-27183	508	1	156	156	NUM
ihlr-27183	508	2	.	.	PUNCT
ihlr-27183	508	3	allele	allele	PROPN
ihlr-27183	508	4	biotechnology	biotechnology	PROPN
ihlr-27183	508	5	&	&	CCONJ
ihlr-27183	508	6	pharm	pharm	PROPN
ihlr-27183	508	7	.	.	PROPN
ihlr-27183	508	8	,	,	PUNCT
ihlr-27183	508	9	inc	inc	PROPN
ihlr-27183	508	10	.	.	PROPN
ihlr-27183	508	11	,	,	PUNCT
ihlr-27183	508	12	2021	2021	NUM
ihlr-27183	508	13	u.s	u.s	PROPN
ihlr-27183	508	14	.	.	PROPN
ihlr-27183	508	15	dist	dist	PROPN
ihlr-27183	508	16	.	.	PUNCT
ihlr-27183	509	1	lexis	lexis	NOUN
ihlr-27183	509	2	85347	85347	NUM
ihlr-27183	509	3	,	,	PUNCT
ihlr-27183	509	4	at	at	ADP
ihlr-27183	509	5	*	*	PROPN
ihlr-27183	509	6	11	11	NUM
ihlr-27183	509	7	,	,	PUNCT
ihlr-27183	509	8	*	*	NOUN
ihlr-27183	509	9	13	13	NUM
ihlr-27183	509	10	,	,	PUNCT
ihlr-27183	509	11	*	*	NOUN
ihlr-27183	509	12	17	17	NUM
ihlr-27183	509	13	.	.	PUNCT
ihlr-27183	510	1	157	157	NUM
ihlr-27183	510	2	.	.	PUNCT
ihlr-27183	510	3	merck	merck	PROPN
ihlr-27183	510	4	kgaa	kgaa	PROPN
ihlr-27183	510	5	,	,	PUNCT
ihlr-27183	510	6	545	545	NUM
ihlr-27183	510	7	u.s	u.s	PROPN
ihlr-27183	510	8	.	.	PROPN
ihlr-27183	510	9	at	at	ADP
ihlr-27183	510	10	202	202	NUM
ihlr-27183	510	11	.	.	PUNCT
ihlr-27183	510	12	158	158	NUM
ihlr-27183	510	13	.	.	PUNCT
ihlr-27183	511	1	see	see	VERB
ihlr-27183	511	2	teva	teva	PROPN
ihlr-27183	511	3	pharms	pharms	PROPN
ihlr-27183	511	4	.	.	PUNCT
ihlr-27183	512	1	usa	usa	PROPN
ihlr-27183	512	2	,	,	PUNCT
ihlr-27183	512	3	inc	inc	PROPN
ihlr-27183	512	4	.	.	PROPN
ihlr-27183	513	1	v.	v.	PROPN
ihlr-27183	513	2	sandoz	sandoz	PROPN
ihlr-27183	513	3	,	,	PUNCT
ihlr-27183	513	4	inc	inc	PROPN
ihlr-27183	513	5	.	.	PROPN
ihlr-27183	513	6	,	,	PUNCT
ihlr-27183	513	7	no	no	INTJ
ihlr-27183	513	8	.	.	NOUN
ihlr-27183	513	9	09	09	NUM
ihlr-27183	513	10	civ	civ	NOUN
ihlr-27183	513	11	.	.	PUNCT
ihlr-27183	514	1	10112	10112	NUM
ihlr-27183	514	2	,	,	PUNCT
ihlr-27183	514	3	2013	2013	NUM
ihlr-27183	514	4	wl	wl	NOUN
ihlr-27183	514	5	3732867	3732867	NUM
ihlr-27183	514	6	,	,	PUNCT
ihlr-27183	514	7	at	at	ADP
ihlr-27183	514	8	*	*	PROPN
ihlr-27183	514	9	6	6	NUM
ihlr-27183	514	10	-	-	SYM
ihlr-27183	514	11	7	7	NUM
ihlr-27183	514	12	(	(	PUNCT
ihlr-27183	514	13	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	514	14	.	.	PROPN
ihlr-27183	514	15	july	july	PROPN
ihlr-27183	514	16	16	16	NUM
ihlr-27183	514	17	,	,	PUNCT
ihlr-27183	514	18	2013	2013	NUM
ihlr-27183	514	19	)	)	PUNCT
ihlr-27183	514	20	.	.	PUNCT
ihlr-27183	515	1	164	164	NUM
ihlr-27183	515	2	indiana	indiana	PROPN
ihlr-27183	515	3	health	health	PROPN
ihlr-27183	515	4	law	law	NOUN
ihlr-27183	515	5	review	review	NOUN
ihlr-27183	515	6	[	[	X
ihlr-27183	515	7	vol	vol	NOUN
ihlr-27183	515	8	.	.	PUNCT
ihlr-27183	515	9	20:143	20:143	PROPN
ihlr-27183	515	10	aimed	aim	VERB
ihlr-27183	515	11	at	at	ADP
ihlr-27183	515	12	defining	define	VERB
ihlr-27183	515	13	the	the	DET
ihlr-27183	515	14	“	"	PUNCT
ihlr-27183	515	15	reasonably	reasonably	ADV
ihlr-27183	515	16	related	related	ADJ
ihlr-27183	515	17	”	"	PUNCT
ihlr-27183	515	18	phrase	phrase	NOUN
ihlr-27183	515	19	in	in	ADP
ihlr-27183	515	20	the	the	DET
ihlr-27183	515	21	statute.159	statute.159	NOUN
ihlr-27183	515	22	however	however	ADV
ihlr-27183	515	23	,	,	PUNCT
ihlr-27183	515	24	in	in	ADP
ihlr-27183	515	25	the	the	DET
ihlr-27183	515	26	same	same	ADJ
ihlr-27183	515	27	way	way	NOUN
ihlr-27183	515	28	merck	merck	NOUN
ihlr-27183	515	29	(	(	PUNCT
ihlr-27183	515	30	primarily	primarily	ADV
ihlr-27183	515	31	concerned	concerned	ADJ
ihlr-27183	515	32	with	with	ADP
ihlr-27183	515	33	the	the	DET
ihlr-27183	515	34	scope	scope	NOUN
ihlr-27183	515	35	of	of	ADP
ihlr-27183	515	36	reasonably	reasonably	ADV
ihlr-27183	515	37	related	related	ADJ
ihlr-27183	515	38	)	)	PUNCT
ihlr-27183	515	39	harmonizes	harmonize	NOUN
ihlr-27183	515	40	with	with	ADP
ihlr-27183	515	41	eli	eli	PROPN
ihlr-27183	515	42	lilly	lilly	PROPN
ihlr-27183	515	43	(	(	PUNCT
ihlr-27183	515	44	primarily	primarily	ADV
ihlr-27183	515	45	concerned	concerned	ADJ
ihlr-27183	515	46	with	with	ADP
ihlr-27183	515	47	the	the	DET
ihlr-27183	515	48	scope	scope	NOUN
ihlr-27183	515	49	of	of	ADP
ihlr-27183	515	50	patented	patented	ADJ
ihlr-27183	515	51	invention	invention	NOUN
ihlr-27183	515	52	)	)	PUNCT
ihlr-27183	515	53	,	,	PUNCT
ihlr-27183	515	54	a	a	DET
ihlr-27183	515	55	more	more	ADV
ihlr-27183	515	56	fulsome	fulsome	ADJ
ihlr-27183	515	57	explanation	explanation	NOUN
ihlr-27183	515	58	must	must	AUX
ihlr-27183	515	59	bound	bind	VERB
ihlr-27183	515	60	the	the	DET
ihlr-27183	515	61	broad	broad	ADJ
ihlr-27183	515	62	principles	principle	NOUN
ihlr-27183	515	63	in	in	ADP
ihlr-27183	515	64	merck	merck	NOUN
ihlr-27183	515	65	as	as	SCONJ
ihlr-27183	515	66	limited	limit	VERB
ihlr-27183	515	67	to	to	ADP
ihlr-27183	515	68	the	the	DET
ihlr-27183	515	69	context	context	NOUN
ihlr-27183	515	70	of	of	ADP
ihlr-27183	515	71	reasonably	reasonably	ADV
ihlr-27183	515	72	related	relate	VERB
ihlr-27183	515	73	activity	activity	NOUN
ihlr-27183	515	74	and	and	CCONJ
ihlr-27183	515	75	not	not	PART
ihlr-27183	515	76	conflicting	conflict	VERB
ihlr-27183	515	77	with	with	ADP
ihlr-27183	515	78	a	a	DET
ihlr-27183	515	79	yet	yet	ADV
ihlr-27183	515	80	to	to	PART
ihlr-27183	515	81	be	be	AUX
ihlr-27183	515	82	articulated	articulate	VERB
ihlr-27183	515	83	general	general	ADJ
ihlr-27183	515	84	rule	rule	NOUN
ihlr-27183	515	85	concerning	concern	VERB
ihlr-27183	515	86	research	research	NOUN
ihlr-27183	515	87	tools	tool	NOUN
ihlr-27183	515	88	.	.	PUNCT
ihlr-27183	516	1	again	again	ADV
ihlr-27183	516	2	,	,	PUNCT
ihlr-27183	516	3	the	the	DET
ihlr-27183	516	4	scope	scope	NOUN
ihlr-27183	516	5	of	of	ADP
ihlr-27183	516	6	“	"	PUNCT
ihlr-27183	516	7	reasonably	reasonably	ADV
ihlr-27183	516	8	related	relate	VERB
ihlr-27183	516	9	”	"	PUNCT
ihlr-27183	516	10	has	have	AUX
ihlr-27183	516	11	not	not	PART
ihlr-27183	516	12	been	be	AUX
ihlr-27183	516	13	defined	define	VERB
ihlr-27183	516	14	in	in	ADP
ihlr-27183	516	15	isolation	isolation	NOUN
ihlr-27183	516	16	:	:	PUNCT
ihlr-27183	516	17	courts	court	NOUN
ihlr-27183	516	18	can	can	AUX
ihlr-27183	516	19	and	and	CCONJ
ihlr-27183	516	20	have	have	AUX
ihlr-27183	516	21	woven	weave	VERB
ihlr-27183	516	22	themes	theme	NOUN
ihlr-27183	516	23	of	of	ADP
ihlr-27183	516	24	reasonably	reasonably	ADV
ihlr-27183	516	25	related	relate	VERB
ihlr-27183	516	26	into	into	ADP
ihlr-27183	516	27	analysis	analysis	NOUN
ihlr-27183	516	28	evaluating	evaluate	VERB
ihlr-27183	516	29	research	research	NOUN
ihlr-27183	516	30	tools	tool	NOUN
ihlr-27183	516	31	as	as	ADP
ihlr-27183	516	32	patented	patent	VERB
ihlr-27183	516	33	inventions.160	inventions.160	NOUN
ihlr-27183	516	34	with	with	ADP
ihlr-27183	516	35	the	the	DET
ihlr-27183	516	36	significance	significance	NOUN
ihlr-27183	516	37	of	of	ADP
ihlr-27183	516	38	the	the	DET
ihlr-27183	516	39	patented	patented	ADJ
ihlr-27183	516	40	invention	invention	NOUN
ihlr-27183	516	41	’s	’s	PART
ihlr-27183	516	42	subjection	subjection	NOUN
ihlr-27183	516	43	to	to	ADP
ihlr-27183	516	44	fda	fda	PROPN
ihlr-27183	516	45	approval	approval	PROPN
ihlr-27183	516	46	formally	formally	ADV
ihlr-27183	516	47	left	leave	VERB
ihlr-27183	516	48	open	open	ADJ
ihlr-27183	516	49	for	for	ADP
ihlr-27183	516	50	the	the	DET
ihlr-27183	516	51	lower	low	ADJ
ihlr-27183	516	52	courts	court	NOUN
ihlr-27183	516	53	,	,	PUNCT
ihlr-27183	516	54	allele	allele	NOUN
ihlr-27183	516	55	presents	present	VERB
ihlr-27183	516	56	a	a	DET
ihlr-27183	516	57	high	high	ADJ
ihlr-27183	516	58	-	-	PUNCT
ihlr-27183	516	59	profile	profile	NOUN
ihlr-27183	516	60	opportunity	opportunity	NOUN
ihlr-27183	516	61	where	where	SCONJ
ihlr-27183	516	62	an	an	DET
ihlr-27183	516	63	unlicensed	unlicensed	ADJ
ihlr-27183	516	64	use	use	NOUN
ihlr-27183	516	65	of	of	ADP
ihlr-27183	516	66	a	a	DET
ihlr-27183	516	67	patented	patented	ADJ
ihlr-27183	516	68	research	research	NOUN
ihlr-27183	516	69	tool	tool	NOUN
ihlr-27183	516	70	may	may	AUX
ihlr-27183	516	71	be	be	AUX
ihlr-27183	516	72	analyzed	analyze	VERB
ihlr-27183	516	73	to	to	PART
ihlr-27183	516	74	provide	provide	VERB
ihlr-27183	516	75	clarity	clarity	NOUN
ihlr-27183	516	76	on	on	ADP
ihlr-27183	516	77	that	that	DET
ihlr-27183	516	78	point.161	point.161	VERB
ihlr-27183	516	79	3	3	NUM
ihlr-27183	516	80	.	.	PUNCT
ihlr-27183	516	81	final	final	ADJ
ihlr-27183	516	82	outcome	outcome	NOUN
ihlr-27183	516	83	inconsistency	inconsistency	NOUN
ihlr-27183	516	84	between	between	ADP
ihlr-27183	516	85	courts	court	NOUN
ihlr-27183	516	86	on	on	ADP
ihlr-27183	516	87	this	this	DET
ihlr-27183	516	88	matter	matter	NOUN
ihlr-27183	516	89	is	be	AUX
ihlr-27183	516	90	not	not	PART
ihlr-27183	516	91	a	a	DET
ihlr-27183	516	92	distant	distant	ADJ
ihlr-27183	516	93	obscurity	obscurity	NOUN
ihlr-27183	516	94	.	.	PUNCT
ihlr-27183	517	1	a	a	DET
ihlr-27183	517	2	student	student	NOUN
ihlr-27183	517	3	of	of	ADP
ihlr-27183	517	4	the	the	DET
ihlr-27183	517	5	subject	subject	NOUN
ihlr-27183	517	6	need	need	NOUN
ihlr-27183	517	7	only	only	ADV
ihlr-27183	517	8	assess	assess	VERB
ihlr-27183	517	9	the	the	DET
ihlr-27183	517	10	probable	probable	ADJ
ihlr-27183	517	11	outcome	outcome	NOUN
ihlr-27183	517	12	of	of	ADP
ihlr-27183	517	13	these	these	DET
ihlr-27183	517	14	two	two	NUM
ihlr-27183	517	15	cases	case	NOUN
ihlr-27183	517	16	based	base	VERB
ihlr-27183	517	17	on	on	ADP
ihlr-27183	517	18	each	each	DET
ihlr-27183	517	19	jurisdiction	jurisdiction	NOUN
ihlr-27183	517	20	’s	’s	PART
ihlr-27183	517	21	precedent	precedent	NOUN
ihlr-27183	517	22	.	.	PUNCT
ihlr-27183	518	1	as	as	SCONJ
ihlr-27183	518	2	illuded	illude	VERB
ihlr-27183	518	3	to	to	ADP
ihlr-27183	518	4	above	above	ADV
ihlr-27183	518	5	,	,	PUNCT
ihlr-27183	518	6	prior	prior	ADV
ihlr-27183	518	7	to	to	ADP
ihlr-27183	518	8	settlement	settlement	NOUN
ihlr-27183	518	9	,	,	PUNCT
ihlr-27183	518	10	allele	allele	PROPN
ihlr-27183	518	11	’s	’s	PART
ihlr-27183	518	12	complaint	complaint	NOUN
ihlr-27183	518	13	in	in	ADP
ihlr-27183	518	14	the	the	DET
ihlr-27183	518	15	southern	southern	ADJ
ihlr-27183	518	16	district	district	PROPN
ihlr-27183	518	17	of	of	ADP
ihlr-27183	518	18	california	california	PROPN
ihlr-27183	518	19	survived	survive	VERB
ihlr-27183	518	20	a	a	DET
ihlr-27183	518	21	motion	motion	NOUN
ihlr-27183	518	22	to	to	PART
ihlr-27183	518	23	dismiss	dismiss	VERB
ihlr-27183	518	24	and	and	CCONJ
ihlr-27183	518	25	the	the	DET
ihlr-27183	518	26	jurisdiction	jurisdiction	NOUN
ihlr-27183	518	27	has	have	VERB
ihlr-27183	518	28	recent	recent	ADJ
ihlr-27183	518	29	precedent	precedent	NOUN
ihlr-27183	518	30	categorically	categorically	ADV
ihlr-27183	518	31	excluding	exclude	VERB
ihlr-27183	518	32	patented	patented	ADJ
ihlr-27183	518	33	inventions	invention	NOUN
ihlr-27183	518	34	not	not	PART
ihlr-27183	518	35	subject	subject	ADJ
ihlr-27183	518	36	to	to	ADP
ihlr-27183	518	37	fda	fda	PROPN
ihlr-27183	518	38	approval	approval	NOUN
ihlr-27183	518	39	from	from	ADP
ihlr-27183	518	40	the	the	DET
ihlr-27183	518	41	safe	safe	ADJ
ihlr-27183	518	42	harbor	harbor	NOUN
ihlr-27183	518	43	.	.	PUNCT
ihlr-27183	519	1	collectively	collectively	ADV
ihlr-27183	519	2	,	,	PUNCT
ihlr-27183	519	3	this	this	PRON
ihlr-27183	519	4	suggests	suggest	VERB
ihlr-27183	519	5	the	the	DET
ihlr-27183	519	6	southern	southern	ADJ
ihlr-27183	519	7	district	district	PROPN
ihlr-27183	519	8	of	of	ADP
ihlr-27183	519	9	california	california	PROPN
ihlr-27183	519	10	is	be	AUX
ihlr-27183	519	11	unlikely	unlikely	ADJ
ihlr-27183	519	12	to	to	PART
ihlr-27183	519	13	extend	extend	VERB
ihlr-27183	519	14	the	the	DET
ihlr-27183	519	15	safe	safe	ADJ
ihlr-27183	519	16	harbor	harbor	NOUN
ihlr-27183	519	17	to	to	PART
ihlr-27183	519	18	immunize	immunize	VERB
ihlr-27183	519	19	the	the	DET
ihlr-27183	519	20	future	future	ADJ
ihlr-27183	519	21	use	use	NOUN
ihlr-27183	519	22	of	of	ADP
ihlr-27183	519	23	patented	patented	ADJ
ihlr-27183	519	24	research	research	NOUN
ihlr-27183	519	25	tools	tool	NOUN
ihlr-27183	519	26	.	.	PUNCT
ihlr-27183	520	1	indeed	indeed	ADV
ihlr-27183	520	2	,	,	PUNCT
ihlr-27183	520	3	this	this	PRON
ihlr-27183	520	4	is	be	AUX
ihlr-27183	520	5	not	not	PART
ihlr-27183	520	6	the	the	DET
ihlr-27183	520	7	first	first	ADJ
ihlr-27183	520	8	time	time	NOUN
ihlr-27183	520	9	,	,	PUNCT
ihlr-27183	520	10	or	or	CCONJ
ihlr-27183	520	11	the	the	DET
ihlr-27183	520	12	last	last	ADJ
ihlr-27183	520	13	time	time	NOUN
ihlr-27183	520	14	,	,	PUNCT
ihlr-27183	520	15	the	the	DET
ihlr-27183	520	16	southern	southern	ADJ
ihlr-27183	520	17	district	district	PROPN
ihlr-27183	520	18	of	of	ADP
ihlr-27183	520	19	california	california	PROPN
ihlr-27183	520	20	has	have	AUX
ihlr-27183	520	21	articulated	articulate	VERB
ihlr-27183	520	22	a	a	DET
ihlr-27183	520	23	narrow	narrow	ADJ
ihlr-27183	520	24	reading	reading	NOUN
ihlr-27183	520	25	of	of	ADP
ihlr-27183	520	26	proveris.162	proveris.162	NOUN
ihlr-27183	520	27	in	in	ADP
ihlr-27183	520	28	contrast	contrast	NOUN
ihlr-27183	520	29	,	,	PUNCT
ihlr-27183	520	30	the	the	DET
ihlr-27183	520	31	southern	southern	ADJ
ihlr-27183	520	32	district	district	NOUN
ihlr-27183	520	33	of	of	ADP
ihlr-27183	520	34	new	new	PROPN
ihlr-27183	520	35	york	york	PROPN
ihlr-27183	520	36	,	,	PUNCT
ihlr-27183	520	37	in	in	ADP
ihlr-27183	520	38	which	which	PRON
ihlr-27183	520	39	allele	allele	NOUN
ihlr-27183	520	40	has	have	AUX
ihlr-27183	520	41	filed	file	VERB
ihlr-27183	520	42	suit	suit	NOUN
ihlr-27183	520	43	against	against	ADP
ihlr-27183	520	44	regeneron	regeneron	PROPN
ihlr-27183	520	45	,	,	PUNCT
ihlr-27183	520	46	has	have	VERB
ihlr-27183	520	47	a	a	DET
ihlr-27183	520	48	recent	recent	ADJ
ihlr-27183	520	49	case	case	NOUN
ihlr-27183	520	50	where	where	SCONJ
ihlr-27183	520	51	the	the	DET
ihlr-27183	520	52	use	use	NOUN
ihlr-27183	520	53	of	of	ADP
ihlr-27183	520	54	so	so	ADV
ihlr-27183	520	55	-	-	PUNCT
ihlr-27183	520	56	called	call	VERB
ihlr-27183	520	57	research	research	NOUN
ihlr-27183	520	58	tools	tool	NOUN
ihlr-27183	520	59	was	be	AUX
ihlr-27183	520	60	shielded	shield	VERB
ihlr-27183	520	61	under	under	ADP
ihlr-27183	520	62	the	the	DET
ihlr-27183	520	63	safe	safe	ADJ
ihlr-27183	520	64	harbor	harbor	NOUN
ihlr-27183	520	65	.	.	PUNCT
ihlr-27183	521	1	therefore	therefore	ADV
ihlr-27183	521	2	,	,	PUNCT
ihlr-27183	521	3	it	it	PRON
ihlr-27183	521	4	once	once	ADV
ihlr-27183	521	5	appeared	appear	VERB
ihlr-27183	521	6	two	two	NUM
ihlr-27183	521	7	cases	case	NOUN
ihlr-27183	521	8	alleging	allege	VERB
ihlr-27183	521	9	similar	similar	ADJ
ihlr-27183	521	10	use	use	NOUN
ihlr-27183	521	11	of	of	ADP
ihlr-27183	521	12	the	the	DET
ihlr-27183	521	13	same	same	ADJ
ihlr-27183	521	14	patented	patented	ADJ
ihlr-27183	521	15	invention	invention	NOUN
ihlr-27183	521	16	were	be	AUX
ihlr-27183	521	17	queued	queue	VERB
ihlr-27183	521	18	up	up	ADP
ihlr-27183	521	19	for	for	ADP
ihlr-27183	521	20	different	different	ADJ
ihlr-27183	521	21	outcomes	outcome	NOUN
ihlr-27183	521	22	.	.	PUNCT
ihlr-27183	522	1	however	however	ADV
ihlr-27183	522	2	,	,	PUNCT
ihlr-27183	522	3	on	on	ADP
ihlr-27183	522	4	march	march	PROPN
ihlr-27183	522	5	2	2	NUM
ihlr-27183	522	6	,	,	PUNCT
ihlr-27183	522	7	2022	2022	NUM
ihlr-27183	522	8	,	,	PUNCT
ihlr-27183	522	9	regeneron	regeneron	NOUN
ihlr-27183	522	10	’s	’s	PART
ihlr-27183	522	11	motion	motion	NOUN
ihlr-27183	522	12	to	to	PART
ihlr-27183	522	13	dismiss	dismiss	VERB
ihlr-27183	522	14	,	,	PUNCT
ihlr-27183	522	15	a	a	DET
ihlr-27183	522	16	motion	motion	NOUN
ihlr-27183	522	17	analogous	analogous	ADJ
ihlr-27183	522	18	159	159	NUM
ihlr-27183	522	19	.	.	PUNCT
ihlr-27183	523	1	justice	justice	PROPN
ihlr-27183	523	2	scalia	scalia	PROPN
ihlr-27183	523	3	is	be	AUX
ihlr-27183	523	4	known	know	VERB
ihlr-27183	523	5	for	for	ADP
ihlr-27183	523	6	strict	strict	ADJ
ihlr-27183	523	7	textualistic	textualistic	ADJ
ihlr-27183	523	8	reading	reading	NOUN
ihlr-27183	523	9	of	of	ADP
ihlr-27183	523	10	statutes	statute	NOUN
ihlr-27183	523	11	and	and	CCONJ
ihlr-27183	523	12	was	be	AUX
ihlr-27183	523	13	often	often	ADV
ihlr-27183	523	14	skeptical	skeptical	ADJ
ihlr-27183	523	15	of	of	ADP
ihlr-27183	523	16	using	use	VERB
ihlr-27183	523	17	legislative	legislative	ADJ
ihlr-27183	523	18	history	history	NOUN
ihlr-27183	523	19	to	to	PART
ihlr-27183	523	20	interpret	interpret	VERB
ihlr-27183	523	21	statutes	statute	NOUN
ihlr-27183	523	22	.	.	PUNCT
ihlr-27183	524	1	he	he	PRON
ihlr-27183	524	2	argued	argue	VERB
ihlr-27183	524	3	it	it	PRON
ihlr-27183	524	4	could	could	AUX
ihlr-27183	524	5	often	often	ADV
ihlr-27183	524	6	support	support	VERB
ihlr-27183	524	7	both	both	DET
ihlr-27183	524	8	sides	side	NOUN
ihlr-27183	524	9	and	and	CCONJ
ihlr-27183	524	10	may	may	AUX
ihlr-27183	524	11	have	have	AUX
ihlr-27183	524	12	been	be	AUX
ihlr-27183	524	13	produced	produce	VERB
ihlr-27183	524	14	to	to	PART
ihlr-27183	524	15	yield	yield	VERB
ihlr-27183	524	16	an	an	DET
ihlr-27183	524	17	interpretation	interpretation	NOUN
ihlr-27183	524	18	not	not	PART
ihlr-27183	524	19	voted	vote	VERB
ihlr-27183	524	20	on	on	ADP
ihlr-27183	524	21	by	by	ADP
ihlr-27183	524	22	congress	congress	PROPN
ihlr-27183	524	23	.	.	PUNCT
ihlr-27183	525	1	see	see	VERB
ihlr-27183	525	2	merck	merck	PROPN
ihlr-27183	525	3	kgaa	kgaa	PROPN
ihlr-27183	525	4	,	,	PUNCT
ihlr-27183	525	5	545	545	NUM
ihlr-27183	525	6	u.s	u.s	PROPN
ihlr-27183	525	7	.	.	PROPN
ihlr-27183	525	8	at	at	ADP
ihlr-27183	525	9	202	202	NUM
ihlr-27183	525	10	,	,	PUNCT
ihlr-27183	525	11	206	206	NUM
ihlr-27183	525	12	,	,	PUNCT
ihlr-27183	525	13	208	208	NUM
ihlr-27183	525	14	(	(	PUNCT
ihlr-27183	525	15	in	in	ADP
ihlr-27183	525	16	each	each	DET
ihlr-27183	525	17	passage	passage	NOUN
ihlr-27183	525	18	scalia	scalia	PROPN
ihlr-27183	525	19	refuses	refuse	VERB
ihlr-27183	525	20	to	to	PART
ihlr-27183	525	21	impose	impose	VERB
ihlr-27183	525	22	a	a	DET
ihlr-27183	525	23	limitation	limitation	NOUN
ihlr-27183	525	24	on	on	ADP
ihlr-27183	525	25	“	"	PUNCT
ihlr-27183	525	26	patented	patented	ADJ
ihlr-27183	525	27	invention	invention	NOUN
ihlr-27183	525	28	”	"	PUNCT
ihlr-27183	525	29	which	which	PRON
ihlr-27183	525	30	was	be	AUX
ihlr-27183	525	31	not	not	PART
ihlr-27183	525	32	introduced	introduce	VERB
ihlr-27183	525	33	by	by	ADP
ihlr-27183	525	34	the	the	DET
ihlr-27183	525	35	statute	statute	NOUN
ihlr-27183	525	36	’s	’s	PART
ihlr-27183	525	37	text	text	NOUN
ihlr-27183	525	38	)	)	PUNCT
ihlr-27183	525	39	.	.	PUNCT
ihlr-27183	526	1	160	160	NUM
ihlr-27183	526	2	.	.	PUNCT
ihlr-27183	526	3	see	see	VERB
ihlr-27183	526	4	teva	teva	PROPN
ihlr-27183	526	5	pharms	pharms	PROPN
ihlr-27183	526	6	.	.	PUNCT
ihlr-27183	527	1	usa	usa	PROPN
ihlr-27183	527	2	,	,	PUNCT
ihlr-27183	527	3	inc	inc	PROPN
ihlr-27183	527	4	.	.	PROPN
ihlr-27183	527	5	,	,	PUNCT
ihlr-27183	527	6	2013	2013	NUM
ihlr-27183	527	7	wl	wl	NOUN
ihlr-27183	527	8	3732867	3732867	NUM
ihlr-27183	527	9	,	,	PUNCT
ihlr-27183	527	10	at	at	ADP
ihlr-27183	527	11	*	*	NUM
ihlr-27183	527	12	6	6	NUM
ihlr-27183	527	13	(	(	PUNCT
ihlr-27183	527	14	quoting	quote	VERB
ihlr-27183	527	15	from	from	ADP
ihlr-27183	527	16	merck	merck	NOUN
ihlr-27183	527	17	specifically	specifically	ADV
ihlr-27183	527	18	when	when	SCONJ
ihlr-27183	527	19	assessing	assess	VERB
ihlr-27183	527	20	whether	whether	SCONJ
ihlr-27183	527	21	the	the	DET
ihlr-27183	527	22	patented	patented	ADJ
ihlr-27183	527	23	invention	invention	NOUN
ihlr-27183	527	24	used	use	VERB
ihlr-27183	527	25	must	must	AUX
ihlr-27183	527	26	itself	itself	PRON
ihlr-27183	527	27	be	be	AUX
ihlr-27183	527	28	subject	subject	ADJ
ihlr-27183	527	29	to	to	ADP
ihlr-27183	527	30	fda	fda	PROPN
ihlr-27183	527	31	approval	approval	PROPN
ihlr-27183	527	32	)	)	PUNCT
ihlr-27183	527	33	.	.	PUNCT
ihlr-27183	528	1	see	see	VERB
ihlr-27183	528	2	also	also	ADV
ihlr-27183	528	3	allele	allele	PROPN
ihlr-27183	528	4	biotechnology	biotechnology	PROPN
ihlr-27183	528	5	&	&	CCONJ
ihlr-27183	528	6	pharm	pharm	PROPN
ihlr-27183	528	7	.	.	PROPN
ihlr-27183	528	8	,	,	PUNCT
ihlr-27183	528	9	inc	inc	PROPN
ihlr-27183	528	10	.	.	PROPN
ihlr-27183	528	11	,	,	PUNCT
ihlr-27183	528	12	2021	2021	NUM
ihlr-27183	528	13	u.s	u.s	PROPN
ihlr-27183	528	14	.	.	PROPN
ihlr-27183	528	15	dist	dist	PROPN
ihlr-27183	528	16	.	.	PUNCT
ihlr-27183	529	1	lexis	lexis	NOUN
ihlr-27183	529	2	85347	85347	NUM
ihlr-27183	529	3	,	,	PUNCT
ihlr-27183	529	4	at	at	ADP
ihlr-27183	529	5	*	*	NOUN
ihlr-27183	529	6	7	7	NUM
ihlr-27183	529	7	(	(	PUNCT
ihlr-27183	529	8	reconciling	reconcile	VERB
ihlr-27183	529	9	merck	merck	NOUN
ihlr-27183	529	10	with	with	ADP
ihlr-27183	529	11	its	its	PRON
ihlr-27183	529	12	narrower	narrow	ADJ
ihlr-27183	529	13	application	application	NOUN
ihlr-27183	529	14	of	of	ADP
ihlr-27183	529	15	the	the	DET
ihlr-27183	529	16	safe	safe	ADJ
ihlr-27183	529	17	harbor	harbor	NOUN
ihlr-27183	529	18	in	in	ADP
ihlr-27183	529	19	the	the	DET
ihlr-27183	529	20	context	context	NOUN
ihlr-27183	529	21	of	of	ADP
ihlr-27183	529	22	“	"	PUNCT
ihlr-27183	529	23	patented	patented	ADJ
ihlr-27183	529	24	invention	invention	NOUN
ihlr-27183	529	25	”	"	PUNCT
ihlr-27183	529	26	)	)	PUNCT
ihlr-27183	529	27	.	.	PUNCT
ihlr-27183	530	1	161	161	NUM
ihlr-27183	530	2	.	.	PUNCT
ihlr-27183	530	3	merck	merck	PROPN
ihlr-27183	530	4	kgaa	kgaa	PROPN
ihlr-27183	530	5	,	,	PUNCT
ihlr-27183	530	6	545	545	NUM
ihlr-27183	530	7	u.s	u.s	PROPN
ihlr-27183	530	8	.	.	PROPN
ihlr-27183	530	9	at	at	ADP
ihlr-27183	530	10	208	208	NUM
ihlr-27183	530	11	n.7	n.7	X
ihlr-27183	530	12	(	(	PUNCT
ihlr-27183	530	13	footnote	footnote	VERB
ihlr-27183	530	14	7	7	NUM
ihlr-27183	530	15	in	in	ADP
ihlr-27183	530	16	merck	merck	PROPN
ihlr-27183	530	17	states	state	NOUN
ihlr-27183	530	18	that	that	SCONJ
ihlr-27183	530	19	though	though	SCONJ
ihlr-27183	530	20	the	the	DET
ihlr-27183	530	21	court	court	NOUN
ihlr-27183	530	22	of	of	ADP
ihlr-27183	530	23	appeals	appeals	PROPN
ihlr-27183	530	24	argued	argue	VERB
ihlr-27183	530	25	limiting	limit	VERB
ihlr-27183	530	26	§	§	PROPN
ihlr-27183	530	27	271(e)(1	271(e)(1	NOUN
ihlr-27183	530	28	)	)	PUNCT
ihlr-27183	530	29	was	be	AUX
ihlr-27183	530	30	appropriate	appropriate	ADJ
ihlr-27183	530	31	to	to	PART
ihlr-27183	530	32	protect	protect	VERB
ihlr-27183	530	33	patents	patent	NOUN
ihlr-27183	530	34	on	on	ADP
ihlr-27183	530	35	research	research	NOUN
ihlr-27183	530	36	tools	tool	NOUN
ihlr-27183	530	37	,	,	PUNCT
ihlr-27183	530	38	the	the	DET
ihlr-27183	530	39	supreme	supreme	PROPN
ihlr-27183	530	40	court	court	PROPN
ihlr-27183	530	41	explicitly	explicitly	ADV
ihlr-27183	530	42	declined	decline	VERB
ihlr-27183	530	43	to	to	PART
ihlr-27183	530	44	“	"	PUNCT
ihlr-27183	530	45	express	express	VERB
ihlr-27183	530	46	a	a	DET
ihlr-27183	530	47	view	view	NOUN
ihlr-27183	530	48	about	about	ADP
ihlr-27183	530	49	whether	whether	SCONJ
ihlr-27183	530	50	,	,	PUNCT
ihlr-27183	530	51	or	or	CCONJ
ihlr-27183	530	52	to	to	ADP
ihlr-27183	530	53	what	what	DET
ihlr-27183	530	54	extent	extent	NOUN
ihlr-27183	530	55	,	,	PUNCT
ihlr-27183	530	56	”	"	PUNCT
ihlr-27183	530	57	research	research	NOUN
ihlr-27183	530	58	tools	tool	NOUN
ihlr-27183	530	59	should	should	AUX
ihlr-27183	530	60	fall	fall	VERB
ihlr-27183	530	61	under	under	ADP
ihlr-27183	530	62	the	the	DET
ihlr-27183	530	63	safe	safe	ADJ
ihlr-27183	530	64	harbor	harbor	NOUN
ihlr-27183	530	65	)	)	PUNCT
ihlr-27183	530	66	.	.	PUNCT
ihlr-27183	531	1	162	162	NUM
ihlr-27183	531	2	.	.	PUNCT
ihlr-27183	532	1	see	see	VERB
ihlr-27183	532	2	isis	isis	NOUN
ihlr-27183	532	3	pharms	pharm	NOUN
ihlr-27183	532	4	.	.	PUNCT
ihlr-27183	532	5	,	,	PUNCT
ihlr-27183	532	6	inc	inc	PROPN
ihlr-27183	532	7	.	.	PROPN
ihlr-27183	533	1	v.	v.	ADP
ihlr-27183	533	2	santaris	santaris	PROPN
ihlr-27183	533	3	pharma	pharma	PROPN
ihlr-27183	533	4	a	a	DET
ihlr-27183	533	5	/	/	SYM
ihlr-27183	533	6	s	s	PROPN
ihlr-27183	533	7	corp	corp	PROPN
ihlr-27183	533	8	.	.	PROPN
ihlr-27183	533	9	,	,	PUNCT
ihlr-27183	533	10	no	no	INTJ
ihlr-27183	533	11	.	.	NOUN
ihlr-27183	533	12	11	11	NUM
ihlr-27183	533	13	-	-	PUNCT
ihlr-27183	533	14	cv-02214	cv-02214	ADJ
ihlr-27183	533	15	,	,	PUNCT
ihlr-27183	533	16	2012	2012	NUM
ihlr-27183	533	17	u.s	u.s	PROPN
ihlr-27183	533	18	.	.	PROPN
ihlr-27183	533	19	dist	dist	PROPN
ihlr-27183	533	20	.	.	PUNCT
ihlr-27183	534	1	lexis	lexis	PROPN
ihlr-27183	534	2	134107	134107	NUM
ihlr-27183	534	3	,	,	PUNCT
ihlr-27183	534	4	at	at	ADP
ihlr-27183	534	5	*	*	NUM
ihlr-27183	534	6	11	11	NUM
ihlr-27183	534	7	(	(	PUNCT
ihlr-27183	534	8	s.d	s.d	PROPN
ihlr-27183	534	9	.	.	PROPN
ihlr-27183	534	10	cal	cal	PROPN
ihlr-27183	534	11	.	.	PUNCT
ihlr-27183	535	1	sept	sept	PROPN
ihlr-27183	535	2	.	.	PROPN
ihlr-27183	535	3	18	18	NUM
ihlr-27183	535	4	,	,	PUNCT
ihlr-27183	535	5	2012	2012	NUM
ihlr-27183	535	6	)	)	PUNCT
ihlr-27183	535	7	.	.	PUNCT
ihlr-27183	536	1	2023	2023	NUM
ihlr-27183	536	2	]	]	PUNCT
ihlr-27183	536	3	the	the	DET
ihlr-27183	536	4	safe	safe	ADJ
ihlr-27183	536	5	harbor	harbor	NOUN
ihlr-27183	536	6	of	of	ADP
ihlr-27183	536	7	35	35	NUM
ihlr-27183	536	8	u.s.c	u.s.c	ADJ
ihlr-27183	536	9	.	.	PUNCT
ihlr-27183	537	1	§	§	PROPN
ihlr-27183	537	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	537	3	)	)	PUNCT
ihlr-27183	537	4	165	165	NUM
ihlr-27183	537	5	to	to	ADP
ihlr-27183	537	6	pfizer	pfizer	PROPN
ihlr-27183	537	7	’s	’s	PART
ihlr-27183	537	8	motion	motion	NOUN
ihlr-27183	537	9	,	,	PUNCT
ihlr-27183	537	10	was	be	AUX
ihlr-27183	537	11	similarly	similarly	ADV
ihlr-27183	537	12	denied	deny	VERB
ihlr-27183	537	13	.	.	PUNCT
ihlr-27183	538	1	as	as	ADP
ihlr-27183	538	2	of	of	ADP
ihlr-27183	538	3	july	july	PROPN
ihlr-27183	538	4	31	31	NUM
ihlr-27183	538	5	,	,	PUNCT
ihlr-27183	538	6	2022	2022	NUM
ihlr-27183	538	7	,	,	PUNCT
ihlr-27183	538	8	both	both	DET
ihlr-27183	538	9	parties	party	NOUN
ihlr-27183	538	10	are	be	AUX
ihlr-27183	538	11	preparing	prepare	VERB
ihlr-27183	538	12	for	for	ADP
ihlr-27183	538	13	a	a	DET
ihlr-27183	538	14	jury	jury	NOUN
ihlr-27183	538	15	trial	trial	NOUN
ihlr-27183	538	16	,	,	PUNCT
ihlr-27183	538	17	the	the	DET
ihlr-27183	538	18	outcome	outcome	NOUN
ihlr-27183	538	19	of	of	ADP
ihlr-27183	538	20	which	which	PRON
ihlr-27183	538	21	will	will	AUX
ihlr-27183	538	22	likely	likely	ADV
ihlr-27183	538	23	raise	raise	VERB
ihlr-27183	538	24	the	the	DET
ihlr-27183	538	25	research	research	NOUN
ihlr-27183	538	26	tool	tool	NOUN
ihlr-27183	538	27	question	question	NOUN
ihlr-27183	538	28	again	again	ADV
ihlr-27183	538	29	on	on	ADP
ihlr-27183	538	30	appeal	appeal	NOUN
ihlr-27183	538	31	.	.	PUNCT
ihlr-27183	539	1	whether	whether	SCONJ
ihlr-27183	539	2	on	on	ADP
ihlr-27183	539	3	appeal	appeal	NOUN
ihlr-27183	539	4	in	in	ADP
ihlr-27183	539	5	this	this	DET
ihlr-27183	539	6	case	case	NOUN
ihlr-27183	539	7	,	,	PUNCT
ihlr-27183	539	8	or	or	CCONJ
ihlr-27183	539	9	in	in	ADP
ihlr-27183	539	10	future	future	ADJ
ihlr-27183	539	11	cases	case	NOUN
ihlr-27183	539	12	with	with	ADP
ihlr-27183	539	13	arguably	arguably	ADV
ihlr-27183	539	14	distinguishable	distinguishable	ADJ
ihlr-27183	539	15	facts	fact	NOUN
ihlr-27183	539	16	,	,	PUNCT
ihlr-27183	539	17	the	the	DET
ihlr-27183	539	18	contradictory	contradictory	ADJ
ihlr-27183	539	19	case	case	NOUN
ihlr-27183	539	20	law	law	NOUN
ihlr-27183	539	21	will	will	AUX
ihlr-27183	539	22	be	be	AUX
ihlr-27183	539	23	advanced	advance	VERB
ihlr-27183	539	24	,	,	PUNCT
ihlr-27183	539	25	and	and	CCONJ
ihlr-27183	539	26	the	the	DET
ihlr-27183	539	27	judge	judge	NOUN
ihlr-27183	539	28	will	will	AUX
ihlr-27183	539	29	resolve	resolve	VERB
ihlr-27183	539	30	each	each	DET
ihlr-27183	539	31	case	case	NOUN
ihlr-27183	539	32	.	.	PUNCT
ihlr-27183	540	1	this	this	DET
ihlr-27183	540	2	scenario	scenario	NOUN
ihlr-27183	540	3	is	be	AUX
ihlr-27183	540	4	contrary	contrary	ADJ
ihlr-27183	540	5	to	to	ADP
ihlr-27183	540	6	the	the	DET
ihlr-27183	540	7	desire	desire	NOUN
ihlr-27183	540	8	for	for	ADP
ihlr-27183	540	9	consistency	consistency	NOUN
ihlr-27183	540	10	in	in	ADP
ihlr-27183	540	11	the	the	DET
ihlr-27183	540	12	law	law	NOUN
ihlr-27183	540	13	and	and	CCONJ
ihlr-27183	540	14	raises	raise	VERB
ihlr-27183	540	15	questions	question	NOUN
ihlr-27183	540	16	related	relate	VERB
ihlr-27183	540	17	to	to	ADP
ihlr-27183	540	18	forum	forum	PROPN
ihlr-27183	540	19	shopping	shopping	NOUN
ihlr-27183	540	20	,	,	PUNCT
ihlr-27183	540	21	equity	equity	NOUN
ihlr-27183	540	22	,	,	PUNCT
ihlr-27183	540	23	and	and	CCONJ
ihlr-27183	540	24	predictability	predictability	NOUN
ihlr-27183	540	25	of	of	ADP
ihlr-27183	540	26	the	the	DET
ihlr-27183	540	27	patent	patent	NOUN
ihlr-27183	540	28	laws	law	NOUN
ihlr-27183	540	29	.	.	PUNCT
ihlr-27183	541	1	b.	b.	VERB
ihlr-27183	541	2	the	the	DET
ihlr-27183	541	3	future	future	NOUN
ihlr-27183	541	4	of	of	ADP
ihlr-27183	541	5	the	the	DET
ihlr-27183	541	6	controversy	controversy	NOUN
ihlr-27183	541	7	1	1	NUM
ihlr-27183	541	8	.	.	PUNCT
ihlr-27183	542	1	an	an	DET
ihlr-27183	542	2	important	important	ADJ
ihlr-27183	542	3	opportunity	opportunity	NOUN
ihlr-27183	542	4	several	several	ADJ
ihlr-27183	542	5	factors	factor	NOUN
ihlr-27183	542	6	unique	unique	ADJ
ihlr-27183	542	7	to	to	ADP
ihlr-27183	542	8	allele	allele	PROPN
ihlr-27183	542	9	’s	’s	PART
ihlr-27183	542	10	case	case	NOUN
ihlr-27183	542	11	against	against	ADP
ihlr-27183	542	12	regeneron	regeneron	NOUN
ihlr-27183	542	13	make	make	VERB
ihlr-27183	542	14	it	it	PRON
ihlr-27183	542	15	a	a	DET
ihlr-27183	542	16	candidate	candidate	NOUN
ihlr-27183	542	17	to	to	PART
ihlr-27183	542	18	solidify	solidify	VERB
ihlr-27183	542	19	the	the	DET
ihlr-27183	542	20	status	status	NOUN
ihlr-27183	542	21	of	of	ADP
ihlr-27183	542	22	research	research	NOUN
ihlr-27183	542	23	tools	tool	NOUN
ihlr-27183	542	24	under	under	ADP
ihlr-27183	542	25	§	§	PROPN
ihlr-27183	542	26	271(e)(1	271(e)(1	NOUN
ihlr-27183	542	27	)	)	PUNCT
ihlr-27183	542	28	.	.	PUNCT
ihlr-27183	543	1	first	first	ADV
ihlr-27183	543	2	,	,	PUNCT
ihlr-27183	543	3	there	there	PRON
ihlr-27183	543	4	is	be	VERB
ihlr-27183	543	5	no	no	DET
ihlr-27183	543	6	dispute	dispute	NOUN
ihlr-27183	543	7	as	as	ADP
ihlr-27183	543	8	to	to	ADP
ihlr-27183	543	9	the	the	DET
ihlr-27183	543	10	nature	nature	NOUN
ihlr-27183	543	11	of	of	ADP
ihlr-27183	543	12	mneongreen	mneongreen	NOUN
ihlr-27183	543	13	—	—	PUNCT
ihlr-27183	543	14	it	it	PRON
ihlr-27183	543	15	is	be	AUX
ihlr-27183	543	16	squarely	squarely	ADV
ihlr-27183	543	17	a	a	DET
ihlr-27183	543	18	research	research	NOUN
ihlr-27183	543	19	tool	tool	NOUN
ihlr-27183	543	20	and	and	CCONJ
ihlr-27183	543	21	used	use	VERB
ihlr-27183	543	22	as	as	ADP
ihlr-27183	543	23	such	such	ADJ
ihlr-27183	543	24	in	in	ADP
ihlr-27183	543	25	the	the	DET
ihlr-27183	543	26	allegedly	allegedly	ADV
ihlr-27183	543	27	infringing	infringe	VERB
ihlr-27183	543	28	activity	activity	NOUN
ihlr-27183	543	29	.	.	PUNCT
ihlr-27183	544	1	relatedly	relatedly	ADV
ihlr-27183	544	2	,	,	PUNCT
ihlr-27183	544	3	it	it	PRON
ihlr-27183	544	4	is	be	AUX
ihlr-27183	544	5	not	not	PART
ihlr-27183	544	6	itself	itself	PRON
ihlr-27183	544	7	subject	subject	ADJ
ihlr-27183	544	8	to	to	ADP
ihlr-27183	544	9	fda	fda	PROPN
ihlr-27183	544	10	approval	approval	NOUN
ihlr-27183	544	11	.	.	PUNCT
ihlr-27183	545	1	second	second	ADJ
ihlr-27183	545	2	,	,	PUNCT
ihlr-27183	545	3	though	though	SCONJ
ihlr-27183	545	4	the	the	DET
ihlr-27183	545	5	proveris	proveris	NOUN
ihlr-27183	545	6	holding	hold	VERB
ihlr-27183	545	7	will	will	AUX
ihlr-27183	545	8	almost	almost	ADV
ihlr-27183	545	9	certainly	certainly	ADV
ihlr-27183	545	10	be	be	AUX
ihlr-27183	545	11	considered	consider	VERB
ihlr-27183	545	12	relevant	relevant	ADJ
ihlr-27183	545	13	,	,	PUNCT
ihlr-27183	545	14	the	the	DET
ihlr-27183	545	15	aerosol	aerosol	NOUN
ihlr-27183	545	16	spray	spray	VERB
ihlr-27183	545	17	analyzer	analyzer	NOUN
ihlr-27183	545	18	in	in	ADP
ihlr-27183	545	19	that	that	DET
ihlr-27183	545	20	case	case	NOUN
ihlr-27183	545	21	was	be	AUX
ihlr-27183	545	22	not	not	PART
ihlr-27183	545	23	in	in	ADP
ihlr-27183	545	24	fact	fact	NOUN
ihlr-27183	545	25	used	use	VERB
ihlr-27183	545	26	for	for	ADP
ihlr-27183	545	27	research	research	NOUN
ihlr-27183	545	28	by	by	ADP
ihlr-27183	545	29	the	the	DET
ihlr-27183	545	30	defendant.163	defendant.163	PROPN
ihlr-27183	545	31	rather	rather	ADV
ihlr-27183	545	32	,	,	PUNCT
ihlr-27183	545	33	it	it	PRON
ihlr-27183	545	34	was	be	AUX
ihlr-27183	545	35	used	use	VERB
ihlr-27183	545	36	for	for	ADP
ihlr-27183	545	37	measuring	measure	VERB
ihlr-27183	545	38	data	datum	NOUN
ihlr-27183	545	39	from	from	ADP
ihlr-27183	545	40	a	a	DET
ihlr-27183	545	41	fully	fully	ADV
ihlr-27183	545	42	designed	design	VERB
ihlr-27183	545	43	consumer	consumer	NOUN
ihlr-27183	545	44	product	product	NOUN
ihlr-27183	545	45	—	—	PUNCT
ihlr-27183	545	46	the	the	DET
ihlr-27183	545	47	data	datum	NOUN
ihlr-27183	545	48	required	require	VERB
ihlr-27183	545	49	by	by	ADP
ihlr-27183	545	50	the	the	DET
ihlr-27183	545	51	fda	fda	PROPN
ihlr-27183	545	52	before	before	ADP
ihlr-27183	545	53	sale.164	sale.164	NOUN
ihlr-27183	545	54	further	far	ADV
ihlr-27183	545	55	,	,	PUNCT
ihlr-27183	545	56	the	the	DET
ihlr-27183	545	57	aerosol	aerosol	NOUN
ihlr-27183	545	58	spray	spray	VERB
ihlr-27183	545	59	analyzer	analyzer	NOUN
ihlr-27183	545	60	in	in	ADP
ihlr-27183	545	61	proveris	proveris	NOUN
ihlr-27183	545	62	was	be	AUX
ihlr-27183	545	63	being	be	AUX
ihlr-27183	545	64	sold	sell	VERB
ihlr-27183	545	65	by	by	ADP
ihlr-27183	545	66	the	the	DET
ihlr-27183	545	67	defendant	defendant	NOUN
ihlr-27183	545	68	to	to	ADP
ihlr-27183	545	69	third	third	ADJ
ihlr-27183	545	70	parties	party	NOUN
ihlr-27183	545	71	who	who	PRON
ihlr-27183	545	72	would	would	AUX
ihlr-27183	545	73	use	use	VERB
ihlr-27183	545	74	it	it	PRON
ihlr-27183	545	75	for	for	ADP
ihlr-27183	545	76	obtaining	obtain	VERB
ihlr-27183	545	77	data	datum	NOUN
ihlr-27183	545	78	for	for	ADP
ihlr-27183	545	79	fda	fda	PROPN
ihlr-27183	545	80	submissions	submission	NOUN
ihlr-27183	545	81	.	.	PUNCT
ihlr-27183	546	1	in	in	ADP
ihlr-27183	546	2	other	other	ADJ
ihlr-27183	546	3	words	word	NOUN
ihlr-27183	546	4	,	,	PUNCT
ihlr-27183	546	5	innova	innova	PROPN
ihlr-27183	546	6	was	be	AUX
ihlr-27183	546	7	making	make	VERB
ihlr-27183	546	8	the	the	DET
ihlr-27183	546	9	device	device	NOUN
ihlr-27183	546	10	to	to	PART
ihlr-27183	546	11	sell	sell	VERB
ihlr-27183	546	12	it	it	PRON
ihlr-27183	546	13	for	for	ADP
ihlr-27183	546	14	a	a	DET
ihlr-27183	546	15	direct	direct	ADJ
ihlr-27183	546	16	profit	profit	NOUN
ihlr-27183	546	17	,	,	PUNCT
ihlr-27183	546	18	not	not	PART
ihlr-27183	546	19	conduct	conduct	VERB
ihlr-27183	546	20	research	research	NOUN
ihlr-27183	546	21	themselves	themselves	PRON
ihlr-27183	546	22	—	—	PUNCT
ihlr-27183	546	23	potentially	potentially	ADV
ihlr-27183	546	24	more	more	ADV
ihlr-27183	546	25	scandalous	scandalous	ADJ
ihlr-27183	546	26	than	than	ADP
ihlr-27183	546	27	in	in	ADP
ihlr-27183	546	28	-	-	PUNCT
ihlr-27183	546	29	house	house	NOUN
ihlr-27183	546	30	use	use	NOUN
ihlr-27183	546	31	of	of	ADP
ihlr-27183	546	32	a	a	DET
ihlr-27183	546	33	molecular	molecular	ADJ
ihlr-27183	546	34	compound	compound	NOUN
ihlr-27183	546	35	.	.	PUNCT
ihlr-27183	547	1	notably	notably	ADV
ihlr-27183	547	2	,	,	PUNCT
ihlr-27183	547	3	mneongreen	mneongreen	NOUN
ihlr-27183	547	4	is	be	AUX
ihlr-27183	547	5	used	use	VERB
ihlr-27183	547	6	for	for	ADP
ihlr-27183	547	7	research	research	NOUN
ihlr-27183	547	8	of	of	ADP
ihlr-27183	547	9	promising	promising	ADJ
ihlr-27183	547	10	compounds	compound	NOUN
ihlr-27183	547	11	,	,	PUNCT
ihlr-27183	547	12	in	in	ADP
ihlr-27183	547	13	identifying	identify	VERB
ihlr-27183	547	14	one	one	NUM
ihlr-27183	547	15	which	which	PRON
ihlr-27183	547	16	may	may	AUX
ihlr-27183	547	17	be	be	AUX
ihlr-27183	547	18	advanced	advanced	ADJ
ihlr-27183	547	19	and	and	CCONJ
ihlr-27183	547	20	eventually	eventually	ADV
ihlr-27183	547	21	require	require	VERB
ihlr-27183	547	22	submission	submission	NOUN
ihlr-27183	547	23	to	to	ADP
ihlr-27183	547	24	the	the	DET
ihlr-27183	547	25	fda	fda	PROPN
ihlr-27183	547	26	.	.	PUNCT
ihlr-27183	548	1	in	in	ADP
ihlr-27183	548	2	that	that	DET
ihlr-27183	548	3	sense	sense	NOUN
ihlr-27183	548	4	,	,	PUNCT
ihlr-27183	548	5	there	there	PRON
ihlr-27183	548	6	are	be	VERB
ihlr-27183	548	7	factual	factual	ADJ
ihlr-27183	548	8	similarities	similarity	NOUN
ihlr-27183	548	9	with	with	ADP
ihlr-27183	548	10	merck.165	merck.165	NOUN
ihlr-27183	548	11	though	though	SCONJ
ihlr-27183	548	12	it	it	PRON
ihlr-27183	548	13	is	be	AUX
ihlr-27183	548	14	not	not	PART
ihlr-27183	548	15	the	the	DET
ihlr-27183	548	16	actual	actual	ADJ
ihlr-27183	548	17	compound	compound	NOUN
ihlr-27183	548	18	with	with	ADP
ihlr-27183	548	19	hopes	hope	NOUN
ihlr-27183	548	20	of	of	ADP
ihlr-27183	548	21	fda	fda	PROPN
ihlr-27183	548	22	submissions	submission	NOUN
ihlr-27183	548	23	being	be	AUX
ihlr-27183	548	24	directed	direct	VERB
ihlr-27183	548	25	at	at	ADP
ihlr-27183	548	26	it	it	PRON
ihlr-27183	548	27	,	,	PUNCT
ihlr-27183	548	28	as	as	ADP
ihlr-27183	548	29	in	in	ADP
ihlr-27183	548	30	merck	merck	NOUN
ihlr-27183	548	31	,	,	PUNCT
ihlr-27183	548	32	mneongreen	mneongreen	PROPN
ihlr-27183	548	33	appears	appear	VERB
ihlr-27183	548	34	to	to	PART
ihlr-27183	548	35	have	have	AUX
ihlr-27183	548	36	been	be	AUX
ihlr-27183	548	37	genetically	genetically	ADV
ihlr-27183	548	38	integral	integral	ADJ
ihlr-27183	548	39	to	to	ADP
ihlr-27183	548	40	those	those	DET
ihlr-27183	548	41	very	very	ADJ
ihlr-27183	548	42	compounds	compound	NOUN
ihlr-27183	548	43	for	for	ADP
ihlr-27183	548	44	the	the	DET
ihlr-27183	548	45	purposes	purpose	NOUN
ihlr-27183	548	46	of	of	ADP
ihlr-27183	548	47	research.166	research.166	NOUN
ihlr-27183	548	48	in	in	ADP
ihlr-27183	548	49	short	short	ADJ
ihlr-27183	548	50	,	,	PUNCT
ihlr-27183	548	51	proveris	proveris	PROPN
ihlr-27183	548	52	may	may	AUX
ihlr-27183	548	53	be	be	AUX
ihlr-27183	548	54	distinguishable	distinguishable	ADJ
ihlr-27183	548	55	,	,	PUNCT
ihlr-27183	548	56	as	as	SCONJ
ihlr-27183	548	57	mneongreen	mneongreen	NOUN
ihlr-27183	548	58	is	be	AUX
ihlr-27183	548	59	the	the	DET
ihlr-27183	548	60	quintessential	quintessential	ADJ
ihlr-27183	548	61	research	research	NOUN
ihlr-27183	548	62	tool	tool	NOUN
ihlr-27183	548	63	.	.	PUNCT
ihlr-27183	549	1	thirdly	thirdly	ADV
ihlr-27183	549	2	,	,	PUNCT
ihlr-27183	549	3	the	the	DET
ihlr-27183	549	4	financial	financial	ADJ
ihlr-27183	549	5	stakes	stake	NOUN
ihlr-27183	549	6	could	could	AUX
ihlr-27183	549	7	scarcely	scarcely	ADV
ihlr-27183	549	8	be	be	AUX
ihlr-27183	549	9	higher	high	ADJ
ihlr-27183	549	10	.	.	PUNCT
ihlr-27183	550	1	though	though	SCONJ
ihlr-27183	550	2	the	the	DET
ihlr-27183	550	3	parties	party	NOUN
ihlr-27183	550	4	are	be	AUX
ihlr-27183	550	5	not	not	PART
ihlr-27183	550	6	financial	financial	ADJ
ihlr-27183	550	7	equals	equal	NOUN
ihlr-27183	550	8	,	,	PUNCT
ihlr-27183	550	9	both	both	PRON
ihlr-27183	550	10	have	have	VERB
ihlr-27183	550	11	adequate	adequate	ADJ
ihlr-27183	550	12	access	access	NOUN
ihlr-27183	550	13	to	to	ADP
ihlr-27183	550	14	funding	funding	NOUN
ihlr-27183	550	15	to	to	PART
ihlr-27183	550	16	fully	fully	ADV
ihlr-27183	550	17	litigate	litigate	VERB
ihlr-27183	550	18	the	the	DET
ihlr-27183	550	19	matter.167	matter.167	ADJ
ihlr-27183	550	20	alleles	allele	NOUN
ihlr-27183	550	21	technology	technology	NOUN
ihlr-27183	550	22	was	be	AUX
ihlr-27183	550	23	powerful	powerful	ADJ
ihlr-27183	550	24	.	.	PUNCT
ihlr-27183	551	1	to	to	PART
ihlr-27183	551	2	illustrate	illustrate	VERB
ihlr-27183	551	3	,	,	PUNCT
ihlr-27183	551	4	mneongreen	mneongreen	PROPN
ihlr-27183	551	5	assisted	assist	VERB
ihlr-27183	551	6	163	163	NUM
ihlr-27183	551	7	.	.	PUNCT
ihlr-27183	552	1	proveris	proveris	PROPN
ihlr-27183	552	2	sci	sci	PROPN
ihlr-27183	552	3	.	.	PROPN
ihlr-27183	552	4	corp	corp	PROPN
ihlr-27183	552	5	.	.	PROPN
ihlr-27183	552	6	,	,	PUNCT
ihlr-27183	552	7	536	536	NUM
ihlr-27183	552	8	f.3d	f.3d	NUM
ihlr-27183	552	9	at	at	ADP
ihlr-27183	552	10	*	*	PROPN
ihlr-27183	552	11	1264	1264	NUM
ihlr-27183	552	12	.	.	PUNCT
ihlr-27183	553	1	164	164	NUM
ihlr-27183	553	2	.	.	PUNCT
ihlr-27183	554	1	i	i	PRON
ihlr-27183	554	2	d.	d.	PROPN
ihlr-27183	554	3	165	165	NUM
ihlr-27183	554	4	.	.	PUNCT
ihlr-27183	554	5	merck	merck	PROPN
ihlr-27183	554	6	kgaa	kgaa	PROPN
ihlr-27183	554	7	,	,	PUNCT
ihlr-27183	554	8	545	545	NUM
ihlr-27183	554	9	u.s	u.s	PROPN
ihlr-27183	554	10	.	.	PROPN
ihlr-27183	554	11	at	at	ADP
ihlr-27183	554	12	193	193	NUM
ihlr-27183	554	13	(	(	PUNCT
ihlr-27183	554	14	merck	merck	PROPN
ihlr-27183	554	15	states	state	NOUN
ihlr-27183	554	16	“	"	PUNCT
ihlr-27183	554	17	§	§	PROPN
ihlr-27183	554	18	271(e)(1	271(e)(1	NOUN
ihlr-27183	554	19	)	)	PUNCT
ihlr-27183	554	20	exempts	exempt	VERB
ihlr-27183	554	21	from	from	ADP
ihlr-27183	554	22	infringement	infringement	NOUN
ihlr-27183	554	23	the	the	DET
ihlr-27183	554	24	use	use	NOUN
ihlr-27183	554	25	of	of	ADP
ihlr-27183	554	26	patented	patent	VERB
ihlr-27183	554	27	compounds	compound	NOUN
ihlr-27183	554	28	in	in	ADP
ihlr-27183	554	29	preclinical	preclinical	ADJ
ihlr-27183	554	30	research	research	NOUN
ihlr-27183	554	31	,	,	PUNCT
ihlr-27183	554	32	even	even	ADV
ihlr-27183	554	33	when	when	SCONJ
ihlr-27183	554	34	the	the	DET
ihlr-27183	554	35	patented	patent	VERB
ihlr-27183	554	36	compounds	compound	NOUN
ihlr-27183	554	37	do	do	AUX
ihlr-27183	554	38	not	not	PART
ihlr-27183	554	39	themselves	themselves	PRON
ihlr-27183	554	40	become	become	VERB
ihlr-27183	554	41	the	the	DET
ihlr-27183	554	42	subject	subject	NOUN
ihlr-27183	554	43	of	of	ADP
ihlr-27183	554	44	an	an	DET
ihlr-27183	554	45	fda	fda	PROPN
ihlr-27183	554	46	submission	submission	NOUN
ihlr-27183	554	47	.	.	PUNCT
ihlr-27183	554	48	”	"	PUNCT
ihlr-27183	554	49	)	)	PUNCT
ihlr-27183	554	50	.	.	PUNCT
ihlr-27183	555	1	166	166	NUM
ihlr-27183	555	2	.	.	PUNCT
ihlr-27183	555	3	amended	amend	VERB
ihlr-27183	555	4	complaint	complaint	NOUN
ihlr-27183	555	5	at	at	ADP
ihlr-27183	555	6	4	4	NUM
ihlr-27183	555	7	,	,	PUNCT
ihlr-27183	555	8	allele	allele	PROPN
ihlr-27183	555	9	biotechnology	biotechnology	PROPN
ihlr-27183	555	10	&	&	CCONJ
ihlr-27183	555	11	pharm	pharm	PROPN
ihlr-27183	555	12	.	.	PROPN
ihlr-27183	555	13	,	,	PUNCT
ihlr-27183	555	14	inc	inc	PROPN
ihlr-27183	555	15	.	.	PROPN
ihlr-27183	555	16	v.	v.	ADP
ihlr-27183	555	17	pfizer	pfizer	PROPN
ihlr-27183	555	18	,	,	PUNCT
ihlr-27183	555	19	inc	inc	PROPN
ihlr-27183	555	20	.	.	PROPN
ihlr-27183	555	21	,	,	PUNCT
ihlr-27183	555	22	no	no	INTJ
ihlr-27183	555	23	.	.	NOUN
ihlr-27183	555	24	20	20	NUM
ihlr-27183	555	25	-	-	PUNCT
ihlr-27183	555	26	cv01958	cv01958	NOUN
ihlr-27183	555	27	-	-	PUNCT
ihlr-27183	555	28	h	h	NOUN
ihlr-27183	555	29	,	,	PUNCT
ihlr-27183	555	30	2021	2021	NUM
ihlr-27183	555	31	u.s	u.s	PROPN
ihlr-27183	555	32	.	.	PROPN
ihlr-27183	555	33	dist	dist	PROPN
ihlr-27183	555	34	.	.	PUNCT
ihlr-27183	556	1	lexis	lexis	NOUN
ihlr-27183	556	2	85347	85347	NUM
ihlr-27183	556	3	(	(	PUNCT
ihlr-27183	556	4	s.d	s.d	PROPN
ihlr-27183	556	5	.	.	PROPN
ihlr-27183	556	6	cal	cal	PROPN
ihlr-27183	556	7	.	.	PUNCT
ihlr-27183	557	1	feb	feb	PROPN
ihlr-27183	557	2	.	.	PROPN
ihlr-27183	557	3	25	25	NUM
ihlr-27183	557	4	,	,	PUNCT
ihlr-27183	557	5	2021	2021	NUM
ihlr-27183	557	6	)	)	PUNCT
ihlr-27183	557	7	.	.	PUNCT
ihlr-27183	558	1	167	167	NUM
ihlr-27183	558	2	.	.	PUNCT
ihlr-27183	558	3	allele	allele	PROPN
ihlr-27183	558	4	biotechnology	biotechnology	PROPN
ihlr-27183	558	5	and	and	CCONJ
ihlr-27183	558	6	pharmaceuticals	pharmaceuticals	PROPN
ihlr-27183	558	7	inc	inc	PROPN
ihlr-27183	558	8	.	.	PROPN
ihlr-27183	558	9	,	,	PUNCT
ihlr-27183	558	10	https://www.allelebiotech.com	https://www.allelebiotech.com	PUNCT
ihlr-27183	559	1	[	[	X
ihlr-27183	559	2	https://perma.cc/74uk-m7uv	https://perma.cc/74uk-m7uv	X
ihlr-27183	559	3	]	]	X
ihlr-27183	559	4	(	(	PUNCT
ihlr-27183	559	5	last	last	ADV
ihlr-27183	559	6	visited	visit	VERB
ihlr-27183	559	7	oct	oct	PROPN
ihlr-27183	559	8	.	.	PROPN
ihlr-27183	559	9	24	24	NUM
ihlr-27183	559	10	,	,	PUNCT
ihlr-27183	559	11	2021	2021	NUM
ihlr-27183	559	12	)	)	PUNCT
ihlr-27183	559	13	;	;	PUNCT
ihlr-27183	559	14	see	see	VERB
ihlr-27183	559	15	also	also	ADV
ihlr-27183	559	16	pfizer	pfizer	NOUN
ihlr-27183	559	17	gross	gross	ADJ
ihlr-27183	559	18	profit	profit	NOUN
ihlr-27183	559	19	2006	2006	NUM
ihlr-27183	559	20	-	-	SYM
ihlr-27183	559	21	2021	2021	NUM
ihlr-27183	559	22	|	|	ADV
ihlr-27183	559	23	pfe	pfe	VERB
ihlr-27183	559	24	,	,	PUNCT
ihlr-27183	559	25	marcotrends	marcotrend	NOUN
ihlr-27183	559	26	,	,	PUNCT
ihlr-27183	559	27	https://www.macrotrends.net/stocks/charts/pfe/pfizer/gross-profit	https://www.macrotrends.net/stocks/charts/pfe/pfizer/gross-profit	PROPN
ihlr-27183	560	1	[	[	X
ihlr-27183	560	2	https://	https://	PROPN
ihlr-27183	560	3	perma.cc/jja7-rl8	perma.cc/jja7-rl8	NOUN
ihlr-27183	560	4	t	t	PROPN
ihlr-27183	560	5	]	]	PUNCT
ihlr-27183	560	6	(	(	PUNCT
ihlr-27183	560	7	last	last	ADV
ihlr-27183	560	8	visited	visit	VERB
ihlr-27183	560	9	nov	nov	PROPN
ihlr-27183	560	10	.	.	PROPN
ihlr-27183	560	11	14	14	NUM
ihlr-27183	560	12	,	,	PUNCT
ihlr-27183	560	13	2021	2021	NUM
ihlr-27183	560	14	)	)	PUNCT
ihlr-27183	560	15	(	(	PUNCT
ihlr-27183	560	16	allele	allele	NOUN
ihlr-27183	560	17	is	be	AUX
ihlr-27183	560	18	a	a	DET
ihlr-27183	560	19	private	private	ADJ
ihlr-27183	560	20	corporation	corporation	NOUN
ihlr-27183	560	21	with	with	ADP
ihlr-27183	560	22	$	$	SYM
ihlr-27183	560	23	18	18	NUM
ihlr-27183	560	24	m	m	NOUN
ihlr-27183	560	25	in	in	ADP
ihlr-27183	560	26	166	166	NUM
ihlr-27183	560	27	indiana	indiana	PROPN
ihlr-27183	560	28	health	health	NOUN
ihlr-27183	560	29	law	law	NOUN
ihlr-27183	560	30	review	review	NOUN
ihlr-27183	561	1	[	[	X
ihlr-27183	561	2	vol	vol	NOUN
ihlr-27183	561	3	.	.	NOUN
ihlr-27183	561	4	20:143	20:143	NUM
ihlr-27183	561	5	pfizer	pfizer	NOUN
ihlr-27183	561	6	in	in	ADP
ihlr-27183	561	7	being	be	AUX
ihlr-27183	561	8	first	first	ADJ
ihlr-27183	561	9	to	to	ADP
ihlr-27183	561	10	market	market	NOUN
ihlr-27183	561	11	in	in	ADP
ihlr-27183	561	12	the	the	DET
ihlr-27183	561	13	vaccine	vaccine	NOUN
ihlr-27183	561	14	race	race	NOUN
ihlr-27183	561	15	—	—	PUNCT
ihlr-27183	561	16	allowing	allow	VERB
ihlr-27183	561	17	it	it	PRON
ihlr-27183	561	18	to	to	PART
ihlr-27183	561	19	immediately	immediately	ADV
ihlr-27183	561	20	secure	secure	VERB
ihlr-27183	561	21	$	$	SYM
ihlr-27183	561	22	400	400	NUM
ihlr-27183	561	23	million	million	NUM
ihlr-27183	561	24	in	in	ADP
ihlr-27183	561	25	grants,168	grants,168	NOUN
ihlr-27183	561	26	an	an	DET
ihlr-27183	561	27	immediate	immediate	ADJ
ihlr-27183	561	28	multi	multi	ADJ
ihlr-27183	561	29	-	-	ADJ
ihlr-27183	561	30	billion	billion	NUM
ihlr-27183	561	31	-	-	PUNCT
ihlr-27183	561	32	dollar	dollar	NOUN
ihlr-27183	561	33	sales	sale	NOUN
ihlr-27183	561	34	contract	contract	NOUN
ihlr-27183	561	35	with	with	ADP
ihlr-27183	561	36	the	the	DET
ihlr-27183	561	37	u.s	u.s	PROPN
ihlr-27183	561	38	.	.	PROPN
ihlr-27183	561	39	department	department	PROPN
ihlr-27183	561	40	of	of	ADP
ihlr-27183	561	41	health	health	PROPN
ihlr-27183	561	42	and	and	CCONJ
ihlr-27183	561	43	human	human	ADJ
ihlr-27183	561	44	services	service	NOUN
ihlr-27183	561	45	and	and	CCONJ
ihlr-27183	561	46	the	the	DET
ihlr-27183	561	47	department	department	NOUN
ihlr-27183	561	48	of	of	ADP
ihlr-27183	561	49	defense,169	defense,169	PROPN
ihlr-27183	561	50	and	and	CCONJ
ihlr-27183	561	51	maintain	maintain	VERB
ihlr-27183	561	52	leading	leading	ADJ
ihlr-27183	561	53	revenues	revenue	NOUN
ihlr-27183	561	54	in	in	ADP
ihlr-27183	561	55	continued	continued	ADJ
ihlr-27183	561	56	vaccine	vaccine	NOUN
ihlr-27183	561	57	sales.170	sales.170	ADV
ihlr-27183	561	58	likewise	likewise	ADV
ihlr-27183	561	59	,	,	PUNCT
ihlr-27183	561	60	regeneron	regeneron	NOUN
ihlr-27183	561	61	used	use	VERB
ihlr-27183	561	62	allele	allele	PROPN
ihlr-27183	561	63	’s	’s	PART
ihlr-27183	561	64	mneongreen	mneongreen	NOUN
ihlr-27183	561	65	to	to	PART
ihlr-27183	561	66	be	be	AUX
ihlr-27183	561	67	beat	beat	VERB
ihlr-27183	561	68	competitors	competitor	NOUN
ihlr-27183	561	69	to	to	ADP
ihlr-27183	561	70	an	an	DET
ihlr-27183	561	71	effective	effective	ADJ
ihlr-27183	561	72	antibody	antibody	NOUN
ihlr-27183	561	73	therapeutic	therapeutic	ADJ
ihlr-27183	561	74	for	for	ADP
ihlr-27183	561	75	those	those	PRON
ihlr-27183	561	76	infected	infect	VERB
ihlr-27183	561	77	with	with	ADP
ihlr-27183	561	78	sars	sar	NOUN
ihlr-27183	561	79	-	-	PUNCT
ihlr-27183	561	80	cov-2	cov-2	NOUN
ihlr-27183	561	81	,	,	PUNCT
ihlr-27183	561	82	helping	help	VERB
ihlr-27183	561	83	it	it	PRON
ihlr-27183	561	84	capture	capture	VERB
ihlr-27183	561	85	over	over	ADP
ihlr-27183	561	86	$	$	SYM
ihlr-27183	561	87	2.59	2.59	NUM
ihlr-27183	561	88	billion	billion	NUM
ihlr-27183	561	89	in	in	ADP
ihlr-27183	561	90	antibody	antibody	NOUN
ihlr-27183	561	91	-	-	PUNCT
ihlr-27183	561	92	related	relate	VERB
ihlr-27183	561	93	revenue	revenue	NOUN
ihlr-27183	561	94	alone	alone	ADV
ihlr-27183	561	95	in	in	ADP
ihlr-27183	561	96	just	just	ADV
ihlr-27183	561	97	the	the	DET
ihlr-27183	561	98	second	second	ADJ
ihlr-27183	561	99	quarter	quarter	NOUN
ihlr-27183	561	100	of	of	ADP
ihlr-27183	561	101	2021.171	2021.171	NUM
ihlr-27183	561	102	assigning	assign	VERB
ihlr-27183	561	103	a	a	DET
ihlr-27183	561	104	monetary	monetary	ADJ
ihlr-27183	561	105	value	value	NOUN
ihlr-27183	561	106	to	to	ADP
ihlr-27183	561	107	that	that	DET
ihlr-27183	561	108	advantage	advantage	NOUN
ihlr-27183	561	109	may	may	AUX
ihlr-27183	561	110	prove	prove	VERB
ihlr-27183	561	111	difficult	difficult	ADJ
ihlr-27183	561	112	.	.	PUNCT
ihlr-27183	562	1	if	if	SCONJ
ihlr-27183	562	2	successful	successful	ADJ
ihlr-27183	562	3	securing	secure	VERB
ihlr-27183	562	4	a	a	DET
ihlr-27183	562	5	verdict	verdict	NOUN
ihlr-27183	562	6	for	for	ADP
ihlr-27183	562	7	infringement	infringement	NOUN
ihlr-27183	562	8	,	,	PUNCT
ihlr-27183	562	9	allele	allele	NOUN
ihlr-27183	562	10	hopes	hope	VERB
ihlr-27183	562	11	to	to	PART
ihlr-27183	562	12	task	task	VERB
ihlr-27183	562	13	a	a	DET
ihlr-27183	562	14	jury	jury	NOUN
ihlr-27183	562	15	with	with	ADP
ihlr-27183	562	16	just	just	ADV
ihlr-27183	562	17	such	such	DET
ihlr-27183	562	18	a	a	DET
ihlr-27183	562	19	difficult	difficult	ADJ
ihlr-27183	562	20	determination	determination	NOUN
ihlr-27183	562	21	.	.	PUNCT
ihlr-27183	563	1	what	what	PRON
ihlr-27183	563	2	share	share	NOUN
ihlr-27183	563	3	of	of	ADP
ihlr-27183	563	4	regeneron	regeneron	PROPN
ihlr-27183	563	5	’s	’s	PART
ihlr-27183	563	6	profits	profit	NOUN
ihlr-27183	563	7	belong	belong	VERB
ihlr-27183	563	8	to	to	ADP
ihlr-27183	563	9	allele	allele	NOUN
ihlr-27183	563	10	?	?	PUNCT
ihlr-27183	564	1	as	as	ADP
ihlr-27183	564	2	such	such	ADJ
ihlr-27183	564	3	,	,	PUNCT
ihlr-27183	564	4	regeneron	regeneron	PROPN
ihlr-27183	564	5	is	be	AUX
ihlr-27183	564	6	strongly	strongly	ADV
ihlr-27183	564	7	motivated	motivated	ADJ
ihlr-27183	564	8	to	to	PART
ihlr-27183	564	9	secure	secure	VERB
ihlr-27183	564	10	a	a	DET
ihlr-27183	564	11	noninfringement	noninfringement	NOUN
ihlr-27183	564	12	verdict	verdict	NOUN
ihlr-27183	564	13	.	.	PUNCT
ihlr-27183	565	1	with	with	ADP
ihlr-27183	565	2	the	the	DET
ihlr-27183	565	3	non	non	NOUN
ihlr-27183	565	4	-	-	NOUN
ihlr-27183	565	5	infringement	infringement	NOUN
ihlr-27183	565	6	so	so	ADV
ihlr-27183	565	7	far	far	ADV
ihlr-27183	565	8	denied	deny	VERB
ihlr-27183	565	9	,	,	PUNCT
ihlr-27183	565	10	settlement	settlement	NOUN
ihlr-27183	565	11	negotiations	negotiation	NOUN
ihlr-27183	565	12	will	will	AUX
ihlr-27183	565	13	surely	surely	ADV
ihlr-27183	565	14	be	be	AUX
ihlr-27183	565	15	considered	consider	VERB
ihlr-27183	565	16	.	.	PUNCT
ihlr-27183	566	1	however	however	ADV
ihlr-27183	566	2	,	,	PUNCT
ihlr-27183	566	3	if	if	SCONJ
ihlr-27183	566	4	negotiations	negotiation	NOUN
ihlr-27183	566	5	are	be	AUX
ihlr-27183	566	6	unsuccessful	unsuccessful	ADJ
ihlr-27183	566	7	,	,	PUNCT
ihlr-27183	566	8	the	the	DET
ihlr-27183	566	9	safe	safe	ADJ
ihlr-27183	566	10	harbor	harbor	NOUN
ihlr-27183	566	11	issue	issue	NOUN
ihlr-27183	566	12	is	be	AUX
ihlr-27183	566	13	sure	sure	ADJ
ihlr-27183	566	14	to	to	PART
ihlr-27183	566	15	arise	arise	VERB
ihlr-27183	566	16	again	again	ADV
ihlr-27183	566	17	on	on	ADP
ihlr-27183	566	18	appeal	appeal	NOUN
ihlr-27183	566	19	.	.	PUNCT
ihlr-27183	567	1	2	2	X
ihlr-27183	567	2	.	.	X
ihlr-27183	567	3	benefit	benefit	NOUN
ihlr-27183	567	4	of	of	ADP
ihlr-27183	567	5	a	a	DET
ihlr-27183	567	6	bright	bright	ADJ
ihlr-27183	567	7	-	-	PUNCT
ihlr-27183	567	8	line	line	NOUN
ihlr-27183	567	9	rule	rule	NOUN
ihlr-27183	567	10	in	in	ADP
ihlr-27183	567	11	a	a	DET
ihlr-27183	567	12	word	word	NOUN
ihlr-27183	567	13	,	,	PUNCT
ihlr-27183	567	14	the	the	DET
ihlr-27183	567	15	benefit	benefit	NOUN
ihlr-27183	567	16	of	of	ADP
ihlr-27183	567	17	having	have	VERB
ihlr-27183	567	18	a	a	DET
ihlr-27183	567	19	bright	bright	ADJ
ihlr-27183	567	20	line	line	NOUN
ihlr-27183	567	21	rule	rule	NOUN
ihlr-27183	567	22	in	in	ADP
ihlr-27183	567	23	law	law	NOUN
ihlr-27183	567	24	is	be	AUX
ihlr-27183	567	25	commonly	commonly	ADV
ihlr-27183	567	26	noted	note	VERB
ihlr-27183	567	27	as	as	ADP
ihlr-27183	567	28	predictability.172	predictability.172	NOUN
ihlr-27183	567	29	in	in	ADP
ihlr-27183	567	30	the	the	DET
ihlr-27183	567	31	same	same	ADJ
ihlr-27183	567	32	way	way	NOUN
ihlr-27183	567	33	detailed	detailed	ADJ
ihlr-27183	567	34	statutes	statute	NOUN
ihlr-27183	567	35	and	and	CCONJ
ihlr-27183	567	36	case	case	NOUN
ihlr-27183	567	37	law	law	NOUN
ihlr-27183	567	38	on	on	ADP
ihlr-27183	567	39	corporations	corporation	NOUN
ihlr-27183	567	40	offer	offer	VERB
ihlr-27183	567	41	value	value	NOUN
ihlr-27183	567	42	to	to	ADP
ihlr-27183	567	43	business	business	NOUN
ihlr-27183	567	44	ventures	venture	NOUN
ihlr-27183	567	45	seeking	seek	VERB
ihlr-27183	567	46	to	to	PART
ihlr-27183	567	47	organize	organize	VERB
ihlr-27183	567	48	as	as	ADP
ihlr-27183	567	49	a	a	DET
ihlr-27183	567	50	corporation	corporation	NOUN
ihlr-27183	567	51	,	,	PUNCT
ihlr-27183	567	52	a	a	DET
ihlr-27183	567	53	clear	clear	ADJ
ihlr-27183	567	54	interpretation	interpretation	NOUN
ihlr-27183	567	55	of	of	ADP
ihlr-27183	567	56	§	§	PROPN
ihlr-27183	567	57	271(e)(1	271(e)(1	PROPN
ihlr-27183	567	58	)	)	PUNCT
ihlr-27183	567	59	’s	’s	PART
ihlr-27183	567	60	“	"	PUNCT
ihlr-27183	567	61	patented	patented	ADJ
ihlr-27183	567	62	invention	invention	NOUN
ihlr-27183	567	63	”	"	PUNCT
ihlr-27183	567	64	would	would	AUX
ihlr-27183	567	65	offer	offer	VERB
ihlr-27183	567	66	research	research	NOUN
ihlr-27183	567	67	tool	tool	NOUN
ihlr-27183	567	68	users	user	NOUN
ihlr-27183	567	69	and	and	CCONJ
ihlr-27183	567	70	developers	developer	NOUN
ihlr-27183	567	71	value	value	VERB
ihlr-27183	567	72	.	.	PUNCT
ihlr-27183	568	1	this	this	DET
ihlr-27183	568	2	clarity	clarity	NOUN
ihlr-27183	568	3	would	would	AUX
ihlr-27183	568	4	add	add	VERB
ihlr-27183	568	5	predictability	predictability	NOUN
ihlr-27183	568	6	to	to	ADP
ihlr-27183	568	7	respective	respective	ADJ
ihlr-27183	568	8	liabilities	liability	NOUN
ihlr-27183	568	9	and	and	CCONJ
ihlr-27183	568	10	inform	inform	VERB
ihlr-27183	568	11	disputes	dispute	NOUN
ihlr-27183	568	12	prior	prior	ADV
ihlr-27183	568	13	to	to	ADP
ihlr-27183	568	14	the	the	DET
ihlr-27183	568	15	cost	cost	NOUN
ihlr-27183	568	16	of	of	ADP
ihlr-27183	568	17	judicial	judicial	ADJ
ihlr-27183	568	18	involvement	involvement	NOUN
ihlr-27183	568	19	.	.	PUNCT
ihlr-27183	569	1	information	information	NOUN
ihlr-27183	569	2	concerning	concern	VERB
ihlr-27183	569	3	liability	liability	NOUN
ihlr-27183	569	4	,	,	PUNCT
ihlr-27183	569	5	or	or	CCONJ
ihlr-27183	569	6	the	the	DET
ihlr-27183	569	7	lack	lack	NOUN
ihlr-27183	569	8	thereof	thereof	ADV
ihlr-27183	569	9	,	,	PUNCT
ihlr-27183	569	10	for	for	ADP
ihlr-27183	569	11	use	use	NOUN
ihlr-27183	569	12	of	of	ADP
ihlr-27183	569	13	research	research	NOUN
ihlr-27183	569	14	tools	tool	NOUN
ihlr-27183	569	15	will	will	AUX
ihlr-27183	569	16	influence	influence	VERB
ihlr-27183	569	17	how	how	SCONJ
ihlr-27183	569	18	researchers	researcher	NOUN
ihlr-27183	569	19	allocate	allocate	VERB
ihlr-27183	569	20	resources	resource	NOUN
ihlr-27183	569	21	for	for	ADP
ihlr-27183	569	22	research	research	NOUN
ihlr-27183	569	23	and	and	CCONJ
ihlr-27183	569	24	development	development	NOUN
ihlr-27183	569	25	.	.	PUNCT
ihlr-27183	570	1	the	the	DET
ihlr-27183	570	2	total	total	ADJ
ihlr-27183	570	3	funding	funding	NOUN
ihlr-27183	570	4	from	from	ADP
ihlr-27183	570	5	three	three	NUM
ihlr-27183	570	6	investors	investor	NOUN
ihlr-27183	570	7	while	while	SCONJ
ihlr-27183	570	8	pfizer	pfizer	NOUN
ihlr-27183	570	9	regularly	regularly	ADV
ihlr-27183	570	10	reports	report	VERB
ihlr-27183	570	11	annual	annual	ADJ
ihlr-27183	570	12	profits	profit	NOUN
ihlr-27183	570	13	in	in	ADP
ihlr-27183	570	14	excess	excess	NOUN
ihlr-27183	570	15	of	of	ADP
ihlr-27183	570	16	$	$	SYM
ihlr-27183	570	17	30	30	NUM
ihlr-27183	570	18	billion	billion	NUM
ihlr-27183	570	19	)	)	PUNCT
ihlr-27183	570	20	.	.	PUNCT
ihlr-27183	571	1	168	168	NUM
ihlr-27183	571	2	.	.	PUNCT
ihlr-27183	571	3	rebecca	rebecca	PROPN
ihlr-27183	571	4	tapscott	tapscott	PROPN
ihlr-27183	571	5	,	,	PUNCT
ihlr-27183	571	6	regeneron	regeneron	PROPN
ihlr-27183	571	7	,	,	PUNCT
ihlr-27183	571	8	pfizer	pfizer	NOUN
ihlr-27183	571	9	and	and	CCONJ
ihlr-27183	571	10	biontech	biontech	NOUN
ihlr-27183	571	11	accused	accuse	VERB
ihlr-27183	571	12	of	of	ADP
ihlr-27183	571	13	infringing	infringe	VERB
ihlr-27183	571	14	allele	allele	NOUN
ihlr-27183	571	15	patent	patent	NOUN
ihlr-27183	571	16	in	in	ADP
ihlr-27183	571	17	connection	connection	NOUN
ihlr-27183	571	18	with	with	ADP
ihlr-27183	571	19	covid-19	covid-19	PROPN
ihlr-27183	571	20	technologies	technology	NOUN
ihlr-27183	571	21	,	,	PUNCT
ihlr-27183	571	22	ipwatchdog	ipwatchdog	PROPN
ihlr-27183	571	23	(	(	PUNCT
ihlr-27183	571	24	oct	oct	PROPN
ihlr-27183	571	25	.	.	PROPN
ihlr-27183	571	26	7	7	NUM
ihlr-27183	571	27	,	,	PUNCT
ihlr-27183	571	28	2020	2020	NUM
ihlr-27183	571	29	)	)	PUNCT
ihlr-27183	571	30	,	,	PUNCT
ihlr-27183	571	31	https://www	https://www	PROPN
ihlr-27183	571	32	.	.	PUNCT
ihlr-27183	571	33	ipwatchdog.com/2020/10/07/regeneron-pfizer-biontech-accused-infringing-allele-patentconnection-covid-19-technologies/id=126017/	ipwatchdog.com/2020/10/07/regeneron-pfizer-biontech-accused-infringing-allele-patentconnection-covid-19-technologies/id=126017/	PROPN
ihlr-27183	572	1	[	[	X
ihlr-27183	572	2	https://perma.cc/a9vd-58hg	https://perma.cc/a9vd-58hg	X
ihlr-27183	572	3	]	]	SYM
ihlr-27183	572	4	.	.	PUNCT
ihlr-27183	573	1	169	169	NUM
ihlr-27183	573	2	.	.	PUNCT
ihlr-27183	574	1	pfizer	pfizer	NOUN
ihlr-27183	574	2	and	and	CCONJ
ihlr-27183	574	3	biontech	biontech	NOUN
ihlr-27183	574	4	announce	announce	VERB
ihlr-27183	574	5	an	an	DET
ihlr-27183	574	6	agreement	agreement	NOUN
ihlr-27183	574	7	with	with	ADP
ihlr-27183	574	8	u.s	u.s	PROPN
ihlr-27183	574	9	.	.	PROPN
ihlr-27183	574	10	government	government	NOUN
ihlr-27183	574	11	for	for	ADP
ihlr-27183	574	12	up	up	ADP
ihlr-27183	574	13	to	to	PART
ihlr-27183	574	14	600	600	NUM
ihlr-27183	574	15	million	million	NUM
ihlr-27183	574	16	doses	dose	NOUN
ihlr-27183	574	17	of	of	ADP
ihlr-27183	574	18	mrna	mrna	PROPN
ihlr-27183	574	19	-	-	PUNCT
ihlr-27183	574	20	based	base	VERB
ihlr-27183	574	21	vaccine	vaccine	NOUN
ihlr-27183	574	22	candidate	candidate	NOUN
ihlr-27183	574	23	against	against	ADP
ihlr-27183	574	24	sars	sar	NOUN
ihlr-27183	574	25	-	-	PUNCT
ihlr-27183	574	26	cov-2	cov-2	NOUN
ihlr-27183	574	27	,	,	PUNCT
ihlr-27183	574	28	businesswire	businesswire	NOUN
ihlr-27183	574	29	(	(	PUNCT
ihlr-27183	574	30	july	july	PROPN
ihlr-27183	574	31	22	22	NUM
ihlr-27183	574	32	,	,	PUNCT
ihlr-27183	574	33	2020	2020	NUM
ihlr-27183	574	34	)	)	PUNCT
ihlr-27183	574	35	,	,	PUNCT
ihlr-27183	574	36	https://www.businesswire.com/news/home/20200722005438/en/	https://www.businesswire.com/news/home/20200722005438/en/	PUNCT
ihlr-27183	574	37	[	[	X
ihlr-27183	574	38	https://perma.cc/m4af2z2d	https://perma.cc/m4af2z2d	X
ihlr-27183	574	39	]	]	X
ihlr-27183	574	40	.	.	PUNCT
ihlr-27183	575	1	170	170	NUM
ihlr-27183	575	2	.	.	PUNCT
ihlr-27183	576	1	kevin	kevin	PROPN
ihlr-27183	576	2	dunleavy	dunleavy	PROPN
ihlr-27183	576	3	,	,	PUNCT
ihlr-27183	576	4	pfizer	pfizer	PROPN
ihlr-27183	576	5	,	,	PUNCT
ihlr-27183	576	6	moderna	moderna	PROPN
ihlr-27183	576	7	will	will	AUX
ihlr-27183	576	8	rake	rake	VERB
ihlr-27183	576	9	in	in	ADP
ihlr-27183	576	10	a	a	DET
ihlr-27183	576	11	combined	combine	VERB
ihlr-27183	576	12	$	$	SYM
ihlr-27183	576	13	93	93	NUM
ihlr-27183	576	14	billion	billion	NUM
ihlr-27183	576	15	next	next	ADJ
ihlr-27183	576	16	year	year	NOUN
ihlr-27183	576	17	on	on	ADP
ihlr-27183	576	18	covid-19	covid-19	PROPN
ihlr-27183	576	19	vaccine	vaccine	NOUN
ihlr-27183	576	20	sales	sale	NOUN
ihlr-27183	576	21	:	:	PUNCT
ihlr-27183	576	22	report	report	NOUN
ihlr-27183	576	23	,	,	PUNCT
ihlr-27183	576	24	fierce	fierce	ADJ
ihlr-27183	576	25	pharma	pharma	NOUN
ihlr-27183	576	26	(	(	PUNCT
ihlr-27183	576	27	oct	oct	PROPN
ihlr-27183	576	28	.	.	PROPN
ihlr-27183	576	29	18	18	NUM
ihlr-27183	576	30	,	,	PUNCT
ihlr-27183	576	31	2021	2021	NUM
ihlr-27183	576	32	)	)	PUNCT
ihlr-27183	576	33	,	,	PUNCT
ihlr-27183	576	34	https://www.fiercepharma	https://www.fiercepharma	PROPN
ihlr-27183	576	35	.	.	PUNCT
ihlr-27183	576	36	com	com	NOUN
ihlr-27183	576	37	/	/	SYM
ihlr-27183	576	38	pharma	pharma	PROPN
ihlr-27183	576	39	/	/	SYM
ihlr-27183	576	40	pfizer	pfizer	NOUN
ihlr-27183	576	41	-	-	PUNCT
ihlr-27183	576	42	moderna	moderna	NOUN
ihlr-27183	576	43	-	-	PUNCT
ihlr-27183	576	44	will	will	AUX
ihlr-27183	576	45	-	-	PUNCT
ihlr-27183	576	46	rake	rake	VERB
ihlr-27183	576	47	-	-	PUNCT
ihlr-27183	576	48	a	a	DET
ihlr-27183	576	49	-	-	PUNCT
ihlr-27183	576	50	combined-93	combined-93	PROPN
ihlr-27183	576	51	-	-	PUNCT
ihlr-27183	576	52	billion	billion	NUM
ihlr-27183	576	53	-	-	PUNCT
ihlr-27183	576	54	next	next	ADJ
ihlr-27183	576	55	-	-	PUNCT
ihlr-27183	576	56	year	year	NOUN
ihlr-27183	576	57	-	-	PUNCT
ihlr-27183	576	58	covid-19	covid-19	PROPN
ihlr-27183	576	59	-	-	PUNCT
ihlr-27183	576	60	sales	sale	NOUN
ihlr-27183	576	61	-	-	PUNCT
ihlr-27183	576	62	saysanalytics	saysanalytic	NOUN
ihlr-27183	576	63	-	-	PUNCT
ihlr-27183	576	64	group	group	NOUN
ihlr-27183	577	1	[	[	X
ihlr-27183	577	2	https://perma.cc/jj6v-dx9s	https://perma.cc/jj6v-dx9s	X
ihlr-27183	577	3	]	]	X
ihlr-27183	577	4	.	.	PUNCT
ihlr-27183	578	1	171	171	NUM
ihlr-27183	578	2	.	.	PUNCT
ihlr-27183	579	1	kevin	kevin	PROPN
ihlr-27183	579	2	dunleavy	dunleavy	PROPN
ihlr-27183	579	3	,	,	PUNCT
ihlr-27183	579	4	surprise	surprise	NOUN
ihlr-27183	579	5	covid-19	covid-19	PROPN
ihlr-27183	579	6	antibody	antibody	NOUN
ihlr-27183	579	7	sales	sale	NOUN
ihlr-27183	579	8	of	of	ADP
ihlr-27183	579	9	$	$	SYM
ihlr-27183	579	10	804	804	NUM
ihlr-27183	579	11	m	m	NOUN
ihlr-27183	579	12	help	help	NOUN
ihlr-27183	579	13	regeneron	regeneron	NOUN
ihlr-27183	579	14	trounce	trounce	VERB
ihlr-27183	579	15	expectations	expectation	NOUN
ihlr-27183	579	16	in	in	ADP
ihlr-27183	579	17	third	third	ADJ
ihlr-27183	579	18	quarter	quarter	NOUN
ihlr-27183	579	19	,	,	PUNCT
ihlr-27183	579	20	fierce	fierce	ADJ
ihlr-27183	579	21	pharma	pharma	NOUN
ihlr-27183	579	22	(	(	PUNCT
ihlr-27183	579	23	nov	nov	PROPN
ihlr-27183	579	24	.	.	PROPN
ihlr-27183	579	25	4	4	NUM
ihlr-27183	579	26	,	,	PUNCT
ihlr-27183	579	27	2021	2021	NUM
ihlr-27183	579	28	)	)	PUNCT
ihlr-27183	579	29	,	,	PUNCT
ihlr-27183	579	30	https://www.fiercepharma	https://www.fiercepharma	PROPN
ihlr-27183	579	31	.	.	PUNCT
ihlr-27183	579	32	com	com	NOUN
ihlr-27183	579	33	/	/	SYM
ihlr-27183	579	34	pharma	pharma	NOUN
ihlr-27183	579	35	/	/	SYM
ihlr-27183	579	36	surprise	surprise	NOUN
ihlr-27183	579	37	-	-	PUNCT
ihlr-27183	579	38	antibody	antibody	NOUN
ihlr-27183	579	39	-	-	PUNCT
ihlr-27183	579	40	sales-804	sales-804	NOUN
ihlr-27183	579	41	-	-	PUNCT
ihlr-27183	579	42	million	million	NUM
ihlr-27183	579	43	-	-	PUNCT
ihlr-27183	579	44	help	help	NOUN
ihlr-27183	579	45	-	-	PUNCT
ihlr-27183	579	46	regeneron	regeneron	NOUN
ihlr-27183	579	47	-	-	PUNCT
ihlr-27183	579	48	exceed	exceed	NOUN
ihlr-27183	579	49	-	-	PUNCT
ihlr-27183	579	50	revenue	revenue	NOUN
ihlr-27183	579	51	-	-	PUNCT
ihlr-27183	579	52	expectationsthird	expectationsthird	NOUN
ihlr-27183	579	53	-	-	PUNCT
ihlr-27183	579	54	quarter	quarter	NOUN
ihlr-27183	580	1	[	[	X
ihlr-27183	580	2	https://perma.cc/3ujw-872x	https://perma.cc/3ujw-872x	X
ihlr-27183	580	3	]	]	X
ihlr-27183	580	4	.	.	PUNCT
ihlr-27183	581	1	172	172	X
ihlr-27183	581	2	.	.	PUNCT
ihlr-27183	581	3	bright	bright	ADJ
ihlr-27183	581	4	-	-	PUNCT
ihlr-27183	581	5	line	line	NOUN
ihlr-27183	581	6	rule	rule	NOUN
ihlr-27183	581	7	,	,	PUNCT
ihlr-27183	581	8	cornell	cornell	PROPN
ihlr-27183	581	9	l.	l.	PROPN
ihlr-27183	581	10	sch	sch	PROPN
ihlr-27183	581	11	.	.	PROPN
ihlr-27183	581	12	,	,	PUNCT
ihlr-27183	581	13	https://www.law.cornell.edu/wex/bright-line_rule	https://www.law.cornell.edu/wex/bright-line_rule	PROPN
ihlr-27183	582	1	[	[	X
ihlr-27183	582	2	https://perma.cc/w5xa-wll4	https://perma.cc/w5xa-wll4	X
ihlr-27183	582	3	]	]	X
ihlr-27183	582	4	(	(	PUNCT
ihlr-27183	582	5	last	last	ADV
ihlr-27183	582	6	visited	visit	VERB
ihlr-27183	582	7	oct	oct	PROPN
ihlr-27183	582	8	.	.	PROPN
ihlr-27183	582	9	23	23	NUM
ihlr-27183	582	10	,	,	PUNCT
ihlr-27183	582	11	2021	2021	NUM
ihlr-27183	582	12	)	)	PUNCT
ihlr-27183	582	13	.	.	PUNCT
ihlr-27183	583	1	2023	2023	NUM
ihlr-27183	583	2	]	]	PUNCT
ihlr-27183	583	3	the	the	DET
ihlr-27183	583	4	safe	safe	ADJ
ihlr-27183	583	5	harbor	harbor	NOUN
ihlr-27183	583	6	of	of	ADP
ihlr-27183	583	7	35	35	NUM
ihlr-27183	583	8	u.s.c	u.s.c	ADJ
ihlr-27183	583	9	.	.	PUNCT
ihlr-27183	584	1	§	§	PROPN
ihlr-27183	584	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	584	3	)	)	PUNCT
ihlr-27183	584	4	167	167	NUM
ihlr-27183	584	5	clearer	clear	ADJ
ihlr-27183	584	6	the	the	DET
ihlr-27183	584	7	rule	rule	NOUN
ihlr-27183	584	8	,	,	PUNCT
ihlr-27183	584	9	the	the	DET
ihlr-27183	584	10	more	more	ADV
ihlr-27183	584	11	efficient	efficient	ADJ
ihlr-27183	584	12	the	the	DET
ihlr-27183	584	13	outcome	outcome	NOUN
ihlr-27183	584	14	.	.	PUNCT
ihlr-27183	585	1	the	the	DET
ihlr-27183	585	2	interpretation	interpretation	NOUN
ihlr-27183	585	3	of	of	ADP
ihlr-27183	585	4	§	§	PROPN
ihlr-27183	585	5	271(e)(1	271(e)(1	PROPN
ihlr-27183	585	6	)	)	PUNCT
ihlr-27183	585	7	needs	need	VERB
ihlr-27183	585	8	a	a	DET
ihlr-27183	585	9	bright	bright	ADJ
ihlr-27183	585	10	-	-	PUNCT
ihlr-27183	585	11	line	line	NOUN
ihlr-27183	585	12	rule	rule	NOUN
ihlr-27183	585	13	.	.	PUNCT
ihlr-27183	586	1	3	3	X
ihlr-27183	586	2	.	.	X
ihlr-27183	586	3	danger	danger	NOUN
ihlr-27183	586	4	of	of	ADP
ihlr-27183	586	5	a	a	DET
ihlr-27183	586	6	bright	bright	ADJ
ihlr-27183	586	7	-	-	PUNCT
ihlr-27183	586	8	line	line	NOUN
ihlr-27183	586	9	rule	rule	NOUN
ihlr-27183	586	10	why	why	SCONJ
ihlr-27183	586	11	has	have	AUX
ihlr-27183	586	12	the	the	DET
ihlr-27183	586	13	court	court	NOUN
ihlr-27183	586	14	been	be	AUX
ihlr-27183	586	15	so	so	ADV
ihlr-27183	586	16	reluctant	reluctant	ADJ
ihlr-27183	586	17	to	to	PART
ihlr-27183	586	18	provide	provide	VERB
ihlr-27183	586	19	a	a	DET
ihlr-27183	586	20	bright	bright	ADJ
ihlr-27183	586	21	-	-	PUNCT
ihlr-27183	586	22	line	line	NOUN
ihlr-27183	586	23	rule	rule	NOUN
ihlr-27183	586	24	on	on	ADP
ihlr-27183	586	25	the	the	DET
ihlr-27183	586	26	status	status	NOUN
ihlr-27183	586	27	of	of	ADP
ihlr-27183	586	28	research	research	NOUN
ihlr-27183	586	29	tools	tool	NOUN
ihlr-27183	586	30	under	under	ADP
ihlr-27183	586	31	the	the	DET
ihlr-27183	586	32	safe	safe	ADJ
ihlr-27183	586	33	harbor	harbor	NOUN
ihlr-27183	586	34	provision	provision	NOUN
ihlr-27183	586	35	of	of	ADP
ihlr-27183	586	36	§	§	PROPN
ihlr-27183	586	37	271(e)(1	271(e)(1	PROPN
ihlr-27183	586	38	)	)	PUNCT
ihlr-27183	586	39	?	?	PUNCT
ihlr-27183	587	1	first	first	ADV
ihlr-27183	587	2	,	,	PUNCT
ihlr-27183	587	3	bright	bright	ADJ
ihlr-27183	587	4	-	-	PUNCT
ihlr-27183	587	5	line	line	NOUN
ihlr-27183	587	6	rules	rule	NOUN
ihlr-27183	587	7	are	be	AUX
ihlr-27183	587	8	often	often	ADV
ihlr-27183	587	9	deemed	deem	VERB
ihlr-27183	587	10	mechanical	mechanical	ADJ
ihlr-27183	587	11	,	,	PUNCT
ihlr-27183	587	12	objective	objective	ADJ
ihlr-27183	587	13	,	,	PUNCT
ihlr-27183	587	14	and	and	CCONJ
ihlr-27183	587	15	invariant	invariant	ADJ
ihlr-27183	587	16	.	.	PUNCT
ihlr-27183	588	1	when	when	SCONJ
ihlr-27183	588	2	applied	apply	VERB
ihlr-27183	588	3	across	across	ADP
ihlr-27183	588	4	all	all	DET
ihlr-27183	588	5	cases	case	NOUN
ihlr-27183	588	6	,	,	PUNCT
ihlr-27183	588	7	mitigating	mitigate	VERB
ihlr-27183	588	8	factors	factor	NOUN
ihlr-27183	588	9	or	or	CCONJ
ihlr-27183	588	10	extenuating	extenuate	VERB
ihlr-27183	588	11	circumstances	circumstance	NOUN
ihlr-27183	588	12	may	may	AUX
ihlr-27183	588	13	be	be	AUX
ihlr-27183	588	14	silenced	silence	VERB
ihlr-27183	588	15	,	,	PUNCT
ihlr-27183	588	16	underemphasized	underemphasize	VERB
ihlr-27183	588	17	or	or	CCONJ
ihlr-27183	588	18	ignored	ignore	VERB
ihlr-27183	588	19	entirely	entirely	ADV
ihlr-27183	588	20	–	–	PUNCT
ihlr-27183	588	21	thus	thus	ADV
ihlr-27183	588	22	violating	violate	VERB
ihlr-27183	588	23	a	a	DET
ihlr-27183	588	24	sense	sense	NOUN
ihlr-27183	588	25	of	of	ADP
ihlr-27183	588	26	fairness	fairness	NOUN
ihlr-27183	588	27	in	in	ADP
ihlr-27183	588	28	a	a	DET
ihlr-27183	588	29	given	give	VERB
ihlr-27183	588	30	outcome.173	outcome.173	NOUN
ihlr-27183	588	31	second	second	ADJ
ihlr-27183	588	32	,	,	PUNCT
ihlr-27183	588	33	courts	court	NOUN
ihlr-27183	588	34	do	do	AUX
ihlr-27183	588	35	not	not	PART
ihlr-27183	588	36	like	like	VERB
ihlr-27183	588	37	to	to	PART
ihlr-27183	588	38	tie	tie	VERB
ihlr-27183	588	39	their	their	PRON
ihlr-27183	588	40	own	own	ADJ
ihlr-27183	588	41	hands	hand	NOUN
ihlr-27183	588	42	.	.	PUNCT
ihlr-27183	589	1	a	a	DET
ihlr-27183	589	2	clear	clear	ADJ
ihlr-27183	589	3	rule	rule	NOUN
ihlr-27183	589	4	will	will	AUX
ihlr-27183	589	5	demand	demand	VERB
ihlr-27183	589	6	an	an	DET
ihlr-27183	589	7	outcome	outcome	NOUN
ihlr-27183	589	8	given	give	VERB
ihlr-27183	589	9	some	some	DET
ihlr-27183	589	10	triggering	trigger	VERB
ihlr-27183	589	11	fact	fact	NOUN
ihlr-27183	589	12	pattern	pattern	NOUN
ihlr-27183	589	13	–	–	PUNCT
ihlr-27183	589	14	regardless	regardless	ADV
ihlr-27183	589	15	of	of	ADP
ihlr-27183	589	16	an	an	DET
ihlr-27183	589	17	unforeseen	unforeseen	ADJ
ihlr-27183	589	18	nuance	nuance	NOUN
ihlr-27183	589	19	the	the	DET
ihlr-27183	589	20	court	court	NOUN
ihlr-27183	589	21	would	would	AUX
ihlr-27183	589	22	have	have	AUX
ihlr-27183	589	23	rather	rather	ADV
ihlr-27183	589	24	weighted	weight	VERB
ihlr-27183	589	25	more	more	ADV
ihlr-27183	589	26	heavily	heavily	ADV
ihlr-27183	589	27	.	.	PUNCT
ihlr-27183	590	1	third	third	ADJ
ihlr-27183	590	2	,	,	PUNCT
ihlr-27183	590	3	and	and	CCONJ
ihlr-27183	590	4	most	most	ADV
ihlr-27183	590	5	relevant	relevant	ADJ
ihlr-27183	590	6	in	in	ADP
ihlr-27183	590	7	the	the	DET
ihlr-27183	590	8	present	present	ADJ
ihlr-27183	590	9	instance	instance	NOUN
ihlr-27183	590	10	,	,	PUNCT
ihlr-27183	590	11	issuing	issue	VERB
ihlr-27183	590	12	a	a	DET
ihlr-27183	590	13	bright	bright	ADJ
ihlr-27183	590	14	-	-	PUNCT
ihlr-27183	590	15	line	line	NOUN
ihlr-27183	590	16	rule	rule	NOUN
ihlr-27183	590	17	limiting	limit	VERB
ihlr-27183	590	18	statutory	statutory	ADJ
ihlr-27183	590	19	language	language	NOUN
ihlr-27183	590	20	which	which	PRON
ihlr-27183	590	21	appears	appear	VERB
ihlr-27183	590	22	broad	broad	ADJ
ihlr-27183	590	23	to	to	ADP
ihlr-27183	590	24	a	a	DET
ihlr-27183	590	25	judge	judge	NOUN
ihlr-27183	590	26	requires	require	VERB
ihlr-27183	590	27	reading	read	VERB
ihlr-27183	590	28	more	more	ADJ
ihlr-27183	590	29	than	than	ADP
ihlr-27183	590	30	the	the	DET
ihlr-27183	590	31	words	word	NOUN
ihlr-27183	590	32	of	of	ADP
ihlr-27183	590	33	the	the	DET
ihlr-27183	590	34	legislature	legislature	NOUN
ihlr-27183	590	35	–	–	PUNCT
ihlr-27183	590	36	it	it	PRON
ihlr-27183	590	37	often	often	ADV
ihlr-27183	590	38	requires	require	VERB
ihlr-27183	590	39	supposing	suppose	VERB
ihlr-27183	590	40	intent	intent	NOUN
ihlr-27183	590	41	of	of	ADP
ihlr-27183	590	42	the	the	DET
ihlr-27183	590	43	legislature	legislature	NOUN
ihlr-27183	590	44	–	–	PUNCT
ihlr-27183	590	45	anathema	anathema	NOUN
ihlr-27183	590	46	to	to	ADP
ihlr-27183	590	47	a	a	DET
ihlr-27183	590	48	strict	strict	ADJ
ihlr-27183	590	49	textualist.174	textualist.174	ADP
ihlr-27183	590	50	4	4	NUM
ihlr-27183	590	51	.	.	PUNCT
ihlr-27183	591	1	a	a	DET
ihlr-27183	591	2	conflict	conflict	NOUN
ihlr-27183	591	3	between	between	ADP
ihlr-27183	591	4	courts	court	NOUN
ihlr-27183	591	5	another	another	DET
ihlr-27183	591	6	obstacle	obstacle	NOUN
ihlr-27183	591	7	to	to	ADP
ihlr-27183	591	8	the	the	DET
ihlr-27183	591	9	adoption	adoption	NOUN
ihlr-27183	591	10	of	of	ADP
ihlr-27183	591	11	a	a	DET
ihlr-27183	591	12	bright	bright	ADJ
ihlr-27183	591	13	line	line	NOUN
ihlr-27183	591	14	rule	rule	NOUN
ihlr-27183	591	15	is	be	AUX
ihlr-27183	591	16	the	the	DET
ihlr-27183	591	17	furthering	furthering	NOUN
ihlr-27183	591	18	of	of	ADP
ihlr-27183	591	19	a	a	DET
ihlr-27183	591	20	controversial	controversial	ADJ
ihlr-27183	591	21	influence	influence	NOUN
ihlr-27183	591	22	of	of	ADP
ihlr-27183	591	23	the	the	DET
ihlr-27183	591	24	supreme	supreme	PROPN
ihlr-27183	591	25	court	court	PROPN
ihlr-27183	591	26	on	on	ADP
ihlr-27183	591	27	the	the	DET
ihlr-27183	591	28	country	country	NOUN
ihlr-27183	591	29	’s	’s	PART
ihlr-27183	591	30	patent	patent	NOUN
ihlr-27183	591	31	laws	law	NOUN
ihlr-27183	591	32	.	.	PUNCT
ihlr-27183	592	1	of	of	ADP
ihlr-27183	592	2	course	course	NOUN
ihlr-27183	592	3	,	,	PUNCT
ihlr-27183	592	4	the	the	DET
ihlr-27183	592	5	supreme	supreme	PROPN
ihlr-27183	592	6	court	court	PROPN
ihlr-27183	592	7	has	have	VERB
ihlr-27183	592	8	general	general	ADJ
ihlr-27183	592	9	subject	subject	ADJ
ihlr-27183	592	10	matter	matter	NOUN
ihlr-27183	592	11	jurisdiction	jurisdiction	NOUN
ihlr-27183	592	12	and	and	CCONJ
ihlr-27183	592	13	is	be	AUX
ihlr-27183	592	14	superior	superior	ADJ
ihlr-27183	592	15	to	to	ADP
ihlr-27183	592	16	the	the	DET
ihlr-27183	592	17	federal	federal	ADJ
ihlr-27183	592	18	circuit	circuit	NOUN
ihlr-27183	592	19	.	.	PUNCT
ihlr-27183	593	1	however	however	ADV
ihlr-27183	593	2	,	,	PUNCT
ihlr-27183	593	3	the	the	DET
ihlr-27183	593	4	federal	federal	ADJ
ihlr-27183	593	5	circuit	circuit	NOUN
ihlr-27183	593	6	was	be	AUX
ihlr-27183	593	7	specifically	specifically	ADV
ihlr-27183	593	8	created	create	VERB
ihlr-27183	593	9	to	to	PART
ihlr-27183	593	10	resolve	resolve	VERB
ihlr-27183	593	11	patent	patent	NOUN
ihlr-27183	593	12	disputes	dispute	NOUN
ihlr-27183	593	13	and	and	CCONJ
ihlr-27183	593	14	provide	provide	VERB
ihlr-27183	593	15	better	well	ADJ
ihlr-27183	593	16	predictability	predictability	NOUN
ihlr-27183	593	17	in	in	ADP
ihlr-27183	593	18	patent	patent	NOUN
ihlr-27183	593	19	law.175	law.175	NOUN
ihlr-27183	593	20	to	to	ADP
ihlr-27183	593	21	what	what	DET
ihlr-27183	593	22	extent	extent	NOUN
ihlr-27183	593	23	the	the	DET
ihlr-27183	593	24	supreme	supreme	PROPN
ihlr-27183	593	25	court	court	PROPN
ihlr-27183	593	26	should	should	AUX
ihlr-27183	593	27	assert	assert	VERB
ihlr-27183	593	28	itself	itself	PRON
ihlr-27183	593	29	in	in	ADP
ihlr-27183	593	30	reviewing	review	VERB
ihlr-27183	593	31	the	the	DET
ihlr-27183	593	32	court	court	NOUN
ihlr-27183	593	33	specifically	specifically	ADV
ihlr-27183	593	34	designated	designate	VERB
ihlr-27183	593	35	to	to	PART
ihlr-27183	593	36	resolve	resolve	VERB
ihlr-27183	593	37	patent	patent	NOUN
ihlr-27183	593	38	disputes	dispute	NOUN
ihlr-27183	593	39	has	have	AUX
ihlr-27183	593	40	been	be	AUX
ihlr-27183	593	41	,	,	PUNCT
ihlr-27183	593	42	and	and	CCONJ
ihlr-27183	593	43	will	will	AUX
ihlr-27183	593	44	continue	continue	VERB
ihlr-27183	593	45	to	to	PART
ihlr-27183	593	46	be	be	AUX
ihlr-27183	593	47	,	,	PUNCT
ihlr-27183	593	48	debated	debate	VERB
ihlr-27183	593	49	.	.	PUNCT
ihlr-27183	594	1	the	the	DET
ihlr-27183	594	2	supreme	supreme	PROPN
ihlr-27183	594	3	court	court	PROPN
ihlr-27183	594	4	has	have	VERB
ihlr-27183	594	5	a	a	DET
ihlr-27183	594	6	habit	habit	NOUN
ihlr-27183	594	7	of	of	ADP
ihlr-27183	594	8	reversing	reverse	VERB
ihlr-27183	594	9	the	the	DET
ihlr-27183	594	10	federal	federal	ADJ
ihlr-27183	594	11	circuit	circuit	NOUN
ihlr-27183	594	12	on	on	ADP
ihlr-27183	594	13	patent	patent	NOUN
ihlr-27183	594	14	cases	case	NOUN
ihlr-27183	594	15	,	,	PUNCT
ihlr-27183	594	16	and	and	CCONJ
ihlr-27183	594	17	has	have	AUX
ihlr-27183	594	18	become	become	VERB
ihlr-27183	594	19	increasingly	increasingly	ADV
ihlr-27183	594	20	active	active	ADJ
ihlr-27183	594	21	in	in	ADP
ihlr-27183	594	22	doing	do	VERB
ihlr-27183	594	23	so	so	ADV
ihlr-27183	594	24	over	over	ADP
ihlr-27183	594	25	the	the	DET
ihlr-27183	594	26	last	last	ADJ
ihlr-27183	594	27	twenty	twenty	NUM
ihlr-27183	594	28	years	year	NOUN
ihlr-27183	594	29	–	–	PUNCT
ihlr-27183	594	30	reversing	reverse	VERB
ihlr-27183	594	31	twenty	twenty	NUM
ihlr-27183	594	32	two	two	NUM
ihlr-27183	594	33	out	out	ADP
ihlr-27183	594	34	of	of	ADP
ihlr-27183	594	35	twenty	twenty	NUM
ihlr-27183	594	36	seven	seven	NUM
ihlr-27183	594	37	cases	case	NOUN
ihlr-27183	594	38	between	between	ADP
ihlr-27183	594	39	2005	2005	NUM
ihlr-27183	594	40	and	and	CCONJ
ihlr-27183	594	41	2015.176	2015.176	NUM
ihlr-27183	594	42	with	with	ADP
ihlr-27183	594	43	the	the	DET
ihlr-27183	594	44	vast	vast	ADJ
ihlr-27183	594	45	majority	majority	NOUN
ihlr-27183	594	46	of	of	ADP
ihlr-27183	594	47	reversals	reversal	NOUN
ihlr-27183	594	48	favoring	favor	VERB
ihlr-27183	594	49	an	an	DET
ihlr-27183	594	50	alleged	allege	VERB
ihlr-27183	594	51	infringer	infringer	NOUN
ihlr-27183	594	52	,	,	PUNCT
ihlr-27183	594	53	it	it	PRON
ihlr-27183	594	54	is	be	AUX
ihlr-27183	594	55	not	not	PART
ihlr-27183	594	56	surprising	surprising	ADJ
ihlr-27183	594	57	the	the	DET
ihlr-27183	594	58	supreme	supreme	PROPN
ihlr-27183	594	59	court	court	PROPN
ihlr-27183	594	60	is	be	AUX
ihlr-27183	594	61	considered	consider	VERB
ihlr-27183	594	62	hostile	hostile	ADJ
ihlr-27183	594	63	to	to	ADP
ihlr-27183	594	64	patent	patent	NOUN
ihlr-27183	594	65	holders	holder	NOUN
ihlr-27183	594	66	;	;	PUNCT
ihlr-27183	594	67	the	the	DET
ihlr-27183	594	68	federal	federal	ADJ
ihlr-27183	594	69	circuit	circuit	NOUN
ihlr-27183	594	70	is	be	AUX
ihlr-27183	594	71	notably	notably	ADV
ihlr-27183	594	72	more	more	ADV
ihlr-27183	594	73	likely	likely	ADJ
ihlr-27183	594	74	to	to	PART
ihlr-27183	594	75	uphold	uphold	VERB
ihlr-27183	594	76	the	the	DET
ihlr-27183	594	77	validity	validity	NOUN
ihlr-27183	594	78	of	of	ADP
ihlr-27183	594	79	a	a	DET
ihlr-27183	594	80	patent.177	patent.177	NOUN
ihlr-27183	594	81	though	though	SCONJ
ihlr-27183	594	82	the	the	DET
ihlr-27183	594	83	supreme	supreme	PROPN
ihlr-27183	594	84	court	court	PROPN
ihlr-27183	594	85	is	be	AUX
ihlr-27183	594	86	the	the	DET
ihlr-27183	594	87	highest	high	ADJ
ihlr-27183	594	88	authority	authority	NOUN
ihlr-27183	594	89	in	in	ADP
ihlr-27183	594	90	united	united	PROPN
ihlr-27183	594	91	states	states	PROPN
ihlr-27183	594	92	patent	patent	NOUN
ihlr-27183	594	93	law	law	NOUN
ihlr-27183	594	94	,	,	PUNCT
ihlr-27183	594	95	it	it	PRON
ihlr-27183	594	96	has	have	VERB
ihlr-27183	594	97	a	a	DET
ihlr-27183	594	98	173	173	NUM
ihlr-27183	594	99	.	.	PUNCT
ihlr-27183	595	1	i	i	PRON
ihlr-27183	595	2	d.	d.	PROPN
ihlr-27183	595	3	174	174	NUM
ihlr-27183	595	4	.	.	PUNCT
ihlr-27183	596	1	see	see	VERB
ihlr-27183	596	2	merck	merck	PROPN
ihlr-27183	596	3	kgaa	kgaa	PROPN
ihlr-27183	596	4	,	,	PUNCT
ihlr-27183	596	5	545	545	NUM
ihlr-27183	596	6	u.s	u.s	PROPN
ihlr-27183	596	7	.	.	PROPN
ihlr-27183	596	8	at	at	ADP
ihlr-27183	596	9	202	202	NUM
ihlr-27183	596	10	,	,	PUNCT
ihlr-27183	596	11	206	206	NUM
ihlr-27183	596	12	(	(	PUNCT
ihlr-27183	596	13	justice	justice	PROPN
ihlr-27183	596	14	scalia	scalia	PROPN
ihlr-27183	596	15	’s	’s	PART
ihlr-27183	596	16	aversion	aversion	NOUN
ihlr-27183	596	17	to	to	PART
ihlr-27183	596	18	“	"	PUNCT
ihlr-27183	596	19	read	read	VERB
ihlr-27183	596	20	narrowly	narrowly	ADV
ihlr-27183	596	21	”	"	PUNCT
ihlr-27183	596	22	where	where	SCONJ
ihlr-27183	596	23	the	the	DET
ihlr-27183	596	24	statutory	statutory	ADJ
ihlr-27183	596	25	text	text	NOUN
ihlr-27183	596	26	“	"	PUNCT
ihlr-27183	596	27	provides	provide	VERB
ihlr-27183	596	28	a	a	DET
ihlr-27183	596	29	wide	wide	ADJ
ihlr-27183	596	30	berth	berth	NOUN
ihlr-27183	596	31	”	"	PUNCT
ihlr-27183	596	32	is	be	AUX
ihlr-27183	596	33	both	both	PRON
ihlr-27183	596	34	illustrative	illustrative	ADJ
ihlr-27183	596	35	in	in	ADP
ihlr-27183	596	36	general	general	ADJ
ihlr-27183	596	37	and	and	CCONJ
ihlr-27183	596	38	captures	capture	VERB
ihlr-27183	596	39	the	the	DET
ihlr-27183	596	40	issue	issue	NOUN
ihlr-27183	596	41	in	in	ADP
ihlr-27183	596	42	the	the	DET
ihlr-27183	596	43	context	context	NOUN
ihlr-27183	596	44	of	of	ADP
ihlr-27183	596	45	this	this	DET
ihlr-27183	596	46	exact	exact	ADJ
ihlr-27183	596	47	statute	statute	NOUN
ihlr-27183	596	48	)	)	PUNCT
ihlr-27183	596	49	.	.	PUNCT
ihlr-27183	597	1	175	175	NUM
ihlr-27183	597	2	.	.	PUNCT
ihlr-27183	597	3	cong	cong	PROPN
ihlr-27183	597	4	.	.	PUNCT
ihlr-27183	598	1	research	research	NOUN
ihlr-27183	598	2	serv	serv	PROPN
ihlr-27183	598	3	.	.	PUNCT
ihlr-27183	598	4	,	,	PUNCT
ihlr-27183	598	5	patent	patent	NOUN
ihlr-27183	598	6	law	law	NOUN
ihlr-27183	598	7	and	and	CCONJ
ihlr-27183	598	8	innovation	innovation	NOUN
ihlr-27183	598	9	:	:	PUNCT
ihlr-27183	598	10	the	the	DET
ihlr-27183	598	11	creation	creation	NOUN
ihlr-27183	598	12	,	,	PUNCT
ihlr-27183	598	13	operation	operation	NOUN
ihlr-27183	598	14	and	and	CCONJ
ihlr-27183	598	15	a	a	DET
ihlr-27183	598	16	twenty	twenty	NUM
ihlr-27183	598	17	-	-	PUNCT
ihlr-27183	598	18	year	year	NOUN
ihlr-27183	598	19	assessment	assessment	NOUN
ihlr-27183	598	20	of	of	ADP
ihlr-27183	598	21	the	the	DET
ihlr-27183	598	22	u.s	u.s	PROPN
ihlr-27183	598	23	.	.	PROPN
ihlr-27183	598	24	court	court	PROPN
ihlr-27183	598	25	of	of	ADP
ihlr-27183	598	26	appeals	appeal	NOUN
ihlr-27183	598	27	for	for	ADP
ihlr-27183	598	28	the	the	DET
ihlr-27183	598	29	federal	federal	ADJ
ihlr-27183	598	30	circuit	circuit	NOUN
ihlr-27183	598	31	1	1	NUM
ihlr-27183	598	32	(	(	PUNCT
ihlr-27183	598	33	2003	2003	NUM
ihlr-27183	598	34	)	)	PUNCT
ihlr-27183	598	35	.	.	PUNCT
ihlr-27183	599	1	176	176	NUM
ihlr-27183	599	2	.	.	PUNCT
ihlr-27183	600	1	osha	osha	PROPN
ihlr-27183	600	2	bergman	bergman	PROPN
ihlr-27183	600	3	watanabe	watanabe	PROPN
ihlr-27183	600	4	burton	burton	PROPN
ihlr-27183	600	5	,	,	PUNCT
ihlr-27183	600	6	why	why	SCONJ
ihlr-27183	600	7	does	do	AUX
ihlr-27183	600	8	the	the	DET
ihlr-27183	600	9	u.s	u.s	PROPN
ihlr-27183	600	10	.	.	PROPN
ihlr-27183	600	11	supreme	supreme	PROPN
ihlr-27183	600	12	court	court	PROPN
ihlr-27183	600	13	keep	keep	VERB
ihlr-27183	600	14	reversing	reverse	VERB
ihlr-27183	600	15	the	the	DET
ihlr-27183	600	16	federal	federal	ADJ
ihlr-27183	600	17	circuit	circuit	NOUN
ihlr-27183	600	18	?	?	PUNCT
ihlr-27183	601	1	(	(	PUNCT
ihlr-27183	601	2	mar	mar	PROPN
ihlr-27183	601	3	.	.	PROPN
ihlr-27183	601	4	31	31	NUM
ihlr-27183	601	5	,	,	PUNCT
ihlr-27183	601	6	2017	2017	NUM
ihlr-27183	601	7	)	)	PUNCT
ihlr-27183	601	8	,	,	PUNCT
ihlr-27183	601	9	https://www.obwbip.com/newsletter/why-doesthe-u-s-supreme-court-keep-reversing-the-federal-circuit	https://www.obwbip.com/newsletter/why-doesthe-u-s-supreme-court-keep-reversing-the-federal-circuit	PROPN
ihlr-27183	602	1	[	[	X
ihlr-27183	602	2	https://perma.cc/9xb3-qje2	https://perma.cc/9xb3-qje2	PROPN
ihlr-27183	602	3	]	]	PUNCT
ihlr-27183	602	4	.	.	PUNCT
ihlr-27183	603	1	177	177	NUM
ihlr-27183	603	2	.	.	PUNCT
ihlr-27183	604	1	i	i	PRON
ihlr-27183	604	2	d.	d.	PROPN
ihlr-27183	604	3	168	168	NUM
ihlr-27183	604	4	indiana	indiana	PROPN
ihlr-27183	604	5	health	health	PROPN
ihlr-27183	604	6	law	law	PROPN
ihlr-27183	604	7	review	review	NOUN
ihlr-27183	604	8	[	[	X
ihlr-27183	604	9	vol	vol	NOUN
ihlr-27183	604	10	.	.	PUNCT
ihlr-27183	604	11	20:143	20:143	PROPN
ihlr-27183	604	12	limited	limited	ADJ
ihlr-27183	604	13	docket	docket	NOUN
ihlr-27183	604	14	for	for	ADP
ihlr-27183	604	15	reviewing	review	VERB
ihlr-27183	604	16	patent	patent	NOUN
ihlr-27183	604	17	cases	case	NOUN
ihlr-27183	604	18	and	and	CCONJ
ihlr-27183	604	19	the	the	DET
ihlr-27183	604	20	federal	federal	ADJ
ihlr-27183	604	21	circuit	circuit	NOUN
ihlr-27183	604	22	generally	generally	ADV
ihlr-27183	604	23	has	have	VERB
ihlr-27183	604	24	the	the	DET
ihlr-27183	604	25	final	final	ADJ
ihlr-27183	604	26	word	word	NOUN
ihlr-27183	604	27	on	on	ADP
ihlr-27183	604	28	all	all	PRON
ihlr-27183	604	29	but	but	SCONJ
ihlr-27183	604	30	a	a	DET
ihlr-27183	604	31	handful178	handful178	PROPN
ihlr-27183	604	32	of	of	ADP
ihlr-27183	604	33	the	the	DET
ihlr-27183	604	34	roughly	roughly	ADV
ihlr-27183	604	35	450	450	NUM
ihlr-27183	604	36	cases	case	NOUN
ihlr-27183	604	37	decided	decide	VERB
ihlr-27183	604	38	annually.179	annually.179	NOUN
ihlr-27183	604	39	as	as	ADP
ihlr-27183	604	40	such	such	ADJ
ihlr-27183	604	41	,	,	PUNCT
ihlr-27183	604	42	though	though	SCONJ
ihlr-27183	604	43	speculation	speculation	NOUN
ihlr-27183	604	44	often	often	ADV
ihlr-27183	604	45	erupts	erupt	VERB
ihlr-27183	604	46	with	with	ADP
ihlr-27183	604	47	any	any	DET
ihlr-27183	604	48	supreme	supreme	PROPN
ihlr-27183	604	49	court	court	NOUN
ihlr-27183	604	50	decision	decision	NOUN
ihlr-27183	604	51	perceived	perceive	VERB
ihlr-27183	604	52	as	as	ADP
ihlr-27183	604	53	threatening	threaten	VERB
ihlr-27183	604	54	the	the	DET
ihlr-27183	604	55	enforceability	enforceability	NOUN
ihlr-27183	604	56	of	of	ADP
ihlr-27183	604	57	patents	patent	NOUN
ihlr-27183	604	58	,	,	PUNCT
ihlr-27183	604	59	as	as	SCONJ
ihlr-27183	604	60	in	in	ADP
ihlr-27183	604	61	merck,180	merck,180	ADJ
ihlr-27183	604	62	concern	concern	NOUN
ihlr-27183	604	63	is	be	AUX
ihlr-27183	604	64	generally	generally	ADV
ihlr-27183	604	65	quelled	quell	VERB
ihlr-27183	604	66	shortly	shortly	ADV
ihlr-27183	604	67	thereafter	thereafter	ADV
ihlr-27183	604	68	by	by	ADP
ihlr-27183	604	69	the	the	DET
ihlr-27183	604	70	less	less	ADV
ihlr-27183	604	71	rigid	rigid	ADJ
ihlr-27183	604	72	and	and	CCONJ
ihlr-27183	604	73	more	more	ADJ
ihlr-27183	604	74	patent	patent	NOUN
ihlr-27183	604	75	-	-	PUNCT
ihlr-27183	604	76	holderfriendly	holderfriendly	ADV
ihlr-27183	604	77	,	,	PUNCT
ihlr-27183	604	78	application	application	NOUN
ihlr-27183	604	79	by	by	ADP
ihlr-27183	604	80	the	the	DET
ihlr-27183	604	81	federal	federal	ADJ
ihlr-27183	604	82	circuit	circuit	NOUN
ihlr-27183	604	83	.	.	PUNCT
ihlr-27183	605	1	with	with	ADP
ihlr-27183	605	2	a	a	DET
ihlr-27183	605	3	practical	practical	ADJ
ihlr-27183	605	4	limit	limit	NOUN
ihlr-27183	605	5	on	on	ADP
ihlr-27183	605	6	case	case	NOUN
ihlr-27183	605	7	-	-	PUNCT
ihlr-27183	605	8	by	by	ADP
ihlr-27183	605	9	-	-	PUNCT
ihlr-27183	605	10	case	case	NOUN
ihlr-27183	605	11	enforcement	enforcement	NOUN
ihlr-27183	605	12	,	,	PUNCT
ihlr-27183	605	13	the	the	DET
ihlr-27183	605	14	threat	threat	NOUN
ihlr-27183	605	15	of	of	ADP
ihlr-27183	605	16	undesirable	undesirable	ADJ
ihlr-27183	605	17	rigidity	rigidity	NOUN
ihlr-27183	605	18	,	,	PUNCT
ihlr-27183	605	19	and	and	CCONJ
ihlr-27183	605	20	a	a	DET
ihlr-27183	605	21	tendency	tendency	NOUN
ihlr-27183	605	22	for	for	SCONJ
ihlr-27183	605	23	the	the	DET
ihlr-27183	605	24	federal	federal	ADJ
ihlr-27183	605	25	circuit	circuit	NOUN
ihlr-27183	605	26	to	to	PART
ihlr-27183	605	27	ameliorate	ameliorate	VERB
ihlr-27183	605	28	resultant	resultant	NOUN
ihlr-27183	605	29	rules	rule	NOUN
ihlr-27183	605	30	,	,	PUNCT
ihlr-27183	605	31	might	might	AUX
ihlr-27183	605	32	a	a	DET
ihlr-27183	605	33	bright	bright	ADJ
ihlr-27183	605	34	line	line	NOUN
ihlr-27183	605	35	rule	rule	NOUN
ihlr-27183	605	36	from	from	ADP
ihlr-27183	605	37	the	the	DET
ihlr-27183	605	38	supreme	supreme	PROPN
ihlr-27183	605	39	court	court	PROPN
ihlr-27183	605	40	quickly	quickly	ADV
ihlr-27183	605	41	become	become	VERB
ihlr-27183	605	42	blurry	blurry	ADJ
ihlr-27183	605	43	?	?	PUNCT
ihlr-27183	606	1	to	to	PART
ihlr-27183	606	2	answer	answer	VERB
ihlr-27183	606	3	this	this	DET
ihlr-27183	606	4	question	question	NOUN
ihlr-27183	606	5	with	with	ADP
ihlr-27183	606	6	any	any	DET
ihlr-27183	606	7	persuasiveness	persuasiveness	NOUN
ihlr-27183	606	8	will	will	AUX
ihlr-27183	606	9	require	require	VERB
ihlr-27183	606	10	unfolding	unfold	VERB
ihlr-27183	606	11	the	the	DET
ihlr-27183	606	12	proposed	propose	VERB
ihlr-27183	606	13	rule	rule	NOUN
ihlr-27183	606	14	–	–	PUNCT
ihlr-27183	606	15	which	which	PRON
ihlr-27183	606	16	will	will	AUX
ihlr-27183	606	17	now	now	ADV
ihlr-27183	606	18	be	be	AUX
ihlr-27183	606	19	explained	explain	VERB
ihlr-27183	606	20	quite	quite	ADV
ihlr-27183	606	21	simply	simply	ADV
ihlr-27183	606	22	.	.	PUNCT
ihlr-27183	607	1	5	5	X
ihlr-27183	607	2	.	.	X
ihlr-27183	607	3	the	the	DET
ihlr-27183	607	4	proposed	propose	VERB
ihlr-27183	607	5	resolution	resolution	NOUN
ihlr-27183	607	6	the	the	DET
ihlr-27183	607	7	supreme	supreme	PROPN
ihlr-27183	607	8	court	court	PROPN
ihlr-27183	607	9	,	,	PUNCT
ihlr-27183	607	10	potentially	potentially	ADV
ihlr-27183	607	11	in	in	ADP
ihlr-27183	607	12	response	response	NOUN
ihlr-27183	607	13	to	to	ADP
ihlr-27183	607	14	these	these	DET
ihlr-27183	607	15	cases	case	NOUN
ihlr-27183	607	16	,	,	PUNCT
ihlr-27183	607	17	should	should	AUX
ihlr-27183	607	18	enunciate	enunciate	VERB
ihlr-27183	607	19	a	a	DET
ihlr-27183	607	20	rule	rule	NOUN
ihlr-27183	607	21	ensuring	ensure	VERB
ihlr-27183	607	22	the	the	DET
ihlr-27183	607	23	enforceability	enforceability	NOUN
ihlr-27183	607	24	of	of	ADP
ihlr-27183	607	25	patents	patent	NOUN
ihlr-27183	607	26	directed	direct	VERB
ihlr-27183	607	27	at	at	ADP
ihlr-27183	607	28	research	research	NOUN
ihlr-27183	607	29	tools	tool	NOUN
ihlr-27183	607	30	.	.	PUNCT
ihlr-27183	608	1	the	the	DET
ihlr-27183	608	2	defining	define	VERB
ihlr-27183	608	3	characteristic	characteristic	NOUN
ihlr-27183	608	4	of	of	ADP
ihlr-27183	608	5	this	this	DET
ihlr-27183	608	6	class	class	NOUN
ihlr-27183	608	7	of	of	ADP
ihlr-27183	608	8	inventions	invention	NOUN
ihlr-27183	608	9	is	be	AUX
ihlr-27183	608	10	that	that	SCONJ
ihlr-27183	608	11	they	they	PRON
ihlr-27183	608	12	are	be	AUX
ihlr-27183	608	13	not	not	PART
ihlr-27183	608	14	themselves	themselves	PRON
ihlr-27183	608	15	subject	subject	ADJ
ihlr-27183	608	16	to	to	ADP
ihlr-27183	608	17	fda	fda	PROPN
ihlr-27183	608	18	approval	approval	NOUN
ihlr-27183	608	19	.	.	PUNCT
ihlr-27183	609	1	hence	hence	ADV
ihlr-27183	609	2	,	,	PUNCT
ihlr-27183	609	3	the	the	DET
ihlr-27183	609	4	safe	safe	ADJ
ihlr-27183	609	5	harbor	harbor	NOUN
ihlr-27183	609	6	of	of	ADP
ihlr-27183	609	7	§	§	PROPN
ihlr-27183	609	8	271(e)(1	271(e)(1	PROPN
ihlr-27183	609	9	)	)	PUNCT
ihlr-27183	609	10	should	should	AUX
ihlr-27183	609	11	not	not	PART
ihlr-27183	609	12	apply	apply	VERB
ihlr-27183	609	13	to	to	ADP
ihlr-27183	609	14	research	research	NOUN
ihlr-27183	609	15	tools	tool	NOUN
ihlr-27183	609	16	and	and	CCONJ
ihlr-27183	609	17	strict	strict	ADJ
ihlr-27183	609	18	symmetry	symmetry	NOUN
ihlr-27183	609	19	between	between	ADP
ihlr-27183	609	20	§	§	PROPN
ihlr-27183	609	21	156	156	NUM
ihlr-27183	609	22	and	and	CCONJ
ihlr-27183	609	23	§	§	PROPN
ihlr-27183	609	24	271(e)(1	271(e)(1	PROPN
ihlr-27183	609	25	)	)	PUNCT
ihlr-27183	609	26	should	should	AUX
ihlr-27183	609	27	be	be	AUX
ihlr-27183	609	28	an	an	DET
ihlr-27183	609	29	unambiguous	unambiguous	ADJ
ihlr-27183	609	30	requisite	requisite	NOUN
ihlr-27183	609	31	for	for	ADP
ihlr-27183	609	32	shielding	shielding	NOUN
ihlr-27183	609	33	under	under	ADP
ihlr-27183	609	34	the	the	DET
ihlr-27183	609	35	safe	safe	ADJ
ihlr-27183	609	36	harbor	harbor	NOUN
ihlr-27183	609	37	.	.	PUNCT
ihlr-27183	610	1	it	it	PRON
ihlr-27183	610	2	is	be	AUX
ihlr-27183	610	3	this	this	DET
ihlr-27183	610	4	author	author	NOUN
ihlr-27183	610	5	’s	’s	PART
ihlr-27183	610	6	position	position	NOUN
ihlr-27183	610	7	that	that	SCONJ
ihlr-27183	610	8	a	a	DET
ihlr-27183	610	9	bright	bright	ADJ
ihlr-27183	610	10	line	line	NOUN
ihlr-27183	610	11	rule	rule	NOUN
ihlr-27183	610	12	from	from	ADP
ihlr-27183	610	13	the	the	DET
ihlr-27183	610	14	supreme	supreme	PROPN
ihlr-27183	610	15	court	court	PROPN
ihlr-27183	610	16	on	on	ADP
ihlr-27183	610	17	this	this	DET
ihlr-27183	610	18	issue	issue	NOUN
ihlr-27183	610	19	would	would	AUX
ihlr-27183	610	20	not	not	PART
ihlr-27183	610	21	be	be	AUX
ihlr-27183	610	22	subject	subject	ADJ
ihlr-27183	610	23	to	to	ADP
ihlr-27183	610	24	typical	typical	ADJ
ihlr-27183	610	25	vulnerabilities	vulnerability	NOUN
ihlr-27183	610	26	or	or	CCONJ
ihlr-27183	610	27	ineffectual	ineffectual	ADJ
ihlr-27183	610	28	application	application	NOUN
ihlr-27183	610	29	in	in	ADP
ihlr-27183	610	30	the	the	DET
ihlr-27183	610	31	lower	low	ADJ
ihlr-27183	610	32	courts	court	NOUN
ihlr-27183	610	33	.	.	PUNCT
ihlr-27183	611	1	initially	initially	ADV
ihlr-27183	611	2	,	,	PUNCT
ihlr-27183	611	3	with	with	ADP
ihlr-27183	611	4	respect	respect	NOUN
ihlr-27183	611	5	to	to	ADP
ihlr-27183	611	6	the	the	DET
ihlr-27183	611	7	rigidity	rigidity	NOUN
ihlr-27183	611	8	of	of	ADP
ihlr-27183	611	9	the	the	DET
ihlr-27183	611	10	rule	rule	NOUN
ihlr-27183	611	11	,	,	PUNCT
ihlr-27183	611	12	the	the	DET
ihlr-27183	611	13	concern	concern	NOUN
ihlr-27183	611	14	surrounding	surround	VERB
ihlr-27183	611	15	a	a	DET
ihlr-27183	611	16	harmful	harmful	ADJ
ihlr-27183	611	17	mechanical	mechanical	ADJ
ihlr-27183	611	18	application	application	NOUN
ihlr-27183	611	19	is	be	AUX
ihlr-27183	611	20	quelled	quell	VERB
ihlr-27183	611	21	due	due	ADP
ihlr-27183	611	22	to	to	ADP
ihlr-27183	611	23	the	the	DET
ihlr-27183	611	24	nature	nature	NOUN
ihlr-27183	611	25	of	of	ADP
ihlr-27183	611	26	the	the	DET
ihlr-27183	611	27	players	player	NOUN
ihlr-27183	611	28	in	in	ADP
ihlr-27183	611	29	this	this	DET
ihlr-27183	611	30	industry	industry	NOUN
ihlr-27183	611	31	.	.	PUNCT
ihlr-27183	612	1	those	those	PRON
ihlr-27183	612	2	made	make	VERB
ihlr-27183	612	3	subject	subject	ADJ
ihlr-27183	612	4	to	to	ADP
ihlr-27183	612	5	liability	liability	NOUN
ihlr-27183	612	6	after	after	ADP
ihlr-27183	612	7	any	any	DET
ihlr-27183	612	8	narrowing	narrowing	NOUN
ihlr-27183	612	9	of	of	ADP
ihlr-27183	612	10	the	the	DET
ihlr-27183	612	11	safe	safe	ADJ
ihlr-27183	612	12	harbor	harbor	NOUN
ihlr-27183	612	13	are	be	AUX
ihlr-27183	612	14	largely	largely	ADV
ihlr-27183	612	15	sophisticated	sophisticated	ADJ
ihlr-27183	612	16	players	player	NOUN
ihlr-27183	612	17	with	with	ADP
ihlr-27183	612	18	a	a	DET
ihlr-27183	612	19	close	close	ADJ
ihlr-27183	612	20	eye	eye	NOUN
ihlr-27183	612	21	on	on	ADP
ihlr-27183	612	22	this	this	DET
ihlr-27183	612	23	very	very	ADJ
ihlr-27183	612	24	topic	topic	NOUN
ihlr-27183	612	25	.	.	PUNCT
ihlr-27183	613	1	a	a	DET
ihlr-27183	613	2	word	word	NOUN
ihlr-27183	613	3	of	of	ADP
ihlr-27183	613	4	warning	warning	NOUN
ihlr-27183	613	5	would	would	AUX
ihlr-27183	613	6	spread	spread	VERB
ihlr-27183	613	7	rapidly	rapidly	ADV
ihlr-27183	613	8	through	through	ADP
ihlr-27183	613	9	a	a	DET
ihlr-27183	613	10	tight	tight	ADJ
ihlr-27183	613	11	community	community	NOUN
ihlr-27183	613	12	of	of	ADP
ihlr-27183	613	13	highly	highly	ADV
ihlr-27183	613	14	skilled	skilled	ADJ
ihlr-27183	613	15	research	research	NOUN
ihlr-27183	613	16	professionals	professional	NOUN
ihlr-27183	613	17	.	.	PUNCT
ihlr-27183	614	1	this	this	DET
ihlr-27183	614	2	warning	warning	NOUN
ihlr-27183	614	3	would	would	AUX
ihlr-27183	614	4	allow	allow	VERB
ihlr-27183	614	5	them	they	PRON
ihlr-27183	614	6	to	to	PART
ihlr-27183	614	7	quickly	quickly	ADV
ihlr-27183	614	8	license	license	VERB
ihlr-27183	614	9	their	their	PRON
ihlr-27183	614	10	use	use	NOUN
ihlr-27183	614	11	of	of	ADP
ihlr-27183	614	12	equipment	equipment	NOUN
ihlr-27183	614	13	belonging	belong	VERB
ihlr-27183	614	14	to	to	ADP
ihlr-27183	614	15	a	a	DET
ihlr-27183	614	16	now	now	ADV
ihlr-27183	614	17	emboldened	embolden	VERB
ihlr-27183	614	18	patent	patent	NOUN
ihlr-27183	614	19	holder	holder	NOUN
ihlr-27183	614	20	or	or	CCONJ
ihlr-27183	614	21	seek	seek	VERB
ihlr-27183	614	22	an	an	DET
ihlr-27183	614	23	alternative	alternative	ADJ
ihlr-27183	614	24	technology	technology	NOUN
ihlr-27183	614	25	.	.	PUNCT
ihlr-27183	615	1	those	those	PRON
ihlr-27183	615	2	affected	affect	VERB
ihlr-27183	615	3	know	know	VERB
ihlr-27183	615	4	they	they	PRON
ihlr-27183	615	5	are	be	AUX
ihlr-27183	615	6	affected	affect	VERB
ihlr-27183	615	7	and	and	CCONJ
ihlr-27183	615	8	generally	generally	ADV
ihlr-27183	615	9	have	have	VERB
ihlr-27183	615	10	suitable	suitable	ADJ
ihlr-27183	615	11	resources	resource	NOUN
ihlr-27183	615	12	to	to	PART
ihlr-27183	615	13	respond	respond	VERB
ihlr-27183	615	14	.	.	PUNCT
ihlr-27183	616	1	beyond	beyond	ADP
ihlr-27183	616	2	the	the	DET
ihlr-27183	616	3	parties	party	NOUN
ihlr-27183	616	4	affected	affect	VERB
ihlr-27183	616	5	,	,	PUNCT
ihlr-27183	616	6	a	a	DET
ihlr-27183	616	7	second	second	ADJ
ihlr-27183	616	8	factor	factor	NOUN
ihlr-27183	616	9	strongly	strongly	ADV
ihlr-27183	616	10	supporting	support	VERB
ihlr-27183	616	11	the	the	DET
ihlr-27183	616	12	success	success	NOUN
ihlr-27183	616	13	of	of	ADP
ihlr-27183	616	14	a	a	DET
ihlr-27183	616	15	bright	bright	ADJ
ihlr-27183	616	16	line	line	NOUN
ihlr-27183	616	17	rule	rule	NOUN
ihlr-27183	616	18	in	in	ADP
ihlr-27183	616	19	this	this	DET
ihlr-27183	616	20	case	case	NOUN
ihlr-27183	616	21	relates	relate	VERB
ihlr-27183	616	22	to	to	ADP
ihlr-27183	616	23	the	the	DET
ihlr-27183	616	24	nature	nature	NOUN
ihlr-27183	616	25	of	of	ADP
ihlr-27183	616	26	the	the	DET
ihlr-27183	616	27	rule	rule	NOUN
ihlr-27183	616	28	itself	itself	PRON
ihlr-27183	616	29	.	.	PUNCT
ihlr-27183	617	1	formally	formally	ADV
ihlr-27183	617	2	recognizing	recognize	VERB
ihlr-27183	617	3	the	the	DET
ihlr-27183	617	4	criteria	criterion	NOUN
ihlr-27183	617	5	of	of	ADP
ihlr-27183	617	6	fda	fda	PROPN
ihlr-27183	617	7	approval	approval	NOUN
ihlr-27183	617	8	calls	call	VERB
ihlr-27183	617	9	for	for	ADP
ihlr-27183	617	10	an	an	DET
ihlr-27183	617	11	objective	objective	ADJ
ihlr-27183	617	12	test	test	NOUN
ihlr-27183	617	13	which	which	PRON
ihlr-27183	617	14	is	be	AUX
ihlr-27183	617	15	resolved	resolve	VERB
ihlr-27183	617	16	through	through	ADP
ihlr-27183	617	17	a	a	DET
ihlr-27183	617	18	purely	purely	ADV
ihlr-27183	617	19	factual	factual	ADJ
ihlr-27183	617	20	inquiry	inquiry	NOUN
ihlr-27183	617	21	.	.	PUNCT
ihlr-27183	618	1	there	there	PRON
ihlr-27183	618	2	is	be	VERB
ihlr-27183	618	3	no	no	DET
ihlr-27183	618	4	heavy	heavy	ADJ
ihlr-27183	618	5	lifting	lifting	NOUN
ihlr-27183	618	6	required	require	VERB
ihlr-27183	618	7	by	by	ADP
ihlr-27183	618	8	courts	court	NOUN
ihlr-27183	618	9	to	to	PART
ihlr-27183	618	10	expand	expand	VERB
ihlr-27183	618	11	upon	upon	SCONJ
ihlr-27183	618	12	the	the	DET
ihlr-27183	618	13	‘	'	PUNCT
ihlr-27183	618	14	reasonableness	reasonableness	NOUN
ihlr-27183	618	15	’	'	PUNCT
ihlr-27183	618	16	standard	standard	NOUN
ihlr-27183	618	17	.	.	PUNCT
ihlr-27183	618	18	178	178	NUM
ihlr-27183	618	19	.	.	PUNCT
ihlr-27183	619	1	devin	devin	PROPN
ihlr-27183	619	2	salmon	salmon	PROPN
ihlr-27183	619	3	,	,	PUNCT
ihlr-27183	619	4	a	a	DET
ihlr-27183	619	5	sign	sign	NOUN
ihlr-27183	619	6	of	of	ADP
ihlr-27183	619	7	the	the	DET
ihlr-27183	619	8	times	time	NOUN
ihlr-27183	619	9	?	?	PUNCT
ihlr-27183	620	1	a	a	DET
ihlr-27183	620	2	brief	brief	ADJ
ihlr-27183	620	3	look	look	NOUN
ihlr-27183	620	4	at	at	ADP
ihlr-27183	620	5	the	the	DET
ihlr-27183	620	6	trend	trend	NOUN
ihlr-27183	620	7	of	of	ADP
ihlr-27183	620	8	patent	patent	NOUN
ihlr-27183	620	9	cases	case	NOUN
ihlr-27183	620	10	before	before	ADP
ihlr-27183	620	11	the	the	DET
ihlr-27183	620	12	us	us	PROPN
ihlr-27183	620	13	supreme	supreme	PROPN
ihlr-27183	620	14	court	court	PROPN
ihlr-27183	620	15	,	,	PUNCT
ihlr-27183	620	16	ip.com	ip.com	PROPN
ihlr-27183	620	17	,	,	PUNCT
ihlr-27183	620	18	https://ip.com/blog/a-sign-of-the-times-a-brief-look-at-the-trendof-patent-cases-before-the-us-supreme-court/	https://ip.com/blog/a-sign-of-the-times-a-brief-look-at-the-trendof-patent-cases-before-the-us-supreme-court/	VERB
ihlr-27183	620	19	[	[	X
ihlr-27183	620	20	https://perma.cc/g8nt-lhjh	https://perma.cc/g8nt-lhjh	X
ihlr-27183	620	21	]	]	X
ihlr-27183	620	22	(	(	PUNCT
ihlr-27183	620	23	last	last	ADV
ihlr-27183	620	24	visited	visit	VERB
ihlr-27183	620	25	oct	oct	PROPN
ihlr-27183	620	26	.	.	PROPN
ihlr-27183	620	27	22	22	NUM
ihlr-27183	620	28	,	,	PUNCT
ihlr-27183	620	29	2021	2021	NUM
ihlr-27183	620	30	)	)	PUNCT
ihlr-27183	620	31	(	(	PUNCT
ihlr-27183	620	32	though	though	SCONJ
ihlr-27183	620	33	the	the	DET
ihlr-27183	620	34	supreme	supreme	PROPN
ihlr-27183	620	35	court	court	PROPN
ihlr-27183	620	36	has	have	AUX
ihlr-27183	620	37	averaged	average	VERB
ihlr-27183	620	38	just	just	ADV
ihlr-27183	620	39	one	one	NUM
ihlr-27183	620	40	or	or	CCONJ
ihlr-27183	620	41	two	two	NUM
ihlr-27183	620	42	patent	patent	NOUN
ihlr-27183	620	43	cases	case	NOUN
ihlr-27183	620	44	per	per	ADP
ihlr-27183	620	45	year	year	NOUN
ihlr-27183	620	46	over	over	ADP
ihlr-27183	620	47	the	the	DET
ihlr-27183	620	48	last	last	ADJ
ihlr-27183	620	49	80	80	NUM
ihlr-27183	620	50	years	year	NOUN
ihlr-27183	620	51	,	,	PUNCT
ihlr-27183	620	52	it	it	PRON
ihlr-27183	620	53	has	have	AUX
ihlr-27183	620	54	roughly	roughly	ADV
ihlr-27183	620	55	tripled	triple	VERB
ihlr-27183	620	56	this	this	DET
ihlr-27183	620	57	average	average	NOUN
ihlr-27183	620	58	over	over	ADP
ihlr-27183	620	59	the	the	DET
ihlr-27183	620	60	last	last	ADJ
ihlr-27183	620	61	10	10	NUM
ihlr-27183	620	62	years	year	NOUN
ihlr-27183	620	63	)	)	PUNCT
ihlr-27183	620	64	.	.	PUNCT
ihlr-27183	621	1	179	179	NUM
ihlr-27183	621	2	.	.	PUNCT
ihlr-27183	622	1	dan	dan	PROPN
ihlr-27183	622	2	bagatell	bagatell	PROPN
ihlr-27183	622	3	,	,	PUNCT
ihlr-27183	622	4	fed	fed	PROPN
ihlr-27183	622	5	.	.	PUNCT
ihlr-27183	622	6	cir	cir	PROPN
ihlr-27183	622	7	.	.	PUNCT
ihlr-27183	623	1	patent	patent	NOUN
ihlr-27183	623	2	decisions	decision	NOUN
ihlr-27183	623	3	in	in	ADP
ihlr-27183	623	4	2019	2019	NUM
ihlr-27183	623	5	:	:	PUNCT
ihlr-27183	623	6	an	an	DET
ihlr-27183	623	7	empirical	empirical	ADJ
ihlr-27183	623	8	review	review	NOUN
ihlr-27183	623	9	,	,	PUNCT
ihlr-27183	623	10	law360	law360	PROPN
ihlr-27183	623	11	(	(	PUNCT
ihlr-27183	623	12	jan	jan	PROPN
ihlr-27183	623	13	.	.	PROPN
ihlr-27183	623	14	9	9	NUM
ihlr-27183	623	15	,	,	PUNCT
ihlr-27183	623	16	2020	2020	NUM
ihlr-27183	623	17	)	)	PUNCT
ihlr-27183	623	18	,	,	PUNCT
ihlr-27183	623	19	https://www.law360.com/articles/1232623/fed-circ-patent-decisions-in-2019-anempirical-review	https://www.law360.com/articles/1232623/fed-circ-patent-decisions-in-2019-anempirical-review	NOUN
ihlr-27183	623	20	[	[	X
ihlr-27183	623	21	https://perma.cc/e8ty-f9ja	https://perma.cc/e8ty-f9ja	X
ihlr-27183	623	22	]	]	SYM
ihlr-27183	623	23	.	.	PUNCT
ihlr-27183	624	1	180	180	NUM
ihlr-27183	624	2	.	.	PUNCT
ihlr-27183	624	3	see	see	VERB
ihlr-27183	624	4	supra	supra	PROPN
ihlr-27183	624	5	note	note	PROPN
ihlr-27183	624	6	26	26	NUM
ihlr-27183	624	7	and	and	CCONJ
ihlr-27183	624	8	accompanying	accompany	VERB
ihlr-27183	624	9	text	text	NOUN
ihlr-27183	624	10	.	.	PUNCT
ihlr-27183	625	1	2023	2023	NUM
ihlr-27183	625	2	]	]	PUNCT
ihlr-27183	625	3	the	the	DET
ihlr-27183	625	4	safe	safe	ADJ
ihlr-27183	625	5	harbor	harbor	NOUN
ihlr-27183	625	6	of	of	ADP
ihlr-27183	625	7	35	35	NUM
ihlr-27183	625	8	u.s.c	u.s.c	ADJ
ihlr-27183	625	9	.	.	PUNCT
ihlr-27183	626	1	§	§	PROPN
ihlr-27183	626	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	626	3	)	)	PUNCT
ihlr-27183	626	4	169	169	NUM
ihlr-27183	626	5	a	a	DET
ihlr-27183	626	6	third	third	ADJ
ihlr-27183	626	7	factor	factor	NOUN
ihlr-27183	626	8	forecasting	forecast	VERB
ihlr-27183	626	9	the	the	DET
ihlr-27183	626	10	success	success	NOUN
ihlr-27183	626	11	of	of	ADP
ihlr-27183	626	12	the	the	DET
ihlr-27183	626	13	rule	rule	NOUN
ihlr-27183	626	14	relates	relate	VERB
ihlr-27183	626	15	to	to	ADP
ihlr-27183	626	16	the	the	DET
ihlr-27183	626	17	dynamic	dynamic	NOUN
ihlr-27183	626	18	between	between	ADP
ihlr-27183	626	19	the	the	DET
ihlr-27183	626	20	supreme	supreme	PROPN
ihlr-27183	626	21	court	court	PROPN
ihlr-27183	626	22	and	and	CCONJ
ihlr-27183	626	23	the	the	DET
ihlr-27183	626	24	federal	federal	ADJ
ihlr-27183	626	25	circuit	circuit	NOUN
ihlr-27183	626	26	.	.	PUNCT
ihlr-27183	627	1	simply	simply	ADV
ihlr-27183	627	2	put	put	VERB
ihlr-27183	627	3	,	,	PUNCT
ihlr-27183	627	4	the	the	DET
ihlr-27183	627	5	rule	rule	NOUN
ihlr-27183	627	6	would	would	AUX
ihlr-27183	627	7	generally	generally	ADV
ihlr-27183	627	8	support	support	VERB
ihlr-27183	627	9	patent	patent	NOUN
ihlr-27183	627	10	enforceability	enforceability	NOUN
ihlr-27183	627	11	and	and	CCONJ
ihlr-27183	627	12	be	be	AUX
ihlr-27183	627	13	favored	favor	VERB
ihlr-27183	627	14	in	in	ADP
ihlr-27183	627	15	its	its	PRON
ihlr-27183	627	16	most	most	ADV
ihlr-27183	627	17	simple	simple	ADJ
ihlr-27183	627	18	form	form	NOUN
ihlr-27183	627	19	at	at	ADP
ihlr-27183	627	20	the	the	DET
ihlr-27183	627	21	federal	federal	ADJ
ihlr-27183	627	22	circuit	circuit	NOUN
ihlr-27183	627	23	.	.	PUNCT
ihlr-27183	628	1	further	far	ADV
ihlr-27183	628	2	,	,	PUNCT
ihlr-27183	628	3	if	if	SCONJ
ihlr-27183	628	4	a	a	DET
ihlr-27183	628	5	desire	desire	NOUN
ihlr-27183	628	6	to	to	PART
ihlr-27183	628	7	alter	alter	VERB
ihlr-27183	628	8	the	the	DET
ihlr-27183	628	9	rule	rule	NOUN
ihlr-27183	628	10	arose	arise	VERB
ihlr-27183	628	11	,	,	PUNCT
ihlr-27183	628	12	there	there	PRON
ihlr-27183	628	13	is	be	VERB
ihlr-27183	628	14	little	little	ADJ
ihlr-27183	628	15	nuance	nuance	NOUN
ihlr-27183	628	16	to	to	PART
ihlr-27183	628	17	leverage	leverage	NOUN
ihlr-27183	628	18	.	.	PUNCT
ihlr-27183	629	1	with	with	ADP
ihlr-27183	629	2	two	two	NUM
ihlr-27183	629	3	recent	recent	ADJ
ihlr-27183	629	4	controversies	controversy	NOUN
ihlr-27183	629	5	emerging	emerge	VERB
ihlr-27183	629	6	in	in	ADP
ihlr-27183	629	7	jurisdictions	jurisdiction	NOUN
ihlr-27183	629	8	having	have	VERB
ihlr-27183	629	9	uncertain	uncertain	ADJ
ihlr-27183	629	10	precedent	precedent	NOUN
ihlr-27183	629	11	,	,	PUNCT
ihlr-27183	629	12	historical	historical	ADJ
ihlr-27183	629	13	revenues	revenue	NOUN
ihlr-27183	629	14	at	at	ADP
ihlr-27183	629	15	stake	stake	NOUN
ihlr-27183	629	16	,	,	PUNCT
ihlr-27183	629	17	and	and	CCONJ
ihlr-27183	629	18	plenty	plenty	NOUN
ihlr-27183	629	19	of	of	ADP
ihlr-27183	629	20	interested	interested	ADJ
ihlr-27183	629	21	money	money	NOUN
ihlr-27183	629	22	available	available	ADJ
ihlr-27183	629	23	for	for	ADP
ihlr-27183	629	24	advocacy	advocacy	NOUN
ihlr-27183	629	25	,	,	PUNCT
ihlr-27183	629	26	the	the	DET
ihlr-27183	629	27	supreme	supreme	PROPN
ihlr-27183	629	28	court	court	PROPN
ihlr-27183	629	29	should	should	AUX
ihlr-27183	629	30	consider	consider	VERB
ihlr-27183	629	31	resolving	resolve	VERB
ihlr-27183	629	32	these	these	DET
ihlr-27183	629	33	cases	case	NOUN
ihlr-27183	629	34	with	with	ADP
ihlr-27183	629	35	a	a	DET
ihlr-27183	629	36	landmark	landmark	ADJ
ihlr-27183	629	37	decision	decision	NOUN
ihlr-27183	629	38	of	of	ADP
ihlr-27183	629	39	clarity	clarity	NOUN
ihlr-27183	629	40	.	.	PUNCT
ihlr-27183	630	1	as	as	ADV
ihlr-27183	630	2	far	far	ADV
ihlr-27183	630	3	as	as	SCONJ
ihlr-27183	630	4	the	the	DET
ihlr-27183	630	5	safe	safe	ADJ
ihlr-27183	630	6	harbor	harbor	NOUN
ihlr-27183	630	7	is	be	AUX
ihlr-27183	630	8	concerned	concern	VERB
ihlr-27183	630	9	,	,	PUNCT
ihlr-27183	630	10	there	there	PRON
ihlr-27183	630	11	is	be	VERB
ihlr-27183	630	12	disagreement	disagreement	NOUN
ihlr-27183	630	13	and	and	CCONJ
ihlr-27183	630	14	ambiguity	ambiguity	NOUN
ihlr-27183	630	15	on	on	ADP
ihlr-27183	630	16	specialized	specialized	ADJ
ihlr-27183	630	17	doctrine	doctrine	NOUN
ihlr-27183	630	18	.	.	PUNCT
ihlr-27183	631	1	whether	whether	SCONJ
ihlr-27183	631	2	research	research	NOUN
ihlr-27183	631	3	tools	tool	NOUN
ihlr-27183	631	4	fall	fall	VERB
ihlr-27183	631	5	under	under	ADP
ihlr-27183	631	6	the	the	DET
ihlr-27183	631	7	safe	safe	ADJ
ihlr-27183	631	8	harbor	harbor	NOUN
ihlr-27183	631	9	is	be	AUX
ihlr-27183	631	10	a	a	DET
ihlr-27183	631	11	matter	matter	NOUN
ihlr-27183	631	12	lower	low	ADJ
ihlr-27183	631	13	courts	court	NOUN
ihlr-27183	631	14	can	can	AUX
ihlr-27183	631	15	manipulate	manipulate	VERB
ihlr-27183	631	16	by	by	ADP
ihlr-27183	631	17	selective	selective	ADJ
ihlr-27183	631	18	use	use	NOUN
ihlr-27183	631	19	of	of	ADP
ihlr-27183	631	20	precedent	precedent	NOUN
ihlr-27183	631	21	.	.	PUNCT
ihlr-27183	632	1	this	this	DET
ihlr-27183	632	2	yields	yield	VERB
ihlr-27183	632	3	uncertainty	uncertainty	NOUN
ihlr-27183	632	4	,	,	PUNCT
ihlr-27183	632	5	expense	expense	NOUN
ihlr-27183	632	6	,	,	PUNCT
ihlr-27183	632	7	and	and	CCONJ
ihlr-27183	632	8	potentially	potentially	ADV
ihlr-27183	632	9	fosters	foster	VERB
ihlr-27183	632	10	bad	bad	ADJ
ihlr-27183	632	11	faith	faith	NOUN
ihlr-27183	632	12	in	in	ADP
ihlr-27183	632	13	competition	competition	NOUN
ihlr-27183	632	14	.	.	PUNCT
ihlr-27183	633	1	alternatively	alternatively	ADV
ihlr-27183	633	2	–	–	PUNCT
ihlr-27183	633	3	and	and	CCONJ
ihlr-27183	633	4	indeed	indeed	ADV
ihlr-27183	633	5	the	the	DET
ihlr-27183	633	6	most	most	ADV
ihlr-27183	633	7	direct	direct	ADJ
ihlr-27183	633	8	means	mean	NOUN
ihlr-27183	633	9	of	of	ADP
ihlr-27183	633	10	clarification	clarification	NOUN
ihlr-27183	633	11	–	–	PUNCT
ihlr-27183	633	12	would	would	AUX
ihlr-27183	633	13	be	be	AUX
ihlr-27183	633	14	for	for	SCONJ
ihlr-27183	633	15	the	the	DET
ihlr-27183	633	16	legislature	legislature	NOUN
ihlr-27183	633	17	to	to	PART
ihlr-27183	633	18	take	take	VERB
ihlr-27183	633	19	unilateral	unilateral	ADJ
ihlr-27183	633	20	action	action	NOUN
ihlr-27183	633	21	.	.	PUNCT
ihlr-27183	634	1	a	a	DET
ihlr-27183	634	2	sufficient	sufficient	ADJ
ihlr-27183	634	3	action	action	NOUN
ihlr-27183	634	4	from	from	ADP
ihlr-27183	634	5	the	the	DET
ihlr-27183	634	6	legislature	legislature	NOUN
ihlr-27183	634	7	would	would	AUX
ihlr-27183	634	8	consist	consist	VERB
ihlr-27183	634	9	of	of	ADP
ihlr-27183	634	10	merely	merely	ADV
ihlr-27183	634	11	an	an	DET
ihlr-27183	634	12	exchange	exchange	NOUN
ihlr-27183	634	13	of	of	ADP
ihlr-27183	634	14	the	the	DET
ihlr-27183	634	15	term	term	NOUN
ihlr-27183	634	16	“	"	PUNCT
ihlr-27183	634	17	patented	patented	ADJ
ihlr-27183	634	18	invention	invention	NOUN
ihlr-27183	634	19	”	"	PUNCT
ihlr-27183	634	20	in	in	ADP
ihlr-27183	634	21	§	§	PROPN
ihlr-27183	634	22	271	271	NUM
ihlr-27183	634	23	for	for	ADP
ihlr-27183	634	24	the	the	DET
ihlr-27183	634	25	§	§	PROPN
ihlr-27183	634	26	156	156	NUM
ihlr-27183	634	27	“	"	PUNCT
ihlr-27183	634	28	product	product	NOUN
ihlr-27183	634	29	”	"	PUNCT
ihlr-27183	634	30	and	and	CCONJ
ihlr-27183	634	31	it	it	PRON
ihlr-27183	634	32	’s	’s	AUX
ihlr-27183	634	33	associated	associate	VERB
ihlr-27183	634	34	definition.181	definition.181	VERB
ihlr-27183	634	35	with	with	ADP
ihlr-27183	634	36	decades	decade	NOUN
ihlr-27183	634	37	of	of	ADP
ihlr-27183	634	38	this	this	DET
ihlr-27183	634	39	debate	debate	NOUN
ihlr-27183	634	40	as	as	ADP
ihlr-27183	634	41	context	context	NOUN
ihlr-27183	634	42	,	,	PUNCT
ihlr-27183	634	43	and	and	CCONJ
ihlr-27183	634	44	§	§	PROPN
ihlr-27183	634	45	156	156	NUM
ihlr-27183	634	46	’s	’s	PART
ihlr-27183	634	47	explicit	explicit	ADJ
ihlr-27183	634	48	definition	definition	NOUN
ihlr-27183	634	49	of	of	ADP
ihlr-27183	634	50	“	"	PUNCT
ihlr-27183	634	51	product”–being	product”–bee	VERB
ihlr-27183	634	52	limited	limited	ADJ
ihlr-27183	634	53	to	to	ADP
ihlr-27183	634	54	articles	article	NOUN
ihlr-27183	634	55	subject	subject	ADJ
ihlr-27183	634	56	to	to	ADP
ihlr-27183	634	57	fda	fda	PROPN
ihlr-27183	634	58	approval182	approval182	PROPN
ihlr-27183	634	59	–	–	PUNCT
ihlr-27183	634	60	this	this	PRON
ihlr-27183	634	61	would	would	AUX
ihlr-27183	634	62	result	result	VERB
ihlr-27183	634	63	in	in	ADP
ihlr-27183	634	64	a	a	DET
ihlr-27183	634	65	clear	clear	ADJ
ihlr-27183	634	66	understanding	understanding	NOUN
ihlr-27183	634	67	and	and	CCONJ
ihlr-27183	634	68	virtually	virtually	ADV
ihlr-27183	634	69	immediate	immediate	ADJ
ihlr-27183	634	70	predictability	predictability	NOUN
ihlr-27183	634	71	among	among	ADP
ihlr-27183	634	72	courts	court	NOUN
ihlr-27183	634	73	.	.	PUNCT
ihlr-27183	635	1	c.	c.	NOUN
ihlr-27183	636	1	the	the	DET
ihlr-27183	636	2	scope	scope	NOUN
ihlr-27183	636	3	of	of	ADP
ihlr-27183	636	4	relevance	relevance	NOUN
ihlr-27183	636	5	1	1	NUM
ihlr-27183	636	6	.	.	PUNCT
ihlr-27183	636	7	illustrative	illustrative	ADJ
ihlr-27183	636	8	importance	importance	NOUN
ihlr-27183	636	9	of	of	ADP
ihlr-27183	636	10	research	research	NOUN
ihlr-27183	636	11	tools	tool	NOUN
ihlr-27183	636	12	i	i	PRON
ihlr-27183	636	13	)	)	PUNCT
ihlr-27183	636	14	molecular	molecular	ADJ
ihlr-27183	636	15	biomarkers	biomarker	NOUN
ihlr-27183	636	16	much	much	ADJ
ihlr-27183	636	17	of	of	ADP
ihlr-27183	636	18	the	the	DET
ihlr-27183	636	19	litigation	litigation	NOUN
ihlr-27183	636	20	discussed	discuss	VERB
ihlr-27183	636	21	centers	center	NOUN
ihlr-27183	636	22	on	on	ADP
ihlr-27183	636	23	this	this	DET
ihlr-27183	636	24	class	class	NOUN
ihlr-27183	636	25	of	of	ADP
ihlr-27183	636	26	research	research	NOUN
ihlr-27183	636	27	tools	tool	NOUN
ihlr-27183	636	28	,	,	PUNCT
ihlr-27183	636	29	but	but	CCONJ
ihlr-27183	636	30	why	why	SCONJ
ihlr-27183	636	31	are	be	AUX
ihlr-27183	636	32	they	they	PRON
ihlr-27183	636	33	important	important	ADJ
ihlr-27183	636	34	?	?	PUNCT
ihlr-27183	637	1	as	as	SCONJ
ihlr-27183	637	2	has	have	AUX
ihlr-27183	637	3	been	be	AUX
ihlr-27183	637	4	explained	explain	VERB
ihlr-27183	637	5	,	,	PUNCT
ihlr-27183	637	6	mneongreen	mneongreen	NOUN
ihlr-27183	637	7	and	and	CCONJ
ihlr-27183	637	8	other	other	ADJ
ihlr-27183	637	9	fluorescent	fluorescent	ADJ
ihlr-27183	637	10	proteins	protein	NOUN
ihlr-27183	637	11	are	be	AUX
ihlr-27183	637	12	considered	consider	VERB
ihlr-27183	637	13	“	"	PUNCT
ihlr-27183	637	14	marker	marker	NOUN
ihlr-27183	637	15	”	"	PUNCT
ihlr-27183	637	16	or	or	CCONJ
ihlr-27183	637	17	“	"	PUNCT
ihlr-27183	637	18	indicator	indicator	NOUN
ihlr-27183	637	19	”	"	PUNCT
ihlr-27183	637	20	proteins	protein	NOUN
ihlr-27183	637	21	.	.	PUNCT
ihlr-27183	638	1	in	in	ADP
ihlr-27183	638	2	the	the	DET
ihlr-27183	638	3	case	case	NOUN
ihlr-27183	638	4	of	of	ADP
ihlr-27183	638	5	vaccine	vaccine	NOUN
ihlr-27183	638	6	research	research	NOUN
ihlr-27183	638	7	,	,	PUNCT
ihlr-27183	638	8	they	they	PRON
ihlr-27183	638	9	annunciate	annunciate	VERB
ihlr-27183	638	10	the	the	DET
ihlr-27183	638	11	existence	existence	NOUN
ihlr-27183	638	12	of	of	ADP
ihlr-27183	638	13	antibodies	antibody	NOUN
ihlr-27183	638	14	successfully	successfully	ADV
ihlr-27183	638	15	produced	produce	VERB
ihlr-27183	638	16	during	during	ADP
ihlr-27183	638	17	clinical	clinical	ADJ
ihlr-27183	638	18	trials	trial	NOUN
ihlr-27183	638	19	of	of	ADP
ihlr-27183	638	20	vaccines	vaccine	NOUN
ihlr-27183	638	21	or	or	CCONJ
ihlr-27183	638	22	similar	similar	ADJ
ihlr-27183	638	23	activities	activity	NOUN
ihlr-27183	638	24	.	.	PUNCT
ihlr-27183	639	1	more	more	ADV
ihlr-27183	639	2	generally	generally	ADV
ihlr-27183	639	3	,	,	PUNCT
ihlr-27183	639	4	molecular	molecular	ADJ
ihlr-27183	639	5	biomarkers	biomarker	NOUN
ihlr-27183	639	6	are	be	AUX
ihlr-27183	639	7	used	use	VERB
ihlr-27183	639	8	to	to	PART
ihlr-27183	639	9	“	"	PUNCT
ihlr-27183	639	10	diagnose	diagnose	NOUN
ihlr-27183	639	11	disease	disease	NOUN
ihlr-27183	639	12	,	,	PUNCT
ihlr-27183	639	13	monitor	monitor	VERB
ihlr-27183	639	14	disease	disease	NOUN
ihlr-27183	639	15	progression	progression	NOUN
ihlr-27183	639	16	and	and	CCONJ
ihlr-27183	639	17	response	response	NOUN
ihlr-27183	639	18	to	to	ADP
ihlr-27183	639	19	therapy	therapy	NOUN
ihlr-27183	639	20	,	,	PUNCT
ihlr-27183	639	21	and	and	CCONJ
ihlr-27183	639	22	are	be	AUX
ihlr-27183	639	23	targets	target	NOUN
ihlr-27183	639	24	for	for	ADP
ihlr-27183	639	25	development	development	NOUN
ihlr-27183	639	26	of	of	ADP
ihlr-27183	639	27	new	new	ADJ
ihlr-27183	639	28	drugs	drug	NOUN
ihlr-27183	639	29	.	.	PUNCT
ihlr-27183	640	1	”183	”183	PUNCT
ihlr-27183	640	2	generally	generally	ADV
ihlr-27183	640	3	,	,	PUNCT
ihlr-27183	640	4	these	these	DET
ihlr-27183	640	5	biomarkers	biomarker	NOUN
ihlr-27183	640	6	are	be	AUX
ihlr-27183	640	7	not	not	PART
ihlr-27183	640	8	subject	subject	ADJ
ihlr-27183	640	9	to	to	ADP
ihlr-27183	640	10	fda	fda	PROPN
ihlr-27183	640	11	approval	approval	NOUN
ihlr-27183	640	12	since	since	SCONJ
ihlr-27183	640	13	they	they	PRON
ihlr-27183	640	14	are	be	AUX
ihlr-27183	640	15	not	not	PART
ihlr-27183	640	16	administered	administer	VERB
ihlr-27183	640	17	to	to	ADP
ihlr-27183	640	18	patients	patient	NOUN
ihlr-27183	640	19	.	.	PUNCT
ihlr-27183	641	1	a	a	DET
ihlr-27183	641	2	lack	lack	NOUN
ihlr-27183	641	3	of	of	ADP
ihlr-27183	641	4	patent	patent	NOUN
ihlr-27183	641	5	protection	protection	NOUN
ihlr-27183	641	6	for	for	ADP
ihlr-27183	641	7	molecular	molecular	ADJ
ihlr-27183	641	8	biomarkers	biomarker	NOUN
ihlr-27183	641	9	would	would	AUX
ihlr-27183	641	10	allow	allow	VERB
ihlr-27183	641	11	uncompensated	uncompensated	ADJ
ihlr-27183	641	12	use	use	NOUN
ihlr-27183	641	13	and	and	CCONJ
ihlr-27183	641	14	copying	copying	NOUN
ihlr-27183	641	15	in	in	ADP
ihlr-27183	641	16	a	a	DET
ihlr-27183	641	17	majority	majority	NOUN
ihlr-27183	641	18	of	of	ADP
ihlr-27183	641	19	their	their	PRON
ihlr-27183	641	20	applications	application	NOUN
ihlr-27183	641	21	–	–	PUNCT
ihlr-27183	641	22	reducing	reduce	VERB
ihlr-27183	641	23	both	both	CCONJ
ihlr-27183	641	24	the	the	DET
ihlr-27183	641	25	value	value	NOUN
ihlr-27183	641	26	of	of	ADP
ihlr-27183	641	27	the	the	DET
ihlr-27183	641	28	inventions	invention	NOUN
ihlr-27183	641	29	and	and	CCONJ
ihlr-27183	641	30	investment	investment	NOUN
ihlr-27183	641	31	in	in	ADP
ihlr-27183	641	32	the	the	DET
ihlr-27183	641	33	technology	technology	NOUN
ihlr-27183	641	34	.	.	PUNCT
ihlr-27183	642	1	181	181	NUM
ihlr-27183	642	2	.	.	PUNCT
ihlr-27183	643	1	§	§	PROPN
ihlr-27183	643	2	156(f	156(f	PROPN
ihlr-27183	643	3	)	)	PUNCT
ihlr-27183	643	4	.	.	PUNCT
ihlr-27183	644	1	182	182	NUM
ihlr-27183	644	2	.	.	PUNCT
ihlr-27183	645	1	i	i	PRON
ihlr-27183	645	2	d.	d.	PROPN
ihlr-27183	645	3	183	183	NUM
ihlr-27183	645	4	.	.	PUNCT
ihlr-27183	646	1	keck	keck	PROPN
ihlr-27183	646	2	graduate	graduate	PROPN
ihlr-27183	646	3	inst	inst	PROPN
ihlr-27183	646	4	.	.	PROPN
ihlr-27183	646	5	,	,	PUNCT
ihlr-27183	646	6	about	about	ADP
ihlr-27183	646	7	the	the	DET
ihlr-27183	646	8	center	center	NOUN
ihlr-27183	646	9	for	for	ADP
ihlr-27183	646	10	biomarker	biomarker	NOUN
ihlr-27183	646	11	research	research	NOUN
ihlr-27183	646	12	,	,	PUNCT
ihlr-27183	646	13	https://www.kgi.edu/	https://www.kgi.edu/	VERB
ihlr-27183	646	14	faculty	faculty	NOUN
ihlr-27183	646	15	-	-	PUNCT
ihlr-27183	646	16	and	and	CCONJ
ihlr-27183	646	17	-	-	PUNCT
ihlr-27183	646	18	research	research	NOUN
ihlr-27183	646	19	/	/	SYM
ihlr-27183	646	20	centers	center	NOUN
ihlr-27183	646	21	-	-	PUNCT
ihlr-27183	646	22	initiatives	initiative	NOUN
ihlr-27183	646	23	/	/	SYM
ihlr-27183	646	24	center	center	NOUN
ihlr-27183	646	25	-	-	PUNCT
ihlr-27183	646	26	for	for	ADP
ihlr-27183	646	27	-	-	PUNCT
ihlr-27183	646	28	biomarker	biomarker	NOUN
ihlr-27183	646	29	-	-	PUNCT
ihlr-27183	646	30	research/	research/	NUM
ihlr-27183	647	1	[	[	NOUN
ihlr-27183	647	2	https://perma.cc/tlf37y5q	https://perma.cc/tlf37y5q	X
ihlr-27183	647	3	]	]	X
ihlr-27183	647	4	(	(	PUNCT
ihlr-27183	647	5	last	last	ADV
ihlr-27183	647	6	visited	visit	VERB
ihlr-27183	647	7	oct	oct	PROPN
ihlr-27183	647	8	.	.	PROPN
ihlr-27183	647	9	24	24	NUM
ihlr-27183	647	10	,	,	PUNCT
ihlr-27183	647	11	2021	2021	NUM
ihlr-27183	647	12	)	)	PUNCT
ihlr-27183	647	13	.	.	PUNCT
ihlr-27183	648	1	170	170	NUM
ihlr-27183	648	2	indiana	indiana	PROPN
ihlr-27183	648	3	health	health	PROPN
ihlr-27183	648	4	law	law	PROPN
ihlr-27183	648	5	review	review	NOUN
ihlr-27183	648	6	[	[	X
ihlr-27183	648	7	vol	vol	NOUN
ihlr-27183	648	8	.	.	PUNCT
ihlr-27183	648	9	20:143	20:143	PROPN
ihlr-27183	648	10	ii	ii	PROPN
ihlr-27183	648	11	)	)	PUNCT
ihlr-27183	648	12	medical	medical	ADJ
ihlr-27183	648	13	laboratory	laboratory	NOUN
ihlr-27183	648	14	devices	device	NOUN
ihlr-27183	648	15	medical	medical	ADJ
ihlr-27183	648	16	devices	device	NOUN
ihlr-27183	648	17	used	use	VERB
ihlr-27183	648	18	as	as	ADP
ihlr-27183	648	19	research	research	NOUN
ihlr-27183	648	20	tools	tool	NOUN
ihlr-27183	648	21	are	be	AUX
ihlr-27183	648	22	more	more	ADV
ihlr-27183	648	23	intuitive	intuitive	ADJ
ihlr-27183	648	24	and	and	CCONJ
ihlr-27183	648	25	are	be	AUX
ihlr-27183	648	26	indeed	indeed	ADV
ihlr-27183	648	27	ubiquitous	ubiquitous	ADJ
ihlr-27183	648	28	.	.	PUNCT
ihlr-27183	649	1	from	from	ADP
ihlr-27183	649	2	laboratory	laboratory	NOUN
ihlr-27183	649	3	microscopes	microscope	NOUN
ihlr-27183	649	4	to	to	ADP
ihlr-27183	649	5	centrifuges	centrifuge	NOUN
ihlr-27183	649	6	,	,	PUNCT
ihlr-27183	649	7	this	this	DET
ihlr-27183	649	8	class	class	NOUN
ihlr-27183	649	9	of	of	ADP
ihlr-27183	649	10	tools	tool	NOUN
ihlr-27183	649	11	is	be	AUX
ihlr-27183	649	12	interacted	interact	VERB
ihlr-27183	649	13	with	with	ADP
ihlr-27183	649	14	in	in	ADP
ihlr-27183	649	15	a	a	DET
ihlr-27183	649	16	high	high	ADJ
ihlr-27183	649	17	-	-	PUNCT
ihlr-27183	649	18	school	school	NOUN
ihlr-27183	649	19	science	science	NOUN
ihlr-27183	649	20	classroom	classroom	NOUN
ihlr-27183	649	21	and	and	CCONJ
ihlr-27183	649	22	the	the	DET
ihlr-27183	649	23	occasional	occasional	ADJ
ihlr-27183	649	24	visit	visit	NOUN
ihlr-27183	649	25	to	to	ADP
ihlr-27183	649	26	the	the	DET
ihlr-27183	649	27	general	general	ADJ
ihlr-27183	649	28	practitioner	practitioner	NOUN
ihlr-27183	649	29	.	.	PUNCT
ihlr-27183	650	1	some	some	PRON
ihlr-27183	650	2	of	of	ADP
ihlr-27183	650	3	these	these	DET
ihlr-27183	650	4	devices	device	NOUN
ihlr-27183	650	5	are	be	AUX
ihlr-27183	650	6	subject	subject	ADJ
ihlr-27183	650	7	to	to	ADP
ihlr-27183	650	8	fda	fda	PROPN
ihlr-27183	650	9	approval	approval	NOUN
ihlr-27183	650	10	,	,	PUNCT
ihlr-27183	650	11	such	such	ADJ
ihlr-27183	650	12	as	as	ADP
ihlr-27183	650	13	a	a	DET
ihlr-27183	650	14	cardiac	cardiac	ADJ
ihlr-27183	650	15	defibrillator	defibrillator	NOUN
ihlr-27183	650	16	,	,	PUNCT
ihlr-27183	650	17	and	and	CCONJ
ihlr-27183	650	18	in	in	ADP
ihlr-27183	650	19	that	that	DET
ihlr-27183	650	20	sense	sense	NOUN
ihlr-27183	650	21	,	,	PUNCT
ihlr-27183	650	22	do	do	AUX
ihlr-27183	650	23	not	not	PART
ihlr-27183	650	24	fall	fall	VERB
ihlr-27183	650	25	within	within	ADP
ihlr-27183	650	26	the	the	DET
ihlr-27183	650	27	typical	typical	ADJ
ihlr-27183	650	28	definition	definition	NOUN
ihlr-27183	650	29	of	of	ADP
ihlr-27183	650	30	a	a	DET
ihlr-27183	650	31	research	research	NOUN
ihlr-27183	650	32	tool	tool	NOUN
ihlr-27183	650	33	.	.	PUNCT
ihlr-27183	651	1	generally	generally	ADV
ihlr-27183	651	2	,	,	PUNCT
ihlr-27183	651	3	devices	device	NOUN
ihlr-27183	651	4	used	use	VERB
ihlr-27183	651	5	in	in	ADP
ihlr-27183	651	6	laboratory	laboratory	NOUN
ihlr-27183	651	7	settings	setting	NOUN
ihlr-27183	651	8	are	be	AUX
ihlr-27183	651	9	not	not	PART
ihlr-27183	651	10	subject	subject	ADJ
ihlr-27183	651	11	to	to	ADP
ihlr-27183	651	12	fda	fda	PROPN
ihlr-27183	651	13	approval	approval	NOUN
ihlr-27183	651	14	and	and	CCONJ
ihlr-27183	651	15	would	would	AUX
ihlr-27183	651	16	be	be	AUX
ihlr-27183	651	17	at	at	ADP
ihlr-27183	651	18	risk	risk	NOUN
ihlr-27183	651	19	of	of	ADP
ihlr-27183	651	20	losing	lose	VERB
ihlr-27183	651	21	patent	patent	NOUN
ihlr-27183	651	22	protection	protection	NOUN
ihlr-27183	651	23	if	if	SCONJ
ihlr-27183	651	24	research	research	NOUN
ihlr-27183	651	25	tools	tool	NOUN
ihlr-27183	651	26	were	be	AUX
ihlr-27183	651	27	widely	widely	ADV
ihlr-27183	651	28	included	include	VERB
ihlr-27183	651	29	in	in	ADP
ihlr-27183	651	30	the	the	DET
ihlr-27183	651	31	ambit	ambit	NOUN
ihlr-27183	651	32	of	of	ADP
ihlr-27183	651	33	§	§	PROPN
ihlr-27183	651	34	271(e)(1	271(e)(1	PROPN
ihlr-27183	651	35	)	)	PUNCT
ihlr-27183	651	36	.	.	PUNCT
ihlr-27183	652	1	a	a	DET
ihlr-27183	652	2	loss	loss	NOUN
ihlr-27183	652	3	of	of	ADP
ihlr-27183	652	4	commercial	commercial	ADJ
ihlr-27183	652	5	value	value	NOUN
ihlr-27183	652	6	in	in	ADP
ihlr-27183	652	7	the	the	DET
ihlr-27183	652	8	development	development	NOUN
ihlr-27183	652	9	of	of	ADP
ihlr-27183	652	10	new	new	ADJ
ihlr-27183	652	11	and	and	CCONJ
ihlr-27183	652	12	improved	improved	ADJ
ihlr-27183	652	13	laboratory	laboratory	NOUN
ihlr-27183	652	14	equipment	equipment	NOUN
ihlr-27183	652	15	,	,	PUNCT
ihlr-27183	652	16	by	by	ADP
ihlr-27183	652	17	the	the	DET
ihlr-27183	652	18	unencumbered	unencumbered	ADJ
ihlr-27183	652	19	copying	copying	NOUN
ihlr-27183	652	20	by	by	ADP
ihlr-27183	652	21	competing	compete	VERB
ihlr-27183	652	22	manufacturers	manufacturer	NOUN
ihlr-27183	652	23	,	,	PUNCT
ihlr-27183	652	24	would	would	AUX
ihlr-27183	652	25	diminish	diminish	VERB
ihlr-27183	652	26	the	the	DET
ihlr-27183	652	27	investment	investment	NOUN
ihlr-27183	652	28	in	in	ADP
ihlr-27183	652	29	this	this	DET
ihlr-27183	652	30	industry	industry	NOUN
ihlr-27183	652	31	and	and	CCONJ
ihlr-27183	652	32	reduce	reduce	VERB
ihlr-27183	652	33	published	publish	VERB
ihlr-27183	652	34	technological	technological	ADJ
ihlr-27183	652	35	advances	advance	NOUN
ihlr-27183	652	36	.	.	PUNCT
ihlr-27183	653	1	iii	iii	X
ihlr-27183	653	2	)	)	PUNCT
ihlr-27183	653	3	artificial	artificial	ADJ
ihlr-27183	653	4	intelligence	intelligence	NOUN
ihlr-27183	653	5	one	one	NUM
ihlr-27183	653	6	technology	technology	NOUN
ihlr-27183	653	7	often	often	ADV
ihlr-27183	653	8	classified	classify	VERB
ihlr-27183	653	9	as	as	ADP
ihlr-27183	653	10	a	a	DET
ihlr-27183	653	11	research	research	NOUN
ihlr-27183	653	12	tool	tool	NOUN
ihlr-27183	653	13	is	be	AUX
ihlr-27183	653	14	artificial	artificial	ADJ
ihlr-27183	653	15	intelligence	intelligence	NOUN
ihlr-27183	653	16	(	(	PUNCT
ihlr-27183	653	17	ai	ai	NOUN
ihlr-27183	653	18	)	)	PUNCT
ihlr-27183	653	19	.	.	PUNCT
ihlr-27183	654	1	for	for	ADP
ihlr-27183	654	2	ai	ai	VERB
ihlr-27183	654	3	to	to	PART
ihlr-27183	654	4	be	be	AUX
ihlr-27183	654	5	patentable	patentable	ADJ
ihlr-27183	654	6	it	it	PRON
ihlr-27183	654	7	must	must	AUX
ihlr-27183	654	8	do	do	VERB
ihlr-27183	654	9	more	more	ADJ
ihlr-27183	654	10	than	than	SCONJ
ihlr-27183	654	11	perform	perform	VERB
ihlr-27183	654	12	mathematical	mathematical	ADJ
ihlr-27183	654	13	formulas	formula	NOUN
ihlr-27183	654	14	,	,	PUNCT
ihlr-27183	654	15	mental	mental	ADJ
ihlr-27183	654	16	processes	process	NOUN
ihlr-27183	654	17	,	,	PUNCT
ihlr-27183	654	18	or	or	CCONJ
ihlr-27183	654	19	organize	organize	VERB
ihlr-27183	654	20	ordinarily	ordinarily	ADV
ihlr-27183	654	21	human	human	VERB
ihlr-27183	654	22	activity.184	activity.184	NOUN
ihlr-27183	654	23	even	even	ADV
ihlr-27183	654	24	so	so	ADV
ihlr-27183	654	25	,	,	PUNCT
ihlr-27183	654	26	thousands	thousand	NOUN
ihlr-27183	654	27	of	of	ADP
ihlr-27183	654	28	ai	ai	PRON
ihlr-27183	654	29	related	related	ADJ
ihlr-27183	654	30	patents	patent	NOUN
ihlr-27183	654	31	have	have	AUX
ihlr-27183	654	32	met	meet	VERB
ihlr-27183	654	33	that	that	DET
ihlr-27183	654	34	burden	burden	NOUN
ihlr-27183	654	35	and	and	CCONJ
ihlr-27183	654	36	have	have	AUX
ihlr-27183	654	37	been	be	AUX
ihlr-27183	654	38	granted	grant	VERB
ihlr-27183	654	39	.	.	PUNCT
ihlr-27183	655	1	the	the	DET
ihlr-27183	655	2	growth	growth	NOUN
ihlr-27183	655	3	of	of	ADP
ihlr-27183	655	4	ai	ai	ADJ
ihlr-27183	655	5	patents	patent	NOUN
ihlr-27183	655	6	in	in	ADP
ihlr-27183	655	7	the	the	DET
ihlr-27183	655	8	medical	medical	ADJ
ihlr-27183	655	9	industry	industry	NOUN
ihlr-27183	655	10	has	have	AUX
ihlr-27183	655	11	experienced	experience	VERB
ihlr-27183	655	12	rapid	rapid	ADJ
ihlr-27183	655	13	acceleration	acceleration	NOUN
ihlr-27183	655	14	since	since	SCONJ
ihlr-27183	655	15	2011	2011	NUM
ihlr-27183	655	16	due	due	ADP
ihlr-27183	655	17	to	to	ADP
ihlr-27183	655	18	a	a	DET
ihlr-27183	655	19	significant	significant	ADJ
ihlr-27183	655	20	increase	increase	NOUN
ihlr-27183	655	21	in	in	ADP
ihlr-27183	655	22	big	big	ADJ
ihlr-27183	655	23	data	datum	NOUN
ihlr-27183	655	24	analytics	analytic	NOUN
ihlr-27183	655	25	and	and	CCONJ
ihlr-27183	655	26	improvements	improvement	NOUN
ihlr-27183	655	27	in	in	ADP
ihlr-27183	655	28	computing	compute	VERB
ihlr-27183	655	29	power.185	power.185	ADJ
ihlr-27183	655	30	patents	patent	NOUN
ihlr-27183	655	31	on	on	ADP
ihlr-27183	655	32	ai	ai	PRON
ihlr-27183	655	33	research	research	NOUN
ihlr-27183	655	34	tools	tool	NOUN
ihlr-27183	655	35	–	–	PUNCT
ihlr-27183	655	36	especially	especially	ADV
ihlr-27183	655	37	those	those	DET
ihlr-27183	655	38	mining	mining	NOUN
ihlr-27183	655	39	and	and	CCONJ
ihlr-27183	655	40	predicting	predict	VERB
ihlr-27183	655	41	usefulness	usefulness	NOUN
ihlr-27183	655	42	of	of	ADP
ihlr-27183	655	43	the	the	DET
ihlr-27183	655	44	astronomical	astronomical	ADJ
ihlr-27183	655	45	number	number	NOUN
ihlr-27183	655	46	of	of	ADP
ihlr-27183	655	47	uncharted	uncharted	ADJ
ihlr-27183	655	48	chemical	chemical	NOUN
ihlr-27183	655	49	compounds	compound	NOUN
ihlr-27183	655	50	–	–	PUNCT
ihlr-27183	655	51	will	will	AUX
ihlr-27183	655	52	become	become	VERB
ihlr-27183	655	53	increasingly	increasingly	ADV
ihlr-27183	655	54	contentious	contentious	ADJ
ihlr-27183	655	55	as	as	SCONJ
ihlr-27183	655	56	the	the	DET
ihlr-27183	655	57	space	space	NOUN
ihlr-27183	655	58	gets	get	VERB
ihlr-27183	655	59	crowded.186	crowded.186	VERB
ihlr-27183	655	60	for	for	ADP
ihlr-27183	655	61	prospective	prospective	ADJ
ihlr-27183	655	62	investors	investor	NOUN
ihlr-27183	655	63	,	,	PUNCT
ihlr-27183	655	64	it	it	PRON
ihlr-27183	655	65	will	will	AUX
ihlr-27183	655	66	be	be	AUX
ihlr-27183	655	67	increasingly	increasingly	ADV
ihlr-27183	655	68	important	important	ADJ
ihlr-27183	655	69	to	to	PART
ihlr-27183	655	70	understand	understand	VERB
ihlr-27183	655	71	the	the	DET
ihlr-27183	655	72	issue	issue	NOUN
ihlr-27183	655	73	of	of	ADP
ihlr-27183	655	74	ai	ai	NOUN
ihlr-27183	655	75	as	as	ADP
ihlr-27183	655	76	research	research	NOUN
ihlr-27183	655	77	tools	tool	NOUN
ihlr-27183	655	78	under	under	ADP
ihlr-27183	655	79	patent	patent	NOUN
ihlr-27183	655	80	protection	protection	NOUN
ihlr-27183	655	81	prior	prior	ADV
ihlr-27183	655	82	to	to	ADP
ihlr-27183	655	83	entering	enter	VERB
ihlr-27183	655	84	into	into	ADP
ihlr-27183	655	85	this	this	DET
ihlr-27183	655	86	new	new	ADJ
ihlr-27183	655	87	era	era	NOUN
ihlr-27183	655	88	.	.	PUNCT
ihlr-27183	656	1	ai	ai	VERB
ihlr-27183	656	2	is	be	AUX
ihlr-27183	656	3	particularly	particularly	ADV
ihlr-27183	656	4	vulnerable	vulnerable	ADJ
ihlr-27183	656	5	to	to	ADP
ihlr-27183	656	6	copying	copy	VERB
ihlr-27183	656	7	as	as	SCONJ
ihlr-27183	656	8	it	it	PRON
ihlr-27183	656	9	is	be	AUX
ihlr-27183	656	10	often	often	ADV
ihlr-27183	656	11	,	,	PUNCT
ihlr-27183	656	12	in	in	ADP
ihlr-27183	656	13	large	large	ADJ
ihlr-27183	656	14	part	part	NOUN
ihlr-27183	656	15	,	,	PUNCT
ihlr-27183	656	16	code	code	NOUN
ihlr-27183	656	17	which	which	PRON
ihlr-27183	656	18	is	be	AUX
ihlr-27183	656	19	run	run	VERB
ihlr-27183	656	20	on	on	ADP
ihlr-27183	656	21	a	a	DET
ihlr-27183	656	22	supercomputer	supercomputer	NOUN
ihlr-27183	656	23	.	.	PUNCT
ihlr-27183	657	1	2	2	X
ihlr-27183	657	2	.	.	X
ihlr-27183	657	3	importance	importance	NOUN
ihlr-27183	657	4	of	of	ADP
ihlr-27183	657	5	patent	patent	NOUN
ihlr-27183	657	6	protection	protection	NOUN
ihlr-27183	657	7	whether	whether	SCONJ
ihlr-27183	657	8	the	the	DET
ihlr-27183	657	9	right	right	NOUN
ihlr-27183	657	10	to	to	PART
ihlr-27183	657	11	exclude	exclude	VERB
ihlr-27183	657	12	extends	extend	NOUN
ihlr-27183	657	13	to	to	ADP
ihlr-27183	657	14	lawfully	lawfully	ADV
ihlr-27183	657	15	patented	patent	VERB
ihlr-27183	657	16	research	research	NOUN
ihlr-27183	657	17	tools	tool	NOUN
ihlr-27183	657	18	must	must	AUX
ihlr-27183	657	19	be	be	AUX
ihlr-27183	657	20	clearly	clearly	ADV
ihlr-27183	657	21	answered	answer	VERB
ihlr-27183	657	22	in	in	ADP
ihlr-27183	657	23	the	the	DET
ihlr-27183	657	24	affirmative	affirmative	NOUN
ihlr-27183	657	25	to	to	PART
ihlr-27183	657	26	secure	secure	VERB
ihlr-27183	657	27	current	current	ADJ
ihlr-27183	657	28	investment	investment	NOUN
ihlr-27183	657	29	,	,	PUNCT
ihlr-27183	657	30	and	and	CCONJ
ihlr-27183	657	31	promote	promote	VERB
ihlr-27183	657	32	future	future	ADJ
ihlr-27183	657	33	investment	investment	NOUN
ihlr-27183	657	34	,	,	PUNCT
ihlr-27183	657	35	in	in	ADP
ihlr-27183	657	36	the	the	DET
ihlr-27183	657	37	above	above	ADJ
ihlr-27183	657	38	industries	industry	NOUN
ihlr-27183	657	39	of	of	ADP
ihlr-27183	657	40	public	public	ADJ
ihlr-27183	657	41	import	import	NOUN
ihlr-27183	657	42	.	.	PUNCT
ihlr-27183	658	1	if	if	SCONJ
ihlr-27183	658	2	a	a	DET
ihlr-27183	658	3	patented	patented	ADJ
ihlr-27183	658	4	research	research	NOUN
ihlr-27183	658	5	tool	tool	NOUN
ihlr-27183	658	6	,	,	PUNCT
ihlr-27183	658	7	requiring	require	VERB
ihlr-27183	658	8	a	a	DET
ihlr-27183	658	9	large	large	ADJ
ihlr-27183	658	10	capital	capital	NOUN
ihlr-27183	658	11	investment	investment	NOUN
ihlr-27183	658	12	,	,	PUNCT
ihlr-27183	658	13	can	can	AUX
ihlr-27183	658	14	be	be	AUX
ihlr-27183	658	15	used	use	VERB
ihlr-27183	658	16	without	without	ADP
ihlr-27183	658	17	compensation	compensation	NOUN
ihlr-27183	658	18	184	184	NUM
ihlr-27183	658	19	.	.	PUNCT
ihlr-27183	659	1	andrew	andrew	PROPN
ihlr-27183	659	2	rapacke	rapacke	PROPN
ihlr-27183	659	3	,	,	PUNCT
ihlr-27183	659	4	are	be	AUX
ihlr-27183	659	5	machine	machine	NOUN
ihlr-27183	659	6	learning	learn	VERB
ihlr-27183	659	7	algorithms	algorithm	NOUN
ihlr-27183	659	8	patentable	patentable	ADJ
ihlr-27183	659	9	?	?	PUNCT
ihlr-27183	659	10	,	,	PUNCT
ihlr-27183	659	11	rapcke	rapcke	PROPN
ihlr-27183	659	12	l.	l.	PROPN
ihlr-27183	659	13	grp	grp	PROPN
ihlr-27183	659	14	.	.	PUNCT
ihlr-27183	660	1	(	(	PUNCT
ihlr-27183	660	2	jan	jan	PROPN
ihlr-27183	660	3	.	.	PROPN
ihlr-27183	660	4	27	27	NUM
ihlr-27183	660	5	,	,	PUNCT
ihlr-27183	660	6	2020	2020	NUM
ihlr-27183	660	7	)	)	PUNCT
ihlr-27183	660	8	,	,	PUNCT
ihlr-27183	660	9	https://arapackelaw.com/patents/softwaremobile-apps/are-machine-learning-algorithmspatentable/	https://arapackelaw.com/patents/softwaremobile-apps/are-machine-learning-algorithmspatentable/	PROPN
ihlr-27183	661	1	[	[	X
ihlr-27183	661	2	https://perma.cc/jax2-vy5v	https://perma.cc/jax2-vy5v	X
ihlr-27183	661	3	]	]	X
ihlr-27183	661	4	.	.	PUNCT
ihlr-27183	662	1	185	185	NUM
ihlr-27183	662	2	.	.	PUNCT
ihlr-27183	663	1	yang	yang	PROPN
ihlr-27183	663	2	xin	xin	PROPN
ihlr-27183	663	3	et	et	PROPN
ihlr-27183	663	4	al	al	PROPN
ihlr-27183	663	5	.	.	PROPN
ihlr-27183	663	6	,	,	PUNCT
ihlr-27183	663	7	the	the	DET
ihlr-27183	663	8	development	development	NOUN
ihlr-27183	663	9	trend	trend	NOUN
ihlr-27183	663	10	of	of	ADP
ihlr-27183	663	11	artificial	artificial	ADJ
ihlr-27183	663	12	intelligence	intelligence	NOUN
ihlr-27183	663	13	in	in	ADP
ihlr-27183	663	14	medical	medical	ADJ
ihlr-27183	663	15	:	:	PUNCT
ihlr-27183	663	16	a	a	DET
ihlr-27183	663	17	patentometric	patentometric	ADJ
ihlr-27183	663	18	analysis	analysis	NOUN
ihlr-27183	663	19	,	,	PUNCT
ihlr-27183	663	20	(	(	PUNCT
ihlr-27183	663	21	1	1	X
ihlr-27183	663	22	)	)	PUNCT
ihlr-27183	663	23	a.i	a.i	PROPN
ihlr-27183	663	24	life	life	PROPN
ihlr-27183	663	25	sci	sci	PROPN
ihlr-27183	663	26	.	.	PROPN
ihlr-27183	663	27	100006	100006	NUM
ihlr-27183	663	28	(	(	PUNCT
ihlr-27183	663	29	2021	2021	NUM
ihlr-27183	663	30	)	)	PUNCT
ihlr-27183	663	31	.	.	PUNCT
ihlr-27183	664	1	186	186	NUM
ihlr-27183	664	2	.	.	PUNCT
ihlr-27183	665	1	sam	sam	PROPN
ihlr-27183	665	2	lemonick	lemonick	PROPN
ihlr-27183	665	3	,	,	PUNCT
ihlr-27183	665	4	exploring	explore	VERB
ihlr-27183	665	5	chemical	chemical	ADJ
ihlr-27183	665	6	space	space	NOUN
ihlr-27183	665	7	:	:	PUNCT
ihlr-27183	665	8	can	can	AUX
ihlr-27183	665	9	ai	ai	AUX
ihlr-27183	665	10	take	take	VERB
ihlr-27183	665	11	us	we	PRON
ihlr-27183	665	12	where	where	SCONJ
ihlr-27183	665	13	no	no	DET
ihlr-27183	665	14	human	human	NOUN
ihlr-27183	665	15	has	have	AUX
ihlr-27183	665	16	gone	go	VERB
ihlr-27183	665	17	before	before	ADV
ihlr-27183	665	18	?	?	PUNCT
ihlr-27183	665	19	,	,	PUNCT
ihlr-27183	665	20	chem	chem	PROPN
ihlr-27183	665	21	.	.	PUNCT
ihlr-27183	666	1	&	&	CCONJ
ihlr-27183	666	2	eng’g	eng’g	PROPN
ihlr-27183	666	3	news	news	PROPN
ihlr-27183	666	4	(	(	PUNCT
ihlr-27183	666	5	apr	apr	PROPN
ihlr-27183	666	6	.	.	PROPN
ihlr-27183	666	7	6	6	NUM
ihlr-27183	666	8	,	,	PUNCT
ihlr-27183	666	9	2020	2020	NUM
ihlr-27183	666	10	)	)	PUNCT
ihlr-27183	666	11	,	,	PUNCT
ihlr-27183	666	12	https://cen.acs.org/physical-chemistry/	https://cen.acs.org/physical-chemistry/	PROPN
ihlr-27183	666	13	computational	computational	ADJ
ihlr-27183	666	14	-	-	PUNCT
ihlr-27183	666	15	chemistry	chemistry	NOUN
ihlr-27183	666	16	/	/	SYM
ihlr-27183	666	17	exploring	explore	VERB
ihlr-27183	666	18	-	-	PUNCT
ihlr-27183	666	19	chemical	chemical	ADJ
ihlr-27183	666	20	-	-	PUNCT
ihlr-27183	666	21	space	space	NOUN
ihlr-27183	666	22	-	-	PUNCT
ihlr-27183	666	23	ai	ai	NOUN
ihlr-27183	666	24	-	-	PUNCT
ihlr-27183	666	25	take/98	take/98	ADJ
ihlr-27183	666	26	/	/	SYM
ihlr-27183	666	27	i13	i13	NOUN
ihlr-27183	666	28	[	[	X
ihlr-27183	666	29	https://perma.cc/2wtz2mae	https://perma.cc/2wtz2mae	X
ihlr-27183	666	30	]	]	X
ihlr-27183	666	31	.	.	PUNCT
ihlr-27183	667	1	2023	2023	NUM
ihlr-27183	667	2	]	]	PUNCT
ihlr-27183	667	3	the	the	DET
ihlr-27183	667	4	safe	safe	ADJ
ihlr-27183	667	5	harbor	harbor	NOUN
ihlr-27183	667	6	of	of	ADP
ihlr-27183	667	7	35	35	NUM
ihlr-27183	667	8	u.s.c	u.s.c	ADJ
ihlr-27183	667	9	.	.	PUNCT
ihlr-27183	668	1	§	§	PROPN
ihlr-27183	668	2	271(e)(1	271(e)(1	PROPN
ihlr-27183	668	3	)	)	PUNCT
ihlr-27183	668	4	171	171	NUM
ihlr-27183	668	5	under	under	ADP
ihlr-27183	668	6	a	a	DET
ihlr-27183	668	7	negotiated	negotiate	VERB
ihlr-27183	668	8	licensing	licensing	NOUN
ihlr-27183	668	9	agreement	agreement	NOUN
ihlr-27183	668	10	,	,	PUNCT
ihlr-27183	668	11	why	why	SCONJ
ihlr-27183	668	12	should	should	AUX
ihlr-27183	668	13	companies	company	NOUN
ihlr-27183	668	14	like	like	ADP
ihlr-27183	668	15	allele	allele	NOUN
ihlr-27183	668	16	invest	invest	VERB
ihlr-27183	668	17	in	in	ADP
ihlr-27183	668	18	producing	produce	VERB
ihlr-27183	668	19	fluorescent	fluorescent	ADJ
ihlr-27183	668	20	proteins	protein	NOUN
ihlr-27183	668	21	capable	capable	ADJ
ihlr-27183	668	22	of	of	ADP
ihlr-27183	668	23	accelerating	accelerate	VERB
ihlr-27183	668	24	the	the	DET
ihlr-27183	668	25	development	development	NOUN
ihlr-27183	668	26	of	of	ADP
ihlr-27183	668	27	future	future	ADJ
ihlr-27183	668	28	vaccines	vaccine	NOUN
ihlr-27183	668	29	?	?	PUNCT
ihlr-27183	669	1	though	though	SCONJ
ihlr-27183	669	2	allele	allele	NOUN
ihlr-27183	669	3	could	could	AUX
ihlr-27183	669	4	use	use	VERB
ihlr-27183	669	5	the	the	DET
ihlr-27183	669	6	technology	technology	NOUN
ihlr-27183	669	7	internally	internally	ADV
ihlr-27183	669	8	,	,	PUNCT
ihlr-27183	669	9	allele	allele	NOUN
ihlr-27183	669	10	generates	generate	VERB
ihlr-27183	669	11	a	a	DET
ihlr-27183	669	12	large	large	ADJ
ihlr-27183	669	13	part	part	NOUN
ihlr-27183	669	14	of	of	ADP
ihlr-27183	669	15	its	its	PRON
ihlr-27183	669	16	revenue	revenue	NOUN
ihlr-27183	669	17	from	from	ADP
ihlr-27183	669	18	producing	produce	VERB
ihlr-27183	669	19	and	and	CCONJ
ihlr-27183	669	20	selling	sell	VERB
ihlr-27183	669	21	cutting	cut	VERB
ihlr-27183	669	22	edge	edge	NOUN
ihlr-27183	669	23	technology	technology	NOUN
ihlr-27183	669	24	for	for	ADP
ihlr-27183	669	25	clinical	clinical	ADJ
ihlr-27183	669	26	and	and	CCONJ
ihlr-27183	669	27	therapeutic	therapeutic	ADJ
ihlr-27183	669	28	use	use	NOUN
ihlr-27183	669	29	and	and	CCONJ
ihlr-27183	669	30	develops	develop	VERB
ihlr-27183	669	31	an	an	DET
ihlr-27183	669	32	array	array	NOUN
ihlr-27183	669	33	of	of	ADP
ihlr-27183	669	34	research	research	NOUN
ihlr-27183	669	35	tools.187	tools.187	NOUN
ihlr-27183	669	36	a	a	DET
ihlr-27183	669	37	second	second	ADJ
ihlr-27183	669	38	consequence	consequence	NOUN
ihlr-27183	669	39	of	of	ADP
ihlr-27183	669	40	limiting	limit	VERB
ihlr-27183	669	41	enforceability	enforceability	NOUN
ihlr-27183	669	42	of	of	ADP
ihlr-27183	669	43	research	research	NOUN
ihlr-27183	669	44	tool	tool	NOUN
ihlr-27183	669	45	patents	patent	NOUN
ihlr-27183	669	46	is	be	AUX
ihlr-27183	669	47	that	that	SCONJ
ihlr-27183	669	48	fewer	few	ADJ
ihlr-27183	669	49	patents	patent	NOUN
ihlr-27183	669	50	will	will	AUX
ihlr-27183	669	51	be	be	AUX
ihlr-27183	669	52	issued	issue	VERB
ihlr-27183	669	53	on	on	ADP
ihlr-27183	669	54	research	research	NOUN
ihlr-27183	669	55	tools	tool	NOUN
ihlr-27183	669	56	commonly	commonly	ADV
ihlr-27183	669	57	used	use	VERB
ihlr-27183	669	58	in	in	ADP
ihlr-27183	669	59	generating	generate	VERB
ihlr-27183	669	60	data	datum	NOUN
ihlr-27183	669	61	for	for	ADP
ihlr-27183	669	62	fda	fda	PROPN
ihlr-27183	669	63	approval	approval	NOUN
ihlr-27183	669	64	.	.	PUNCT
ihlr-27183	670	1	this	this	PRON
ihlr-27183	670	2	will	will	AUX
ihlr-27183	670	3	discourage	discourage	VERB
ihlr-27183	670	4	public	public	ADJ
ihlr-27183	670	5	disclosure	disclosure	NOUN
ihlr-27183	670	6	of	of	ADP
ihlr-27183	670	7	available	available	ADJ
ihlr-27183	670	8	technology	technology	NOUN
ihlr-27183	670	9	for	for	ADP
ihlr-27183	670	10	research	research	NOUN
ihlr-27183	670	11	tools	tool	NOUN
ihlr-27183	670	12	and	and	CCONJ
ihlr-27183	670	13	preclude	preclude	VERB
ihlr-27183	670	14	possible	possible	ADJ
ihlr-27183	670	15	advancements	advancement	NOUN
ihlr-27183	670	16	thereupon	thereupon	ADV
ihlr-27183	670	17	.	.	PUNCT
ihlr-27183	671	1	rather	rather	ADV
ihlr-27183	671	2	,	,	PUNCT
ihlr-27183	671	3	developers	developer	NOUN
ihlr-27183	671	4	of	of	ADP
ihlr-27183	671	5	research	research	NOUN
ihlr-27183	671	6	tools	tool	NOUN
ihlr-27183	671	7	may	may	AUX
ihlr-27183	671	8	elect	elect	VERB
ihlr-27183	671	9	for	for	ADP
ihlr-27183	671	10	keeping	keep	VERB
ihlr-27183	671	11	trade	trade	NOUN
ihlr-27183	671	12	secrets	secret	NOUN
ihlr-27183	671	13	.	.	PUNCT
ihlr-27183	672	1	protecting	protect	VERB
ihlr-27183	672	2	the	the	DET
ihlr-27183	672	3	trade	trade	NOUN
ihlr-27183	672	4	secrets	secret	NOUN
ihlr-27183	672	5	may	may	AUX
ihlr-27183	672	6	needlessly	needlessly	ADV
ihlr-27183	672	7	complicate	complicate	VERB
ihlr-27183	672	8	experiments	experiment	NOUN
ihlr-27183	672	9	required	require	VERB
ihlr-27183	672	10	to	to	PART
ihlr-27183	672	11	generate	generate	VERB
ihlr-27183	672	12	data	datum	NOUN
ihlr-27183	672	13	for	for	ADP
ihlr-27183	672	14	the	the	DET
ihlr-27183	672	15	fda	fda	PROPN
ihlr-27183	672	16	or	or	CCONJ
ihlr-27183	672	17	limit	limit	VERB
ihlr-27183	672	18	where	where	SCONJ
ihlr-27183	672	19	the	the	DET
ihlr-27183	672	20	experiments	experiment	NOUN
ihlr-27183	672	21	may	may	AUX
ihlr-27183	672	22	be	be	AUX
ihlr-27183	672	23	conducted	conduct	VERB
ihlr-27183	672	24	.	.	PUNCT
ihlr-27183	673	1	these	these	DET
ihlr-27183	673	2	outcomes	outcome	NOUN
ihlr-27183	673	3	would	would	AUX
ihlr-27183	673	4	slow	slow	VERB
ihlr-27183	673	5	the	the	DET
ihlr-27183	673	6	progress	progress	NOUN
ihlr-27183	673	7	of	of	ADP
ihlr-27183	673	8	valuable	valuable	ADJ
ihlr-27183	673	9	technologies	technology	NOUN
ihlr-27183	673	10	.	.	PUNCT
ihlr-27183	674	1	some	some	PRON
ihlr-27183	674	2	may	may	AUX
ihlr-27183	674	3	argue	argue	VERB
ihlr-27183	674	4	an	an	DET
ihlr-27183	674	5	exception	exception	NOUN
ihlr-27183	674	6	should	should	AUX
ihlr-27183	674	7	be	be	AUX
ihlr-27183	674	8	carved	carve	VERB
ihlr-27183	674	9	out	out	ADP
ihlr-27183	674	10	for	for	ADP
ihlr-27183	674	11	the	the	DET
ihlr-27183	674	12	case	case	NOUN
ihlr-27183	674	13	where	where	SCONJ
ihlr-27183	674	14	a	a	DET
ihlr-27183	674	15	patented	patented	ADJ
ihlr-27183	674	16	research	research	NOUN
ihlr-27183	674	17	tool	tool	NOUN
ihlr-27183	674	18	is	be	AUX
ihlr-27183	674	19	the	the	DET
ihlr-27183	674	20	exclusive	exclusive	ADJ
ihlr-27183	674	21	option	option	NOUN
ihlr-27183	674	22	for	for	ADP
ihlr-27183	674	23	obtaining	obtain	VERB
ihlr-27183	674	24	specific	specific	ADJ
ihlr-27183	674	25	data	datum	NOUN
ihlr-27183	674	26	required	require	VERB
ihlr-27183	674	27	for	for	ADP
ihlr-27183	674	28	fda	fda	PROPN
ihlr-27183	674	29	approval	approval	NOUN
ihlr-27183	674	30	.	.	PUNCT
ihlr-27183	675	1	if	if	SCONJ
ihlr-27183	675	2	the	the	DET
ihlr-27183	675	3	holder	holder	NOUN
ihlr-27183	675	4	of	of	ADP
ihlr-27183	675	5	the	the	DET
ihlr-27183	675	6	patent	patent	NOUN
ihlr-27183	675	7	on	on	ADP
ihlr-27183	675	8	the	the	DET
ihlr-27183	675	9	research	research	NOUN
ihlr-27183	675	10	tool	tool	NOUN
ihlr-27183	675	11	and	and	CCONJ
ihlr-27183	675	12	the	the	DET
ihlr-27183	675	13	patent	patent	NOUN
ihlr-27183	675	14	on	on	ADP
ihlr-27183	675	15	the	the	DET
ihlr-27183	675	16	drug	drug	NOUN
ihlr-27183	675	17	are	be	AUX
ihlr-27183	675	18	one	one	NUM
ihlr-27183	675	19	and	and	CCONJ
ihlr-27183	675	20	the	the	DET
ihlr-27183	675	21	same	same	ADJ
ihlr-27183	675	22	,	,	PUNCT
ihlr-27183	675	23	the	the	DET
ihlr-27183	675	24	owner	owner	NOUN
ihlr-27183	675	25	could	could	AUX
ihlr-27183	675	26	conceivably	conceivably	ADV
ihlr-27183	675	27	delay	delay	VERB
ihlr-27183	675	28	fda	fda	PROPN
ihlr-27183	675	29	approval	approval	NOUN
ihlr-27183	675	30	by	by	ADP
ihlr-27183	675	31	withholding	withhold	VERB
ihlr-27183	675	32	the	the	DET
ihlr-27183	675	33	required	require	VERB
ihlr-27183	675	34	patented	patented	ADJ
ihlr-27183	675	35	research	research	NOUN
ihlr-27183	675	36	tool	tool	NOUN
ihlr-27183	675	37	,	,	PUNCT
ihlr-27183	675	38	thus	thus	ADV
ihlr-27183	675	39	extending	extend	VERB
ihlr-27183	675	40	their	their	PRON
ihlr-27183	675	41	monopoly	monopoly	NOUN
ihlr-27183	675	42	.	.	PUNCT
ihlr-27183	676	1	this	this	DET
ihlr-27183	676	2	reasoning	reasoning	NOUN
ihlr-27183	676	3	is	be	AUX
ihlr-27183	676	4	not	not	PART
ihlr-27183	676	5	persuasive	persuasive	ADJ
ihlr-27183	676	6	and	and	CCONJ
ihlr-27183	676	7	fails	fail	VERB
ihlr-27183	676	8	to	to	PART
ihlr-27183	676	9	consider	consider	VERB
ihlr-27183	676	10	existing	exist	VERB
ihlr-27183	676	11	processes	process	NOUN
ihlr-27183	676	12	and	and	CCONJ
ihlr-27183	676	13	procedures	procedure	NOUN
ihlr-27183	676	14	.	.	PUNCT
ihlr-27183	677	1	such	such	DET
ihlr-27183	677	2	an	an	DET
ihlr-27183	677	3	exception	exception	NOUN
ihlr-27183	677	4	is	be	AUX
ihlr-27183	677	5	not	not	PART
ihlr-27183	677	6	required	require	VERB
ihlr-27183	677	7	because	because	SCONJ
ihlr-27183	677	8	the	the	DET
ihlr-27183	677	9	research	research	NOUN
ihlr-27183	677	10	tool	tool	NOUN
ihlr-27183	677	11	may	may	AUX
ihlr-27183	677	12	be	be	AUX
ihlr-27183	677	13	properly	properly	ADV
ihlr-27183	677	14	licensed	license	VERB
ihlr-27183	677	15	by	by	ADP
ihlr-27183	677	16	the	the	DET
ihlr-27183	677	17	generic	generic	NOUN
ihlr-27183	677	18	.	.	PUNCT
ihlr-27183	678	1	if	if	SCONJ
ihlr-27183	678	2	the	the	DET
ihlr-27183	678	3	holder	holder	NOUN
ihlr-27183	678	4	is	be	AUX
ihlr-27183	678	5	unwilling	unwilling	ADJ
ihlr-27183	678	6	,	,	PUNCT
ihlr-27183	678	7	a	a	DET
ihlr-27183	678	8	case	case	NOUN
ihlr-27183	678	9	for	for	ADP
ihlr-27183	678	10	mandatory	mandatory	ADJ
ihlr-27183	678	11	licensing	licensing	NOUN
ihlr-27183	678	12	may	may	AUX
ihlr-27183	678	13	be	be	AUX
ihlr-27183	678	14	considered	consider	VERB
ihlr-27183	678	15	under	under	ADP
ihlr-27183	678	16	those	those	DET
ihlr-27183	678	17	rare	rare	ADJ
ihlr-27183	678	18	circumstances	circumstance	NOUN
ihlr-27183	678	19	.	.	PUNCT
ihlr-27183	679	1	nullifying	nullify	VERB
ihlr-27183	679	2	the	the	DET
ihlr-27183	679	3	patent	patent	NOUN
ihlr-27183	679	4	amounts	amount	NOUN
ihlr-27183	679	5	to	to	ADP
ihlr-27183	679	6	taking	take	VERB
ihlr-27183	679	7	property	property	NOUN
ihlr-27183	679	8	rights	right	NOUN
ihlr-27183	679	9	promised	promise	VERB
ihlr-27183	679	10	by	by	ADP
ihlr-27183	679	11	the	the	DET
ihlr-27183	679	12	constitution188	constitution188	PROPN
ihlr-27183	679	13	and	and	CCONJ
ihlr-27183	679	14	otherwise	otherwise	ADV
ihlr-27183	679	15	does	do	AUX
ihlr-27183	679	16	not	not	PART
ihlr-27183	679	17	advance	advance	VERB
ihlr-27183	679	18	the	the	DET
ihlr-27183	679	19	state	state	NOUN
ihlr-27183	679	20	of	of	ADP
ihlr-27183	679	21	science	science	NOUN
ihlr-27183	679	22	.	.	PUNCT
ihlr-27183	680	1	iv	iv	X
ihlr-27183	680	2	.	.	PUNCT
ihlr-27183	680	3	conclusion	conclusion	VERB
ihlr-27183	680	4	any	any	DET
ihlr-27183	680	5	ambiguity	ambiguity	NOUN
ihlr-27183	680	6	in	in	ADP
ihlr-27183	680	7	a	a	DET
ihlr-27183	680	8	statute	statute	NOUN
ihlr-27183	680	9	is	be	AUX
ihlr-27183	680	10	properly	properly	ADV
ihlr-27183	680	11	presumed	presume	VERB
ihlr-27183	680	12	a	a	DET
ihlr-27183	680	13	legislative	legislative	ADJ
ihlr-27183	680	14	failure	failure	NOUN
ihlr-27183	680	15	.	.	PUNCT
ihlr-27183	681	1	as	as	ADP
ihlr-27183	681	2	such	such	ADJ
ihlr-27183	681	3	,	,	PUNCT
ihlr-27183	681	4	the	the	DET
ihlr-27183	681	5	duty	duty	NOUN
ihlr-27183	681	6	to	to	PART
ihlr-27183	681	7	remove	remove	VERB
ihlr-27183	681	8	alternative	alternative	ADJ
ihlr-27183	681	9	readings	reading	NOUN
ihlr-27183	681	10	and	and	CCONJ
ihlr-27183	681	11	denounce	denounce	NOUN
ihlr-27183	681	12	misconceived	misconceive	VERB
ihlr-27183	681	13	case	case	NOUN
ihlr-27183	681	14	law	law	NOUN
ihlr-27183	681	15	rests	rest	VERB
ihlr-27183	681	16	first	first	ADV
ihlr-27183	681	17	with	with	ADP
ihlr-27183	681	18	the	the	DET
ihlr-27183	681	19	legislature	legislature	NOUN
ihlr-27183	681	20	.	.	PUNCT
ihlr-27183	682	1	adopting	adopt	VERB
ihlr-27183	682	2	symmetric	symmetric	ADJ
ihlr-27183	682	3	language	language	NOUN
ihlr-27183	682	4	and	and	CCONJ
ihlr-27183	682	5	definitions	definition	NOUN
ihlr-27183	682	6	between	between	ADP
ihlr-27183	682	7	§	§	PROPN
ihlr-27183	682	8	156	156	NUM
ihlr-27183	682	9	and	and	CCONJ
ihlr-27183	682	10	§	§	PROPN
ihlr-27183	682	11	271	271	NUM
ihlr-27183	682	12	of	of	ADP
ihlr-27183	682	13	the	the	DET
ihlr-27183	682	14	act	act	NOUN
ihlr-27183	682	15	would	would	AUX
ihlr-27183	682	16	resolve	resolve	VERB
ihlr-27183	682	17	the	the	DET
ihlr-27183	682	18	ambiguity	ambiguity	NOUN
ihlr-27183	682	19	faced	face	VERB
ihlr-27183	682	20	by	by	ADP
ihlr-27183	682	21	federal	federal	ADJ
ihlr-27183	682	22	district	district	NOUN
ihlr-27183	682	23	courts	court	NOUN
ihlr-27183	682	24	and	and	CCONJ
ihlr-27183	682	25	prospective	prospective	ADJ
ihlr-27183	682	26	litigants	litigant	NOUN
ihlr-27183	682	27	.	.	PUNCT
ihlr-27183	683	1	while	while	SCONJ
ihlr-27183	683	2	an	an	DET
ihlr-27183	683	3	amendment	amendment	NOUN
ihlr-27183	683	4	from	from	ADP
ihlr-27183	683	5	the	the	DET
ihlr-27183	683	6	legislature	legislature	NOUN
ihlr-27183	683	7	is	be	AUX
ihlr-27183	683	8	the	the	DET
ihlr-27183	683	9	preferable	preferable	ADJ
ihlr-27183	683	10	solution	solution	NOUN
ihlr-27183	683	11	,	,	PUNCT
ihlr-27183	683	12	the	the	DET
ihlr-27183	683	13	supreme	supreme	PROPN
ihlr-27183	683	14	court	court	PROPN
ihlr-27183	683	15	must	must	AUX
ihlr-27183	683	16	not	not	PART
ihlr-27183	683	17	be	be	AUX
ihlr-27183	683	18	idle	idle	ADJ
ihlr-27183	683	19	while	while	SCONJ
ihlr-27183	683	20	opposing	oppose	VERB
ihlr-27183	683	21	interpretations	interpretation	NOUN
ihlr-27183	683	22	leave	leave	VERB
ihlr-27183	683	23	an	an	DET
ihlr-27183	683	24	issue	issue	NOUN
ihlr-27183	683	25	essentially	essentially	ADV
ihlr-27183	683	26	without	without	ADP
ihlr-27183	683	27	law	law	NOUN
ihlr-27183	683	28	.	.	PUNCT
ihlr-27183	684	1	if	if	SCONJ
ihlr-27183	684	2	the	the	DET
ihlr-27183	684	3	remaining	remain	VERB
ihlr-27183	684	4	allele	allele	NOUN
ihlr-27183	684	5	case	case	NOUN
ihlr-27183	684	6	is	be	AUX
ihlr-27183	684	7	eventually	eventually	ADV
ihlr-27183	684	8	appealed	appeal	VERB
ihlr-27183	684	9	to	to	ADP
ihlr-27183	684	10	the	the	DET
ihlr-27183	684	11	supreme	supreme	PROPN
ihlr-27183	684	12	court	court	PROPN
ihlr-27183	684	13	,	,	PUNCT
ihlr-27183	684	14	the	the	DET
ihlr-27183	684	15	court	court	NOUN
ihlr-27183	684	16	should	should	AUX
ihlr-27183	684	17	enunciate	enunciate	VERB
ihlr-27183	684	18	an	an	DET
ihlr-27183	684	19	interpretation	interpretation	NOUN
ihlr-27183	684	20	of	of	ADP
ihlr-27183	684	21	merck	merck	PROPN
ihlr-27183	684	22	and	and	CCONJ
ihlr-27183	684	23	§	§	PROPN
ihlr-27183	684	24	271	271	NUM
ihlr-27183	684	25	which	which	PRON
ihlr-27183	684	26	explicitly	explicitly	ADV
ihlr-27183	684	27	excludes	exclude	VERB
ihlr-27183	684	28	patented	patented	ADJ
ihlr-27183	684	29	inventions	invention	NOUN
ihlr-27183	684	30	not	not	PART
ihlr-27183	684	31	themselves	themselves	PRON
ihlr-27183	684	32	subject	subject	ADJ
ihlr-27183	684	33	to	to	ADP
ihlr-27183	684	34	fda	fda	PROPN
ihlr-27183	684	35	approval	approval	NOUN
ihlr-27183	684	36	.	.	PUNCT
ihlr-27183	685	1	the	the	DET
ihlr-27183	685	2	supreme	supreme	PROPN
ihlr-27183	685	3	court	court	PROPN
ihlr-27183	685	4	should	should	AUX
ihlr-27183	685	5	clarify	clarify	VERB
ihlr-27183	685	6	that	that	SCONJ
ihlr-27183	685	7	research	research	NOUN
ihlr-27183	685	8	tools	tool	NOUN
ihlr-27183	685	9	are	be	AUX
ihlr-27183	685	10	not	not	PART
ihlr-27183	685	11	within	within	ADP
ihlr-27183	685	12	the	the	DET
ihlr-27183	685	13	purview	purview	NOUN
ihlr-27183	685	14	of	of	ADP
ihlr-27183	685	15	§	§	PROPN
ihlr-27183	685	16	271(e)(1	271(e)(1	PROPN
ihlr-27183	685	17	)	)	PUNCT
ihlr-27183	685	18	and	and	CCONJ
ihlr-27183	685	19	clarify	clarify	VERB
ihlr-27183	685	20	that	that	SCONJ
ihlr-27183	685	21	the	the	DET
ihlr-27183	685	22	“	"	PUNCT
ihlr-27183	685	23	product	product	NOUN
ihlr-27183	685	24	”	"	PUNCT
ihlr-27183	685	25	of	of	ADP
ihlr-27183	685	26	§	§	PROPN
ihlr-27183	685	27	156	156	NUM
ihlr-27183	685	28	has	have	VERB
ihlr-27183	685	29	the	the	DET
ihlr-27183	685	30	same	same	ADJ
ihlr-27183	685	31	scope	scope	NOUN
ihlr-27183	685	32	as	as	ADP
ihlr-27183	685	33	the	the	DET
ihlr-27183	685	34	“	"	PUNCT
ihlr-27183	685	35	patented	patented	ADJ
ihlr-27183	685	36	invention	invention	NOUN
ihlr-27183	685	37	”	"	PUNCT
ihlr-27183	685	38	of	of	ADP
ihlr-27183	685	39	§	§	PROPN
ihlr-27183	685	40	271	271	NUM
ihlr-27183	685	41	.	.	PUNCT
ihlr-27183	686	1	while	while	SCONJ
ihlr-27183	686	2	the	the	DET
ihlr-27183	686	3	judiciary	judiciary	NOUN
ihlr-27183	686	4	is	be	AUX
ihlr-27183	686	5	not	not	PART
ihlr-27183	686	6	licensed	license	VERB
ihlr-27183	686	7	to	to	PART
ihlr-27183	686	8	write	write	VERB
ihlr-27183	686	9	laws	law	NOUN
ihlr-27183	686	10	,	,	PUNCT
ihlr-27183	686	11	and	and	CCONJ
ihlr-27183	686	12	the	the	DET
ihlr-27183	686	13	nation	nation	NOUN
ihlr-27183	686	14	admires	admire	VERB
ihlr-27183	686	15	judicial	judicial	ADJ
ihlr-27183	686	16	humility	humility	NOUN
ihlr-27183	686	17	,	,	PUNCT
ihlr-27183	686	18	the	the	DET
ihlr-27183	686	19	duty	duty	NOUN
ihlr-27183	686	20	to	to	PART
ihlr-27183	686	21	interpret	interpret	VERB
ihlr-27183	686	22	is	be	AUX
ihlr-27183	686	23	of	of	ADP
ihlr-27183	686	24	particular	particular	ADJ
ihlr-27183	686	25	187	187	NUM
ihlr-27183	686	26	.	.	PUNCT
ihlr-27183	687	1	second	second	ADJ
ihlr-27183	687	2	amended	amend	VERB
ihlr-27183	687	3	complaint	complaint	NOUN
ihlr-27183	687	4	at	at	ADP
ihlr-27183	687	5	4	4	NUM
ihlr-27183	687	6	,	,	PUNCT
ihlr-27183	687	7	allele	allele	PROPN
ihlr-27183	687	8	biotechnology	biotechnology	PROPN
ihlr-27183	687	9	&	&	CCONJ
ihlr-27183	687	10	pharm	pharm	PROPN
ihlr-27183	687	11	.	.	PROPN
ihlr-27183	687	12	,	,	PUNCT
ihlr-27183	687	13	inc	inc	PROPN
ihlr-27183	687	14	.	.	PROPN
ihlr-27183	688	1	v.	v.	ADP
ihlr-27183	688	2	regeneron	regeneron	PROPN
ihlr-27183	688	3	pharm	pharm	PROPN
ihlr-27183	688	4	’s	’s	PART
ihlr-27183	688	5	,	,	PUNCT
ihlr-27183	688	6	inc	inc	PROPN
ihlr-27183	688	7	.	.	PROPN
ihlr-27183	688	8	,	,	PUNCT
ihlr-27183	688	9	no	no	INTJ
ihlr-27183	688	10	.	.	NOUN
ihlr-27183	688	11	20	20	NUM
ihlr-27183	688	12	-	-	PUNCT
ihlr-27183	688	13	cv-08255	cv-08255	NOUN
ihlr-27183	688	14	,	,	PUNCT
ihlr-27183	688	15	2021	2021	NUM
ihlr-27183	688	16	wl	wl	NOUN
ihlr-27183	688	17	2880694	2880694	NUM
ihlr-27183	688	18	(	(	PUNCT
ihlr-27183	688	19	s.d.n.y	s.d.n.y	PROPN
ihlr-27183	688	20	apr	apr	PROPN
ihlr-27183	688	21	.	.	PROPN
ihlr-27183	688	22	8	8	NUM
ihlr-27183	688	23	,	,	PUNCT
ihlr-27183	688	24	2021	2021	NUM
ihlr-27183	688	25	)	)	PUNCT
ihlr-27183	688	26	.	.	PUNCT
ihlr-27183	689	1	188	188	NUM
ihlr-27183	689	2	.	.	PUNCT
ihlr-27183	690	1	u.s	u.s	PROPN
ihlr-27183	690	2	.	.	PROPN
ihlr-27183	690	3	const	const	PROPN
ihlr-27183	690	4	.	.	PUNCT
ihlr-27183	690	5	art	art	NOUN
ihlr-27183	690	6	.	.	PUNCT
ihlr-27183	691	1	i	i	PRON
ihlr-27183	691	2	,	,	PUNCT
ihlr-27183	691	3	§	§	PROPN
ihlr-27183	691	4	8	8	NUM
ihlr-27183	691	5	cl	cl	NOUN
ihlr-27183	691	6	.	.	NOUN
ihlr-27183	691	7	8	8	NUM
ihlr-27183	691	8	.	.	X
ihlr-27183	691	9	172	172	NUM
ihlr-27183	691	10	indiana	indiana	PROPN
ihlr-27183	691	11	health	health	PROPN
ihlr-27183	691	12	law	law	PROPN
ihlr-27183	691	13	review	review	NOUN
ihlr-27183	691	14	[	[	X
ihlr-27183	691	15	vol	vol	NOUN
ihlr-27183	691	16	.	.	PUNCT
ihlr-27183	691	17	20:143	20:143	NUM
ihlr-27183	691	18	importance	importance	NOUN
ihlr-27183	691	19	when	when	SCONJ
ihlr-27183	691	20	ambiguity	ambiguity	NOUN
ihlr-27183	691	21	has	have	AUX
ihlr-27183	691	22	resulted	result	VERB
ihlr-27183	691	23	in	in	ADP
ihlr-27183	691	24	inconsistent	inconsistent	ADJ
ihlr-27183	691	25	application	application	NOUN
ihlr-27183	691	26	of	of	ADP
ihlr-27183	691	27	the	the	DET
ihlr-27183	691	28	patent	patent	NOUN
ihlr-27183	691	29	laws	law	NOUN
ihlr-27183	691	30	.	.	PUNCT
ihlr-27183	692	1	poorly	poorly	ADV
ihlr-27183	692	2	worded	word	VERB
ihlr-27183	692	3	statutes	statute	NOUN
ihlr-27183	692	4	need	need	AUX
ihlr-27183	692	5	not	not	PART
ihlr-27183	692	6	beget	beget	VERB
ihlr-27183	692	7	murky	murky	ADJ
ihlr-27183	692	8	interpretations	interpretation	NOUN
ihlr-27183	692	9	.	.	PUNCT
ihlr-27183	693	1	whether	whether	SCONJ
ihlr-27183	693	2	a	a	DET
ihlr-27183	693	3	particular	particular	ADJ
ihlr-27183	693	4	use	use	NOUN
ihlr-27183	693	5	of	of	ADP
ihlr-27183	693	6	a	a	DET
ihlr-27183	693	7	patented	patented	ADJ
ihlr-27183	693	8	invention	invention	NOUN
ihlr-27183	693	9	in	in	ADP
ihlr-27183	693	10	the	the	DET
ihlr-27183	693	11	united	united	PROPN
ihlr-27183	693	12	states	states	PROPN
ihlr-27183	693	13	is	be	AUX
ihlr-27183	693	14	patent	patent	NOUN
ihlr-27183	693	15	infringement	infringement	NOUN
ihlr-27183	693	16	should	should	AUX
ihlr-27183	693	17	not	not	PART
ihlr-27183	693	18	depend	depend	VERB
ihlr-27183	693	19	on	on	ADP
ihlr-27183	693	20	which	which	PRON
ihlr-27183	693	21	federal	federal	ADJ
ihlr-27183	693	22	district	district	NOUN
ihlr-27183	693	23	one	one	NUM
ihlr-27183	693	24	lives	live	VERB
ihlr-27183	693	25	within	within	ADV
ihlr-27183	693	26	.	.	PUNCT